
<html lang="en"     class="pb-page"  data-request-id="b4996e88-2c61-4d6d-a8d4-3044cbbde677"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-18;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b01882;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective" /></meta><meta name="dc.Creator" content="Tara Man  Kadayat" /></meta><meta name="dc.Creator" content="Aarajana  Shrestha" /></meta><meta name="dc.Creator" content="Yong Hyun  Jeon" /></meta><meta name="dc.Creator" content="Hongchan  An" /></meta><meta name="dc.Creator" content="Jina  Kim" /></meta><meta name="dc.Creator" content="Sung Jin  Cho" /></meta><meta name="dc.Creator" content="Jungwook  Chin" /></meta><meta name="dc.Description" content="One of the three subtypes of the peroxisome proliferator-activated receptor (PPAR) functioning as a transcription factor is the PPARβ or PPARδ. PPARδ is crucial to pathophysiological processes, inc..." /></meta><meta name="Description" content="One of the three subtypes of the peroxisome proliferator-activated receptor (PPAR) functioning as a transcription factor is the PPARβ or PPARδ. PPARδ is crucial to pathophysiological processes, inc..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 15, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01882" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01882" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01882" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01882" /></link>
        
    
    

<title>Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01882" /></meta><meta property="og:title" content="Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0014.jpeg" /></meta><meta property="og:description" content="One of the three subtypes of the peroxisome proliferator-activated receptor (PPAR) functioning as a transcription factor is the PPARβ or PPARδ. PPARδ is crucial to pathophysiological processes, including metabolic disorders, liver diseases, and cardiovascular diseases. In the past, the clinical development of PPARδ-selective agonist drugs has been stalled due to potential safety-related issues. Despite the elusiveness of such a drug, efforts continue in developing drugs that target PPARδ due to advances in the knowledge of the PPARδ receptor’s structure and functions. While several preclinical and clinical studies are reported on PPARδ agonists, there is limited data with no clinical evidence available for PPARδ-selective antagonists. In this review, we mainly focus on the challenges of PPARδ selectivity and the medicinal chemistry of most active agonists discovered by different pharmaceutical companies and institutes. With this in mind, we also provide an update on the development status of PPARδ agonists that are undergoing clinical trials and their therapeutic promise for the treatment of various diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01882"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01882">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01882&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01882&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01882&amp;href=/doi/10.1021/acs.jmedchem.9b01882" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 10109-10134</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01596" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b02038" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Tara Man Kadayat</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tara Man Kadayat</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tara+Man++Kadayat">Tara Man Kadayat</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aarajana Shrestha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aarajana Shrestha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea</div><div class="loa-info-affiliations-info">College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aarajana++Shrestha">Aarajana Shrestha</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yong Hyun Jeon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yong Hyun Jeon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea</div><div class="loa-info-affiliations-info">Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yong+Hyun++Jeon">Yong Hyun Jeon</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3161-7698" title="Orcid link">http://orcid.org/0000-0003-3161-7698</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hongchan An</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongchan An</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongchan++An">Hongchan An</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6689-9571" title="Orcid link">http://orcid.org/0000-0001-6689-9571</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jina Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jina Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jina++Kim">Jina Kim</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sung Jin Cho</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sung Jin Cho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea</div><div class="loa-info-affiliations-info">Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, Republic of Korea</div></div><span class="conrtib-corresp"><strong>*</strong>For S.J.C.: phone, +82-53-790-5226; fax, +82-53-790-5219; email, <a href="/cdn-cgi/l/email-protection#e1928b82898ea185868c8887cf9384cf8a93"><span class="__cf_email__" data-cfemail="a0d3cac3c8cfe0c4c7cdc9c68ed2c58ecbd2">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sung+Jin++Cho">Sung Jin Cho</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4786-8830" title="Orcid link">http://orcid.org/0000-0002-4786-8830</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jungwook Chin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jungwook Chin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea</div></div><span class="conrtib-corresp"><strong>*</strong>For J.C.: phone, +82-53-790-5257; fax, +82-53-790-5219; email, <a href="/cdn-cgi/l/email-protection#a6ccd1c5cecfc8e6c2c1cbcfc088d4c388cdd4"><span class="__cf_email__" data-cfemail="402a372328292e0024272d29266e32256e2b32">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jungwook++Chin">Jungwook Chin</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6060-0508" title="Orcid link">http://orcid.org/0000-0001-6060-0508</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01882&amp;href=/doi/10.1021%2Facs.jmedchem.9b01882" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 10109–10134</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 15, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 November 2019</li><li><span class="item_label"><b>Published</b> online</span>15 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01882" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01882</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10109%26pageCount%3D26%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTara%2BMan%2BKadayat%252C%2BAarajana%2BShrestha%252C%2BYong%2BHyun%2BJeon%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D18%26contentID%3Dacs.jmedchem.9b01882%26title%3DTargeting%2BPeroxisome%2BProliferator-Activated%2BReceptor%2BDelta%2B%2528PPAR%25CE%25B4%2529%253A%2BA%2BMedicinal%2BChemistry%2BPerspective%26numPages%3D26%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10134%26publicationDate%3DSeptember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01882"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1762</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01882" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tara&quot;,&quot;last_name&quot;:&quot;Man Kadayat&quot;},{&quot;first_name&quot;:&quot;Aarajana&quot;,&quot;last_name&quot;:&quot;Shrestha&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Hyun Jeon&quot;},{&quot;first_name&quot;:&quot;Hongchan&quot;,&quot;last_name&quot;:&quot;An&quot;},{&quot;first_name&quot;:&quot;Jina&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Sung&quot;,&quot;last_name&quot;:&quot;Jin Cho&quot;},{&quot;first_name&quot;:&quot;Jungwook&quot;,&quot;last_name&quot;:&quot;Chin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;10109-10134&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01882&quot;},&quot;abstract&quot;:&quot;One of the three subtypes of the peroxisome proliferator-activated receptor (PPAR) functioning as a transcription factor is the PPARβ or PPARδ. PPARδ is crucial to pathophysiological processes, including metabolic disorders, liver diseases, and cardiovascular diseases. In the past, the clinical development of PPARδ-selective agonist drugs has been stalled due to potential safety-related issues. Despite the elusiveness of such a drug, efforts continue in developing drugs that target PPARδ due to advances in the knowledge of the PPARδ receptor’s structure and functions. While several preclinical and clinical studies are reported on PPARδ agonists, there is limited data with no clinical evidence available for PPARδ-selective antagonists. In this review, we mainly focus on the challenges of PPARδ selectivity and the medicinal chemistry of most active agonists discovered by different pharmaceutical companies and institutes. With this in mind, we also provide an update on the development status of PPARδ agonists th&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01882&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01882" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01882&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01882" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01882&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01882" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01882&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01882&amp;href=/doi/10.1021/acs.jmedchem.9b01882" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01882" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01882" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01882%26sid%3Dliteratum%253Aachs%26pmid%3D32539376%26genre%3Darticle%26aulast%3DKadayat%26date%3D2020%26atitle%3DTargeting%2BPeroxisome%2BProliferator-Activated%2BReceptor%2BDelta%2B%2528PPAR%25CE%25B4%2529%253A%2BA%2BMedicinal%2BChemistry%2BPerspective%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D18%26spage%3D10109%26epage%3D10134%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/jmcmar.2020.63.issue-18/20200924/jmcmar.2020.63.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">One of the three subtypes of the peroxisome proliferator-activated receptor (PPAR) functioning as a transcription factor is the PPARβ or PPARδ. PPARδ is crucial to pathophysiological processes, including metabolic disorders, liver diseases, and cardiovascular diseases. In the past, the clinical development of PPARδ-selective agonist drugs has been stalled due to potential safety-related issues. Despite the elusiveness of such a drug, efforts continue in developing drugs that target PPARδ due to advances in the knowledge of the PPARδ receptor’s structure and functions. While several preclinical and clinical studies are reported on PPARδ agonists, there is limited data with no clinical evidence available for PPARδ-selective antagonists. In this review, we mainly focus on the challenges of PPARδ selectivity and the medicinal chemistry of most active agonists discovered by different pharmaceutical companies and institutes. With this in mind, we also provide an update on the development status of PPARδ agonists that are undergoing clinical trials and their therapeutic promise for the treatment of various diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15431" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15431" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Peroxisome proliferator-activated receptors (PPARs) are members of the ligand-activated transcription factors of nuclear receptors. Depending on distinct ligand specificity, their physiological roles, and tissue distribution, PPARs are categorized into three isotypes: PPARα, PPARγ, and PPARδ.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In particular, PPARδ (delta) (also referred as PPARβ) is one of the three isotypes of the PPAR transcription factor superfamily that are essential in several biological functions. Unlike PPARα and PPARγ, this isoform is ubiquitously expressed. Therefore, its function and application were the least understood among the PPARs in drug discovery chemistry.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> However, after the discovery of high-affinity synthetic PPARδ agonists such as GW0742 and GW501516, several researchers have investigated the role of PPARδ, not only in obesity and diabetes but also in other conditions such as cancer,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> neurological disorder,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> inflammation,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> dyslipidemia,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> cardiac disease,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and liver disease.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Some studies have suggested that PPARδ is activated by endogenous polyunsaturated fatty acids, arachidonic acid, 15-hydroxyeicosatetraenoic acid (15-HETE), and prostacyclin.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> However, the physiological significance of these endogenous PPARδ natural ligands is unknown. A preclinical study by Kurtz et al.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> revealed that carbaprostacyclin, a semisynthetic analogue of prostacyclin,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> acts as a PPARδ agonist that prevents the accumulation of excess placental lipids in diabetic rats. Concurrently, Kim et al.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> identified phosphoiodyn A (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) from a Korean sponge (<i>Placospongia</i> sp.) as a potent and selective human PPARδ agonist (EC<sub>50</sub> of 23.7 nM) with over 200-fold selectivity compared to PPARα and PPARγ. More recently, Zhao et al.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> identified picrasidine N, a natural dimeric alkaloid obtained from the plant <i>Picrasma quassioides</i>, as a new isotype-selective and gene-selective PPARδ agonist.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of (A) Carbaprostacyclin (prostacyclin-derived potent PPARδ agonist), (B) Phosphoiodyn A (marine natural product PPARδ-selective agonist), (C) Picrasidine N (natural plant-derived PPARδ-selective agonist), (D) GSK3787 (synthetic PPARδ-selective antagonist).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After the first report on synthetic PPARδ agonists in 1997, several research groups have synthesized both PPARδ-selective agonists and antagonists to understand the pharmacology of PPARδ for developing novel therapeutic agents. Some preliminary experimental reports on PPARδ antagonists, such as GSK3787 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), have suggested their beneficial effects on cancer and psoriasis.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19−22)</a> To our knowledge, there are only a limited number of studies focused on the discovery of antagonists. Some researchers have speculated the possibility of the development of selective PPARδ antagonists as new drugs for cancer therapy. Unlike PPARδ agonists, no clinical evidence is available for PPARδ antagonists. In this review, we aim to summarize selective PPARδ agonists introduced to date, with particular focus on recent clinical development efforts against various diseases.</div><div class="NLM_p last">A recent review paper by Takada and Makishima has covered several novel PPARδ-selective agonists that were patented to develop new drugs that can treat metabolic, muscular, vascular, and neuronal diseases.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Yet, there is no FDA-approved drug specifically targeting PPARδ. Clinical trials of selective PPARδ agonists, such as MBX-8025/Seladelpar (CymaBay Therapeutics), REN-001 (Reneo Pharmaceuticals), and ASP0367 and ASP1128 (Mitobridge/Astellas Pharma), are underway to make them available for clinical use (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifiers NCT03551522, NCT04024813, NCT03833128, NCT04226274, NCT04184882, and NCT03941483). In this Perspective, we will provide an update on the medicinal chemistry aspects of the most potent and selective PPARδ agonists. We will also provide updates on the efforts made for preclinical and clinical development as potential therapeutic agents, primarily for the treatment of metabolic, liver, and muscular diseases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Biological Roles of PPARδ</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75245" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75245" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Upon activation, PPARδ heterodimerizes with the retinoid X receptor (RXR) before binding with the peroxisome proliferator response element (PPRE) region in the DNA of target genes to stimulate or repress gene transcription. A recent study has suggested that interactions between a specific amino acid residue of PPARδ ligand-binding domain and its agonist are key factors that determine the transcriptional activation or repression activity of PPARδ.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> A recent study<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> showed that unlike GW0742, a synthetic PPARδ agonist that induces the expression of various PPAR target genes, such as PDK4 (pyruvate dehydrogenase kinase 4), ANGPTL4 (angiopoietin like protein 4), ADRP (adipose differentiation-related protein), and CPT1 (carnitine palmytoyltransferase 1), a natural alkaloid called picrasidine N only transactivated the ANGPTL4 gene. The result suggested picrasidine N as a novel and gene-selective PPARδ agonist that can be used to elucidate the function and mechanism of specific PPARδ-regulated gene expressions. In skeletal muscle, GW501516 acts as a key regulator of PPARδ-induced gene expression and promotes energy consumption preference from carbohydrate to lipid as the main energy substrate.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Narkar et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> in 2008 described GW501516 as an exercise mimetic drug because GW501516 and exercise training synergistically enhanced oxidative myofibers and running endurance in adult mice by inducing expression of genes linked to muscle remodeling, oxidative metabolism, and mitochondrial biogenesis. GW501516 has been sold as “Cardarine” through black market channels and was reportedly misused by athletes and fitness trainers for weight loss and performance enhancement.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Therefore, the World Anti-Doping Agency added GW501516 and related PPARδ agonists to its list of prohibited substances in 2009.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Several studies have demonstrated that PPARδ has a wide variety of biological effects. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> summarizes a schematic summary of PPARδ activation’s effects on various diseases.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. A schematic summary of the effects of PPARδ activation in various diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  PPARδ in Metabolic Disorders</h3><div class="NLM_p">Over the last two decades, several reports have revealed that PPARδ is crucial in regulating lipid metabolism and glucose homeostasis. Its activation is especially helpful in preventing metabolic disorders such as obesity, type 2 diabetes, and dyslipidemia.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32">(29−32)</a><a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> illustrates the several underlying mechanisms of PPARδ agonists in preventing obesity. The activation of PPARδ induces fat burning in skeletal muscles by either enhancing fatty acid oxidation or increasing the oxidative metabolism of different muscle fiber types.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> Sodhi et al.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> demonstrated that PPARδ activation plays a role in suppressing angiotensin II-mediated lipid accumulation and adipocyte growth, suggesting the potential therapeutic benefit of PPARδ agonist in obesity. In contrast, some previous reports suggested that PPARδ activation may play role in adipocyte differentiation and lipid accumulation.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> These critical findings could be explained by the indirect role of PPARδ in regulating PPARγ expression<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and how adipocyte differentiation requires cAMP-elevating agents.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> These findings emphasize the need for highly selective PPARδ agonist in the treatment of obesity.</div><div class="NLM_p">PPARδ activation reduces the amount of very-low-density lipoprotein-triglyceride (VLDL-TG) by increasing hepatic fatty acid oxidation.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Oliver et al.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> demonstrated that PPARδ agonists increase high-density lipoprotein (HDL)-cholesterol levels by increasing the number of HDL’s hepatic apolipoproteins, namely <i>ApoA1</i> and <i>ApoA</i>2. The activation of PPARδ plays a role in reducing low-density lipoprotein (LDL) cholesterol levels by decreasing intestinal cholesterol absorption.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p last">Lee et al.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> even reported that PPARδ activation improves glucose metabolism and insulin sensitivity. In skeletal muscles, PPARδ activation induces fatty acid oxidation and glucose uptake, and by interacting with AMPK (5′ adenosine monophosphate-activated protein kinase), it also prevents insulin resistance caused by endoplasmic reticulum (ER) stress.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−43)</a> In adipocytes and hepatocytes, PPARδ activation is responsible for preventing IL-6-induced insulin resistance by inhibiting the signal transducer and activator of transcription 3 (STAT3) pathway.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Kim et al. recently determined that the GW501516 inhibited TNF-α-induced decrease of adiponectin expression and enhanced insulin sensitivity by increasing insulin receptor expression.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> It enhanced mitochondrial oxidation in pancreatic β-cells that increases glucose-stimulated insulin secretion.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Yang et al.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> even indicated that PPARδ activation could upregulate glucagon-like peptide-1 (GLP-1) expression, inhibiting the palmitate-induced apoptosis of pancreatic β-cells. More recently, Doktorova et al.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> suggested that the activation of intestinal PPARδ prevents diet-induced obesity, dyslipidemia, and insulin resistance. Despite many preclinical and clinical development efforts, there are no PPARδ agonists clinically available as drugs for metabolic disorders as of this writing.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2.  PPARδ in Liver Diseases</h3><div class="NLM_p last">In the liver, PPARδ is expressed in hepatocytes, hepatic stellate cells, and Kupffer cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Besides the regulation of glucose and fatty acid metabolism, studies have suggested that PPARδ also has a vital role in controlling different types of liver diseases. These types include nonalcoholic steatohepatitis (NASH), liver fibrosis, nonalcoholic fatty liver disease (NAFLD), and primary biliary cholangitis/cirrhosis (PBC).<a onclick="showRef(event, 'ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51">(49−51)</a> PPARδ activation was found to improve inflammation and hepatic steatosis by inhibiting inflammatory responses and reducing the levels of IL-1β in a mouse model.<a onclick="showRef(event, 'ref9 ref52'); return false;" href="javascript:void(0);" class="ref ref9 ref52">(9,52)</a> Lee et al. even suggested that PPARδ agonists suppress the inflammatory cytokines TNF-α and MCP-1, proving beneficial in NAFLD.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> A more recent study by Tong et al.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> suggested that PPARδ activation prevents hepatic steatosis by autophagy formation, promoted by AMPK, and suppressed by the mammalian target of rapamycin (mTOR) pathway. Furthermore, PPARδ agonist GW0742 activation reduces CCl<sub>4</sub>-induced hepatotoxicity through the downregulation of proinflammatory genes.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> A study by Iwaisako et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> demonstrated the beneficial effects of a selective PPARδ agonist KD-3010 in animal models of liver injury and fibrosis. Notably, the same study indicated that GW501516 did not have any beneficial effects on the same experimental animal models. Iwaisako et al.’s study<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> also suggested that PPARδ agonists with distinct pharmacophores could have different effects on pathological conditions due to different factors such as the compound’s potency, pharmacokinetic profile, and specificity for PPARα and PPARγ. Despite several promising studies on PPARδ agonists that have antifibrotic, hepatoprotective, and choleretic effects in a mouse model, none has produced a viable drug for liver disease in the market.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> Recent clinical trials of the selective PPARδ agonist MBX-8025 (Seladelpar) suggested positive aspects in developing new drugs for the treatment of PBC and related liver diseases (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifiers NCT03602560, NCT03551522, and NCT04024813).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.3.  PPARδ in Cardiovascular Diseases</h3><div class="NLM_p">PPARδ is one of the key transcription factors maintaining the normal physiology of the heart. Because of its prominent expression level in cardiomyocytes, PPARδ reportedly controls myocardial energy metabolism by regulating fatty acid and glucose utilization as well as lipid metabolism.<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(56−58)</a> As a protecting factor, PPARδ maintains mitochondrial redox homeostasis, regulates expression levels of endogenous antioxidants, and exerts anti-inflammatory effects.<a onclick="showRef(event, 'ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61">(59−61)</a> In various cardiac pathophysiological conditions (e.g., angiotensin II and TAC-induced left ventricular pressure overload, doxorubicin-induced cardiac cytotoxicity, and STZ-induced diabetic heart), PPARδ levels are found to be downregulated.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> The deletion of PPARδ impairs cardiac dysfunction, cardiac hypertrophy, remodeling, cardiomyopathy, and heart failure.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a> Many studies on PPARδ agonists are found to protect from various cardiac disorders such as myocardial ischemia-reperfusion injury (IRI), reduced infarct size, and fibrotic remodeling.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66,67)</a> PPARδ agonists, such as GW0742, can protect cardiac hypertrophy from postmyocardial infarction.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Several reports have also demonstrated that PPARδ signaling is impaired in myocardial ischemia, doxorubicin cardiotoxicity, cardiac hypertrophy, and diabetic cardiomyopathy.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Even though further investigations are required to uncover the underlying mechanisms of PPARδ, its crucial role in heart physiology and pathology has attracted interest in developing novel therapeutics to treat cardiovascular disorders.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p last">Jiang et al. recently reviewed the role of PPARδ activation in managing metabolic hypertension caused by vascular dysfunction and metabolic disturbance.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> PPARδ is reportedly vital in maintaining these vascular functions: increasing the expression of the vascular endothelial growth factor receptor (VEGFR), enhancing the proliferation and angiogenesis of endothelial cells, and promoting the vasodilation of vascular endothelial cells. PPARδ even reduces harmful inflammation and reactive oxygen species (ROS) production in vascular smooth muscle cells.<a onclick="showRef(event, 'ref70 ref71 ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref70 ref71 ref72 ref73">(70−73)</a> Another study by Zhang et al.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> recently demonstrated a novel underlying mechanism of GW501516 for preventing vascular disease by increasing DHFR (dihydrofolate reductase) gene expression and activating the BH<sub>4</sub> (tetrahydrobiopterin) salvage pathway.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.4.  PPARδ in Wound Healing and Regeneration</h3><div class="NLM_p last">Magadum et al.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> recently summarized the role of PPARδ in wound healing and regenerative processes through apoptosis, energy metabolism, inflammation, cell proliferation and differentiation, and angiogenesis. PPARδ activation studies have suggested its vital role in the skin,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> endothelial tissue,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> and corneal epithelial<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> wound healing, along with the regeneration of bone<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> and skeletal muscle.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Liu et al.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> indicated that PPARδ upregulates phosphoinositide-dependent kinase 1 (PDK1)/Akt and transcription factor E2f signaling, which control hepatocyte proliferation in regenerating liver. Furthermore, PPARδ activation inhibits fibrosis and apoptosis and promotes angiogenesis and proliferation of cardiomyocytes, thereby enhancing cardiac muscle healing and regeneration.<a onclick="showRef(event, 'ref67 ref81'); return false;" href="javascript:void(0);" class="ref ref67 ref81">(67,81)</a> From these studies, researchers suggest that the development of PPARδ agonists has excellent therapeutic potential for enhancing regenerative processes.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.5.  PPARδ in Neurodegenerative Diseases</h3><div class="NLM_p last">PPARδ plays a vital role in neuroprotection, myelination, astroglia differentiation, neurogenesis, and oligodendrocyte differentiation.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82,83)</a> PPARδ activation promotes fatty acid metabolism and antioxidant and anti-inflammatory mechanisms in the brain.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> A study by Blass et al.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> has highlighted a patent suggesting that PPARδ is essential for normal neurophysiological processes. The study further states that PPARδ could be a promising target for the development of an antidemyelinating drug for multiple sclerosis. Several studies have demonstrated that PPARδ agonist GW0742 provides neuroprotection in a mouse model of Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis.<a onclick="showRef(event, 'ref85 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref85 ref86 ref87">(85−87)</a> Dickey et al. from the University of California San Diego demonstrated that KD-3010, a PPARδ-specific agonist, may be valuable for treating neurodegenerative diseases like Huntington’s disease, Alzheimer’s disease, and Parkinson’s disease.<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88,89)</a> Particularly, they reported the basis for the neuroprotective effect of PPARδ by activating autophagy and thereby enhancing oxidative metabolism and promoting protein and mitochondrial quality control.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> A recent study<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> also indicated that GW501516 inhibits the nucleotide-binding domain and leucine-rich-repeat-protein 3 (NLRP3) inflammasome-mediated neuroinflammation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mouse model of Parkinson’s disease. Despite these studies, more research efforts are needed to develop drugs targeting PPARδ for neurodegenerative diseases.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.6.  PPARδ in Cancer</h3><div class="NLM_p last">The role of PPARδ in oncology is the most controversial aspect, as several reports regarding its association in tumor suppression and tumor promotion have been discrepant.<a onclick="showRef(event, 'ref4 ref91 ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref4 ref91 ref92 ref93">(4,91−93)</a> Several studies have shown that PPARδ is linked to colon,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> breast,<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> lung,<a onclick="showRef(event, 'ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref95 ref96">(95,96)</a> and skin<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> cancers. PPARδ’s association with cancer was first reported with colorectal cancer, and there were several controversial and conflicting reports about the effect of PPARδ activation on colorectal tumors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> For instance, Gupta et al.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> reported that PPARδ activation plays a role in promoting colon cancer, while another report by Marin et al.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> showed that PPARδ activation inhibits colon carcinogenesis. Likewise, some studies suggested that PPARδ promotes the formation of breast cancer,<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> while a few others demonstrated the suppressive role of PPARδ on breast cancer.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Pedchenko et al. reported that PPARδ activation induces proliferative effects on nonsmall cell lung cancer (NSCLC).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> More specifically, PPARδ showed antiapoptotic and antiproliferative properties through phosphoinositide 3-kinase (PI3K)/Akt1 and cyclooxygenase 2 (COX-2) pathways. Montagner et al. reported that PPARδ expression was positively correlated with skin cancer.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Zhou et al. recently reported an underlying mechanism of selective PPARδ agonist GW501516 on colorectal cancer, tumor growth, and cancer metabolism.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> The study’s results show that GW501516 significantly enhanced proinflammatory gene expressions (COX-2, IL-6, IL-8, and MCP-1) in an inflamed colon. Ding et al. also suggested the role of GW501516 in tumor formation, as demonstrated by the GW501516-induced expressions of glucose transporter 1 (Glut1) and solute carrier family 1 member 5 (SLC1A5) in several cancer cell lines, including HeLa and HCT-116.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> However, because of several controversial reports about its relationship to cancer, further studies are required to better define the role of PPARδ activation in cancer biology.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">2.7.  PPARδ in Other Diseases</h3><div class="NLM_p">Researchers have also investigated PPARδ’s effects on other diseases besides the ones described above. For example, Banno et al. recently highlighted the role of PPARs, including PPARδ, in the pathogenesis of asthma.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> The study reports that PPARδ agonists show anti-inflammatory activities associated with the pathophysiology of asthma. Some studies have demonstrated in a mouse model that selective PPARδ agonist GW0742 is crucial in protecting lung tissue by inhibiting leukocyte infiltration, the proliferation of pulmonary fibroblast, and LPS-induced neutrophil infiltration into lung tissues.<a onclick="showRef(event, 'ref104 ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref104 ref105 ref106">(104−106)</a> Despite these reports on the anti-inflammatory effects of PPARδ agonists, further studies are necessary to establish the role of PPARδ in pulmonary inflammation and identify PPARδ as a therapeutic target for the treatment of asthma. A patent<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> filed by researchers from the University of Toledo described cinnamic acid-containing PPARδ agonists as potential therapeutic agents for preventing bone disorders, including osteoporosis, osteoarthritis, and metabolic bone disorders. However, more studies are needed to expand the role of PPARδ agonists in the treatment of bone disorders.</div><div class="NLM_p last">Downes et al. recently demonstrated the beneficial effects of PPARδ activation in Duchenne muscular dystrophy (DMD) and acute kidney injury (AKI).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> MA-0204 (compound <b>37</b>), a potent and selective PPARδ agonist, increased the transcription of PPARδ target gene PDK4 in the muscles of mice. In DMD patient-derived muscle myoblasts, MA-0204 improved fatty acid oxidation and increased expression of PPARδ target genes PDK4, ANGPTL4, and CPT1a.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> ASP0367 (MA-0211, structure not disclosed) is currently under phase I clinical trial in pediatric male subjects with DMD (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT04184882). According to the Mitobridge Web site, Bracken et al. reported that MA-0204 also improved mitochondria activity and promoted renal function recovery after AKI.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Currently, a peripherally active PPARδ-selective agonist ASP1128 (MA-0217, structure not disclosed) is under phase II clinical study (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT03941483) in subjects at risk for AKI following cardiac surgery.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">3.  Structural Features of PPARδ</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All three PPAR isotypes (PPARα, PPARδ, and PPARγ) share a common structural organization. <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A shows a schematic representation of their structural and functional domains. In this structure, there are four functional domains: the N-terminal domain, the DNA-binding domain (DBD), the flexible hinge domain, and the ligand-binding domain (LBD).<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Generally, the N-terminal region is poorly conserved among the three PPAR isotypes and contains the ligand-independent activation function-1 (AF-1). Following that, the highly conserved DNA-binding domain consists of two zinc finger-like structures, which bind to specific DNA sequences (hormone response elements). Then the flexible hinge region allows the movement of the LBD relative to the DNA-binding domain.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> LBD contains activation function-2 (AF-2), a ligand-dependent activation domain that plays a vital role in converting PPARs to an active form. PPARα, PPARδ, and PPARγ have 60–70% sequence similarities within their LBDs.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> LBD is also comprised of a three-layered helix sandwich of 12 α-helices and four β-strands. Four helices (H4, H5, H8, and H9) are sandwiched between helices H1, H3, H7, and H10 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> There are 34 amino acid residues that line the wall of the ligand-binding cavity. Although approximately 80% of these residues are conserved among the three isotypes, small differences in the size and sequence of amino acid residue provide ligand specificity.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Schematic one-dimensional representation of the functional domain structures of PPARs. (B) Published Apo PPARδ crystal structure of the three-layered helix sandwich. The three layers of the α-helical sandwich are shown in red, purple, and blue. β-Strands are shown in the yellow shapes and the loops in white.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> (C) General schematic structural features of the binding modes of PPARδ agonists (GW501516, a selective PPARδ agonist). (B) Reprinted with permission from ref <a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a>, Copyright 1999 Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The knowledge of PPARδ agonist interactions with subtype-specific residues in the LBD of the PPARδ receptor has guided the discovery of selective PPARδ agonists. There are several reports on crystallographic studies exploring the binding mode of an agonist with the LBD of the PPARδ receptor.<a onclick="showRef(event, 'ref114 ref116 ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref114 ref116 ref117 ref118">(114,116−118)</a> The basic structure of a PPARδ agonist consists of a head, a linker, and a tail, as illustrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C by GW501516, the first PPARδ selective agonist in clinical trials. Its head usually consists of a carboxylate group and a phenyl ring, the linker consists of a flexible carbon chain and/or heteroatoms/heterocycle, and the tail typically consists of an aromatic or heteroaromatic hydrophobic group. Most importantly, the head contributes to hydrogen bonding interaction in front of the AF-2. The linker is involved in hydrophobic interactions with helix 3, and the tail is arranged within a large cavity of the ligand-binding site through hydrophobic interactions.</div><div class="NLM_p">In 1999, Xu et al.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> reported the cocrystal structure of a high-affinity PPARδ synthetic ligand GW2433 bound to hPPARδ-LBDs. The cocrystal structure indicated that the ligand-binding cavity consists of three arms: arm I, arm II, and arm III. Arm I is mainly framed by polar residues helices H3, H5, H10, H11, and H12. Arm II, which is framed by hydrophobic residues, is located at the “entrance” of the ligand-binding cavity near the β-strands. Arm III is also framed by hydrophobic residues and located at helix H5. The carboxylate moiety of GW2433 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) anchors adjacent to the AF-2 helix at the base of the Y-shaped cavity, forming hydrogen bonds with amino acids H287, H413, and Y437 (arm I; <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Generally, the potency of PPAR agonists depends on the bonding of its carboxylate moiety with the phenolic hydroxyl group of Y437. The hydrophobic moiety of GW2433 binds in tail-down (arm II) or tail-up (arm III) configurations.<a onclick="showRef(event, 'ref114 ref116'); return false;" href="javascript:void(0);" class="ref ref114 ref116">(114,116)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) The structure of GW2433. (B) The reported structure of the ligand-binding site of GW2433-bound hPPARδ (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GWX">1GWX</a>).<a onclick="showRef(event, 'ref114 ref116'); return false;" href="javascript:void(0);" class="ref ref114 ref116">(114,116)</a> The blue dashed lines indicate a Y-shaped ligand-binding cavity, while the extended arms I, II, and III are labeled. Hydrogen bonds between the ligands and residues Y437, H287, and H413 are indicated as black dashed lines. The H2′–H3 loop and activation factor-2 (AF-2) are highlighted in orange and purple, respectively.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> (C) A stereo view of the crystallographic structure of the complex hPPARδ-LBD:GW0742, showing hPPARδ-LBD residues belonging to arm I, arm II, and arm III that stabilize the GW0742. (D) Comparison of the amino acid residues in arms I, II, and III of human PPARα, δ, and γ. Residues of PPARδ ligand-binding sites involved in contact with GW0742 are highlighted in bold blue. Residues Val312 and Ile328 underscored in arm II of PPARδ denote residues responsible for the GW0742’s PPARδ-selective activation.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> (E) Design of a potent and selective PPARδ agonist <b>35</b> and a published complex structure of hPPARδ-LBD with compound <b>35</b>. Close-up view of the ligand-binding site for compound <b>35</b> and hPPARδ-LBD. (B,E) Reprinted with permission from ref <a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a>. Copyright 2017 National Academy of Sciences. (C) Reprinted with permission from ref <a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a>. Copyright 2012 Public Library of Science .</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2012, Polikarpov and co-workers demonstrated the X-ray crystal structure of the human PPARδ receptor–GW0742 complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TKM">3TKM</a>) to demonstrate possible methods for the rational design of PPARδ-selective agonists.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> The crystal structure of GW0742 (<b>7</b>), with hPPARδ-LBD, showed 29 binding interactions (3 polar and 26 apolar interactions) of GW0742 with amino acid residues in ligand-binding sites of PPARδ (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). The polar interactions between the GW0742’s carboxylate group and residues His287, His413, and Tyr437 in arm I are essential for receptor activation. Meanwhile, the nonpolar interactions between the hydrophobic tail of GW0742 and residues Val312 (V) and Ile328 (I) of arm II are crucial for the compound’s PPARδ selectivity</div><div class="NLM_p">The following are the residues in contact with GW0742 from each arm. Arm I: of the 12 amino acids, eight residues Phe246 (F), Cys249 (C), His287 (H), Phe291 (F), Ile327 (I), His413 (H), Leu433 (L), and Tyr437 (Y). Arm II: of the 12 amino acids, five residues Val245 (V), Val305 (V), Val312 (V), Leu317 (L), and Ile328 (I). Arm III: of the nine residues, two residues, Thr252 (T) and Leu294 (L) (bold residues, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C,D). There is a slight difference in residue sequence among the three isotypes. Notably, only the PPARα consists of Tyr314 (Y) compared to histidine residues (δHis287/γHis351), and only the PPARγ consists of Tyr355 (Y) residue compared to phenylalanine residues (αPhe318/δPhe391) at equivalent regions in other isoforms. This information about residue sequence patterns allows researchers to design highly potent and selective receptor ligands. A mutational and docking study of amino acids in arm II of hPPARδ compared with equivalent regions of hPPARα and hPPARγ revealed two residues: Val312 (V) and Ile328 (I) of arm II. They are crucial for the PPARδ-selective activation by GW0742 (underscored residues, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D).<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Notably, two amino acid residues in arm II of PPARδ, δVal312 (αIle339/γMet376 and δ Ile328 (αMet355/γMet392), have bulkier residues in equivalent regions of PPARα and PPARγ.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> From this study, Polikarpov and co-workers also indicated that due to bulky amino acid substitution in PPARα and PPARγ, agonists with rigid and large hydrophobic tails and short linkers do not activate these isotypes (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). The hydrophobic tail of GW0742 occupies arm II, whereas hydrophobic tails of PPARα and PPARγ-selective agonists simultaneously occupy arms II and III. It was also interesting to note that some amino acid residues in PPARδ have similar-sized residues at equivalent regions of PPARα and PPARγ, δHis287 (αTyr314/γHis351), δPhe291 (αPhe318/γTyr355), δVal245 (αIle272/γIle309), and δVal305 (αVal332/γIle369). Overall, this study deepened our understanding of the molecular basis for designing PPAR-selective agonists.</div><div class="NLM_p last">Recently, Wu et al. reported a unique synthetic agonist (compound <b>35</b>) that bound with PPARδ 510-fold more tightly than PPARα and PPARγ.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> The finding revealed the structural basis for PPARδ high selectivity and how it eventually reduced adverse effects by avoiding the activation of PPARγ-linked genes. Focusing on binding interactions with residues that are only present in PPARδ, Wu et al. designed agonists that best occupy both arms II and III of PPARδ, while improving PPARδ selectivity over the PPARα and γ-receptors. The complex 3D structure of hPPARδ-LBD with compound <b>35</b> also indicated that the hexanoic acid moiety in the head of compound <b>35</b> anchors adjacent to the AF-2 helix and forms hydrogen bonds with polar residues H287, H413, and Y437 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E). A proximal lipophilic group in the tail is positioned mostly in arm II, and a dialkylbenzamide core at the linker lies close to arm III. Wu et al. revealed the role of PPARδ-specific residues and the shape of synthetic agonists for determining PPARδ selectivity. The presence of tryptophan residue (W228) near the H2′–H3 loop, specific to the PPARδ receptor, was presumed to be the structural basis of a potential mechanism for high selectivity.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> However, the tumorigenesis activity of a PPARδ agonist, such as GW501516, was still unclear as to whether this was due to PPARδ activation or due to the off-target effects of the agonist.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">4.  Medicinal Chemistry of Synthetic PPARδ Agonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">4.1.  Synthetic PPARδ Agonists: Past Approaches and Limitations</h3><div class="NLM_p">Although the human PPARδ receptor was cloned in 1992, there were no synthetic PPARδ agonists reported until Merck and Company first reported a synthetic PPARδ agonist L-631033 (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) in 1997.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Since then, several research groups from pharmaceutical companies and academic institutions have reported selective PPARδ agonists to demonstrate its role in diabetes, obesity, cancer, and other physiological conditions.<a onclick="showRef(event, 'ref4 ref29 ref30 ref31 ref91 ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref4 ref29 ref30 ref31 ref91 ref92 ref93">(4,29−31,91−93)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C, all synthetic PPARδ agonists have a common structure: a head, a linker, and a tail.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of rationally designed PPARδ agonists reported by Merck, GlaxoSmithKline, and Bayer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">PPARδ selectivity over PPARα and PPARγ is one of the key points driving the discovery and development of PPARδ agonists with an improved safety profile. Researchers have utilized computational and medicinal chemistry strategies such as structure-based modification and structure-guided optimization techniques to achieve PPARδ selectivity. Moreover, a new computational method using an in-house machine learning algorithm, Iterative Stochastic Elimination (ISE) has been reported for discovering selective PPARδ agonists.<a onclick="showRef(event, 'ref120 ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref120 ref121 ref122">(120−122)</a> The structures of synthetic PPARδ agonists, identified by several groups, are shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>–<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">4.1.1.  Merck</h4><div class="NLM_p last">In 1997, researchers from Merck Research Laboratory (New Jersey, USA) first reported the synthetic ligand L-631033 (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), which resembles fatty acids with a phenyl ring in the middle of the chain, as a weak activator of the PPARδ receptor.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> After two years,<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> the Merck group then identified L-165041 (<b>2</b>) as a more potent PPARδ agonist. L-165041 displayed more than 10-fold selectivity for human PPARδ receptors over other human subtypes, PPARα and PPARγ. An in vivo experiment revealed that L-165041 has no significant effect on lowering plasma glucose or triglycerides in obese, insulin-resistant <i>db</i>/<i>db</i> mice. However, it did affect plasma cholesterol even at a lower dose in the same in vivo experiment.<a onclick="showRef(event, 'ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref123 ref124">(123,124)</a> Studies by Lim et al. suggested L-165041 as a potential therapeutic agent for controlling pathologic hepatic and cardiovascular conditions.<a onclick="showRef(event, 'ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref125 ref126">(125,126)</a> Moreover, the Merck group also reported a new series of phenylacetic acid derivatives, with L-165461 (<b>3</b>), L-783483 (<b>4</b>), and L-796449 (<b>5</b>) having a potent agonistic effect on the human PPARδ.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> These compounds showed significant glucose- and triglyceride-lowering activities in mice. However, the major drawback was that they were active on all of the three human PPAR subtypes.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">4.1.2.  GlaxoSmithKline</h4><div class="NLM_p last">In 1997, Brown et al. from Glaxo Wellcome R&D (later merged as GlaxoSmithKline) reported GW2433 (<b>6</b>) as the first high-affinity PPARδ agonist.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> GW2433 is a trisubstituted urea analogue that incorporated a phenoxyisobutyric acid monomer, generally present in the bezafibrate, a lipid-lowering drug. In 2001, the same group reported on the potent subtype-selective PPARδ agonists GW0742 (<b>7</b>) and GW501516 (<b>8</b>) with a thiazole core. These two compounds demonstrated their efficacy in increasing HDL-cholesterol and insulin sensitivity while decreasing LDL-cholesterol and triglyceride levels in insulin-resistant obese rhesus monkeys. In 2003, GlaxoSmithKline initiated a phase II clinical trial of GW501516 for dyslipidemia (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT00158899) and was expected to file for FDA approval in 2008. However, the company discontinued the clinical trial of GW501516 in September of 2007 after they observed a rapid induction of cancers in their animal studies.<a onclick="showRef(event, 'ref129 ref130 ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref129 ref130 ref131 ref132">(129−132)</a> Since then, GW501516 and GW0742 have been used as chemical tools for exploring the structural and rational design of new potent and selective PPARδ agonists.<a onclick="showRef(event, 'ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref116 ref117">(116,117)</a> Researchers have also used the two compounds to demonstrate the role of PPARδ in different pathophysiological conditions, including atherosclerosis, hypertension, inflammation, and kidney disease.<a onclick="showRef(event, 'ref69 ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref69 ref133 ref134">(69,133,134)</a> However, there have been no further reports on their clinical trials as of this writing.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">4.1.3.  Bayer</h4><div class="NLM_p last">In 2005, Weigand et al.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> from Bayer Health Care reported the synthesis of a new, potent, and selective PPARδ agonist (<b>9</b>) derived as a hybrid structure of GW501516 and compound <b>A</b> (a selective PPARα agonist). Preliminary in vitro studies suggested that <b>9</b> may have favorable pharmacokinetics. Further pharmacological studies of <b>9</b> were expected to develop this compound as a potential candidate for the treatment of obesity, atherosclerosis, and dyslipidemia.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> However, there are no recent updates on compound <b>9</b>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">4.1.4.  Novartis</h4><div class="NLM_p">In 2006, Epple et al. from the Novartis Research team<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> identified Y-shaped 1,3,5-substituted aryl derivative (<b>10</b>) as a highly potent and selective PPARδ agonist, grounded on structure-based drug design using the Y-shaped GW2433 (<b>6</b>) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Compound <b>10</b> also showed a favorable pharmacokinetic profile. From the docking results of compound <b>B (</b>an isoxazole group containing PPAR pan agonist) and GW2433, the same group identified compound <b>11</b>,<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> a novel trisubstituted isoxazole, as a potent and selective PPARδ agonist. It is notable that unlike other reported PPARδ agonists, compound <b>11</b> does not contain a flexible linker between the hydrophobic tail and the functional head. In 2009, Epple et al.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> identified the bisaryl-substituted thiazole core containing compound <b>12</b> using the structural optimization of compound <b>10</b> and GW501516. Compound <b>12</b> was notable for showing excellent pharmacokinetic properties. They demonstrated that compound <b>12</b> plays an essential role in regulating genes involved in energy homeostasis.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> However, our search revealed that no further reports are available on compound <b>12</b>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of rationally designed PPARδ agonists reported by Novartis, Novo Nordisk, and Johnson & Johnson.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">4.1.5.  Novo Nordisk</h4><div class="NLM_p last">A group of Novo Nordisk researchers was also involved in developing selective PPARδ agonists. In 2007, Havranek<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> reported a selective and potent alkynylallylic moiety containing Y-shaped PPARδ agonist (<b>13</b>) using the structural combination of compound <b>10</b> and a PPAR pan agonist (compound <b>C</b>). Per et al. described the synthesis of the sodium salt of morpholine containing alkynylallylic phenoxy acetic acid as a selective PPARδ agonist (<b>14</b>; NN-0606) for the treatment of metabolic disorders.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> The phase I clinical trial of NN-0606 was discontinued, reportedly for strategic reasons.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> However, NN-0606 (now licensed by Reneo Pharmaceuticals as REN-001) has found its way into clinical trials once more in the hopes of developing treatments for rare diseases, including primary mitochondrial myopathy (PMM), fatty acid oxidation disorders (FAOD), and McArdle diseases.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">4.1.6.  Johnson & Johnson</h4><div class="NLM_p last">In 2007, Zhang et al.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> from Johnson & Johnson reported a novel series of Y-shaped alkylthiophenoxyacetic acids from the structural modification of GW501516 (<b>8</b>) and L-165041 (<b>2</b>). Most of the synthesized compounds showed a highly potent and PPARδ-specific agonistic activity as potential agents for the treatment of dyslipidemia, obesity, and diabetes. From the structure–activity relationship (SAR) study, Zhang et al. demonstrated that the chirality at the Y-intersection and the length of the side arm and the backbone are important for PPARδ agonist activity. Compound <b>15</b> had potent activity (EC<sub>50</sub> = 0.03 nM) and showed a favorable pharmacokinetic profile.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Notably, MBX-8025 (<b>16</b>, also known as Seladelpar) was first reported by Johnson & Johnson in 2007 as a selective and potent PPARδ agonist. However, it was originally discovered by Ortho-McNeil Pharmaceuticals (a subsidiary of Johnson & Johnson).<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> In 2009, the same group reported a di-<i>n</i>-propyl substituted compound <b>17</b> as the most potent (EC<sub>50</sub> = 8.6 nM) PPARδ-specific agonist with a favorable pharmacokinetic profile.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Shen et al. identified thiadiazole compound <b>18</b>, based on structure modification of GW501516, as a potent and selective PPARδ agonist.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> However, none of the compounds have seen further reports on their development by Johnson & Johnson except for MBX-8025. MBX-8025 is now under clinical development by CymaBay Therapeutics for liver diseases, including nonalcoholic steatohepatitis and primary biliary cholangitis (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifiers NCT03551522 and NCT03602560).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">4.1.7.  Pfizer</h4><div class="NLM_p">In 2007, researchers from Pfizer Global R&D (Michigan, USA) reported the synthesis of benzofuran, benzothiophene, indole, and benzyloxybenzyl-based compounds as potential agents for the treatment of dyslipidemia (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146,147)</a> From the SAR study, they identified benzyloxybenzyl-based compound <b>19</b>, which showed more than 1000-fold selectivity of PPARδ over PPARα with an EC<sub>50</sub> of 70 nM.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> In another report, the group designed a series of new compounds with steric crowding around the acidic part. They identified benzothiophene-based compound <b>20</b> (EC<sub>50</sub> = 14.7 nM) and indole-based compound <b>21</b> (EC<sub>50</sub> = 4 nM), suggesting that they could be used as chemical tools for elucidating the biological functions of PPARδ.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of rationally designed PPARδ agonists reported by Pfizer, Nippon, AstraZeneca, and Kalypsys.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">4.1.8.  Nippon Chemiphar</h4><div class="NLM_p last">In 2011, Sakuma et al.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> from Nippon Chemiphar Co. Ltd. reported a new and unique benzisoxazole ring containing compound <b>22</b> as a potent PPARδ selective agonist. Compound <b>22</b> showed a strong stimulatory effect on the differentiation of oligodendrocyte in vitro, thereby confirming the potential for the development of an effective drug that could alleviate demyelinating disorders. In May 2017, Hirai et al. from Nippon Chemiphar reported the effects of NCP-1046 (structure not disclosed), a novel PPARδ agonist for wound healing.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> NCP-1046 showed an approximately 1000-fold selectivity for human PPARδ over PPARα and PPARγ in in vitro PPAR transactivation assays. Notably, in a rat pressure ulcer model, a significant decrease in wound closure time was reported in 0.005% NCP-1046 ointment-treated mice group compared to their vehicle-treated mice when treated topically for 5 days. Moreover, a dose of 0.05% NCP-1046 ointment resulted in significantly enhanced wound healing in diabetic mice models. Although there is no updated data on NCP-1046, that study suggests that NCP-1046 might be effective in low doses for chronic wounds.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">4.1.9.  AstraZeneca</h4><div class="NLM_p last">In 2011, researchers from AstraZeneca reported the synthesis of tetrahydroisoquinoline derivatives from the structural basis of compound <b>9</b> (developed by Bayer) as selective PPARδ agonists for metabolic disorders, including dyslipidemia, diabetes, obesity, and atherosclerosis.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Among those synthesized compounds, <b>23</b> exhibited highly selective and potent agonist activity at PPARδ (EC<sub>50</sub> = 5 nM). The same group reported further optimization leading to the discovery of the most potent and selective PPARδ agonist, compound <b>24</b> (EC<sub>50</sub> = 3 nM) from the prepared new series of 8-oxybenz[<i>c</i>]azepine derivatives.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> However, since then, no further reports on their developments have been published by AstraZeneca as of this writing, suggesting that the programs have been discontinued.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">4.1.10.  Kalypsys</h4><div class="NLM_p last">Researchers from Kalypsys Inc. reported the synthesis of a series of aryl sulfonamide, sulfonyl, and indole derivatives as potential PPARδ-selective agonists for the treatment of metabolic disorders.<a onclick="showRef(event, 'ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref151 ref152">(151,152)</a> Guha et al. reported that KD-3010 (compound <b>25</b>), a highly selective and potent PPARδ agonist with a unique piperazine sulfonyl core, exhibits beneficial effects for the treatment of metabolic disease and nonalcoholic steatohepatitis (NASH).<a onclick="showRef(event, 'ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref153 ref154">(153,154)</a> Recent studies by Dickey et al. demonstrated KD-3010’s value in the treatment of neurodegenerative diseases, such as Huntington’s disease, Alzheimer’s disease, and Parkinson’s disease.<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88,89)</a></div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">4.1.11.  Orléans, Tokyo, Pennsylvania, Seoul National, and Hebrew University of Jerusalem</h4><div class="NLM_p">Besides pharmaceutical companies, a few universities have reported potent and selective PPARδ agonists (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). In 2006, Basséne et al. from the Université d’Orléans identified phenoxyacetic acid compound <b>26</b>, based on the structure of L-165041 (<b>2</b>), as a potent and selective PPARδ agonist.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> The following year, Kasuga et al.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> from the University of Tokyo reported the synthesis of a series of 3-(4-alkoxyphenyl)propanoic acid derivatives based on the structure of TIPP-401 (a PPAR α/δ dual agonist). From SAR studies, the group identified compound <b>27</b> (TIPP-204) with an <i>n</i>-butoxy group exhibiting extremely potent and selective PPARδ transactivation activity, better than and more distinct from GW501516. The structure of PPARδ LBD in complex with compound <b>27</b> has been reported to determine PPARδ-specific binding modes.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of selective PPARδ agonists reported by different universities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Researchers from Pennsylvania State University described the role of PPARδ receptor in cell proliferation and cancer.<a onclick="showRef(event, 'ref93 ref158 ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref93 ref158 ref159 ref160">(93,158−160)</a> In February 2010, Genovese et al. reported a natural propenoic acid derivative, 4′-geranyloxyferulic acid (<b>28</b>), that activated PPARδ and inhibited the cell proliferation of a human skin cancer cell line.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> In the same year, a group of researchers from Pennsylvania State University and Penn State Hershey Cancer Institute reported an efficient synthesis of a novel PPARδ agonist (<b>29</b>) as a selenium analogue of GW501516 with potential anticancer properties.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></div><div class="NLM_p">In 2010, Kang’s group from the Seoul National University (SNU) in Korea, reported a synthesis and in vivo antiatherogenic activity of a series of selenium-containing isosteres of GW501516.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Among these compounds, <b>29</b> is notable for showing potent and selective PPARδ agonist activity (EC<sub>50</sub> = 0.9 nM). From the results of the in vivo experiment in atherosclerosis mouse models, compound <b>29</b> was considered as a potential agent for the treatment of atherosclerosis. In 2012, Ham et al.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> reported a synthesis of novel Y-shaped PPARδ-selective agonists by substituting alkyl or aryl groups at the α-position of sulfide. Compounds <b>30</b>, <b>31</b>, and <b>32</b> exhibited highly potent and selective PPARδ agonistic activity and were proposed as safer potential candidates for the treatment of obesity.</div><div class="NLM_p last">In 2019, Da’adoosh et al. from the Hebrew University of Jerusalem<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> reported the discovery of novel hit and lead molecules using a new structure-based computational tool. They applied a combination of two computational methods: docking and Iterative Stochastic Elimination (ISE), a machine learning algorithm. From the virtual screening of 1.56 million molecules applying ISE, followed by docking to the PPARδ structure, 306 molecules were selected for in vitro testing. Finally, Da’adoosh et al. discovered 13 compounds, including GNF-0242 (<b>33</b>) and GNF-8065 (<b>34</b>), that showed highly selective agonistic activity for PPARδ with EC<sub>50</sub> between 4 and 19 nM.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">4.1.12.  Salk Institute</h4><div class="NLM_p">In 2017, Wu et al. from the Salk Institute for Biological Studies rationally designed and synthesized a new generation of potent and selective PPARδ agonists to improve PPARδ selectivity (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> On the basis of the skeleton of GW501516, they designed a series of compounds with various substituents to occupy arms I, II, and III for PPARδ selectivity. Compound <b>35</b> was identified as the most specific for PPARδ (EC<sub>50</sub> = 19.6 nM) compared to PPARα and PPARγ. Unlike GW501516, compound <b>35</b> contains a hexanoic acid headgroup, which interacts with the AF-2 region of arm I. The study also revealed a potential mode of action of PPARδ ligand selectivity, which could further contribute to design a safer and more potent PPARδ selective agonist to treat metabolic disorders.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of rationally designed PPARδ agonists reported by Salk Institute, Mitobridge/Astellas, and DGMIF/SNU.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">4.1.13.  Mitobridge/Astellas</h4><div class="NLM_p last">Lagu et al.<a onclick="showRef(event, 'ref109 ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref109 ref165 ref166">(109,165,166)</a> from Mitobridge, a wholly owned subsidiary of Astellas Pharma, reported several compounds synthesized by the structural modification of benzamide PPARδ agonist <b>35</b>. The group<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> identified compound <b>36</b> as a selective PPARδ agonist with improved pharmacokinetic properties using structure–activity relationships. The in vivo study on gene expression data analysis indicated that compound <b>36</b> is safer than GW501516.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Lagu et al.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> also reported another potent and selective PPARδ agonist, MA-0204 (<b>37</b>) by isosteric replacement of the amide group with an imidazole ring. Furthermore, in vitro and in vivo assays in mice and rats indicated that compound <b>37</b> has a favorable pharmacokinetic profile, suggesting that the compound is a potential agent for the treatment of Duchenne muscular dystrophy (DMD). A recent joint patent by researchers from Mitobridge and Salk Institute described a new series of imidazole containing selective PPARδ agonists (including <b>37</b>) for potential use in the treatment of several diseases, such as muscular diseases, renal diseases, metabolic diseases, and demyelinating diseases.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> A more recent study by Lagu et al. addressed a cardiac safety concern for compound <b>37</b> by synthesizing new compounds with minimal hERG inhibitory activity. New compounds were synthesized by modifying the basicity of the imidazole core of compound <b>37</b>.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">4.1.14.  DGMIF/SNU</h4><div class="NLM_p last">Our group at Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF) has also been in search of new, selective, and potent PPARδ agonists. We have reported the design and synthesis of a new series of Y-shaped biaryl PPARδ agonists in collaboration with Kang’s group at SNU. We identified compound <b>38</b> as a highly potent and selective PPARδ agonist with an EC<sub>50</sub> value of 2.6 nM.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> From the results of molecular docking studies, in vitro ADME/Tox, and in vivo pharmacokinetic studies, compound <b>38</b> demonstrated itself as a promising candidate for the treatment of PPARδ-related diseases. In another study, we reported an enantioselective synthesis of a natural product, pulicatin-inspired, unique methyl-thiazoline-core containing novel compound <b>39</b> as a highly potent PPARδ agonist (EC<sub>50</sub> = 6.2 nM).<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Furthermore, we recently reported a simple and efficient synthetic route of a dimethyl-thiazoline-core containing compound <b>40</b> as a new scaffold for PPARδ agonist.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">4.2.  Structure–Activity Relationships</h3><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> illustrates the SAR of highly selective, synthetic PPARδ agonists reported by various companies and institutes from 1999 to 2019. One of them, L-165041 (<b>2</b>), has a phenoxyacetic acid group and was identified as the first selective human PPARδ agonist. Another phenylacetic acid derivative, L-783483 (<b>4</b>), with a trifluoromethyl benzoisoxazole group at the tail, exhibited better selectivity than L-165041.<a onclick="showRef(event, 'ref123 ref170'); return false;" href="javascript:void(0);" class="ref ref123 ref170">(123,170)</a> A phenoxyacetic acid derivative GW501516 (<b>8</b>) with a thiazole core at the linker showed enhanced PPARδ agonistic activity (EC<sub>50</sub> = 1 nM) and selectivity over 1100-fold against PPARα and 850-fold PPARγ in a cell-based transactivation assay. It is interesting to note that the addition of a fluorine substituent at the <i>ortho</i>-position to the CF<sub>3</sub> group (<b>7</b>, GW0742) showed similar potency but better selectivity compared to <b>8</b>.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Notably, many reports have demonstrated the discovery of selective PPARδ agonists through a modification of sides or positions of the head, the linker, or the tail of GW501516.<a onclick="showRef(event, 'ref138 ref143 ref163 ref172'); return false;" href="javascript:void(0);" class="ref ref138 ref143 ref163 ref172">(138,143,163,172)</a> The phenoxyacetic acid compound <b>9</b>, synthesized through the structural modification of GW501516’s linker and tail, also improved PPARδ selectivity (EC<sub>50</sub> = 3 nM) over other subtypes (EC<sub>50</sub> = >10000 nM for PPARα and PPARγ).<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Furthermore, Y-shaped compounds <b>10</b> and <b>11</b> were synthesized based on the structure of GW2433, also have high PPARδ selectivity confirmed by in vitro transactivation assay.<a onclick="showRef(event, 'ref136 ref137'); return false;" href="javascript:void(0);" class="ref ref136 ref137">(136,137)</a> The promising activity of compound <b>11</b> indicates that a flexible linker may not be needed for PPARδ selectivity. Furthermore, another compound (<b>12</b>), synthesized based on GW501516 by substituting a <i>para</i>-methoxy pyridine group at position 4 of a thiazole ring was also tolerable for selective PPARδ agonistic activity.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Potency of Synthetic PPARδ Agonists (nM) on Human PPAR Receptor</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0011.gif" alt="" id="gr10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0012.gif" alt="" id="GRAPHIC-d7e1554-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0013.gif" alt="" id="GRAPHIC-d7e1555-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0017.gif" alt="" id="GRAPHIC-d7e1556-autogenerated" /></img><div></div></div><div class="NLM_p">A <i>para</i>-alkylthiophenoxyacetic acid derivative (<b>16</b>; MBX-8025), synthesized based on the structure of GW501516 (<b>8</b>) and L-165041 (<b>2</b>), also showed a potent and selective PPARδ agonistic effect (EC<sub>50</sub> = 2 nM) against other subtypes (EC<sub>50</sub> = >1000 nM for PPARα and PPARγ).<a onclick="showRef(event, 'ref143 ref172'); return false;" href="javascript:void(0);" class="ref ref143 ref172">(143,172)</a> MBX-8025 is now under active investigation as a potential therapeutic agent for liver diseases (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifiers NCT03602560, NCT03551522, and NCT04024813)</div><div class="NLM_p">Another study showed that steric crowding around the acidic part might improve PPARδ selectivity. Compound <b>22</b>, with a unique benzisoxazole ring, acted as a potent hPPARδ transactivation activity with an EC<sub>50</sub> of 4.5 nM. It showed more than 2000-fold PPARδ selectivity over PPARα and PPARγ.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Furthermore, the effects of substituents at anilide moiety was also investigated. Compound <b>23</b>, with a tetrahydroisoquinoline group based on compound <b>9</b>, also acted as a potent and selective PPARδ agonist (EC<sub>50</sub> = 5, 2500, and 20000 nM for PPARδ, PPARα, and PPARγ, respectively).<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div><div class="NLM_p">The potent 8-oxybenz[<i>c</i>]azepine compound <b>D</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A), with a PPARδ EC<sub>50</sub> value of 25 nM showed 128-fold selectivity over other subtypes.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Further structure-based modification via the introduction of an ethyl group adjacent to the benzazepine nitrogen yielded compound <b>24</b>, which showed improved activity and PPARδ selectivity with an EC<sub>50</sub> value of 3 nM against other subtypes (EC<sub>50</sub> = 6000 nM for PPARα and >20000 nM for PPARγ).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structure-based design of highly selective PPARδ agonists <b>24</b> and <b>38</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another study reported the synthesis of phenoxyacetic acid compound <b>26</b>, modifying the structure of L-165041 (<b>2</b>) to improve its potency and PPARδ selectivity.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> The study suggested the beneficial effects of a pyridine ring at the tail of the compound. Compound <b>27</b> (TIPP-204), synthesized by a small modification at the structure of TIPP-401 (a PPAR α/δ dual agonist), showed potent transactivation activity and PPARδ selectivity. The finding indicated the importance of a butoxy group at the 4-position of the aromatic ring of the head.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Compound <b>27</b> exhibited more than 250-fold selectivity to the PPARα and over 1200-fold selectivity to PPARγ. Compound <b>29</b>, synthesized as a selenium analogue of GW501516, showed improved activity and PPARδ selectivity (EC<sub>50</sub> = 0.9, >1000, and >1000 nM for PPARδ, PPARα, and PPARγ, respectively) compared to GW501516.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Moreover, a Y-shaped PPARδ selective agonist (<b>30</b>) prepared by substituting the halophenyl group at the α-position of the sulfide also exhibited improved activity and PPARδ selectivity. Compound <b>30</b> showed strong PPARδ agonistic activity (EC<sub>50</sub> = 1.6 nM) with 625- and 6250-fold selectivity over PPARα and PPARγ.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> Notably, some structurally different novel compounds have been discovered as highly selective PPARδ agonists using ligand-based machine learning and structural modeling techniques. Among these compounds, <b>33</b> (GNF-0242), with an amide linker moiety, showed the most selective PPARδ agonist activity (EC<sub>50</sub> = 4 nM).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Compound <b>35</b>, synthesized by modifying the head, the tail, and the linker of the GW501516 skeleton, displayed potent and selective transactivation PPARδ (EC<sub>50</sub> = 19.6 nM) activity.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Further methyl substitution at α- and β- positions of an acidic part of compound <b>35</b> led to another selective PPARδ agonist (<b>36</b>) (EC<sub>50</sub> = 37 nM), which has an improved pharmacokinetic and safety profile.<a onclick="showRef(event, 'ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref165 ref166">(165,166)</a> Another highly specific PPARδ (EC<sub>50</sub> value of 0.4 nM) agonist, compound <b>37</b> (MA-0204), was discovered using the X-ray crystallographic information on <b>36</b>. A SAR study revealed the importance of the isosteric replacement of linker (amide group) with imidazole moiety, and replacing the 2-furyl group with 4-trifluoromethoxy group for improved PPARδ selectivity over PPARα and PPARγ.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div><div class="NLM_p last">Finally, on the basis of the structure of GW501516 and compound <b>35</b>, we recently synthesized and detailed an SAR of Y-shaped biaryl analogues and identified the novel compound (<b>38</b>), with a high transactivation activity (PPARδ EC<sub>50</sub> = 2.6 nM) and over 3846-fold selectivity to PPARα and PPARγ.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Compound <b>38</b> was designed based on the structure of GW501516 by replacing a thiazole group with a phenyl ring (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> We found that the introduction of a benzyl group at the α-carbon adjacent to the sulfur is crucial for selectivity. In comparison with GW501516, compound <b>38</b> showed enhanced selectivity with more than 5-fold greater PPARδ selectivity. Molecular docking studies of <b>38</b> with the crystal structure of PPARδ revealed the phenyl moiety at the α-position of the sulfur group might have contributed for enhanced PPARδ selectivity.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">5.  Preclinical and Clinical Development Status</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">On the basis of information in the Cortellis database (Clarivate Analytics), we found that a number of PPARδ agonists reached early stage clinical trials, with some of them under active development.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> The major PPARδ-selective agonists that reached to clinical trials for metabolic disorders are GW501516 (GlaxoSmithKline),<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> NN-0606 (Novo Nordisk),<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> KD-3010 (Kalypsys),<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> CER-002 (Cerenis Therapeutics/ABIONYX Pharma),<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> and MBX-8025 (Metabolex).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> However, there are still no PPARδ-targeting drugs in the market.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> As of this writing, three major companies, CymaBay Therapeutics (MBX-8025), Reneo Pharmaceuticals (REN-001/HPP-593), and Mitobridge/Astellas Pharma (ASP0367 and ASP1128), are actively involved in the clinical development of PPARδ agonists for liver diseases, mitochondrial diseases, musculoskeletal diseases, and acute kidney injury (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifiers NCT03551522, NCT04024813, NCT03602560, NCT03862846, NCT03833128, NCT04226274, NCT04184882, and NCT03941483).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Development Status of PPARδ-Selective Agonists in Clinical Trials<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PPARδ agonist</th><th class="colsep0 rowsep0" align="center">development phase</th><th class="colsep0 rowsep0" align="center">company</th><th class="colsep0 rowsep0" align="center">indication</th><th class="colsep0 rowsep0" align="center">clinical trial ID</th><th class="colsep0 rowsep0" align="center">status</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MBX-8025 (<b>16</b>)</td><td class="colsep0 rowsep0" align="left">phase II (April 2018)</td><td class="colsep0 rowsep0" align="left">CymaBay Therapeutics</td><td class="colsep0 rowsep0" align="left">NASH</td><td class="colsep0 rowsep0" align="left">NCT03551522</td><td class="colsep0 rowsep0" align="left">discontinued</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">phase II (August 2019)</td><td class="colsep0 rowsep0" align="left">CymaBay Therapeutics</td><td class="colsep0 rowsep0" align="left">PSC</td><td class="colsep0 rowsep0" align="left">NCT04024813</td><td class="colsep0 rowsep0" align="left">discontinued</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">phase III (November 2018)</td><td class="colsep0 rowsep0" align="left">CymaBay Therapeutics</td><td class="colsep0 rowsep0" align="left">PBC</td><td class="colsep0 rowsep0" align="left">NCT03602560</td><td class="colsep0 rowsep0" align="left">on hold</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">      </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">REN-001(<b>14</b>)</td><td class="colsep0 rowsep0" align="left">phase I (May 2019)</td><td class="colsep0 rowsep0" align="left">Reneo Pharma</td><td class="colsep0 rowsep0" align="left">PMM</td><td class="colsep0 rowsep0" align="left">NCT03862846</td><td class="colsep0 rowsep0" align="left">active</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">phase I (April 2019)</td><td class="colsep0 rowsep0" align="left">Reneo Pharma</td><td class="colsep0 rowsep0" align="left">FAOD</td><td class="colsep0 rowsep0" align="left">NCT03833128</td><td class="colsep0 rowsep0" align="left">active</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">phase I (Dec 2019)</td><td class="colsep0 rowsep0" align="left">Reneo Pharma</td><td class="colsep0 rowsep0" align="left">McArdle disease</td><td class="colsep0 rowsep0" align="left">NCT04226274</td><td class="colsep0 rowsep0" align="left">active</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">       </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ASP0367</td><td class="colsep0 rowsep0" align="left">phase I (January 2020)</td><td class="colsep0 rowsep0" align="left">Mitobridge/Astellas Pharma</td><td class="colsep0 rowsep0" align="left">DMD</td><td class="colsep0 rowsep0" align="left">NCT04184882</td><td class="colsep0 rowsep0" align="left">active</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">       </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ASP1128</td><td class="colsep0 rowsep0" align="left">phase II (November 2019)</td><td class="colsep0 rowsep0" align="left">Mitobridge/Astellas Pharma</td><td class="colsep0 rowsep0" align="left">AKI</td><td class="colsep0 rowsep0" align="left">NCT03941483</td><td class="colsep0 rowsep0" align="left">active</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">NASH, nonalcoholic steatohepatitis; PSC, primary sclerosing cholangitis; PBC, primary biliary cholangitis/cirrhosis; PMM, primary mitochondrial myopathy; FAOD, fatty acid oxidation disorders; DMD, duchenne muscular dystrophy; AKI, acute kidney injury. The clinical trials at <a href="http://clinicaltrials.gov" class="extLink">clinicaltrials.gov</a> are referred to using NCT numbers. Structures of ASP0367 and ASP1128 are not disclosed.</p></div></div></div><div class="NLM_p">MBX-8025 (<b>16</b>), a PPARδ agonist, was being developed by Metabolex in collaboration with Ortho-McNeil and Johnson & Johnson for type 2 diabetes and dyslipidemia.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Since 2015, CymaBay Therapeutics (formerly known as Metabolex) is actively developing MBX-8025 for chronic liver diseases, under license from Ortho-McNeil.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> MBX-8025 received an orphan drug designation from the US FDA and the European Medicines Agency in November 2016 and September 2017, respectively, for the treatment of PBC.<a onclick="showRef(event, 'ref177 ref178'); return false;" href="javascript:void(0);" class="ref ref177 ref178">(177,178)</a> CymaBay Therapeutics started a phase II, double-blind, randomized, placebo-controlled study (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT03551522) in April 2018 to evaluate the activity of MBX-8025 in subjects with nonalcoholic steatohepatitis (NASH). In November 2018, a 52-week, placebo-controlled, randomized, phase III study (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT03602560) began to evaluate the safety and efficacy of MBX-8025 in subjects with PBC and an inadequate response to or intolerance to ursodeoxycholic acid. In August 2019, a randomized, double-blind, placebo-controlled, parallel-group, phase II trial (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT04024813) of MBX-8025 began in patients with primary sclerosing cholangitis (PSC). However, the company announced in November 2019 the termination of the trial for NASH and PSC due to the initial histological examination of the patient’s liver, where biopsies showed inflammation and erosion of the hepatic parenchyma region, with or without biliary injury observed in the phase IIb study of MBX-8025 in NASH.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> The company also decided to put the trials for PBC on hold. However, it is hard to say whether the safety issue of MBX-8025 is PPARδ-related or compound-related. Thus, further studies are required for addressing the issue raised in the phase IIb study of MBX-8025 in NASH. While it is interesting to note the GENFIT Biopharmaceutical’s announcement on November 26, 2019, that the Data Safety Monitoring Board (DSMB) has recommended the continuation of GFT-505’s (Elafibranor, a dual agonist of the PPARα and PPARδ isotypes) phase 3 RESOLVE-IT clinical trial in NASH without any modifications.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> Additionally, it is importnat to note that GFT-505 and MBX-8025 have cleared the two-year carcinogenicity studies in rodents, which suggests that the tumorigenicity of GW501516 may be compound-specific not a PPARδ-specific phenomenon.<a onclick="showRef(event, 'ref181 ref182'); return false;" href="javascript:void(0);" class="ref ref181 ref182">(181,182)</a></div><div class="NLM_p">High Point Pharmaceuticals, a division of vTv Therapeutics Inc., reported in 2013 the phase I clinical study of HPP-593 (formerly NN-0606, now REN-001) for muscle atrophy (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT01524406).<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> In December 2017, vTv Therapeutics licensed worldwide rights to research, develop, and commercialize REN-001 to Reneo Pharmaceuticals (a clinical-stage pharmaceutical company focused on the development of therapies for patients with mitochondrial genetic diseases).<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Reneo Pharmaceuticals started an open-label phase I trial to evaluate the safety and tolerability of 12-week treatments with REN-001 in subjects with primary mitochondrial myopathy, PMM (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT03862846), and FAOD (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT03833128). In September 2019, Reneo Pharmaceuticals announced that the US FDA granted an orphan drug designation to REN-001 for the treatment of FAOD.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> In addition to PMM and FAOD, Reneo Pharmaceuticals recently initiated a phase I clinical trial of REN-001 to treat McArdle disease (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT04226274). McArdle disease is a rare inherited muscle disorder caused by the inability of the body to break down glycogen in muscle cells.</div><div class="NLM_p">Mitobridge (now a subsidiary of Astellas Pharma) is developing ASP0367 (structure not disclosed) as an oral formulation for the potential treatment of mitochondrial diseases, including Duchenne muscular dystrophy (DMD). Astellas Pharma initiated a phase I clinical trial of ASP0367 to evaluate its safety, tolerability, and preliminary efficacy in pediatric male subjects with DMD. This study is expected to end by May 2021 (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT04184882). Astellas Pharma’s other PPARδ-selective agonist ASP1128 (structure not disclosed) is under phase II clinical study (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT03941483) to investigate its efficacy, safety, and tolerability in 220 patients at risk of acute kidney injury (AKI) following cardiac surgery. In October 2019, the US FDA granted Fast Track designation to the treatment of patients at increased risk of developing moderate to severe AKI after coronary artery bypass or valve surgery.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a></div><div class="NLM_p">There are continuous efforts that are notable for repurposing PPARδ-selective agonists, such as GW501516, KD-3010, MBX-8025, and NN-0606/REN-001 for novel indications (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). One of the most studied PPARδ agonists was GlaxoSmithKline’s GW501516 (<b>8</b>), which completed a phase II clinical trial for dyslipidemia (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT00158899). Unfortunately, it was discontinued in 2007 due to the observation that it rapidly induced cancer in long-term animal toxicity studies.<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129,130)</a> Recent study has demonstrated that they could be developed for Parkinson’s disease.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. PPARδ-Selective Agonists with Repurposed Indication</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">old indication</th><th class="colsep0 rowsep0" align="center">new indication</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GW501516 (<b>8</b>)</td><td class="colsep0 rowsep0" align="left">dyslipidemia, type 2 diabetes,<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> and obesity<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> (GlaxoSmithKline)</td><td class="colsep0 rowsep0" align="left">Parkinson’s disease<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> (Nanjing Medical University)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NN-0606/REN-001 (<b>14</b>)</td><td class="colsep0 rowsep0" align="left">type 2 diabetes<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> (Novo Nordisk)</td><td class="colsep0 rowsep0" align="left">primary mitochondrial myopathy, fatty acid oxidation disorders, and McArdle disease<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> (vTv Therapeutics/Reneo Pharmaceuticals)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KD-3010 (<b>25</b>)</td><td class="colsep0 rowsep0" align="left">metabolic disorders<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> (Kalypsys)</td><td class="colsep0 rowsep0" align="left">neurodegenerative diseases<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88,89)</a> (University of California San Diego)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MBX-8025 (<b>16</b>)</td><td class="colsep0 rowsep0" align="left">type 2 diabetes, and dyslipidemia<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> (Metabolex)</td><td class="colsep0 rowsep0" align="left">nonalcoholic steatohepatitis, primary sclerosing cholangitis, and primary biliary cholangitis/cirrhosis<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> (CymaBay Therapeutics)</td></tr></tbody></table></div></div><div class="NLM_p last">Novo Nordisk discontinued its phase I clinical development of NN-0606 (<b>14</b>) for type 2 diabetes due to strategic reasons.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> The NN-0606 is now being developed by Reneo Pharmaceuticals as REN-001 (<b>14</b>) for PMM, FAOD, and McArdle disease.<a onclick="showRef(event, 'ref142 ref186'); return false;" href="javascript:void(0);" class="ref ref142 ref186">(142,186)</a> In March 2009, Kalypsys announced the completion of phase I clinical trial of KD-3010 (<b>25</b>) for metabolic disorders and the preparation for phase II trials. However, there has been no further development on KD-3010 since that time. A recent study from the University of California San Diego demonstrated the neuroprotective effect of KD-3010 in neurodegenerative diseases such as Huntington’s disease.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> It is also notable that MBX-8025 (<b>16</b>) was under clinical trial for type 2 diabetes and dyslipidemia by Metabolex.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> CymaBay Therapeutics was putting huge efforts to repurpose MBX-8025 and develop therapeutics for NASH, PSC, and PBC (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). However, the company has recently terminated the phase 2b clinical trial of MBX-8025 in subjects with NASH and the phase 2 study in subjects with PSC. Moreover, the company has decided to halt all studies of MBX-8025 in subjects with PBC.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">6.  Perspectives and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PPARδ is a ligand-activated transcription factor that plays a central role in regulating various cellular and physiological functions<a onclick="showRef(event, 'ref5 ref6 ref58 ref75'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref58 ref75">(5,6,58,75)</a> Several reports described the importance of PPARδ activation in various diseases such as metabolic disorder, liver disease, cardiovascular disease, and neurological disease. However, there is still a need for detailed studies to understand the molecular mechanism of PPARδ functions. Moreover, pathophysiological functions of PPARδ in response to endogenous PPARδ ligands, and other nuclear receptors remains unclear.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> A recent study on the high-resolution protein X-ray crystallographic structure of highly selective PPARδ agonists cocrystallized with hPPARδ LBDs has advanced our understanding of the interactions between the subtype-specific amino acid residues in the ligand-binding pocket of the PPARδ and its agonists.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Some reports on PPARδ activation, especially to cancer initiation and progression, have influenced studies to explore how PPARδ antagonists can function in cancer prevention.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Despite that, the medicinal chemistry perspective of PPARδ agonist studies is continuously growing, with several promising reports. Pharmaceutical companies and research institutes have utilized various techniques for the discovery and optimization of PPARδ agonists concerning potency and selectivity. Several computational approaches, including a recently developed computational method using an in-house machine learning algorithm, Iterative Stochastic Elimination (ISE), have been reported to be essential for designing novel and selective PPARδ agonists.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Therefore, in this review, we focused on studies tackling the discovery and structure–activity relationships of the most promising active PPARδ synthetic agonists discovered within the last two decades.</div><div class="NLM_p">Although there are no FDA-approved drugs that specifically target PPARδ, several clinical trials that investigate the safety and efficacy of selective PPARδ agonists have been performed, while some issues needed to be addressed carefully (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifiers NCT03551522, NCT04024813, NCT03602560, NCT03862846, NCT03833128, NCT04226274, NCT04184882, and NCT03941483). One of the major issues is the safety profile of PPARδ agonists, which was called into question after researchers observed how GW501516 induced cancer in multiple organs in long-term animal toxicological studies.<a onclick="showRef(event, 'ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref131 ref132">(131,132)</a> Interestingly, reports showing the clearance of two-year carcinogenicity studies in rodents by MBX-8025 and GFT-505 suggest that the tumorigenicity of GW501516 may be a compound-specific not PPARδ-specific phenomenon.<a onclick="showRef(event, 'ref181 ref182'); return false;" href="javascript:void(0);" class="ref ref181 ref182">(181,182)</a> However, the use of GW501516 did not promote tumor development in early human studies performed in 12 weeks (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT00388180).<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> The long-term effects of GW501516 in humans are still unknown. In order to address the issue of tumorigenesis of PPARδ agonists, a long-term studies of one or more PPARδ agonists in human will be necessary. Controversies surrounding the role of PPARδ in tumor prevention and tumor promotion in animal studies should be addressed by cell-type-specific or tissue-specific studies with selective PPARδ agonists and antagonists. The reason for this research approach is because PPARδ differently regulates gene expression in rodent and human cells.<a onclick="showRef(event, 'ref188 ref189'); return false;" href="javascript:void(0);" class="ref ref188 ref189">(188,189)</a> Efforts to produce PPARδ-specific drugs must improve its isotype selectivity to avoid unwanted off-target side effects, which were observed due to PPARα and PPARγ activation.<a onclick="showRef(event, 'ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref190 ref191">(190,191)</a></div><div class="NLM_p last">In conclusion, several preclinical and clinical studies demonstrated that PPARδ activation is an attractive therapeutic strategy for the prevention and treatment of various diseases, including metabolic disorder, liver disease, and muscular disease. However, due to the ubiquitous expression of PPARδ, careful studies on tissue-targeted drug delivery are needed to prevent these drugs from posing certain health risks on humans. Despite several obstacles regarding the development of drugs that specifically target PPARδ, recent reports on the clinical development of REN-001, ASP0367, ASP1128, and MBX-8025 have bolstered the efforts of pharmaceutical scientists attempting to bring PPARδ-selective agonists into the market. Collectively, this perspective will provide insight and guidance for the future design and development of drugs selectively targeting PPARδ.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01882" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sung Jin Cho</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Leading-edge
Research Center for Drug Discovery and Development for Diabetes and
Metabolic Disease, Kyungpook National University
Hospital, Daegu 41404, Republic of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4786-8830" title="Orcid link">http://orcid.org/0000-0002-4786-8830</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9eedf4fdf6f1defaf9f3f7f8b0ecfbb0f5ec"><span class="__cf_email__" data-cfemail="b8cbd2dbd0d7f8dcdfd5d1de96cadd96d3ca">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jungwook Chin</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6060-0508" title="Orcid link">http://orcid.org/0000-0001-6060-0508</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c8a2bfaba0a1a688acafa5a1aee6baade6a3ba"><span class="__cf_email__" data-cfemail="620815010a0b0c2206050f0b044c10074c0910">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tara Man Kadayat</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aarajana Shrestha</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">College
of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Hyun Jeon</span> - <span class="hlFld-Affiliation affiliation">Laboratory
Animal Center, Daegu-Gyeongbuk Medical Innovation
Foundation, Daegu 41061, Republic of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Leading-edge
Research Center for Drug Discovery and Development for Diabetes and
Metabolic Disease, Kyungpook National University
Hospital, Daegu 41404, Republic of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3161-7698" title="Orcid link">http://orcid.org/0000-0003-3161-7698</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongchan An</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6689-9571" title="Orcid link">http://orcid.org/0000-0001-6689-9571</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jina Kim</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>T.M.K, A.S., and Y.H.J. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Tara Man Kadayat</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=BIO-d7e2237-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Tara Man Kadayat</b> is a registered pharmacist graduated with honors from Pokhara University, Nepal. From 2009 to 2010, he worked as a pharmacology instructor at Nepalgunj Medical College. He was awarded a Korean Government Scholarship to pursue his graduate studies in Korea. In 2016, he received his Ph.D. in Medicinal Chemistry from the College of Pharmacy Yeungnam University, under the guidance of Professor Eung-Seok Lee. Afterward, he joined the Daegu-Gyeongbuk Medical Innovation Foundation’s (DGMIF) New Drug Development Center. In the center, he is engaged in designing efficient synthetic routes for natural and synthetic small molecules and synthesizing PPARδ-agonists, ERRγ-inverse agonists, and HDAC inhibitors. As a principal researcher of a national grant funded by the NRF Korea, he is currently focused on discovery of novel epigenetic inhibitors.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Aarajana Shrestha</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=BIO-d7e2242-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Aarajana Shrestha</b> obtained her bachelor’s degree in Pharmaceutical Sciences with honors from Pokhara University-affiliated Central Institute of Science and Technology (CIST) College Kathmandu in Nepal. She then received her Master’s and Ph.D. degrees in Medicinal Chemistry from Yeungnam University College of Pharmacy in Korea, where she pursued her postdoctoral research under the direction of Professor Eung-Seok Lee. In her Ph.D., she designed and synthesized several heterocyclic small molecules for breast cancer and inflammatory bowel disease. She has published over 25 papers in various medicinal chemistry and pharmaceutical journals, including the <i>Journal of Medicinal Chemistry</i> and the <i>European Journal of Medicinal Chemistry and Chemical Communication</i>. Recently, she joined the DGMIF’s New Drug Development Center to develop biologically active molecules for cardiovascular-metabolic diseases and cancer.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Yong Hyun Jeon</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=BIO-d7e2253-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yong Hyun Jeon</b> studied cancer biology, cancer immunology, and molecular imaging at Seoul National University, South Korea, where he received his Ph.D. in 2008 under the guidance of Prof. June-Key Chung. After a two-year postdoctoral stay in the group of Prof. Brian D. Ross at the University of Michigan (Molecular Imaging Center), he returned to Kyungpook National University, where he initially became a research assistant professor in 2013. In 2017, he joined to DGMIF, where he became a senior researcher at the Laboratory Animal Center. His research focuses on the development of novel drug and theranostic agents for the treatment of metabolic diseases, thyroid cancer, and inflammatory diseases.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Hongchan An</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=BIO-d7e2258-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hongchan An</b> received his B.S. and Ph.D. degrees in Pharmacy in 2008 and 2014 from Seoul National University (SNU) under the guidance of Prof. Young-Ger Suh. He continued his work on the total synthesis of natural products and medicinal chemistry as a postdoctoral researcher of Research Institute of Pharmaceutical Sciences at SNU by 2015. In 2016, he joined the research group of Prof. Thomas Kodadek at The Scripps Research Institute—Scripps Florida for his postdoctoral works on solid-phase construction of DNA-encoded libraries using conformationally constrained oligomers. He joined the Medicinal Chemistry Department of New Drug Development Center, DGMIF, in 2019. His current research interests include drug discovery using small molecules for metabolic disorders, fluid imbalance, and ophthalmic diseases.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Jina Kim</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=BIO-d7e2263-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jina Kim</b> received her Master’s degree in Organic Chemistry in 2012 from Keimyung University under the guidance of Prof. Jinho Lee. In 2013, she joined the Medicinal Chemistry Department of New Drug Development Center of DGMIF, where she has carried out the design and synthesis of small molecules for nuclear receptor ligands and epigenetic modulators. Since 2019, she is working on her Ph.D. in the Research Institute of Pharmaceutical Sciences at Kyungpook National University. Currently, her research focuses on design and discovery of novel small molecules acting on estrogen-related receptor gamma.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Sung Jin Cho</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=BIO-d7e2268-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sung Jin Cho</b> received his degrees in medicinal and pharmaceutical chemistry in 2004 at Yonsei University. Upon completion of his postdoctoral work of CNS drug discovery in Prof. Alan P. Kozikowski’s group at the University of Illinois at Chicago, USA, he joined Process R&D Laboratories of SK Corp in 2010. Since 2012, he has been a principal researcher in discovery chemistry group at the New Drug Development Center of DGMIF to support national drug discovery programs. His current research interests include small-molecule drug discovery targeting nuclear receptors and their application in chemical/biological research.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Jungwook Chin</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=BIO-d7e2273-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jungwook Chin</b> received his Ph.D. in Marine Natural Products Chemistry and Medicinal Chemistry from Seoul National University in 2009, under the guidance of Professor Heonjoong Kang. Afterward, he joined Stanford University’s Chemistry Department and then the Medicinal Chemistry/Drug Discovery department at DGMIF’s New Drug Development Center. At the center, he is engaged in designing efficient synthetic routes for natural products using retrobiosynthetic approach. He is also involved in designing and synthesizing nuclear receptor ligands (AR, LXR, PPAR, ERR/ER ligands), epigenetic modulators, and RNA-targeted small molecules. Dr. Chin is currently the Principal Research Scientist of DGMIF’s New Drug Development Center.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Professor Heonjoong Kang, Seoul National University, for his guidance and his pioneering work on nuclear receptor research in Korea. This work was supported by grants from the National Research Foundation of Korea (NRF) funded by the Korean Government Ministry of Education, Science, ICT, & Future Planning (NRF-2017R1C1B1005599, NRF-2017M3A9G7073088, NRF-2018R1D1A1B07047143, NRF-2020R1C1C1009350, NRF-2020R1C1C1007221).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AMPK</td><td class="NLM_def"><p class="first last">5′ adenosine monophosphate-activated protein kinase</p></td></tr><tr><td class="NLM_term">ADRP</td><td class="NLM_def"><p class="first last">adipose differentiation-related protein</p></td></tr><tr><td class="NLM_term">ANGPTL4</td><td class="NLM_def"><p class="first last">angiopoietin like protein 4</p></td></tr><tr><td class="NLM_term">CPT1</td><td class="NLM_def"><p class="first last">carnitine palmytoyltransferase 1</p></td></tr><tr><td class="NLM_term">COX-2</td><td class="NLM_def"><p class="first last">cyclooxygenase 2</p></td></tr><tr><td class="NLM_term">DHFR</td><td class="NLM_def"><p class="first last">dihydrofolate reductase</p></td></tr><tr><td class="NLM_term">DMD</td><td class="NLM_def"><p class="first last">duchenne muscular dystrophy</p></td></tr><tr><td class="NLM_term">FAOD</td><td class="NLM_def"><p class="first last">fatty acid oxidation disorders</p></td></tr><tr><td class="NLM_term">FFA1</td><td class="NLM_def"><p class="first last">free fatty acid receptor 1</p></td></tr><tr><td class="NLM_term">Glut1</td><td class="NLM_def"><p class="first last">glucose transporter 1</p></td></tr><tr><td class="NLM_term">HDL</td><td class="NLM_def"><p class="first last">high-density lipoprotein</p></td></tr><tr><td class="NLM_term">HoFH</td><td class="NLM_def"><p class="first last">homozygous familial hypercholesterolemia</p></td></tr><tr><td class="NLM_term">15-HETE</td><td class="NLM_def"><p class="first last">15-hydroxyeicosatetraenoic acid</p></td></tr><tr><td class="NLM_term">IRI</td><td class="NLM_def"><p class="first last">ischemia-reperfusion injury</p></td></tr><tr><td class="NLM_term">LDL</td><td class="NLM_def"><p class="first last">low-density lipoprotein</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">MPTP</td><td class="NLM_def"><p class="first last">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</p></td></tr><tr><td class="NLM_term">NAFLD</td><td class="NLM_def"><p class="first last">nonalcoholic fatty liver disease</p></td></tr><tr><td class="NLM_term">NASH</td><td class="NLM_def"><p class="first last">nonalcoholic steatohepatitis</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">NLRP3</td><td class="NLM_def"><p class="first last">nucleotide-binding domain and leucine-rich-repeat-protein 3</p></td></tr><tr><td class="NLM_term">PDK1/Akt</td><td class="NLM_def"><p class="first last">phosphoinositide-dependent kinase 1</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PDK4</td><td class="NLM_def"><p class="first last">pyruvate dehydrogenase kinase 4</p></td></tr><tr><td class="NLM_term">PBC</td><td class="NLM_def"><p class="first last">primary biliary cholangitis/cirrhosis</p></td></tr><tr><td class="NLM_term">PMM</td><td class="NLM_def"><p class="first last">primary mitochondrial myopathy</p></td></tr><tr><td class="NLM_term">PSC</td><td class="NLM_def"><p class="first last">primary sclerosing cholangitis</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">SLC1A5</td><td class="NLM_def"><p class="first last">solute carrier family 1 member 5</p></td></tr><tr><td class="NLM_term">STZ</td><td class="NLM_def"><p class="first last">streptozotocin</p></td></tr><tr><td class="NLM_term">SLE</td><td class="NLM_def"><p class="first last">systemic lupus erythematosus</p></td></tr><tr><td class="NLM_term">BH<sub>4</sub></td><td class="NLM_def"><p class="first last">tetrahydrobiopterin</p></td></tr><tr><td class="NLM_term">TAC</td><td class="NLM_def"><p class="first last">transverse aortic constriction</p></td></tr><tr><td class="NLM_term">VEGFR</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor</p></td></tr><tr><td class="NLM_term">VLDL-TG</td><td class="NLM_def"><p class="first last">very low-density lipoprotein-triglyceride</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 191 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moller, D. E.</span></span> <span> </span><span class="NLM_article-title">The Mechanisms of Action of PPARs</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">435</span>, <span class="refDoi"> DOI: 10.1146/annurev.med.53.082901.104018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1146%2Fannurev.med.53.082901.104018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11818483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitl2mt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=409-435&author=J.+Bergerauthor=D.+E.+Moller&title=The+Mechanisms+of+Action+of+PPARs&doi=10.1146%2Fannurev.med.53.082901.104018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Mechanisms of Action of PPARs</span></div><div class="casAuthors">Berger, Joel; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">409-435</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The peroxisome proliferator-activated receptors (PPARs) are a group of three nuclear receptor isoforms, PPARγ, PPARα, and PPARδ, encoded by different genes.  PPARs are ligand-regulated transcription factors that control gene expression by binding to specific response elements (PPREs) within promoters.  PPARs bind as heterodimers with a retinoid X receptor and, upon binding agonist, interact with co-factors such that the rate of transcription initiation is increased.  The PPARs play a crit. physiol. role as lipid sensors and regulators of lipid metab.  Fatty acids and eicosanoids have been identified as natural ligands for the PPARs.  More potent synthetic PPAR ligands, including the fibrates and thiazolidinediones, have proven effective in the treatment of dyslipidemia and diabetes.  Use of such ligands has allowed researchers to unveil many potential roles for the PPARs in pathol. states including atherosclerosis, inflammation, cancer, infertility, and demyelination.  Here, we present the current state of knowledge regarding the mol. mechanisms of PPAR action and the involvement of the PPARs in the etiol. and treatment of several chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6rxPu_VgKKLVg90H21EOLACvtfcHk0lgG2T0U6vvWuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitl2mt7s%253D&md5=cc724640866d5fa365b4e637d85f6732</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.53.082901.104018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.53.082901.104018%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DThe%2520Mechanisms%2520of%2520Action%2520of%2520PPARs%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2002%26volume%3D53%26spage%3D409%26epage%3D435%26doi%3D10.1146%2Fannurev.med.53.082901.104018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luquet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Soriano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jehl-Pietri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenrich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimaldi, P. A.</span></span> <span> </span><span class="NLM_article-title">Roles of PPAR delta in Lipid Absorption and Metabolism: A New Target for the Treatment of Type 2 Diabetes</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1740</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2004.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbadis.2004.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15949697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFCrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1740&publication_year=2005&pages=313-317&author=S.+Luquetauthor=C.+Gaudelauthor=D.+Holstauthor=J.+Lopez-Sorianoauthor=C.+Jehl-Pietriauthor=A.+Fredenrichauthor=P.+A.+Grimaldi&title=Roles+of+PPAR+delta+in+Lipid+Absorption+and+Metabolism%3A+A+New+Target+for+the+Treatment+of+Type+2+Diabetes&doi=10.1016%2Fj.bbadis.2004.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes</span></div><div class="casAuthors">Luquet, Serge; Gaudel, Celine; Holst, Dorte; Lopez-Soriano, Joaquin; Jehl-Pietri, Chantal; Fredenrich, Alexandre; Grimaldi, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1740</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-317</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptors (PPARs) are lipid-activated transcription factors exerting several functions in development and metab.  PPARα, activated by polyunsatd. fatty acids and fibrates, is implicated in regulation of lipid metab., lipoprotein synthesis and metab. and inflammatory response in liver and other tissues.  PPARγ plays important roles in regulation of proliferation and differentiation of several cell types, including adipose cells.  Its activation by thiazolidinediones results in insulin sensitization and antidiabetic action.  Until recently, the physiol. functions of PPARδ remain elusive.  The utilization of specific agonists and of appropriate cellular and animal models revealed that PPARδ has an important role in metabolic adaptation of several tissues to environmental changes.  Treatment of obese animals by specific PPARδ agonists results in normalization of metabolic parameters and redn. of adiposity.  The nuclear receptor appeared to be implicated in the regulation of fatty acid burning capacities of skeletal muscle and adipose tissue by controlling the expression of genes involved in fatty acid uptake, β-oxidn. and energy uncoupling.  PPARδ is also implicated in the adaptive metabolic response of skeletal muscle to endurance exercise by controlling the no. of oxidative myofibers.  Given the results obtained with animal models, PPARδ agonists may have therapeutic usefulness in metabolic syndrome by increasing fatty acid consumption in skeletal muscle and adipose tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY-uVNEu9Q3rVg90H21EOLACvtfcHk0lgG2T0U6vvWuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFCrurs%253D&md5=1ec87eda53962cbf2bc5e59739b90905</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2004.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2004.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DLuquet%26aufirst%3DS.%26aulast%3DGaudel%26aufirst%3DC.%26aulast%3DHolst%26aufirst%3DD.%26aulast%3DLopez-Soriano%26aufirst%3DJ.%26aulast%3DJehl-Pietri%26aufirst%3DC.%26aulast%3DFredenrich%26aufirst%3DA.%26aulast%3DGrimaldi%26aufirst%3DP.%2BA.%26atitle%3DRoles%2520of%2520PPAR%2520delta%2520in%2520Lipid%2520Absorption%2520and%2520Metabolism%253A%2520A%2520New%2520Target%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2005%26volume%3D1740%26spage%3D313%26epage%3D317%26doi%3D10.1016%2Fj.bbadis.2004.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, R. K.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptors (PPARs) as Therapeutic Target in Neurodegenerative Disorders</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>483</i></span>,  <span class="NLM_fpage">1166</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.08.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbrc.2016.08.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27514452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyitr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2017&pages=1166-1177&author=S.+Agarwalauthor=A.+Yadavauthor=R.+K.+Chaturvedi&title=Peroxisome+Proliferator-activated+Receptors+%28PPARs%29+as+Therapeutic+Target+in+Neurodegenerative+Disorders&doi=10.1016%2Fj.bbrc.2016.08.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders</span></div><div class="casAuthors">Agarwal, Swati; Yadav, Anuradha; Chaturvedi, Rajnish Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1166-1177</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors and they serve to be a promising therapeutic target for several neurodegenerative disorders, which includes Parkinson disease, Alzheimer's disease, Huntington disease and Amyotrophic Lateral Sclerosis.  PPARs play an important role in the downregulation of mitochondrial dysfunction, proteasomal dysfunction, oxidative stress, and neuroinflammation, which are the major causes of the pathogenesis of neurodegenerative disorders.  In this review, we discuss about the role of PPARs as therapeutic targets in neurodegenerative disorders.  Several exptl. approaches suggest potential application of PPAR agonist as well as antagonist in the treatment of neurodegenerative disorders.  Several epidemiol. studies found that the regular usage of PPAR activating non-steroidal anti-inflammatory drugs is effective in decreasing the progression of neurodegenerative diseases including PD and AD.  We also reviewed the neuroprotective effects of PPAR agonists and assocd. mechanism of action in several neurodegenerative disorders both in vitro as well as in vivo animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmB7cvlUA4M7Vg90H21EOLACvtfcHk0lgfybZGxodtSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyitr%252FJ&md5=98a18a443ab2a6e10bcd46a3bf889f3b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.08.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.08.043%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DA.%26aulast%3DChaturvedi%26aufirst%3DR.%2BK.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptors%2520%2528PPARs%2529%2520as%2520Therapeutic%2520Target%2520in%2520Neurodegenerative%2520Disorders%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D483%26spage%3D1166%26epage%3D1177%26doi%3D10.1016%2Fj.bbrc.2016.08.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, R.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ in Human Cancer</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2016.10.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.biochi.2016.10.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27916645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOltrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=90-99&author=R.+M%C3%BCller&title=PPAR%CE%B2%2F%CE%B4+in+Human+Cancer&doi=10.1016%2Fj.biochi.2016.10.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ in human cancer</span></div><div class="casAuthors">Mueller, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90-99</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The nuclear receptor factor peroxisome proliferator-activated receptor (PPARβ/δ) can regulate its target genes by transcriptional activation or repression through both ligand-dependent and independent mechanism as well as by interactions with other transcription factors.  PPARβ/δ exerts essential regulatory functions in intermediary metab. that have been elucidated in detail, but clearly also plays a role in inflammation, differentiation, apoptosis and other cancer-assocd. processes, which is, however, mechanistically only partly understood.  Consistent with these functions clin. assocns. link the expression of PPARβ/δ and its target genes to an unfavorable outcome of several human cancers.  However, the available data do not yield a clear picture of PPARβ/δ's role in cancer-assocd. processes and are in fact partly controversial.  This article provides an overview of this research area and discusses the role of PPARβ/δ in cancer in light of the complex mechanisms of its transcriptional regulation and its potential as a druggable anti-cancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3o_xMr_T8CrVg90H21EOLACvtfcHk0lgfybZGxodtSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOltrrL&md5=25f48b7968294de3851ea54736d28286</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2016.10.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2016.10.019%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520in%2520Human%2520Cancer%26jtitle%3DBiochimie%26date%3D2017%26volume%3D136%26spage%3D90%26epage%3D99%26doi%3D10.1016%2Fj.biochi.2016.10.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, T.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span> <span> </span><span class="NLM_article-title">PPARδ is an APC-regulated Target of Nonsteroidal Anti-inflammatory Drugs</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81664-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS0092-8674%2800%2981664-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10555149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Gqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=335-345&author=T.-C.+Heauthor=T.+A.+Chanauthor=B.+Vogelsteinauthor=K.+W.+Kinzler&title=PPAR%CE%B4+is+an+APC-regulated+Target+of+Nonsteroidal+Anti-inflammatory+Drugs&doi=10.1016%2FS0092-8674%2800%2981664-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs</span></div><div class="casAuthors">He, Tong-Chuan; Chan, Timothy A.; Vogelstein, Bert; Kinzler, Kenneth W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">335-345</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PPARδ was identified as a target of APC through the anal. of global gene expression profiles in human colorectal cancer (CRC) cells.  PPARδ expression was elevated in CRCs and repressed by APC in CRC cells.  This repression was mediated by β-catenin/Tcf-4-responsive elements in the PPARδ promoter.  The ability of PPARs to bind eicosanoids suggested that PPARδ might be a target of chemopreventive non-steroidal anti-inflammatory drugs (NSAIDs).  Reporters contg. PPARδ-responsive elements were repressed by the NSAID sulindac.  Furthermore, sulindac was able to disrupt the ability of PPARδ to bind its recognition sequences.  These findings suggest that NSAIDs inhibit tumorigenesis through inhibition of PPARδ, the gene for which is normally regulated by APC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt8U6N3sHH_7Vg90H21EOLACvtfcHk0lgfybZGxodtSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Gqs7k%253D&md5=fa435945158d8e44477fdb3d55219fbe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981664-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981664-5%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DT.-C.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DPPAR%25CE%25B4%2520is%2520an%2520APC-regulated%2520Target%2520of%2520Nonsteroidal%2520Anti-inflammatory%2520Drugs%26jtitle%3DCell%26date%3D1999%26volume%3D99%26spage%3D335%26epage%3D345%26doi%3D10.1016%2FS0092-8674%2800%2981664-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwashita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, N.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective Efficacy of the Peroxisome Proliferator-activated Receptor δ-selective Agonists In Vitro and In Vivo</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>320</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1096</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.115758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1124%2Fjpet.106.115758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17167170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1WgtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1087-1096&author=A.+Iwashitaauthor=Y.+Muramatsuauthor=T.+Yamazakiauthor=M.+Muramotoauthor=Y.+Kitaauthor=S.+Yamazakiauthor=K.+Miharaauthor=A.+Moriguchiauthor=N.+Matsuoka&title=Neuroprotective+Efficacy+of+the+Peroxisome+Proliferator-activated+Receptor+%CE%B4-selective+Agonists+In+Vitro+and+In+Vivo&doi=10.1124%2Fjpet.106.115758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective efficacy of the peroxisome proliferator-activated receptor δ-selective agonists in vitro and in vivo</span></div><div class="casAuthors">Iwashita, Akinori; Muramatsu, Yuko; Yamazaki, Takao; Muramoto, Masakazu; Kita, Yasuhiro; Yamazaki, Shunji; Mihara, Kayoko; Moriguchi, Akira; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1087-1096</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor superfamily and function as ligand-modulated transcription factors that regulate gene expression in many important biol. processes.  The PPARδ subtype has the highest expression in the brain and is postulated to play a major role in neuronal cell function; however, the precise physiol. roles of this receptor remain to be elucidated.  Herein, we show that the high-affinity PPARδ agonists L-165041 [4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propoxyl]phenoxy]-acetic acid and GW501516 [2-methyl4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-triazol-5-yl)-methylsulfanyl)phenoxy acetic acid] protect against cytotoxin-induced SH-SY5Y cell injury in vitro and both ischemic brain injury and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in vivo.  In the SH-SY5Y studies, treatment with L-165041 or GW501516 significantly and concn.-dependently attenuated cell death following thapsigargin, 1-methyl-4-phenylpyridinium, or staurosporine exposure, with the extent of damage correlated with the level of caspase-3 inhibition.  In the transient (90 min) middle cerebral artery occlusion model of ischemic brain injury in rats, i.c.v. infusion of L-165041 or GW501516 significantly attenuated the ischemic brain damage measured 24 h after reperfusion.  Moreover, the PPARδ agonists also significantly attenuated MPTP-induced depletion of striatal dopamine and related metabolite contents in mouse brain.  These results demonstrate that subtype-selective PPARδ agonists possess antiapoptotic properties in vitro, which may underlie their potential neuroprotective potential in in vivo exptl. models of cerebral ischemia and Parkinson's disease (PD).  These findings suggest that PPARδ agonists could be useful tools for understanding the role of PPARδ in other neurodegenerative disorders, as well as attractive therapeutic candidates for stroke and neurodegenerative diseases such as PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyN0bNjzlop7Vg90H21EOLACvtfcHk0lipTVi4nzBhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1WgtLY%253D&md5=ec2b2359134c34cd4efca38c9e33c764</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.115758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.115758%26sid%3Dliteratum%253Aachs%26aulast%3DIwashita%26aufirst%3DA.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DMuramoto%26aufirst%3DM.%26aulast%3DKita%26aufirst%3DY.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DMihara%26aufirst%3DK.%26aulast%3DMoriguchi%26aufirst%3DA.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DNeuroprotective%2520Efficacy%2520of%2520the%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4-selective%2520Agonists%2520In%2520Vitro%2520and%2520In%2520Vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1087%26epage%3D1096%26doi%3D10.1124%2Fjpet.106.115758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peraza, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">The Role of Peroxisome Proliferator-activated Receptor-β/δ in Epithelial Cell Growth and Differentiation</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2005.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.cellsig.2005.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16109478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=9-20&author=A.+D.+Burdickauthor=D.+J.+Kimauthor=M.+A.+Perazaauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=The+Role+of+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+in+Epithelial+Cell+Growth+and+Differentiation&doi=10.1016%2Fj.cellsig.2005.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiation</span></div><div class="casAuthors">Burdick, Andrew D.; Kim, Dae J.; Peraza, Marjorie A.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-20</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The physiol. and pharmacol. roles of peroxisome proliferator-activated receptor-β (PPARβ-also referred to as PPARδ) are just beginning to emerge.  It has recently become clear that PPARβ has a function in epithelial tissues, but controversy exists due to inconsistencies in the literature.  There is strong evidence that ligand activation of PPARβ can induce terminal differentiation of keratinocytes, with a concomitant inhibition of cell proliferation.  However, the role of PPARβ in keratinocyte-specific apoptosis is less clear.  Addnl., the role of PPARβ in colonic epithelium remains unclear due to conflicting evidence suggesting that ligand activation of PPARβ can potentiate, as well as attenuate, intestinal cancer.  Recent studies revealed that ligand activation of PPARβ can induce fatty acid catabolism in skeletal muscle and is assocd. with improved insulin sensitivity, attenuated wt. gain and elevated HDL levels thus demonstrating promising potential for targeting PPARβ for treating obesity, dyslipidemias and type 2 diabetes.  Therefore, it becomes crit. to det. the safety of PPARβ ligands.  This review focuses on recent literature describing the role of PPARβ in epithelial tissues and highlights crit. discrepancies that need to be resolved for a more comprehensive understanding of how this receptor modulates epithelial homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZiOaK1_krLVg90H21EOLACvtfcHk0lipTVi4nzBhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrzM&md5=7b88323aaff8064c499d66efe1c98695</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2005.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2005.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DBurdick%26aufirst%3DA.%2BD.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DPeraza%26aufirst%3DM.%2BA.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520Role%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520in%2520Epithelial%2520Cell%2520Growth%2520and%2520Differentiation%26jtitle%3DCell.%2520Signalling%26date%3D2006%26volume%3D18%26spage%3D9%26epage%3D20%26doi%3D10.1016%2Fj.cellsig.2005.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span> <span> </span><span class="NLM_article-title">PPARbeta/delta Ligands as Modulators of the Inflammatory Response</span>. <i>Curr. Opin. Investig. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18465655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntl2rsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=463-469&author=K.+S.+Kilgoreauthor=A.+N.+Billin&title=PPARbeta%2Fdelta+Ligands+as+Modulators+of+the+Inflammatory+Response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ ligands as modulators of the inflammatory response</span></div><div class="casAuthors">Kilgore, Kenneth S.; Billin, Andrew N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptors (PPARs) are steroid hormone nuclear receptors encoded by three genes: α, γ and β/δ.  Small-mol. agonists of this family of receptors, mostly PPARα and PPARγ agonists, possess pronounced anti-inflammatory effects; however, the use of selective PPARβ/δ agonists in preclin. studies suggests that this subtype also possesses anti-inflammatory properties.  In vivo data suggest that ligands to the β/δ isoform have activity in a no. of disease models that are partly driven by the inflammatory response.  Thus, selective activation of PPARβ/δ may represent a promising therapeutic approach for the treatment of diseases that have inflammation as a central component of their pathophysiol.  An overview of preclin. data that support the ability of PPARβ/δ agonists to modulate the inflammatory response is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolUpPhCY76QbVg90H21EOLACvtfcHk0lipTVi4nzBhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntl2rsbs%253D&md5=75966b86679646c97aa02aba93ca00c5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKilgore%26aufirst%3DK.%2BS.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26atitle%3DPPARbeta%252Fdelta%2520Ligands%2520as%2520Modulators%2520of%2520the%2520Inflammatory%2520Response%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2008%26volume%3D9%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Calvo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Marco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astudillo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balsinde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomer, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">The PPARβ/δ Activator GW501516 Prevents the Down-egulation of AMPK Caused by a High-fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">1848</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.1210/en.2010-1468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1210%2Fen.2010-1468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21363937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVKqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=1848-1859&author=E.+Barrosoauthor=R.+Rodr%C3%ADguez-Calvoauthor=L.+Serrano-Marcoauthor=A.+M.+Astudilloauthor=J.+Balsindeauthor=X.+Palomerauthor=M.+V%C3%A1zquez-Carrera&title=The+PPAR%CE%B2%2F%CE%B4+Activator+GW501516+Prevents+the+Down-egulation+of+AMPK+Caused+by+a+High-fat+Diet+in+Liver+and+Amplifies+the+PGC-1%CE%B1-Lipin+1-PPAR%CE%B1+Pathway+Leading+to+Increased+Fatty+Acid+Oxidation&doi=10.1210%2Fen.2010-1468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-lipin 1-PPARα pathway leading to increased fatty acid oxidation</span></div><div class="casAuthors">Barroso, Emma; Rodriguez-Calvo, Ricardo; Serrano-Marco, Lucia; Astudillo, Alma M.; Balsinde, Jesus; Palomer, Xavier; Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1848-1859</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Metabolic syndrome-assocd. dyslipidemia is mainly initiated by hepatic overprodn. of the plasma lipoproteins carrying triglycerides.  Here we examd. the effects of the peroxisome proliferator-activated receptors (PPAR)-β/δ activator GW501516 on high-fat diet (HFD)-induced hypertriglyceridemia and hepatic fatty acid oxidn.  Exposure to the HFD caused hypertriglyceridemia that was accompanied by reduced hepatic mRNA levels of PPAR-γ coactivator 1 (PGC-1)-α and lipin 1, and these effects were prevented by GW501516 treatment.  GW501516 treatment also increased nuclear lipin 1 protein levels, leading to amplification in the PGC-1α-PPARα signaling system, as demonstrated by the increase in PPARα levels and PPARα-DNA binding activity and the increased expression of PPARα-target genes involved in fatty acid oxidn.  These effects of GW501516 were accompanied by an increase in plasma β-hydroxybutyrate levels, demonstrating enhanced hepatic fatty acid oxidn.  Moreover, GW501516 increased the levels of the hepatic endogenous ligand for PPARα, 16:0/18:1-phosphatidilcholine and markedly enhanced the expression of the hepatic Vldl receptor.  Interestingly, GW501516 prevented the redn. in AMP-activated protein kinase (AMPK) phosphorylation and the increase in phosphorylated levels of ERK1/2 caused by HFD.  In addn., our data indicate that the activation of AMPK after GW501516 treatment in mice fed HFD might be the result of an increase in the AMP to ATP ratio in hepatocytes.  These findings indicate that the hypotriglyceridemic effect of GW501516 in HFD-fed mice is accompanied by an increase in phospho-AMPK levels and the amplification of the PGC-1α-lipin 1-PPARα pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoatnfQ6xMbCbVg90H21EOLACvtfcHk0lj5dMJmb-E_CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVKqurc%253D&md5=cd9ea28617eb0777ffe36ecbd28b6104</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1210%2Fen.2010-1468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2010-1468%26sid%3Dliteratum%253Aachs%26aulast%3DBarroso%26aufirst%3DE.%26aulast%3DRodr%25C3%25ADguez-Calvo%26aufirst%3DR.%26aulast%3DSerrano-Marco%26aufirst%3DL.%26aulast%3DAstudillo%26aufirst%3DA.%2BM.%26aulast%3DBalsinde%26aufirst%3DJ.%26aulast%3DPalomer%26aufirst%3DX.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DThe%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Activator%2520GW501516%2520Prevents%2520the%2520Down-egulation%2520of%2520AMPK%2520Caused%2520by%2520a%2520High-fat%2520Diet%2520in%2520Liver%2520and%2520Amplifies%2520the%2520PGC-1%25CE%25B1-Lipin%25201-PPAR%25CE%25B1%2520Pathway%2520Leading%2520to%2520Increased%2520Fatty%2520Acid%2520Oxidation%26jtitle%3DEndocrinology%26date%3D2011%26volume%3D152%26spage%3D1848%26epage%3D1859%26doi%3D10.1210%2Fen.2010-1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barlaka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galatou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellidis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravingerova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazou, A.</span></span> <span> </span><span class="NLM_article-title">Role of Pleiotropic Properties of Peroxisome Proliferator-activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection</span>. <i>Cardiovasc. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1111/1755-5922.12166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1111%2F1755-5922.12166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=26589375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFOktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=37-48&author=E.+Barlakaauthor=E.+Galatouauthor=K.+Mellidisauthor=T.+Ravingerovaauthor=A.+Lazou&title=Role+of+Pleiotropic+Properties+of+Peroxisome+Proliferator-activated+Receptors+in+the+Heart%3A+Focus+on+the+Nonmetabolic+Effects+in+Cardiac+Protection&doi=10.1111%2F1755-5922.12166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection</span></div><div class="casAuthors">Barlaka, Eleftheria; Galatou, Eleftheria; Mellidis, Kyriakos; Ravingerova, Tanya; Lazou, Antigone</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-48</span>CODEN:
                <span class="NLM_cas:coden">CTAHCA</span>;
        ISSN:<span class="NLM_cas:issn">1755-5914</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Peroxisome proliferator-activated receptors, PPARα, PPARβ/δ, and PPARγ, are a group of nuclear receptors that function as transcriptional regulators of lipid metab., energy homeostasis, and inflammation.  Given the role of metab. imbalance under pathol. states of the heart, PPARs have emerged as important therapeutic targets, and accumulating evidence highlights their protective role in the improvement of cardiac function under diverse pathol. settings.  Although the role of PPARs in the regulation of cardiac substrate utilization preference and energy homeostasis is well documented, their effects related to the regulation of cellular inflammatory and redox responses in the heart are less studied.  In this review, we provide an overview on recent progress with respect to understanding the role of the nonmetabolic effects of PPARs in cardiac dysfunction, namely during ischemia/reperfusion injury, hypertrophy, and cardiac failure, and highlight the mechanisms underlying the protective effects against inflammation, oxidative stress, and cell death.  The role of receptor-independent, nongenomic effects of PPAR agonists is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf_rtPnhP9y7Vg90H21EOLACvtfcHk0lj5dMJmb-E_CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFOktQ%253D%253D&md5=379cb4f64c714f661f5ff06b7b219586</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2F1755-5922.12166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1755-5922.12166%26sid%3Dliteratum%253Aachs%26aulast%3DBarlaka%26aufirst%3DE.%26aulast%3DGalatou%26aufirst%3DE.%26aulast%3DMellidis%26aufirst%3DK.%26aulast%3DRavingerova%26aufirst%3DT.%26aulast%3DLazou%26aufirst%3DA.%26atitle%3DRole%2520of%2520Pleiotropic%2520Properties%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptors%2520in%2520the%2520Heart%253A%2520Focus%2520on%2520the%2520Nonmetabolic%2520Effects%2520in%2520Cardiac%2520Protection%26jtitle%3DCardiovasc.%2520Ther.%26date%3D2016%26volume%3D34%26spage%3D37%26epage%3D48%26doi%3D10.1111%2F1755-5922.12166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwaisako, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haimerl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirlin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnabl, B.</span></span> <span> </span><span class="NLM_article-title">Protection from Liver Fibrosis by a Peroxisome Proliferator-activated Receptor δ Agonist</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">E1369</span>– <span class="NLM_lpage">E1376</span>, <span class="refDoi"> DOI: 10.1073/pnas.1202464109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.1202464109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22538808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVOnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=E1369-E1376&author=K.+Iwaisakoauthor=M.+Haimerlauthor=Y.-H.+Paikauthor=K.+Tauraauthor=Y.+Kodamaauthor=C.+Sirlinauthor=E.+Yuauthor=R.+T.+Yuauthor=M.+Downesauthor=R.+M.+Evansauthor=D.+A.+Brennerauthor=B.+Schnabl&title=Protection+from+Liver+Fibrosis+by+a+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist&doi=10.1073%2Fpnas.1202464109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist</span></div><div class="casAuthors">Iwaisako, Keiko; Haimerl, Michael; Paik, Yong-Han; Taura, Kojiro; Kodama, Yuzo; Sirlin, Claude; Yu, Elizabeth; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.; Brenner, David A.; Schnabl, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">E1369-E1376, SE1369/1-SE1369/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor delta (PPARδ), a member of the nuclear receptor family, is emerging as a key metabolic regulator with pleiotropic actions on various tissues including fat, skeletal muscle, and liver.  Here we show that the PPARδ agonist KD3010, but not the well-validated GW501516, dramatically ameliorates liver injury induced by carbon tetrachloride (CCl4) injections.  Deposition of extracellular matrix proteins was lower in the KD3010-treated group than in the vehicle- or GW501516-treated group.  Interestingly, profibrogenic connective tissue growth factor was induced significantly by GW501516, but not by KD3010, following CCl4 treatment.  The hepatoprotective and antifibrotic effect of KD3010 was confirmed in a model of cholestasis-induced liver injury and fibrosis using bile duct ligation for 3 wk.  Primary hepatocytes treated with KD3010 but not GW501516 were protected from starvation or CCl4-induced cell death, in part because of reduced reactive oxygen species prodn.  In conclusion, our data demonstrate that an orally active PPARδ agonist has hepatoprotective and antifibrotic effects in animal models of liver fibrosis, suggesting a possible mechanistic and therapeutic approach in treating patients with chronic liver diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnEkKoHzrbmrVg90H21EOLACvtfcHk0lhxSnhGioL6xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVOnt7s%253D&md5=23baed11cc982053df607a0e667e5af2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1202464109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1202464109%26sid%3Dliteratum%253Aachs%26aulast%3DIwaisako%26aufirst%3DK.%26aulast%3DHaimerl%26aufirst%3DM.%26aulast%3DPaik%26aufirst%3DY.-H.%26aulast%3DTaura%26aufirst%3DK.%26aulast%3DKodama%26aufirst%3DY.%26aulast%3DSirlin%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DBrenner%26aufirst%3DD.%2BA.%26aulast%3DSchnabl%26aufirst%3DB.%26atitle%3DProtection%2520from%2520Liver%2520Fibrosis%2520by%2520a%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3DE1369%26epage%3DE1376%26doi%3D10.1073%2Fpnas.1202464109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-g.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paria, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moller, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzaskos, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S. K.</span></span> <span> </span><span class="NLM_article-title">Cyclo-oxygenase-2-derived Prostacyclin Mediates Embryo Implantation in the Mouse via PPARδ</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1561</span>– <span class="NLM_lpage">1574</span>, <span class="refDoi"> DOI: 10.1101/gad.13.12.1561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1101%2Fgad.13.12.1561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10385625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1MXktlOhsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1561-1574&author=H.+Limauthor=R.+A.+Guptaauthor=W.-g.+Maauthor=B.+C.+Pariaauthor=D.+E.+Mollerauthor=J.+D.+Morrowauthor=R.+N.+DuBoisauthor=J.+M.+Trzaskosauthor=S.+K.+Dey&title=Cyclo-oxygenase-2-derived+Prostacyclin+Mediates+Embryo+Implantation+in+the+Mouse+via+PPAR%CE%B4&doi=10.1101%2Fgad.13.12.1561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ</span></div><div class="casAuthors">Lim, Hyunjung; Gupta, Rajnish A.; Ma, Wen-Ge; Paria, Bibhash C.; Moller, David E.; Morrow, Jason D.; DuBois, Raymond N.; Trzaskos, James M.; Dey, Sudhansu K.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1561-1574</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The authors have demonstrated previously that cyclo-oxygenase-2 (COX2), the rate-limiting enzyme in the biosynthesis of prostaglandins (PGs), is essential for blastocyst implantation and decidualization.  However, the candidate PG(s) that participates in these processes and the mechanism of its action remain undefined.  Using COX2-deficient mice and multiple approaches, the authors demonstrate herein that COX2-derived prostacyclin (PGI2) is the primary PG that is essential for implantation and decidualization.  Several lines of evidence suggest that the effects of PGI2 are mediated by its activation of the nuclear hormone receptor PPARδ, demonstrating the first reported biol. function of this receptor signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0jrsofrvVl7Vg90H21EOLACvtfcHk0lhxSnhGioL6xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktlOhsbw%253D&md5=9e9bb37755513cff82da6d4d2f9bf26e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.12.1561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.12.1561%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DH.%26aulast%3DGupta%26aufirst%3DR.%2BA.%26aulast%3DMa%26aufirst%3DW.-g.%26aulast%3DParia%26aufirst%3DB.%2BC.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26aulast%3DTrzaskos%26aufirst%3DJ.%2BM.%26aulast%3DDey%26aufirst%3DS.%2BK.%26atitle%3DCyclo-oxygenase-2-derived%2520Prostacyclin%2520Mediates%2520Embryo%2520Implantation%2520in%2520the%2520Mouse%2520via%2520PPAR%25CE%25B4%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D1561%26epage%3D1574%26doi%3D10.1101%2Fgad.13.12.1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geraci, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, R. N.</span></span> <span> </span><span class="NLM_article-title">Prostacyclin-mediated Activation of Peroxisome Proliferator-activated Receptor δ in Colorectal Cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">13275</span>– <span class="NLM_lpage">13280</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.24.13275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.97.24.13275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11087869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVOjsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=13275-13280&author=R.+A.+Guptaauthor=J.+Tanauthor=W.+F.+Krauseauthor=M.+W.+Geraciauthor=T.+M.+Willsonauthor=S.+K.+Deyauthor=R.+N.+DuBois&title=Prostacyclin-mediated+Activation+of+Peroxisome+Proliferator-activated+Receptor+%CE%B4+in+Colorectal+Cancer&doi=10.1073%2Fpnas.97.24.13275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer</span></div><div class="casAuthors">Gupta, Rajnish A.; Tan, Jian; Krause, Wade F.; Geraci, Mark W.; Willson, Timothy M.; Dey, Sudhansu K.; DuBois, Raymond N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13275-13280</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">There is evidence from both genetic and pharmacol. studies to suggest that the cyclooxygenase-2 (COX-2) enzyme plays a causal role in the development of colorectal cancer.  However, little is known about the identity or role of the eicosanoid receptor pathways activated by COX-derived prostaglandins (PG).  The authors previously have reported that COX-2-derived prostacyclin promotes embryo implantation in the mouse uterus via activation of the nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR) δ.  In light of the recent finding that PPARδ is a target of β-catenin transactivation, it is important to det. whether this signaling pathway is operative during the development of colorectal cancer.  Anal. of PPARδ mRNA in matched normal and tumor samples revealed that expression of PPARδ, similar to COX-2, is up-regulated in colorectal carcinomas.  In situ hybridization studies demonstrate that PPARδ is expressed in normal colon and localized to the epithelial cells at the very tips of the mucosal glands.  In contrast, expression of PPARδ mRNA in colorectal tumors was more widespread with increased levels in transformed epithelial cells.  Anal. of PPARδ and COX-2 mRNA in serial sections suggested they were colocalized to the same region within a tumor.  Finally, transient transfection assays established that endogenously synthesized prostacyclin (PGI2) could serve as a ligand for PPARδ.  In addn., the stable PGI2 analog, carbaprostacyclin, and a synthetic PPARδ agonist induced transactivation of endogenous PPARδ in human colon carcinoma cells.  The authors conclude from these observations that PPARδ, similar to COX-2, is aberrantly expressed in colorectal tumors and that endogenous PPARδ is transcriptionally responsive to PGI2.  However, the functional consequence of PPARδ activation in colon carcinogenesis still needs to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosPvlXKDhVXbVg90H21EOLACvtfcHk0liTrndrJO1apg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVOjsr8%253D&md5=8adadad6b2e680dcedd16e256a5341ed</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.24.13275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.24.13275%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DR.%2BA.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DKrause%26aufirst%3DW.%2BF.%26aulast%3DGeraci%26aufirst%3DM.%2BW.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DDey%26aufirst%3DS.%2BK.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26atitle%3DProstacyclin-mediated%2520Activation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520in%2520Colorectal%2520Cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D13275%26epage%3D13280%26doi%3D10.1073%2Fpnas.97.24.13275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schumann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adhikary, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkernagel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnitzer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schober, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nockher, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiewe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinartz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Brüsselbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, R.</span></span> <span> </span><span class="NLM_article-title">Deregulation of PPARβ/δ Target Genes in Tumor-associated Macrophages by Fatty Acid Ligands in the Ovarian Cancer Microenvironment</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">13416</span>– <span class="NLM_lpage">13433</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.18632%2Foncotarget.3826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25968567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC2MfjsFSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=13416-13433&author=T.+Schumannauthor=T.+Adhikaryauthor=A.+Wortmannauthor=F.+Finkernagelauthor=S.+Lieberauthor=E.+Schnitzerauthor=N.+Legrandauthor=Y.+Schoberauthor=W.+A.+Nockherauthor=P.+M.+Tothauthor=W.+E.+Diederichauthor=A.+Nistauthor=T.+Stieweauthor=U.+Wagnerauthor=S.+Reinartzauthor=S.+M%C3%BCller-Br%C3%BCsselbachauthor=R.+M%C3%BCller&title=Deregulation+of+PPAR%CE%B2%2F%CE%B4+Target+Genes+in+Tumor-associated+Macrophages+by+Fatty+Acid+Ligands+in+the+Ovarian+Cancer+Microenvironment&doi=10.18632%2Foncotarget.3826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment</span></div><div class="casAuthors">Schumann Tim; Adhikary Till; Wortmann Annika; Finkernagel Florian; Lieber Sonja; Schnitzer Evelyn; Legrand Nathalie; Muller-Brusselbach Sabine; Muller Rolf; Schober Yvonne; Nockher W Andreas; Toth Philipp M; Diederich Wibke E; Nist Andrea; Stiewe Thorsten; Wagner Uwe; Reinartz Silke</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">13416-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is a lipid ligand-inducible transcription factor associated with macrophage polarization.  However, its function in tumor-associated macrophages (TAMs) has not been investigated to date.  Here, we report the PPARβ/δ-regulated transcriptome and cistrome for TAMs from ovarian carcinoma patients.  Comparison with monocyte-derived macrophages shows that the vast majority of direct PPARβ/δ target genes are upregulated in TAMs and largely refractory to synthetic agonists, but repressible by inverse agonists.  Besides genes with metabolic functions, these include cell type-selective genes associated with immune regulation and tumor progression, e.g., LRP5, CD300A, MAP3K8 and ANGPTL4.  This deregulation is not due to increased expression of PPARβ/δ or its enhanced recruitment to target genes.  Instead, lipidomic analysis of malignancy-associated ascites revealed high concentrations of polyunsaturated fatty acids, in particular linoleic acid, acting as potent PPARβ/δ agonists in macrophages.  These fatty acid ligands accumulate in lipid droplets in TAMs, thereby providing a reservoir of PPARβ/δ ligands.  These observations suggest that the deregulation of PPARβ/δ target genes by ligands of the tumor microenvironment contributes to the pro-tumorigenic polarization of ovarian carcinoma TAMs.  This conclusion is supported by the association of high ANGPTL4 expression with a shorter relapse-free survival in serous ovarian carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQKXDQm87QVYHy-c-E1v-fmfW6udTcc2ebCYRy1Xrja6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfjsFSktA%253D%253D&md5=595d16fe0aae865d381c97e7ffec2248</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3826%26sid%3Dliteratum%253Aachs%26aulast%3DSchumann%26aufirst%3DT.%26aulast%3DAdhikary%26aufirst%3DT.%26aulast%3DWortmann%26aufirst%3DA.%26aulast%3DFinkernagel%26aufirst%3DF.%26aulast%3DLieber%26aufirst%3DS.%26aulast%3DSchnitzer%26aufirst%3DE.%26aulast%3DLegrand%26aufirst%3DN.%26aulast%3DSchober%26aufirst%3DY.%26aulast%3DNockher%26aufirst%3DW.%2BA.%26aulast%3DToth%26aufirst%3DP.%2BM.%26aulast%3DDiederich%26aufirst%3DW.%2BE.%26aulast%3DNist%26aufirst%3DA.%26aulast%3DStiewe%26aufirst%3DT.%26aulast%3DWagner%26aufirst%3DU.%26aulast%3DReinartz%26aufirst%3DS.%26aulast%3DM%25C3%25BCller-Br%25C3%25BCsselbach%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26atitle%3DDeregulation%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Target%2520Genes%2520in%2520Tumor-associated%2520Macrophages%2520by%2520Fatty%2520Acid%2520Ligands%2520in%2520the%2520Ovarian%2520Cancer%2520Microenvironment%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D13416%26epage%3D13433%26doi%3D10.18632%2Foncotarget.3826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jawerbaum, A.</span></span> <span> </span><span class="NLM_article-title">Carbaprostacyclin, a PPARdelta Agonist, Ameliorates Excess Lipid Accumulation in Diabetic Rat Placentas</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2010.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.lfs.2010.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=20338185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVenur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=781-790&author=M.+Kurtzauthor=E.+Capobiancoauthor=N.+Mart%C3%ADnezauthor=J.+Fern%C3%A1ndezauthor=R.+Higaauthor=V.+Whiteauthor=A.+Jawerbaum&title=Carbaprostacyclin%2C+a+PPARdelta+Agonist%2C+Ameliorates+Excess+Lipid+Accumulation+in+Diabetic+Rat+Placentas&doi=10.1016%2Fj.lfs.2010.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Carbaprostacyclin, a PPARδ agonist, ameliorates excess lipid accumulation in diabetic rat placentas</span></div><div class="casAuthors">Kurtz, Melisa; Capobianco, Evangelina; Martinez, Nora; Fernandez, Jimena; Higa, Romina; White, Veronica; Jawerbaum, Alicia</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">21-22</span>),
    <span class="NLM_cas:pages">781-790</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aims: Maternal diabetes impairs placental development and metab.  Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors relevant in metabolic homeostasis.  We investigated the concns. of PPARδ and its endogenous agonist prostacyclin (PGI2), as well as the effects of carbaprostacylin (cPGI2, a PPARδ agonist) on lipid metab. in placentas from control and streptozotocin-induced diabetic rats on day 13.5 of gestation.  Main methods: The placentas were explanted to evaluate PPARδ expression and PGI2 concns., and cultured with cPGI2 for further anal. of lipid metab. (concns. and 14C-acetate derived synthesis of triglycerides, cholesteryl esters, phospholipids, cholesterol and free fatty acids; release of glycerol and lipid peroxidn.).  Key findings: Reduced PGI2 concns. were found in the placentas from diabetic rats when compared to controls. cPGI2 addns. reduced the concns. and synthesis of several lipid species, increased lipid catabolism and reduced lipid peroxidn. in the placenta.  These effects were more marked in diabetic tissues, which presented alterations in the lipid metabolic parameters evaluated. cPGI2 addns. increased placental PPARδ and acyl-CoA oxidase expression, which are changes possibly involved in the catabolic effects obsd.  Significance: The present study reveals the capability of cPGI2 to regulate placental lipid metab. and PPARδ expression, and suggests that preserving appropriate PGI2 concns. in the placenta may help to metabolize maternal derived lipid overload in diabetic gestations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkw3Z0cryf8rVg90H21EOLACvtfcHk0lgDU35sq7AZ3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVenur8%253D&md5=902cddd4502a10c0bf661831e703eed0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2010.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2010.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DKurtz%26aufirst%3DM.%26aulast%3DCapobianco%26aufirst%3DE.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DN.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DJ.%26aulast%3DHiga%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DJawerbaum%26aufirst%3DA.%26atitle%3DCarbaprostacyclin%252C%2520a%2520PPARdelta%2520Agonist%252C%2520Ameliorates%2520Excess%2520Lipid%2520Accumulation%2520in%2520Diabetic%2520Rat%2520Placentas%26jtitle%3DLife%2520Sci.%26date%3D2010%26volume%3D86%26spage%3D781%26epage%3D790%26doi%3D10.1016%2Fj.lfs.2010.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forman, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Hypolipidemic Drugs, Polyunsaturated Fatty acids, and Eicosanoids are Ligands for Peroxisome Proliferator-activated Receptors α and δ</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">4312</span>– <span class="NLM_lpage">4317</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.9.4312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.94.9.4312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=9113986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK2sXjtVyhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=4312-4317&author=B.+M.+Formanauthor=J.+Chenauthor=R.+M.+Evans&title=Hypolipidemic+Drugs%2C+Polyunsaturated+Fatty+acids%2C+and+Eicosanoids+are+Ligands+for+Peroxisome+Proliferator-activated+Receptors+%CE%B1+and+%CE%B4&doi=10.1073%2Fpnas.94.9.4312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ</span></div><div class="casAuthors">Forman, Barry Marc; Chen, Jasmine; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4312-4317</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fatty acids (FAs) and their derivs. are essential cellular metabolites whose concns. must be closely regulated.  This implies that regulatory circuits exist which can sense changes in FA levels.  Indeed, the peroxisome proliferator-activated receptor α (PPARα) regulates lipid homeostasis and is transcriptionally activated by a variety of lipid-like compds.  It remains nuclear as to how these structurally diverse compds. can activate a single receptor.  A novel conformation-based assay that screens activators for their ability to bind to PPARα/δ and induce DNA binding has been developed.  It is shown here that specific FAs, eicosanoids, and hypolipidemic drugs are ligands for PPARα or PPARδ.  Because altered FA levels are assocd. with obesity, atherosclerosis, hypertension, and diabetes, PPARs may serve as mol. sensors that are central to the development and treatment of these metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ScUan5LKD7Vg90H21EOLACvtfcHk0lgDU35sq7AZ3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtVyhsbs%253D&md5=71fa1629903741d90d1e1ca487f69c90</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.9.4312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.9.4312%26sid%3Dliteratum%253Aachs%26aulast%3DForman%26aufirst%3DB.%2BM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DHypolipidemic%2520Drugs%252C%2520Polyunsaturated%2520Fatty%2520acids%252C%2520and%2520Eicosanoids%2520are%2520Ligands%2520for%2520Peroxisome%2520Proliferator-activated%2520Receptors%2520%25CE%25B1%2520and%2520%25CE%25B4%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D4312%26epage%3D4317%26doi%3D10.1073%2Fpnas.94.9.4312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span> <span> </span><span class="NLM_article-title">Phosphoiodyns A and B, Unique Phosphorus-containing Iodinated Polyacetylenes from a Korean Sponge Placospongia sp</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1021/ol3031318</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol3031318" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCjurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=100-103&author=H.+Kimauthor=J.+Chinauthor=H.+Choiauthor=K.+Baekauthor=T.-G.+Leeauthor=S.+E.+Parkauthor=W.+Wangauthor=D.+Hahnauthor=I.+Yangauthor=J.+Leeauthor=B.+Munauthor=M.+Ekinsauthor=S.-J.+Namauthor=H.+Kang&title=Phosphoiodyns+A+and+B%2C+Unique+Phosphorus-containing+Iodinated+Polyacetylenes+from+a+Korean+Sponge+Placospongia+sp&doi=10.1021%2Fol3031318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoiodyns A and B, Unique Phosphorus-Containing Iodinated Polyacetylenes from a Korean Sponge Placospongia sp.</span></div><div class="casAuthors">Kim, Hiyoung; Chin, Jungwook; Choi, Hyukjae; Baek, Kyungryul; Lee, Tae-Gu; Park, Seong Eon; Wang, Weihong; Hahn, Dongyup; Yang, Inho; Lee, Jihye; Mun, Bora; Ekins, Merrick; Nam, Sang-Jip; Kang, Heonjoong</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-103</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two unprecedented phosphorus-contg. iodinated polyacetylenes, phosphoiodyns A and B (1-2), were isolated from a Korean marine sponge Placospongia sp.  Their structures were elucidated by spectroscopic data anal.  Phosphoiodyn A exhibited potent agonistic activity on human peroxisome proliferator-activated receptor delta (hPPARδ) with an EC50 of 23.7 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjCFAfSshMQ7Vg90H21EOLACvtfcHk0lihkmNnrS8Z4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCjurzL&md5=bec58cb754ce99ecf8209dbb61810763</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fol3031318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol3031318%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DBaek%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DT.-G.%26aulast%3DPark%26aufirst%3DS.%2BE.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMun%26aufirst%3DB.%26aulast%3DEkins%26aufirst%3DM.%26aulast%3DNam%26aufirst%3DS.-J.%26aulast%3DKang%26aufirst%3DH.%26atitle%3DPhosphoiodyns%2520A%2520and%2520B%252C%2520Unique%2520Phosphorus-containing%2520Iodinated%2520Polyacetylenes%2520from%2520a%2520Korean%2520Sponge%2520Placospongia%2520sp%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D100%26epage%3D103%26doi%3D10.1021%2Fol3031318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakatabi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">Picrasidine N is a Subtype-selective PPARβ/δ Agonist</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00909</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00909" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVynsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=879-885&author=S.+Zhaoauthor=Y.+Kannoauthor=W.+Liauthor=H.+Wakatabiauthor=T.+Sasakiauthor=K.+Koikeauthor=K.+Nemotoauthor=H.+Li&title=Picrasidine+N+is+a+Subtype-selective+PPAR%CE%B2%2F%CE%B4+Agonist&doi=10.1021%2Facs.jnatprod.5b00909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Picrasidine N Is a Subtype-Selective PPARβ/δ Agonist</span></div><div class="casAuthors">Zhao, Shuai; Kanno, Yuichiro; Li, Wei; Wakatabi, Honami; Sasaki, Tatsunori; Koike, Kazuo; Nemoto, Kiyomitsu; Li, Huicheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">879-885</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Recently, growing evidence of the pivotal roles of peroxisome proliferator-activated receptor (PPAR) β/δ in various physiol. functions, including lipid homeostasis, cancer, and inflammation, has raised interest in this receptor.  In this study, the naturally occurring dimeric alkaloid picrasidine N from Picrasma quassioides was identified as a novel PPARβ/δ agonist from a library consisting of plant exts. and natural compds. using a mammalian one-hybrid assay, and this compd. was characterized.  Picrasidine N activated PPARβ/δ but did not activate or slightly activated PPARα and PPARγ.  Furthermore, a peroxisome proliferator response element-driven luciferase reporter gene assay demonstrated that picrasidine N enhanced PPARβ/δ transcriptional activity.  Moreover, picrasidine N selectively induced mRNA expression of ANGPTL4, which is a PPAR target gene.  This observation is quite different from previously identified synthetic PPARβ/δ agonists, which can induce the expression of not only ANGPTL4 but also other PPAR target genes, such as ADRP, PDK4, and CPT-1.  These results demonstrate that picrasidine N is a potent subtype-selective and gene-selective PPARβ/δ agonist, suggesting its potential as a lead compd. for further drug development.  This compd. would also be a useful chem. tool for elucidating the mechanism of PPARβ/δ-regulated specific gene expression and the biol. significance of PPARβ/δ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNePGzGQ45gLVg90H21EOLACvtfcHk0lihkmNnrS8Z4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVynsrw%253D&md5=6cecf8ebe753c8e58bcdb81222fe78a4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00909%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWakatabi%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DK.%26aulast%3DNemoto%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DH.%26atitle%3DPicrasidine%2520N%2520is%2520a%2520Subtype-selective%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Agonist%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D879%26epage%3D885%26doi%3D10.1021%2Facs.jnatprod.5b00909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makishima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span> <span> </span><span class="NLM_article-title">Novel Biphenylcarboxylic Acid Peroxisome Proliferator-activated Receptor (PPAR) δ Selective Antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6595</span>– <span class="NLM_lpage">6599</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2009.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19853439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGisLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6595-6599&author=J.-i.+Kasugaauthor=S.+Ishidaauthor=D.+Yamasakiauthor=M.+Makishimaauthor=T.+Doiauthor=Y.+Hashimotoauthor=H.+Miyachi&title=Novel+Biphenylcarboxylic+Acid+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29+%CE%B4+Selective+Antagonists&doi=10.1016%2Fj.bmcl.2009.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Novel biphenylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) δ selective antagonists</span></div><div class="casAuthors">Kasuga, Jun-ichi; Ishida, Seiichi; Yamasaki, Daisuke; Makishima, Makoto; Doi, Takefumi; Hashimoto, Yuichi; Miyachi, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6595-6599</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel PPARδ antagonists were designed and synthesized based on the crystal structure of the PPARδ full agonist TIPP-204 bound to the PPARδ ligand-binding domain, in combination with the nuclear receptor helix 12 folding modification hypothesis.  Representative compd. I exhibits PPARδ-preferential antagonistic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqujjfEhHLLI7Vg90H21EOLACvtfcHk0lijYK6rmwAvkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGisLnJ&md5=a5003619d384470ae60f2f3c5d320c57</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DKasuga%26aufirst%3DJ.-i.%26aulast%3DIshida%26aufirst%3DS.%26aulast%3DYamasaki%26aufirst%3DD.%26aulast%3DMakishima%26aufirst%3DM.%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DNovel%2520Biphenylcarboxylic%2520Acid%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%2520%25CE%25B4%2520Selective%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6595%26epage%3D6599%26doi%3D10.1016%2Fj.bmcl.2009.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiethe, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Way, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leesnitzer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrihew, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeune, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of 4-chloro-<i>N</i>-(2-{[5-trifluoromethyl)-2-pyridyl] sulfonyl} ethyl) Benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-activated Receptor δ (PPARδ) Antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1857</span>– <span class="NLM_lpage">1861</span>, <span class="refDoi"> DOI: 10.1021/jm900464j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900464j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1857-1861&author=B.+G.+Shearerauthor=R.+W.+Wietheauthor=A.+Asheauthor=A.+N.+Billinauthor=J.+M.+Wayauthor=T.+B.+Stanleyauthor=C.+D.+Wagnerauthor=R.+X.+Xuauthor=L.+M.+Leesnitzerauthor=R.+V.+Merrihewauthor=T.+W.+Shearerauthor=M.+R.+Jeuneauthor=J.+C.+Ulrichauthor=T.+M.+Willson&title=Identification+and+Characterization+of+4-chloro-N-%282-%7B%5B5-trifluoromethyl%29-2-pyridyl%5D+sulfonyl%7D+ethyl%29+Benzamide+%28GSK3787%29%2C+a+Selective+and+Irreversible+Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29+Antagonist&doi=10.1021%2Fjm900464j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist</span></div><div class="casAuthors">Shearer, Barry G.; Wiethe, Robert W.; Ashe, Adam; Billin, Andrew N.; Way, James M.; Stanley, Thomas B.; Wagner, Craig D.; Xu, Robert X.; Leesnitzer, Lisa M.; Merrihew, Raymond V.; Shearer, Todd W.; Jeune, Michael R.; Ulrich, John C.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1857-1861</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GSK3787 (I) was identified as a potent and selective ligand for PPARδ with good pharmacokinetic properties.  A detailed binding study using mass spectral anal. confirmed covalent binding to Cys249 within the PPARδ binding pocket.  Gene expression studies showed that pyridylsulfone 3 antagonized the transcriptional activity of PPARδ and inhibited basal CPT1a gene transcription.  Compd. 3 is a PPARδ antagonist with utility as a tool to elucidate PPARδ cell biol. and pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_XYlOh8G0b7Vg90H21EOLACvtfcHk0lhrbUNLg8RKZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGisrc%253D&md5=401381858ca225791e8a90c13bb9d5e4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm900464j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900464j%26sid%3Dliteratum%253Aachs%26aulast%3DShearer%26aufirst%3DB.%2BG.%26aulast%3DWiethe%26aufirst%3DR.%2BW.%26aulast%3DAshe%26aufirst%3DA.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DWay%26aufirst%3DJ.%2BM.%26aulast%3DStanley%26aufirst%3DT.%2BB.%26aulast%3DWagner%26aufirst%3DC.%2BD.%26aulast%3DXu%26aufirst%3DR.%2BX.%26aulast%3DLeesnitzer%26aufirst%3DL.%2BM.%26aulast%3DMerrihew%26aufirst%3DR.%2BV.%26aulast%3DShearer%26aufirst%3DT.%2BW.%26aulast%3DJeune%26aufirst%3DM.%2BR.%26aulast%3DUlrich%26aufirst%3DJ.%2BC.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DIdentification%2520and%2520Characterization%2520of%25204-chloro-N-%25282-%257B%255B5-trifluoromethyl%2529-2-pyridyl%255D%2520sulfonyl%257D%2520ethyl%2529%2520Benzamide%2520%2528GSK3787%2529%252C%2520a%2520Selective%2520and%2520Irreversible%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1857%26epage%3D1861%26doi%3D10.1021%2Fjm900464j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaoude, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrieki, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moussalli, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broaddus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shureiqi, I.</span></span> <span> </span><span class="NLM_article-title">Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">969</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-18-1790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1158%2F0008-5472.CAN-18-1790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30679176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=954-969&author=Y.+Liuauthor=Y.+Deguchiauthor=R.+Tianauthor=D.+Weiauthor=L.+Wuauthor=W.+Chenauthor=W.+Xuauthor=M.+Xuauthor=F.+Liuauthor=S.+Gaoauthor=J.+C.+Jaoudeauthor=S.+P.+Chriekiauthor=M.+J.+Moussalliauthor=M.+Gageaauthor=J.+Morrisauthor=R.+R.+Broaddusauthor=X.+Zuoauthor=I.+Shureiqi&title=Pleiotropic+Effects+of+PPARD+Accelerate+Colorectal+Tumorigenesis%2C+Progression%2C+and+Invasion&doi=10.1158%2F0008-5472.CAN-18-1790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pleiotropic effects of PPARD accelerate colorectal tumorigenesis, progression, and invasion</span></div><div class="casAuthors">Liu, Yi; Deguchi, Yasunori; Tian, Rui; Wei, Daoyan; Wu, Ling; Chen, Weidong; Xul, Weiguo; Xul, Min; Liu, Fuyao; Gaol, Shen; Jaoude, Jonathan C.; Chriekil, Sarah P.; Moussalli, Micheline J.; Gagea, Mihai; Morris, Jeffrey; Broaddus, Russell R.; Zuo, Xiangsheng; Shureiqi, Imad</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">954-969</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">APC mutations activate aberrant β-catenin signaling to drive initiation of colorectal cancer; however, colorectal cancer progression requires addnl. mol. mechanisms.  PPAR-delta (PPARD), a downstream target of β-catenin, is upregulated in colorectal cancer.  However, promotion of intestinal tumorigenesis following deletion of PPARD in Apcmin mice has raised questions about then Federationn Federation effects of PPARD on aberrant 13-catenin activation and colorectal cancer.  In this study, we used mouse models of PPARD overexpression or deletion combined with APC mutation (ApcΔ580) in intestinal epithelial cells (IEC) to elucidate the contributions of PPARD in colorectal cancer.  Overexpression or deletion of PPARD in !LC augmented or suppressed β-catenin activation via up- or downregulation of BMP7/TAK1 signaling and strongly promoted or sup- pressed colorectal cancer, resp.  Depletion of PPARD in human colorectal cancer organoid cells inhibited BMP7/ β-catenin signaling and suppressed organoid self-renewal.  Treatment with PPARD agonist GW501516 enhanced colorectal cancer tumorigenesis in ApcΔ580 mice, whereas treatment with PPARD antagonist GSK3787 suppressed tumorigenesis.  PPARD expression was significantly higher in human colorectal cancer-invasive fronts vs. their paired tumor centers and adenomas.  Reverse-phase protein microarray and validation studies identified PPARD- mediated upregulation of other proinvasive pathways: connexin 43, PDGFRβ, AKT1, EIF4G1, and CDKI.  Our data demonstrate that PPARD strongly potentiates multiple tumorigenic pathways to promote colorectal cancer progression and invasiveness.  Significance: These findings address long-standing. important, and unresolved questions related to the potential role of PPARD in APC mutation-dependent colorectal tumorigenesis by showing PPARD activation enhances APC mutation-dependent tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv23iJAEIvQrVg90H21EOLACvtfcHk0lg8B6b0kOrYTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWjurk%253D&md5=1a48e300b9aee975193d5035f4837b38</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-18-1790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-18-1790%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDeguchi%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DJaoude%26aufirst%3DJ.%2BC.%26aulast%3DChrieki%26aufirst%3DS.%2BP.%26aulast%3DMoussalli%26aufirst%3DM.%2BJ.%26aulast%3DGagea%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DBroaddus%26aufirst%3DR.%2BR.%26aulast%3DZuo%26aufirst%3DX.%26aulast%3DShureiqi%26aufirst%3DI.%26atitle%3DPleiotropic%2520Effects%2520of%2520PPARD%2520Accelerate%2520Colorectal%2520Tumorigenesis%252C%2520Progression%252C%2520and%2520Invasion%26jtitle%3DCancer%2520Res.%26date%3D2019%26volume%3D79%26spage%3D954%26epage%3D969%26doi%3D10.1158%2F0008-5472.CAN-18-1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hack, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foerster, J.</span></span> <span> </span><span class="NLM_article-title">Skin-targeted Inhibition of PPAR β/δ by Selective Antagonists to Treat PPAR β/δ−mediated Psoriasis-like Skin Disease in vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e37097</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0037097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pone.0037097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22606335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFWqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=K.+Hackauthor=L.+Reillyauthor=C.+Palmerauthor=K.+D.+Readauthor=S.+Norvalauthor=R.+Kimeauthor=K.+Boothauthor=J.+Foerster&title=Skin-targeted+Inhibition+of+PPAR+%CE%B2%2F%CE%B4+by+Selective+Antagonists+to+Treat+PPAR+%CE%B2%2F%CE%B4%E2%88%92mediated+Psoriasis-like+Skin+Disease+in+vivo&doi=10.1371%2Fjournal.pone.0037097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ - mediated psoriasis-like skin disease in vivo</span></div><div class="casAuthors">Hack, Katrin; Reilly, Louise; Palmer, Colin; Read, Kevin D.; Norval, Suzanne; Kime, Robert; Booth, Kally; Foerster, John</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e37097</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We have previously shown that peroxisome proliferator activating receptor β/δ (PPAR β/δ is overexpressed in psoriasis.  PPAR β/δ is not present in adult epidermis of mice.  Targeted expression of PPAR β/δ and activation by a selective synthetic agonist is sufficient to induce an inflammatory skin disease resembling psoriasis.  Several signalling pathways dysregulated in psoriasis are replicated in this model, suggesting that PPAR β/δ activation contributes to psoriasis pathogenesis.  Thus, inhibition of PPAR β/δ might harbor therapeutical potential.  Since PPAR β/δ has pleiotropic functions in metab., skin-targeted inhibition offer the potential of reducing systemic adverse effects.  Here, we report that three selective PPAR β/δ antagonists, GSK0660, compd. 3 h, and GSK3787 can be formulated for topical application to the skin and that their skin concn. can be accurately quantified using ultra-high performance liq. chromatog. (UPLC)/mass spectrometry.  These antagonists show efficacy in our transgenic mouse model in reducing psoriasis - like changes triggered by activation of PPAR β/δ.  PPAR β/δ antagonists GSK0660 and compd. 3 do not exhibit systemic drug accumulation after prolonged application to the skin, nor do they induce inflammatory or irritant changes.  Significantly, the irreversible PPAR β/δ antagonist (GSK3787) retains efficacy when applied topically only three times per wk which could be of practical clin. usefulness.  Our data suggest that topical inhibition of PPAR β/δ to treat psoriasis may warrant further exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSSHbNF8VWSbVg90H21EOLACvtfcHk0lg8B6b0kOrYTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFWqtL4%253D&md5=1f3bc7b0dacee685986ea2a674d0aef8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0037097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0037097%26sid%3Dliteratum%253Aachs%26aulast%3DHack%26aufirst%3DK.%26aulast%3DReilly%26aufirst%3DL.%26aulast%3DPalmer%26aufirst%3DC.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DKime%26aufirst%3DR.%26aulast%3DBooth%26aufirst%3DK.%26aulast%3DFoerster%26aufirst%3DJ.%26atitle%3DSkin-targeted%2520Inhibition%2520of%2520PPAR%2520%25CE%25B2%252F%25CE%25B4%2520by%2520Selective%2520Antagonists%2520to%2520Treat%2520PPAR%2520%25CE%25B2%252F%25CE%25B4%25E2%2588%2592mediated%2520Psoriasis-like%2520Skin%2520Disease%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0037097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makishima, M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor Agonists and Antagonists: A Patent Review (2014-present)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1080/13543776.2020.1703952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1080%2F13543776.2020.1703952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31825687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVaqtr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=1-13&author=I.+Takadaauthor=M.+Makishima&title=Peroxisome+Proliferator-activated+Receptor+Agonists+and+Antagonists%3A+A+Patent+Review+%282014-present%29&doi=10.1080%2F13543776.2020.1703952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)</span></div><div class="casAuthors">Takada, Ichiro; Makishima, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptors (PPARs), PPARα, PPARδ, and PPARγ, play an important role in the regulation of various physiol. processes, specifically lipid and energy metab. and immunity.  PPARα agonists (fibrates) and PPARγ agonists (thiazolidinediones) are used for the treatment of hypertriglyceridemia and type 2 diabetes, resp.  PPARδ activation enhances mitochondrial and energy metab. but PPARδ-acting drugs are not yet available.  Many synthetic ligands for PPARs have been developed to expand their therapeutic applications.: The authors searched recent patent activity regarding PPAR ligands.  Novel PPARα agonists, PPARδ agonists, PPARγ agonists, PPARα/γ dual agonists, and PPARγ antagonists have been claimed for the treatment of metabolic disease and inflammatory disease.  Methods for the combination of PPAR ligands with other drugs and expanded application of PPAR agonists for bone and neurol. disease have been also claimed.: Novel PPAR ligands and the combination of PPAR ligands with other drugs have been claimed for the treatment of mitochondrial disease, inflammatory/autoimmune disease, neurol. disease, and cancer in addn. to metabolic diseases including dyslipidemia and type 2 diabetes.  Selective therapeutic actions of PPAR ligands should be exploited to avoid adverse effects.  More basic studies are needed to elucidate the mol. mechanisms of selective actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo51fz3chW3ybVg90H21EOLACvtfcHk0lg8B6b0kOrYTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVaqtr3L&md5=e31b4fd8d6da157c48ddf77a5412eb08</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1080%2F13543776.2020.1703952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2020.1703952%26sid%3Dliteratum%253Aachs%26aulast%3DTakada%26aufirst%3DI.%26aulast%3DMakishima%26aufirst%3DM.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520Agonists%2520and%2520Antagonists%253A%2520A%2520Patent%2520Review%2520%25282014-present%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2020%26volume%3D30%26spage%3D1%26epage%3D13%26doi%3D10.1080%2F13543776.2020.1703952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sng, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span> <span> </span><span class="NLM_article-title">Transcriptional Control of Physiological and Pathological Processes by the Nuclear Receptor PPAR beta/delta</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2016.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.plipres.2016.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27665713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1WntbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2016&pages=98-122&author=N.+S.+Tanauthor=M.+V%C3%A1zquez-Carreraauthor=A.+Montagnerauthor=M.+K.+Sngauthor=H.+Guillouauthor=W.+Wahli&title=Transcriptional+Control+of+Physiological+and+Pathological+Processes+by+the+Nuclear+Receptor+PPAR+beta%2Fdelta&doi=10.1016%2Fj.plipres.2016.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ</span></div><div class="casAuthors">Tan, Nguan Soon; Vazquez-Carrera, Manuel; Montagner, Alexandra; Sng, Ming Keat; Guillou, Herve; Wahli, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-122</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are a class of transcription factors that belong to the nuclear hormone receptor superfamily, and their activities are dependent on their resp. ligands. Since the discovery of PPARa (NR1C1) as a receptor that mediates peroxisome proliferation in rodent hepatocytes.  We predict that the use of genetic and pharmacol. approaches, such as tissue- and/or cell-type specific conditional knockout animal models along with specific PPARy/d agonists and antagonists, will prove to be useful in clarifying the role of PPARy/d in various diseases. Such approaches may also reveal novel roles of PPARy/d in the initiation and progression of particular diseases, and such studies could aid in the future design of novel and efficient pharmacol. agents that target PPARy/d for the treatment of many diseases. Realizing this goal will require multidisciplinary collaborative efforts of various scientists and clinicians.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaWGFA7GFUh7Vg90H21EOLACvtfcHk0lgaaRImKgN8Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1WntbzN&md5=7c200bbc4cb73cfaf915e72af33ed624</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2016.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2016.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DN.%2BS.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26aulast%3DMontagner%26aufirst%3DA.%26aulast%3DSng%26aufirst%3DM.%2BK.%26aulast%3DGuillou%26aufirst%3DH.%26aulast%3DWahli%26aufirst%3DW.%26atitle%3DTranscriptional%2520Control%2520of%2520Physiological%2520and%2520Pathological%2520Processes%2520by%2520the%2520Nuclear%2520Receptor%2520PPAR%2520beta%252Fdelta%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2016%26volume%3D64%26spage%3D98%26epage%3D122%26doi%3D10.1016%2Fj.plipres.2016.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunmair, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dörig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szöcs, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadlbauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gras, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderwald, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nohl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldhäusl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fürnsinn, C.</span></span> <span> </span><span class="NLM_article-title">Activation of PPAR-δ in Isolated Rat Skeletal Muscle Switches Fuel Preference from Glucose to Fatty Acids</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2713</span>– <span class="NLM_lpage">2722</span>, <span class="refDoi"> DOI: 10.1007/s00125-006-0357-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1007%2Fs00125-006-0357-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16960684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOqsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2713-2722&author=B.+Brunmairauthor=K.+Staniekauthor=J.+D%C3%B6rigauthor=Z.+Sz%C3%B6csauthor=K.+Stadlbauerauthor=V.+Marianauthor=F.+Grasauthor=C.+Anderwaldauthor=H.+Nohlauthor=W.+Waldh%C3%A4uslauthor=C.+F%C3%BCrnsinn&title=Activation+of+PPAR-%CE%B4+in+Isolated+Rat+Skeletal+Muscle+Switches+Fuel+Preference+from+Glucose+to+Fatty+Acids&doi=10.1007%2Fs00125-006-0357-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of PPAR-δ in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids</span></div><div class="casAuthors">Brunmair, B.; Staniek, K.; Doerig, J.; Szoecs, Z.; Stadlbauer, K.; Marian, V.; Gras, F.; Anderwald, C.; Nohl, H.; Waldhaeusl, W.; Fuernsinn, C.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2713-2722</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Aims/hypothesis: GW501516, an agonist of peroxisome proliferator-activated receptor-δ (PPAR-δ), increases lipid combustion and exerts antidiabetic action in animals, effects which are attributed mainly to direct effects on skeletal muscle.  We explored such actions further in isolated rat skeletal muscle.  Materials and methods: Specimens of rat skeletal muscle were pretreated with GW501516 (0.01-30 μmol/l) for 0.5, 4 or 24 h and rates of fuel metab. were then measured.  In addn., effects on mitochondrial function were detd. in isolated rat liver mitochondria.  Results: At concns. between 0.01 and 1 μmol/l, GW501516 dose-dependently increased fatty acid oxidn. but reduced glucose utilization in isolated muscle.  Thus after 24 h of preincubation with 1 μmol/l GW501516, palmitate oxidn. increased by +46±10%, and the following decreased as specified: glucose oxidn. -46±8%, glycogen synthesis -42±6%, lactate release -20±2%, glucose transport -15±6% (all p<0.05).  Redn. of glucose utilization persisted independently of insulin stimulation or muscle fiber type, but depended on fatty acid availability (the effect on glucose transport in the absence of fatty acids was an increase of 30±9%, p<0.01), suggesting a role for the glucose-fatty acid cycle.  At higher concns., GW501516 uncoupled oxidative phosphorylation by direct action on isolated mitochondria.  Conclusions/interpretation: GW501516-induced activation of PPAR-δ reduces glucose utilization by skeletal muscle through a switch in mitochondrial substrate preference from carbohydrate to lipid.  High concns. of GW501516 induce mitochondrial uncoupling independently of PPAR-δ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXvcen1q6sYbVg90H21EOLACvtfcHk0lgaaRImKgN8Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOqsrrO&md5=117b361468b8db34b89c741dcdbde1e6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00125-006-0357-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-006-0357-6%26sid%3Dliteratum%253Aachs%26aulast%3DBrunmair%26aufirst%3DB.%26aulast%3DStaniek%26aufirst%3DK.%26aulast%3DD%25C3%25B6rig%26aufirst%3DJ.%26aulast%3DSz%25C3%25B6cs%26aufirst%3DZ.%26aulast%3DStadlbauer%26aufirst%3DK.%26aulast%3DMarian%26aufirst%3DV.%26aulast%3DGras%26aufirst%3DF.%26aulast%3DAnderwald%26aufirst%3DC.%26aulast%3DNohl%26aufirst%3DH.%26aulast%3DWaldh%25C3%25A4usl%26aufirst%3DW.%26aulast%3DF%25C3%25BCrnsinn%26aufirst%3DC.%26atitle%3DActivation%2520of%2520PPAR-%25CE%25B4%2520in%2520Isolated%2520Rat%2520Skeletal%2520Muscle%2520Switches%2520Fuel%2520Preference%2520from%2520Glucose%2520to%2520Fatty%2520Acids%26jtitle%3DDiabetologia%26date%3D2006%26volume%3D49%26spage%3D2713%26epage%3D2722%26doi%3D10.1007%2Fs00125-006-0357-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narkar, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banayo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihaylova, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juguilon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">AMPK and PPARδ Agonists are Exercise Mimetics</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2008.06.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.cell.2008.06.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18674809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSis77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2008&pages=405-415&author=V.+A.+Narkarauthor=M.+Downesauthor=R.+T.+Yuauthor=E.+Emblerauthor=Y.-X.+Wangauthor=E.+Banayoauthor=M.+M.+Mihaylovaauthor=M.+C.+Nelsonauthor=Y.+Zouauthor=H.+Juguilonauthor=H.+Kangauthor=R.+Shawauthor=R.+M.+Evans&title=AMPK+and+PPAR%CE%B4+Agonists+are+Exercise+Mimetics&doi=10.1016%2Fj.cell.2008.06.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK and PPARδ agonists are exercise mimetics</span></div><div class="casAuthors">Narkar, Vihang A.; Downes, Michael; Yu, Ruth T.; Embler, Emi; Wang, Yong-Xu; Banayo, Ester; Mihaylova, Maria M.; Nelson, Michael C.; Zou, Yuhua; Juguilon, Henry; Kang, Heonjoong; Shaw, Reuben J.; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-415</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The benefits of endurance exercise on general health make it desirable to identify orally active agents that would mimic or potentiate the effects of exercise to treat metabolic diseases.  Although certain natural compds., such as resveratrol, have endurance-enhancing activities, their exact metabolic targets remain elusive.  The authors therefore tested the effect of pathway-specific drugs on endurance capacities of mice in a treadmill running test.  The authors found that PPARβ/δ agonist and exercise training synergistically increase oxidative myofibers and running endurance in adult mice.  Because training activates AMPK and PGC1α, the authors then tested whether the orally active AMPK agonist AICAR might be sufficient to overcome the exercise requirement.  Unexpectedly, even in sedentary mice, 4 wk of AICAR treatment alone induced metabolic genes and enhanced running endurance by 44%.  These results demonstrate that AMPK-PPARδ pathway can be targeted by orally active drugs to enhance training adaptation or even to increase endurance without exercise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD68stW4M_DrVg90H21EOLACvtfcHk0lh1FSaD43rsuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSis77P&md5=a0ee8bab9c8e445554176abc7d65d6e1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.06.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.06.051%26sid%3Dliteratum%253Aachs%26aulast%3DNarkar%26aufirst%3DV.%2BA.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DEmbler%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DBanayo%26aufirst%3DE.%26aulast%3DMihaylova%26aufirst%3DM.%2BM.%26aulast%3DNelson%26aufirst%3DM.%2BC.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DJuguilon%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DR.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DAMPK%2520and%2520PPAR%25CE%25B4%2520Agonists%2520are%2520Exercise%2520Mimetics%26jtitle%3DCell%26date%3D2008%26volume%3D134%26spage%3D405%26epage%3D415%26doi%3D10.1016%2Fj.cell.2008.06.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Australian Government Department
of Health, Therapeutic Goods Administration</span> <a href="https://www.tga.gov.au/book-page/12-cardarine#fn8" class="extLink">https://www.tga.gov.au/book-page/12-cardarine#fn8</a> (accessed Mar 14, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Australian+Government+Department%0Aof+Health%2C+Therapeutic+Goods+Administration+https%3A%2F%2Fwww.tga.gov.au%2Fbook-page%2F12-cardarine%23fn8+%28accessed+Mar+14%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span> <i>The World Anti-Doping
Code: The 2009 Prohibited List International
Standard</i>; <span class="NLM_publisher-name">The World Anti-Doping Agency</span>, <span class="NLM_year">2009</span>;  p 6, <a href="https://www.wada-ama.org/sites/default/files/resources/files/WADA_Prohibited_List_2009_EN.pdf" class="extLink">https://www.wada-ama.org/sites/default/files/resources/files/WADA_Prohibited_List_2009_EN.pdf</a> (accessed 2020-02-16).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+World+Anti-Doping%0ACode%3A+The+2009+Prohibited+List+International%0AStandard%3B+The+World+Anti-Doping+Agency%2C+2009%3B+p+6%2C+https%3A%2F%2Fwww.wada-ama.org%2Fsites%2Fdefault%2Ffiles%2Fresources%2Ffiles%2FWADA_Prohibited_List_2009_EN.pdf+%28accessed+2020-02-16%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520World%2520Anti-Doping%250ACode%253A%2520The%25202009%2520Prohibited%2520List%2520International%250AStandard%26pub%3DThe%2520World%2520Anti-Doping%2520Agency%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-H.</span></span> <span> </span><span class="NLM_article-title">PPARδ as a Therapeutic Target in Metabolic Disease</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>582</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2007.11.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.febslet.2007.11.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18036566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOltb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2008&pages=26-31&author=S.+M.+Reillyauthor=C.-H.+Lee&title=PPAR%CE%B4+as+a+Therapeutic+Target+in+Metabolic+Disease&doi=10.1016%2Fj.febslet.2007.11.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ as a therapeutic target in metabolic disease</span></div><div class="casAuthors">Reilly, Shannon M.; Lee, Chih-Hao</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">582</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-31</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  PPARδ is the only member in the PPAR subfamily of nuclear receptors that is not a target of current drugs.  Animal studies demonstrate PPARδ activation exerts many favorable effects, including reducing wt. gain, increasing skeletal muscle metabolic rate and endurance, improving insulin sensitivity and cardiovascular function and suppressing atherogenic inflammation.  These activities stem largely from the ability of PPARδ to control energy balance, reduce fat burden and protect against lipotoxicity caused by ectopic lipid deposition.  Therefore, PPARδ represents a novel therapeutic target and the development of PPARδ agonists/modulators may be useful for treating the whole spectrum of metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFlGSQ1PqMmbVg90H21EOLACvtfcHk0lh1FSaD43rsuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOltb3O&md5=7060f7e5e0c7b59a190b478d5afcd0b5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2007.11.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2007.11.040%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DC.-H.%26atitle%3DPPAR%25CE%25B4%2520as%2520a%2520Therapeutic%2520Target%2520in%2520Metabolic%2520Disease%26jtitle%3DFEBS%2520Lett.%26date%3D2008%26volume%3D582%26spage%3D26%26epage%3D31%26doi%3D10.1016%2Fj.febslet.2007.11.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, J.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor δ (PPARδ), a Novel Target Site for Drug Discovery in Metabolic Syndrome</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2006.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.phrs.2006.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16713711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XltFCntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2006&pages=501-507&author=S.+Takahashiauthor=T.+Tanakaauthor=T.+Kodamaauthor=J.+Sakai&title=Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29%2C+a+Novel+Target+Site+for+Drug+Discovery+in+Metabolic+Syndrome&doi=10.1016%2Fj.phrs.2006.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor δ (PPARδ), a novel target site for drug discovery in metabolic syndrome</span></div><div class="casAuthors">Takahashi, Sadao; Tanaka, Toshiya; Kodama, Tatsuhiko; Sakai, Juro</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">501-507</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The development of new treatments for metabolic syndrome is urgent project for decreasing the prevalence of coronary heart disease and diabetes mellitus in the advanced countries.  Peroxisome proliferator-activated receptor (PPAR)α and γ agonists have shed light on the treatment of hypertriglyceridemia and type 2 diabetes mellitus, resp.  Among PPARs, anal. of the PPARδ functions is lagging behind because specific PPARδ agonists have not been developed.  The appearance of new PPARδ agonists is brightening the prospects for elucidating the physiol. role of PPARδ.  PPARδ is a new target for the treatment of metabolic syndrome.  In particular, the fact that fatty acid oxidn. and energy dissipation in skeletal muscle and adipose tissue by PPARδ agonists lead to improved lipid profile, reduced adiposity and insulin sensitivity is a breakthrough.  It seems that treatment of PPARδ agonists operate similarly to the caloric restriction and prolonged exercise.  We suggest that the physiol. role of PPARδ may be an indicator for switching from glucose metab. to fatty acid metab.  To receive new benefits of PPARδ agonists against metabolic syndrome by increasing fatty acid consumption in skeletal muscle and adipose tissue, we need to unveil more details on the functions of PPARδ itself and its agonists in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplgTkaL1pP8LVg90H21EOLACvtfcHk0lgB7eo7w3Zlvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltFCntLY%253D&md5=9f59c0b468af0a9357508b057f5017ab</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2006.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2006.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DJ.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%252C%2520a%2520Novel%2520Target%2520Site%2520for%2520Drug%2520Discovery%2520in%2520Metabolic%2520Syndrome%26jtitle%3DPharmacol.%2520Res.%26date%3D2006%26volume%3D53%26spage%3D501%26epage%3D507%26doi%3D10.1016%2Fj.phrs.2006.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimaldi, P. A.</span></span> <span> </span><span class="NLM_article-title">Roles of PPARδ in the Control of Muscle Development and Metabolism</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1130</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1042/bst0311130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1042%2Fbst0311130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=14641010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1yqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1130-1132&author=P.+A.+Grimaldi&title=Roles+of+PPAR%CE%B4+in+the+Control+of+Muscle+Development+and+Metabolism&doi=10.1042%2Fbst0311130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of PPARδ in the control of muscle development and metabolism</span></div><div class="casAuthors">Grimaldi, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1130-1132</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">PPARδ (peroxisome proliferator-activated receptor δ)-specific agonists decrease plasma lipids and insulinemia in obese animals.  As skeletal muscle is one of the major organs for fatty acid catabolism, we have investigated the roles of the nuclear receptor in the control of muscle development and lipid metab., by using two approaches.  We have used C2C12 myotubes in which the PPARδ activity was altered by overexpression of either native or dominant-neg. (DN) mutant forms of PPARδ.  Treatment of C2C12 cells by specific PPARδ agonists promotes expression of genes for proteins of fatty acid catabolism and increases fatty acid oxidn.  These responses were increased in C2C12-PPARδ cells and impaired in C2C12-PPARδDN cells.  We also constructed animal models with muscle-specific expression of PPARδ (Cre/Lox approach).  The effects of muscle-specific alteration of PPARδ activity were studied on muscle development and metab. as well as on body fat mass.  These expts. indicated that PPARδ plays a crucial role in myofiber typing detn. and regulation of muscle oxidative capabilities, and that muscle-specific overexpression of the nuclear receptor leads to redn. of adipocyte size and body fat mass.  These data strongly suggest that PPARδ controls fatty acid catabolism in muscle and that its activation by synthetic agonists could prevent or correct obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5cuusDiEyALVg90H21EOLACvtfcHk0lgB7eo7w3Zlvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1yqu7w%253D&md5=1b42a6d28a27e33ef9ef284f7afd6fa2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1042%2Fbst0311130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311130%26sid%3Dliteratum%253Aachs%26aulast%3DGrimaldi%26aufirst%3DP.%2BA.%26atitle%3DRoles%2520of%2520PPAR%25CE%25B4%2520in%2520the%2520Control%2520of%2520Muscle%2520Development%2520and%2520Metabolism%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1130%26epage%3D1132%26doi%3D10.1042%2Fbst0311130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barish, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narkar, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">PPARδ: A Dagger in the Heart of the Metabolic Syndrome</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">590</span>– <span class="NLM_lpage">597</span>, <span class="refDoi"> DOI: 10.1172/JCI27955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1172%2FJCI27955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16511591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlGkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=590-597&author=G.+D.+Barishauthor=V.+A.+Narkarauthor=R.+M.+Evans&title=PPAR%CE%B4%3A+A+Dagger+in+the+Heart+of+the+Metabolic+Syndrome&doi=10.1172%2FJCI27955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ: a dagger in the heart of the metabolic syndrome</span></div><div class="casAuthors">Barish, Grant D.; Narkar, Vihang A.; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">590-597</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Obesity is a growing threat to global health by virtue of its assocn. with insulin resistance, glucose intolerance, hypertension, and dyslipidemia, collectively known as the metabolic syndrome or syndrome X.  The nuclear receptors PPARα and PPARγ are therapeutic targets for hypertriglyceridemia and insulin resistance, resp., and drugs that modulate these receptors are currently in clin. use.  More recent work on the less-described PPAR isotype PPARδ has uncovered a dual benefit for both hypertriglyceridemia and insulin resistance, highlighting the broad potential of PPARδ in the treatment of metabolic disease.  PPARδ enhances fatty acid catabolism and energy uncoupling in adipose tissue and muscle, and it suppresses macrophage-derived inflammation.  Its combined activities in these and other tissues make it a multifaceted therapeutic target for the metabolic syndrome with the potential to control wt. gain, enhance phys. endurance, improve insulin sensitivity, and ameliorate atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTHfUmDmD-sLVg90H21EOLACvtfcHk0lilpZJY0jk_og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlGkt7w%253D&md5=0349ad1425ce5277f93a495983eb675d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1172%2FJCI27955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI27955%26sid%3Dliteratum%253Aachs%26aulast%3DBarish%26aufirst%3DG.%2BD.%26aulast%3DNarkar%26aufirst%3DV.%2BA.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DPPAR%25CE%25B4%253A%2520A%2520Dagger%2520in%2520the%2520Heart%2520of%2520the%2520Metabolic%2520Syndrome%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D590%26epage%3D597%26doi%3D10.1172%2FJCI27955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiep, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor δ Activates Fat Metabolism to Prevent Obesity</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(03)00269-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS0092-8674%2803%2900269-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=12705865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlOqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2003&pages=159-170&author=Y.-X.+Wangauthor=C.-H.+Leeauthor=S.+Tiepauthor=R.+T.+Yuauthor=J.+Hamauthor=H.+Kangauthor=R.+M.+Evans&title=Peroxisome+Proliferator-activated+Receptor+%CE%B4+Activates+Fat+Metabolism+to+Prevent+Obesity&doi=10.1016%2FS0092-8674%2803%2900269-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity</span></div><div class="casAuthors">Wang, Yong-Xu; Lee, Chih-Hao; Tiep, Sambath; Yu, Ruth T.; Ham, Jungyeob; Kang, Heonjoong; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-170</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In contrast to the well-established roles of PPARγ and PPARα in lipid metab., little is known for PPARδ in this process.  We show here that targeted activation of PPARδ in adipose tissue specifically induces expression of genes required for fatty acid oxidn. and energy dissipation, which in turn leads to improved lipid profiles and reduced adiposity.  Importantly, these animals are completely resistant to both high-fat diet-induced and genetically predisposed (Leprdb/db) obesity.  As predicted, acute treatment of Leprdb/db mice with a PPARδ agonist depletes lipid accumulation.  In parallel, PPARδ-deficient mice challenged with high-fat diet show reduced energy uncoupling and are prone to obesity.  In vitro, activation of PPARδ in adipocytes and skeletal muscle cells promotes fatty acid oxidn. and utilization.  Our findings suggest that PPARδ serves as a widespread regulator of fat burning and identify PPARδ as a potential target in treatment of obesity and its assocd. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEL6XcVEcZDrVg90H21EOLACvtfcHk0lilpZJY0jk_og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlOqs7k%253D&md5=e55d314934eba1f464a74ca145108cff</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2900269-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252900269-1%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DLee%26aufirst%3DC.-H.%26aulast%3DTiep%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Activates%2520Fat%2520Metabolism%2520to%2520Prevent%2520Obesity%26jtitle%3DCell%26date%3D2003%26volume%3D113%26spage%3D159%26epage%3D170%26doi%3D10.1016%2FS0092-8674%2803%2900269-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayuga-Ocampo, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Regulation of Muscle Fiber Type and Running Endurance by PPARδ</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e294</span> <span class="refDoi"> DOI: 10.1371/journal.pbio.0020294</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pbio.0020294" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15328533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BD2crisVCltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&author=Y.-X.+Wangauthor=C.-L.+Zhangauthor=R.+T.+Yuauthor=H.+K.+Choauthor=M.+C.+Nelsonauthor=C.+R.+Bayuga-Ocampoauthor=J.+Hamauthor=H.+Kangauthor=R.+M.+Evans&title=Regulation+of+Muscle+Fiber+Type+and+Running+Endurance+by+PPAR%CE%B4&doi=10.1371%2Fjournal.pbio.0020294"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of muscle fiber type and running endurance by PPARdelta</span></div><div class="casAuthors">Wang Yong-Xu; Zhang Chun-Li; Yu Ruth T; Cho Helen K; Nelson Michael C; Bayuga-Ocampo Corinne R; Ham Jungyeob; Kang Heonjoong; Evans Ronald M</div><div class="citationInfo"><span class="NLM_cas:title">PLoS biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e294</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Endurance exercise training can promote an adaptive muscle fiber transformation and an increase of mitochondrial biogenesis by triggering scripted changes in gene expression.  However, no transcription factor has yet been identified that can direct this process.  We describe the engineering of a mouse capable of continuous running of up to twice the distance of a wild-type littermate.  This was achieved by targeted expression of an activated form of peroxisome proliferator-activated receptor delta (PPARdelta) in skeletal muscle, which induces a switch to form increased numbers of type I muscle fibers.  Treatment of wild-type mice with PPARdelta agonist elicits a similar type I fiber gene expression profile in muscle.  Moreover, these genetically generated fibers confer resistance to obesity with improved metabolic profiles, even in the absence of exercise.  These results demonstrate that complex physiologic properties such as fatigue, endurance, and running capacity can be molecularly analyzed and manipulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJMikAQ3UnnTAEfvC7EH1LfW6udTcc2ebS3-yBQCZa07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crisVCltA%253D%253D&md5=d9d4a4d68234fad3b7ff66c429f96814</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.0020294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.0020294%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DZhang%26aufirst%3DC.-L.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DCho%26aufirst%3DH.%2BK.%26aulast%3DNelson%26aufirst%3DM.%2BC.%26aulast%3DBayuga-Ocampo%26aufirst%3DC.%2BR.%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DRegulation%2520of%2520Muscle%2520Fiber%2520Type%2520and%2520Running%2520Endurance%2520by%2520PPAR%25CE%25B4%26jtitle%3DPLoS%2520Biol.%26date%3D2004%26volume%3D2%26doi%3D10.1371%2Fjournal.pbio.0020294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stechschulte, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favero, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodella, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jude, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, N. G.</span></span> <span> </span><span class="NLM_article-title">PPARδ Binding to Heme Oxygenase 1 Promoter Prevents Angiotensin II-induced Adipocyte Dysfunction in Goldblatt Hypertensive Rats</span>. <i>Int. J. Obes.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1038/ijo.2013.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fijo.2013.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlGjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=456-465&author=K.+Sodhiauthor=N.+Puriauthor=D.+H.+Kimauthor=T.+Hindsauthor=L.+A.+Stechschulteauthor=G.+Faveroauthor=L.+Rodellaauthor=J.+Shapiroauthor=D.+Judeauthor=N.+G.+Abraham&title=PPAR%CE%B4+Binding+to+Heme+Oxygenase+1+Promoter+Prevents+Angiotensin+II-induced+Adipocyte+Dysfunction+in+Goldblatt+Hypertensive+Rats&doi=10.1038%2Fijo.2013.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats</span></div><div class="casAuthors">Sodhi, K.; Puri, N.; Kim, D. H.; Hinds, T. D.; Stechschulte, L. A.; Favero, G.; Rodella, L.; Shapiro, J. I.; Jude, D.; Abraham, N. G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Obesity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">456-465</span>CODEN:
                <span class="NLM_cas:coden">IJOBDP</span>;
        ISSN:<span class="NLM_cas:issn">0307-0565</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Objective: Renin-angiotensin system (RAS) regulates adipogenic response with adipocyte hypertrophy by increasing oxidative stress.  Recent studies have shown the role of peroxisome proliferator-activated receptor-δ (PPARδ) agonist in attenuation of angiotensin II-induced oxidative stress.  The aim of this study was to explore a potential mechanistic link between PPARδ and the cytoprotective enzyme heme oxygenase-1 (HO-1) and to elucidate the contribution of HO-1 to the adipocyte regulatory effects of PPARδ agonism in an animal model of enhanced RAS, the Goldblatt 2 kidney 1 clip (2K1C) model.  Method: We first established a direct stimulatory effect of the PPARδ agonist (GW 501516) on the HO-1 gene by demonstrating increased luciferase activity in COS-7 cells transfected with a luciferase-HO-1 promoter construct.  Sprague-Dawley rats were divided into four groups: sham-operated animals, 2K1C rats and 2K1C rats treated with GW 501516, in the absence or presence of the HO activity inhibitor, stannous mesoporphyrin (SnMP).  Results: 2K1C animals had increased visceral adiposity, adipocyte hypertrophy, increased inflammatory cytokines, increased circulatory and adipose tissue levels of renin and Ang II along with increased adipose tissue gp91 phox expression (P<0.05) when compared with sham-operated animals.  Treatment with GW 501516 increased adipose tissue HO-1 and adiponectin levels (P<0.01) along with enhancement of Wnt10b and β-catenin expression.  HO-1 induction was accompanied by the decreased expression of Wnt5b, mesoderm specific transcript (mest) and C/EBPα levels and an increased no. of small adipocytes (P<0.05).  These effects of GW501516 were reversed in 2K1C animals exposed to SnMP (P<0.05).  Conclusion: Taken together, our study demonstrates, for the first time, that increased levels of Ang II contribute towards adipose tissue dysregulation, which is abated by PPARδ-mediated upregulation of the heme-HO system.  These findings highlight the pivotal role and symbiotic relationship of HO-1, adiponectin and PPARδ in the regulation of metabolic homeostasis in adipose tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmse7rKGJMdbVg90H21EOLACvtfcHk0lilpZJY0jk_og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlGjtbo%253D&md5=0dfca2b1f0b5b299f586fc4d104b3f67</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fijo.2013.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fijo.2013.116%26sid%3Dliteratum%253Aachs%26aulast%3DSodhi%26aufirst%3DK.%26aulast%3DPuri%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DHinds%26aufirst%3DT.%26aulast%3DStechschulte%26aufirst%3DL.%2BA.%26aulast%3DFavero%26aufirst%3DG.%26aulast%3DRodella%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DJ.%26aulast%3DJude%26aufirst%3DD.%26aulast%3DAbraham%26aufirst%3DN.%2BG.%26atitle%3DPPAR%25CE%25B4%2520Binding%2520to%2520Heme%2520Oxygenase%25201%2520Promoter%2520Prevents%2520Angiotensin%2520II-induced%2520Adipocyte%2520Dysfunction%2520in%2520Goldblatt%2520Hypertensive%2520Rats%26jtitle%3DInt.%2520J.%2520Obes.%26date%3D2014%26volume%3D38%26spage%3D456%26epage%3D465%26doi%3D10.1038%2Fijo.2013.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flindt, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristiansen, K.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor δ (PPARδ)-mediated Regulation of Preadipocyte Proliferation and Gene Expression is Dependent on cAMP Signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">3175</span>– <span class="NLM_lpage">3182</span>, <span class="refDoi"> DOI: 10.1074/jbc.M005567200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1074%2Fjbc.M005567200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11069900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtFWjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=3175-3182&author=J.+B.+Hansenauthor=H.+Zhangauthor=T.+H.+Rasmussenauthor=R.+K.+Petersenauthor=E.+N.+Flindtauthor=K.+Kristiansen&title=Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29-mediated+Regulation+of+Preadipocyte+Proliferation+and+Gene+Expression+is+Dependent+on+cAMP+Signaling&doi=10.1074%2Fjbc.M005567200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor δ (PPARδ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling</span></div><div class="casAuthors">Hansen, Jacob B.; Zhang, Hongbin; Rasmussen, Thomas H.; Petersen, Rasmus K.; Flindt, Esben N.; Kristiansen, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3175-3182</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptor γ (PPARγ) is a key regulator of terminal adipocyte differentiation.  PPARδ is expressed in preadipocytes, but the importance of this PPAR subtype in adipogenesis has been a matter of debate.  Here we present a crit. evaluation of the role of PPARδ in adipocyte differentiation.  We demonstrate that treatment of NIH-3T3 fibroblasts overexpressing PPARδ with std. adipogenic inducers led to induction of PPARγ2 expression and terminal adipocyte differentiation in a manner that was strictly dependent on simultaneous administration of a PPARδ ligand and methylisobutylxanthine (MIX) or other cAMP elevating agents.  We further show that ligands and MIX synergistically stimulated PPARδ-mediated transactivation.  In 3T3-L1 preadipocytes, simultaneous administration of a PPARδ-selective ligand and MIX significantly enhanced the early expression of PPARγ and ALBP/aP2, but only modestly promoted terminal differentiation as detd. by lipid accumulation.  Finally, we provide evidence that synergistic activation of PPARδ promotes mitotic clonal expansion in 3T3-L1 cells with or without forced expression of PPARδ.  In conclusion, our results suggest that PPARδ may play a role in the proliferation of adipocyte precursor cells, whereas activation of endogenous PPARδ in 3T3-L1 cells appears to have only minor impact on the processes leading to terminal adipocyte differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUarK1GNdyHrVg90H21EOLACvtfcHk0lipL-m4CdbfhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtFWjtbY%253D&md5=fab72455cfee032150cf8fdfeff39539</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M005567200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M005567200%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DJ.%2BB.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRasmussen%26aufirst%3DT.%2BH.%26aulast%3DPetersen%26aufirst%3DR.%2BK.%26aulast%3DFlindt%26aufirst%3DE.%2BN.%26aulast%3DKristiansen%26aufirst%3DK.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529-mediated%2520Regulation%2520of%2520Preadipocyte%2520Proliferation%2520and%2520Gene%2520Expression%2520is%2520Dependent%2520on%2520cAMP%2520Signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D3175%26epage%3D3182%26doi%3D10.1074%2Fjbc.M005567200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsusue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ Potentiates PPARγ-stimulated Adipocyte Differentiation</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1477</span>– <span class="NLM_lpage">1479</span>, <span class="refDoi"> DOI: 10.1096/fj.04-1944fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1096%2Ffj.04-1944fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15247146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlKku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1477-1479&author=K.+Matsusueauthor=J.+M.+Petersauthor=F.+J.+Gonzalez&title=PPAR%CE%B2%2F%CE%B4+Potentiates+PPAR%CE%B3-stimulated+Adipocyte+Differentiation&doi=10.1096%2Ffj.04-1944fje"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ potentiates PPARγ-stimulated adipocyte differentiation</span></div><div class="casAuthors">Matsusue, Kimihiko; Peters, Jeffrey M.; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1477-1479, 10.1096/fj.04-1944fje</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">It is well established that peroxisome proliferator-activated receptor-γ (PPARγ) has a crit. role in modulating adipocyte differentiation based on gain-of-function and loss-of-function expts.  However, recent gain-of-function expts. suggest that PPARβ may also have a role in mediating adipocyte differentiation.  Because ligands for PPARs can activate more than one receptor isoform, the specific role of PPARβ in adipocyte differentiation was examd. using PPARβ-null adipocytes.  Wild-type adipocytes accumulate lipids in response to differentiation signaling induced from std. differentiation medium, and this effect is significantly reduced in PPARβ-null adipocytes.  The addn. of the PPARβ ligand L165041 to the std. differentiation medium causes enhanced adipocyte differentiation and lipid accumulation, and this effect is diminished in adipocytes lacking expression of PPARPβ.  Treatment of wild-type adipocytes with the PPARγ ligand troglitazone causes accelerated adipocyte differentiation and lipid accumulation, and this effect is marginally reduced in PPARβ-null adipocytes.  Expression patterns of mRNA markers of early and late adipocyte differentiation are consistent with the morphol. and biochem. differences obsd.  Results from these studies demonstrate that in the absence of PPARβ expression, adipocyte differentiation is significantly impaired, providing loss-of-function evidence supporting a role for this receptor in adipocyte differentiation.  These results also demonstrate that L165041-stimulated adipocyte differentiation and lipid accumulation is mediated by PPARβ.  In addn., as the ability of troglitazone to induce adipocyte differentiation is also impaired in PPARβ null adipocytes, this suggests that both PPARβ and PPARγ isoforms are required to facilitate maximal lipid accumulation and differentiation during adipogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ41bYMHz1XrVg90H21EOLACvtfcHk0lipL-m4CdbfhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlKku74%253D&md5=8ebec16d28490ec12ab8922c40155bed</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1096%2Ffj.04-1944fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.04-1944fje%26sid%3Dliteratum%253Aachs%26aulast%3DMatsusue%26aufirst%3DK.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520Potentiates%2520PPAR%25CE%25B3-stimulated%2520Adipocyte%2520Differentiation%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D1477%26epage%3D1479%26doi%3D10.1096%2Ffj.04-1944fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenk, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaith, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plunket, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodkin, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winegar, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sznaidman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span> <span> </span><span class="NLM_article-title">A Selective Peroxisome Proliferator-activated Receptor δ Agonist Promotes Reverse Cholesterol Transport</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">5306</span>– <span class="NLM_lpage">5311</span>, <span class="refDoi"> DOI: 10.1073/pnas.091021198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.091021198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11309497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1Ontro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=5306-5311&author=W.+R.+Oliverauthor=J.+L.+Shenkauthor=M.+R.+Snaithauthor=C.+S.+Russellauthor=K.+D.+Plunketauthor=N.+L.+Bodkinauthor=M.+C.+Lewisauthor=D.+A.+Winegarauthor=M.+L.+Sznaidmanauthor=M.+H.+Lambertauthor=H.+E.+Xuauthor=D.+D.+Sternbachauthor=S.+A.+Kliewerauthor=B.+C.+Hansenauthor=T.+M.+Willson&title=A+Selective+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist+Promotes+Reverse+Cholesterol+Transport&doi=10.1073%2Fpnas.091021198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport</span></div><div class="casAuthors">Oliver, William R., Jr.; Shenk, Jennifer L.; Snaith, Mike R.; Russell, Caroline S.; Plunket, Kelli D.; Bodkin, Noni L.; Lewis, Michael C.; Winegar, Deborah A.; Sznaidman, Marcos L.; Lambert, Millard H.; Xu, H. Eric; Sternbach, Daniel D.; Kliewer, Steven A.; Hansen, Barbara C.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5306-5311</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) are dietary lipid sensors that regulate fatty acid and carbohydrate metab.  The hypolipidemic effects of the fibrate drugs and the antidiabetic effects of the glitazone drugs in humans are due to activation of the α (NR1C1) and γ (NR1C3) subtypes, resp.  By contrast, the therapeutic potential of the δ (NR1C2) subtype is unknown, due in part to the lack of selective ligands.  We have used combinatorial chem. and structure-based drug design to develop a potent and subtype-selective PPARδ agonist, GW501516.  In macrophages, fibroblasts, and intestinal cells, GW501516 increases expression of the reverse cholesterol transporter ATP-binding cassette A1 and induces apolipoprotein A1-specific cholesterol efflux.  When dosed to insulin-resistant middle-aged obese rhesus monkeys, GW501516 causes a dramatic dose-dependent rise in serum high d. lipoprotein cholesterol while lowering the levels of small-dense low d. lipoprotein, fasting triglycerides, and fasting insulin.  Our results suggest that PPARδ agonists may be effective drugs to increase reverse cholesterol transport and decrease cardiovascular disease assocd. with the metabolic syndrome X.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL7t8Lud53sbVg90H21EOLACvtfcHk0ljujF6ppw62wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1Ontro%253D&md5=a831ae5815399dad336dd50e852ed3f8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.091021198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.091021198%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DW.%2BR.%26aulast%3DShenk%26aufirst%3DJ.%2BL.%26aulast%3DSnaith%26aufirst%3DM.%2BR.%26aulast%3DRussell%26aufirst%3DC.%2BS.%26aulast%3DPlunket%26aufirst%3DK.%2BD.%26aulast%3DBodkin%26aufirst%3DN.%2BL.%26aulast%3DLewis%26aufirst%3DM.%2BC.%26aulast%3DWinegar%26aufirst%3DD.%2BA.%26aulast%3DSznaidman%26aufirst%3DM.%2BL.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DHansen%26aufirst%3DB.%2BC.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DA%2520Selective%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%2520Promotes%2520Reverse%2520Cholesterol%2520Transport%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D5306%26epage%3D5311%26doi%3D10.1073%2Fpnas.091021198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Der Veen, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruit, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havinga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baller, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lestavel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groot, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groen, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuipers, F.</span></span> <span> </span><span class="NLM_article-title">Reduced Cholesterol Absorption upon PPARdelta Activation Coincides with Decreased Intestinal Expression of NPC1L1</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1194/jlr.M400400-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1194%2Fjlr.M400400-JLR200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15604518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Slsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=526-534&author=J.+N.+Van%0ADer+Veenauthor=J.+K.+Kruitauthor=R.+Havingaauthor=J.+F.+Ballerauthor=G.+Chiminiauthor=S.+Lestavelauthor=B.+Staelsauthor=P.+H.+Grootauthor=A.+K.+Groenauthor=F.+Kuipers&title=Reduced+Cholesterol+Absorption+upon+PPARdelta+Activation+Coincides+with+Decreased+Intestinal+Expression+of+NPC1L1&doi=10.1194%2Fjlr.M400400-JLR200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced cholesterol absorption upon PPARδ activation coincides with decreased intestinal expression of NPC1L1</span></div><div class="casAuthors">Van der Veen, Jelske N.; Kruit, Janine K.; Havinga, Rick; Baller, Julius F. W.; Chimini, Giovanna; Lestavel, Sophie; Staels, Bart; Groot, Pieter H. E.; Groen, Albert K.; Kuipers, Folkert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">526-534</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) control the transcription of genes involved in lipid metab.  Activation of PPARδ may have antiatherogenic effects through the increase of plasma HDL, theor. promoting reverse cholesterol transport from peripheral tissues toward the liver for removal via bile and feces.  Effects of PPARδ activation by GW610742 were evaluated in wild-type and Abca1-deficient (Abca1-/-) mice that lack HDL.  Treatment with GW610742 resulted in an ∼50% increase of plasma HDL-cholesterol in wild-type mice, whereas plasma cholesterol levels remained extremely low in Abca1-/- mice.  Yet, biliary cholesterol secretion rates were similar in untreated wild-type and Abca1-/- mice and unaltered upon treatment.  Unexpectedly, PPARδ activation led to enhanced fecal neutral sterol loss in both groups without any changes in intestinal Abca1, Abcg5, Abcg8, and 3-hydroxy-3-methylglutaryl-CoA reductase expression.  Moreover, GW610742 treatment resulted in a 43% redn. of fractional cholesterol absorption in wild-type mice, coinciding with a significantly reduced expression of the cholesterol absorption protein Niemann-Pick C1-like 1 (Npc1l1) in the intestine.  PPARδ activation is assocd. with increased plasma HDL and reduced intestinal cholesterol absorption efficiency that may be related to decreased intestinal Npc1l1 expression.  Thus, PPARδ is a promising target for drugs aimed to treat or prevent atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp44jjr5VPCw7Vg90H21EOLACvtfcHk0ljujF6ppw62wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Slsbk%253D&md5=d14003c9f632fea50906b6ffa293e8d3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M400400-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M400400-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BVeen%26aufirst%3DJ.%2BN.%26aulast%3DKruit%26aufirst%3DJ.%2BK.%26aulast%3DHavinga%26aufirst%3DR.%26aulast%3DBaller%26aufirst%3DJ.%2BF.%26aulast%3DChimini%26aufirst%3DG.%26aulast%3DLestavel%26aufirst%3DS.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DGroot%26aufirst%3DP.%2BH.%26aulast%3DGroen%26aufirst%3DA.%2BK.%26aulast%3DKuipers%26aufirst%3DF.%26atitle%3DReduced%2520Cholesterol%2520Absorption%2520upon%2520PPARdelta%2520Activation%2520Coincides%2520with%2520Decreased%2520Intestinal%2520Expression%2520of%2520NPC1L1%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2005%26volume%3D46%26spage%3D526%26epage%3D534%26doi%3D10.1194%2Fjlr.M400400-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hevener, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehl, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olefsky, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">PPARδ Regulates Glucose Metabolism and Insulin Sensitivity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">3444</span>– <span class="NLM_lpage">3449</span>, <span class="refDoi"> DOI: 10.1073/pnas.0511253103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.0511253103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16492734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XksF2ku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3444-3449&author=C.-H.+Leeauthor=P.+Olsonauthor=A.+Hevenerauthor=I.+Mehlauthor=L.-W.+Chongauthor=J.+M.+Olefskyauthor=F.+J.+Gonzalezauthor=J.+Hamauthor=H.+Kangauthor=J.+M.+Petersauthor=R.+M.+Evans&title=PPAR%CE%B4+Regulates+Glucose+Metabolism+and+Insulin+Sensitivity&doi=10.1073%2Fpnas.0511253103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ regulates glucose metabolism and insulin sensitivity</span></div><div class="casAuthors">Lee, Chih-Hao; Olson, Peter; Hevener, Andrea; Mehl, Isaac; Chong, Ling-Wa; Olefsky, Jerrold M.; Gonzalez, Frank J.; Ham, Jungyeob; Kang, Heonjoong; Peters, Jeffrey M.; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3444-3449</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The metabolic syndrome is a collection of obesity-related disorders.  The peroxisome proliferator-activated receptors (PPARs) regulate transcription in response to fatty acids and, as such, are potential therapeutic targets for these diseases.  We show that PPARδ (NR1C2) knockout mice are metabolically less active and glucose-intolerant, whereas receptor activation in db/db mice improves insulin sensitivity.  Euglycemic-hyperinsulinemic-clamp expts. further demonstrate that a PPARδ-specific agonist suppresses hepatic glucose output, increases glucose disposal, and inhibits free fatty acid release from adipocytes.  Unexpectedly, gene array and functional analyses suggest that PPARδ ameliorates hyperglycemia by increasing glucose flux through the pentose phosphate pathway and enhancing fatty acid synthesis.  Coupling increased hepatic carbohydrate catabolism with its ability to promote β-oxidn. in muscle allows PPARδ to regulate metabolic homeostasis and enhance insulin action by complementary effects in distinct tissues.  The combined hepatic and peripheral actions of PPARδ suggest new therapeutic approaches to treat type II diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqag9xStyn2Z7Vg90H21EOLACvtfcHk0lgNh9zSMVoEig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksF2ku70%253D&md5=fedf92bc22bb42e4c204e3be75abc51f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0511253103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0511253103%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.-H.%26aulast%3DOlson%26aufirst%3DP.%26aulast%3DHevener%26aufirst%3DA.%26aulast%3DMehl%26aufirst%3DI.%26aulast%3DChong%26aufirst%3DL.-W.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DPPAR%25CE%25B4%2520Regulates%2520Glucose%2520Metabolism%2520and%2520Insulin%2520Sensitivity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D3444%26epage%3D3449%26doi%3D10.1073%2Fpnas.0511253103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkart-Hartman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloszy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, D. P.</span></span> <span> </span><span class="NLM_article-title">The Nuclear Receptor PPARβ/δ Programs Muscle Glucose Metabolism in Cooperation with AMPK and MEF2</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2619</span>– <span class="NLM_lpage">2630</span>, <span class="refDoi"> DOI: 10.1101/gad.178434.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1101%2Fgad.178434.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22135324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlsl2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=2619-2630&author=Z.+Ganauthor=E.+M.+Burkart-Hartmanauthor=D.-H.+Hanauthor=B.+Finckauthor=T.+C.+Leoneauthor=E.+Y.+Smithauthor=J.+E.+Ayalaauthor=J.+Holloszyauthor=D.+P.+Kelly&title=The+Nuclear+Receptor+PPAR%CE%B2%2F%CE%B4+Programs+Muscle+Glucose+Metabolism+in+Cooperation+with+AMPK+and+MEF2&doi=10.1101%2Fgad.178434.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The nuclear receptor PPARβ/δ programs muscle glucose metabolism in cooperation with AMPK and MEF2</span></div><div class="casAuthors">Gan, Zhenji; Burkart-Hartman, Eileen M.; Han, Dong-Ho; Finck, Brian; Leone, Teresa C.; Smith, Emily Y.; Ayala, Julio E.; Holloszy, John; Kelly, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2619-2630</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">To identify new gene regulatory pathways controlling skeletal muscle energy metab., comparative studies were conducted on muscle-specific transgenic mouse lines expressing the nuclear receptors peroxisome proliferator-activated receptor α (PPARα; muscle creatine kinase [MCK]-PPARα) or PPARβ/δ (MCK-PPARβ/δ).  MCK-PPARβ/δ mice are known to have enhanced exercise performance, whereas MCK-PPARα mice perform at low levels.  Transcriptional profiling revealed that the lactate dehydrogenase b (Ldhb)/Ldha gene expression ratio is increased in MCK-PPARβ/δ muscle, an isoenzyme shift that diverts pyruvate into the mitochondrion for the final steps of glucose oxidn.  PPARβ/δ gain- and loss-of-function studies in skeletal myotubes demonstrated that PPARβ/δ, but not PPARα, interacts with the exercise-inducible kinase AMP-activated protein kinase (AMPK) to synergistically activate Ldhb gene transcription by cooperating with myocyte enhancer factor 2A (MEF2A) in a PPARβ/δ ligand-independent manner.  MCK-PPARβ/δ muscle was shown to have high glycogen stores, increased levels of GLUT4, and augmented capacity for mitochondrial pyruvate oxidn., suggesting a broad reprogramming of glucose utilization pathways.  Lastly, exercise studies demonstrated that MCK-PPARβ/δ mice persistently oxidized glucose compared with nontransgenic controls, while exhibiting supranormal performance.  These results identify a transcriptional regulatory mechanism that increases capacity for muscle glucose utilization in a pattern that resembles the effects of exercise training.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV2aSoQaRr_bVg90H21EOLACvtfcHk0lgNh9zSMVoEig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlsl2msw%253D%253D&md5=957b60674782b37b5f0dd8f0733cc63a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1101%2Fgad.178434.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.178434.111%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DZ.%26aulast%3DBurkart-Hartman%26aufirst%3DE.%2BM.%26aulast%3DHan%26aufirst%3DD.-H.%26aulast%3DFinck%26aufirst%3DB.%26aulast%3DLeone%26aufirst%3DT.%2BC.%26aulast%3DSmith%26aufirst%3DE.%2BY.%26aulast%3DAyala%26aufirst%3DJ.%2BE.%26aulast%3DHolloszy%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DD.%2BP.%26atitle%3DThe%2520Nuclear%2520Receptor%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Programs%2520Muscle%2520Glucose%2520Metabolism%2520in%2520Cooperation%2520with%2520AMPK%2520and%2520MEF2%26jtitle%3DGenes%2520Dev.%26date%3D2011%26volume%3D25%26spage%3D2619%26epage%3D2630%26doi%3D10.1101%2Fgad.178434.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salvadó, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Foix, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomer, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ Prevents Endoplasmic Reticulum Stress-associated Inflammation and Insulin Resistance in Skeletal Muscle Cells Through an AMPK-dependent Mechanism</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2135</span>, <span class="refDoi"> DOI: 10.1007/s00125-014-3331-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1007%2Fs00125-014-3331-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25063273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Gks73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2126-2135&author=L.+Salvad%C3%B3author=E.+Barrosoauthor=A.+M.+G%C3%B3mez-Foixauthor=X.+Palomerauthor=L.+Michalikauthor=W.+Wahliauthor=M.+V%C3%A1zquez-Carrera&title=PPAR%CE%B2%2F%CE%B4+Prevents+Endoplasmic+Reticulum+Stress-associated+Inflammation+and+Insulin+Resistance+in+Skeletal+Muscle+Cells+Through+an+AMPK-dependent+Mechanism&doi=10.1007%2Fs00125-014-3331-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism</span></div><div class="casAuthors">Salvado, Laia; Barroso, Emma; Gomez-Foix, Anna Maria; Palomer, Xavier; Michalik, Liliane; Wahli, Walter; Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2126-2135</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aim/hypothesis: Endoplasmic reticulum (ER) stress, which is involved in the link between inflammation and insulin resistance, contributes to the development of type 2 diabetes mellitus.  In this study, we assessed whether peroxisome proliferator-activated receptor (PPAR)β/δ prevented ER stress-assocd. inflammation and insulin resistance in skeletal muscle cells.  Methods: Studies were conducted in mouse C2C12 myotubes, in the human myogenic cell line LHCN-M2 and in skeletal muscle from wild-type and PPARβ/δ-deficient mice and mice exposed to a high-fat diet.  Results: The PPARβ/δ agonist GW501516 prevented lipid-induced ER stress in mouse and human myotubes and in skeletal muscle of mice fed a high-fat diet.  PPARβ/δ activation also prevented thapsigargin- and tunicamycin-induced ER stress in human and murine skeletal muscle cells.  In agreement with this, PPARβ/δ activation prevented ER stress-assocd. inflammation and insulin resistance, and glucose-intolerant PPARβ/δ-deficient mice showed increased phosphorylated levels of inositol-requiring 1 transmembrane kinase/endonuclease-1α in skeletal muscle.  Our findings demonstrate that PPARβ/δ activation prevents ER stress through the activation of AMP-activated protein kinase (AMPK), and the subsequent inhibition of extracellular-signal-regulated kinase (ERK)1/2 due to the inhibitory crosstalk between AMPK and ERK1/2, since overexpression of a dominant neg. AMPK construct (K45R) reversed the effects attained by PPARβ/δ activation.  Conclusions/interpretation: Overall, these findings indicate that PPARβ/δ prevents ER stress, inflammation and insulin resistance in skeletal muscle cells by activating AMPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHCyGO8lv08LVg90H21EOLACvtfcHk0lgNh9zSMVoEig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Gks73E&md5=fca954518b59fd8f82687b4a26262d7e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs00125-014-3331-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-014-3331-8%26sid%3Dliteratum%253Aachs%26aulast%3DSalvad%25C3%25B3%26aufirst%3DL.%26aulast%3DBarroso%26aufirst%3DE.%26aulast%3DG%25C3%25B3mez-Foix%26aufirst%3DA.%2BM.%26aulast%3DPalomer%26aufirst%3DX.%26aulast%3DMichalik%26aufirst%3DL.%26aulast%3DWahli%26aufirst%3DW.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520Prevents%2520Endoplasmic%2520Reticulum%2520Stress-associated%2520Inflammation%2520and%2520Insulin%2520Resistance%2520in%2520Skeletal%2520Muscle%2520Cells%2520Through%2520an%2520AMPK-dependent%2520Mechanism%26jtitle%3DDiabetologia%26date%3D2014%26volume%3D57%26spage%3D2126%26epage%3D2135%26doi%3D10.1007%2Fs00125-014-3331-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cnop, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foufelle, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velloso, L. A.</span></span> <span> </span><span class="NLM_article-title">Endoplasmic Reticulum Stress, Obesity and Diabetes</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2011.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.molmed.2011.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21889406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=59-68&author=M.+Cnopauthor=F.+Foufelleauthor=L.+A.+Velloso&title=Endoplasmic+Reticulum+Stress%2C+Obesity+and+Diabetes&doi=10.1016%2Fj.molmed.2011.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic reticulum stress, obesity and diabetes</span></div><div class="casAuthors">Cnop, Miriam; Foufelle, Fabienne; Velloso, Licio A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-68</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The endoplasmic reticulum (ER) stress response, also commonly known as the unfolded protein response (UPR), is an adaptive response used to align ER functional capacity with demand.  It is activated in various tissues under conditions related to obesity and type 2 diabetes.  Hypothalamic ER stress contributes to inflammation and leptin/insulin resistance.  Hepatic ER stress contributes to the development of steatosis and insulin resistance, and components of the UPR regulate liver lipid metab.  ER stress in enlarged fat tissues induces inflammation and modifies adipokine secretion, and satd. fats cause ER stress in muscle.  Finally, prolonged ER stress impairs insulin synthesis and causes pancreatic β cell apoptosis.  In this review, we discuss ways in which ER stress operates as a common mol. pathway in the pathogenesis of obesity and diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4sRB0R3CMMLVg90H21EOLACvtfcHk0li3i4I94XkrzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVSgtw%253D%253D&md5=21fb3f4b129b33837cd0ec25e5a740f1</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2011.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2011.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DCnop%26aufirst%3DM.%26aulast%3DFoufelle%26aufirst%3DF.%26aulast%3DVelloso%26aufirst%3DL.%2BA.%26atitle%3DEndoplasmic%2520Reticulum%2520Stress%252C%2520Obesity%2520and%2520Diabetes%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D59%26epage%3D68%26doi%3D10.1016%2Fj.molmed.2011.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Marco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Calvo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Kochairi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomer, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–stimulated Adipocytes</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1990</span>– <span class="NLM_lpage">1999</span>, <span class="refDoi"> DOI: 10.2337/db10-0704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.2337%2Fdb10-0704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21617181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVChu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=1990-1999&author=L.+Serrano-Marcoauthor=R.+Rodr%C3%ADguez-Calvoauthor=I.+El+Kochairiauthor=X.+Palomerauthor=L.+Michalikauthor=W.+Wahliauthor=M.+V%C3%A1zquez-Carrera&title=Activation+of+Peroxisome+Proliferator%E2%80%93Activated+Receptor-%CE%B2%2F-%CE%B4+%28PPAR-%CE%B2%2F-%CE%B4%29+Ameliorates+Insulin+Signaling+and+Reduces+SOCS3+Levels+by+Inhibiting+STAT3+in+Interleukin-6%E2%80%93stimulated+Adipocytes&doi=10.2337%2Fdb10-0704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes</span></div><div class="casAuthors">Serrano-Marco, Lucia; Rodriguez-Calvo, Ricardo; El Kochairi, Ilhem; Palomer, Xavier; Michalik, Liliane; Wahli, Walter; Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1990-1999</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Objective: It has been suggested that interleukin (IL)-6 is one of the mediators linking obesity-derived chronic inflammation with insulin resistance through activation of STAT3, with subsequent upregulation of suppressor of cytokine signaling 3 (SOCS3).  We evaluated whether peroxisome proliferator-activated receptor (PPAR)-β/-δ prevented activation of the IL-6-STAT3-SOCS3 pathway and insulin resistance in adipocytes.  Research Design and Methods: Adipocytes and white adipose tissue from wild-type and PPAR-β/-δ-null mice were used to evaluate the effect of PPAR-β/-δ on the IL-6-STAT3-SOCS3 pathway.  Results: First, we obsd. that the PPAR-β/-δ agonist GW501516 prevented both IL-6-dependent redn. in insulin-stimulated Akt phosphorylation and glucose uptake in adipocytes.  In addn., this drug treatment abolished IL-6-induced SOCS3 expression in differentiated 3T3-L1 adipocytes.  This effect was assocd. with the capacity of the drug to prevent IL-6-induced STAT3 phosphorylation on Tyr705 and Ser727 residues in vitro and in vivo.  Moreover, GW501516 prevented IL-6-dependent induction of extracellular signal-related kinase (ERK)1/2, a serine-threonine-protein kinase involved in serine STAT3 phosphorylation.  Furthermore, in white adipose tissue from PPAR-β/-δ-null mice, STAT3 phosphorylation (Tyr705 and Ser727), STAT3 DNA-binding activity, and SOCS3 protein levels were higher than in wild-type mice.  Several steps in STAT3 activation require its assocn. with heat shock protein 90 (Hsp90), which was prevented by GW501516 as revealed in immunopptn. studies.  Consistent with this finding, the STAT3-Hsp90 assocn. was enhanced in white adipose tissue from PPAR-β/-δ-null mice compared with wild-type mice.  Conclusions: Collectively, our findings indicate that PPAR-β/-δ activation prevents IL-6-induced STAT3 activation by inhibiting ERK1/2 and preventing the STAT3-Hsp90 assocn., an effect that may contribute to the prevention of cytokine-induced insulin resistance in adipocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorMzXks5dNjbVg90H21EOLACvtfcHk0li3i4I94XkrzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVChu7o%253D&md5=8c64a2f948b858413b72aecdff8cef53</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2337%2Fdb10-0704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb10-0704%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano-Marco%26aufirst%3DL.%26aulast%3DRodr%25C3%25ADguez-Calvo%26aufirst%3DR.%26aulast%3DEl%2BKochairi%26aufirst%3DI.%26aulast%3DPalomer%26aufirst%3DX.%26aulast%3DMichalik%26aufirst%3DL.%26aulast%3DWahli%26aufirst%3DW.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DActivation%2520of%2520Peroxisome%2520Proliferator%25E2%2580%2593Activated%2520Receptor-%25CE%25B2%252F-%25CE%25B4%2520%2528PPAR-%25CE%25B2%252F-%25CE%25B4%2529%2520Ameliorates%2520Insulin%2520Signaling%2520and%2520Reduces%2520SOCS3%2520Levels%2520by%2520Inhibiting%2520STAT3%2520in%2520Interleukin-6%25E2%2580%2593stimulated%2520Adipocytes%26jtitle%3DDiabetes%26date%3D2011%26volume%3D60%26spage%3D1990%26epage%3D1999%26doi%3D10.2337%2Fdb10-0704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, h.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-N.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ Agonist GW501516 Inhibits TNFα-induced Repression of Adiponectin and Insulin Receptor in 3T3-L1 Adipocytes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>510</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2019.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbrc.2019.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30739791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXislKrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2019&pages=621-628&author=W.+J.+Kimauthor=W.+Leeauthor=Y.+Jungauthor=h.-J.+Jangauthor=Y.+K.+Kimauthor=S.-N.+Kim&title=PPAR%CE%B2%2F%CE%B4+Agonist+GW501516+Inhibits+TNF%CE%B1-induced+Repression+of+Adiponectin+and+Insulin+Receptor+in+3T3-L1+Adipocytes&doi=10.1016%2Fj.bbrc.2019.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ agonist GW501516 inhibits TNFα-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes</span></div><div class="casAuthors">Kim, Won Jun; Lee, Woojung; Jung, Yujung; Jang, hyuk-Jai; Kim, Yong Kee; Kim, Su-Nam</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">621-628</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous reports have shown that PPARβ/δ agonists ameliorate insulin resistance assocd. with type 2 diabetes mellitus (T2DM).  To det. the role of PPARβ/δ in tumor necrosis factor α (TNFα)-mediated insulin resistance, we investigated expression levels of adiponectin and insulin receptor (IR) in response to treatment with the PPARβ/δ agonist GW501516 with or without TNFα, a proinflammatory cytokine, in differentiated 3T3-L1 adipocytes.  GW501516 induced adipocyte differentiation and the expression of adiponectin in a dose-dependent manner in differentiated adipocytes.  TNFα treatment reduced adiponectin expression at the end of differentiation.  This effect was reversed by GW501516 co-treatment with TNFα.  TNFα treatment decreased adipogenic marker genes such as PPARγ, aP2, resistin, and GLUT4, and GW501516 reversed the effects of TNFα.  GW501516 treatment increased the expression of insulin receptor and inhibited TNFα-mediated repression of insulin receptor.  Our results showed that GW501516 abrogated TNFα-induced insulin resistance.  In summary, our study demonstrated that the PPARβ/δ agonist, GW501516 reversed TNFα-induced decreases in adipocyte differentiation and adiponectin expression, and improved insulin sensitivity by increasing the expression of insulin receptor.  Therefore, PPARδ may be a promising therapeutic target for treatment of insulin resistance in patients with T2DM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj4yd7j2CVVrVg90H21EOLACvtfcHk0li3i4I94XkrzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXislKrtbg%253D&md5=167dabe92b8d52dff6c69dcf5eacbc0e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2019.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2019.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DJang%26aufirst%3Dh.-J.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DKim%26aufirst%3DS.-N.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520Agonist%2520GW501516%2520Inhibits%2520TNF%25CE%25B1-induced%2520Repression%2520of%2520Adiponectin%2520and%2520Insulin%2520Receptor%2520in%25203T3-L1%2520Adipocytes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2019%26volume%3D510%26spage%3D621%26epage%3D628%26doi%3D10.1016%2Fj.bbrc.2019.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmadian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sul, H. S.</span></span> <span> </span><span class="NLM_article-title">Desnutrin/ATGL Activates PPARδ to Promote Mitochondrial Function for insulin Secretion in islet β cells</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">895</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2013.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.cmet.2013.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=24268737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKisLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=883-895&author=T.+Tangauthor=M.+J.+Abbottauthor=M.+Ahmadianauthor=A.+B.+Lopesauthor=Y.+Wangauthor=H.+S.+Sul&title=Desnutrin%2FATGL+Activates+PPAR%CE%B4+to+Promote+Mitochondrial+Function+for+insulin+Secretion+in+islet+%CE%B2+cells&doi=10.1016%2Fj.cmet.2013.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Desnutrin/ATGL Activates PPARδ to Promote Mitochondrial Function for Insulin Secretion in Islet β Cells</span></div><div class="casAuthors">Tang, Tianyi; Abbott, Marcia J.; Ahmadian, Maryam; Lopes, Andressa B.; Wang, Yuhui; Sul, Hei Sook</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">883-895</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Excessive caloric intake leading to obesity is assocd. with insulin resistance and dysfunction of islet β cells.  High-fat feeding decreases desnutrin (also called ATGL/PNPLA2) levels in islets.  Here we show that desnutrin ablation via RIP-Cre (βKO) or RIP-CreER results in hyperglycemia with impaired glucose-stimulated insulin secretion (GSIS).  Due to decreased lipolysis, islets have higher TAG content but lower free FA levels.  βKO islets exhibit impaired mitochondrial respiration and lower prodn. of ATP required for GSIS, along with decreased expression of PPARδ target genes involved in mitochondrial oxidn.  Furthermore, synthetic PPARδ, but not PPARα, agonist restores GSIS and expression of mitochondrial oxidative genes in βKO mice, revealing that desnutrin-catalyzed lipolysis generates PPARδ ligands.  Finally, adenoviral expression of desnutrin in βKO islets restores all defects of βKO islet phenotype and function, including GSIS and mitochondrial defects, demonstrating the crit. role of the desnutrin-PPARδ-mitochondrial oxidn. axis in regulating islet β cell GSIS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAFILYlAE9y7Vg90H21EOLACvtfcHk0lgqgVOOV5iUYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKisLvK&md5=e87675cb448ba5a89e11be77e4fb7087</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2013.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2013.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DT.%26aulast%3DAbbott%26aufirst%3DM.%2BJ.%26aulast%3DAhmadian%26aufirst%3DM.%26aulast%3DLopes%26aufirst%3DA.%2BB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSul%26aufirst%3DH.%2BS.%26atitle%3DDesnutrin%252FATGL%2520Activates%2520PPAR%25CE%25B4%2520to%2520Promote%2520Mitochondrial%2520Function%2520for%2520insulin%2520Secretion%2520in%2520islet%2520%25CE%25B2%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2013%26volume%3D18%26spage%3D883%26epage%3D895%26doi%3D10.1016%2Fj.cmet.2013.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, N.</span></span> <span> </span><span class="NLM_article-title">Activation of PPARβ/δ Protects Pancreatic β cells from Palmitate-induced Apoptosis by Upregulating the Expression of GLP-1 Receptor</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2013.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.cellsig.2013.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=24269940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVSgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=268-278&author=Y.+Yangauthor=Y.+Tongauthor=M.+Gongauthor=Y.+Luauthor=C.+Wangauthor=M.+Zhouauthor=Q.+Yangauthor=T.+Maoauthor=N.+Tong&title=Activation+of+PPAR%CE%B2%2F%CE%B4+Protects+Pancreatic+%CE%B2+cells+from+Palmitate-induced+Apoptosis+by+Upregulating+the+Expression+of+GLP-1+Receptor&doi=10.1016%2Fj.cellsig.2013.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor</span></div><div class="casAuthors">Yang, Yan; Tong, Yuzhen; Gong, Meng; Lu, Yanrong; Wang, Chengshi; Zhou, Mingliang; Yang, Qiu; Mao, Tingrui; Tong, Nanwei</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-278</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We previously showed that activated peroxisome proliferator-activated receptor (PPAR)β/δ can protect pancreatic β cells against lipotoxic apoptosis.  However, the mol. mechanism remained unclear.  Glucagon-like peptide-1 receptor (GLP-1R) has been reported to exhibit a protective effect against lipotoxic apoptosis in pancreatic β cells.  In the present study, we aimed to investigate the underlying mol. mechanisms that PPARβ/δ activation suppressed apoptosis and improved β cell function impaired by fatty acids, focusing on contribution of GLP-1R.  Isolated rat islets and rat insulin-secreting INS-1 cells were treated with the PPARβ/δ agonist GW501516 (GW) in the presence or absence of palmitate (PA) and transfected with siRNA for PPARβ/δ or treated with the PPARβ/δ antagonist GSK0660.  Apoptosis was assessed by DNA fragmentation, Hoechst 33342 staining and flow cytometry.  GLP-1R expression in INS-1 cells and islets was assayed by immunoblotting, quant. PCR (qPCR) and immunofluorescence staining.  SREBP-1c, Caveolin-1, Akt, Bcl-2, Bcl-xl and caspase-3 expression was measured using immunoblotting and qPCR.  Our results showed that PPARβ/δ activation decreased apoptosis in β cells and robustly stimulated GLP-1R expression under lipotoxic conditions.  GW enhanced glucose-stimulated insulin secretion (GSIS) impaired by PA through stimulation of GLP-1R expression in β cells.  Moreover, SREBP-1c/Caveolin-1 signaling was involved in PPARβ/δ-regulated GLP-1R expression.  Finally, GW exerted anti-apoptotic effects via interfering with GLP-1R-dependent Akt/Bcl-2 and Bcl-xl/caspase-3 signaling pathways.  Our study suggested that the anti-apoptotic action of GW may involve its transcriptional regulation of GLP-1R, and PPARβ/δ activation may represent a new therapeutic method for protecting pancreatic β cells from lipotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMcsdJoteZ57Vg90H21EOLACvtfcHk0lgqgVOOV5iUYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVSgsw%253D%253D&md5=4f40fce3a5d4ee5bf816632e8642a89a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2013.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2013.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DGong%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DMao%26aufirst%3DT.%26aulast%3DTong%26aufirst%3DN.%26atitle%3DActivation%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Protects%2520Pancreatic%2520%25CE%25B2%2520cells%2520from%2520Palmitate-induced%2520Apoptosis%2520by%2520Upregulating%2520the%2520Expression%2520of%2520GLP-1%2520Receptor%26jtitle%3DCell.%2520Signalling%26date%3D2014%26volume%3D26%26spage%3D268%26epage%3D278%26doi%3D10.1016%2Fj.cellsig.2013.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doktorova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwarts, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zutphen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van DIjk, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloks, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harkema, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bruin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkade, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, J. W.</span></span> <span> </span><span class="NLM_article-title">Intestinal PPARδ Protects Against Diet-induced Obesity, Insulin Resistance and Dyslipidemia</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">846</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-00889-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fs41598-017-00889-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=28404991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC1cvntlOgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=846&author=M.+Doktorovaauthor=I.+Zwartsauthor=T.+van+Zutphenauthor=T.+H.+Van+DIjkauthor=V.+W.+Bloksauthor=L.+Harkemaauthor=A.+De+Bruinauthor=M.+Downesauthor=R.+M.+Evansauthor=H.+J.+Verkadeauthor=J.+W.+Jonker&title=Intestinal+PPAR%CE%B4+Protects+Against+Diet-induced+Obesity%2C+Insulin+Resistance+and+Dyslipidemia&doi=10.1038%2Fs41598-017-00889-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia</span></div><div class="casAuthors">Doktorova Marcela; Zwarts Irene; Zutphen Tim van; Bloks Vincent W; Bruin Alain de; Verkade Henkjan J; Jonker Johan W; Dijk Theo H van; Harkema Liesbeth; Bruin Alain de; Downes Michael; Evans Ronald M</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">846</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peroxisome proliferator-activated receptor δ (PPARδ) is a ligand-activated transcription factor that has an important role in lipid metabolism.  Activation of PPARδ stimulates fatty acid oxidation in adipose tissue and skeletal muscle and improves dyslipidemia in mice and humans.  PPARδ is highly expressed in the intestinal tract but its physiological function in this organ is not known.  Using mice with an intestinal epithelial cell-specific deletion of PPARδ, we show that intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia.  Furthermore, absence of intestinal PPARδ abolished the ability of PPARδ agonist GW501516 to increase plasma levels of HDL-cholesterol.  Together, our findings show that intestinal PPARδ is important in maintaining metabolic homeostasis and suggest that intestinal-specific activation of PPARδ could be a therapeutic approach for treatment of the metabolic syndrome and dyslipidemia, while avoiding systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxtgej_xcBI6-9TkgmBqTqfW6udTcc2eZx-AwICa4uqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvntlOgug%253D%253D&md5=94f4cfda86a4c1ed44a993ebbb0357f8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-00889-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-00889-z%26sid%3Dliteratum%253Aachs%26aulast%3DDoktorova%26aufirst%3DM.%26aulast%3DZwarts%26aufirst%3DI.%26aulast%3Dvan%2BZutphen%26aufirst%3DT.%26aulast%3DVan%2BDIjk%26aufirst%3DT.%2BH.%26aulast%3DBloks%26aufirst%3DV.%2BW.%26aulast%3DHarkema%26aufirst%3DL.%26aulast%3DDe%2BBruin%26aufirst%3DA.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DVerkade%26aufirst%3DH.%2BJ.%26aulast%3DJonker%26aufirst%3DJ.%2BW.%26atitle%3DIntestinal%2520PPAR%25CE%25B4%2520Protects%2520Against%2520Diet-induced%2520Obesity%252C%2520Insulin%2520Resistance%2520and%2520Dyslipidemia%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D846%26doi%3D10.1038%2Fs41598-017-00889-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowlus, C. L.</span></span> <span> </span><span class="NLM_article-title">Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis</span>. <i>Gastroenterol. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">154</span>– <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC1MbpvVOrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=154-163&author=R.+Baharauthor=K.+A.+Wongauthor=C.+H.+Liuauthor=C.+L.+Bowlus&title=Update+on+New+Drugs+and+Those+in+Development+for+the+Treatment+of+Primary+Biliary+Cholangitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis</span></div><div class="casAuthors">Bahar Runalia; Wong Kimberly A; Liu Chung H; Bowlus Christopher L</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">154-163</span>
        ISSN:<span class="NLM_cas:issn">1554-7914</span>.
    </div><div class="casAbstract">Primary biliary cholangitis (PBC) is an autoimmune inflammatory liver disease of the interlobular bile ducts that can lead to cirrhosis and liver failure.  Until recently, the only effective treatment was ursodeoxycholic acid (UDCA).  However, up to 40% of PBC patients have an inadequate response to UDCA and may continue to have disease progression.  Several models have been developed, including the UK-PBC and GLOBE scores, to assist in identifying patients who may benefit from second-line therapies, such as the farnesoid X receptor (FXR) agonist obeticholic acid (OCA).  The addition of OCA can significantly improve serum alkaline phosphatase and total bilirubin, which are strong surrogate markers of clinical outcomes in PBC.  Other alternatives, including the peroxisome proliferator-activated receptor (PPAR)-α agonists fenofibrate and bezafibrate, may also improve liver biochemistries in PBC patients with an inadequate response to UDCA, but further study is needed to demonstrate their safety and long-term efficacy.  Other novel agents, including those targeting the FXR pathway and PPAR-δ agonists, have shown promising results and may alter the therapeutic landscape of PBC in the near future.  For now, OCA remains the only approved second-line agent for PBC patients with an inadequate response to UDCA while results of long-term studies of its safety and clinical benefit are awaited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDQCanGEFYzZZoeNcnHOQ9fW6udTcc2eYHgzfmPsuMArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbpvVOrtg%253D%253D&md5=46c31e96ea8a1e92d5c45fb838696bf2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBahar%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DK.%2BA.%26aulast%3DLiu%26aufirst%3DC.%2BH.%26aulast%3DBowlus%26aufirst%3DC.%2BL.%26atitle%3DUpdate%2520on%2520New%2520Drugs%2520and%2520Those%2520in%2520Development%2520for%2520the%2520Treatment%2520of%2520Primary%2520Biliary%2520Cholangitis%26jtitle%3DGastroenterol.%2520Hepatol.%26date%3D2018%26volume%3D14%26spage%3D154%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span> <span> </span><span class="NLM_article-title">Emerging Novel Treatments for Autoimmune Liver Diseases</span>. <i>Hepatol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1111/hepr.13347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1111%2Fhepr.13347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30969002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FjvVKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2019&pages=489-499&author=A.+Tanaka&title=Emerging+Novel+Treatments+for+Autoimmune+Liver+Diseases&doi=10.1111%2Fhepr.13347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging novel treatments for autoimmune liver diseases</span></div><div class="casAuthors">Tanaka Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology research : the official journal of the Japan Society of Hepatology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">489-499</span>
        ISSN:<span class="NLM_cas:issn">1386-6346</span>.
    </div><div class="casAbstract">The etiology of autoimmune liver diseases, such as autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC), still remains largely unknown and no therapeutic agents that are able to "cure" these diseases have been developed.  Although corticosteroids for AIH and ursodeoxycholic acid for PBC have been shown to significantly improve liver transplantation (LT)-free survival and are recommended as first-line drugs, treatment strategies for patients who show incomplete response to these drugs have not yet been fully established.  No drug is significantly associated with long LT-free survival in PSC patients.  Nevertheless, with progress in genetics, immunology, and cellular biology, several new compounds or antibodies are expected to have an effect on autoimmune liver diseases and several drugs are under consideration for clinical use.  Although most clinical trials have been carried out in the USA or Europe, some are, or will be, undertaken in Japan in the future.  In this review, the current standard-of-care of autoimmune liver diseases will be summarized, together with emerging novel treatments relevant to clinical practice in Japan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQN1Ak8wZEfR-_Q9URG6Dx8fW6udTcc2eYHgzfmPsuMArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FjvVKgug%253D%253D&md5=e5e2667850ac8f11286a1a36f834291c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fhepr.13347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fhepr.13347%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DA.%26atitle%3DEmerging%2520Novel%2520Treatments%2520for%2520Autoimmune%2520Liver%2520Diseases%26jtitle%3DHepatol.%2520Res.%26date%3D2019%26volume%3D49%26spage%3D489%26epage%3D499%26doi%3D10.1111%2Fhepr.13347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palomer, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro-Delgado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peña, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botteri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montori-Grau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">913</span>, <span class="refDoi"> DOI: 10.3390/ijms19030913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms19030913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOntLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=913&author=X.+Palomerauthor=E.+Barrosoauthor=J.+Pizarro-Delgadoauthor=L.+Pe%C3%B1aauthor=G.+Botteriauthor=M.+Zareiauthor=D.+Aguilarauthor=M.+Montori-Grauauthor=M.+V%C3%A1zquez-Carrera&title=PPAR%CE%B2%2F%CE%B4%3A+A+Key+Therapeutic+Target+in+Metabolic+Disorders&doi=10.3390%2Fijms19030913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ: a key therapeutic target in metabolic disorders</span></div><div class="casAuthors">Palomer, Xavier; Barroso, Emma; Pizarro-Delgado, Javier; Pena, Lucia; Botteri, Gaia; Zarei, Mohammad; Aguilar, David; Montori-Grau, Marta; Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">913/1-913/14</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Research in recent years on peroxisome proliferator-activated receptor (PPAR)β/δ indicates that it plays a key role in the maintenance of energy homeostasis, both at the cellular level and within the organism as a whole.  PPARβ/δ activation might help prevent the development of metabolic disorders, including obesity, dyslipidemia, type 2 diabetes mellitus and non-alc. fatty liver disease.  This review highlights research findings on the PPARβ/δ regulation of energy metab. and the development of diseases related to altered cellular and body metab.  It also describes the potential of the pharmacol. activation of PPARβ/δ as a treatment for human metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0WVMgCBkeK7Vg90H21EOLACvtfcHk0lhFyxBI0EtHfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOntLrJ&md5=22b43757cebddc4b1afb814457d92089</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3390%2Fijms19030913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19030913%26sid%3Dliteratum%253Aachs%26aulast%3DPalomer%26aufirst%3DX.%26aulast%3DBarroso%26aufirst%3DE.%26aulast%3DPizarro-Delgado%26aufirst%3DJ.%26aulast%3DPe%25C3%25B1a%26aufirst%3DL.%26aulast%3DBotteri%26aufirst%3DG.%26aulast%3DZarei%26aufirst%3DM.%26aulast%3DAguilar%26aufirst%3DD.%26aulast%3DMontori-Grau%26aufirst%3DM.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%253A%2520A%2520Key%2520Therapeutic%2520Target%2520in%2520Metabolic%2520Disorders%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D913%26doi%3D10.3390%2Fijms19030913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeon, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Je, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, K. S.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor-delta Agonist Ameliorated Inflammasome Activation in Nonalcoholic Fatty Liver Disease</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">12787</span>– <span class="NLM_lpage">12799</span>, <span class="refDoi"> DOI: 10.3748/wjg.v21.i45.12787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3748%2Fwjg.v21.i45.12787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=26668503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSisb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=12787-12799&author=H.+J.+Leeauthor=J.+E.+Yeonauthor=E.+J.+Koauthor=E.+L.+Yoonauthor=S.+J.+Suhauthor=K.+Kangauthor=H.+R.+Kimauthor=S.+H.+Kangauthor=Y.+J.+Yooauthor=J.+Jeauthor=B.+J.+Leeauthor=J.+H.+Kimauthor=Y.+S.+Seoauthor=H.+J.+Yimauthor=K.+S.+Byun&title=Peroxisome+Proliferator-activated+Receptor-delta+Agonist+Ameliorated+Inflammasome+Activation+in+Nonalcoholic+Fatty+Liver+Disease&doi=10.3748%2Fwjg.v21.i45.12787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease</span></div><div class="casAuthors">Lee, Hyun Jung; Yeon, Jong Eun; Ko, Eun Jung; Yoon, Eileen L.; Suh, Sang Jun; Kang, Keunhee; Kim, Hae Rim; Kang, Seoung Hee; Yoo, Yang Jae; Je, Jihye; Lee, Beom Jae; Kim, Ji Hoon; Seo, Yeon Seok; Yim, Hyung Joon; Byun, Kwan Soo</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">12787-12799</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">2219-2840</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Inc.</span>)
        </div><div class="casAbstract">AIM: To evaluate the inflammasome activation and the effect of peroxisome proliferator-activated receptors (PPAR)-δ agonist treatment in nonalcoholic fatty liver disease (NAFLD) models.  METHODS: Male C57BL/6J mice were classified according to control or high fat diet (HFD) with or without PPAR-δ agonist (GW) over period of 12 wk [control, HFD, HFD + lipopolysaccharide (LPS), HFD + LPS + GW group].  HepG2 cells were exposed to palmitic acid (PA) and/or LPS in the absence or presence of GW.  RESULTS: HFD caused glucose intolerance and hepatic steatosis.  In mice fed an HFD with LPS, caspase-1 and interleukin (IL)-1β in the liver were significantly increased.  Treatment with GW ameliorated the steatosis and inhibited overexpression of pro-inflammatory cytokines.  In HepG2 cells, PA and LPS treatment markedly increased mRNA of several nucleotide-binding and oligomerization domain-like receptor family members (NLRP3, NLRP6, and NLRP10), caspase-1 and IL-1β.  PA and LPS also exaggerated reactive oxygen species prodn.  All of the above effects of PA and LPS were reduced by GW.  GW also enhanced the phosphorylation of AMPK-α.  CONCLUSION: PPAR-δ agonist reduces fatty acid induced inflammation and steatosis by suppressing inflammasome activation.  Targeting the inflammasome by the PPAR-δ agonist may have therapeutic implication for NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptDOuwhetQMLVg90H21EOLACvtfcHk0lgWT1YXeo2DEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSisb7E&md5=f307e251001832767594ae087be6a67c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v21.i45.12787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v21.i45.12787%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DYeon%26aufirst%3DJ.%2BE.%26aulast%3DKo%26aufirst%3DE.%2BJ.%26aulast%3DYoon%26aufirst%3DE.%2BL.%26aulast%3DSuh%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DKang%26aufirst%3DS.%2BH.%26aulast%3DYoo%26aufirst%3DY.%2BJ.%26aulast%3DJe%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DB.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSeo%26aufirst%3DY.%2BS.%26aulast%3DYim%26aufirst%3DH.%2BJ.%26aulast%3DByun%26aufirst%3DK.%2BS.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor-delta%2520Agonist%2520Ameliorated%2520Inflammasome%2520Activation%2520in%2520Nonalcoholic%2520Fatty%2520Liver%2520Disease%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2015%26volume%3D21%26spage%3D12787%26epage%3D12799%26doi%3D10.3748%2Fwjg.v21.i45.12787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naowaboot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. H.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor δ Agonist Attenuates Hepatic Steatosis by Anti-inflammatory Mechanism</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.3858/emm.2012.44.10.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3858%2Femm.2012.44.10.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22824914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ygtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=578-585&author=M.+Y.+Leeauthor=R.+Choiauthor=H.+M.+Kimauthor=E.+J.+Choauthor=B.+H.+Kimauthor=Y.+S.+Choiauthor=J.+Naowabootauthor=E.+Y.+Leeauthor=Y.+C.+Yangauthor=J.+Y.+Shinauthor=Y.+G.+Shinauthor=C.+H.+Chung&title=Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist+Attenuates+Hepatic+Steatosis+by+Anti-inflammatory+Mechanism&doi=10.3858%2Femm.2012.44.10.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism</span></div><div class="casAuthors">Lee, Mi Young; Choi, Ran; Kim, Hong Min; Cho, Eun Ju; Kim, Bo Hwan; Choi, Yeon Sik; Naowaboot, Jarinyaporn; Lee, Eun Young; Yang, Young Chul; Shin, Jang Yel; Shin, Young Goo; Chung, Choon Hee</div><div class="citationInfo"><span class="NLM_cas:title">Experimental & Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">578-585</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1226-3613</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Although peroxisome proliferator receptor (PPAR)-α and PPAR-γ agonist were developed as chem. tools to uncover biol. roles for the PPARs such as lipid and carbohydrate metab., PPAR-δ was not fully investigated.  In this study, the authors examd. the effects of the PPAR-δ agonist GW0742 on fatty liver changes and inflammatory markers.  The authors investigated the effects of PPAR-δ agonist GW0742 on fatty liver changes in OLETF rats.  Intrahepatic triglyceride contents and expression of inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) and also, PPAR-γ coactivator (PGC)-1α gene were evaluated in liver tissues of OLETF rats and HepG2 cells after GW0742 treatment.  The level of TNF-α and MCP-1 was also examd. in supernatant of Raw264.7 cell culture.  To address the effects of GW0742 on insulin signaling, the authors performed in vitro study with AML12 mouse hepatocytes.  Rats treated with GW0742 (10 mg/kg/day) from 26-36 wk showed improvement in fatty infiltration of the liver.  In liver tissues, mRNA expressions of TNF-α, MCP-1, and PGC-1α were significantly decreased in diabetic rats treated with GW0742 compared to diabetic control rats.  The authors also obsd. that GW0742 had inhibitory effects on palmitic acid-induced fatty accumulation and inflammatory markers in HepG2 and Raw264.7 cells.  The expression level of Akt and IRS-1 was significantly increased by treatment with GW0742.  The PPAR-δ agonist may attenuate hepatic fat accumulation through anti-inflammatory mechanism, reducing hepatic PGC-1α gene expression, and improvement of insulin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF4xueBHzIv7Vg90H21EOLACvtfcHk0lgWT1YXeo2DEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ygtrvP&md5=b9f93e8f6546268a9369a12794efa531</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.3858%2Femm.2012.44.10.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3858%252Femm.2012.44.10.066%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BY.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DCho%26aufirst%3DE.%2BJ.%26aulast%3DKim%26aufirst%3DB.%2BH.%26aulast%3DChoi%26aufirst%3DY.%2BS.%26aulast%3DNaowaboot%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DE.%2BY.%26aulast%3DYang%26aufirst%3DY.%2BC.%26aulast%3DShin%26aufirst%3DJ.%2BY.%26aulast%3DShin%26aufirst%3DY.%2BG.%26aulast%3DChung%26aufirst%3DC.%2BH.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%2520Attenuates%2520Hepatic%2520Steatosis%2520by%2520Anti-inflammatory%2520Mechanism%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2012%26volume%3D44%26spage%3D578%26epage%3D585%26doi%3D10.3858%2Femm.2012.44.10.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">PPARδ Attenuates Hepatic Steatosis through Autophagy-mediated Fatty Acid Oxidation</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">197</span>, <span class="refDoi"> DOI: 10.1038/s41419-019-1458-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fs41419-019-1458-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30814493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BB3cfosVyqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=197&author=L.+Tongauthor=L.+Wangauthor=S.+Yaoauthor=L.+Jinauthor=J.+Yangauthor=Y.+Zhangauthor=G.+Ningauthor=Z.+Zhang&title=PPAR%CE%B4+Attenuates+Hepatic+Steatosis+through+Autophagy-mediated+Fatty+Acid+Oxidation&doi=10.1038%2Fs41419-019-1458-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation</span></div><div class="casAuthors">Tong Lei; Wang Long; Yao Shuangshuang; Jin Lina; Yang Jian; Zhang Yifei; Ning Guang; Zhang Zhiguo</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peroxisome proliferator-activated receptor δ (PPARδ) belongs to the nuclear receptor family and is involved in metabolic diseases.  Although PPARδ is known to attenuate hepatic lipid deposition, its mechanism remains unclear.  Here, we show that PPARδ is a potent stimulator of hepatic autophagic flux.  The expression levels of PPARδ and autophagy-related proteins were decreased in liver tissues from obese and ageing mice.  Pharmacological and adenovirus-mediated increases in PPARδ expression and activity were achieved in obese transgenic db/db and high fat diet-fed mice.  Using genetic, pharmacological and metabolic approaches, we demonstrate that PPARδ reduces intrahepatic lipid content and stimulates β-oxidation in liver and hepatic cells by an autophagy-lysosomal pathway involving AMPK/mTOR signalling.  These results provide novel insight into the lipolytic actions of PPARδ through autophagy in the liver and highlight its potential beneficial effects in NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUkuP5l07_zWK_SFaaT9INfW6udTcc2eYVR8Sl_T3es7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfosVyqtw%253D%253D&md5=e08fdeb582efbb2cc5aa12ffb87fe591</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fs41419-019-1458-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-019-1458-8%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DNing%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DPPAR%25CE%25B4%2520Attenuates%2520Hepatic%2520Steatosis%2520through%2520Autophagy-mediated%2520Fatty%2520Acid%2520Oxidation%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26spage%3D197%26doi%3D10.1038%2Fs41419-019-1458-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palkar, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isom, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdew, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Ligand Activation of Peroxisome Proliferator-activated Receptor β/δ (PPARβ/δ) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">418</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfn142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1093%2Ftoxsci%2Fkfn142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18622026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWitL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=418-428&author=W.+Shanauthor=P.+S.+Palkarauthor=I.+A.+Murrayauthor=E.+I.+McDevittauthor=M.+J.+Kennettauthor=B.+H.+Kangauthor=H.+C.+Isomauthor=G.+H.+Perdewauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Ligand+Activation+of+Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+%28PPAR%CE%B2%2F%CE%B4%29+Attenuates+Carbon+Tetrachloride+Hepatotoxicity+by+Downregulating+Proinflammatory+Gene+Expression&doi=10.1093%2Ftoxsci%2Fkfn142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Activation of Peroxisome Proliferator-Activated Receptor β/δ (PPARβ/δ) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression</span></div><div class="casAuthors">Shan, Weiwei; Palkar, Prajakta S.; Murray, Iain A.; McDevitt, Emily I.; Kennett, Mary J.; Kang, Boo Hyon; Isom, Harriet C.; Perdew, Gary H.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">418-428</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor (PPAR) β/δ-null mice exhibit exacerbated hepatotoxicity in response to administration of carbon tetrachloride (CCl4).  To det. whether ligand activation of the receptor protects against chem. toxicity in the liver, wild-type and PPARβ/δ-null mice were administered CCl4 with or without coadministration of the highly specific PPARβ/δ ligand GW0742.  Biomarkers of liver toxicity, including serum alanine aminotransferase (ALT) and hepatic tumor necrosis factor (TNF) α mRNA, were significantly higher in CCl4-treated PPARβ/δ-null mice compared to wild-type mice.  Hepatic expression of TNF-like weak inducer of apoptosis receptor (TWEAKr) and S100 calcium-binding protein A6 (S100A6/calcyclin), genes involved in nuclear factor kappa B signaling, was higher in the CCl4-treated PPARβ/δ-null mice compared to wild-type mice.  GW0742 treatment resulted in reduced serum ALT concn. and lower expression of CCl4-induced TNF-α, S100A6, monocyte chemoattractant protein-1 (MCP1), and TWEAKr in wild-type mice, and these effects were not obsd. in PPARβ/δ-null mice.  Expression of TNF-α was higher in PPARβ/δ-null primary hepatocytes in response to interleukin-1β treatment compared to wild-type hepatocytes, but GW0742 did not significantly modulate TNF-α expression in hepatocytes from either genotype.  While PPARβ/δ-null hepatic stellate exhibited higher rates of proliferation compared to wild-type cells, GW0742 did not affect α-smooth muscle actin expression in these cells.  Combined, these findings demonstrate that ligand activation of PPARβ/δ protects against chem. induced hepatotoxicity by downregulating expression of proinflammatory genes.  Hepatocytes and hepatic stellate cells do not appear to directly mediate the inhibitory effects of ligand activation of PPARβ/δ in liver, suggesting the involvement of paracrine and autocrine events mediated by hepatic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSsc_n7ADSVbVg90H21EOLACvtfcHk0ljEsO-9Co9Ahg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWitL7F&md5=5b470096f0fac1de1156d7c4bea6f552</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfn142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfn142%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DW.%26aulast%3DPalkar%26aufirst%3DP.%2BS.%26aulast%3DMurray%26aufirst%3DI.%2BA.%26aulast%3DMcDevitt%26aufirst%3DE.%2BI.%26aulast%3DKennett%26aufirst%3DM.%2BJ.%26aulast%3DKang%26aufirst%3DB.%2BH.%26aulast%3DIsom%26aufirst%3DH.%2BC.%26aulast%3DPerdew%26aufirst%3DG.%2BH.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DLigand%2520Activation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520%2528PPAR%25CE%25B2%252F%25CE%25B4%2529%2520Attenuates%2520Carbon%2520Tetrachloride%2520Hepatotoxicity%2520by%2520Downregulating%2520Proinflammatory%2520Gene%2520Expression%26jtitle%3DToxicol.%2520Sci.%26date%3D2008%26volume%3D105%26spage%3D418%26epage%3D428%26doi%3D10.1093%2Ftoxsci%2Fkfn142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor δ Activates Fatty Acid Oxidation in Cultured Neonatal and Adult Cardiomyocytes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2003.11.127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbrc.2003.11.127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=14684157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2004&pages=277-286&author=L.+Chengauthor=G.+Dingauthor=Q.+Qinauthor=Y.+Xiaoauthor=D.+Woodsauthor=Y.+E.+Chenauthor=Q.+Yang&title=Peroxisome+Proliferator-activated+Receptor+%CE%B4+Activates+Fatty+Acid+Oxidation+in+Cultured+Neonatal+and+Adult+Cardiomyocytes&doi=10.1016%2Fj.bbrc.2003.11.127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor δ activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes</span></div><div class="casAuthors">Cheng, Lihong; Ding, Guoliang; Qin, Qianhong; Xiao, Yan; Woods, David; Chen, Yuqing E.; Yang, Qinglin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-286</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARα, -γ and -δ) are nuclear receptors involved in transcriptional regulations of lipid metab.  The effect of PPARα in regulation of cardiac fatty acid oxidn. has been well characterized.  Whether PPARδ also independently regulates fatty acid oxidn. in the heart remains unclear.  In this study, we tested the hypothesis that PPARδ activates fatty acids oxidn. in cardiomyocytes through transcriptional activation that are independent of PPARα.  Our results first indicate that PPARδ abundantly expresses in nucleus of cardiomyocytes.  Palmitate oxidn. rates were significantly increased in both neonatal and adult cardiomyocytes after treatment of a PPARδ-selective ligand (GW0742).  Further increases of fatty acid oxidn. were evident when the treatment was applied to cardiomyocytes overexpressing a wild type PPARδ, but not a mutant PPARδ that lacks the intact carboxyl ligand-binding domain.  Furthermore, genes of fatty acid oxidn. enzymes were significantly upregulated in cultured rat neonatal cardiomyocytes when exposed to GW0742.  GW0742 can restore partly the expression of certain key genes of fatty acid oxidn. in mouse adult cardiomyocytes isolated from PPARα knockout mice.  Therefore, while active crosstalk between PPARδ and -α may exist, PPARδ regulates cardiac fatty acid oxidn. in the heart at least partly independent of PPARα.  We conclude that PPARδ may play a key role in cardiac energy balance and may serve as a "sensor" of fatty acid of other endogenous ligands in controlling fatty acids oxidn. levels in the hearts under normal and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolLqPIht_8XLVg90H21EOLACvtfcHk0lgIh0Oy2jtx0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWmt7k%253D&md5=a654fa5c5f43f8b44d4404d65f75a4ec</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2003.11.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2003.11.127%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DQ.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DWoods%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%2BE.%26aulast%3DYang%26aufirst%3DQ.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Activates%2520Fatty%2520Acid%2520Oxidation%2520in%2520Cultured%2520Neonatal%2520and%2520Adult%2520Cardiomyocytes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D313%26spage%3D277%26epage%3D286%26doi%3D10.1016%2Fj.bbrc.2003.11.127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, P.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.-T.</span></span> <span> </span><span class="NLM_article-title">Activation of Receptors δ (PPARδ) by Agonist (GW0742) may Enhance Lipid Metabolism in Heart Both In Vivo and In Vitro</span>. <i>Horm. Metab. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1055/s-0033-1348317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1055%2Fs-0033-1348317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23803968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyntrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=880-886&author=S.-C.+Kuoauthor=P.-M.+Kuauthor=L.-J.+Chenauthor=H.-S.+Niuauthor=J.-T.+Cheng&title=Activation+of+Receptors+%CE%B4+%28PPAR%CE%B4%29+by+Agonist+%28GW0742%29+may+Enhance+Lipid+Metabolism+in+Heart+Both+In+Vivo+and+In+Vitro&doi=10.1055%2Fs-0033-1348317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of receptors δ (PPARδ) by agonist (GW0742) may enhance lipid metabolism in heart both in vivo and in vitro</span></div><div class="casAuthors">Kuo, S.-C.; Ku, P.-M.; Chen, L.-J.; Niu, H.-S.; Cheng, J.-T.</div><div class="citationInfo"><span class="NLM_cas:title">Hormone and Metabolic Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">880-886</span>CODEN:
                <span class="NLM_cas:coden">HMMRA2</span>;
        ISSN:<span class="NLM_cas:issn">0018-5043</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">It has been documented that cardiac agents may regulate the lipid metab. through increased expression of PPARδ in cardiac cells.  However, the effect on lipid metab. by direct activation of PPARδ is still unknown.  The present study applied specific PPARδ agonist (GW0742) to investigate this point in the heart of Wistar rats and in the primary cultured cardiomyocytes from neonatal rat.  Expressions of PPARδ in the heart and cardiomyocytes after treatment with GW0742 were detected using Western blots.  The fatty acid (FA) oxidn. and the citric acid (TCA) cycle related genes in cardiomyocytes were also examd.  In addn., PPARδ antagonist (GSK0660) and siRNA-PPARδ were employed to characterize the potential mechanisms.  After a 7-day treatment with GW0742, expressions of PPARδ in the heart were markedly increased.  Increased expressions of FA oxidn. and TCA cycle related genes were also obsd. both in vivo and in vitro.  This action of GW0742 was blocked by GSK0660 or by siRNA-PPARδ.  The obtained results show that activation of PPARδ by GW0742 is responsible for the increase of FA oxidn. and TCA cycle related genes in hearts.  Role of PPARδ in the regulation of lipid metab. in heart is then established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo78rhETtfevLVg90H21EOLACvtfcHk0lgIh0Oy2jtx0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyntrfN&md5=42084a48f690c7b96f50143eceb3f71f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1055%2Fs-0033-1348317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0033-1348317%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DS.-C.%26aulast%3DKu%26aufirst%3DP.-M.%26aulast%3DChen%26aufirst%3DL.-J.%26aulast%3DNiu%26aufirst%3DH.-S.%26aulast%3DCheng%26aufirst%3DJ.-T.%26atitle%3DActivation%2520of%2520Receptors%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%2520by%2520Agonist%2520%2528GW0742%2529%2520may%2520Enhance%2520Lipid%2520Metabolism%2520in%2520Heart%2520Both%2520In%2520Vivo%2520and%2520In%2520Vitro%26jtitle%3DHorm.%2520Metab.%2520Res.%26date%3D2013%26volume%3D45%26spage%3D880%26epage%3D886%26doi%3D10.1055%2Fs-0033-1348317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Q.</span></span> <span> </span><span class="NLM_article-title">PPARδ, a Potential Therapeutic Target for Heart Disease</span>. <i>Nucl. Receptor Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">101375</span>, <span class="refDoi"> DOI: 10.32527/2018/101375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.32527%2F2018%2F101375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31032335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWnurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=101375&author=Q.+Yangauthor=Q.+Long&title=PPAR%CE%B4%2C+a+Potential+Therapeutic+Target+for+Heart+Disease&doi=10.32527%2F2018%2F101375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ, a potential therapeutic target for heart disease</span></div><div class="casAuthors">Yang, Qinglin; Long, Qinqiang</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Receptor Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101375</span>CODEN:
                <span class="NLM_cas:coden">NRRUAZ</span>;
        ISSN:<span class="NLM_cas:issn">2314-5714</span>.
    
            (<span class="NLM_cas:orgname">AgiAl Publishing House</span>)
        </div><div class="casAbstract">The nuclear receptor peroxisome proliferator-activated receptor δ (PPARδ) can transcriptionally regulate target genes.  PPARδ exerts essential regulatory functions in the heart, which requires const. energy supply.  PPARδ plays a key role in energy metab., controlling not only fatty acid (FA) and glucose oxidn., but also redox homeostasis, mitochondrial biogenesis, inflammation, and cardiomyocyte proliferation.  PPARδ signaling is impaired in the heart under various pathol. conditions, such as pathol. cardiac hypertrophy, myocardial ischemia/reperfusion, doxorubicin cardiotoxicity and diabetic cardiomyopathy.  PPARδ deficiency in the heart leads to cardiac dysfunction, myocardial lipid accumulation, cardiac hypertrophy/remodeling and heart failure.  This article provides an up-today overview of this research area and discusses the role of PPARδ in the heart in light of the complex mechanisms of its transcriptional regulation and its potential as a translatable therapeutic target for the treatment of cardiac disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBl96r48mG7bVg90H21EOLACvtfcHk0lgIh0Oy2jtx0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWnurfI&md5=ceba6651087fc282dfccf294aff580d1</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.32527%2F2018%2F101375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.32527%252F2018%252F101375%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLong%26aufirst%3DQ.%26atitle%3DPPAR%25CE%25B4%252C%2520a%2520Potential%2520Therapeutic%2520Target%2520for%2520Heart%2520Disease%26jtitle%3DNucl.%2520Receptor%2520Res.%26date%3D2018%26volume%3D5%26spage%3D101375%26doi%3D10.32527%2F2018%2F101375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasmin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flühmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desvergne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span> <span> </span><span class="NLM_article-title">Critical Roles of PPARβ/δ in Keratinocyte Response to Inflammation</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3263</span>– <span class="NLM_lpage">3277</span>, <span class="refDoi"> DOI: 10.1101/gad.207501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1101%2Fgad.207501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11751632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFyktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=3263-3277&author=N.+S.+Tanauthor=L.+Michalikauthor=N.+Noyauthor=R.+Yasminauthor=C.+Pacotauthor=M.+Heimauthor=B.+Fl%C3%BChmannauthor=B.+Desvergneauthor=W.+Wahli&title=Critical+Roles+of+PPAR%CE%B2%2F%CE%B4+in+Keratinocyte+Response+to+Inflammation&doi=10.1101%2Fgad.207501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Critical roles of PPARβ/δ in keratinocyte response to inflammation</span></div><div class="casAuthors">Tan, Nguan Soon; Michalik, Liliane; Noy, Noa; Yasmin, Rubina; Pacot, Corinne; Heim, Manuel; Fluhmann, Beat; Desvergne, Beatrice; Wahli, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3263-3277</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The immediate response to skin injury is the release of inflammatory signals.  It is shown here, by use of cultures of primary keratinocytes from wild-type and PPARβ/δ-/- mice, that such signals including TNF-α and IFN-γ, induce keratinocyte differentiation.  This cytokine-dependent cell differentiation pathway requires up-regulation of the PPARβ/δ gene via the stress-assocd. kinase cascade, which targets an AP-1 site in the PPARβ/δ promoter.  In addn., the pro-inflammatory cytokines also initiate the prodn. of endogenous PPARβ/δ ligands, which are essential for PPARβ/δ activation and action.  Activated PPARβ/δ regulates the expression of genes assocd. with apoptosis resulting in an increased resistance of cultured keratinocytes to cell death.  This effect is also obsd. in vivo during wound healing after an injury, as shown in dorsal skin of PPARβ/δ+/+ and PPARβ/δ+/- mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwvmyqE9fSCrVg90H21EOLACvtfcHk0lgIh0Oy2jtx0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFyktQ%253D%253D&md5=170d3f3709789dd974f730ac41ec6316</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1101%2Fgad.207501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.207501%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DN.%2BS.%26aulast%3DMichalik%26aufirst%3DL.%26aulast%3DNoy%26aufirst%3DN.%26aulast%3DYasmin%26aufirst%3DR.%26aulast%3DPacot%26aufirst%3DC.%26aulast%3DHeim%26aufirst%3DM.%26aulast%3DFl%25C3%25BChmann%26aufirst%3DB.%26aulast%3DDesvergne%26aufirst%3DB.%26aulast%3DWahli%26aufirst%3DW.%26atitle%3DCritical%2520Roles%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520in%2520Keratinocyte%2520Response%2520to%2520Inflammation%26jtitle%3DGenes%2520Dev.%26date%3D2001%26volume%3D15%26spage%3D3263%26epage%3D3277%26doi%3D10.1101%2Fgad.207501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Guardia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomer, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coll, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Calvo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Kochairi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ Activation Blocks Lipid-induced Inflammatory Pathways in Mouse Heart and Human Cardiac Cells.</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1811</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2010.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbalip.2010.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1811&publication_year=2011&pages=59-67&author=D.+%C3%81lvarez-Guardiaauthor=X.+Palomerauthor=T.+Collauthor=L.+Serranoauthor=R.+Rodr%C3%ADguez-Calvoauthor=M.+M.+Davidsonauthor=M.+Merlosauthor=I.+El+Kochairiauthor=L.+Michalikauthor=W.+Wahliauthor=M.+V%C3%A1zquez-Carrera&title=PPAR%CE%B2%2F%CE%B4+Activation+Blocks+Lipid-induced+Inflammatory+Pathways+in+Mouse+Heart+and+Human+Cardiac+Cells.&doi=10.1016%2Fj.bbalip.2010.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells</span></div><div class="casAuthors">Alvarez-Guardia, David; Palomer, Xavier; Coll, Teresa; Serrano, Lucia; Rodriguez-Calvo, Ricardo; Davidson, Mercy M.; Merlos, Manuel; El Kochairi, Ilhem; Michalik, Liliane; Wahli, Walter; Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1811</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">59-67</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Owing to its high fat content, the classical Western diet has a range of adverse effects on the heart, including enhanced inflammation, hypertrophy, and contractile dysfunction.  Proinflammatory factors secreted by cardiac cells, which are under the transcriptional control of nuclear factor-κB (NF-κB), may contribute to heart failure and dilated cardiomyopathy.  The underlying mechanisms are complex, since they are linked to systemic metabolic abnormalities and changes in cardiomyocyte phenotype.  Peroxisome proliferator-activated receptors (PPARs) are transcription factors that regulate metab. and are capable of limiting myocardial inflammation and hypertrophy via inhibition of NF-κB.  Since PPARβ/δ is the most prevalent PPAR isoform in the heart, we analyzed the effects of the PPARβ/δ agonist GW501516 on inflammatory parameters.  A high-fat diet induced the expression of tumor necrosis factor-α, monocyte chemoattractant protein-1, and interleukin-6, and enhanced the activity of NF-κB in the heart of mice.  GW501516 abrogated this enhanced proinflammatory profile.  Similar results were obtained when human cardiac AC16 cells exposed to palmitate were coincubated with GW501516.  PPARβ/δ activation by GW501516 enhanced the phys. interaction between PPARβ/δ and p65, which suggests that this mechanism may also interfere NF-κB transactivation capacity in the heart.  GW501516-induced PPARβ/δ activation can attenuate the inflammatory response induced in human cardiac AC16 cells exposed to the satd. fatty acid palmitate and in mice fed a high-fat diet.  This is relevant, esp. taking into account that PPARβ/δ has been postulated as a potential target in the treatment of obesity and the insulin resistance state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvPNNTs5H-BLVg90H21EOLACvtfcHk0ljrWKwSxuJoVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFOrsw%253D%253D&md5=c40d86185ae9b00c316fde65ad53fd14</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2010.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2010.11.002%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2581lvarez-Guardia%26aufirst%3DD.%26aulast%3DPalomer%26aufirst%3DX.%26aulast%3DColl%26aufirst%3DT.%26aulast%3DSerrano%26aufirst%3DL.%26aulast%3DRodr%25C3%25ADguez-Calvo%26aufirst%3DR.%26aulast%3DDavidson%26aufirst%3DM.%2BM.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DEl%2BKochairi%26aufirst%3DI.%26aulast%3DMichalik%26aufirst%3DL.%26aulast%3DWahli%26aufirst%3DW.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520Activation%2520Blocks%2520Lipid-induced%2520Inflammatory%2520Pathways%2520in%2520Mouse%2520Heart%2520and%2520Human%2520Cardiac%2520Cells.%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2011%26volume%3D1811%26spage%3D59%26epage%3D67%26doi%3D10.1016%2Fj.bbalip.2010.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chawla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbiztondo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boisvert, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1126/science.1087344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1126%2Fscience.1087344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=12970571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotV2itrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=453-457&author=C.-H.+Leeauthor=A.+Chawlaauthor=N.+Urbiztondoauthor=D.+Liaoauthor=W.+A.+Boisvertauthor=R.+M.+Evans&title=Transcriptional+Repression+of+Atherogenic+Inflammation%3A+Modulation+by+PPAR%CE%B4&doi=10.1126%2Fscience.1087344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ</span></div><div class="casAuthors">Lee, Chih-Hao; Chawla, Ajay; Urbiztondo, Ned; Liao, Debbie; Boisvert, William A.; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5644</span>),
    <span class="NLM_cas:pages">453-457</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The formation of an atherosclerotic lesion is mediated by lipid-laden macrophages (foam cells), which also establish chronic inflammation assocd. with lesion progression.  The peroxisome proliferator-activated receptor (PPAR) γ promotes lipid uptake and efflux in these atherogenic cells.  In contrast, we found that the closely related receptor PPARδ controls the inflammatory status of the macrophage.  Deletion of PPARδ from foam cells increased the availability of inflammatory suppressors, which in turn reduced atherosclerotic lesion area by more than 50%.  We propose an unconventional ligand-dependent transcriptional pathway in which PPARδ controls an inflammatory switch through its assocn. and disassocn. with transcriptional repressors.  PPARδ and its ligands may thus serve as therapeutic targets to attenuate inflammation and slow the progression of atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTSMnhYMagXbVg90H21EOLACvtfcHk0ljrWKwSxuJoVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotV2itrw%253D&md5=077a91664a849c9a5d0b8494c703e29f</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1126%2Fscience.1087344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1087344%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.-H.%26aulast%3DChawla%26aufirst%3DA.%26aulast%3DUrbiztondo%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DBoisvert%26aufirst%3DW.%2BA.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DTranscriptional%2520Repression%2520of%2520Atherogenic%2520Inflammation%253A%2520Modulation%2520by%2520PPAR%25CE%25B4%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D453%26epage%3D457%26doi%3D10.1126%2Fscience.1087344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.-G.</span></span> <span> </span><span class="NLM_article-title">Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro</span>. <i>Chin. Med. Sci. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.1016/S1001-9294(16)30008-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS1001-9294%2816%2930008-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=26960306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC28jovFentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=245-251&author=L.+Shengauthor=X.+Yangauthor=P.+Yeauthor=Y.-X.+Liuauthor=C.-G.+Han&title=Effect+of+Atorvastatin+on+Expression+of+Peroxisome+Proliferator-activated+Receptor+beta%2Fdelta+in+Angiotensin+II-induced+Hypertrophic+Myocardial+Cells+In+Vitro&doi=10.1016%2FS1001-9294%2816%2930008-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro</span></div><div class="casAuthors">Sheng Li; Yang Xu; Ye Ping; Liu Yong-xue; Han Chun-guang</div><div class="citationInfo"><span class="NLM_cas:title">Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">245-51</span>
        ISSN:<span class="NLM_cas:issn">1001-9294</span>.
    </div><div class="casAbstract">OBJECTIVE:  To explore the effect of atorvastatin on cardiac hypertrophy and to determine the potential mechanism involved.  METHODS:  An in vitro cardiomyocyte hypertrophy from neonatal rats was induced with angiotensin II (Ang II) stimulation.  Before Ang II stimulation, the cultured rat cardiac myocytes were pretreated with atorvastatin at different concentrations (0.1, 1, and 10 μmol/L).  The following parameters were evaluated: the myocyte surface area, 3H-leucine incorporation into myocytes, mRNA expressions of atrial natriuretic peptide, brain natriuretic peptide, matrix metalloproteinase 9, matrix metalloproteinase 2, and interleukin-1β, mRNA and protein expressions of the δ/β peroxisome proliferator-activated receptor (PPAR) subtypes.  RESULTS:  It was shown that atorvastatin could ameliorate Ang II-induced neonatal cardiomyocyte hypertrophy in the area of cardiomyocytes, 3H-leucine incorporation, and the expression of atrial natriuretic peptide and brain natriuretic peptide markedly.  Meanwhile, atorvastatin also inhibited the augmented mRNA level of several cytokines in hypertrophic myocytes.  Furthermore, the down-regulated expression of PPAR- δ/β at both the mRNA and protein levels in hypertrophic myocytes could be significantly reversed by atorvastatin treatment.  CONCLUSIONS:  Atorvastatin could improve Ang II-induced cardiac hypertrophy and inhibit the expression of cytokines.  Such effect might be partly achieved through activation of the PPAR-δ/β pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTObfLOOe7bTKcY7HFp97qMfW6udTcc2eYRtEw_XRZtl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jovFentw%253D%253D&md5=43b17ecd8c64a843b274e8d2609bd7a8</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS1001-9294%2816%2930008-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1001-9294%252816%252930008-6%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.-X.%26aulast%3DHan%26aufirst%3DC.-G.%26atitle%3DEffect%2520of%2520Atorvastatin%2520on%2520Expression%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520beta%252Fdelta%2520in%2520Angiotensin%2520II-induced%2520Hypertrophic%2520Myocardial%2520Cells%2520In%2520Vitro%26jtitle%3DChin.%2520Med.%2520Sci.%2520J.%26date%3D2015%26volume%3D30%26spage%3D245%26epage%3D251%26doi%3D10.1016%2FS1001-9294%2816%2930008-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Baicalin Attenuates Cardiac Dysfunction and Myocardial Remodeling in a Chronic Pressure-overload Mice Model</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1159/000459708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1159%2F000459708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=28214892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2017&pages=849-864&author=Y.+Zhangauthor=P.+Liaoauthor=M.+Zhuauthor=W.+Liauthor=D.+Huauthor=S.+Guanauthor=L.+Chen&title=Baicalin+Attenuates+Cardiac+Dysfunction+and+Myocardial+Remodeling+in+a+Chronic+Pressure-overload+Mice+Model&doi=10.1159%2F000459708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Baicalin Attenuates Cardiac Dysfunction and Myocardial Remodeling in a Chronic Pressure-Overload Mice Model</span></div><div class="casAuthors">Zhang, Yanqing; Liao, Pingping; Zhu, Meng-en; Li, Wei; Hu, Dan; Guan, Siming; Chen, Long</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">849-864</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Baicalin has been shown to be effective for various animal models of cardiovascular diseases, such as pulmonary hypertension, atherosclerosis and myocardial ischemic injury.  However, whether baicalin plays a role in cardiac hypertrophy remains unknown.  Here we investigated the protective effects of baicalin on cardiac hypertrophy induced by pressure overload and explored the potential mechanisms involved.  Methods: C57BL/6J-mice were treated with baicalin or vehicle following transverse aortic constriction or Sham surgery for up to 8 wk, and at different time points, cardiac function and heart size measurement and histol. and biochem. examn. were performed.  Results: Mice under pressure overload exhibited cardiac dysfunction, high mortality, myocardial hypertrophy, increased apoptosis and fibrosis markers, and suppressed cardiac expression of PPARα and PPARβ/δ.  However, oral administration of baicalin improved cardiac dysfunction, decreased mortality, and attenuated histol. and biochem. changes described above.  These protective effects of baicalin were assocd. with reduced heart and cardiomyocyte size, lower fetal genes expression, attenuated cardiac fibrosis, lower expression of profibrotic markers, and decreased apoptosis signals in heart tissue.  Moreover, we found that baicalin induced PPARα and PPARβ/δ expression in vivo and in vitro.  Subsequent expts. demonstrated that long-term baicalin treatment presented no obvious cardiac lipotoxicity.  Conclusions: The present results demonstrated that baicalin attenuates pressure overload induced cardiac dysfunction and ventricular remodeling, which would be due to suppressed cardiac hypertrophy, fibrosis, apoptosis and metabolic abnormality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCobAC6Z8Fq7Vg90H21EOLACvtfcHk0liu8whVfCvw2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFejtbs%253D&md5=906414a936fc8fec3a7c238278dc9098</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1159%2F000459708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000459708%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DBaicalin%2520Attenuates%2520Cardiac%2520Dysfunction%2520and%2520Myocardial%2520Remodeling%2520in%2520a%2520Chronic%2520Pressure-overload%2520Mice%2520Model%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2017%26volume%3D41%26spage%3D849%26epage%3D864%26doi%3D10.1159%2F000459708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brako, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span> <span> </span><span class="NLM_article-title">Cardiomyocyte-restricted Peroxisome Proliferator-activated Receptor-δ Deletion Perturbs Myocardial Fatty Acid Oxidation and Leads to Cardiomyopathy</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1245</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1038/nm1116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fnm1116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15475963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVOgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1245-1250&author=L.+Chengauthor=G.+Dingauthor=Q.+Qinauthor=Y.+Huangauthor=W.+Lewisauthor=N.+Heauthor=R.+M.+Evansauthor=M.+D.+Schneiderauthor=F.+A.+Brakoauthor=Y.+Xiaoauthor=Y.+E.+Chenauthor=Q.+Yang&title=Cardiomyocyte-restricted+Peroxisome+Proliferator-activated+Receptor-%CE%B4+Deletion+Perturbs+Myocardial+Fatty+Acid+Oxidation+and+Leads+to+Cardiomyopathy&doi=10.1038%2Fnm1116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy</span></div><div class="casAuthors">Cheng, Lihong; Ding, Guoliang; Qin, Qianhong; Huang, Yao; Lewis, William; He, Nu; Evans, Ronald M.; Schneider, Michael D.; Brako, Florence A.; Xiao, Yan; Chen, Yuqing E.; Yang, Qinglin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1245-1250</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fatty acid oxidn. (FAO) is a primary energy source for meeting the heart's energy requirements.  Peroxisome proliferator-activated receptor-δ (PPAR-δ) may have important roles in FAO.  But it remains unclear whether PPAR-δ is required for maintaining basal myocardial FAO.  The authors show that cre-loxP-mediated cardiomyocyte-restricted deletion of PPAR-δ in mice downregulates constitutive expression of key FAO genes and decreases basal myocardial FAO.  These mice have cardiac dysfunction, progressive myocardial lipid accumulation, cardiac hypertrophy and congestive heart failure with reduced survival.  Thus, chronic myocardial PPAR-δ deficiency leads to lipotoxic cardiomyopathy.  Together, the authors' data show that PPAR-δ is a crucial determinant of constitutive myocardial FAO and is necessary to maintain energy balance and normal cardiac function.  The authors suggest that PPAR-δ is a potential therapeutic target in treating lipotoxic cardiomyopathy and other heart diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBGArHkUrGjbVg90H21EOLACvtfcHk0liu8whVfCvw2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVOgsbo%253D&md5=cb2044c7e9e0fa655769efdec9b0ecea</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnm1116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1116%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLewis%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DN.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DSchneider%26aufirst%3DM.%2BD.%26aulast%3DBrako%26aufirst%3DF.%2BA.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%2BE.%26aulast%3DYang%26aufirst%3DQ.%26atitle%3DCardiomyocyte-restricted%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B4%2520Deletion%2520Perturbs%2520Myocardial%2520Fatty%2520Acid%2520Oxidation%2520and%2520Leads%2520to%2520Cardiomyopathy%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D1245%26epage%3D1250%26doi%3D10.1038%2Fnm1116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbiah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhelyabovska, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor {delta} is an Essential Transcriptional Regulator for Mitochondrial Protection and Biogenesis in Adult Heart</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">911</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.109.206185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1161%2FCIRCRESAHA.109.206185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=20075336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1aku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2010&pages=911-919&author=P.+Wangauthor=J.+Liuauthor=Y.+Liauthor=S.+Wuauthor=J.+Luoauthor=H.+Yangauthor=R.+Subbiahauthor=J.+Chathamauthor=O.+Zhelyabovskaauthor=Q.+Yang&title=Peroxisome+Proliferator-activated+Receptor+%7Bdelta%7D+is+an+Essential+Transcriptional+Regulator+for+Mitochondrial+Protection+and+Biogenesis+in+Adult+Heart&doi=10.1161%2FCIRCRESAHA.109.206185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome Proliferator-Activated Receptor δ Is an Essential Transcriptional Regulator for Mitochondrial Protection and Biogenesis in Adult Heart</span></div><div class="casAuthors">Wang, Peiyong; Liu, Jian; Li, Yuquan; Wu, Sijie; Luo, Jinwen; Yang, Huan; Subbiah, Ramasamy; Chatham, John; Zhelyabovska, Olga; Yang, Qinglin</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">911-919</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Rationale: Peroxisome proliferator-activated receptors (PPARs) (α, γ, and δ/β) are nuclear hormone receptors and ligand-activated transcription factors that serve as key determinants of myocardial fatty acid metab.  Long-term cardiomyocyte-restricted PPARδ deficiency in mice leads to depressed myocardial fatty acid oxidn., bioenergetics, and premature death with lipotoxic cardiomyopathy.  Objective: To explore the essential role of PPARδ in the adult heart.  Methods and results: We investigated the consequences of inducible short-term PPARδ knockout in the adult mouse heart.  In addn. to a substantial transcriptional down regulation of lipid metabolic proteins, short-term PPARδ knockout in the adult mouse heart attenuated cardiac expression of both Cu/Zn superoxide dismutase and manganese superoxide dismutase, leading to increased oxidative damage to the heart.  Moreover, expression of key mitochondrial biogenesis determinants such as PPARγ coactivator-1 were substantially decreased in the short-term PPARδ deficient heart, concomitant with a decreased mitochondrial DNA copy no.  Rates of palmitate and glucose oxidn. were markedly depressed in cardiomyocytes of PPARδ knockout hearts.  Consequently, PPARδ deficiency in the adult heart led to depressed cardiac performance and cardiac hypertrophy.  Conclusions: PPARδ is an essential regulator of cardiac mitochondrial protection and biogenesis and PPARδ activation can be a potential therapeutic target for cardiac disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoddF_qmSjVKLVg90H21EOLACvtfcHk0liu8whVfCvw2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1aku7Y%253D&md5=b0df60643f159d8a20c421d5c0f2e621</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.109.206185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.109.206185%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSubbiah%26aufirst%3DR.%26aulast%3DChatham%26aufirst%3DJ.%26aulast%3DZhelyabovska%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DQ.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%257Bdelta%257D%2520is%2520an%2520Essential%2520Transcriptional%2520Regulator%2520for%2520Mitochondrial%2520Protection%2520and%2520Biogenesis%2520in%2520Adult%2520Heart%26jtitle%3DCirc.%2520Res.%26date%3D2010%26volume%3D106%26spage%3D911%26epage%3D919%26doi%3D10.1161%2FCIRCRESAHA.109.206185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castiglia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantozzi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">Activation of Peroxisome Proliferator-activated Receptor-β/δ Attenuates Myocardial Ischemia/Reperfusion Injury in the Rat</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1097/SHK.0b013e3181cd86d6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1097%2FSHK.0b013e3181cd86d6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19997057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFequrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=117-124&author=A.+Kapoorauthor=M.+Collinoauthor=S.+Castigliaauthor=R.+Fantozziauthor=C.+Thiemermann&title=Activation+of+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+Attenuates+Myocardial+Ischemia%2FReperfusion+Injury+in+the+Rat&doi=10.1097%2FSHK.0b013e3181cd86d6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of peroxisome proliferator-activated receptor-β/δ attenuates myocardial ischemia/reperfusion injury in the rat</span></div><div class="casAuthors">Kapoor, Amar; Collino, Massimo; Castiglia, Sara; Fantozzi, Roberto; Thiemermann, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Shock</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">SAGUAI</span>;
        ISSN:<span class="NLM_cas:issn">1073-2322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) is a transcription factor that belongs to the PPAR nuclear hormone receptor family.  There is little information about the effects of the immediate administration of specific ligands of PPAR-β/δ (e.g., GW0742) in animal models of myocardial I/R injury.  Using a rat model of regional myocardial I/R in vivo, we have investigated the effects of immediate administration of GW0742 on myocardial infarct size.  Male Wistar rats were subjected to 25 min of regional ischemia followed by 2 h of reperfusion and treated with GW0742 (3, 30, or 300μg/kg i.v. given at 30 min before ischemia and again at the start of reperfusion).  Higher doses (30 or 300 μg/kg i.v.) of GW0742 caused a redn. in infarct size, whereas the lowest dose used was not effective.  The degree of cardioprotection was similar when GW0742 (30 μg/kg i.v.) was given on reperfusion alone.  The redn. in infarct size afforded by GW0742 was not reduced by the competitive irreversible PPAR-α antagonist GW6471 (1 mg/kg i.v., 15 min before ischemia).  GW0742 (30 μg/kg i.v.) reduced the I/R-induced (a) decrease in the phosphorylation of Akt and glycogen synthase kinase-3β, (b) nuclear translocation of the p65 subunit of nuclear factor-κB (activation of nuclear factor-κB), and (c) increase in the expression of iNOS and cyclooxygenase-2.  Thus, immediate administration of the PPAR-β/δ ligand GW0742 during reperfusion reduces myocardial infarct size in the rat by a mechanism that may involve inhibition of the activity of glycogen synthase kinase-3β secondary to activation of the Akt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6KP7DaNi-bVg90H21EOLACvtfcHk0liRCLMhw3XZ1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFequrY%253D&md5=01198136691767c42bbd926127c345b9</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1097%2FSHK.0b013e3181cd86d6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FSHK.0b013e3181cd86d6%26sid%3Dliteratum%253Aachs%26aulast%3DKapoor%26aufirst%3DA.%26aulast%3DCollino%26aufirst%3DM.%26aulast%3DCastiglia%26aufirst%3DS.%26aulast%3DFantozzi%26aufirst%3DR.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DActivation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520Attenuates%2520Myocardial%2520Ischemia%252FReperfusion%2520Injury%2520in%2520the%2520Rat%26jtitle%3DShock%26date%3D2010%26volume%3D34%26spage%3D117%26epage%3D124%26doi%3D10.1097%2FSHK.0b013e3181cd86d6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magadum, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevarao, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickramasinghe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renikunta, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, F. B.</span></span> <span> </span><span class="NLM_article-title">Live Cell Screening Platform Identifies PPARδ as a Regulator of Cardiomyocyte Proliferation and Cardiac Repair</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1002</span>– <span class="NLM_lpage">1019</span>, <span class="refDoi"> DOI: 10.1038/cr.2017.84</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fcr.2017.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=28621328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCiu77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1002-1019&author=A.+Magadumauthor=Y.+Dingauthor=L.+Heauthor=T.+Kimauthor=M.+D.+Vasudevaraoauthor=Q.+Longauthor=K.+Yangauthor=N.+Wickramasingheauthor=H.+V.+Renikuntaauthor=N.+Duboisauthor=G.+Weidingerauthor=Q.+Yangauthor=F.+B.+Engel&title=Live+Cell+Screening+Platform+Identifies+PPAR%CE%B4+as+a+Regulator+of+Cardiomyocyte+Proliferation+and+Cardiac+Repair&doi=10.1038%2Fcr.2017.84"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repair</span></div><div class="casAuthors">Magadum, Ajit; Ding, Yishu; He, Lan; Kim, Teayoun; Vasudevarao, Mohankrishna Dalvoy; Long, Qinqiang; Yang, Kevin; Wickramasinghe, Nadeera; Renikunta, Harsha V.; Dubois, Nicole; Weidinger, Gilbert; Yang, Qinglin; Engel, Felix B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1002-1019</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Zebrafish can efficiently regenerate their heart through cardiomyocyte proliferation.  In contrast, mammalian cardiomyocytes stop proliferating shortly after birth, limiting the regenerative capacity of the postnatal mammalian heart.  Therefore, if the endogenous potential of postnatal cardiomyocyte proliferation could be enhanced, it could offer a promising future therapy for heart failure patients.  Here, we set out to systematically identify small mols. triggering postnatal cardiomyocyte proliferation.  By screening chem. compd. libraries utilizing a Fucci-based system for assessing cell cycle stages, we identified carbacyclin as an inducer of postnatal cardiomyocyte proliferation.  In vitro, carbacyclin induced proliferation of neonatal and adult mononuclear rat cardiomyocytes via a peroxisome proliferator-activated receptor δ (PPARδ)/PDK1/p308Akt/GSK3β/β-catenin pathway.  Inhibition of PPARδ reduced cardiomyocyte proliferation during zebrafish heart regeneration.  Notably, inducible cardiomyocyte-specific overexpression of constitutively active PPARδ as well as treatment with PPARδ agonist after myocardial infarction in mice induced cell cycle progression in cardiomyocytes, reduced scarring, and improved cardiac function.  Collectively, we established a cardiomyocyte proliferation screening system and present a new drugable target with promise for the treatment of cardiac pathologies caused by cardiomyocyte loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWtdu-HNEs4LVg90H21EOLACvtfcHk0lh8oP9ZZs8qYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCiu77M&md5=bd076d337a4d32fc280af2da3ff8edca</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fcr.2017.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2017.84%26sid%3Dliteratum%253Aachs%26aulast%3DMagadum%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DVasudevarao%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DWickramasinghe%26aufirst%3DN.%26aulast%3DRenikunta%26aufirst%3DH.%2BV.%26aulast%3DDubois%26aufirst%3DN.%26aulast%3DWeidinger%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DEngel%26aufirst%3DF.%2BB.%26atitle%3DLive%2520Cell%2520Screening%2520Platform%2520Identifies%2520PPAR%25CE%25B4%2520as%2520a%2520Regulator%2520of%2520Cardiomyocyte%2520Proliferation%2520and%2520Cardiac%2520Repair%26jtitle%3DCell%2520Res.%26date%3D2017%26volume%3D27%26spage%3D1002%26epage%3D1019%26doi%3D10.1038%2Fcr.2017.84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kojonazarov, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luitel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sydykov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahal, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul-Clark, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonvini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schermuly, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. A.</span></span> <span> </span><span class="NLM_article-title">The Peroxisome Proliferator-activated Receptor β/δ Agonist GW0742 has Direct Protective Effects on Right Heart Hypertrophy</span>. <i>Pulm. Circ.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1086/674755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1086%2F674755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25006409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC2cbgslyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=926-935&author=B.+Kojonazarovauthor=H.+Luitelauthor=A.+Sydykovauthor=B.+K.+Dahalauthor=M.+J.+Paul-Clarkauthor=S.+Bonviniauthor=A.+Reedauthor=R.+T.+Schermulyauthor=J.+A.+Mitchell&title=The+Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+Agonist+GW0742+has+Direct+Protective+Effects+on+Right+Heart+Hypertrophy&doi=10.1086%2F674755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">The peroxisome proliferator-activated receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophy</span></div><div class="casAuthors">Kojonazarov Baktybek; Luitel Himal; Sydykov Akylbek; Dahal Bhola K; Schermuly Ralph T; Paul-Clark Mark J; Bonvini Sara; Reed Anna; Mitchell Jane A</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary circulation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">926-35</span>
        ISSN:<span class="NLM_cas:issn">2045-8932</span>.
    </div><div class="casAbstract">Pulmonary hypertension is a debilitating disease with no cure.  We have previously shown that peroxisome proliferator-activated receptor (PPAR) β/δ agonists protect the right heart in hypoxia-driven pulmonary hypertension without affecting vascular remodeling.  PPARβ/δ is an important receptor in lipid metabolism, athletic performance, and the sensing of prostacyclin.  Treatment of right heart hypertrophy and failure in pulmonary hypertension is an emerging target for future therapy.  Here we have investigated the potential of GW0742, a PPARβ agonist, to act directly on the right heart in vivo and what transcriptomic signatures are associated with its actions.  Right heart hypertrophy and failure was induced in mice using a pulmonary artery banding (PAB) model.  GW0742 was administered throughout the study.  Cardiovascular parameters were measured using echocardiography and pressure monitoring.  Fibrosis and cellular changes were measured using immunohistochemistry.  Transcriptomics were measured using the Illumina MouseRef-8v3 BeadChip array and analyzed using GeneSpring GX (ver. 11.0).  PAB resulted in right heart hypertrophy and failure and in increased fibrosis.  GW0742 reduced or prevented the effects of PAB on all parameters measured.  GW0742 altered a number of genes in the transcriptome, with Angptl4 emerging as the top gene altered (increased) in animals with PAB.  In conclusion, the PPARβ/δ agonist GW0742 has direct protective effects on the right heart in vivo.  These observations identify PPARβ/δ as a viable therapeutic target to treat pulmonary hypertension that may complement current and future vasodilator drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkT4oI_ibeCYNpW7w2tapOfW6udTcc2eZQlDG-yn3qP7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbgslyjug%253D%253D&md5=f0a36ffc57cc4a73c99f95704489d49d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1086%2F674755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F674755%26sid%3Dliteratum%253Aachs%26aulast%3DKojonazarov%26aufirst%3DB.%26aulast%3DLuitel%26aufirst%3DH.%26aulast%3DSydykov%26aufirst%3DA.%26aulast%3DDahal%26aufirst%3DB.%2BK.%26aulast%3DPaul-Clark%26aufirst%3DM.%2BJ.%26aulast%3DBonvini%26aufirst%3DS.%26aulast%3DReed%26aufirst%3DA.%26aulast%3DSchermuly%26aufirst%3DR.%2BT.%26aulast%3DMitchell%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520Agonist%2520GW0742%2520has%2520Direct%2520Protective%2520Effects%2520on%2520Right%2520Heart%2520Hypertrophy%26jtitle%3DPulm.%2520Circ.%26date%3D2013%26volume%3D3%26spage%3D926%26epage%3D935%26doi%3D10.1086%2F674755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span> <span> </span><span class="NLM_article-title">PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension</span>. <i>Int. J. Hypertens.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">7809216</span>, <span class="refDoi"> DOI: 10.1155/2019/7809216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1155%2F2019%2F7809216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31073415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BB3M7kt1Cltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=7809216&author=Y.+Jiangauthor=Q.+Liauthor=M.+Jiaauthor=Z.+Yan&title=PPAR%CE%B4%3A+A+Potential+Therapeutic+Target+for+the+Treatment+of+Metabolic+Hypertension&doi=10.1155%2F2019%2F7809216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension</span></div><div class="casAuthors">Jiang Yanli; Li Qiang; Jia Mengxiao; Yan Zhencheng</div><div class="citationInfo"><span class="NLM_cas:title">International journal of hypertension</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7809216</span>
        ISSN:<span class="NLM_cas:issn">2090-0384</span>.
    </div><div class="casAbstract">High blood pressure and its associated cardiovascular diseases have been major risks for public health.  Multiple metabolic risk factors can cause the vascular dysfunction and vascular lesion, and the hypertension due to metabolic disturbances was defined as metabolic hypertension.  The members of a subfamily of the nuclear receptors, peroxisome proliferator-activated receptors (PPARs), were found to be key regulators of metabolism and vascular function.  We provide up-to-date knowledge on the role of subtype PPARδ in the regulation of metabolism and vascular function and the effect of its intervention on the metabolic hypertension management.  We hope to give some insights into the development of more effective treatments of metabolic hypertension and its main complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvb05-GXS2e5dYoSR9eyvsfW6udTcc2ea04mwqCAqjT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7kt1Cltw%253D%253D&md5=419b184b85e88dfdefea34e7c6a85399</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1155%2F2019%2F7809216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2019%252F7809216%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DZ.%26atitle%3DPPAR%25CE%25B4%253A%2520A%2520Potential%2520Therapeutic%2520Target%2520for%2520the%2520Treatment%2520of%2520Metabolic%2520Hypertension%26jtitle%3DInt.%2520J.%2520Hypertens.%26date%3D2019%26volume%3D2019%26spage%3D7809216%26doi%3D10.1155%2F2019%2F7809216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suarez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCollum, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bretz, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capozzi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penn, J. S.</span></span> <span> </span><span class="NLM_article-title">Modulation of VEGF-Induced Retinal Vascular Permeability by Peroxisome Proliferator-activated Receptor-β/δ</span>. <i>Invest. Ophthalmol. Vis. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8232</span>– <span class="NLM_lpage">8240</span>, <span class="refDoi"> DOI: 10.1167/iovs.14-14217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1167%2Fiovs.14-14217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25406289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=8232-8240&author=S.+Suarezauthor=G.+W.+McCollumauthor=C.+A.+Bretzauthor=R.+Yangauthor=M.+E.+Capozziauthor=J.+S.+Penn&title=Modulation+of+VEGF-Induced+Retinal+Vascular+Permeability+by+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4&doi=10.1167%2Fiovs.14-14217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ</span></div><div class="casAuthors">Suarez, Sandra; McCollum, Gary W.; Bretz, Colin A.; Yang, Rong; Capozzi, Megan E.; Penn, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8232-8240</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">PURPOSE.  Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability contributes to diabetic macular edema (DME), a serious vision-threatening condition.  Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) antagonist/reverse agonist, GSK0660, inhibits VEGF-induced human retinal microvascular endothelial cell (HRMEC) proliferation, tubulogenesis, and oxygen-induced retinal vasculopathy in newborn rats.  These VEGF-induced HRMEC behaviors and VEGF-induced disruption of endothelial cell junctional complexes may well share mol. signaling events.  Thus, we sought to examine the role of PPARβ/δ in VEGF-induced retinal hyperpermeability.  METHODS.  Transendothelial elec. resistance (TEER) measurements were performed on HRMEC monolayers to assess permeability.  Claudin-1/Claudin-5 localization in HRMEC monolayers was detd. by immunocytochem.  Extracellular signal-regulated protein kinases 1 and 2 (Erk 1/2) phosphorylation, VEGF receptor 1 (VEGFR1) and R2 were assayed by Western blot anal.  Expression of VEGFR1 and R2 was measured by quant. RT-PCR.  Last, retinal vascular permeability was assayed in vivo by Evans blue extravasation.  RESULTS.  Human retinal microvascular endothelial cell monolayers treated with VEGF for 24 h showed decreased TEER values that were completely reversed by the highest concn. of GSK0660 (10 μM) and PPARβ/δ-directed siRNA (20 μM).  In HRMEC treated with VEGF, GSK0660 stabilized tight-junctions as evidenced by Claudin-1 staining, reduced phosphorylation of Erk1/2, and reduced VEGFR1/2 expression.  Peroxisome proliferator-activated receptor β/δ siRNA had a similar effect on VEGFR expression and Claudin-1, supporting the specificity of GSK0660 in our expts.  Last, GSK0660 significantly inhibited VEGF-induced retinal vascular permeability and reduced retinal VEGFR1and R2 levels in C57BL/6 mice.  CONCLUSIONS.  These data suggest a protective effect for PPARβ/δ antagonism against VEGF induced vascular permeability, possibly through reduced VEGFR expression.  Therefore, antagonism/reverse agonism of PPARβ/δ siRNA may represent a novel therapeutic methodol. against retinal hyperpermeability and is worthy of future investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1o9V79OcYt7Vg90H21EOLACvtfcHk0liKF-XPfS1OuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSrsro%253D&md5=7b3daae21925d6473298b86e2900ebeb</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1167%2Fiovs.14-14217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.14-14217%26sid%3Dliteratum%253Aachs%26aulast%3DSuarez%26aufirst%3DS.%26aulast%3DMcCollum%26aufirst%3DG.%2BW.%26aulast%3DBretz%26aufirst%3DC.%2BA.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DCapozzi%26aufirst%3DM.%2BE.%26aulast%3DPenn%26aufirst%3DJ.%2BS.%26atitle%3DModulation%2520of%2520VEGF-Induced%2520Retinal%2520Vascular%2520Permeability%2520by%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%26jtitle%3DInvest.%2520Ophthalmol.%2520Vis.%2520Sci.%26date%3D2014%26volume%3D55%26spage%3D8232%26epage%3D8240%26doi%3D10.1167%2Fiovs.14-14217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bishop-Bailey, D.</span></span> <span> </span><span class="NLM_article-title">PPARs and Angiogenesis</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1605</span>, <span class="refDoi"> DOI: 10.1042/BST20110643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1042%2FBST20110643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22103494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaiur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1601-1605&author=D.+Bishop-Bailey&title=PPARs+and+Angiogenesis&doi=10.1042%2FBST20110643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">PPARs and angiogenesis</span></div><div class="casAuthors">Bishop-Bailey, David</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1601-1605</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The PPAR (peroxisome-proliferator-activated receptor) family consists of three ligand-activated nuclear receptors: PPARα, PPARβ/δ and PPARγ.  These PPARs have important roles in the regulation of glucose and fatty acid metab., cell differentiation and immune function, but were also found to be expressed in endothelial cells in the late 1990s.  The early endothelial focus of PPARs was PPARγ, the mol. target for the insulin-sensitizing thiazolidinedione/glitazone class of drugs.  Activation of PPARγ was shown to inhibit angiogenesis in vitro and in models of retinopathy and cancer, whereas more recent data point to a crit. role in the development of the vasculature in the placenta.  Similarly, PPARα, the mol. target for the fibrate class of drugs, also has anti-angiogenic properties in exptl. models.  In contrast, unlike PPARα or PPARγ, activation of PPARβ/δ induces angiogenesis, in vitro and in vivo, and has been suggested to be a crit. component of the angiogenic switch in pancreatic cancer.  Moreover, PPARβ/δ is an exercise mimetic and appears to contribute to the angiogenic remodelling of cardiac and skeletal muscle induced by exercise.  This evidence and the emerging mechanisms by which PPARs act in endothelial cells are discussed in more detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot0HeRp8yoFbVg90H21EOLACvtfcHk0liB3dEnpGROjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaiur7E&md5=dd45c2e06051b94dd6648b7aa5680bfd</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1042%2FBST20110643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110643%26sid%3Dliteratum%253Aachs%26aulast%3DBishop-Bailey%26aufirst%3DD.%26atitle%3DPPARs%2520and%2520Angiogenesis%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2011%26volume%3D39%26spage%3D1601%26epage%3D1605%26doi%3D10.1042%2FBST20110643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span> <span> </span><span class="NLM_article-title">Polydatin Restores Endothelium-dependent Relaxation in Rat Aorta Rings Impaired by High Glucose: A Novel Insight Into the PPARβ-NO Signaling Pathway</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0126249</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0126249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pone.0126249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25941823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslSisrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=Y.+Wuauthor=L.+Xueauthor=W.+Duauthor=B.+Huangauthor=C.+Tangauthor=C.+Liuauthor=H.+Qiuauthor=Q.+Jiang&title=Polydatin+Restores+Endothelium-dependent+Relaxation+in+Rat+Aorta+Rings+Impaired+by+High+Glucose%3A+A+Novel+Insight+Into+the+PPAR%CE%B2-NO+Signaling+Pathway&doi=10.1371%2Fjournal.pone.0126249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Polydatin restores endothelium-dependent relaxation in rat aorta rings impaired by high glucose: a novel insight into the PPARβ-NO signaling pathway</span></div><div class="casAuthors">Wu, Yang; Xue, Lai; Du, Weimin; Huang, Bo; Tang, Cuiping; Liu, Changqing; Qiu, Hongmei; Jiang, Qingsong</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0126249/1-e0126249/14</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Polydatin, a natural component from Polygonum Cuspidatum, has important therapeutic effects on metabolic syndrome.  A novel therapeutic strategy using polydatin to improve vascular function has recently been proposed to treat diabetes-related cardiovascular complications.  However, the biol. role and mol. basis of polydatin's action on vascular endothelial cells (VECs)-mediated vasodilatation under diabetes-related hyperglycemia condition remain elusive.  The present study aimed to assess the contribution of polydatin in restoring endothelium-dependent relaxation and to det. the details of its underlying mechanism.  By measuring endothelium-dependent relaxation, we found that acetylcholine-induced vasodilation was impaired by elevated glucose (55 mmol/L); however, polydatin (1, 3, 10 μmol/L) could restore the relaxation in a dose-dependent manner.  Polydatin could also improve the histol. damage to endothelial cells in the thoracic aorta.  Polydatin's effects were mediated via promoting the expression of endothelial NO synthase (eNOS), enhancing eNOS activity and decreasing the inducible NOS (iNOS) level, finally resulting in a beneficial increase in NO release, which probably, at least in part, through activation of the PPARβ signaling pathway.  The results provided a novel insight into polydatin action, via PPARβ-NO signaling pathways, in restoring endothelial function in high glucose conditions.  The results also indicated the potential utility of polydatin to treat diabetes related cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDFPls36iLTrVg90H21EOLACvtfcHk0liB3dEnpGROjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslSisrnF&md5=e6eeca6205ae5ee46bb9d7f35d486ee6</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0126249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0126249%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DQ.%26atitle%3DPolydatin%2520Restores%2520Endothelium-dependent%2520Relaxation%2520in%2520Rat%2520Aorta%2520Rings%2520Impaired%2520by%2520High%2520Glucose%253A%2520A%2520Novel%2520Insight%2520Into%2520the%2520PPAR%25CE%25B2-NO%2520Signaling%2520Pathway%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0126249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">PPAR Agonist GW501516 Inhibits PDGF-Stimulated Pulmonary Arterial Smooth Muscle Cell Function Related to Pathological Vascular Remodeling</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">903947</span>, <span class="refDoi"> DOI: 10.1155/2013/903947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1155%2F2013%2F903947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23607100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC3srntlWgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=903947&author=G.+Liuauthor=X.+Liauthor=Y.+Liauthor=X.+Tangauthor=J.+Xuauthor=R.+Liauthor=P.+Haoauthor=Y.+Sun&title=PPAR+Agonist+GW501516+Inhibits+PDGF-Stimulated+Pulmonary+Arterial+Smooth+Muscle+Cell+Function+Related+to+Pathological+Vascular+Remodeling&doi=10.1155%2F2013%2F903947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ agonist GW501516 inhibits PDGF-stimulated pulmonary arterial smooth muscle cell function related to pathological vascular remodeling</span></div><div class="casAuthors">Liu Guangjie; Li Xuan; Li Yan; Tang Xin; Xu Jie; Li Ran; Hao Peng; Sun Yongchang</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">903947</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pulmonary arterial hypertension (PAH) is a severe and progressive disease, a key feature of which is pulmonary vascular remodeling.  Growth factors, cytokines, and lipid mediators are involved in this remodeling process.  Recent reports suggest that the peroxisome proliferator-activated receptors (PPARs) play important roles in the regulation of cell growth and differentiation as well as tissue wounding and repair.  In this study, we examined the role of PPAR δ in the regulation of proliferation, migration, collagen synthesis, and chemokine production in human pulmonary arterial smooth muscle cells (HPASMCs).  The data showed that PPAR δ was the most abundant isoform in HPASMCs.  PPAR δ was upregulated in HPASMCs treated with PDGF, which is the major mediator in pulmonary vascular remodeling.  Activation of PPAR δ by GW501516, a specific PPAR δ ligand, significantly inhibited PDGF-induced proliferation in HPASMCs.  The inhibitory effect of GW501516 on HPASMCs was associated with decreased expression of cyclin D1, cyclin D3, CDK2, and CDK4 as well as increased expression of the cell cycle inhibitory genes G0S2 and P27(kip1).  Pretreatment of HPASMCs with GW501516 significantly inhibited PDGF-induced cell migration and collagen synthesis.  GW501516 also significantly attenuated TNF-mediated expression of MCP-1.  These results suggest that PPAR δ may be a potential therapeutic target against the progression of vascular remodeling in PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKNrPxBH56Bq-9TkgmBqTqfW6udTcc2ebXYfzMQjAut7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srntlWgsg%253D%253D&md5=ee1ee2fd9aa64683ec141b84983b2246</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1155%2F2013%2F903947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F903947%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DHao%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DPPAR%2520Agonist%2520GW501516%2520Inhibits%2520PDGF-Stimulated%2520Pulmonary%2520Arterial%2520Smooth%2520Muscle%2520Cell%2520Function%2520Related%2520to%2520Pathological%2520Vascular%2520Remodeling%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2013%26volume%3D2013%26spage%3D903947%26doi%3D10.1155%2F2013%2F903947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span> <span> </span><span class="NLM_article-title">PPARδ Agonist Prevents Endothelial Dysfunction via Induction of Dihydrofolate Reductase Gene and Activation of Tetrahydrobiopterin Salvage Pathway</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">2945</span>– <span class="NLM_lpage">2961</span>, <span class="refDoi"> DOI: 10.1111/bph.14745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1111%2Fbph.14745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31144304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlalsr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=2945-2961&author=Z.+Zhangauthor=X.+Xieauthor=Q.+Yaoauthor=J.+Liuauthor=Y.+Tianauthor=C.+Yangauthor=L.+Xiaoauthor=N.+Wang&title=PPAR%CE%B4+Agonist+Prevents+Endothelial+Dysfunction+via+Induction+of+Dihydrofolate+Reductase+Gene+and+Activation+of+Tetrahydrobiopterin+Salvage+Pathway&doi=10.1111%2Fbph.14745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ agonist prevents endothelial dysfunction via induction of dihydrofolate reductase gene and activation of tetrahydrobiopterin salvage pathway</span></div><div class="casAuthors">Zhang, Zihui; Xie, Xinya; Yao, Qinyu; Liu, Jia; Tian, Ying; Yang, Chunmiao; Xiao, Lei; Wang, Nanping</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2945-2961</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Impaired endothelium-dependent relaxation (EDR) is a hallmark of endothelial dysfunction.  A deficiency of tetrahydrobiopterin (BH4) causes endothelial NOS to produce ROS rather than NO.  PPARδ is an emerging target for pharmacol. intervention of endothelial dysfunction.  Thus, the present study examd. the role of PPARδ in the regulation of dihydrofolate reductase (DHFR), a key enzyme in the BH4 salvage pathway.  Exptl. Approach : Gene expression was measured by using qRT-PCR and western blotting.  Biopterins and ROS were detd. by using HPLC.  NO was measured with fluorescent dye and ESR spectroscopy.  Vasorelaxation was measured by Multi Myograph System.  Key Results : The PPARδ agonist GW501516 increased DHFR and BH4 levels in endothelial cells (ECs).  The effect was blocked by PPARδ antagonist GSK0660.  Chromatin immunopptn. identified PPAR-responsive elements within the 5'-flanking region of the human DHFR gene.  The promoter activity was examd. with luciferase assays using deletion reporters.  Importantly, DHFR expression was suppressed by palmitic acid (PA, a satd. fatty acid) but increased by docosahexaenoic acid (DHA, a polyunsatd. fatty acid).  GSK0660 prevented DHA-induced increased DHFR expression.  Conversely, the suppressive effect of PA was mitigated by GW501516.  In mouse aortae, GW501516 ameliorated the PA-impaired EDR.  However, this vasoprotective effect was attenuated by DHFR siRNA or methotrexate.  In EC-specific Ppard knockout mice, GW501516 failed to improve vasorelaxation.  Conclusion and Implications : PPARδ prevented endothelial dysfunction by increasing DHFR and activating the BH4 salvage pathway.  These results provide a novel mechanism for the protective roles of PPARδ against vascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCA0-O8x5bPrVg90H21EOLACvtfcHk0liek-ecqx-5FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlalsr7M&md5=3c6f127dd43c6c38820ce00e6335c159</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1111%2Fbph.14745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14745%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DN.%26atitle%3DPPAR%25CE%25B4%2520Agonist%2520Prevents%2520Endothelial%2520Dysfunction%2520via%2520Induction%2520of%2520Dihydrofolate%2520Reductase%2520Gene%2520and%2520Activation%2520of%2520Tetrahydrobiopterin%2520Salvage%2520Pathway%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D176%26spage%3D2945%26epage%3D2961%26doi%3D10.1111%2Fbph.14745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magadum, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, F.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ: Linking Metabolism to Regeneration</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2013</span>, <span class="refDoi"> DOI: 10.3390/ijms19072013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms19072013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKlsbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=2013&author=A.+Magadumauthor=F.+Engel&title=PPAR%CE%B2%2F%CE%B4%3A+Linking+Metabolism+to+Regeneration&doi=10.3390%2Fijms19072013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ: linking metabolism to regeneration</span></div><div class="casAuthors">Magadum, Ajit; Engel, Felix B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2013/1-2013/23</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In contrast to the general belief that regeneration is a rare event, mainly occurring in simple organisms, the ability of regeneration is widely distributed in the animal kingdom.  Yet, the efficiency and extent of regeneration varies greatly.  Humans can recover from blood loss as well as damage to tissues like bone and liver.  Yet damage to the heart and brain cannot be reversed, resulting in scaring.  Thus, there is a great interest in understanding the mol. mechanisms of naturally occurring regeneration and to apply this knowledge to repair human organs.  During regeneration, injury-activated immune cells induce wound healing, extracellular matrix remodeling, migration, dedifferentiation and/or proliferation with subsequent differentiation of somatic or stem cells.  An anti-inflammatory response stops the regenerative process, which ends with tissue remodeling to achieve the original functional state.  Notably, many of these processes are assocd. with enhanced glycolysis.  Therefore, peroxisome proliferator-activated receptor (PPAR) β/δ-which is known to be involved for example in lipid catabolism, glucose homeostasis, inflammation, survival, proliferation, differentiation, as well as mammalian regeneration of the skin, bone and liver-appears to be a promising target to promote mammalian regeneration.  This review summarizes our current knowledge of PPARβ/δ in processes assocd. with wound healing and regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSpDhpZVmuS7Vg90H21EOLACvtfcHk0liek-ecqx-5FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKlsbjJ&md5=3eed4eb37e49a1ae7ad64e7fa4f766e9</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.3390%2Fijms19072013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19072013%26sid%3Dliteratum%253Aachs%26aulast%3DMagadum%26aufirst%3DA.%26aulast%3DEngel%26aufirst%3DF.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%253A%2520Linking%2520Metabolism%2520to%2520Regeneration%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D2013%26doi%3D10.3390%2Fijms19072013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyner, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katusic, Z. S.</span></span> <span> </span><span class="NLM_article-title">Activation of Peroxisome Proliferator-activated Receptor−δ Enhances Regenerative Capacity of Human Endothelial Progenitor Cells by Stimulating Biosynthesis of Tetrahydrobiopterin</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.111.172189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1161%2FHYPERTENSIONAHA.111.172189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21709207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFCktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2011&pages=287-294&author=T.+Heauthor=L.+A.+Smithauthor=T.+Luauthor=M.+J.+Joynerauthor=Z.+S.+Katusic&title=Activation+of+Peroxisome+Proliferator-activated+Receptor%E2%88%92%CE%B4+Enhances+Regenerative+Capacity+of+Human+Endothelial+Progenitor+Cells+by+Stimulating+Biosynthesis+of+Tetrahydrobiopterin&doi=10.1161%2FHYPERTENSIONAHA.111.172189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Peroxisome Proliferator-Activated Receptor-δ Enhances Regenerative Capacity of Human Endothelial Progenitor Cells by Stimulating Biosynthesis of Tetrahydrobiopterin</span></div><div class="casAuthors">He, Tongrong; Smith, Leslie A.; Lu, Tong; Joyner, Michael J.; Katusic, Zvonimir S.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-294</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The mechanisms underlying the regenerative capacity of endothelial progenitor cells (EPCs) are not fully understood.  We hypothesized that biosynthesis of tetrahydrobiopterin is an important mechanism responsible for the stimulatory effects of peroxisome proliferator-activated receptor-δ (PPARδ) activation on regenerative function of human EPCs.  Treatment of human EPCs with a selective PPARδ agonist GW 501516 for 24 h increased the levels of mRNA, protein, and enzymic activity of GTP cyclohydrolase I (GTPCH I), as well as the prodn. of tetrahydrobiopterin.  The effects of GW 501516 were mediated by suppression of PTEN expression, thereby increasing phosphorylation of AKT.  The AKT signaling also mediated GW 501516-induced phosphorylation of endothelial NO synthase.  In addn., activation of PPARδ significantly enhanced proliferation of EPCs.  This effect was abolished by the GTPCH I inhibitor, 2,4-diamino-6-hydroxypyrimidine, or genetic inactivation of GTPCH I with small interfering RNA but not by inhibition of endothelial NO synthase with N-nitro-L-arginine Me ester.  Supplementation of NO did not reverse 2,4-diamino-6-hydroxypyrimidine-inhibited 5-bromodeoxyuridine incorporation.  Furthermore, transplantation of human EPCs stimulated re-endothelialization in a mouse model of carotid artery injury.  Pretreatment of EPCs with GW 501516 significantly enhanced the ability of transplanted EPCs to repair denuded endothelium.  GTPCH I-small interfering RNA transfection significantly inhibited in vivo regenerative capacity of EPCs stimulated with GW 501516.  Thus, in human EPCs, activation of PPARδ stimulates expression and activity of GTPCH I and biosynthesis of tetrahydrobiopterin via PTEN-AKT signaling pathway.  This effect enhances the regenerative function of EPCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF8vGp5RLSWbVg90H21EOLACvtfcHk0liek-ecqx-5FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFCktrs%253D&md5=c5798c3145711166144bc9077584453d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.111.172189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.111.172189%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DJoyner%26aufirst%3DM.%2BJ.%26aulast%3DKatusic%26aufirst%3DZ.%2BS.%26atitle%3DActivation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%25E2%2588%2592%25CE%25B4%2520Enhances%2520Regenerative%2520Capacity%2520of%2520Human%2520Endothelial%2520Progenitor%2520Cells%2520by%2520Stimulating%2520Biosynthesis%2520of%2520Tetrahydrobiopterin%26jtitle%3DHypertension%26date%3D2011%26volume%3D58%26spage%3D287%26epage%3D294%26doi%3D10.1161%2FHYPERTENSIONAHA.111.172189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, S.</span></span> <span> </span><span class="NLM_article-title">Functional Role of PPARδ in Corneal Epithelial Wound Healing</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">598</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2011.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.ajpath.2011.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22119718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVentbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2012&pages=583-598&author=Y.+Nakamuraauthor=T.+Nakamuraauthor=T.+Taruiauthor=J.+Inoueauthor=S.+Kinoshita&title=Functional+Role+of+PPAR%CE%B4+in+Corneal+Epithelial+Wound+Healing&doi=10.1016%2Fj.ajpath.2011.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Functional role of PPARδ in corneal epithelial wound healing</span></div><div class="casAuthors">Nakamura, Yoshikuni; Nakamura, Takahiro; Tarui, Takeshi; Inoue, Jun; Kinoshita, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">583-598</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptor (PPAR) δ is involved in tissue repair.  In this study, we investigated the functional role of PPARδ in corneal epithelial wound healing.  In an in vivo corneal wound-healing model, the changes of PPARδ expression in corneal epithelia were examd. by immunofluorescence microscopy, and the effect of topical administrations of a PPARδ agonist on corneal wound healing was also evaluated.  The inhibitory effect of a PPARδ agonist on the cytokine-induced death of human corneal epithelial cells was evaluated using a DNA fragmentation assay kit.  The changes of PPARδ expression and epithelial cell death were also investigated using human corneoscleral tissues ex vivo.  Our findings showed that PPARδ expression was temporally up-regulated in corneal epithelial cells during exptl. wound healing and that topical administration of a PPARδ agonist significantly promoted the healing of exptl. corneal epithelial wounds.  In human corneal epithelial cells, up-regulation of PPARδ and DNA fragmentation was demonstrated by stimulation with cytokines, and the DNA fragmentation was significantly inhibited by pretreatment with a PPARδ agonist.  By using human corneoscleral tissues ex vivo, PPARδ was up-regulated in both healthy corneal epithelia (during re-epithelialization) and diseased corneal epithelia.  Inflammatory stimulation-induced corneal epithelial cell death was inhibited by pretreatment with a PPARδ agonist.  These results strongly suggest that PPARδ is involved in the corneal epithelial wound healing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsZx_xbNt1SrVg90H21EOLACvtfcHk0lg30h23eTNRdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVentbw%253D&md5=5f292abef860492ccf53871707ffcd21</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DTarui%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DJ.%26aulast%3DKinoshita%26aufirst%3DS.%26atitle%3DFunctional%2520Role%2520of%2520PPAR%25CE%25B4%2520in%2520Corneal%2520Epithelial%2520Wound%2520Healing%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D180%26spage%3D583%26epage%3D598%26doi%3D10.1016%2Fj.ajpath.2011.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scholtysek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenbeisser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uderhardt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ipseiz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donhauser, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djouad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuckermann, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desvergne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronke, G.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ Governs Wnt Signaling and Bone Turnover</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1038/nm.3146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fnm.3146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23542786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFOqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=608-613&author=C.+Scholtysekauthor=J.+Katzenbeisserauthor=H.+Fuauthor=S.+Uderhardtauthor=N.+Ipseizauthor=C.+Stollauthor=M.+M.+Zaissauthor=M.+Stockauthor=L.+Donhauserauthor=C.+B%C3%B6hmauthor=A.+Kleyerauthor=A.+Hessauthor=K.+Engelkeauthor=J.+P.+Davidauthor=F.+Djouadauthor=J.+P.+Tuckermannauthor=B.+Desvergneauthor=G.+Schettauthor=G.+Kronke&title=PPAR%CE%B2%2F%CE%B4+Governs+Wnt+Signaling+and+Bone+Turnover&doi=10.1038%2Fnm.3146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ governs Wnt signaling and bone turnover</span></div><div class="casAuthors">Scholtysek, Carina; Katzenbeisser, Julia; Fu, He; Uderhardt, Stefan; Ipseiz, Natacha; Stoll, Cornelia; Zaiss, Mario M.; Stock, Michael; Donhauser, Laura; Boehm, Christina; Kleyer, Arnd; Hess, Andreas; Engelke, Klaus; David, Jean-Pierre; Djouad, Farida; Tuckermann, Jan Peter; Desvergne, Beatrice; Schett, Georg; Kroenke, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">608-613</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) act as metabolic sensors and central regulators of fat and glucose homeostasis.  Furthermore, PPARγ has been implicated as major catabolic regulator of bone mass in mice and humans.  However, a potential involvement of other PPAR subtypes in the regulation of bone homeostasis has remained elusive.  Here we report a previously unrecognized role of PPARβ/δ as a key regulator of bone turnover and the crosstalk between osteoblasts and osteoclasts.  In contrast to activation of PPARγ, activation of PPARβ/δ amplified Wnt-dependent and β-catenin-dependent signaling and gene expression in osteoblasts, resulting in increased expression of osteoprotegerin (OPG) and attenuation of osteoblast-mediated osteoclastogenesis.  Accordingly, PPARβ/δ-deficient mice had lower Wnt signaling activity, lower serum concns. of OPG, higher nos. of osteoclasts and osteopenia.  Pharmacol. activation of PPARβ/δ in a mouse model of postmenopausal osteoporosis led to normalization of the altered ratio of tumor necrosis factor superfamily, member 11 (RANKL, also called TNFSF11) to OPG, a rebalancing of bone turnover and the restoration of normal bone d.  Our findings identify PPARβ/δ as a promising target for an alternative approach in the treatment of osteoporosis and related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxWzkK_7oC47Vg90H21EOLACvtfcHk0lg30h23eTNRdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFOqt7k%253D&md5=b9dfec00b6d5fc0fc1a26ae1d6fd3bcb</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fnm.3146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3146%26sid%3Dliteratum%253Aachs%26aulast%3DScholtysek%26aufirst%3DC.%26aulast%3DKatzenbeisser%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DUderhardt%26aufirst%3DS.%26aulast%3DIpseiz%26aufirst%3DN.%26aulast%3DStoll%26aufirst%3DC.%26aulast%3DZaiss%26aufirst%3DM.%2BM.%26aulast%3DStock%26aufirst%3DM.%26aulast%3DDonhauser%26aufirst%3DL.%26aulast%3DB%25C3%25B6hm%26aufirst%3DC.%26aulast%3DKleyer%26aufirst%3DA.%26aulast%3DHess%26aufirst%3DA.%26aulast%3DEngelke%26aufirst%3DK.%26aulast%3DDavid%26aufirst%3DJ.%2BP.%26aulast%3DDjouad%26aufirst%3DF.%26aulast%3DTuckermann%26aufirst%3DJ.%2BP.%26aulast%3DDesvergne%26aufirst%3DB.%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DKronke%26aufirst%3DG.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520Governs%2520Wnt%2520Signaling%2520and%2520Bone%2520Turnover%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D608%26epage%3D613%26doi%3D10.1038%2Fnm.3146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manickam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span> <span> </span><span class="NLM_article-title">Roles of Peroxisome Proliferator-activated Receptor β/δ in Skeletal Muscle Physiology</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2016.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.biochi.2016.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27916646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOlu77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=42-48&author=R.+Manickamauthor=W.+Wahli&title=Roles+of+Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+in+Skeletal+Muscle+Physiology&doi=10.1016%2Fj.biochi.2016.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology</span></div><div class="casAuthors">Manickam, Ravikumar; Wahli, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-48</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">More than two decades of studying Peroxisome Proliferator-Activated Receptors (PPARs) has led to an understanding of their implications in various physiol. processes that are key for health and disease.  All three PPAR isotypes, PPARα, PPARβ/δ, and PPARγ, are activated by a variety of mols., including fatty acids, eicosanoids and phospholipids, and regulate a spectrum of genes involved in development, lipid and carbohydrate metab., inflammation, and proliferation and differentiation of many cell types in different tissues.  The hypolipidemic and antidiabetic functions of PPARα and PPARγ in response to fibrate and thiazolidinedione treatment, resp., are well documented.  However, until more recently the functions of PPARβ/δ were less well defined, but are now becoming more recognized in fatty acid metab., energy expenditure, and tissue repair.  Skeletal muscle is an active metabolic organ with high plasticity for adaptive responses to varying conditions such as fasting or phys. exercise.  It is the major site of energy expenditure resulting from lipid and glucose catabolism.  Here, we review the multifaceted roles of PPARβ/δ in skeletal muscle physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjKJDWc2-Nc7Vg90H21EOLACvtfcHk0lg6eHZBy5MmUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOlu77O&md5=a0567f3f548a4eb2dc6c98a606ecbea6</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2016.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2016.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DManickam%26aufirst%3DR.%26aulast%3DWahli%26aufirst%3DW.%26atitle%3DRoles%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520in%2520Skeletal%2520Muscle%2520Physiology%26jtitle%3DBiochimie%26date%3D2017%26volume%3D136%26spage%3D42%26epage%3D48%26doi%3D10.1016%2Fj.biochi.2016.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.-J.</span></span> <span> </span><span class="NLM_article-title">PPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e65644</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0065644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pone.0065644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23823620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVOhs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=H.-X.+Liuauthor=Y.+Fangauthor=Y.+Huauthor=F.+J.+Gonzalezauthor=J.+Fangauthor=Y.-J.+Wan&title=PPAR%CE%B2+Regulates+Liver+Regeneration+by+Modulating+Akt+and+E2f+Signaling&doi=10.1371%2Fjournal.pone.0065644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ regulates liver regeneration by modulating Akt and E2f signaling</span></div><div class="casAuthors">Liu, Hui-Xin; Fang, Yaping; Hu, Ying; Gonzalez, Frank J.; Fang, Jianwen; Wan, Yu-Jui Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e65644</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The current study tests the hypothesis that peroxisome proliferator-activated receptor β (PPARβ) has a role in liver regeneration due to its effect in regulating energy homeostasis and cell proliferation.  The role of PPARβ in liver regeneration was studied using two-third partial hepatectomy (PH) in Wild-type (WT) and PPARβ-null (KO) mice.  In KO mice, liver regeneration was delayed and the no. of Ki-67 pos. cells reached the peak at 60 h rather than at 36-48 h after PH shown in WT mice.  RNA-sequencing uncovered 1344 transcriptomes that were differentially expressed in regenerating WT and KO livers.  About 70% of those differentially expressed genes involved in glycolysis and fatty acid synthesis pathways failed to induce during liver regeneration due to PPARβ deficiency.  The delayed liver regeneration in KO mice was accompanied by lack of activation of phosphoinositide-dependent kinase 1 (PDK1)/Akt.  In addn., cell proliferation-assocd. increase of genes encoding E2f transcription factor (E2f) 1-2 and E2f7-8 as well as their downstream target genes were not noted in KO livers 36-48 h after PH.  E2fs have dual roles in regulating metab. and proliferation.  Moreover, transient steatosis was only found in WT, but not in KO mice 36 h after PH.  These data suggested that PPARβ-regulated PDK1/Akt and E2f signaling that controls metab. and proliferation is involved in the normal progression of liver regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog6SyDx5tgwrVg90H21EOLACvtfcHk0lg6eHZBy5MmUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVOhs77L&md5=ada732e7441f6943bc41fbf1a6dad3b2</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0065644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0065644%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.-J.%26atitle%3DPPAR%25CE%25B2%2520Regulates%2520Liver%2520Regeneration%2520by%2520Modulating%2520Akt%2520and%2520E2f%2520Signaling%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0065644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burkart, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandam, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtois, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gierasch, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoghi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, D. P.</span></span> <span> </span><span class="NLM_article-title">Nuclear Receptors PPARβ/δ and PPARα Direct Distinct Metabolic Regulatory Programs in the Mouse Heart</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">3930</span>– <span class="NLM_lpage">3939</span>, <span class="refDoi"> DOI: 10.1172/JCI32578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1172%2FJCI32578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18037994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsValsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=3930-3939&author=E.+M.+Burkartauthor=N.+Sambandamauthor=X.+Hanauthor=R.+W.+Grossauthor=M.+Courtoisauthor=C.+M.+Gieraschauthor=K.+Shoghiauthor=M.+J.+Welchauthor=D.+P.+Kelly&title=Nuclear+Receptors+PPAR%CE%B2%2F%CE%B4+and+PPAR%CE%B1+Direct+Distinct+Metabolic+Regulatory+Programs+in+the+Mouse+Heart&doi=10.1172%2FJCI32578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart</span></div><div class="casAuthors">Burkart, Eileen M.; Sambandam, Nandakumar; Han, Xianlin; Gross, Richard W.; Courtois, Michael; Gierasch, Carolyn M.; Shoghi, Kooresh; Welch, Michael J.; Kelly, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3930-3939</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">In the diabetic heart, chronic activation of the PPARα pathway drives excessive fatty acid (FA) oxidn., lipid accumulation, reduced glucose utilization, and cardiomyopathy.  The related nuclear receptor, PPARβ/δ, is also highly expressed in the heart, yet its function has not been fully delineated.  To address its role in myocardial metab., we generated transgenic mice with cardiac-specific expression of PPARβ/δ, driven by the myosin heavy chain (MHC-PPARβ/δ mice).  In striking contrast to MHC-PPARα mice, MHC-PPARβ/δ mice had increased myocardial glucose utilization, did not accumulate myocardial lipid, and had normal cardiac function.  Consistent with these obsd. metabolic phenotypes, we found that expression of genes involved in cellular FA transport were activated by PPARα but not by PPARβ/δ.  Conversely, cardiac glucose transport and glycolytic genes were activated in MHC-PPARβ/δ mice, but repressed in MHC-PPARα mice.  In reporter assays, we showed that PPARβ/δ and PPARα exerted differential transcriptional control of the GLUT4 promoter, which may explain the obsd. isotype-specific effects on glucose uptake.  Furthermore, myocardial injury due to ischemia/reperfusion injury was significantly reduced in the MHC-PPARβ/δ mice compared with control or MHC-PPARα mice, consistent with an increased capacity for myocardial glucose utilization.  These results demonstrate that PPARα and PPARβ/δ drive distinct cardiac metabolic regulatory programs and identify PPARβ/δ as a potential target for metabolic modulation therapy aimed at cardiac dysfunction caused by diabetes and ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr06Tz8YFObBLVg90H21EOLACvtfcHk0lg6eHZBy5MmUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsValsLzM&md5=e47e82eb0c9b93c4974c3a0581dc5495</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1172%2FJCI32578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI32578%26sid%3Dliteratum%253Aachs%26aulast%3DBurkart%26aufirst%3DE.%2BM.%26aulast%3DSambandam%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DGross%26aufirst%3DR.%2BW.%26aulast%3DCourtois%26aufirst%3DM.%26aulast%3DGierasch%26aufirst%3DC.%2BM.%26aulast%3DShoghi%26aufirst%3DK.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DKelly%26aufirst%3DD.%2BP.%26atitle%3DNuclear%2520Receptors%2520PPAR%25CE%25B2%252F%25CE%25B4%2520and%2520PPAR%25CE%25B1%2520Direct%2520Distinct%2520Metabolic%2520Regulatory%2520Programs%2520in%2520the%2520Mouse%2520Heart%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D3930%26epage%3D3939%26doi%3D10.1172%2FJCI32578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quignodon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desvergne, B.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor <i>β/δ</i> in the Brain: Facts and Hypothesis</span>. <i>PPAR Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>2008</i></span>,  <span class="NLM_fpage">780452</span>, <span class="refDoi"> DOI: 10.1155/2008/780452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1155%2F2008%2F780452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19009042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BD1cjjvFOquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=780452&author=M.+J.+Hallauthor=L.+Quignodonauthor=B.+Desvergne&title=Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+in+the+Brain%3A+Facts+and+Hypothesis&doi=10.1155%2F2008%2F780452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome Proliferator-Activated Receptor beta/delta in the Brain: Facts and Hypothesis</span></div><div class="casAuthors">Hall M G; Quignodon Laure; Desvergne Beatrice</div><div class="citationInfo"><span class="NLM_cas:title">PPAR research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">2008</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">780452</span>
        ISSN:<span class="NLM_cas:issn">1687-4757</span>.
    </div><div class="casAbstract">peroxisome proliferator-activated receptors (PPARs) are nuclear receptors acting as lipid sensors.  Besides its metabolic activity in peripheral organs, the PPAR beta/delta isotype is highly expressed in the brain and its deletion in mice induces a brain developmental defect.  Nevertheless, exploration of PPARbeta action in the central nervous system remains sketchy.  The lipid content alteration observed in PPARbeta null brains and the positive action of PPARbeta agonists on oligodendrocyte differentiation, a process characterized by lipid accumulation, suggest that PPARbeta acts on the fatty acids and/or cholesterol metabolisms in the brain.  PPARbeta could also regulate central inflammation and antioxidant mechanisms in the damaged brain.  Even if not fully understood, the neuroprotective effect of PPARbeta agonists highlights their potential benefit to treat various acute or chronic neurological disorders.  In this perspective, we need to better understand the basic function of PPARbeta in the brain.  This review proposes different leads for future researches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ73SzE7ijUMgyMywPm6HgQfW6udTcc2ebWRVhGwOsy2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjjvFOquw%253D%253D&md5=1233ad6ab1fa2596a1502c52bc4e319c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1155%2F2008%2F780452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2008%252F780452%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DM.%2BJ.%26aulast%3DQuignodon%26aufirst%3DL.%26aulast%3DDesvergne%26aufirst%3DB.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520in%2520the%2520Brain%253A%2520Facts%2520and%2520Hypothesis%26jtitle%3DPPAR%2520Res.%26date%3D2008%26volume%3D2008%26spage%3D780452%26doi%3D10.1155%2F2008%2F780452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suppiramaniam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span> <span> </span><span class="NLM_article-title">Hippocampal Genetic Knockdown of PPARδ Causes Depression-Like Behaviors and Neurogenesis Suppression</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1093/ijnp/pyz008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1093%2Fijnp%2Fpyz008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31038173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFCmtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2019&pages=372-382&author=F.+Chenauthor=X.+Yuauthor=G.+Mengauthor=Z.+Meiauthor=Y.+Duauthor=H.+Sunauthor=M.+N.+Reedauthor=L.+Kongauthor=V.+Suppiramaniamauthor=H.+Hongauthor=S.+Tang&title=Hippocampal+Genetic+Knockdown+of+PPAR%CE%B4+Causes+Depression-Like+Behaviors+and+Neurogenesis+Suppression&doi=10.1093%2Fijnp%2Fpyz008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Hippocampal genetic knockdown of PPARδ causes depression-like behaviors and neurogenesis suppression</span></div><div class="casAuthors">Chen, Fang; Yu, Xuben; Meng, Guoliang; Mei, Zhenlin; Du, Yifeng; Sun, Hongbin; Reed, Miranda N.; Kong, Lingyi; Suppiramaniam, Vishnu; Hong, Hao; Tang, Susu</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">372-382</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Although depression is the leading cause of disability worldwide, its pathophysiol. is poorly understood.  Our previous study showed that hippocampal peroxisome proliferator-activated receptor δ (PPARδ) overexpression displays antidepressive effect and enhances hippocampal neurogenesis during chronic stress.  Herein, we further extended our curiosity to investigate whether downregulating PPARδ could cause depressive-like behaviors through downregulation of neurogenesis.  Methods: Stereotaxic injection of lentiviral vector, expressing short hairpin RNA complementary to the coding exon of PPARδ, was done into the bilateral dentate gyri of the hippocampus, and the depression-like behaviors were obsd. in mice.  Addnl., hippocampal neurogenesis, brain-derived neurotrophic factor and cAMP response element-binding protein were measured both in vivo and in vitro.  Results: Hippocampal PPARδ knockdown caused depressive-like behaviors and significantly decreased neurogenesis, neuronal differentiation, levels of mature brain-derived neurotrophic factor and phosphorylated cAMP response element-binding protein in the hippocampus.  In vitro study further confirmed that PPARδ knockdown could inhibit proliferation and differentiation of neural stem cells.  Furthermore, these effects were mimicked by repeated systemic administration of a PPARδ antagonist, GSK0660 (1 or 3 mg/kg i.p. for 21 d).  Conclusions: These findings suggest that downregulation of hippocampal PPARδ is assocd. with depressive behaviors in mice through an inhibitory effect on cAMP response element-binding protein/brain-derived neurotrophic factor-mediated adult neurogenesis in the hippocampus, providing new insights into the pathogenesis of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2gkFSx93J7Vg90H21EOLACvtfcHk0lhQ6EFJXY1AKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFCmtbfN&md5=71d7ed18e4ffed64298fca31cf9adf22</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Fijnp%2Fpyz008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fijnp%252Fpyz008%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DMeng%26aufirst%3DG.%26aulast%3DMei%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DReed%26aufirst%3DM.%2BN.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DSuppiramaniam%26aufirst%3DV.%26aulast%3DHong%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DS.%26atitle%3DHippocampal%2520Genetic%2520Knockdown%2520of%2520PPAR%25CE%25B4%2520Causes%2520Depression-Like%2520Behaviors%2520and%2520Neurogenesis%2520Suppression%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2019%26volume%3D22%26spage%3D372%26epage%3D382%26doi%3D10.1093%2Fijnp%2Fpyz008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blass, B.</span></span> <span> </span><span class="NLM_article-title">PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00301</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00301" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVSnsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=824-825&author=B.+Blass&title=PPAR+Agonists%2C+Compounds%2C+Pharmaceutical+Compositions%2C+and+Methods+of+Use+Thereof&doi=10.1021%2Facsmedchemlett.6b00301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof</span></div><div class="casAuthors">Blass, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">824-825</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEu_Gipk89W7Vg90H21EOLACvtfcHk0lhQ6EFJXY1AKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVSnsLnL&md5=3f2a34ac0e31059f810fdbfbe0569db8</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00301%26sid%3Dliteratum%253Aachs%26aulast%3DBlass%26aufirst%3DB.%26atitle%3DPPAR%2520Agonists%252C%2520Compounds%252C%2520Pharmaceutical%2520Compositions%252C%2520and%2520Methods%2520of%2520Use%2520Thereof%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D824%26epage%3D825%26doi%3D10.1021%2Facsmedchemlett.6b00301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polak, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dello Russo, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilyuk, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinstein, D. L.</span></span> <span> </span><span class="NLM_article-title">Protective Effects of a Peroxisome Proliferator-activated Receptor-β/δ Agonist in Experimental Autoimmune Encephalomyelitis</span>. <i>J. Neuroimmunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.jneuroim.2005.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.jneuroim.2005.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16098614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVynt7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2005&pages=65-75&author=P.+E.+Polakauthor=S.+Kalininauthor=C.+D.+Dello+Russoauthor=V.+Gavrilyukauthor=A.+Sharpauthor=J.+M.+Petersauthor=J.+Richardsonauthor=T.+M.+Willsonauthor=G.+Weinbergauthor=D.+L.+Feinstein&title=Protective+Effects+of+a+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+Agonist+in+Experimental+Autoimmune+Encephalomyelitis&doi=10.1016%2Fj.jneuroim.2005.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effects of a peroxisome proliferator-activated receptor-β/δ agonist in experimental autoimmune encephalomyelitis</span></div><div class="casAuthors">Polak, Paul E.; Kalinin, Sergey; Dello Russo, Cinzia; Gavrilyuk, Vitaliy; Sharp, Anthony; Peters, Jeffrey M.; Richardson, Jill; Willson, Tim M.; Weinberg, Guy; Feinstein, Douglas L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">65-75</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Agonists of the peroxisome proliferator-activated receptor gamma (PPARγ) exert anti-inflammatory and anti-proliferative effects which led to testing of these drugs in exptl. autoimmune encephalomyelitis (EAE), a model for multiple sclerosis.  In contrast, the effect of PPAR delta (PPARδ) agonists in EAE is not yet known.  We show that oral administration of the selective PPARδ agonist GW0742 reduced clin. symptoms in C57BL/6 mice that had been immunized with encephalitogenic myelin oligodendrocyte glycoprotein (MOG) peptide.  In contrast to previous results with PPARγ agonists, GW0742 only modestly attenuated clin. symptoms when the drug was provided simultaneously with immunization, but a greater redn. was obsd. if administered during disease progression.  Reduced clin. symptoms were accompanied by a redn. in the appearance of new cortical lesions, however cerebellar lesion load was not reduced.  Treatment of T-cells with GW0742 either in vivo or in vitro did not reduce IFNγ prodn.; however GW0742 reduced astroglial and microglial inflammatory activation and IL-1β levels in EAE brain.  RTPCR anal. showed that GW0742 increased expression of some myelin genes.  These data demonstrate that PPARδ agonists, like other PPAR ligands, can exert protective actions in an autoimmune model of demyelinating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozoFhbYjLPLLVg90H21EOLACvtfcHk0lhEpoDtGcBM3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVynt7bJ&md5=6cfd07b1f8b870cf47361a68e1758c12</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2005.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2005.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DPolak%26aufirst%3DP.%2BE.%26aulast%3DKalinin%26aufirst%3DS.%26aulast%3DDello%2BRusso%26aufirst%3DC.%2BD.%26aulast%3DGavrilyuk%26aufirst%3DV.%26aulast%3DSharp%26aufirst%3DA.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DJ.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWeinberg%26aufirst%3DG.%26aulast%3DFeinstein%26aufirst%3DD.%2BL.%26atitle%3DProtective%2520Effects%2520of%2520a%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520Agonist%2520in%2520Experimental%2520Autoimmune%2520Encephalomyelitis%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2005%26volume%3D168%26spage%3D65%26epage%3D75%26doi%3D10.1016%2Fj.jneuroim.2005.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalinin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinstein, D. L.</span></span> <span> </span><span class="NLM_article-title">A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.2174/156720509789207949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.2174%2F156720509789207949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19874267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFChtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=431-437&author=S.+Kalininauthor=J.+C.+Richardsonauthor=D.+L.+Feinstein&title=A+PPARdelta+Agonist+Reduces+Amyloid+Burden+and+Brain+Inflammation+in+a+Transgenic+Mouse+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.2174%2F156720509789207949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease</span></div><div class="casAuthors">Kalinin, Sergey; Richardson, Jill C.; Feinstein, Douglas L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">431-437</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Agonists of the peroxisome proliferator activated receptor gamma (PPARγ) have been shown to reduce inflammatory responses in several animal models of neurol. diseases and conditions and to reduce amyloid burden in transgenic mice expressing mutant forms of human amyloid precursor protein.  However, the effects of activating the related receptor PPARdelta (PPARδ), which is expressed at higher levels in the brain than PPARγ, on inflammation and amyloid burden have not been explored.  In this study we tested the effects of the selective PPARδ agonist GW742 in 5xFAD mice which harbor 3 mutations in amyloid precursor protein and 2 mutations in presenilin 1, develop plaques by 5-6 wk of age, and show robust inflammation and neuronal damage.  Oral delivery of GW742 significantly reduced amyloid plaque burden in the subiculum region of 3-mo old male and female 5xFAD mice.  GW742 also significantly reduced astrocyte activation, suggesting anti-inflammatory effects on glia cells.  The changes in plaque burden were accompanied by increased expression of the amyloid degrading enzymes neprilysin and insulin degrading enzyme, while in transfected HEK293 cells, GW742 activated a neprilysin promoter driving luciferase expression.  These results suggest that, as found for some PPARγ agonists, PPARδ agonists can also reduce amyloid burden likely to be mediated by effects on amyloid clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-PRmA2bp067Vg90H21EOLACvtfcHk0lhEpoDtGcBM3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFChtrvJ&md5=8702ee6f785b6389ec4e85141e7c89a3</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2174%2F156720509789207949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720509789207949%26sid%3Dliteratum%253Aachs%26aulast%3DKalinin%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DJ.%2BC.%26aulast%3DFeinstein%26aufirst%3DD.%2BL.%26atitle%3DA%2520PPARdelta%2520Agonist%2520Reduces%2520Amyloid%2520Burden%2520and%2520Brain%2520Inflammation%2520in%2520a%2520Transgenic%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2009%26volume%3D6%26spage%3D431%26epage%3D437%26doi%3D10.2174%2F156720509789207949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mounsey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustafa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teismann, P.</span></span> <span> </span><span class="NLM_article-title">A Peroxisome Proliferator-activated Receptor-δ Agonist Provides Neuroprotection in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine Model of Parkinson’s Disease</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>240</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2013.02.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.neuroscience.2013.02.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23500098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=240&publication_year=2013&pages=191-203&author=H.+Martinauthor=R.+Mounseyauthor=K.+Satheauthor=S.+Mustafaauthor=M.+Nelsonauthor=R.+Evansauthor=P.+Teismann&title=A+Peroxisome+Proliferator-activated+Receptor-%CE%B4+Agonist+Provides+Neuroprotection+in+the+1-Methyl-4-phenyl-1%2C+2%2C+3%2C+6-tetrahydropyridine+Model+of+Parkinson%E2%80%99s+Disease&doi=10.1016%2Fj.neuroscience.2013.02.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">A peroxisome proliferator-activated receptor-δ agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease</span></div><div class="casAuthors">Martin, H. L.; Mounsey, R. B.; Sathe, K.; Mustafa, S.; Nelson, M. C.; Evans, R. M.; Teismann, P.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">240</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-203</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor (PPAR)-γ and PPARα have shown neuroprotective effects in models of Parkinson's disease (PD).  The role of the third, more ubiquitous isoform PPARδ has not been fully explored.  This study investigated the role of PPARδ in PD using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to model the dopaminergic neurodegeneration of PD.  In vitro administration of the PPARδ antagonist GSK0660 (1 μM) increased the detrimental effect of 1-methyl-4-phenylpyridinium iodide (MPP+) on cell viability, which was reversed by co-treatment with agonist GW0742 (1 μM).  GW0742 alone did not affect MPP+ toxicity.  PPARδ was expressed in the nucleus of dopaminergic neurons and in astrocytes.  Striatal PPARδ levels were increased (over two-fold) immediately after MPTP treatment (30 mg/kg for 5 consecutive days) compared to saline-treated mice.  PPARδ heterozygous mice were not protected against MPTP toxicity.  Intra-striatal infusion of GW0742 (84 μg/day) reduced the MPTP-induced loss of dopaminergic neurons (5036 ± 195) when compared to vehicle-infused mice (3953 ± 460).  These results indicate that agonism of PPARδ provides protection against MPTP toxicity, in agreement with the effects of other PPAR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkRqduiWHIobVg90H21EOLACvtfcHk0ljU1_B-s6qGnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVGhs7s%253D&md5=f386ef071f15887b3027029ed80f9064</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.02.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.02.058%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DH.%26aulast%3DMounsey%26aufirst%3DR.%26aulast%3DSathe%26aufirst%3DK.%26aulast%3DMustafa%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DR.%26aulast%3DTeismann%26aufirst%3DP.%26atitle%3DA%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B4%2520Agonist%2520Provides%2520Neuroprotection%2520in%2520the%25201-Methyl-4-phenyl-1%252C%25202%252C%25203%252C%25206-tetrahydropyridine%2520Model%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D240%26spage%3D191%26epage%3D203%26doi%3D10.1016%2Fj.neuroscience.2013.02.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore-Hall, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampat, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttgereit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, M.-J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arreola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimov, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaasterland, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarowski, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopher, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masliah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Spada, A. R.</span></span> <span> </span><span class="NLM_article-title">PPAR-δ is Repressed in Huntington’s disease, is Required for Normal Neuronal Function and can be Targeted Therapeutically</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1038/nm.4003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fnm.4003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=26642438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFOmtbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=37-45&author=A.+S.+Dickeyauthor=V.+V.+Pinedaauthor=T.+Tsunemiauthor=P.+P.+Liuauthor=H.+C.+Mirandaauthor=S.+K.+Gilmore-Hallauthor=N.+Lomasauthor=K.+R.+Sampatauthor=A.+Buttgereitauthor=M.-J.+M.+Torresauthor=A.+L.+Floresauthor=M.+Arreolaauthor=N.+Arbezauthor=S.+S.+Akimovauthor=T.+C.+Gaasterlandauthor=E.+R.+Lazarowskiauthor=C.+A.+Rossauthor=G.+W.+Yeoauthor=B.+L.+Sopherauthor=G.+K.+Magnusonauthor=A.+B.+Pinkertonauthor=E.+Masliahauthor=A.+R.+La+Spada&title=PPAR-%CE%B4+is+Repressed+in+Huntington%E2%80%99s+disease%2C+is+Required+for+Normal+Neuronal+Function+and+can+be+Targeted+Therapeutically&doi=10.1038%2Fnm.4003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically</span></div><div class="casAuthors">Dickey, Audrey S.; Pineda, Victor V.; Tsunemi, Taiji; Liu, Patrick P.; Miranda, Helen C.; Gilmore-Hall, Stephen K.; Lomas, Nicole; Sampat, Kunal R.; Buttgereit, Anne; Torres, Mark-Joseph Manalang; Flores, April L.; Arreola, Martin; Arbez, Nicolas; Akimov, Sergey S.; Gaasterland, Terry; Lazarowski, Eduardo R.; Ross, Christopher A.; Yeo, Gene W.; Sopher, Bryce L.; Magnuson, Gavin K.; Pinkerton, Anthony B.; Masliah, Eliezer; La Spada, Albert R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-45</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the huntingtin (HTT) gene, which encodes a polyglutamine tract in the HTT protein.  We found that peroxisome proliferator-activated receptor delta (PPAR-δ) interacts with HTT and that mutant HTT represses PPAR-δ-mediated transactivation.  Increased PPAR-δ transactivation ameliorated mitochondrial dysfunction and improved cell survival of neurons from mouse models of HD.  Expression of dominant-neg. PPAR-δ in the central nervous system of mice was sufficient to induce motor dysfunction, neurodegeneration, mitochondrial abnormalities and transcriptional alterations that recapitulated HD-like phenotypes.  Expression of dominant-neg. PPAR-δ specifically in the striatum of medium spiny neurons in mice yielded HD-like motor phenotypes, accompanied by striatal neuron loss.  In mouse models of HD, pharmacol. activation of PPAR-δ using the agonist KD3010 improved motor function, reduced neurodegeneration and increased survival.  PPAR-δ activation also reduced HTT-induced neurotoxicity in vitro and in medium spiny-like neurons generated from stem cells derived from individuals with HD, indicating that PPAR-δ activation may be beneficial in HD and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-Qe2EEES9-LVg90H21EOLACvtfcHk0ljU1_B-s6qGnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFOmtbzO&md5=750ff43fc3796bd941cc58c87b9dd534</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fnm.4003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4003%26sid%3Dliteratum%253Aachs%26aulast%3DDickey%26aufirst%3DA.%2BS.%26aulast%3DPineda%26aufirst%3DV.%2BV.%26aulast%3DTsunemi%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DP.%2BP.%26aulast%3DMiranda%26aufirst%3DH.%2BC.%26aulast%3DGilmore-Hall%26aufirst%3DS.%2BK.%26aulast%3DLomas%26aufirst%3DN.%26aulast%3DSampat%26aufirst%3DK.%2BR.%26aulast%3DButtgereit%26aufirst%3DA.%26aulast%3DTorres%26aufirst%3DM.-J.%2BM.%26aulast%3DFlores%26aufirst%3DA.%2BL.%26aulast%3DArreola%26aufirst%3DM.%26aulast%3DArbez%26aufirst%3DN.%26aulast%3DAkimov%26aufirst%3DS.%2BS.%26aulast%3DGaasterland%26aufirst%3DT.%2BC.%26aulast%3DLazarowski%26aufirst%3DE.%2BR.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DYeo%26aufirst%3DG.%2BW.%26aulast%3DSopher%26aufirst%3DB.%2BL.%26aulast%3DMagnuson%26aufirst%3DG.%2BK.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DLa%2BSpada%26aufirst%3DA.%2BR.%26atitle%3DPPAR-%25CE%25B4%2520is%2520Repressed%2520in%2520Huntington%25E2%2580%2599s%2520disease%252C%2520is%2520Required%2520for%2520Normal%2520Neuronal%2520Function%2520and%2520can%2520be%2520Targeted%2520Therapeutically%26jtitle%3DNat.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D37%26epage%3D45%26doi%3D10.1038%2Fnm.4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arreola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampat, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kanegan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore-Hall, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masliah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Spada, A. R.</span></span> <span> </span><span class="NLM_article-title">PPARδ Activation by Bexarotene Promotes Neuroprotection by Restoring Bioenergetic and Quality Control Homeostasis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">eaal2332</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aal2332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1126%2Fscitranslmed.aal2332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=29212711" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=eaal2332&author=A.+S.+Dickeyauthor=D.+N.+Sanchezauthor=M.+Arreolaauthor=K.+R.+Sampatauthor=W.+Fanauthor=N.+Arbezauthor=S.+Akimovauthor=M.+J.+Van+Kaneganauthor=K.+Ohnishiauthor=S.+K.+Gilmore-Hallauthor=A.+L.+Floresauthor=J.+M.+Nguyenauthor=N.+Lomasauthor=C.+L.+Hsuauthor=D.+C.+Loauthor=C.+A.+Rossauthor=E.+Masliahauthor=R.+M.+Evansauthor=A.+R.+La+Spada&title=PPAR%CE%B4+Activation+by+Bexarotene+Promotes+Neuroprotection+by+Restoring+Bioenergetic+and+Quality+Control+Homeostasis&doi=10.1126%2Fscitranslmed.aal2332"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aal2332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aal2332%26sid%3Dliteratum%253Aachs%26aulast%3DDickey%26aufirst%3DA.%2BS.%26aulast%3DSanchez%26aufirst%3DD.%2BN.%26aulast%3DArreola%26aufirst%3DM.%26aulast%3DSampat%26aufirst%3DK.%2BR.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DArbez%26aufirst%3DN.%26aulast%3DAkimov%26aufirst%3DS.%26aulast%3DVan%2BKanegan%26aufirst%3DM.%2BJ.%26aulast%3DOhnishi%26aufirst%3DK.%26aulast%3DGilmore-Hall%26aufirst%3DS.%2BK.%26aulast%3DFlores%26aufirst%3DA.%2BL.%26aulast%3DNguyen%26aufirst%3DJ.%2BM.%26aulast%3DLomas%26aufirst%3DN.%26aulast%3DHsu%26aufirst%3DC.%2BL.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DLa%2BSpada%26aufirst%3DA.%2BR.%26atitle%3DPPAR%25CE%25B4%2520Activation%2520by%2520Bexarotene%2520Promotes%2520Neuroprotection%2520by%2520Restoring%2520Bioenergetic%2520and%2520Quality%2520Control%2520Homeostasis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26spage%3Deaal2332%26doi%3D10.1126%2Fscitranslmed.aal2332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Q.</span></span> <span> </span><span class="NLM_article-title">PPARß/δ Agonist Alleviates NLRP3 Inflammasome-mediated Neuroinflammation in the MPTP Mouse Model of Parkinson’s Disease</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2018.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbr.2018.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=29885849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1agsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2019&pages=483-489&author=L.+Chenauthor=L.+Xueauthor=J.+Zhengauthor=X.+Tianauthor=Y.+Zhangauthor=Q.+Tong&title=PPAR%C3%9F%2F%CE%B4+Agonist+Alleviates+NLRP3+Inflammasome-mediated+Neuroinflammation+in+the+MPTP+Mouse+Model+of+Parkinson%E2%80%99s+Disease&doi=10.1016%2Fj.bbr.2018.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">PPARss/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease</span></div><div class="casAuthors">Chen, Linfang; Xue, Liujun; Zheng, Jinlong; Tian, Xiangyang; Zhang, Yingdong; Tong, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">483-489</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recent studies have indicated that peroxisome proliferator-activated receptor β/δ (PPARss/δ) agonists exert neuroprotective effects in the model of Parkinson's disease (PD).  Furthermore, PPARss/δ agonists have been shown to have potential anti-inflammatory activity, but the underlying mechanisms remain obscure.  Emerging evidence indicates that the nucleotide-binding domain and leucine-rich-repeat-protein 3 (NLRP3) inflammasome-mediated neuroinflammation plays a crucial role in the pathogenesis of PD.  In the present study we investigate whether PPARss/δ agonists alleviate NLRP3-mediated neuroinflammation in the 1- methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of PD.  We administered GW501516, a selective and high-affinity PPARss/δ agonist, via intracerebroventricular infusion.  Locomotor activities were tested by open field tests and the pole test.  The levels of dopamine and its metabolites were detd. using highperformance liq. chromatog.  Dopaminergic neurodegeneration was assessed via Western blot anal.  The levels of oxidative stress were detected via spectrophotometric assays.  The expressions of pro-inflammatory cytokines were measured by performing quant. real-time RT-PCR and ELISA.  Western blot anal. was used to assess NLRP3 inflammasome activation.  Our results show that GW501516 reduced movement impairment in PD mice; furthermore, it attenuated dopaminergic neurodegeneration in the midbrain and the depletion of dopamine in the striatum and it inhibited inflammatory reactions and NLRP3 inflammasome activation in the midbrain of PD mice.  More importantly, it attenuated astrocytic reaction but had no significant effect on microglial reaction in the midbrain of PD mice.  Collectively, our findings demonstrate for the first time that the specific PPARss/δ agonist GW501516 alleviates NLRP3 inflammasome-mediated neuroinflammation in astrocytes in the MPTP mouse model of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqotnME7QYESLVg90H21EOLACvtfcHk0lg-m0vVbHBnCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1agsb7I&md5=3c8e84371c2968069bfda5ade2238d17</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2018.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2018.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DQ.%26atitle%3DPPAR%25C3%259F%252F%25CE%25B4%2520Agonist%2520Alleviates%2520NLRP3%2520Inflammasome-mediated%2520Neuroinflammation%2520in%2520the%2520MPTP%2520Mouse%2520Model%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2019%26volume%3D356%26spage%3D483%26epage%3D489%26doi%3D10.1016%2Fj.bbr.2018.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, R.</span></span> <span> </span><span class="NLM_article-title">Establishing the Role of PPARβ/δ in Carcinogenesis</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2015.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.tem.2015.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=26490384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=595-607&author=J.+M.+Petersauthor=F.+J.+Gonzalezauthor=R.+M%C3%BCller&title=Establishing+the+Role+of+PPAR%CE%B2%2F%CE%B4+in+Carcinogenesis&doi=10.1016%2Fj.tem.2015.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Establishing the Role of PPARβ/δ in Carcinogenesis</span></div><div class="casAuthors">Peters, Jeffrey M.; Gonzalez, Frank J.; Muller, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">595-607</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The role of the nuclear hormone receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in carcinogenesis is controversial because conflicting studies indicate that it both inhibits and promotes tumorigenesis.  In this review, we focus on recent studies on PPARβ/δ including the significance of increased or decreased PPARβ/δ expression in cancers; a range of opposing mechanisms describing how PPARβ/δ agonists, antagonists, and inverse agonists regulate tumorigenesis and/or whether there may be cell context-specific mechanisms; and whether activating or inhibiting PPARβ/δ is feasible for cancer chemoprevention and/or therapy.  Research questions that need to be addressed are highlighted to establish whether PPARβ/δ can be effectively targeted for cancer chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknhl6H-zW0rVg90H21EOLACvtfcHk0lijGDbW4A9K6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqurnK&md5=5ff1d51b2103f66d78d245ce5ba90f91</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2015.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2015.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26atitle%3DEstablishing%2520the%2520Role%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520in%2520Carcinogenesis%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2015%26volume%3D26%26spage%3D595%26epage%3D607%26doi%3D10.1016%2Fj.tem.2015.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colby, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaoude, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shureiqi, I.</span></span> <span> </span><span class="NLM_article-title">The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3339</span>, <span class="refDoi"> DOI: 10.3390/ijms19113339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms19113339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlGjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=3339&author=Y.+Liuauthor=J.+K.+Colbyauthor=X.+Zuoauthor=J.+Jaoudeauthor=D.+Weiauthor=I.+Shureiqi&title=The+Role+of+PPAR-%CE%B4+in+Metabolism%2C+Inflammation%2C+and+Cancer%3A+Many+Characters+of+a+Critical+Transcription+Factor&doi=10.3390%2Fijms19113339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">The role of PPAR-δ in metabolism, inflammation, and cancer: many characters of a critical transcription factor</span></div><div class="casAuthors">Liu, Yi; Colby, Jennifer K.; Zuo, Xiangsheng; Jaoude, Jonathan; Wei, Daoyan; Shureiqi, Imad</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3339/1-3339/14</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptor-delta (PPAR-δ), one of three members of the PPAR group in the nuclear receptor superfamily, is a ligand-activated transcription factor.  PPAR-δ regulates important cellular metabolic functions that contribute to maintaining energy balance.  PPAR-δ is esp. important in regulating fatty acid uptake, transport, and β-oxidn. as well as insulin secretion and sensitivity.  These salutary PPAR-δ functions in normal cells are thought to protect against metabolic-syndrome-related diseases, such as obesity, dyslipidemia, insulin resistance/type 2 diabetes, hepatosteatosis, and atherosclerosis.  Given the high clin. burden these diseases pose, highly selective synthetic activating ligands of PPAR-δ were developed as potential preventive/therapeutic agents.  Some of these compds. showed some efficacy in clin. trials focused on metabolic-syndrome-related conditions.  However, the clin. development of PPAR-δ agonists was halted because various lines of evidence demonstrated that cancer cells upregulated PPAR-δ expression/activity as a defense mechanism against nutritional deprivation and energy stresses, improving their survival and promoting cancer progression.  This review discusses the complex relationship between PPAR-δ in health and disease and highlights our current knowledge regarding the different roles that PPAR-δ plays in metab., inflammation, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgFda63KBmOLVg90H21EOLACvtfcHk0lijGDbW4A9K6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlGjtrs%253D&md5=14c2f5c1423bd28a64b302bbef07ec8d</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3390%2Fijms19113339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19113339%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DColby%26aufirst%3DJ.%2BK.%26aulast%3DZuo%26aufirst%3DX.%26aulast%3DJaoude%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DShureiqi%26aufirst%3DI.%26atitle%3DThe%2520Role%2520of%2520PPAR-%25CE%25B4%2520in%2520Metabolism%252C%2520Inflammation%252C%2520and%2520Cancer%253A%2520Many%2520Characters%2520of%2520a%2520Critical%2520Transcription%2520Factor%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D3339%26doi%3D10.3390%2Fijms19113339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borland, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Ligand Activation of Peroxisome Proliferator-activated Receptor-β/δ (PPARβ/δ) and Inhibition of Cyclooxygenase 2 (COX2) Attenuate Colon Carcinogenesis through Independent Signaling Mechanisms</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgm209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1093%2Fcarcin%2Fbgm209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17893232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1aitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=169-176&author=H.+E.+Hollingsheadauthor=M.+G.+Borlandauthor=A.+N.+Billinauthor=T.+M.+Willsonauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Ligand+Activation+of+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+%28PPAR%CE%B2%2F%CE%B4%29+and+Inhibition+of+Cyclooxygenase+2+%28COX2%29+Attenuate+Colon+Carcinogenesis+through+Independent+Signaling+Mechanisms&doi=10.1093%2Fcarcin%2Fbgm209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms</span></div><div class="casAuthors">Hollingshead, Holly E.; Borland, Michael G.; Billin, Andrew N.; Willson, Timothy M.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-176</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Cyclooxygenase (COX) 2-derived prostaglandin E2 (PGE2) promotes colorectal carcinoma growth and invasion, and inhibition of COX2 by non-steroidal anti-inflammatory drugs is known to inhibit these processes.  There is controversy regarding the effect of ligand activation of peroxisome proliferator-activated receptor (PPAR)-β/δ on colon carcinogenesis, although collective evidence from independent labs. suggest that ligand activation of PPARβ/δ leads to the induction of terminal differentiation coupled with inhibition of cell growth in a variety of models.  The present study examd. the hypothesis that ligand activation of PPARβ/δ and inhibition of COX2 attenuate colon cancer through independent mechanisms and that combining these two mechanisms will enhance this inhibition.  Colon cancer was induced by administering azoxymethane to wild-type and PPARβ/δ-null mice.  Cohorts of mice were treated with GW0742 (a PPARβ/δ ligand), nimesulide (a COX2 inhibitor) or a combination of GW0742 and nimesulide.  Inhibition of COX2 by nimesulide attenuated colon cancer and ligand activation of PPARβ/δ by GW0742 had inhibitory effects.  However, the combined treatment of GW0742 and nimesulide did not cause an enhancement in the attenuation of colon cancer.  Mechanistically, the effects of these compds. occurred through independent mechanisms as increased levels of differentiation markers as a result of ligand activation of PPARβ/δ were not found with COX2 inhibition, and a redn. in PGE2 levels resulting from COX2 inhibition was not obsd. in response to ligand activation of PPARβ/δ.  Results from these studies effectively dissoc. COX2 inhibition and PPARβ/δ activity during colon carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoruGMOyB6ISbVg90H21EOLACvtfcHk0ljMR1HWqp-ZNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1aitr4%253D&md5=8943f24f7fadb2da1549142c1350a35e</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgm209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgm209%26sid%3Dliteratum%253Aachs%26aulast%3DHollingshead%26aufirst%3DH.%2BE.%26aulast%3DBorland%26aufirst%3DM.%2BG.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DLigand%2520Activation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520%2528PPAR%25CE%25B2%252F%25CE%25B4%2529%2520and%2520Inhibition%2520of%2520Cyclooxygenase%25202%2520%2528COX2%2529%2520Attenuate%2520Colon%2520Carcinogenesis%2520through%2520Independent%2520Signaling%2520Mechanisms%26jtitle%3DCarcinogenesis%26date%3D2008%26volume%3D29%26spage%3D169%26epage%3D176%26doi%3D10.1093%2Fcarcin%2Fbgm209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorczynski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaner, D.</span></span> <span> </span><span class="NLM_article-title">PPAR-delta Promotes Survival of Breast Cancer Cells in Harsh Metabolic Conditions</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e232</span> <span class="refDoi"> DOI: 10.1038/oncsis.2016.41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Foncsis.2016.41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27270614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2rtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&author=X.+Wangauthor=G.+Wangauthor=Y.+Shiauthor=L.+Sunauthor=R.+Gorczynskiauthor=Y.+Liauthor=Z.+Xuauthor=D.+Spaner&title=PPAR-delta+Promotes+Survival+of+Breast+Cancer+Cells+in+Harsh+Metabolic+Conditions&doi=10.1038%2Foncsis.2016.41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions</span></div><div class="casAuthors">Wang, X.; Wang, G.; Shi, Y.; Sun, L.; Gorczynski, R.; Li, Y.-J.; Xu, Z.; Spaner, D. E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogenesis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e232</span>CODEN:
                <span class="NLM_cas:coden">ONCOCT</span>;
        ISSN:<span class="NLM_cas:issn">2157-9024</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Expression of the nuclear receptor peroxisome proliferator activated receptor delta (PPARδ) in breast cancer cells is neg. assocd. with patient survival, but the underlying mechanisms are not clear.  High PPARδ protein levels in rat breast adenocarcinomas were found to be assocd. with increased growth in soft agar and mice.  Transgenic expression of PPARδ increased the ability of human breast cancer cell lines to migrate in vitro and form lung metastases in mice.  PPARδ also conferred the ability to grow in exhausted tissue culture media and survive in low-glucose and other endoplasmic reticulum stress conditions such as hypoxia.  Upregulation of PPARδ by glucocorticoids or synthetic agonists also protected human breast cancer cells from low glucose.  Survival in low glucose was related to increased antioxidant defenses mediated in part by catalase and also to late AKT phosphorylation, which is assocd. with the prolonged glucose-deprivation response.  Synthetic antagonists reversed the survival benefits conferred by PPARδ in vitro.  These findings suggest that PPARδ conditions breast cancer cells to survive in harsh microenvironmental conditions by reducing oxidative stress and enhancing survival signaling responses.  Drugs that target PPARδ may have a role in the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquHZ575ike5rVg90H21EOLACvtfcHk0ljMR1HWqp-ZNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2rtL8%253D&md5=17c864f609ffb2b862d40bafdd0aadbf</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Foncsis.2016.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foncsis.2016.41%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DGorczynski%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DSpaner%26aufirst%3DD.%26atitle%3DPPAR-delta%2520Promotes%2520Survival%2520of%2520Breast%2520Cancer%2520Cells%2520in%2520Harsh%2520Metabolic%2520Conditions%26jtitle%3DOncogenesis%26date%3D2016%26volume%3D5%26doi%3D10.1038%2Foncsis.2016.41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pedchenko, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massion, P. P.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor β/δ Expression and Activation in Lung Cancer</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2007-0426OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1165%2Frcmb.2007-0426OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18566335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKitrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2008&pages=689-696&author=T.+V.+Pedchenkoauthor=A.+L.+Gonzalezauthor=D.+Wangauthor=R.+N.+DuBoisauthor=P.+P.+Massion&title=Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+Expression+and+Activation+in+Lung+Cancer&doi=10.1165%2Frcmb.2007-0426OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor β/δ expression and activation in lung cancer</span></div><div class="casAuthors">Pedchenko, Tetyana V.; Gonzalez, Adriana L.; Wang, DingZhi; DuBois, Raymond N.; Massion, Pierre P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">689-696</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is a ligand-binding inducible transcriptional factor linked to carcinogenesis.  Important functions of PPARβ/δ were demonstrated in series of human epithelial cancers; however, its role in lung cancer remains controversial.  We investigated the differential expression level and localization of PPARβ/δ in tumors and adjacent normal lung tissue, and the effect of PPARβ/δ activation on lung cancer cell proliferation and apoptosis.  PPARβ/δ was expressed in all studied human non-small cell lung cancers, and strong PPARβ/δ immunoreactivity was obsd. in epithelial cells of more than 75% of studied lung tumors.  PPARβ/δ expression was consistently limited to the cancer cells in tumor tissue, while in adjacent normal lung tissue it was limited predominantly to the mononuclear cells.  We found that ligand-binding activation of PPARβ/δ stimulates cell proliferation (an effect that was blocked by a dominant-neg. construct of PPARβ/δ), stimulates anchorage-independent cell growth, and inhibits apoptosis in lung cancer cell lines.  Importantly, the activation of PPARβ/δ induces Akt phosphorylation correlated with up-regulation of PDK1, down-regulation of PTEN, and increased expression of Bcl-xL and COX-2.  These findings indicate that PPARβ/δ exerts proliferative and anti-apoptotic effects via PI3K/Akt1 and COX-2 pathways.  In conclusion, PPARβ/δ is strongly expressed in the majority of lung cancers, and its activation induces proliferative and survival response in non-small cell lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5ad7OPzQyTrVg90H21EOLACvtfcHk0lhj1wgLIH2CYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKitrfI&md5=52d6a291e2678edc6cb87846d02ed29b</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2007-0426OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2007-0426OC%26sid%3Dliteratum%253Aachs%26aulast%3DPedchenko%26aufirst%3DT.%2BV.%26aulast%3DGonzalez%26aufirst%3DA.%2BL.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26aulast%3DMassion%26aufirst%3DP.%2BP.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520Expression%2520and%2520Activation%2520in%2520Lung%2520Cancer%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2008%26volume%3D39%26spage%3D689%26epage%3D696%26doi%3D10.1165%2Frcmb.2007-0426OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Escudero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbone, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catapano, C. V.</span></span> <span> </span><span class="NLM_article-title">Transcriptional and Non-transcriptional Functions of PPARβ/δ in Non-small Cell Lung Cancer</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e46009</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0046009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pone.0046009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23049921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGhtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=D.+Geniniauthor=R.+Garcia-Escuderoauthor=G.+M.+Carboneauthor=C.+V.+Catapano&title=Transcriptional+and+Non-transcriptional+Functions+of+PPAR%CE%B2%2F%CE%B4+in+Non-small+Cell+Lung+Cancer&doi=10.1371%2Fjournal.pone.0046009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional and non-transcriptional functions of PPARβ/δ in non-small cell lung cancer</span></div><div class="casAuthors">Genini, Davide; Garcia-Escudero, Ramon; Carbone, Giuseppina M.; Catapano, Carlo V.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e46009</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is a nuclear receptor involved in regulation of lipid and glucose metab., wound healing and inflammation.  PPARβ/δ has been assocd. also with cancer.  Here we investigated the expression of PPARβ/δ and components of the prostaglandin biosynthetic pathway in non-small cell lung cancer (NSCLC).  We found increased expression of PPARβ/δ, Cox-2, cPLA2, PGES and VEGF in human NSCLC compared to normal lung.  In NSCLC cell lines PPARβ/δ activation increased proliferation and survival, while PPARβ/δ knock-down reduced viability and increased apoptosis.  PPARβ/δ agonists induced Cox-2 and VEGF transcription, suggesting the existence of feed-forward loops promoting cell survival, inflammation and angiogenesis.  These effects were seen only in high PPARβ/δ expressing cells, while low expressing cells were less or not affected.  The effects were also abolished by PPARβ/δ knock-down or incubation with a PPARβ/δ antagonist.  Induction of VEGF was due to both binding of PPARβ/δ to the VEGF promoter and PI3K activation through a non-genomic mechanism.  We found that PPARβ/δ interacted with the PI3K regulatory subunit p85α leading to PI3K activation and Akt phosphorylation.  Collectively, these data indicate that PPARβ/δ might be a central element in lung carcinogenesis controlling multiple pathways and representing a potential target for NSCLC treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYO_bRePhvx7Vg90H21EOLACvtfcHk0lhj1wgLIH2CYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGhtLfI&md5=5e02eac5c95bb48dfdb6b7f11c1e7bf1</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0046009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0046009%26sid%3Dliteratum%253Aachs%26aulast%3DGenini%26aufirst%3DD.%26aulast%3DGarcia-Escudero%26aufirst%3DR.%26aulast%3DCarbone%26aufirst%3DG.%2BM.%26aulast%3DCatapano%26aufirst%3DC.%2BV.%26atitle%3DTranscriptional%2520and%2520Non-transcriptional%2520Functions%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520in%2520Non-small%2520Cell%2520Lung%2520Cancer%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0046009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montagner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallichet
Blanc, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sng, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottaz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degueurce, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baruchet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antsiferova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Saati, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span> <span> </span><span class="NLM_article-title">Src is Activated by the Nuclear Receptor Peroxisome Proliferator-activated Receptor β/δ in Ultraviolet Radiation Induced Skin Cancer</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1002/emmm.201302666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1002%2Femmm.201302666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=24203162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvFKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=80-98&author=A.+Montagnerauthor=M.+B.+Delgadoauthor=C.+Tallichet%0ABlancauthor=J.+S.+Chanauthor=M.+K.+Sngauthor=H.+Mottazauthor=G.+Degueurceauthor=Y.+Lippiauthor=C.+Moretauthor=M.+Baruchetauthor=M.+Antsiferovaauthor=S.+Wernerauthor=D.+Hohlauthor=T.+Al+Saatiauthor=P.+J.+Farmerauthor=N.+S.+Tanauthor=L.+Michalikauthor=W.+Wahli&title=Src+is+Activated+by+the+Nuclear+Receptor+Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+in+Ultraviolet+Radiation+Induced+Skin+Cancer&doi=10.1002%2Femmm.201302666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer</span></div><div class="casAuthors">Montagner, Alexandra; Delgado, Maria B.; Tallichet-Blanc, Corinne; Chan, Jeremy S. K.; Sng, Ming K.; Mottaz, Helene; Degueurce, Gwendoline; Lippi, Yannick; Moret, Catherine; Baruchet, Michael; Antsiferova, Maria; Werner, Sabine; Hohl, Daniel; Al Saati, Talal; Farmer, Pierre J.; Tan, Nguan S.; Michalik, Liliane; Wahli, Walter</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-98</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Although non-melanoma skin cancer (NMSC) is the most common human cancer and its incidence continues to rise worldwide, the mechanisms underlying its development remain incompletely understood.  Here, we unveil a cascade of events involving peroxisome proliferator-activated receptor (PPAR) β/δ and the oncogene Src, which promotes the development of UV-induced skin cancer in mice.  UV-induced PPARβ/δ activity, which directly stimulated Src expression, increased Src kinase activity and enhanced the EGFR/Erk1/2 signalling pathway, resulting in increased epithelial-to-mesenchymal transition (EMT) marker expression.  Consistent with these observations, PPARβ/δ-null mice developed fewer and smaller skin tumors, and a PPARβ/δ antagonist prevented UV-dependent Src stimulation.  Furthermore, the expression of PPARβ/δ pos. correlated with the expression of SRC and EMT markers in human skin squamous cell carcinoma (SCC), and critically, linear models applied to several human epithelial cancers revealed an interaction between PPARβ/δ and SRC and TGFβ1 transcriptional levels.  Taken together, these observations motivate the future evaluation of PPARβ/δ modulators to attenuate the development of several epithelial cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKDhlgcaReIrVg90H21EOLACvtfcHk0lhj1wgLIH2CYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvFKhuw%253D%253D&md5=daebc7b735f53c0dad38e00b09139d9f</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Femmm.201302666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201302666%26sid%3Dliteratum%253Aachs%26aulast%3DMontagner%26aufirst%3DA.%26aulast%3DDelgado%26aufirst%3DM.%2BB.%26aulast%3DTallichet%2BBlanc%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DJ.%2BS.%26aulast%3DSng%26aufirst%3DM.%2BK.%26aulast%3DMottaz%26aufirst%3DH.%26aulast%3DDegueurce%26aufirst%3DG.%26aulast%3DLippi%26aufirst%3DY.%26aulast%3DMoret%26aufirst%3DC.%26aulast%3DBaruchet%26aufirst%3DM.%26aulast%3DAntsiferova%26aufirst%3DM.%26aulast%3DWerner%26aufirst%3DS.%26aulast%3DHohl%26aufirst%3DD.%26aulast%3DAl%2BSaati%26aufirst%3DT.%26aulast%3DFarmer%26aufirst%3DP.%2BJ.%26aulast%3DTan%26aufirst%3DN.%2BS.%26aulast%3DMichalik%26aufirst%3DL.%26aulast%3DWahli%26aufirst%3DW.%26atitle%3DSrc%2520is%2520Activated%2520by%2520the%2520Nuclear%2520Receptor%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520in%2520Ultraviolet%2520Radiation%2520Induced%2520Skin%2520Cancer%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D80%26epage%3D98%26doi%3D10.1002%2Femmm.201302666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katkuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, R. N.</span></span> <span> </span><span class="NLM_article-title">Activation of Nuclear Hormone Receptor Peroxisome Proliferator-activated Receptor-δ Accelerates Intestinal Adenoma Growth</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1038/nm993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fnm993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=14758356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Wnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=245-247&author=R.+A.+Guptaauthor=D.+Wangauthor=S.+Katkuriauthor=H.+Wangauthor=S.+K.+Deyauthor=R.+N.+DuBois&title=Activation+of+Nuclear+Hormone+Receptor+Peroxisome+Proliferator-activated+Receptor-%CE%B4+Accelerates+Intestinal+Adenoma+Growth&doi=10.1038%2Fnm993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-δ accelerates intestinal adenoma growth</span></div><div class="casAuthors">Gupta, Rajnish A.; Wang, Dingzhi; Katkuri, Sharada; Wang, Haibin; Dey, Sudhansu K.; DuBois, Raymond N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-247</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors treated Apcmin mice, which are predisposed to intestinal polyposis, with a selective synthetic agonist of peroxisome proliferator-activated receptor-δ (PPAR-δ).  Exposure of Apcmin mice to the PPAR-δ ligand GW501516 resulted in a significant increase in the no. and size of intestinal polyps.  The most prominent effect was on polyp size; mice treated with the PPAR-δ activator had a fivefold increase in the no. of polyps larger than 2 mm.  The authors' results implicate PPAR-δ in the regulation of intestinal adenoma growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9HsQ1uQcNULVg90H21EOLACvtfcHk0li40DnN-b4wSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Wnur0%253D&md5=6864a34542e02b3680fdf86492a2d678</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fnm993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm993%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DKatkuri%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDey%26aufirst%3DS.%2BK.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26atitle%3DActivation%2520of%2520Nuclear%2520Hormone%2520Receptor%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B4%2520Accelerates%2520Intestinal%2520Adenoma%2520Growth%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D245%26epage%3D247%26doi%3D10.1038%2Fnm993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marin, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peraza, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Ligand Activation of Peroxisome Proliferator-activated Receptor β Inhibits Colon Carcinogenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">4394</span>– <span class="NLM_lpage">4401</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-4277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1158%2F0008-5472.CAN-05-4277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16618765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFSlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4394-4401&author=H.+E.+Marinauthor=M.+A.+Perazaauthor=A.+N.+Billinauthor=T.+M.+Willsonauthor=J.+M.+Wardauthor=M.+J.+Kennettauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Ligand+Activation+of+Peroxisome+Proliferator-activated+Receptor+%CE%B2+Inhibits+Colon+Carcinogenesis&doi=10.1158%2F0008-5472.CAN-05-4277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Activation of Peroxisome Proliferator-Activated Receptor β Inhibits Colon Carcinogenesis</span></div><div class="casAuthors">Marin, Holly E.; Peraza, Marjorie A.; Billin, Andrew N.; Willson, Timothy M.; Ward, Jerrold M.; Kennett, Mary J.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4394-4401</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">There is considerable debate whether peroxisome proliferator-activated receptor β/δ (PPARβ/δ) ligands potentiate or suppress colon carcinogenesis.  Whereas administration of a PPARβ ligand causes increased small intestinal tumorigenesis in Apcmin/+ mice, PPARβ-null (Pparb-/-) mice exhibit increased colon polyp multiplicity in colon cancer bioassays, suggesting that ligand activation of this receptor will inhibit colon carcinogenesis.  This hypothesis was examd. by treating wild-type (Pparb+/+) and Pparb-/- with azoxymethane, coupled with a highly specific PPARβ ligand, GW0742.  Ligand activation of PPARβ in Pparb+/+ mice caused an increase in the expression of mRNA encoding adipocyte differentiation-related protein, fatty acid-binding protein, and cathepsin E.  These findings are indicative of colonocyte differentiation, which was confirmed by immunohistochem. anal.  No PPARβ-dependent differences in replicative DNA synthesis or expression of phosphatase and tensin homolog, phosphoinositide-dependent kinase, integrin-linked kinase, or phospho-Akt were detected in ligand-treated mouse colonic epithelial cells although increased apoptosis was found in GW0742-treated Pparb+/+ mice.  Consistent with increased colonocyte differentiation and apoptosis, inhibition of colon polyp multiplicity was also found in ligand-treated Pparb+/+ mice, and all of these effects were not found in Pparb-/- mice.  In contrast to previous reports suggesting that activation of PPARβ potentiates intestinal tumorigenesis, here we show that ligand activation of PPARβ attenuates chem. induced colon carcinogenesis and that PPARβ-dependent induction of cathepsin E could explain the reported disparity in the literature about the effect of ligand activation of PPARβ in the intestine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3kmul5SHAMbVg90H21EOLACvtfcHk0li40DnN-b4wSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFSlur8%253D&md5=6d5f90159a456ad15d2f35b043a7beb8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-4277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-4277%26sid%3Dliteratum%253Aachs%26aulast%3DMarin%26aufirst%3DH.%2BE.%26aulast%3DPeraza%26aufirst%3DM.%2BA.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWard%26aufirst%3DJ.%2BM.%26aulast%3DKennett%26aufirst%3DM.%2BJ.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DLigand%2520Activation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%2520Inhibits%2520Colon%2520Carcinogenesis%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4394%26epage%3D4401%26doi%3D10.1158%2F0008-5472.CAN-05-4277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Girroir, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor-β/δ (PPARβ/δ) Ligands Inhibit Growth of UACC903 and MCF7 Human Cancer Cell Lines</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>243</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1016/j.tox.2007.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.tox.2007.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18054822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCgtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=2008&pages=236-243&author=E.+E.+Girroirauthor=H.+E.+Hollingsheadauthor=A.+N.+Billinauthor=T.+M.+Willsonauthor=G.+P.+Robertsonauthor=A.+K.+Sharmaauthor=S.+Aminauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+%28PPAR%CE%B2%2F%CE%B4%29+Ligands+Inhibit+Growth+of+UACC903+and+MCF7+Human+Cancer+Cell+Lines&doi=10.1016%2Fj.tox.2007.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines</span></div><div class="casAuthors">Girroir, Elizabeth E.; Hollingshead, Holly E.; Billin, Andrew N.; Willson, Timothy M.; Robertson, Gavin P.; Sharma, Arun K.; Amin, Shantu; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">236-243</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands for the treatment of diseases including metabolic syndrome, diabetes and obesity has been hampered due to contradictory findings on their potential safety.  For example, while some reports show that ligand activation of PPARβ/δ promotes the induction of terminal differentiation and inhibition of cell growth, other reports suggest that PPARβ/δ ligands potentiate tumorigenesis by increasing cell proliferation.  Some of the contradictory findings could be due in part to differences in the ligand examd., the presence or absence of serum in cell cultures, differences in cell lines or differences in the method used to quantify cell growth.  For these reasons, this study examd. the effect of ligand activation of PPARβ/δ on cell growth of two human cancer cell lines, MCF7 (breast cancer) and UACC903 (melanoma) in the presence or absence of serum using two highly specific PPARβ/δ ligands, GW0742 or GW501516.  Culturing cells in the presence of either GW0742 or GW501516 caused upregulation of the known PPARβ/δ target gene angiopoietin-like protein 4 (ANGPTL4).  Inhibition of cell growth was obsd. in both cell lines cultured in the presence of either GW0742 or GW501516, and the presence or absence of serum had little influence on this inhibition.  Results from the present studies demonstrate that ligand activation of PPARβ/δ inhibits the growth of both MCF7 and UACC903 cell lines and provide further evidence that PPARβ/δ ligands are not mitogenic in human cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhAIn0DDsKNrVg90H21EOLACvtfcHk0ljaIEKA_XBfag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCgtrnL&md5=98bc5bef67aa676258b8232a3b6fcb43</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.tox.2007.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tox.2007.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DGirroir%26aufirst%3DE.%2BE.%26aulast%3DHollingshead%26aufirst%3DH.%2BE.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DRobertson%26aufirst%3DG.%2BP.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520%2528PPAR%25CE%25B2%252F%25CE%25B4%2529%2520Ligands%2520Inhibit%2520Growth%2520of%2520UACC903%2520and%2520MCF7%2520Human%2520Cancer%2520Cell%2520Lines%26jtitle%3DToxicology%26date%3D2008%26volume%3D243%26spage%3D236%26epage%3D243%26doi%3D10.1016%2Fj.tox.2007.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span> <span> </span><span class="NLM_article-title">PPARδ Agonist Enhances Colitis-associated Colorectal Cancer</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>842</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2018.10.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.ejphar.2018.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30391747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyqsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=842&publication_year=2019&pages=248-254&author=D.+Zhouauthor=J.+Jinauthor=Q.+Liuauthor=J.+Shiauthor=Y.+Hou&title=PPAR%CE%B4+Agonist+Enhances+Colitis-associated+Colorectal+Cancer&doi=10.1016%2Fj.ejphar.2018.10.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ agonist enhances colitis-associated colorectal cancer</span></div><div class="casAuthors">Zhou, Danya; Jin, Jianhua; Liu, Qian; Shi, Juanjuan; Hou, Yongzhong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">842</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">248-254</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As a nuclear receptor, peroxisome proliferator-activated receptor-δ (PPARδ) plays a crit. role in regulating inflammation and cancer, while it is still unclear the mechanism of PPARδ agonist GW501516 on colitis-assocd. colorectal cancer.  Here we found that GW501516 significantly enhanced colitis-assocd. colorectal cancer in AOM/DSS-induced mice.  In addn., PPARδ agonist GW501516 enhanced pro-inflammatory gene expressions (COX-2, IL-6, IL-8 and MCP-1) in inflamed colon.  Further anal. showed that GW501516 increased the expressions of Glut1 and SLC1A5 in colon cancer cells as well as AOM/DSS-induced colorectal tumors.  These findings revealed a new mechanism of PPARδ agonist GW501516-mediated colitis-assocd. colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAAd6HgYlvO7Vg90H21EOLACvtfcHk0ljaIEKA_XBfag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyqsbvJ&md5=126a502e69d849530f46787b49fcf1cc</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2018.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2018.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DY.%26atitle%3DPPAR%25CE%25B4%2520Agonist%2520Enhances%2520Colitis-associated%2520Colorectal%2520Cancer%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D842%26spage%3D248%26epage%3D254%26doi%3D10.1016%2Fj.ejphar.2018.10.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span> <span> </span><span class="NLM_article-title">Metformin Inhibits PPARδ Agonist-mediated Tumor Growth by Reducing Glut1 and SLC1A5 Expressions of Cancer Cells</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>857</i></span>,  <span class="NLM_fpage">172425</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2019.172425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.ejphar.2019.172425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31150647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2iu7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=857&publication_year=2019&pages=172425&author=J.+Dingauthor=Q.+Gouauthor=J.+Jinauthor=J.+Shiauthor=Q.+Liuauthor=Y.+Hou&title=Metformin+Inhibits+PPAR%CE%B4+Agonist-mediated+Tumor+Growth+by+Reducing+Glut1+and+SLC1A5+Expressions+of+Cancer+Cells&doi=10.1016%2Fj.ejphar.2019.172425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells</span></div><div class="casAuthors">Ding, Jiajun; Gou, Qian; Jin, Jianhua; Shi, Juanjuan; Liu, Qian; Hou, Yongzhong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">857</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">172425</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As a nuclear receptor, ligand binding and activated PPARδ (peroxisome-proliferator-activated receptor δ) plays an important role in regulation of inflammation, metab. and cancer, while it is unclear the effect of metformin on PPARδ-mediated cancer cell metab.  Here we found that PPARδ agonist GW501516 significantly increased Glut1 (Glucose transporter 1) and SLC1A5 (solutecarrier family 1 member 5) gene and protein expressions in HCT-116, SW480, HeLa, and MCF-7 cancer cell lines, while metformin inhibited this event, which was assocd. with metformin-mediated inhibition of PPARδ activity in response to GW501516.  Importantly, GW501516 inhibited the binding of PPARδ to AMPK, while metformin reversed this process.  Metformin inhibited Glut1 and SLC1A5 expressions leading to reduced influx of glucose and glutamine in cancer cells, which is assocd. with reduced tumor growth.  These findings suggest that metformin inhibited PPARδ agonist GW501516-induced cancer cell metab. and tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0jao2pRmabVg90H21EOLACvtfcHk0lhGt3ASOSjRKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2iu7vN&md5=d05b096d427480e3058794ed8aa3c161</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2019.172425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2019.172425%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGou%26aufirst%3DQ.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DY.%26atitle%3DMetformin%2520Inhibits%2520PPAR%25CE%25B4%2520Agonist-mediated%2520Tumor%2520Growth%2520by%2520Reducing%2520Glut1%2520and%2520SLC1A5%2520Expressions%2520of%2520Cancer%2520Cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D857%26spage%3D172425%26doi%3D10.1016%2Fj.ejphar.2019.172425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmi, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, R. C.</span></span> <span> </span><span class="NLM_article-title">PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma</span>. <i>Nucl. Receptor Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">101306</span>, <span class="refDoi"> DOI: 10.11131/2018/101306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.11131%2F2018%2F101306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=29450204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWnurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=101306&author=A.+Bannoauthor=A.+T.+Reddyauthor=S.+P.+Lakshmiauthor=R.+C.+Reddy&title=PPARs%3A+Key+Regulators+of+Airway+Inflammation+and+Potential+Therapeutic+Targets+in+Asthma&doi=10.11131%2F2018%2F101306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">PPARs: key regulators of airway inflammation and potential therapeutic targets in asthma</span></div><div class="casAuthors">Banno, Asoka; Reddy, Aravind T.; Lakshmi, Sowmya P.; Reddy, Raju C.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Receptor Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101306</span>CODEN:
                <span class="NLM_cas:coden">NRRUAZ</span>;
        ISSN:<span class="NLM_cas:issn">2314-5714</span>.
    
            (<span class="NLM_cas:orgname">AgiAl Publishing House</span>)
        </div><div class="casAbstract">Asthma affects approx. 300 million people worldwide, significantly impacting quality of life and healthcare costs.  While current therapies are effective in controlling many patients' symptoms, a large no. continue to experience exacerbations or treatment-related adverse effects.  Alternative therapies are thus urgently needed.  Accumulating evidence has shown that the peroxisome proliferator-activated receptor (PPAR) family of nuclear hormone receptors, comprising PPARα, PPARβ/δ, and PPARγ, is involved in asthma pathogenesis and that ligand-induced activation of these receptors suppresses asthma pathol.  PPAR agonists exert their anti-inflammatory effects primarily by suppressing pro-inflammatory mediators and antagonizing the pro-inflammatory functions of various cell types relevant to asthma pathophysiol.  Exptl. findings strongly support the potential clin. benefits of PPAR agonists in the treatment of asthma.  We review current literature, highlighting PPARs' key role in asthma pathogenesis and their agonists' therapeutic potential.  With addnl. research and rigorous clin. studies, PPARs may become attractive therapeutic targets in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJAqMw2GP0LVg90H21EOLACvtfcHk0lhGt3ASOSjRKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWnurrF&md5=0b6ea7f25f43a7710251de8febf61ad7</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.11131%2F2018%2F101306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.11131%252F2018%252F101306%26sid%3Dliteratum%253Aachs%26aulast%3DBanno%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DA.%2BT.%26aulast%3DLakshmi%26aufirst%3DS.%2BP.%26aulast%3DReddy%26aufirst%3DR.%2BC.%26atitle%3DPPARs%253A%2520Key%2520Regulators%2520of%2520Airway%2520Inflammation%2520and%2520Potential%2520Therapeutic%2520Targets%2520in%2520Asthma%26jtitle%3DNucl.%2520Receptor%2520Res.%26date%3D2018%26volume%3D5%26spage%3D101306%26doi%3D10.11131%2F2018%2F101306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galuppo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterniti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span> <span> </span><span class="NLM_article-title">GW0742, A High Affinity PPAR-β/δ Agonist Reduces Lung Inflammation Induced by Bleomycin Instillation in Mice</span>. <i>Int. J. Immunopathol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1046</span>, <span class="refDoi"> DOI: 10.1177/039463201002300408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1177%2F039463201002300408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21244753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivFWmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=1033-1046&author=M.+Galuppoauthor=R.+Di+Paolaauthor=E.+Mazzonauthor=E.+Espositoauthor=I.+Paternitiauthor=A.+Kapoorauthor=C.+Thiemermannauthor=S.+Cuzzocrea&title=GW0742%2C+A+High+Affinity+PPAR-%CE%B2%2F%CE%B4+Agonist+Reduces+Lung+Inflammation+Induced+by+Bleomycin+Instillation+in+Mice&doi=10.1177%2F039463201002300408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">GW 0742, a high affinity PPAR-β/δ agonist reduces lung inflammation induced by bleomycin instillation in mice</span></div><div class="casAuthors">Galuppo, M.; Di Paola, R.; Mazzon, E.; Esposito, E.; Paterniti, I.; Kapoor, A.; Thiemermann, C.; Cuzzocrea, S.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopathology and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1033-1046</span>CODEN:
                <span class="NLM_cas:coden">IJIPE4</span>;
        ISSN:<span class="NLM_cas:issn">0394-6320</span>.
    
            (<span class="NLM_cas:orgname">Biolife s.a.s.</span>)
        </div><div class="casAbstract">Peroxisome Proliferator-Activated Receptor β/δ belongs to a family of ligand-activated transcription factors.  Recent data have clarified its metabolic roles and enhanced the potential role of this receptor as a pharmacol. target.  Moreover, although its role in acute inflammation remains unclear, being the nuclear receptor PPAR β/δ widely expressed in many tissues, including the vascular endothelium, we assume that the infiltration of PMNs into tissues, a prominent feature in inflammation, may also be related to PPAR β/δ.  Mice subjected to intratracheal instillation of bleomycin (BLEO, 1 mg/kg), a glycopeptide produced by the bacterium Streptomyces verticillus, develop lung inflammation and injury characterized by a significant neutrophil infiltration and tissue edema.  Therefore, the aim of this study was to investigate the effects of GW0742, a synthetic high affinity PPAR β/δ agonist, and its possible role in preventing the advance of inflammatory and apoptotic processes induced by bleomycin, that long-term leads to the appearance of pulmonary fibrosis.  Our data showed that GW0742-treatment (0.3 mg/Kg, 10% DMSO, i.p.) has therapeutic effects on pulmonary damage, decreasing many inflammatory and apoptotic parameters detected by measurement of: (1) cytokine prodn.; (2) leukocyte accumulation, indirectly measured as decrease of myeloperoxidase (MPO) activity; (3) IκBα degrdn. and NF-κB nuclear translocation; (4) ERK phosphorylation; (5) stress oxidative by NO formation due to iNOS expression; (6) nitrotyrosine and PAR localization; (7) the degree of apoptosis, evaluated by Bax and Bcl-2 balance, FAS ligand expression and TUNEL staining.  Taken together, our results clearly show that GW0742 reduces the lung injury and inflammation due to the intratracheal BLEO-instillation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu-3Auf7LufrVg90H21EOLACvtfcHk0lhwgvXGcyHPaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivFWmtr0%253D&md5=ff1928c215061f6823f1c56d785db212</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1177%2F039463201002300408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F039463201002300408%26sid%3Dliteratum%253Aachs%26aulast%3DGaluppo%26aufirst%3DM.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DPaterniti%26aufirst%3DI.%26aulast%3DKapoor%26aufirst%3DA.%26aulast%3DThiemermann%26aufirst%3DC.%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3DGW0742%252C%2520A%2520High%2520Affinity%2520PPAR-%25CE%25B2%252F%25CE%25B4%2520Agonist%2520Reduces%2520Lung%2520Inflammation%2520Induced%2520by%2520Bleomycin%2520Instillation%2520in%2520Mice%26jtitle%3DInt.%2520J.%2520Immunopathol.%2520Pharmacol.%26date%3D2010%26volume%3D23%26spage%3D1033%26epage%3D1046%26doi%3D10.1177%2F039463201002300408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haskova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, K.</span></span> <span> </span><span class="NLM_article-title">Modulation of LPS-induced Pulmonary Neutrophil Infiltration and Cytokine Production by the Selective PPARβ/δ Ligand GW0742</span>. <i>Inflammation Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1007/s00011-007-7157-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1007%2Fs00011-007-7157-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18622687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSrsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=314-321&author=Z.+Haskovaauthor=B.+Hoangauthor=G.+Luoauthor=L.+Morganauthor=A.+Billinauthor=F.+Baroneauthor=B.+Shearerauthor=M.+Bartonauthor=K.+Kilgore&title=Modulation+of+LPS-induced+Pulmonary+Neutrophil+Infiltration+and+Cytokine+Production+by+the+Selective+PPAR%CE%B2%2F%CE%B4+Ligand+GW0742&doi=10.1007%2Fs00011-007-7157-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARβ/δ ligand GW0742</span></div><div class="casAuthors">Haskova, Z.; Hoang, B.; Luo, G.; Morgan, L. A.; Billin, A. N.; Barone, F. C.; Shearer, B. G.; Barton, M. E.; Kilgore, K. S.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">314-321</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">The objective was to define the antiinflammatory effects of PPARβ/δ activation by use of the selective PPARβ/δ ligand (GW0742) in a model of lipopolysaccharide (LPS)-induced pulmonary inflammation.  Male BALB/c mice were pretreated for three days with the PPARβ/δ agonist, GW0742, prior to induction of LPS-mediated pulmonary inflammation.  Bronchial alveolar lavage fluid (BALF) was analyzed for inflammatory cell influx and for levels of pro-inflammatory mediators.  BALF-derived inflammatory cells were also collected for mRNA anal.  Pretreatment with GW0742 resulted in a significant decrease in leukocyte recruitment into the pulmonary space.  Protein and mRNA levels of the pro-inflammatory cytokines IL-6, IL-1β and TNFα in BALF were found to be significantly decreased in GW0742-treated animals (30 mg/kg).  A significant decrease in granulocyte macrophage-colony stimulating factor (GM-CSF), a major regulator of neutrophil chemotaxis (via its downstream actions on TNFα and other cytokines/chemokines), activation and survival, was also noted in the BALF levels of GW0742-treated animals.  The present study demonstrates that activation of PPARβ/δ attenuates the degree of inflammation in a model of LPS-induced pulmonary inflammation and may therefore represent a novel therapeutic approach for the treatment of inflammation-mediated pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0s9m0a5fBDLVg90H21EOLACvtfcHk0lhwgvXGcyHPaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSrsL%252FO&md5=bd8d4381a20ab0712a214831a4089fc6</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1007%2Fs00011-007-7157-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-007-7157-4%26sid%3Dliteratum%253Aachs%26aulast%3DHaskova%26aufirst%3DZ.%26aulast%3DHoang%26aufirst%3DB.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DMorgan%26aufirst%3DL.%26aulast%3DBillin%26aufirst%3DA.%26aulast%3DBarone%26aufirst%3DF.%26aulast%3DShearer%26aufirst%3DB.%26aulast%3DBarton%26aufirst%3DM.%26aulast%3DKilgore%26aufirst%3DK.%26atitle%3DModulation%2520of%2520LPS-induced%2520Pulmonary%2520Neutrophil%2520Infiltration%2520and%2520Cytokine%2520Production%2520by%2520the%2520Selective%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Ligand%2520GW0742%26jtitle%3DInflammation%2520Res.%26date%3D2008%26volume%3D57%26spage%3D314%26epage%3D321%26doi%3D10.1007%2Fs00011-007-7157-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ali, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FitzGerald, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desvergne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop-Bailey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. A.</span></span> <span> </span><span class="NLM_article-title">Role of Prostacyclin versus Peroxisome Proliferator-activated Receptor β Receptors in Prostacyclin Sensing by Lung Fibroblasts</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2005-0289OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1165%2Frcmb.2005-0289OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16239641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVGrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=242-246&author=F.+Y.+Aliauthor=K.+Eganauthor=G.+A.+FitzGeraldauthor=B.+Desvergneauthor=W.+Wahliauthor=D.+Bishop-Baileyauthor=T.+D.+Warnerauthor=J.+A.+Mitchell&title=Role+of+Prostacyclin+versus+Peroxisome+Proliferator-activated+Receptor+%CE%B2+Receptors+in+Prostacyclin+Sensing+by+Lung+Fibroblasts&doi=10.1165%2Frcmb.2005-0289OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Role of prostacyclin versus peroxisome proliferator-activated receptor β receptors in prostacyclin sensing by lung fibroblasts</span></div><div class="casAuthors">Ali, Ferhana Y.; Egan, Karine; FitzGerald, Garret A.; Desvergne, Beatrice; Wahli, Walter; Bishop-Bailey, David; Warner, Timothy D.; Mitchell, Jane A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-246</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Prostacyclin and its mimetics are used therapeutically for the treatment of pulmonary hypertension.  These drugs act via cell surface prostacyclin receptors (IP receptors); however, some of them can also activate the nuclear receptor peroxisome proliferator-activated receptor β (PPARβ).  We examd. the possibility that PPARβ is a therapeutic target for the treatment of pulmonary hypertension.  Using the newly approved (for pulmonary hypertension) prostacyclin mimetic treprostinil sodium, reporter gene assays for PPARβ activation and measurement of lung fibroblast proliferation were analyzed.  Treprostinil sodium was found to activate PPARβ in reporter gene assays and to inhibit proliferation of human lung fibroblasts at concns. consistent with an effect on PPARs but not on IP receptors.  The effects of treprostinil sodium on human lung cell proliferation are mimicked by those of the highly selective PPARβ ligand GW 0742.  There are no receptor antagonists for PPARβ or for IP receptors, but by using lung fibroblasts cultured from mice lacking PPARβ (PPARβ-/-) or IP (IP-/-), we demonstrate that the antiproliferative effects of treprostinil sodium are mediated by PPARβ and not IP in lung fibroblasts.  These observations suggest that some of the local, longer-term benefits of treprostinil sodium on reducing the remodeling assocd. with pulmonary hypertension may be mediated by PPARβ.  This study is the first to identify PPARβ as a potential therapeutic target for the treatment of pulmonary hypertension, which is important because orally active PPARβ ligands have been developed for the treatment of dyslipidemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpILe62RqewJLVg90H21EOLACvtfcHk0lgd6kpZ4CP9TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVGrtrc%253D&md5=8283d611a1e4c185939969a544a6d04a</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2005-0289OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2005-0289OC%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DF.%2BY.%26aulast%3DEgan%26aufirst%3DK.%26aulast%3DFitzGerald%26aufirst%3DG.%2BA.%26aulast%3DDesvergne%26aufirst%3DB.%26aulast%3DWahli%26aufirst%3DW.%26aulast%3DBishop-Bailey%26aufirst%3DD.%26aulast%3DWarner%26aufirst%3DT.%2BD.%26aulast%3DMitchell%26aufirst%3DJ.%2BA.%26atitle%3DRole%2520of%2520Prostacyclin%2520versus%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%2520Receptors%2520in%2520Prostacyclin%2520Sensing%2520by%2520Lung%2520Fibroblasts%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2006%26volume%3D34%26spage%3D242%26epage%3D246%26doi%3D10.1165%2Frcmb.2005-0289OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heck, B. E.</span>; <span class="NLM_string-name">Kim, D. H.</span>; <span class="NLM_string-name">Erhardt, P.</span>; <span class="NLM_string-name">Kress, B.</span></span>, <span> </span><span class="NLM_article-title">Analogs of Peroxisome Proliferator-activated Receptor (PPAR) Agonists, and Methods of Using the Same</span>. US <span class="NLM_patent">9695137B2</span>, Jul 4, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=B.+E.+Heck&author=D.+H.+Kim&author=P.+Erhardt&author=B.+Kress&title=Analogs+of+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29+Agonists%2C+and+Methods+of+Using+the+Same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHeck%26aufirst%3DB.%2BE.%26atitle%3DAnalogs%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%2520Agonists%252C%2520and%2520Methods%2520of%2520Using%2520the%2520Same%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span>; <span class="NLM_string-name">Evans, R. M.</span>; <span class="NLM_string-name">Kluge, A.</span>; <span class="NLM_string-name">Lagu, B.</span>; <span class="NLM_string-name">Miura, M.</span>; <span class="NLM_string-name">Panigrahi, S. K.</span>; <span class="NLM_string-name">Patane, M.</span>; <span class="NLM_string-name">Samajdar, S.</span>; <span class="NLM_string-name">Senaiar, R.</span>; <span class="NLM_string-name">Takahashi, T.</span></span> <span> </span><span class="NLM_article-title">PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof</span>. US <span class="NLM_patent">10479775B1</span>, Nov 19, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=M.+Downes&author=R.+M.+Evans&author=A.+Kluge&author=B.+Lagu&author=M.+Miura&author=S.+K.+Panigrahi&author=M.+Patane&author=S.+Samajdar&author=R.+Senaiar&author=T.+Takahashi&title=PPAR+Agonists%2C+Compounds%2C+Pharmaceutical+Compositions%2C+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDownes%26aufirst%3DM.%26atitle%3DPPAR%2520Agonists%252C%2520Compounds%252C%2520Pharmaceutical%2520Compositions%252C%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluge, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenburg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddeeris, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basinski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senaiar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaleel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patane, M. A.</span></span> <span> </span><span class="NLM_article-title">Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00287</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00287" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWrsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=935-940&author=B.+Laguauthor=A.+F.+Klugeauthor=E.+Tozzoauthor=R.+Fredenburgauthor=E.+L.+Bellauthor=M.+M.+Goddeerisauthor=P.+Dwyerauthor=A.+Basinskiauthor=R.+S.+Senaiarauthor=M.+Jaleelauthor=N.+K.+Tiwariauthor=S.+K.+Panigrahiauthor=N.+R.+Krishnamurthyauthor=T.+Takahashiauthor=M.+A.+Patane&title=Selective+PPAR%CE%B4+Modulators+Improve+Mitochondrial+Function%3A+Potential+Treatment+for+Duchenne+Muscular+Dystrophy+%28DMD%29&doi=10.1021%2Facsmedchemlett.8b00287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)</span></div><div class="casAuthors">Lagu, Bharat; Kluge, Arthur F.; Tozzo, Effie; Fredenburg, Ross; Bell, Eric L.; Goddeeris, Matthew M.; Dwyer, Peter; Basinski, Andrew; Senaiar, Ramesh S.; Jaleel, Mahaboobi; Tiwari, Nirbhay Kumar; Panigrahi, Sunil K.; Krishnamurthy, Narasimha Rao; Takahashi, Taisuke; Patane, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">935-940</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arylheterocyclylmethylphenoxyalkanoic and -alkenoic acids such as I were prepd. as selective activators of PPARδ for potential use in improving mitochondrial function and for treatment of Duchenne muscular dystrophy (DMD); the heterocyclyl moiety was designed to mimic the cis-amide conformation found in the crystal structure of a previously prepd. PPARδ activator to the ligand binding domain of PPARδ.  The activation of PPARδ, selectivities for PPARδ over PPARα and PPARγ, and pharmacokinetics (half-lives, clearance, and AUC) in mice were detd. for the compds.  I (MA-0204) was a potent, selective PPARδ modulator with good pharmacokinetic properties.  I was tested in vivo in mice and in myoblasts isolated from a DMD patient; I altered the expression of PPARδ target genes and improved fatty acid oxidn., indicating that I may be useful for treating DMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO9q2q5vM90LVg90H21EOLACvtfcHk0lgd6kpZ4CP9TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWrsLbN&md5=2c9dccc70c48966cbd30df8f27c06304</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00287%26sid%3Dliteratum%253Aachs%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DKluge%26aufirst%3DA.%2BF.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DFredenburg%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DE.%2BL.%26aulast%3DGoddeeris%26aufirst%3DM.%2BM.%26aulast%3DDwyer%26aufirst%3DP.%26aulast%3DBasinski%26aufirst%3DA.%26aulast%3DSenaiar%26aufirst%3DR.%2BS.%26aulast%3DJaleel%26aufirst%3DM.%26aulast%3DTiwari%26aufirst%3DN.%2BK.%26aulast%3DPanigrahi%26aufirst%3DS.%2BK.%26aulast%3DKrishnamurthy%26aufirst%3DN.%2BR.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26atitle%3DSelective%2520PPAR%25CE%25B4%2520Modulators%2520Improve%2520Mitochondrial%2520Function%253A%2520Potential%2520Treatment%2520for%2520Duchenne%2520Muscular%2520Dystrophy%2520%2528DMD%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D935%26epage%3D940%26doi%3D10.1021%2Facsmedchemlett.8b00287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span> <i>MA-0204 Modulation
of PPARd Protects and Promotes Recovery after
AKI in Normal Rats and Aged Diabetic CKD Zsf1 Rats by Enhancing Fatty
Acid Oxidation in Proximal Tubular Epithelial Cells</i>; <span class="NLM_publisher-name">Mitobridge</span>, <span class="NLM_year">2020</span>; <a href="https://www.mitobridge.com/images/resources/ASNposter1.pdf" class="extLink">https://www.mitobridge.com/images/resources/ASNposter1.pdf</a> (accessed
2020-02-06).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MA-0204+Modulation%0Aof+PPARd+Protects+and+Promotes+Recovery+after%0AAKI+in+Normal+Rats+and+Aged+Diabetic+CKD+Zsf1+Rats+by+Enhancing+Fatty%0AAcid+Oxidation+in+Proximal+Tubular+Epithelial+Cells%3B+Mitobridge%2C+2020%3B+https%3A%2F%2Fwww.mitobridge.com%2Fimages%2Fresources%2FASNposter1.pdf+%28accessed%0A2020-02-06%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DMA-0204%2520Modulation%250Aof%2520PPARd%2520Protects%2520and%2520Promotes%2520Recovery%2520after%250AAKI%2520in%2520Normal%2520Rats%2520and%2520Aged%2520Diabetic%2520CKD%2520Zsf1%2520Rats%2520by%2520Enhancing%2520Fatty%250AAcid%2520Oxidation%2520in%2520Proximal%2520Tubular%2520Epithelial%2520Cells%26pub%3DMitobridge%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boitier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautier, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R.</span></span> <span> </span><span class="NLM_article-title">Advances in Understanding the Regulation of Apoptosis and Mitosis by Peroxisome Proliferator-activated Receptors in Pre-clinical Models: Relevance for Human Health and Disease</span>. <i>Comp. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1186/1476-5926-2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1186%2F1476-5926-2-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=12622871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC2sbntFamug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=3&author=E.+Boitierauthor=J.-C.+Gautierauthor=R.+Roberts&title=Advances+in+Understanding+the+Regulation+of+Apoptosis+and+Mitosis+by+Peroxisome+Proliferator-activated+Receptors+in+Pre-clinical+Models%3A+Relevance+for+Human+Health+and+Disease&doi=10.1186%2F1476-5926-2-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease</span></div><div class="casAuthors">Boitier Eric; Gautier Jean-Charles; Roberts Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Comparative hepatology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn">1476-5926</span>.
    </div><div class="casAbstract">Peroxisome proliferator activated receptors (PPARs) are a family of related receptors implicated in a diverse array of biological processes.  There are 3 main isotypes of PPARs known as PPARalpha, PPARbeta and PPARgamma and each is organized into domains associated with a function such as ligand binding, activation and DNA binding.  PPARs are activated by ligands, which can be both endogenous such as fatty acids or their derivatives, or synthetic, such as peroxisome proliferators, hypolipidaemic drugs, anti-inflammatory or insulin-sensitizing drugs.  Once activated, PPARs bind to DNA and regulate gene transcription.  The different isotypes differ in their expression patterns, lending clues on their function.  PPARalpha is expressed mainly in liver whereas PPARgamma is expressed in fat and in some macrophages.  Activation of PPARalpha in rodent liver is associated with peroxisome proliferation and with suppression of apoptosis and induction of cell proliferation.  The mechanism by which activation of PPARalpha regulates apoptosis and proliferation is unclear but is likely to involve target gene transcription.  Similarly, PPARgamma is involved in the induction of cell growth arrest occurring during the differentiation process of fibroblasts to adipocytes.  However, it has been implicated in the regulation of cell cycle and cell proliferation in colon cancer models.  Less in known concerning PPARbeta but it was identified as a downstream target gene for APC/beta-catenin/T cell factor-4 tumor suppressor pathway, which is involved in the regulation of growth promoting genes such as c-myc and cyclin D1.  Marked species and tissue differences in the expression of PPARs complicate the extrapolation of pre-clinical data to humans.  For example, PPARalpha ligands such as the hypolipidaemic fibrates have been used extensively in the clinic over the past 20 years to treat cardiovascular disease and side effects of clinical fibrate use are rare, despite the observation that these compounds are rodent carcinogens.  Similarly, adverse clinical responses have been seen with PPARgamma ligands that were not predicted by pre-clinical models.  Here, we consider the response to PPAR ligands seen in pre-clinical models of efficacy and safety in the context of human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4NRYnlY2Xr62q3xNe7a7QfW6udTcc2eaVkgSiehcqsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbntFamug%253D%253D&md5=4dd9e4a1df8593635a7e60cd443e67c0</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1186%2F1476-5926-2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-5926-2-3%26sid%3Dliteratum%253Aachs%26aulast%3DBoitier%26aufirst%3DE.%26aulast%3DGautier%26aufirst%3DJ.-C.%26aulast%3DRoberts%26aufirst%3DR.%26atitle%3DAdvances%2520in%2520Understanding%2520the%2520Regulation%2520of%2520Apoptosis%2520and%2520Mitosis%2520by%2520Peroxisome%2520Proliferator-activated%2520Receptors%2520in%2520Pre-clinical%2520Models%253A%2520Relevance%2520for%2520Human%2520Health%2520and%2520Disease%26jtitle%3DComp.%2520Hepatol.%26date%3D2003%26volume%3D2%26spage%3D3%26doi%3D10.1186%2F1476-5926-2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brélivet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moras, D.</span></span> <span> </span><span class="NLM_article-title">Structural Analysis of Nuclear Receptors: From Isolated Domains to Integral Proteins</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2011.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.mce.2011.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21888944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFegsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2012&pages=466-473&author=Y.+Br%C3%A9livetauthor=N.+Rochelauthor=D.+Moras&title=Structural+Analysis+of+Nuclear+Receptors%3A+From+Isolated+Domains+to+Integral+Proteins&doi=10.1016%2Fj.mce.2011.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of nuclear receptors: From isolated domains to integral proteins</span></div><div class="casAuthors">Brelivet, Yann; Rochel, Natacha; Moras, Dino</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">466-473</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NRs) are ligand dependent transcription factors that regulate gene expression.  A no. of in depth structure-function relationship studies have been performed, in particular with drug design perspectives.  Recent structural results concerning integral receptors in diverse functional states, obtained using a combination of different methods, now allow a better understanding of the mechanisms involved in mol. regulation.  The structural data highlight the importance of DNA sequences for binding selectivity and the role of promoter response elements in the spatial organization of the protein domains into functional complexes.  The soln. structures of several heterodimer complexes reveal how the DNA directs the positioning of coactivators.  In the case of PPARγ-RXRα the comparison with the crystal structure reveals two different conformational states that illustrate the flexibility of the receptors.  The results shed light on the dynamics of the mol. recognition process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPsKh1SmCr-rVg90H21EOLACvtfcHk0lhMps6YYh4gtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFegsbzI&md5=c9f9061705e48b5ee67411b28a5f449d</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2011.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2011.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25A9livet%26aufirst%3DY.%26aulast%3DRochel%26aufirst%3DN.%26aulast%3DMoras%26aufirst%3DD.%26atitle%3DStructural%2520Analysis%2520of%2520Nuclear%2520Receptors%253A%2520From%2520Isolated%2520Domains%2520to%2520Integral%2520Proteins%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2012%26volume%3D348%26spage%3D466%26epage%3D473%26doi%3D10.1016%2Fj.mce.2011.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montana, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plunket, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oplinger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gampe, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span> <span> </span><span class="NLM_article-title">Structural Determinants of Ligand Binding Selectivity between the Peroxisome Proliferator-activated Receptors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">13919</span>– <span class="NLM_lpage">13924</span>, <span class="refDoi"> DOI: 10.1073/pnas.241410198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.241410198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11698662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVyntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=13919-13924&author=H.+E.+Xuauthor=M.+H.+Lambertauthor=V.+G.+Montanaauthor=K.+D.+Plunketauthor=L.+B.+Mooreauthor=J.+L.+Collinsauthor=J.+A.+Oplingerauthor=S.+A.+Kliewerauthor=R.+T.+Gampeauthor=D.+D.+McKeeauthor=J.+T.+Mooreauthor=T.+M.+Willson&title=Structural+Determinants+of+Ligand+Binding+Selectivity+between+the+Peroxisome+Proliferator-activated+Receptors&doi=10.1073%2Fpnas.241410198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors</span></div><div class="casAuthors">Xu, H. Eric; Lambert, Millard H.; Montana, Valerie G.; Plunket, Kelli D.; Moore, Linda B.; Collins, Jon L.; Oplinger, Jeffery A.; Kliewer, Steven A.; Gampe, Robert T., Jr.; McKee, David D.; Moore, John T.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13919-13924</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) are transcriptional regulators of glucose, lipid, and cholesterol metab.  We report the x-ray crystal structure of the ligand binding domain of PPARα (NR1C1) as a complex with the agonist ligand GW409544 and a coactivator motif from the steroid receptor coactivator 1.  Through comparison of the crystal structures of the ligand binding domains of the three human PPARs, we have identified mol. determinants of subtype selectivity.  A single amino acid, which is tyrosine in PPARα and histidine in PPARγ, imparts subtype selectivity for both thiazolidinedione and nonthiazolidinedione ligands.  The availability of high-resoln. cocrystal structures of the three PPAR subtypes will aid the design of drugs for the treatments of metabolic and cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOdfCKg7wgXrVg90H21EOLACvtfcHk0lhMps6YYh4gtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVyntbk%253D&md5=563a630106a1396dc047ea6f89d7e0e1</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1073%2Fpnas.241410198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.241410198%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DMontana%26aufirst%3DV.%2BG.%26aulast%3DPlunket%26aufirst%3DK.%2BD.%26aulast%3DMoore%26aufirst%3DL.%2BB.%26aulast%3DCollins%26aufirst%3DJ.%2BL.%26aulast%3DOplinger%26aufirst%3DJ.%2BA.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DGampe%26aufirst%3DR.%2BT.%26aulast%3DMcKee%26aufirst%3DD.%2BD.%26aulast%3DMoore%26aufirst%3DJ.%2BT.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DStructural%2520Determinants%2520of%2520Ligand%2520Binding%2520Selectivity%2520between%2520the%2520Peroxisome%2520Proliferator-activated%2520Receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D13919%26epage%3D13924%26doi%3D10.1073%2Fpnas.241410198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montana, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisely, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milburn, M. V.</span></span> <span> </span><span class="NLM_article-title">Molecular Recognition of Fatty Acids by Peroxisome Proliferator-activated Receptors</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(00)80467-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS1097-2765%2800%2980467-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10198642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1MXit1OmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1999&pages=397-403&author=H.+E.+Xuauthor=M.+H.+Lambertauthor=V.+G.+Montanaauthor=D.+J.+Parksauthor=S.+G.+Blanchardauthor=P.+J.+Brownauthor=D.+D.+Sternbachauthor=J.+M.+Lehmannauthor=G.+B.+Wiselyauthor=T.+M.+Willsonauthor=S.+A.+Kliewerauthor=M.+V.+Milburn&title=Molecular+Recognition+of+Fatty+Acids+by+Peroxisome+Proliferator-activated+Receptors&doi=10.1016%2FS1097-2765%2800%2980467-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of fatty acids by peroxisome proliferator-activated receptors</span></div><div class="casAuthors">Xu, H. Eric; Lambert, Millard H.; Montana, Valerie G.; Parks, Derek J.; Blanchard, Steven G.; Brown, Peter J.; Sternbach, Daniel D.; Lehmann, Jurgen M.; Wisely, G. Bruce; Willson, Timothy M.; Kliewer, Steven A.; Milburn, Michael V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-403</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) are nuclear receptors for fatty acids (FAs) that regulate glucose and lipid homeostasis.  We report the crystal structure of the PPARδ ligand-binding domain (LBD) bound to either the FA eicosapentaenoic acid (EPA) or the synthetic fibrate GW2433.  The carboxylic acids of EPA and GW2433 interact directly with the activation function 2 (AF-2) helix.  The hydrophobic tail of EPA adopts two distinct conformations within the large hydrophobic cavity.  GW2433 occupies essentially the same space as EPA bound in both conformations.  These structures provide mol. insight into the propensity for PPARs to interact with a variety of synthetic and natural compds., including FAs that vary in both chain length and degree of satn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMNTuvvB2z5LVg90H21EOLACvtfcHk0ljGX1i_0N6bWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1OmsLY%253D&md5=890b5f9178bbe6ceb4959a069889fc5c</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2800%2980467-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252800%252980467-0%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DMontana%26aufirst%3DV.%2BG.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DBlanchard%26aufirst%3DS.%2BG.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26aulast%3DWisely%26aufirst%3DG.%2BB.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26atitle%3DMolecular%2520Recognition%2520of%2520Fatty%2520Acids%2520by%2520Peroxisome%2520Proliferator-activated%2520Receptors%26jtitle%3DMol.%2520Cell%26date%3D1999%26volume%3D3%26spage%3D397%26epage%3D403%26doi%3D10.1016%2FS1097-2765%2800%2980467-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoete, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosdidier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michielin, O.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor structures: Ligand Specificity, Molecular Switch and Interactions with Regulators</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1771</i></span>,  <span class="NLM_fpage">915</span>– <span class="NLM_lpage">925</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2007.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbalip.2007.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17317294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFensrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1771&publication_year=2007&pages=915-925&author=V.+Zoeteauthor=A.+Grosdidierauthor=O.+Michielin&title=Peroxisome+Proliferator-activated+Receptor+structures%3A+Ligand+Specificity%2C+Molecular+Switch+and+Interactions+with+Regulators&doi=10.1016%2Fj.bbalip.2007.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators</span></div><div class="casAuthors">Zoete, Vincent; Grosdidier, Aurelien; Michielin, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1771</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">915-925</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptors (PPARs) compose a family of nuclear receptors that mediate the effects of lipidic ligands at the transcriptional level.  In this review, we highlight advances in the understanding of the PPAR ligand binding domain (LBD) structure at the at. level.  The overall structure of PPARs LBD is described, and important protein ligand interactions are presented.  Structure-activity relationships between isotypes structures and ligand specificity are addressed.  It is shown that the numerous exptl. three-dimensional structures available, together with in silico simulations, help understanding the role played by the activating function-2 (AF-2) in PPARs activation and its underlying mol. mechanism.  The relation between the PPARs constitutive activity and the intrinsic stability of the active conformation is discussed.  Finally, the interactions of PPARs LBD with co-activators or co-repressors, as well as with the retinoid X receptor (RXR) are described and considered in relation to PPARs activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolFocNTpJfvbVg90H21EOLACvtfcHk0ljGX1i_0N6bWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFensrs%253D&md5=09981bf8f4413e95010ac28a46a749cf</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2007.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2007.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DZoete%26aufirst%3DV.%26aulast%3DGrosdidier%26aufirst%3DA.%26aulast%3DMichielin%26aufirst%3DO.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520structures%253A%2520Ligand%2520Specificity%252C%2520Molecular%2520Switch%2520and%2520Interactions%2520with%2520Regulators%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2007%26volume%3D1771%26spage%3D915%26epage%3D925%26doi%3D10.1016%2Fj.bbalip.2007.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baiga, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Clair, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockley-Noel, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Specific Ligation of the Peroxisome Proliferator-activated Receptor δ</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E2563</span>– <span class="NLM_lpage">E2570</span>, <span class="refDoi"> DOI: 10.1073/pnas.1621513114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.1621513114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=28320959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksV2rtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E2563-E2570&author=C.-C.+Wuauthor=T.+J.+Baigaauthor=M.+Downesauthor=J.+J.+La+Clairauthor=A.+R.+Atkinsauthor=S.+B.+Richardauthor=W.+Fanauthor=T.+A.+Stockley-Noelauthor=M.+E.+Bowmanauthor=J.+P.+Noelauthor=R.+M.+Evans&title=Structural+Basis+for+Specific+Ligation+of+the+Peroxisome+Proliferator-activated+Receptor+%CE%B4&doi=10.1073%2Fpnas.1621513114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ</span></div><div class="casAuthors">Wu, Chyuan-Chuan; Baiga, Thomas J.; Downes, Michael; La Clair, James J.; Atkins, Annette R.; Richard, Stephane B.; Fan, Weiwei; Stockley-Noel, Theresa A.; Bowman, Marianne E.; Noel, Joseph P.; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">E2563-E2570</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptor (PPAR) family comprises 3 subtypes: PPARα, PPARγ, and PPARδ.  PPARδ transcriptionally modulates lipid metab. and the control of energy homeostasis; therefore, PPARδ agonists are promising agents for treating a variety of metabolic disorders.  In the present study, we developed a panel of rationally designed PPARδ agonists.  The modular motif afforded efficient syntheses using building blocks optimized for interactions with subtype-specific residues in the PPARδ ligand-binding domain (LBD).  A combination of at.-resoln. protein x-ray crystallog. structures, ligand-dependent LBD stabilization assays, and cell-based transactivation measurements delineated structure-activity relations (SARs) for PPARδ-selective targeting and structural modulation.  We identified key ligand-induced conformational transitions of a conserved Trp side-chain in the LBD that triggered reorganization of the H2'-H3 surface segment of PPARδ.  The subtype-specific conservation of H2'-H3 sequences suggested that this architectural remodeling constitutes a previously unrecognized conformational switch accompanying ligand-dependent PPARδ transcriptional regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_4Y68bHgj87Vg90H21EOLACvtfcHk0li18oH07TuWJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksV2rtr0%253D&md5=36b00797c0931f7c08dc2a223b815dee</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1621513114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1621513114%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.-C.%26aulast%3DBaiga%26aufirst%3DT.%2BJ.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DLa%2BClair%26aufirst%3DJ.%2BJ.%26aulast%3DAtkins%26aufirst%3DA.%2BR.%26aulast%3DRichard%26aufirst%3DS.%2BB.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DStockley-Noel%26aufirst%3DT.%2BA.%26aulast%3DBowman%26aufirst%3DM.%2BE.%26aulast%3DNoel%26aufirst%3DJ.%2BP.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DStructural%2520Basis%2520for%2520Specific%2520Ligation%2520of%2520the%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE2563%26epage%3DE2570%26doi%3D10.1073%2Fpnas.1621513114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batista, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivella, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratieri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueira, A. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polikarpov, I.</span></span> <span> </span><span class="NLM_article-title">Structural Insights into Human Peroxisome Proliferator-activated Receptor delta (PPAR-delta) Selective Ligand Binding</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e33643</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0033643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pone.0033643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22606221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslOqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=F.+A.+Batistaauthor=D.+B.+Trivellaauthor=A.+Bernardesauthor=J.+Gratieriauthor=P.+S.+Oliveiraauthor=A.+C.+M.+Figueiraauthor=P.+Webbauthor=I.+Polikarpov&title=Structural+Insights+into+Human+Peroxisome+Proliferator-activated+Receptor+delta+%28PPAR-delta%29+Selective+Ligand+Binding&doi=10.1371%2Fjournal.pone.0033643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into human peroxisome proliferator activated receptor delta (PPAR-Delta) selective ligand binding</span></div><div class="casAuthors">Batista, Fernanda A. H.; Trivella, Daniela B. B.; Bernardes, Amanda; Gratieri, Joyce; Oliveira, Paulo S. L.; Figueira, Ana Carolina M.; Webb, Paul; Polikarpov, Igor</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e33643</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Peroxisome proliferator activated receptors (PPARs δ, α and γ) are closely related transcription factors that exert distinct effects on fatty acid and glucose metab., cardiac disease, inflammatory response and other processes.  Several groups developed PPAR subtype specific modulators to trigger desirable effects of particular PPARs without harmful side effects assocd. with activation of other subtypes.  Presently, however, many compds. that bind to one of the PPARs cross-react with others and rational strategies to obtain highly selective PPAR modulators are far from clear.  GW0742 is a synthetic ligand that binds PPARδ more than 300-fold more tightly than PPARα or PPARγ but the structural basis of PPARδ:GW0742 interactions and reasons for strong selectivity are not clear.  Here we report the crystal structure of the PPARδ:GW0742 complex.  Comparisons of the PPARδ:GW0742 complex with published structures of PPARs in complex with α and γ selective agonists and pan agonists suggests that two residues (Val312 and Ile328) in the buried hormone binding pocket play special roles in PPARδ selective binding and exptl. and computational anal. of effects of mutations in these residues confirms this and suggests that bulky substituents that line the PPARα and γ ligand binding pockets as structural barriers for GW0742 binding.  This anal. suggests general strategies for selective PPARδ ligand design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr48uxmn7tYRLVg90H21EOLACvtfcHk0li18oH07TuWJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslOqtrw%253D&md5=6689a8eecf63013e382bc85e10720e68</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0033643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0033643%26sid%3Dliteratum%253Aachs%26aulast%3DBatista%26aufirst%3DF.%2BA.%26aulast%3DTrivella%26aufirst%3DD.%2BB.%26aulast%3DBernardes%26aufirst%3DA.%26aulast%3DGratieri%26aufirst%3DJ.%26aulast%3DOliveira%26aufirst%3DP.%2BS.%26aulast%3DFigueira%26aufirst%3DA.%2BC.%2BM.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DPolikarpov%26aufirst%3DI.%26atitle%3DStructural%2520Insights%2520into%2520Human%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520delta%2520%2528PPAR-delta%2529%2520Selective%2520Ligand%2520Binding%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0033643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maltarollo, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronenberger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windshugel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrenger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trossini, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honorio, K. M.</span></span> <span> </span><span class="NLM_article-title">Advances and Challenges in Drug Design of PPARδ Ligands</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.2174/1389450118666170414113159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.2174%2F1389450118666170414113159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=28413978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ansLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=144-154&author=V.+G.+Maltarolloauthor=T.+Kronenbergerauthor=B.+Windshugelauthor=C.+Wrengerauthor=G.+H.+Trossiniauthor=K.+M.+Honorio&title=Advances+and+Challenges+in+Drug+Design+of+PPAR%CE%B4+Ligands&doi=10.2174%2F1389450118666170414113159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Advances and Challenges in Drug Design of PPARδ Ligands</span></div><div class="casAuthors">Maltarollo, Vinicius Goncalves; Kronenberger, Thales; Windshugel, Bjorn; Wrenger, Carsten; Goulart Trossini, Gustavo Henrique; Honorio, Kathia Maria</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-154</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Peroxisome proliferator-activated receptors (PPAR) are nuclear receptors activated by endogenous fatty acids and prostaglandins that are classified into three types: &#945;, &#947; and &#948;, which have different functions and tissue distribution.  PPAR modulators have been exploited to the treatment of important metabolic diseases, such as type 2 diabetes mellitus and metabolic syndrome, which are considered relevant epidemic diseases currently.  Along the last decades, several studies have reported structural differences between the three PPAR subtypes assocd. with the discovery of selective ligands, dual and pan-agonists.  Nowadays, there are several approved drugs that activate PPAR&#945; (fibrates) and PPAR&#947; (glitazones), but up to now there is none clin. used drug targeting PPAR&#948;.  Addnl., several side-effects assocd. with the use of PPAR&#945; and &#947; agonists are reported by regulatory agencies, which do not indicate anymore their use as first-line drugs.  Objective: A significant new market has grown in the last years, focusing on the development of new PPAR&#948; agonists as drug candidates to treat metabolic diseases and, in this sense, this study proposes to review the structural requirements to achieve selective PPAR&#948; activation, as well to discuss the most relevant agonists in clin. trials, providing information on the current phase in the drug discovery and design targeting PPAR&#948;.  Conclusion: Several PPAR&#948; ligands with high potency were reported in the literature and were designed or discovered by a combination of exptl. and computational approaches.  Furthermore, the reported importance of pockets and individual residues at PPAR&#948; binding site as well as the importance of substituent and some physicochem. properties that could help to design of new classes of agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreETjwJhVMmLVg90H21EOLACvtfcHk0lj_BXrZNbcNNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ansLo%253D&md5=0d98d8a7d47b65866e46288607d60f6a</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.2174%2F1389450118666170414113159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450118666170414113159%26sid%3Dliteratum%253Aachs%26aulast%3DMaltarollo%26aufirst%3DV.%2BG.%26aulast%3DKronenberger%26aufirst%3DT.%26aulast%3DWindshugel%26aufirst%3DB.%26aulast%3DWrenger%26aufirst%3DC.%26aulast%3DTrossini%26aufirst%3DG.%2BH.%26aulast%3DHonorio%26aufirst%3DK.%2BM.%26atitle%3DAdvances%2520and%2520Challenges%2520in%2520Drug%2520Design%2520of%2520PPAR%25CE%25B4%2520Ligands%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2018%26volume%3D19%26spage%3D144%26epage%3D154%26doi%3D10.2174%2F1389450118666170414113159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutledge, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A.</span></span> <span> </span><span class="NLM_article-title">Structural Requirements and Cell-type Specificity for Ligand Activation of Peroxisome Proliferator-activated Receptors</span>. <i>J. Steroid Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/S0960-0760(97)00064-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS0960-0760%2897%2900064-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=9449199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1cXksF2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1997&pages=1-8&author=T.+E.+Johnsonauthor=M.+K.+Hollowayauthor=R.+Vogelauthor=S.+J.+Rutledgeauthor=J.+J.+Perkinsauthor=G.+A.+Rodanauthor=A.+Schmidt&title=Structural+Requirements+and+Cell-type+Specificity+for+Ligand+Activation+of+Peroxisome+Proliferator-activated+Receptors&doi=10.1016%2FS0960-0760%2897%2900064-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors</span></div><div class="casAuthors">Johnson, Timothy E.; Holloway, M. Katharine; Vogel, Robert; Rutledge, Sue Jane; Perkins, James J.; Rodan, Gideon A.; Schmidt, Azriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The mammalian peroxisome proliferator-activated receptor (PPAR) family consists of three different subtypes, PPARα, hNUC1/PPARσ and PPARγ.  Selective agonists have been identified for PPARα and PPARγ but not for hNUC1, and consequently little is known about the genes that are controlled by this receptor.  Using ligand-dependent transcription assays in COS-7 cells, we screened a variety of PPAR activating agents to identify a selective activator of hNUC1.  We found that the potent peroxisome proliferator, Wy-14643, and the PPARγ-selective thiazolidinedione, BRL 49653, were poor activators of hNUC1 (EC50s of >100 μM).  Short chain fatty acids (FAs) appeared more selective for PPARα than for hNUC1, whereas the very long chain FA, erucic acid (C22:1) was more selective for hNUC1.  Using erucic acid as a probe, we conducted a topol. similarity search of the Merck Chem. Collection and identified a fatty acid-like compd., L-631,033 4-(2-acetyl-6-hydroxyundecyl) cinnamic acid, that was a selective activator of hNUC1 (EC50 of 2 μM), but was much less selective for PPARα or PPARγ (EC50s of >100 μM).  Structure-function anal. of PPAR activation by L-631,033 structural analogs showed that receptor selectivity depends on the position of the carboxyl group relative to the Ph ring on the mol.  Transfection expts. in several cell types: an osteoblastic cell line (MB 1.8), a mouse liver cell line (ML-457), rat aortic smooth muscle cells (RSMCs) and COS-7 cells revealed differences in the activation profile of specific ligands.  The most notable differences were obsd. in RSMCs, where transactivation by L-631,033 and Wy-14643, but not by BRL 49653, was markedly reduced, and in MB 1.8 cells, where oleic acid failed to activate PPARs.  These findings identify certain structural features in PPAR-activating agents that modulate PPAR activation, and suggest that as with other nuclear receptors, activation is cell-type specific.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryGLf9zoMyWbVg90H21EOLACvtfcHk0lj_BXrZNbcNNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksF2huw%253D%253D&md5=e7057442ad5d4d4496c7ee25d7b67e1e</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2897%2900064-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252897%252900064-2%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BE.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DVogel%26aufirst%3DR.%26aulast%3DRutledge%26aufirst%3DS.%2BJ.%26aulast%3DPerkins%26aufirst%3DJ.%2BJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DSchmidt%26aufirst%3DA.%26atitle%3DStructural%2520Requirements%2520and%2520Cell-type%2520Specificity%2520for%2520Ligand%2520Activation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptors%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D63%26spage%3D1%26epage%3D8%26doi%3D10.1016%2FS0960-0760%2897%2900064-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luckhurst, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botterell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chohan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walding, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of N-alkylated 8-oxybenz [c] azepine Derivatives as Selective PPARδ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2010.10.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21075629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SqsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=531-536&author=C.+A.+Luckhurstauthor=M.+Ratcliffeauthor=L.+Steinauthor=M.+Furberauthor=S.+Botterellauthor=D.+Laughtonauthor=W.+Tomlinsonauthor=R.+Weaverauthor=K.+Chohanauthor=A.+Walding&title=Synthesis+and+Biological+Evaluation+of+N-alkylated+8-oxybenz+%5Bc%5D+azepine+Derivatives+as+Selective+PPAR%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2010.10.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonists</span></div><div class="casAuthors">Luckhurst, Christopher A.; Ratcliffe, Marianne; Stein, Linda; Furber, Mark; Botterell, Sara; Laughton, David; Tomlinson, Wendy; Weaver, Richard; Chohan, Kamaldeep; Walding, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">531-536</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of small mol. benzazepine derivs., e.g. I (R1 = H, Et, n-Bu; R2 = 4-ClC6H4, 2,4-Cl2C6H3, 2,5-MeC6H3, 3,5-dichloro-2-pyridyl, etc.), as agonists of human peroxisome proliferator-activated receptor δ (PPARδ) that displayed excellent selectivity over the PPARα and PPARγ subtypes is described.  Compd. I [R1 = (R)-Et; R2 = 2,4-Cl2C6H3] displayed good PK in the rat and efficacy in upregulation of pyruvate dehydrogenase kinase, isoenzyme 4 (PDK4) mRNA in human primary myotubes, a biomarker for increased fatty acid oxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLXsb3CuLUr7Vg90H21EOLACvtfcHk0lhXTXE-LrtHIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SqsbnL&md5=6ef76030deb80d6f1765816d57e409ac</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.083%26sid%3Dliteratum%253Aachs%26aulast%3DLuckhurst%26aufirst%3DC.%2BA.%26aulast%3DRatcliffe%26aufirst%3DM.%26aulast%3DStein%26aufirst%3DL.%26aulast%3DFurber%26aufirst%3DM.%26aulast%3DBotterell%26aufirst%3DS.%26aulast%3DLaughton%26aufirst%3DD.%26aulast%3DTomlinson%26aufirst%3DW.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DChohan%26aufirst%3DK.%26aulast%3DWalding%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520N-alkylated%25208-oxybenz%2520%255Bc%255D%2520azepine%2520Derivatives%2520as%2520Selective%2520PPAR%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D531%26epage%3D536%26doi%3D10.1016%2Fj.bmcl.2010.10.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londhe, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadayat, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of an Orally Available “Y”-shaped Biaryl Peroxisome Proliferator-activated Receptor δ Agonist</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4382</span>– <span class="NLM_lpage">4389</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.06.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmc.2018.06.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30054191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVShsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=4382-4389&author=D.-S.+Kimauthor=J.+Leeauthor=A.+M.+Londheauthor=T.+M.+Kadayatauthor=J.+Jooauthor=H.+Hwangauthor=K.-H.+Kimauthor=A.+N.+Paeauthor=J.+Chinauthor=S.+J.+Choauthor=H.+Kang&title=Synthesis+and+Evaluation+of+an+Orally+Available+%E2%80%9CY%E2%80%9D-shaped+Biaryl+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist&doi=10.1016%2Fj.bmc.2018.06.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of an orally available "Y"-shaped biaryl peroxisome proliferator-activated receptor δ agonist</span></div><div class="casAuthors">Kim, Dong-Su; Lee, Jaehwan; Londhe, Ashwini M.; Kadayat, Tara Man; Joo, Jeongmin; Hwang, Hayoung; Kim, Kyung-Hee; Pae, Ae Nim; Chin, Jungwook; Cho, Sung Jin; Kang, Heonjoong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4382-4389</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, we designed and synthesized several novel "Y"-shaped biaryl PPARδ agonists.  Structure-activity relationship (SAR) studies demonstrated that compd. 3a was the most active agonist with an EC50 of 2.6nM.  We also synthesized and evaluated enantiospecific R and S isomers of compd. 3a to confirm that R isomer (EC50=0.7nM) shows much more potent activity than S isomer (EC50=6.1nM).  Mol. docking studies between the PPAR ligand binding domain and enantiospecific R and S isomers of compd. 3a were performed.  In vitro absorption, distribution, metab., excretion, and toxicity (ADMET) and in vivo PK profiles show that compd. 3a possesses superior drug-like properties including good bioavailability.  Our overall results clearly demonstrate that this orally administrable PPARδ agonist 3a is a viable drug candidate for the treatment of various PPARδ-related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5dkyhwpT29bVg90H21EOLACvtfcHk0lhXTXE-LrtHIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVShsbvF&md5=55a0cadbcad38a53bd58547afe441951</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.06.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.06.044%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.-S.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLondhe%26aufirst%3DA.%2BM.%26aulast%3DKadayat%26aufirst%3DT.%2BM.%26aulast%3DJoo%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.-H.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520an%2520Orally%2520Available%2520%25E2%2580%259CY%25E2%2580%259D-shaped%2520Biaryl%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D4382%26epage%3D4389%26doi%3D10.1016%2Fj.bmc.2018.06.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Da’adoosh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldblum, A.</span></span> <span> </span><span class="NLM_article-title">Discovering Highly Selective and Diverse PPAR-delta Agonists by Ligand Based Machine Learning and Structural Modeling</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1106</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-38508-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fs41598-019-38508-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30705343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BB3cjns1Cmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1106&author=B.+Da%E2%80%99adooshauthor=D.+Marcusauthor=A.+Rayanauthor=F.+Kingauthor=J.+Cheauthor=A.+Goldblum&title=Discovering+Highly+Selective+and+Diverse+PPAR-delta+Agonists+by+Ligand+Based+Machine+Learning+and+Structural+Modeling&doi=10.1038%2Fs41598-019-38508-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling</span></div><div class="casAuthors">Da'adoosh Benny; Marcus David; Rayan Anwar; Goldblum Amiram; Rayan Anwar; Rayan Anwar; King Fred; Che Jianwei; Che Jianwei</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1106</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PPAR-δ agonists are known to enhance fatty acid metabolism, preserving glucose and physical endurance and are suggested as candidates for treating metabolic diseases.  None have reached the clinic yet.  Our Machine Learning algorithm called "Iterative Stochastic Elimination" (ISE) was applied to construct a ligand-based multi-filter ranking model to distinguish between confirmed PPAR-δ agonists and random molecules.  Virtual screening of 1.56 million molecules by this model picked ~2500 top ranking molecules.  Subsequent docking to PPAR-δ structures was mainly evaluated by geometric analysis of the docking poses rather than by energy criteria, leading to a set of 306 molecules that were sent for testing in vitro.  Out of those, 13 molecules were found as potential PPAR-δ agonist leads with EC50 between 4-19 nM and 14 others with EC50 below 10 μM.  Most of the nanomolar agonists were found to be highly selective for PPAR-δ and are structurally different than agonists used for model building.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLZIEKyN30hpWtyewyzkyLfW6udTcc2eZZAksOXPBJFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjns1Cmtg%253D%253D&md5=aa6c1094a1b74e8626b851b734edfae7</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-38508-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-38508-8%26sid%3Dliteratum%253Aachs%26aulast%3DDa%25E2%2580%2599adoosh%26aufirst%3DB.%26aulast%3DMarcus%26aufirst%3DD.%26aulast%3DRayan%26aufirst%3DA.%26aulast%3DKing%26aufirst%3DF.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DGoldblum%26aufirst%3DA.%26atitle%3DDiscovering%2520Highly%2520Selective%2520and%2520Diverse%2520PPAR-delta%2520Agonists%2520by%2520Ligand%2520Based%2520Machine%2520Learning%2520and%2520Structural%2520Modeling%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D1106%26doi%3D10.1038%2Fs41598-019-38508-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibowitz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doebber, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbrecht, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullinan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moller, D. E.</span></span> <span> </span><span class="NLM_article-title">Novel Peroxisome Proliferator-activated Receptor (PPAR)γ and PPARδ Ligands Produce Distinct Biological Effects</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">6718</span>– <span class="NLM_lpage">6725</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.10.6718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1074%2Fjbc.274.10.6718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10037770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1ektb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=6718-6725&author=J.+Bergerauthor=M.+D.+Leibowitzauthor=T.+W.+Doebberauthor=A.+Elbrechtauthor=B.+Zhangauthor=G.+Zhouauthor=C.+Biswasauthor=C.+A.+Cullinanauthor=N.+S.+Hayesauthor=Y.+Liauthor=M.+Tanenauthor=J.+Ventreauthor=M.+S.+Wuauthor=G.+D.+Bergerauthor=R.+Mosleyauthor=R.+Marquisauthor=C.+Santiniauthor=S.+P.+Sahooauthor=R.+L.+Tolmanauthor=R.+G.+Smithauthor=D.+E.+Moller&title=Novel+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29%CE%B3+and+PPAR%CE%B4+Ligands+Produce+Distinct+Biological+Effects&doi=10.1074%2Fjbc.274.10.6718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects</span></div><div class="casAuthors">Berger, Joel; Leibowitz, Mark D.; Doebber, Thomas W.; Elbrecht, Alex; Zhang, Bei; Zhou, Gaochou; Biswas, Chhabi; Cullinan, Catherine A.; Hayes, Nancy S.; Li, Ying; Tanen, Michael; Ventre, John; Wu, Margaret S.; Berger, Gregory D.; Mosley, Ralph; Marquis, Robert; Santini, Conrad; Sahoo, Soumya P.; Tolman, Richard L.; Smith, Roy G.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6718-6725</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) include three receptor subtypes encoded by sep. genes: PPARα, PPARδ, and PPARγ.  PPARγ has been implicated as a mediator of adipocyte differentiation and the mechanism by which thiazolidinedione drugs exert in vivo insulin sensitization.  Here we characterized novel, non-thiazolidinedione agonists for PPARγy and PPARδ that were identified by radioligand binding assays.  In transient transactivation assays these ligands were agonists of the receptors to which they bind.  Protease protection studies showed that ligand binding produced specific alterations in receptor conformation.  Both PPARγ and PPARδ directly interacted with a nuclear receptor co-activator (CREB-binding protein) in an agonist-dependent manner.  Only the PPARγ agonists were able to promote differentiation of 3T3-L1 preadipocytes.  In diabetic db/db mice all PPARγ agonists were orally active insulin-sensitizing agents producing redns. of elevated plasma glucose and triglyceride concns.  In contrast, selective in vivo activation of PPARδ did not significantly affect these parameters.  In vivo PPARα activation with WY-14653 resulted in redns. in elevated triglyceride levels with minimal effect on hyperglycemia.  We conclude that: 1. synthetic non-thiazolidinediones can serve as ligands of PPARγ and PPARδ; 2. ligand-dependent activation of PPARδ involves an apparent conformational change and assocn. of the receptor ligand binding domain with CREB-binding protein; 3. PPARγ activation (but not PPARδ or PPARα activation) is sufficient to potentiate preadipocyte differentiation; 4. non-thiazolidinedione PPARγ agonists improve hyperglycemia and hypertriglyceridemia in vivo; 5. although PPARα activation is sufficient to affect triglyceride metab., PPARδ activation does not appear to modulate glucose or triglyceride levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprKgGs_6YukLVg90H21EOLACvtfcHk0lj0KTSlLyvZQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1ektb0%253D&md5=c62b5d778386a81d91221d6330f8e8d3</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.10.6718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.10.6718%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DLeibowitz%26aufirst%3DM.%2BD.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DCullinan%26aufirst%3DC.%2BA.%26aulast%3DHayes%26aufirst%3DN.%2BS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%2BS.%26aulast%3DBerger%26aufirst%3DG.%2BD.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DMarquis%26aufirst%3DR.%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DSahoo%26aufirst%3DS.%2BP.%26aulast%3DTolman%26aufirst%3DR.%2BL.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DNovel%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%25CE%25B3%2520and%2520PPAR%25CE%25B4%2520Ligands%2520Produce%2520Distinct%2520Biological%2520Effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D6718%26epage%3D6725%26doi%3D10.1074%2Fjbc.274.10.6718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henke, B. R.</span></span> <span> </span><span class="NLM_article-title">The PPARs: From Orphan Receptors to Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1021/jm990554g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990554g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht1Churk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=527-550&author=T.+M.+Willsonauthor=P.+J.+Brownauthor=D.+D.+Sternbachauthor=B.+R.+Henke&title=The+PPARs%3A+From+Orphan+Receptors+to+Drug+Discovery&doi=10.1021%2Fjm990554g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">The PPARs: From orphan receptors to drug discovery</span></div><div class="casAuthors">Willson, Timothy M.; Brown, Peter J.; Sternbach, Daniel D.; Henke, Brad R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-550</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 326 refs. is given on peroxisome proliferator-activated receptors (PPARs).  The structural and functional anal. of the different PPAR subtypes is summarized and their function as hormone receptors for dietary fatty acids and certain eicosanoids in different species and in many metabolically active tissues is described.  Progress is reported in the development of drugs, which use PPARs as mol. targets, for the treatment of human metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocp31Cq_kgebVg90H21EOLACvtfcHk0liQGtiaCdcmRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht1Churk%253D&md5=003b19fe3fdf813411d6a2ac5aefdc01</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm990554g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990554g%26sid%3Dliteratum%253Aachs%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DHenke%26aufirst%3DB.%2BR.%26atitle%3DThe%2520PPARs%253A%2520From%2520Orphan%2520Receptors%2520to%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D527%26epage%3D550%26doi%3D10.1021%2Fjm990554g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.-Y.</span></span> <span> </span><span class="NLM_article-title">PPARδ ligand L-165041 Ameliorates Western Diet-induced Hepatic Lipid Accumulation and Inflammation in LDLR–/– Mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>622</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2009.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.ejphar.2009.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19766624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OnsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=622&publication_year=2009&pages=45-51&author=H.-J.+Limauthor=J.-H.+Parkauthor=S.+Leeauthor=H.-E.+Choiauthor=K.-S.+Leeauthor=H.-Y.+Park&title=PPAR%CE%B4+ligand+L-165041+Ameliorates+Western+Diet-induced+Hepatic+Lipid+Accumulation+and+Inflammation+in+LDLR%E2%80%93%2F%E2%80%93+Mice&doi=10.1016%2Fj.ejphar.2009.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR-/- mice</span></div><div class="casAuthors">Lim, Hyun-Joung; Park, Jin-Hee; Lee, Seahyoung; Choi, Hye-Eun; Lee, Kuy-Sook; Park, Hyun-Young</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">622</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Although peroxisome proliferator-activated receptor delta (PPARδ) has been implicated in energy metab. and lipid oxidn. process, detailed roles of PPARδ in lipid homeostasis under pathol. conditions still remain controversial.  Thus, we investigated the effect of PPARδ ligand L-165041 on Western diet-induced fatty liver using low-d. lipoprotein receptor-deficient (LDLR-/-) mice.  LDLR-/- mice received either L-165041 (5 mg/kg/day) or vehicle (0.1 N NaOH) with Western diet for 16 wk.  According to our data, L-165041 drastically reduced lipid accumulation in the liver, decreasing total hepatic cholesterol and triglyceride content compared to the vehicle group.  Gene expression anal. demonstrated that L-165041 lowered hepatic expression of PPARγ, apolipoprotein B, interleukin 1 beta (IL-1β), and interleukin-6.  In contrast, L-165041 increased hepatic expressions of PPARδ, lipoprotein lipase (LPL), and ATP-binding cassette transporter G1 (ABCG1).  Our data suggest that L-165041 might be effective in preventing Western diet-induced hepatic steatosis by regulating genes involved in lipid metab. and the inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlaPZ68NJirVg90H21EOLACvtfcHk0liQGtiaCdcmRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OnsrrP&md5=91243b3e20bfe4dc0f3c8b6555413bc9</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DH.-J.%26aulast%3DPark%26aufirst%3DJ.-H.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DH.-E.%26aulast%3DLee%26aufirst%3DK.-S.%26aulast%3DPark%26aufirst%3DH.-Y.%26atitle%3DPPAR%25CE%25B4%2520ligand%2520L-165041%2520Ameliorates%2520Western%2520Diet-induced%2520Hepatic%2520Lipid%2520Accumulation%2520and%2520Inflammation%2520in%2520LDLR%25E2%2580%2593%252F%25E2%2580%2593%2520Mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D622%26spage%3D45%26epage%3D51%26doi%3D10.1016%2Fj.ejphar.2009.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.-Y.</span></span> <span> </span><span class="NLM_article-title">PPARδ agonist L-165041 Inhibits Rat Vascular Smooth Muscle Cell Proliferation and Migration via Inhibition of Cell Cycle</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2008.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.atherosclerosis.2008.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18585719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2009&pages=446-454&author=H.-J.+Limauthor=S.+Leeauthor=J.-H.+Parkauthor=K.-S.+Leeauthor=H.-E.+Choiauthor=K.-S.+Chungauthor=H.-H.+Leeauthor=H.-Y.+Park&title=PPAR%CE%B4+agonist+L-165041+Inhibits+Rat+Vascular+Smooth+Muscle+Cell+Proliferation+and+Migration+via+Inhibition+of+Cell+Cycle&doi=10.1016%2Fj.atherosclerosis.2008.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle</span></div><div class="casAuthors">Lim, Hyun-Joung; Lee, Seahyoung; Park, Jin-Hee; Lee, Kuy-Sook; Choi, Hye-Eun; Chung, Kyung-Sook; Lee, Hyoung-Hee; Park, Hyun-Young</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">446-454</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptor (PPAR) family of nuclear hormone receptors consists of three subtypes (α, β/δ, and γ).  PPARδ is ubiquitously expressed and involved in lipid and glucose metab.  However, the effect of PPARδ on vascular smooth muscle cell (VSMC) proliferation and migration has not been fully elucidated yet.  Here, we investigated the effect of L-165041, a selective ligand for PPARδ, on PDGF-induced rat VSMC proliferation.  Our data show that L-165041 inhibited rat VSMC proliferation in a dose dependent manner by blocking G1 to S phase progression and repressing the phosphorylation of retinoblastoma protein (Rb).  Furthermore, L-165041 inhibited PDGF-induced expression of cyclin D1 and CDK4.  These effects less likely involve PPARγ pathway because PPARγ antagonist GW9662 pretreatment failed to reverse the inhibitory effect of L-165041 on rVSMC proliferation and migration.  For in vivo studies, L-165041 was administered to Sprague-Dawley rats using osmotic pumps before and after the carotid balloon injury, and L-165041 decreased neointima formation after the carotid injury.  In conclusion, our results suggest that PPARδ ligand L-165041 can be a therapeutic agent to control pathol. cardiovascular conditions such as restenosis and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopY78gEGyaeLVg90H21EOLACvtfcHk0likn8BnxqAogw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFegsrw%253D&md5=5f62f073a45cef807d14107652d22e0f</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2008.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2008.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DH.-J.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DJ.-H.%26aulast%3DLee%26aufirst%3DK.-S.%26aulast%3DChoi%26aufirst%3DH.-E.%26aulast%3DChung%26aufirst%3DK.-S.%26aulast%3DLee%26aufirst%3DH.-H.%26aulast%3DPark%26aufirst%3DH.-Y.%26atitle%3DPPAR%25CE%25B4%2520agonist%2520L-165041%2520Inhibits%2520Rat%2520Vascular%2520Smooth%2520Muscle%2520Cell%2520Proliferation%2520and%2520Migration%2520via%2520Inhibition%2520of%2520Cell%2520Cycle%26jtitle%3DAtherosclerosis%26date%3D2009%26volume%3D202%26spage%3D446%26epage%3D454%26doi%3D10.1016%2Fj.atherosclerosis.2008.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacNaul, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doebber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moller, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, S. P.</span></span> <span> </span><span class="NLM_article-title">Phenylacetic Acid Derivatives as hPPAR Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1280</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00115-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS0960-894X%2803%2900115-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=12657263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1277-1280&author=C.+Santiniauthor=G.+D.+Bergerauthor=W.+Hanauthor=R.+Mosleyauthor=K.+MacNaulauthor=J.+Bergerauthor=T.+Doebberauthor=M.+Wuauthor=D.+E.+Mollerauthor=R.+L.+Tolmanauthor=S.+P.+Sahoo&title=Phenylacetic+Acid+Derivatives+as+hPPAR+Agonists&doi=10.1016%2FS0960-894X%2803%2900115-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylacetic acid derivatives as hPPAR agonists</span></div><div class="casAuthors">Santini, Conrad; Berger, Gregory D.; Han, Wei; Mosley, Ralph; MacNaul, Karen; Berger, Joel; Doebber, Thomas; Wu, Margaret; Moller, David E.; Tolman, Richard L.; Sahoo, Soumya P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1277-1280</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Beginning with the weakly active lead structure (I), a new series of hPPAR agonists was developed.  In vivo glucose and triglyceride lowering activity was obtained by homologation and oxamination , then conversion to substituted benzisoxazoles.  Further manipulation afforded two benzofurans.  One compd. was of comparable potency as a glucose and triglyceride lowering agent in insulin resistant rodents to BRL 49653.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-EZ1ky1nXpbVg90H21EOLACvtfcHk0likn8BnxqAogw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKjtrY%253D&md5=93d7025b97fde7e0ed16878eb08ec941</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900115-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900115-X%26sid%3Dliteratum%253Aachs%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DG.%2BD.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DMacNaul%26aufirst%3DK.%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DDoebber%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DTolman%26aufirst%3DR.%2BL.%26aulast%3DSahoo%26aufirst%3DS.%2BP.%26atitle%3DPhenylacetic%2520Acid%2520Derivatives%2520as%2520hPPAR%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1277%26epage%3D1280%26doi%3D10.1016%2FS0960-894X%2803%2900115-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Oliver, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomkinson, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fivush, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T.M.</span></span> <span> </span><span class="NLM_article-title">Identification of Peroxisome Proliferator-activated Receptor Ligands from a Biased Chemical Library</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(97)90299-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS1074-5521%2897%2990299-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=9427656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1MXkslCnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=909-918&author=P.+J.+Brownauthor=T.+A.+Smith-Oliverauthor=P.+S.+Charifsonauthor=N.+C.+Tomkinsonauthor=A.+M.+Fivushauthor=D.+D.+Sternbachauthor=L.+E.+Wadeauthor=L.+Orband-Millerauthor=D.+J.+Parksauthor=S.+G.+Blanchardauthor=S.+A.+Kliewerauthor=J.+M.+Lehmannauthor=T.M.+Willson&title=Identification+of+Peroxisome+Proliferator-activated+Receptor+Ligands+from+a+Biased+Chemical+Library&doi=10.1016%2FS1074-5521%2897%2990299-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library</span></div><div class="casAuthors">Brown, Peter J.; Smith-Oliver, Tracey A.; Charifson, Paul S.; Tomkinson, Nicholas C. O.; Fivush, Adam M.; Sternbach, Daniel D.; Wade, Laura E.; Orband-Miller, Lisa; Parks, Derek J.; Blanchard, Steven G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-918</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">Background: The peroxisome proliferator-activated receptors (PPARs) were cloned as orphan members of the nuclear receptor superfamily of transcription factors.  The identification of subtype-selective ligands for PPARα and PPARγ has led to the discovery of their roles in the regulation of lipid metab. and glucose homeostasis.  No subtype-selective PPARδ ligands are available and the function of this subtype is currently unknown.  Results: A three-component library was designed in which one of the monomers was biased towards the PPARs and the other two monomers were chosen to add chem. diversity.  Synthesis and screening of the library resulted in the identification of pools with activity on each of the PPAR subtypes.  Deconvolution of the pools with the highest activity on PPARδ led to the identification of GW 2433 as the first high-affinity PPARδ ligand.  [3H]GW 2433 is an effective radioligand for use in PPARδ competition-binding assays.  Conclusions: The synthesis of biased chem. libraries is an efficient approach to the identification of lead mols. for members of sequence-related receptor families.  This approach is well suited to the discovery of small-mol. ligands for orphan receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjqD5wlZOv2LVg90H21EOLACvtfcHk0lh9rqEG6QiT6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslCnsbo%253D&md5=40dca84a8aa5de38f8d444f782c98c16</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2897%2990299-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252897%252990299-4%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSmith-Oliver%26aufirst%3DT.%2BA.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DTomkinson%26aufirst%3DN.%2BC.%26aulast%3DFivush%26aufirst%3DA.%2BM.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DWade%26aufirst%3DL.%2BE.%26aulast%3DOrband-Miller%26aufirst%3DL.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DBlanchard%26aufirst%3DS.%2BG.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26aulast%3DWillson%26aufirst%3DT.M.%26atitle%3DIdentification%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520Ligands%2520from%2520a%2520Biased%2520Chemical%2520Library%26jtitle%3DChem.%2520Biol.%26date%3D1997%26volume%3D4%26spage%3D909%26epage%3D918%26doi%3D10.1016%2FS1074-5521%2897%2990299-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span> <span> </span><span class="NLM_article-title">PPAR-β/δ Agonists for Type 2 Diabetes and Dyslipidemia: an Adopted Orphan Still Looking for a Home</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1465</span>– <span class="NLM_lpage">1471</span>, <span class="refDoi"> DOI: 10.1517/13543784.17.10.1465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1517%2F13543784.17.10.1465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18808307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCjurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1465-1471&author=A.+N.+Billin&title=PPAR-%CE%B2%2F%CE%B4+Agonists+for+Type+2+Diabetes+and+Dyslipidemia%3A+an+Adopted+Orphan+Still+Looking+for+a+Home&doi=10.1517%2F13543784.17.10.1465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR-β/δ agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home</span></div><div class="casAuthors">Billin, Andrew N.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1465-1471</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The identification of small mol. agonists for the nuclear receptor peroxisome proliferator-activated receptor beta/delta (PPAR-β/δ, NR1C2) has enabled the characterization of this receptor's functions in preclin. models.  Subsequently, a no. of small mol. agonists of PPAR-β/δ have been progressed into clin. trials.  This review will examine the major preclin. findings that underpin the hypothesis that PPAR-β/δ agonists may be beneficial in treating dyslipidemia and Type 2 diabetes, as well as emerging clin. data with a variety of PPAR-β/δ agonists.  The literature concerning preclin. expts. that combine in vivo and in vitro mechanistic studies are reviewed and compared with the results of the early clin. trials.  Thus far, the activities of the agonists seen in the clinic are broadly similar to those seen in preclin. models.  However, it is still not known if PPAR-β/δ agonists will truly be differentiated enough from current treatments to justify their use in treating dyslipidemia or Type 2 diabetes.  Major challenges for the development of PPAR-β/δ agonists exist and the path forward is as yet undefined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiP0MwvREFjrVg90H21EOLACvtfcHk0lh9rqEG6QiT6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCjurrN&md5=2809a5fe9644b50f92c797f890866cbe</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1517%2F13543784.17.10.1465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.17.10.1465%26sid%3Dliteratum%253Aachs%26aulast%3DBillin%26aufirst%3DA.%2BN.%26atitle%3DPPAR-%25CE%25B2%252F%25CE%25B4%2520Agonists%2520for%2520Type%25202%2520Diabetes%2520and%2520Dyslipidemia%253A%2520an%2520Adopted%2520Orphan%2520Still%2520Looking%2520for%2520a%2520Home%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1465%26epage%3D1471%26doi%3D10.1517%2F13543784.17.10.1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahebkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, G. F.</span></span> <span> </span><span class="NLM_article-title">New Peroxisome Proliferator-activated Receptor Agonists: Potential Treatments for Atherogenic Dyslipidemia and Non-alcoholic Fatty Liver Disease</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1517/14656566.2014.876992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1517%2F14656566.2014.876992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=24428677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFamsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=493-503&author=A.+Sahebkarauthor=G.+T.+Chewauthor=G.+F.+Watts&title=New+Peroxisome+Proliferator-activated+Receptor+Agonists%3A+Potential+Treatments+for+Atherogenic+Dyslipidemia+and+Non-alcoholic+Fatty+Liver+Disease&doi=10.1517%2F14656566.2014.876992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease</span></div><div class="casAuthors">Sahebkar, Amirhossein; Chew, Gerard T.; Watts, Gerald F.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">493-503</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Novel peroxisome proliferator-activated receptor (PPAR) modulators (selective PPAR modulators [SPPARMs]) and dual PPAR agonists may have an important role in the treatment of cardiometabolic disorders owing to lipid-modifying, insulin-sensitizing and anti-inflammatory effects.  Areas covered: This review summarizes the efficacy of new PPAR agonists and SPPARMs that are under development for the treatment of atherogenic dyslipidemia and non-alc. fatty liver disease (NAFLD).  Expert opinion: ABT-335 is a new formulation of fenofibrate that has been approved for concomitant use with statins.  K-877, a SPPARM-α with encouraging preliminary results in modulating atherogenic dyslipidemia, and INT131, a SPPARM-γ with predominantly insulin-sensitizing actions, may also have favorable lipid-modifying effects.  Although the development of dual PPAR-α/γ agonists (glitazars) and the SPPARM-δ GW501516 has been abandoned because of safety issues, another SPPARM-δ (MBX-8025) and a dual PPAR-α/δ agonist (GFT-505) have shown promising efficacy in decreasing plasma triglyceride and increasing high-d. lipoprotein cholesterol concns., as well as improving insulin sensitivity and liver function.  The beneficial effects of GFT-505 are complemented by preclin. findings that indicate redn. of hepatic fat accumulation, inflammation and fibrosis, making it a promising candidate for the treatment of NAFLD/nonalcoholic steatohepatitis (NASH).  Long-term trials are required to test the efficacy and safety of these new PPAR agonists in reducing cardiovascular outcomes and treating NAFLD/NASH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG9sfsoyVFALVg90H21EOLACvtfcHk0li4eiRWTv6ilw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFamsbg%253D&md5=7a70b9ae9ea4dd1db45d1ff04a2026e9</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1517%2F14656566.2014.876992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2014.876992%26sid%3Dliteratum%253Aachs%26aulast%3DSahebkar%26aufirst%3DA.%26aulast%3DChew%26aufirst%3DG.%2BT.%26aulast%3DWatts%26aufirst%3DG.%2BF.%26atitle%3DNew%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520Agonists%253A%2520Potential%2520Treatments%2520for%2520Atherogenic%2520Dyslipidemia%2520and%2520Non-alcoholic%2520Fatty%2520Liver%2520Disease%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2014%26volume%3D15%26spage%3D493%26epage%3D503%26doi%3D10.1517%2F14656566.2014.876992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geiger, L.</span>; <span class="NLM_string-name">Dunsford, W.</span>; <span class="NLM_string-name">Lewis, D.</span>; <span class="NLM_string-name">Brennan, C.</span>; <span class="NLM_string-name">Liu, K.</span>; <span class="NLM_string-name">Newsholme, S.</span></span> <span> </span><span class="NLM_article-title">PS 895-Rat Carcinogenicity Study with GW501516, a PPAR delta Agonist</span>.  <i>48th Annual Meeting of the Society of Toxicology, March 15–19, 2009, Baltimore</i>; <span class="NLM_publisher-name">Society of Toxicology</span>, <span class="NLM_year">2009</span>; p  <span class="NLM_fpage">185</span>. <a href="https://web.archive.org/web/20150504013406/http:/www.toxicology.org/AI/PUB/Tox/2009Tox.pdf" class="extLink">https://web.archive.org/web/20150504013406/http:/www.toxicology.org/AI/PUB/Tox/2009Tox.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=185&author=L.+Geiger&author=W.+Dunsford&author=D.+Lewis&author=C.+Brennan&author=K.+Liu&author=S.+Newsholme&title=PS+895-Rat+Carcinogenicity+Study+with+GW501516%2C+a+PPAR+delta+Agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGeiger%26aufirst%3DL.%26atitle%3DPS%2520895-Rat%2520Carcinogenicity%2520Study%2520with%2520GW501516%252C%2520a%2520PPAR%2520delta%2520Agonist%26jtitle%3D48th%2520Annual%2520Meeting%2520of%2520the%2520Society%2520of%2520Toxicology%252C%2520March%252015%25E2%2580%259319%252C%25202009%252C%2520Baltimore%26pub%3DSociety%2520of%2520Toxicology%26date%3D2009%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newsholme, S.</span>; <span class="NLM_string-name">Dunsford, W.</span>; <span class="NLM_string-name">Brodie, T.</span>; <span class="NLM_string-name">Brennan, C.</span>; <span class="NLM_string-name">Brown, M.</span>; <span class="NLM_string-name">Geiger, L.</span></span> <span> </span><span class="NLM_article-title">PS 896-Mouse Carcinogenicity Study with GW501516, a PPAR delta Agonist</span>.  <i>48th Annual Meeting of the Society of Toxicology, March 16–19, 2009, Baltimore</i>. <span class="NLM_publisher-name">Society of Toxicology</span>, <span class="NLM_year">2009</span>; p  <span class="NLM_fpage">185</span>. <a href="https://web.archive.org/web/20150504013406/http:/www.toxicology.org/AI/PUB/Tox/2009Tox.pdf" class="extLink">https://web.archive.org/web/20150504013406/http:/www.toxicology.org/AI/PUB/Tox/2009Tox.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=185&author=S.+Newsholme&author=W.+Dunsford&author=T.+Brodie&author=C.+Brennan&author=M.+Brown&author=L.+Geiger&title=PS+896-Mouse+Carcinogenicity+Study+with+GW501516%2C+a+PPAR+delta+Agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DNewsholme%26aufirst%3DS.%26atitle%3DPS%2520896-Mouse%2520Carcinogenicity%2520Study%2520with%2520GW501516%252C%2520a%2520PPAR%2520delta%2520Agonist%26jtitle%3D48th%2520Annual%2520Meeting%2520of%2520the%2520Society%2520of%2520Toxicology%252C%2520March%252016%25E2%2580%259319%252C%25202009%252C%2520Baltimore%26pub%3DSociety%2520of%2520Toxicology%26date%3D2009%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tesse, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andriantsitohaina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragot, T.</span></span> <span> </span><span class="NLM_article-title">PPAR Activity in Cardiovascular Diseases: a Potential Pharmacological Target</span>. <i>PPAR Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span>,  <span class="NLM_fpage">745821</span>, <span class="refDoi"> DOI: 10.1155/2009/745821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1155%2F2009%2F745821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19325917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BD1M3jslejtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=745821&author=A.+Tesseauthor=R.+Andriantsitohainaauthor=T.+Ragot&title=PPAR+Activity+in+Cardiovascular+Diseases%3A+a+Potential+Pharmacological+Target&doi=10.1155%2F2009%2F745821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ activity in cardiovascular diseases: A potential pharmacological target</span></div><div class="casAuthors">Tesse Angela; Andriantsitohaina Ramaroson; Ragot Thierry</div><div class="citationInfo"><span class="NLM_cas:title">PPAR research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2009</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">745821</span>
        ISSN:<span class="NLM_cas:issn">1687-4757</span>.
    </div><div class="casAbstract">Activation of peroxisome proliferator-activated receptors (PPARs), and particularly of PPARα and PPARγ, using selective agonists, is currently used in the treatment of metabolic diseases such as hypertriglyceridemia and type 2 diabetes mellitus.  PPARα and PPARγ anti-inflammatory, antiproliferative and antiangiogenic properties in cardiovascular cells were extensively clarified in a variety of in vitro and in vivo models.  In contrast, the role of PPARδ in cardiovascular system is poorly understood.  Prostacyclin, the predominant prostanoid released by vascular cells, is a putative endogenous agonist for PPARδ, but only recently PPARδ selective synthetic agonists were found, improving studies about the physiological and pathophysiological roles of PPARδ activation.  Recent reports suggest that the PPARδ activation may play a pivotal role to regulate inflammation, apoptosis, and cell proliferation, suggesting that this transcriptional factor could become an interesting pharmacological target to regulate cardiovascular cell apoptosis, proliferation, inflammation, and metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPs-wl7dOX5a2q3xNe7a7QfW6udTcc2eb6vrql5m-Mhrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3jslejtA%253D%253D&md5=d74d12f08066eb941c3258ce552e151c</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1155%2F2009%2F745821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2009%252F745821%26sid%3Dliteratum%253Aachs%26aulast%3DTesse%26aufirst%3DA.%26aulast%3DAndriantsitohaina%26aufirst%3DR.%26aulast%3DRagot%26aufirst%3DT.%26atitle%3DPPAR%2520Activity%2520in%2520Cardiovascular%2520Diseases%253A%2520a%2520Potential%2520Pharmacological%2520Target%26jtitle%3DPPAR%2520Res.%26date%3D2009%26volume%3D2009%26spage%3D745821%26doi%3D10.1155%2F2009%2F745821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasrallah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hébert, R. L.</span></span> <span> </span><span class="NLM_article-title">The PPAR Ligand GW501516 Reduces Growth but Not Apoptosis in Mouse Inner Medullary Collecting Duct Cells</span>. <i>PPAR Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span>,  <span class="NLM_fpage">706283</span>, <span class="refDoi"> DOI: 10.1155/2009/706283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1155%2F2009%2F706283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19266055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ovFKrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=706283&author=J.+Clarkauthor=R.+Nasrallahauthor=R.+L.+H%C3%A9bert&title=The+PPAR+Ligand+GW501516+Reduces+Growth+but+Not+Apoptosis+in+Mouse+Inner+Medullary+Collecting+Duct+Cells&doi=10.1155%2F2009%2F706283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">The PPARδ ligand GW501516 reduces growth but not apoptosis in mouse inner medullary collecting duct cells</span></div><div class="casAuthors">Clark Jordan; Nasrallah Rania; Hebert Richard L</div><div class="citationInfo"><span class="NLM_cas:title">PPAR research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2009</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">706283</span>
        ISSN:<span class="NLM_cas:issn">1687-4757</span>.
    </div><div class="casAbstract">The collecting duct (CD) expresses considerable amounts of PPARδ.  While its role is unknown in the CD, in other renal cells it has been shown to regulate both growth and apoptosis.  We thus hypothesized that PPARδ reduces apoptotic responses and stimulates cell growth in the mouse CD, and examined the effect of GW501516, a synthetic PPARδ ligand, on these responses in mouse IMCD-K2 cells.  High doses of GW501516 decreased both DNA and protein synthesis in these cells by 80%, but had no overall effect on cell viability.  Although anisomycin treatment resulted in an increase of caspase-3 levels of about 2.59-fold of control, GW501516 did not affect anisomycin-induced changes in active caspase-3 levels.  These results show that a PPARδ ligand inhibits growth but does not affect anisomycin-apoptosis in a mouse IMCD cell line.  This could have therapeutic implications for renal diseases associated with increased CD growth responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOHATOeyYDN0Q0lWbKiCflfW6udTcc2eZBH2jT_5So_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ovFKrtw%253D%253D&md5=a294ebb4236546cc8b43b1b41ec51765</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1155%2F2009%2F706283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2009%252F706283%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DNasrallah%26aufirst%3DR.%26aulast%3DH%25C3%25A9bert%26aufirst%3DR.%2BL.%26atitle%3DThe%2520PPAR%2520Ligand%2520GW501516%2520Reduces%2520Growth%2520but%2520Not%2520Apoptosis%2520in%2520Mouse%2520Inner%2520Medullary%2520Collecting%2520Duct%2520Cells%26jtitle%3DPPAR%2520Res.%26date%3D2009%26volume%3D2009%26spage%3D706283%26doi%3D10.1155%2F2009%2F706283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weigand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittrich-Wengenroth, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckroth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaupel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, M.</span></span> <span> </span><span class="NLM_article-title">Minor Structural Modifications Convert a Selective PPARα Agonist into a Potent, Highly Selective PPARδ Agonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4619</span>– <span class="NLM_lpage">4623</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2005.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16115765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVSru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4619-4623&author=S.+Weigandauthor=H.+Bischoffauthor=E.+Dittrich-Wengenrothauthor=H.+Heckrothauthor=D.+Langauthor=A.+Vaupelauthor=M.+Woltering&title=Minor+Structural+Modifications+Convert+a+Selective+PPAR%CE%B1+Agonist+into+a+Potent%2C+Highly+Selective+PPAR%CE%B4+Agonist&doi=10.1016%2Fj.bmcl.2005.06.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Minor structural modifications convert a selective PPARα agonist into a potent, highly selective PPARδ agonist</span></div><div class="casAuthors">Weigand, Stefan; Bischoff, Hilmar; Dittrich-Wengenroth, Elke; Heckroth, Heike; Lang, Dieter; Vaupel, Andrea; Woltering, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4619-4623</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the solid-phase synthesis and pharmacol. evaluation of a new series of small-mol. agonists of the human peroxisome proliferator-activated receptor δ (PPARδ) based on a lead structure from our PPARα program.  Compd. I showed good pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGF1DtnxMwqbVg90H21EOLACvtfcHk0lhacDqgzaotyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVSru78%253D&md5=3a159829fddcfa41ac96c2951fa22ad2</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DWeigand%26aufirst%3DS.%26aulast%3DBischoff%26aufirst%3DH.%26aulast%3DDittrich-Wengenroth%26aufirst%3DE.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DLang%26aufirst%3DD.%26aulast%3DVaupel%26aufirst%3DA.%26aulast%3DWoltering%26aufirst%3DM.%26atitle%3DMinor%2520Structural%2520Modifications%2520Convert%2520a%2520Selective%2520PPAR%25CE%25B1%2520Agonist%2520into%2520a%2520Potent%252C%2520Highly%2520Selective%2520PPAR%25CE%25B4%2520Agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4619%26epage%3D4623%26doi%3D10.1016%2Fj.bmcl.2005.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Epple, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerken, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iskandar, M.</span></span> <span> </span><span class="NLM_article-title">1, 3, 5-Trisubstituted Aryls as Highly Selective PPARδ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2969</span>– <span class="NLM_lpage">2973</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.02.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2006.02.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16546385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFygt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2969-2973&author=R.+Eppleauthor=M.+Azimioaraauthor=R.+Russoauthor=B.+Bursulayaauthor=S.-S.+Tianauthor=A.+Gerkenauthor=M.+Iskandar&title=1%2C+3%2C+5-Trisubstituted+Aryls+as+Highly+Selective+PPAR%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2006.02.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">1,3,5-Trisubstituted aryls as highly selective PPARδ agonists</span></div><div class="casAuthors">Epple, Robert; Azimioara, Mihai; Russo, Ross; Bursulaya, Badry; Tian, Shin-Shay; Gerken, Andrea; Iskandar, Maya</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2969-2973</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of highly potent and selective PPARδ agonists is described using the known non-selective ligand GW2433 as a structural template.  Compd. 1 is bioavailable, potent (10 nM), and shows no cross-activity with other PPAR subtypes up to 10 μM, making it a useful tool in studying the biol. effects of selective PPARδ activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW7T2nUocvn7Vg90H21EOLACvtfcHk0lgt6AqPh4CTWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFygt7c%253D&md5=88ee3a803c1d49a04a07dd5f08b063d4</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.02.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.02.079%26sid%3Dliteratum%253Aachs%26aulast%3DEpple%26aufirst%3DR.%26aulast%3DAzimioara%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DS.-S.%26aulast%3DGerken%26aufirst%3DA.%26aulast%3DIskandar%26aufirst%3DM.%26atitle%3D1%252C%25203%252C%25205-Trisubstituted%2520Aryls%2520as%2520Highly%2520Selective%2520PPAR%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2969%26epage%3D2973%26doi%3D10.1016%2Fj.bmcl.2006.02.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Epple, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wityak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanewsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerken, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iskandar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.-S.</span></span> <span> </span><span class="NLM_article-title">3, 4, 5-Trisubstituted Isoxazoles as Novel PPARδ Agonists: Part 1</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4376</span>– <span class="NLM_lpage">4380</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2006.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16750626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFertLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4376-4380&author=R.+Eppleauthor=R.+Russoauthor=M.+Azimioaraauthor=C.+Cowauthor=Y.+Xieauthor=X.+Wangauthor=J.+Wityakauthor=D.+Karanewskyauthor=A.+Gerkenauthor=M.+Iskandarauthor=E.+Saezauthor=M.+H.+Seidelauthor=S.-S.+Tian&title=3%2C+4%2C+5-Trisubstituted+Isoxazoles+as+Novel+PPAR%CE%B4+Agonists%3A+Part+1&doi=10.1016%2Fj.bmcl.2006.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists</span></div><div class="casAuthors">Epple, Robert; Russo, Ross; Azimioara, Mihai; Cow, Christopher; Xie, Yongping; Wang, Xing; Wityak, John; Karanewsky, Don; Gerken, Andrea; Iskandar, Maya; Saez, Enrique; Seidel, H. Martin; Tian, Shin-Shay</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4376-4380</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors report the identification of a novel series of trisubstituted isoxazoles as PPAR activators from a high-throughput screen.  A series of structural optimizations led to improved efficacy and excellent functional receptor selectivity for PPARδ.  The isoxazoles represent a series of agonists which display a scaffold that lies outside the typical PPAR agonist motif.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAvw4diG8II7Vg90H21EOLACvtfcHk0lgt6AqPh4CTWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFertLY%253D&md5=879c14f32d1515ce9099d1f8685530dd</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DEpple%26aufirst%3DR.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DAzimioara%26aufirst%3DM.%26aulast%3DCow%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DKaranewsky%26aufirst%3DD.%26aulast%3DGerken%26aufirst%3DA.%26aulast%3DIskandar%26aufirst%3DM.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DSeidel%26aufirst%3DM.%2BH.%26aulast%3DTian%26aufirst%3DS.-S.%26atitle%3D3%252C%25204%252C%25205-Trisubstituted%2520Isoxazoles%2520as%2520Novel%2520PPAR%25CE%25B4%2520Agonists%253A%2520Part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4376%26epage%3D4380%26doi%3D10.1016%2Fj.bmcl.2006.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Epple, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wityak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanewsky, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyên-Trân, V. T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spalding, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerken, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iskandar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.-S.</span></span> <span> </span><span class="NLM_article-title">Novel Bisaryl Substituted Thiazoles and Oxazoles as Highly Potent and Selective Peroxisome Proliferator-activated Receptor δ Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1021/jm9007399</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9007399" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVClurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=77-105&author=R.+Eppleauthor=C.+Cowauthor=Y.+Xieauthor=M.+Azimioaraauthor=R.+Russoauthor=X.+Wangauthor=J.+Wityakauthor=D.+S.+Karanewskyauthor=T.+Tuntlandauthor=V.+T.+B.+Nguy%C3%AAn-Tr%C3%A2nauthor=C.+C.+Ngoauthor=D.+Huangauthor=E.+Saezauthor=T.+Spaldingauthor=A.+Gerkenauthor=M.+Iskandarauthor=H.+M.+Seidelauthor=S.-S.+Tian&title=Novel+Bisaryl+Substituted+Thiazoles+and+Oxazoles+as+Highly+Potent+and+Selective+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonists&doi=10.1021%2Fjm9007399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Bisaryl Substituted Thiazoles and Oxazoles as Highly Potent and Selective Peroxisome Proliferator-Activated Receptor δ Agonists</span></div><div class="casAuthors">Epple, Robert; Cow, Christopher; Xie, Yongping; Azimioara, Mihai; Russo, Ross; Wang, Xing; Wityak, John; Karanewsky, Donald S.; Tuntland, Tove; Nguyen-Tran, Van T. B.; Cuc Ngo, Cara; Huang, David; Saez, Enrique; Spalding, Tracy; Gerken, Andrea; Iskandar, Maya; Seidel, H. Martin; Tian, Shin-Shay</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-105</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery, synthesis, and optimization of compd. I from a high-throughput screening hit to highly potent and selective peroxisome proliferator-activated receptor δ (PPARδ) agonists are reported.  The synthesis and structure-activity relationship in this series are described in detail.  On the basis of a general schematic PPAR pharmacophore model, scaffold I was divided into headgroup, linker, and tailgroup and successively optimized for PPAR activation using in vitro PPAR transactivation assays.  A (2-methylphenoxy)acetic acid headgroup, a flexible linker, and a five-membered heteroarom. center ring with two hydrophobic aryl substituents were required for efficient and selective PPARδ activation.  The fine-tuning of these aryl substituents led to an array of highly potent and selective compds. such as compd. II, displaying an excellent pharmacokinetic profile in mouse.  In an in vivo acute dosing model, selected members of this array were shown to induce the expression of pyruvate dehydrogenase kinase-4 (PDK4) and uncoupling protein-3 (UCP3), genes that are known to be involved in energy homeostasis and regulated by PPARδ in skeletal muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMfZfyIV-SvrVg90H21EOLACvtfcHk0lhRxvfn0u0rsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVClurnJ&md5=943649f2307befb02170b34ceca4326e</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm9007399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9007399%26sid%3Dliteratum%253Aachs%26aulast%3DEpple%26aufirst%3DR.%26aulast%3DCow%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DAzimioara%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DKaranewsky%26aufirst%3DD.%2BS.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DNguy%25C3%25AAn-Tr%25C3%25A2n%26aufirst%3DV.%2BT.%2BB.%26aulast%3DNgo%26aufirst%3DC.%2BC.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DSpalding%26aufirst%3DT.%26aulast%3DGerken%26aufirst%3DA.%26aulast%3DIskandar%26aufirst%3DM.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DTian%26aufirst%3DS.-S.%26atitle%3DNovel%2520Bisaryl%2520Substituted%2520Thiazoles%2520and%2520Oxazoles%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D77%26epage%3D105%26doi%3D10.1021%2Fjm9007399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Havranek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogensen, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratina, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppesen, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihera, P.</span></span> <span> </span><span class="NLM_article-title">Novel Selective PPARδ Agonists: Optimization of Activity by Modification of Alkynylallylic Moiety</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4144</span>– <span class="NLM_lpage">4149</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2007.05.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17553681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVKns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4144-4149&author=M.+Havranekauthor=P.+Sauerbergauthor=J.+P.+Mogensenauthor=P.+Kratinaauthor=C.+B.+Jeppesenauthor=I.+Petterssonauthor=P.+Pihera&title=Novel+Selective+PPAR%CE%B4+Agonists%3A+Optimization+of+Activity+by+Modification+of+Alkynylallylic+Moiety&doi=10.1016%2Fj.bmcl.2007.05.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective PPARδ agonists: Optimization of activity by modification of alkynylallylic moiety</span></div><div class="casAuthors">Havranek, Miroslav; Sauerberg, Per; Mogensen, John P.; Kratina, Pavel; Jeppesen, Claus B.; Pettersson, Ingrid; Pihera, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4144-4149</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Y-shaped mols. bearing alkynylallylic moieties were found to be potent and selective PPARδ activators.  The alkynylallylic moiety was synthesized from alkyn-1-ols by hydroalumination followed by a cross-coupling reaction.  Series of active compds. were obtained by stepwise changing the structure of a known PPARpan agonist into Y-shaped compds.  The most active and selective compd., I, had a PPARδ potency of 0.13 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmhoVrD4tMVbVg90H21EOLACvtfcHk0lhRxvfn0u0rsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVKns7c%253D&md5=e8d583937cdb724730deb423d536f278</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.051%26sid%3Dliteratum%253Aachs%26aulast%3DHavranek%26aufirst%3DM.%26aulast%3DSauerberg%26aufirst%3DP.%26aulast%3DMogensen%26aufirst%3DJ.%2BP.%26aulast%3DKratina%26aufirst%3DP.%26aulast%3DJeppesen%26aufirst%3DC.%2BB.%26aulast%3DPettersson%26aufirst%3DI.%26aulast%3DPihera%26aufirst%3DP.%26atitle%3DNovel%2520Selective%2520PPAR%25CE%25B4%2520Agonists%253A%2520Optimization%2520of%2520Activity%2520by%2520Modification%2520of%2520Alkynylallylic%2520Moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4144%26epage%3D4149%26doi%3D10.1016%2Fj.bmcl.2007.05.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sauerberg, S.</span>; <span class="NLM_string-name">Pihera, P.</span>; <span class="NLM_string-name">Polivka, Z.</span>; <span class="NLM_string-name">Havranek, M.</span>; <span class="NLM_string-name">Pettersson, I.</span>; <span class="NLM_string-name">Mogensen, J. P.</span></span> <span> </span><span class="NLM_article-title">Phenoxy Acetic Acids as PPAR delta Activators</span>. International Patent <span class="NLM_patent">WO2007071766A2</span>, Jun 28, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=S.+Sauerberg&author=P.+Pihera&author=Z.+Polivka&author=M.+Havranek&author=I.+Pettersson&author=J.+P.+Mogensen&title=Phenoxy+Acetic+Acids+as+PPAR+delta+Activators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSauerberg%26aufirst%3DS.%26atitle%3DPhenoxy%2520Acetic%2520Acids%2520as%2520PPAR%2520delta%2520Activators%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colca, J. R.</span></span> <span> </span><span class="NLM_article-title">Discontinued Drug in 2007: Renal, Endocrine and Metabolic Drugs</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1641</span>– <span class="NLM_lpage">1650</span>, <span class="refDoi"> DOI: 10.1517/13543784.17.11.1641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1517%2F13543784.17.11.1641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18922101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CmsbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1641-1650&author=J.+R.+Colca&title=Discontinued+Drug+in+2007%3A+Renal%2C+Endocrine+and+Metabolic+Drugs&doi=10.1517%2F13543784.17.11.1641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Discontinued drug in 2007: renal, endocrine and metabolic drugs</span></div><div class="casAuthors">Colca, Jerry R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1641-1650</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  This perspective is the first part of an annual series of papers discussing drugs dropped from clin. development in the previous year.  Specifically, this paper focuses on the 14 renal, endocrine and metabolic drugs discontinued in 2007.  The candidates covered in this summary were being developed for treatment of diabetes, obesity, reproductive and urogenital health issues, and growth hormone deficiency.  Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase I - III clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNtGm68GBILLVg90H21EOLACvtfcHk0liNTfU2KLxWwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CmsbbO&md5=2e063ec890e78d7f8992630e0b7590d5</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1517%2F13543784.17.11.1641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.17.11.1641%26sid%3Dliteratum%253Aachs%26aulast%3DColca%26aufirst%3DJ.%2BR.%26atitle%3DDiscontinued%2520Drug%2520in%25202007%253A%2520Renal%252C%2520Endocrine%2520and%2520Metabolic%2520Drugs%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1641%26epage%3D1650%26doi%3D10.1517%2F13543784.17.11.1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span> <i>HPP593</i>; <span class="NLM_publisher-name">vTv Therapeutics</span>, <span class="NLM_year">2017</span>; <a href="https://vtvtherapeutics.com/pipeline/hpp593/" class="extLink">https://vtvtherapeutics.com/pipeline/hpp593/</a> (accessed 2020-02-12).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+HPP593%3B+vTv+Therapeutics%2C+2017%3B+https%3A%2F%2Fvtvtherapeutics.com%2Fpipeline%2Fhpp593%2F+%28accessed+2020-02-12%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DHPP593%26pub%3DvTv%2520Therapeutics%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarest, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, G.-H.</span></span> <span> </span><span class="NLM_article-title">Discovery of Para-alkylthiophenoxyacetic Acids as a Novel Series of Potent and Selective PPARδ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3855</span>– <span class="NLM_lpage">3859</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2007.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17524639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVCltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3855-3859&author=R.+Zhangauthor=A.+Wangauthor=A.+DeAngelisauthor=P.+Peltonauthor=J.+Xuauthor=P.+Zhuauthor=L.+Zhouauthor=K.+Demarestauthor=W.+V.+Murrayauthor=G.-H.+Kuo&title=Discovery+of+Para-alkylthiophenoxyacetic+Acids+as+a+Novel+Series+of+Potent+and+Selective+PPAR%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2007.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of para-alkylthiophenoxyacetic acids as a novel series of potent and selective PPARδ agonists</span></div><div class="casAuthors">Zhang, Rui; Wang, Aihua; DeAngelis, Alan; Pelton, Patricia; Xu, Jun; Zhu, Peifang; Zhou, Lubing; Demarest, Keith; Murray, William V.; Kuo, Gee-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3855-3859</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A novel series of potent and selective PPARδ agonists, p-alkylthiophenoxyacetic acids [I, X = S, O, S(O); Y = O, CH2; R = OH, MeO, OMOM, Me, etc.] was identified.  The synthesis and structure-activity relationships are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrewkJuqJPxjbVg90H21EOLACvtfcHk0liNTfU2KLxWwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVCltbw%253D&md5=b7974387d421bb4f1fa6882ab89733df</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DDeAngelis%26aufirst%3DA.%26aulast%3DPelton%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26aulast%3DKuo%26aufirst%3DG.-H.%26atitle%3DDiscovery%2520of%2520Para-alkylthiophenoxyacetic%2520Acids%2520as%2520a%2520Novel%2520Series%2520of%2520Potent%2520and%2520Selective%2520PPAR%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3855%26epage%3D3859%26doi%3D10.1016%2Fj.bmcl.2007.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber-McMaster, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarest, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, G. H.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR of Para-alkylthiophenoxyacetic Acids as Potent and Selective PPARδ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1101</span>– <span class="NLM_lpage">1104</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.12.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2008.12.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19168353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1101-1104&author=R.+Zhangauthor=A.+DeAngelisauthor=A.+Wangauthor=E.+Sieber-McMasterauthor=X.+Liauthor=R.+Russellauthor=P.+Peltonauthor=J.+Xuauthor=P.+Zhuauthor=L.+Zhouauthor=K.+Demarestauthor=W.+V.+Murrayauthor=G.+H.+Kuo&title=Discovery+and+SAR+of+Para-alkylthiophenoxyacetic+Acids+as+Potent+and+Selective+PPAR%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2008.12.113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARδ agonists</span></div><div class="casAuthors">Zhang, Rui; De Angelis, Alan; Wang, Aihua; Sieber-McMaster, Ellen; Li, Xun; Russell, Ronald; Pelton, Patricia; Xu, Jun; Zhu, Peifang; Zhou, Lubing; Demarest, Keith; Murray, William V.; Kuo, Gee-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1101-1104</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthesis and SAR of para-alkylthiophenoxyacetic acids was described.  Achiral compds. I [R1R2 = CMe2, (CH2)2; R1 = R2 = n-Pr] were identified as potent and selective PPARδ agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXrta22nBA_bVg90H21EOLACvtfcHk0lgKh-7D_l_Jtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wrt7g%253D&md5=6028da6eee6963cd3bb6abd2a66a3d36</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.113%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDeAngelis%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSieber-McMaster%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DPelton%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26aulast%3DKuo%26aufirst%3DG.%2BH.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520Para-alkylthiophenoxyacetic%2520Acids%2520as%2520Potent%2520and%2520Selective%2520PPAR%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1101%26epage%3D1104%26doi%3D10.1016%2Fj.bmcl.2008.12.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber-McMaster, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarest, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, G. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Structure–activity Relationships of Thiadiazole-derivatives as Potent and Orally Active Peroxisome Proliferator-activated Receptor α/δ Dual Agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3321</span>– <span class="NLM_lpage">3341</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmc.2007.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18155554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFeqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=3321-3341&author=L.+Shenauthor=Y.+Zhangauthor=A.+Wangauthor=E.+Sieber-McMasterauthor=X.+Chenauthor=P.+Peltonauthor=J.+Z.+Xuauthor=M.+Yangauthor=P.+Zhuauthor=L.+Zhouauthor=M.+Reumanauthor=Z.+Huauthor=R.+Russellauthor=A.+C.+Gibbsauthor=H.+Rossauthor=K.+Demarestauthor=W.+V.+Murrayauthor=G.+H.+Kuo&title=Synthesis+and+Structure%E2%80%93activity+Relationships+of+Thiadiazole-derivatives+as+Potent+and+Orally+Active+Peroxisome+Proliferator-activated+Receptor+%CE%B1%2F%CE%B4+Dual+Agonists&doi=10.1016%2Fj.bmc.2007.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors α/δ dual agonists</span></div><div class="casAuthors">Shen, Lan; Zhang, Yan; Wang, Aihua; Sieber-McMaster, Ellen; Chen, Xiaoli; Pelton, Patricia; Xu, June Z.; Yang, Maria; Zhu, Peifang; Zhou, Lubing; Reuman, Michael; Hu, Zhiyong; Russell, Ronald; Gibbs, Alan C.; Ross, Hamish; Demarest, Keith; Murray, William V.; Kuo, Gee-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3321-3341</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Replacement of the methyl-thiazole moiety of GW501516 (a PPARδ selective agonist) with [1,2,4]thiadiazole gave compd. 21 (I) which unexpectedly displayed submicromolar potency as a partial agonist at PPARα in addn. to the high potency at PPARδ.  A structure-activity relationships study of 21 resulted in the identification of 40 as a potent and selective PPARα/δ dual agonist.  Compd. 40 and its close analogs represent a new series of PPARα/δ dual agonists.  The high potency, high selectivity, significant gene induction, excellent PK profiles, low P 450 inhibition or induction, and good in vivo efficacy in four animal models support 40 being selected as a pre-clin. study candidate, and may render 40 as a valuable pharmacol. tool in elucidating the complex roles of PPARα/δ dual agonists, and the potential usage for the treatment of metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0jJSgGujySLVg90H21EOLACvtfcHk0lgKh-7D_l_Jtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFeqsbs%253D&md5=f97267398567b5034c7edae1dd0f1632</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSieber-McMaster%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPelton%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%2BZ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DReuman%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DRoss%26aufirst%3DH.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26aulast%3DKuo%26aufirst%3DG.%2BH.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593activity%2520Relationships%2520of%2520Thiadiazole-derivatives%2520as%2520Potent%2520and%2520Orally%2520Active%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B1%252F%25CE%25B4%2520Dual%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D3321%26epage%3D3341%26doi%3D10.1016%2Fj.bmc.2007.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bratton, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulaski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unangst, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Potent and Selective Benzyloxybenzyl-based Peroxisome Proliferator-activated Receptor (PPAR) δ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3624</span>– <span class="NLM_lpage">3629</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.04.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2007.04.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17498950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFaitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3624-3629&author=L.+D.+Brattonauthor=G.+F.+Filzenauthor=A.+Geyerauthor=J.+K.+Hoffmanauthor=G.+Luauthor=J.+Pulaskiauthor=B.+K.+Trivediauthor=P.+C.+Unangstauthor=X.+Xu&title=Discovery+of+Highly+Potent+and+Selective+Benzyloxybenzyl-based+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29+%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2007.04.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent and selective benzyloxybenzyl-based peroxisome proliferator-activator receptor (PPAR) δ agonists</span></div><div class="casAuthors">Bratton, Larry D.; Filzen, Gary F.; Geyer, Andrew; Hoffman, Jennifer K.; Lu, Gina; Pulaski, Jim; Trivedi, Bharat K.; Unangst, Paul C.; Xu, Xiangyang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3624-3629</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 1,4-benzyloxybenzylsulfanylaryl carboxylic acids, e.g. I (R1 = Ph, 4-MeOC6H4, 4-ClC6H4, etc.) and II (R2 = H, F), were prepd. and their activities for PPAR receptor subtypes (α, δ, and γ) with potential indications for the treatment of dyslipidemia were investigated.  I (R1 = 4-F3CC6H4) displayed the greatest binding affinity (IC50 = 10 nM) and selectivity (120-fold) for PPARδ over PPARα.  Many of the analogs investigated were found to be highly selective for PPARδ and were dependent on the point of attachment of the substituent.  In the 1,2-series, analog II (R2 = 5-F) was found to be the most potent (IC50 = 1.7 nM) and selective (>1000-fold) compd. for PPARδ.  None of the compds. tested showed appreciable binding affinity for PPARγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhZz78FnwEkrVg90H21EOLACvtfcHk0lgd7nFi930V9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFaitL0%253D&md5=b8078689543a9d9330039e23cc663575</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.04.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.04.046%26sid%3Dliteratum%253Aachs%26aulast%3DBratton%26aufirst%3DL.%2BD.%26aulast%3DFilzen%26aufirst%3DG.%2BF.%26aulast%3DGeyer%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%2BK.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DPulaski%26aufirst%3DJ.%26aulast%3DTrivedi%26aufirst%3DB.%2BK.%26aulast%3DUnangst%26aufirst%3DP.%2BC.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520Highly%2520Potent%2520and%2520Selective%2520Benzyloxybenzyl-based%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%2520%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3624%26epage%3D3629%26doi%3D10.1016%2Fj.bmcl.2007.04.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erasga, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulaski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorenson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unangst, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of Selective Benzothiophene, Benzofuran, and Indole-based Peroxisome Proliferator-activated Receptor δ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3630</span>– <span class="NLM_lpage">3635</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.04.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2007.04.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17512197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFaitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3630-3635&author=G.+F.+Filzenauthor=L.+Brattonauthor=X.-M.+Chengauthor=N.+Erasgaauthor=A.+Geyerauthor=C.+Leeauthor=G.+Luauthor=J.+Pulaskiauthor=R.+J.+Sorensonauthor=P.+C.+Unangstauthor=B.+K.+Trivediauthor=X.+Xu&title=Synthesis+and+SAR+of+Selective+Benzothiophene%2C+Benzofuran%2C+and+Indole-based+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2007.04.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor δ agonists</span></div><div class="casAuthors">Filzen, Gary F.; Bratton, Larry; Cheng, Xue-Min; Erasga, Noe; Geyer, Andrew; Lee, Chitase; Lu, Gina; Pulaski, Jim; Sorenson, Roderick J.; Unangst, Paul C.; Trivedi, B. K.; Xu, Xiangyang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3630-3635</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Recent literature has suggested the benefit of selective PPARδ agonists for the treatment of atherosclerosis and other disease states assocd. with the metabolic syndrome.  Therefore the synthesis and structure-activity relationships of selective PPARδ agonists are reported.  The research began with identification of a benzothiophene template which was modified by the addn. of various thiazolyl, isoxazolyl, and benzyloxy-benzyl moieties.  Further elucidation of the SAR led to the identification of benzofuran and indole based templates.  Three chem. templates, e.g., I (X = O, S) and II, with varying degrees of affinity and potency for PPARδ vs. the PPARα and PPARγ subtypes were discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp879sbRiaFVbVg90H21EOLACvtfcHk0li74y261U6Bow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFaitLo%253D&md5=c0faf4559e4130413b84abfef09bfbc4</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.04.047%26sid%3Dliteratum%253Aachs%26aulast%3DFilzen%26aufirst%3DG.%2BF.%26aulast%3DBratton%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DX.-M.%26aulast%3DErasga%26aufirst%3DN.%26aulast%3DGeyer%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DPulaski%26aufirst%3DJ.%26aulast%3DSorenson%26aufirst%3DR.%2BJ.%26aulast%3DUnangst%26aufirst%3DP.%2BC.%26aulast%3DTrivedi%26aufirst%3DB.%2BK.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520Selective%2520Benzothiophene%252C%2520Benzofuran%252C%2520and%2520Indole-based%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3630%26epage%3D3635%26doi%3D10.1016%2Fj.bmcl.2007.04.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakawa, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a Novel Human PPARδ Selective Agonist and its Stimulatory Effect on Oligodendrocyte Differentiation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2010.11.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21112784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sqsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=240-244&author=S.+Sakumaauthor=T.+Endoauthor=T.+Kandaauthor=H.+Nakamuraauthor=S.+Yamasakiauthor=T.+Yamakawa&title=Synthesis+of+a+Novel+Human+PPAR%CE%B4+Selective+Agonist+and+its+Stimulatory+Effect+on+Oligodendrocyte+Differentiation&doi=10.1016%2Fj.bmcl.2010.11.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a novel human PPARδ selective agonist and its stimulatory effect on oligodendrocyte differentiation</span></div><div class="casAuthors">Sakuma, Shogo; Endo, Tsuyoshi; Kanda, Takashi; Nakamura, Hideki; Yamasaki, Satomi; Yamakawa, Tomio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-244</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel peroxisome proliferator-activated receptor (PPAR)δ selective agonist with a characteristic benzisoxazole ring, I, was successfully synthesized.  Compd. I exhibited potent human PPARδ transactivation activity and high δ selectivity.  Further, it stimulated differentiation of primary oligodendrocyte precursor cells in vitro, indicating that it may be an effective drug in the treatment of demyelinating disorders such as multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4B5Mta2tQlLVg90H21EOLACvtfcHk0li74y261U6Bow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sqsb7J&md5=3a7d74f2f007c601a273b75699478f26</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DSakuma%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DT.%26aulast%3DKanda%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DYamasaki%26aufirst%3DS.%26aulast%3DYamakawa%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520a%2520Novel%2520Human%2520PPAR%25CE%25B4%2520Selective%2520Agonist%2520and%2520its%2520Stimulatory%2520Effect%2520on%2520Oligodendrocyte%2520Differentiation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D240%26epage%3D244%26doi%3D10.1016%2Fj.bmcl.2010.11.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakawa, T.</span></span> <span> </span><span class="NLM_article-title">Effects of a Novel PPARδ Agonist NCP-1046 on the Wound Healing in Animal Models</span>. <i>J. Dermatol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>86</i></span>, <span class="NLM_elocation-id">e92</span> <span class="refDoi"> DOI: 10.1016/j.jdermsci.2017.02.269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.jdermsci.2017.02.269" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2017&author=T.+Hiraiauthor=T.+Hamanoauthor=T.+Yamakawa&title=Effects+of+a+Novel+PPAR%CE%B4+Agonist+NCP-1046+on+the+Wound+Healing+in+Animal+Models&doi=10.1016%2Fj.jdermsci.2017.02.269"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.jdermsci.2017.02.269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdermsci.2017.02.269%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DT.%26aulast%3DHamano%26aufirst%3DT.%26aulast%3DYamakawa%26aufirst%3DT.%26atitle%3DEffects%2520of%2520a%2520Novel%2520PPAR%25CE%25B4%2520Agonist%2520NCP-1046%2520on%2520the%2520Wound%2520Healing%2520in%2520Animal%2520Models%26jtitle%3DJ.%2520Dermatol.%2520Sci.%26date%3D2017%26volume%3D86%26doi%3D10.1016%2Fj.jdermsci.2017.02.269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luckhurst, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allenby, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botterell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walding, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Isoindoline and Tetrahydroisoquinoline Derivatives as Potent, Selective PPARδ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2010.10.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21094606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SqsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=492-496&author=C.+A.+Luckhurstauthor=L.+A.+Steinauthor=M.+Furberauthor=N.+Webbauthor=M.+J.+Ratcliffeauthor=G.+Allenbyauthor=S.+Botterellauthor=W.+Tomlinsonauthor=B.+Martinauthor=A.+Walding&title=Discovery+of+Isoindoline+and+Tetrahydroisoquinoline+Derivatives+as+Potent%2C+Selective+PPAR%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2010.10.117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARδ agonists</span></div><div class="casAuthors">Luckhurst, Christopher A.; Stein, Linda A.; Furber, Mark; Webb, Nicola; Ratcliffe, Marianne J.; Allenby, Gary; Botterell, Sara; Tomlinson, Wendy; Martin, Barrie; Walding, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">492-496</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small mol. isoindoline and tetrahydroisoquinoline derivs. have been identified as selective agonists of human peroxisome proliferator-activated receptor δ (PPARδ).  Compd. 18 (I) demonstrated efficacy in a biomarker for increased fatty acid oxidn., with upregulation of pyruvate dehydrogenase kinase, isoenzyme 4 (PDK4) in human primary myotubes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOjy--dYG4fbVg90H21EOLACvtfcHk0li74y261U6Bow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SqsbjK&md5=781fec41ffa71df5e2422561e66dc037</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.117%26sid%3Dliteratum%253Aachs%26aulast%3DLuckhurst%26aufirst%3DC.%2BA.%26aulast%3DStein%26aufirst%3DL.%2BA.%26aulast%3DFurber%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DN.%26aulast%3DRatcliffe%26aufirst%3DM.%2BJ.%26aulast%3DAllenby%26aufirst%3DG.%26aulast%3DBotterell%26aufirst%3DS.%26aulast%3DTomlinson%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DB.%26aulast%3DWalding%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520Isoindoline%2520and%2520Tetrahydroisoquinoline%2520Derivatives%2520as%2520Potent%252C%2520Selective%2520PPAR%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D492%26epage%3D496%26doi%3D10.1016%2Fj.bmcl.2010.10.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span>; <span class="NLM_string-name">Malecha, J. M.</span>; <span class="NLM_string-name">Noble, S. G.</span>; <span class="NLM_string-name">Duron, S. G.</span>; <span class="NLM_string-name">Lindstrom, A. K.</span>; <span class="NLM_string-name">Shiau, A. K.</span></span> <span> </span><span class="NLM_article-title">Aryl Sulfonamide and Sulfonyl Compounds as Modulators of PPAR and Methods of Treating Metabolic Disorders</span>. International Patent <span class="NLM_patent">WO2005115983A1</span>, Dec 8, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=C.+Zhao&author=J.+M.+Malecha&author=S.+G.+Noble&author=S.+G.+Duron&author=A.+K.+Lindstrom&author=A.+K.+Shiau&title=Aryl+Sulfonamide+and+Sulfonyl+Compounds+as+Modulators+of+PPAR+and+Methods+of+Treating+Metabolic+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DC.%26atitle%3DAryl%2520Sulfonamide%2520and%2520Sulfonyl%2520Compounds%2520as%2520Modulators%2520of%2520PPAR%2520and%2520Methods%2520of%2520Treating%2520Metabolic%2520Disorders%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malecha, J. M.</span>; <span class="NLM_string-name">Zhao, C.</span>; <span class="NLM_string-name">Robinson, C. K. M.</span>; <span class="NLM_string-name">Duron, S. G.</span>; <span class="NLM_string-name">Sertc, M.</span></span>’ <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, S. A.</span></span> <span> </span><span class="NLM_article-title">(5-(2-Phenyl)-thiazol-5-ylmethoxy)-indol-1-yl)-acetic Acid Derivatives and Related Compounds as Modulators of the Human PPAR-delta Receptor for the Treatment of Metabolic Disorders such as Type 2 Diabetes</span>. International Patent <span class="NLM_patent">WO2005060958A1</span>, Jul 7, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.+M.+Malecha&author=C.+Zhao&author=C.+K.+M.+Robinson&author=S.+G.+Duron&author=M.+Sertcauthor=S.+A.+Noble&title=%285-%282-Phenyl%29-thiazol-5-ylmethoxy%29-indol-1-yl%29-acetic+Acid+Derivatives+and+Related+Compounds+as+Modulators+of+the+Human+PPAR-delta+Receptor+for+the+Treatment+of+Metabolic+Disorders+such+as+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMalecha%26aufirst%3DJ.%2BM.%26aulast%3DNoble%26aufirst%3DS.%2BA.%26atitle%3D%25285-%25282-Phenyl%2529-thiazol-5-ylmethoxy%2529-indol-1-yl%2529-acetic%2520Acid%2520Derivatives%2520and%2520Related%2520Compounds%2520as%2520Modulators%2520of%2520the%2520Human%2520PPAR-delta%2520Receptor%2520for%2520the%2520Treatment%2520of%2520Metabolic%2520Disorders%2520such%2520as%2520Type%25202%2520Diabetes%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guha, M.</span>; <span class="NLM_string-name">Deng, M.</span>; <span class="NLM_string-name">Malecha, J.</span>; <span class="NLM_string-name">Kabakibi, A.</span>; <span class="NLM_string-name">Oshiro, G.</span>; <span class="NLM_string-name">Rao, T.</span></span> <span> </span><span class="NLM_article-title">KD3010, a PPARβ/δ Selective Small Molecule Agonist, Improves Hyperglycemia and Insulin Resistance While Alleviating Rosiglitazone-induced Side Effects in Murine Models</span>.  <i>Circulation</i> <span class="NLM_year">2006</span>,  <span class="NLM_volume">114</span>, <span class="NLM_issue">18</span>,  <span class="NLM_fpage">843</span> <a href="https://www.ahajournals.org/doi/abs/10.1161/circ.114.suppl_18.II_843-a" class="extLink">https://www.ahajournals.org/doi/abs/10.1161/circ.114.suppl_18.II_843-a</a>(accessed 2019-10-14)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Guha&author=M.+Deng&author=J.+Malecha&author=A.+Kabakibi&author=G.+Oshiro&author=T.+Rao&title=KD3010%2C+a+PPAR%CE%B2%2F%CE%B4+Selective+Small+Molecule+Agonist%2C+Improves+Hyperglycemia+and+Insulin+Resistance+While+Alleviating+Rosiglitazone-induced+Side+Effects+in+Murine+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGuha%26aufirst%3DM.%26atitle%3DKD3010%252C%2520a%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Selective%2520Small%2520Molecule%2520Agonist%252C%2520Improves%2520Hyperglycemia%2520and%2520Insulin%2520Resistance%2520While%2520Alleviating%2520Rosiglitazone-induced%2520Side%2520Effects%2520in%2520Murine%2520Models%26jtitle%3DCirculation%26date%3D2006%26volume%3D114%26issue%3D18%26spage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guha, M.</span>; <span class="NLM_string-name">Grint, P.</span></span> <span> </span><span class="NLM_article-title">Sulfonyl-substituted Bicyclic Compounds as PPAR Modulators for the Treatment of Non-alcoholic Steatohepatitis</span>. International Patent <span class="NLM_patent">WO2008091863A1</span>, Jul 31, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+Guha&author=P.+Grint&title=Sulfonyl-substituted+Bicyclic+Compounds+as+PPAR+Modulators+for+the+Treatment+of+Non-alcoholic+Steatohepatitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuha%26aufirst%3DM.%26atitle%3DSulfonyl-substituted%2520Bicyclic%2520Compounds%2520as%2520PPAR%2520Modulators%2520for%2520the%2520Treatment%2520of%2520Non-alcoholic%2520Steatohepatitis%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ekambomé Basséne, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzenet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennuyer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caignard, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacquet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillaumet, G.</span></span> <span> </span><span class="NLM_article-title">Studies Towards the Conception of New Selective PPARβ/δ Ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4528</span>– <span class="NLM_lpage">4532</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2006.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16797985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFOlt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4528-4532&author=C.+E.+Ekambom%C3%A9+Bass%C3%A9neauthor=F.+Suzenetauthor=N.+Hennuyerauthor=B.+Staelsauthor=D.-H.+Caignardauthor=C.+Dacquetauthor=P.+Renardauthor=G.+Guillaumet&title=Studies+Towards+the+Conception+of+New+Selective+PPAR%CE%B2%2F%CE%B4+Ligands&doi=10.1016%2Fj.bmcl.2006.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Studies towards the conception of new selective PPARβ/δ ligands</span></div><div class="casAuthors">Ekambome Bassene, Carine; Suzenet, Franck; Hennuyer, Nathalie; Staels, Bart; Caignard, Daniel-Henri; Dacquet, Catherine; Renard, Pierre; Guillaumet, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4528-4532</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to define new PPARβ/δ ligands, SAR study on the selective PPARβ/δ activator L-165,041 led to the identification of one key functional group for selective PPARβ/δ activation.  Furthermore, taking advantage of SAR studies done elsewhere on the most selective PPARβ/δ ligand GW501516, the conception of new ligands showing good affinity for PPARβ/δ is reported.  Finally, synthesis and biol. evaluation of pyridine analogs have shown the beneficial effect of the pyridine ring on the PPARβ/δ subtype selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6qJYTerZ9r7Vg90H21EOLACvtfcHk0ljeDvHWIWjUqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFOlt7c%253D&md5=bf968057270f35ded9f2574eb301dbbe</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DEkambom%25C3%25A9%2BBass%25C3%25A9ne%26aufirst%3DC.%2BE.%26aulast%3DSuzenet%26aufirst%3DF.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DCaignard%26aufirst%3DD.-H.%26aulast%3DDacquet%26aufirst%3DC.%26aulast%3DRenard%26aufirst%3DP.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DStudies%2520Towards%2520the%2520Conception%2520of%2520New%2520Selective%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4528%26epage%3D4532%26doi%3D10.1016%2Fj.bmcl.2006.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagome, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sako, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makishima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of Potent, Structurally Novel Peroxisome Proliferator-activated Receptor (PPAR) δ-selective Agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5177</span>– <span class="NLM_lpage">5190</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmc.2007.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17532641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlahtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5177-5190&author=J.-i.+Kasugaauthor=I.+Nakagomeauthor=A.+Aoyamaauthor=K.+Sakoauthor=M.+Ishizawaauthor=M.+Oguraauthor=M.+Makishimaauthor=S.+Hironoauthor=Y.+Hashimotoauthor=H.+Miyachi&title=Design%2C+Synthesis%2C+and+Evaluation+of+Potent%2C+Structurally+Novel+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29+%CE%B4-selective+Agonists&doi=10.1016%2Fj.bmc.2007.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) δ-selective agonists</span></div><div class="casAuthors">Kasuga, Jun-ichi; Nakagome, Izumi; Aoyama, Atsushi; Sako, Kumiko; Ishizawa, Michiyasu; Ogura, Michitaka; Makishima, Makoto; Hirono, Shuichi; Hashimoto, Yuichi; Miyachi, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5177-5190</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 3-(4-alkoxyphenyl)propanoic acid derivs. was prepd. as candidate peroxisome proliferator-activated receptor (PPAR) δ-selective agonists, based on our previously discovered potent human PPARα/δ dual agonist TIPP-401 as a lead compd.  Structure-activity relationship studies clearly indicated the importance of the chain length of the alkoxy group at the 4-position, and the n-butoxy compd. exhibited the most potent PPARδ transactivation activity and highest PPARδ selectivity.  The (S)-enantiomer of a representative compd. exhibited extremely potent PPARδ transactivation activity, comparable with or somewhat superior to that of the known PPARδ-selective agonist, GW-501516.  The representative compd. regulated the expression of genes involved in lipid and glucose homeostasis, and should be useful not only as a chem. tool to study PPARδ function, but also as a candidate drug for the treatment of metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoFPJ77LHuI7Vg90H21EOLACvtfcHk0ljeDvHWIWjUqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlahtrc%253D&md5=d59bbd64acfb30e221ee6a09bb30186b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DKasuga%26aufirst%3DJ.-i.%26aulast%3DNakagome%26aufirst%3DI.%26aulast%3DAoyama%26aufirst%3DA.%26aulast%3DSako%26aufirst%3DK.%26aulast%3DIshizawa%26aufirst%3DM.%26aulast%3DOgura%26aufirst%3DM.%26aulast%3DMakishima%26aufirst%3DM.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Potent%252C%2520Structurally%2520Novel%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%2520%25CE%25B4-selective%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5177%26epage%3D5190%26doi%3D10.1016%2Fj.bmc.2007.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirakawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, K.</span></span> <span> </span><span class="NLM_article-title">Adaptability and Selectivity of Human Peroxisome Proliferator-activated Receptor (PPAR) Pan Agonists Revealed from Crystal Structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1107/S0907444909015935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1107%2FS0907444909015935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19622862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=786-795&author=T.+Oyamaauthor=K.+Toyotaauthor=T.+Wakuauthor=Y.+Hirakawaauthor=N.+Nagasawaauthor=J.-i.+Kasugaauthor=Y.+Hashimotoauthor=H.+Miyachiauthor=K.+Morikawa&title=Adaptability+and+Selectivity+of+Human+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29+Pan+Agonists+Revealed+from+Crystal+Structures&doi=10.1107%2FS0907444909015935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures</span></div><div class="casAuthors">Oyama, Takuji; Toyota, Kenji; Waku, Tsuyoshi; Hirakawa, Yuko; Nagasawa, Naoko; Kasuga, Jun ichi; Hashimoto, Yuichi; Miyachi, Hiroyuki; Morikawa, Kosuke</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">786-795</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear hormone receptor family, which is defined as transcriptional factors that are activated by the binding of ligands to their ligand-binding domains (LBDs).  Although the three PPAR subtypes display different tissue distribution patterns and distinct pharmacol. profiles, they all are essentially related to fatty-acid and glucose metab.  Since the PPARs share similar 3-dimensional structures within the LBDs, synthetic ligands which simultaneously activate 2 or all of the PPARs could be potent candidates in terms of drugs for the treatment of abnormal metabolic homeostasis.  The structures of several PPAR LBDs were detd. in complex with synthetic ligands, derivs. of 3-(4-alkoxyphenyl)propanoic acid, which exhibit unique agonistic activities.  The PPARα and PPARγ LBDs were complexed with the same pan agonist, TIPP-703, which activates all three PPARs and their crystal structures were detd.  The two LBD-ligand complex structures revealed how the pan agonist is adapted to the similar, but significantly different, ligand-binding pockets of the PPARs.  The structures of the PPARδ LBD in complex with an α/δ-selective ligand, TIPP-401, and with a related δ-specific ligand, TIPP-204, were also detd.  The comparison between the two PPARδ complexes revealed how each ligand exhibits either a 'dual selective' or 'single specific' binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsqRY6vaJ6TLVg90H21EOLACvtfcHk0ljme0RGrJfJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCgurs%253D&md5=417380ca8b0392b5ee4909ec3f9eb017</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1107%2FS0907444909015935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909015935%26sid%3Dliteratum%253Aachs%26aulast%3DOyama%26aufirst%3DT.%26aulast%3DToyota%26aufirst%3DK.%26aulast%3DWaku%26aufirst%3DT.%26aulast%3DHirakawa%26aufirst%3DY.%26aulast%3DNagasawa%26aufirst%3DN.%26aulast%3DKasuga%26aufirst%3DJ.-i.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DMiyachi%26aufirst%3DH.%26aulast%3DMorikawa%26aufirst%3DK.%26atitle%3DAdaptability%2520and%2520Selectivity%2520of%2520Human%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%2520Pan%2520Agonists%2520Revealed%2520from%2520Crystal%2520Structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D786%26epage%3D795%26doi%3D10.1107%2FS0907444909015935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor β (δ)-dependent Regulation of Ubiquitin C Expression Contributes to Attenuation of Skin Carcinogenesis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">23719</span>– <span class="NLM_lpage">23727</span>, <span class="refDoi"> DOI: 10.1074/jbc.M312063200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1074%2Fjbc.M312063200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15033975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Giu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=23719-23727&author=D.+J.+Kimauthor=T.+E.+Akiyamaauthor=F.+S.+Harmanauthor=A.+M.+Burnsauthor=W.+Shanauthor=J.+M.+Wardauthor=M.+J.+Kennettauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Peroxisome+Proliferator-activated+Receptor+%CE%B2+%28%CE%B4%29-dependent+Regulation+of+Ubiquitin+C+Expression+Contributes+to+Attenuation+of+Skin+Carcinogenesis&doi=10.1074%2Fjbc.M312063200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome Proliferator-activated Receptor β (δ)-dependent Regulation of Ubiquitin C Expression Contributes to Attenuation of Skin Carcinogenesis</span></div><div class="casAuthors">Kim, Dae J.; Akiyama, Taro E.; Harman, Fred S.; Burns, Amanda M.; Shan, Weiwei; Ward, Jerrold M.; Kennett, Mary J.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">23719-23727</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The role of peroxisome proliferator-activated receptor-β (PPARβ) in the mol. regulation of skin carcinogenesis was examd.  Increased caspase-3 activity assocd. with apoptosis was found in the skin of wild-type mice after tumor promotion with 12-O-tetradecanoylphorbol-13-acetate, and this effect was diminished in PPARβ-null mice.  The onset of tumor formation, tumor size, and tumor multiplicity induced from a two-stage carcinogen bioassay (7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate) were significantly enhanced in PPARβ-null mice compared with wild-type mice.  To begin to characterize the mol. changes underlying this PPARβ-dependent phenotype, microarray anal. was performed and a no. of differentially regulated gene products were identified including ubiquitin C.  Subsequent promoter anal., reporter gene assays, site-directed mutagenesis, and electrophoretic mobility shift assays provide evidence that PPARβ regulates ubiquitin C expression, and that ubiquitination of proteins is influenced by PPARβ.  These results strongly suggest that activation of PPARβ-dependent target genes provides a novel strategy to inhibit tumor promotion and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDNr7zKPcEmrVg90H21EOLACvtfcHk0ljme0RGrJfJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Giu7w%253D&md5=37d2da030b72ecade40160ec168828eb</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M312063200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M312063200%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DHarman%26aufirst%3DF.%2BS.%26aulast%3DBurns%26aufirst%3DA.%2BM.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DWard%26aufirst%3DJ.%2BM.%26aulast%3DKennett%26aufirst%3DM.%2BJ.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%2520%2528%25CE%25B4%2529-dependent%2520Regulation%2520of%2520Ubiquitin%2520C%2520Expression%2520Contributes%2520to%2520Attenuation%2520of%2520Skin%2520Carcinogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D23719%26epage%3D23727%26doi%3D10.1074%2Fjbc.M312063200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicol, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator–activated Receptor-δ Attenuates Colon Carcinogenesis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1038/nm1026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fnm1026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15048110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsF2jt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=481-483&author=F.+S.+Harmanauthor=C.+J.+Nicolauthor=H.+E.+Marinauthor=J.+M.+Wardauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Peroxisome+Proliferator%E2%80%93activated+Receptor-%CE%B4+Attenuates+Colon+Carcinogenesis&doi=10.1038%2Fnm1026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor-δ attenuates colon carcinogenesis</span></div><div class="casAuthors">Harman, Fred S.; Nicol, Christopher J.; Marin, Holly E.; Ward, Jerrold M.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">481-483</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor-δ (PPAR-δ; also known as PPAR-β) is expressed at high levels in colon tumors, but its contribution to colon cancer is unclear.  The authors examd. the role of PPAR-δ in colon carcinogenesis using PPAR-δ-deficient (Ppard-/-) mice.  In both the Min mutant and chem. induced mouse models, colon polyp formation was significantly greater in mice nullizygous for PPAR-δ.  In contrast to previous reports suggesting that activation of PPAR-δ potentiates colon polyp formation, here the authors show that PPAR-δ attenuates colon carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpztWIaEnnr-LVg90H21EOLACvtfcHk0ljme0RGrJfJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsF2jt7c%253D&md5=45a168cdec14e5641e068b76e206c0e2</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1038%2Fnm1026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1026%26sid%3Dliteratum%253Aachs%26aulast%3DHarman%26aufirst%3DF.%2BS.%26aulast%3DNicol%26aufirst%3DC.%2BJ.%26aulast%3DMarin%26aufirst%3DH.%2BE.%26aulast%3DWard%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DPeroxisome%2520Proliferator%25E2%2580%2593activated%2520Receptor-%25CE%25B4%2520Attenuates%2520Colon%2520Carcinogenesis%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D481%26epage%3D483%26doi%3D10.1038%2Fnm1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdew, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor-β/δ Inhibits Epidermal Cell Proliferation by Down-regulation of Kinase Activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">9519</span>– <span class="NLM_lpage">9527</span>, <span class="refDoi"> DOI: 10.1074/jbc.M413808200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1074%2Fjbc.M413808200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15632134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVChs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=9519-9527&author=D.+J.+Kimauthor=I.+A.+Murrayauthor=A.+M.+Burnsauthor=F.+J.+Gonzalezauthor=G.+H.+Perdewauthor=J.+M.+Peters&title=Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+Inhibits+Epidermal+Cell+Proliferation+by+Down-regulation+of+Kinase+Activity&doi=10.1074%2Fjbc.M413808200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor-β/δ inhibits epidermal cell proliferation by down-regulation of kinase activity</span></div><div class="casAuthors">Kim, Dae J.; Murray, Iain A.; Burns, Amanda M.; Gonzalez, Frank J.; Perdew, Gary H.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">9519-9527</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Recent work has shown that peroxisome proliferator-activated receptor β (PPARβ) attenuates cell proliferation and skin carcinogenesis, and this is due in part to regulation of ubiquitin C expression.  In these studies, the role of PPARβ in modulating ubiquitin-dependent protein kinase Cα (PKCα) levels and phosphorylation signaling pathways was evaluated.  Intracellular phosphorylation anal. showed that phosphorylated PKCα and other kinases were lower in wild-type mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate (TPA) as compared with PPARβ-null mouse skin.  No differences in expression levels of other PKC isoforms present in skin were obsd.  Lower ubiquitination of PKCα was found in TPA-treated PPARβ-null skin as compared with wild-type, and inhibition of ubiquitin-dependent proteasome degrdn. prevented TPA-induced down-regulation of PKCα.  The activity of PKCα and downstream signaling kinases is enhanced, and expression of cyclooxygenase-2 (COX-2) is significantly greater, in PPARβ-null mouse skin in response to TPA compared with wild-type mouse skin.  Inhibition of PKCα or COX-2 reduced cell proliferation in TPA-treated PPARβ-null keratinocytes in a dose-dependent manner, whereas it only slightly influenced cell proliferation in wild-type keratinocytes.  Combined, these studies provide strong evidence that PPARβ attenuates cell proliferation by modulating PKCα/Raf1/MEK/ERK activity that may be due in part to reduced ubiquitin-dependent turnover of PKCα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonQT5SU3gzfrVg90H21EOLACvtfcHk0lirTfZJjh5Edw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVChs74%253D&md5=fe96e026833cd5a6f93fa9095b4754b0</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413808200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413808200%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DMurray%26aufirst%3DI.%2BA.%26aulast%3DBurns%26aufirst%3DA.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPerdew%26aufirst%3DG.%2BH.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520Inhibits%2520Epidermal%2520Cell%2520Proliferation%2520by%2520Down-regulation%2520of%2520Kinase%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D9519%26epage%3D9527%26doi%3D10.1074%2Fjbc.M413808200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foreman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borland, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epifano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">A Natural Propenoic Acid Derivative Activates Peroxisome Proliferator-activated Receptor-β/δ (PPARβ/δ)</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2010.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.lfs.2010.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=20153754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=493-498&author=S.+Genoveseauthor=J.+E.+Foremanauthor=M.+G.+Borlandauthor=F.+Epifanoauthor=F.+J.+Gonzalezauthor=M.+Curiniauthor=J.+M.+Peters&title=A+Natural+Propenoic+Acid+Derivative+Activates+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+%28PPAR%CE%B2%2F%CE%B4%29&doi=10.1016%2Fj.lfs.2010.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)</span></div><div class="casAuthors">Genovese, Salvatore; Foreman, Jennifer E.; Borland, Michael G.; Epifano, Francesco; Gonzalez, Frank J.; Curini, Massimo; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">493-498</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aims: Previous studies showed that natural prenyloxyphenylpropanoid derivs. have potent biol. properties in vivo.  Given the structural similarities between these compds. and known peroxisome proliferator-activated receptor (PPAR) agonists, the present study examd. the hypothesis that propenoic acid derivs. activate PPARs.  Main methods: Chimeric reporter assays were performed to identify propenoic acid derivates that could activate PPARs.  Quant. polymerase chain reaction (qPCR) anal. of wild-type and Pparβ/δ-null mouse primary keratinocytes was performed to det. if a test compd. could specifically activate PPARβ/δ.  A human epithelial carcinoma cell line and primary mouse keratinocytes were used to det. the effect of the compd. on cell proliferation.  Key findings: Three of the propenoic acid derivs. activated PPARs, with the greatest efficacy being obsd. with prenyloxycinnamic acid derivs. 4'-geranyloxyferulic acid (compd. 1) for PPARβ/δ.  Compd. 1 increased expression of a known PPARβ/δ target gene through a mechanism that requires PPARβ/δ.  Inhibition of cell proliferation by compd. 1 was found in a human epithelial carcinoma cell line.  Significance: Results from these studies demonstrate that compd. 1 can activate PPARβ/δ and inhibit cell proliferation of a human skin cancer cell line, suggesting that the biol. effects of 4'-geranyloxyferulic acid may be mediated in part by activating this PPAR isoform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0Cdkj3zx6bVg90H21EOLACvtfcHk0lirTfZJjh5Edw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslShsLo%253D&md5=0decd8ffe5bd0855cbb304029de8ed32</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2010.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2010.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DS.%26aulast%3DForeman%26aufirst%3DJ.%2BE.%26aulast%3DBorland%26aufirst%3DM.%2BG.%26aulast%3DEpifano%26aufirst%3DF.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DCurini%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Natural%2520Propenoic%2520Acid%2520Derivative%2520Activates%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520%2528PPAR%25CE%25B2%252F%25CE%25B4%2529%26jtitle%3DLife%2520Sci.%26date%3D2010%26volume%3D86%26spage%3D493%26epage%3D498%26doi%3D10.1016%2Fj.lfs.2010.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sk, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Isosteric Selenium Analog of the PPARβ/δ Agonist GW501516 and Comparison of Biological Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4050</span>– <span class="NLM_lpage">4052</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.05.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2010.05.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=20542425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4050-4052&author=A.+K.+Sharmaauthor=U.+H.+Skauthor=P.+Heauthor=J.+M.+Petersauthor=S.+Amin&title=Synthesis+of+Isosteric+Selenium+Analog+of+the+PPAR%CE%B2%2F%CE%B4+Agonist+GW501516+and+Comparison+of+Biological+Activity&doi=10.1016%2Fj.bmcl.2010.05.094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of isosteric selenium analog of the PPARβ/δ agonist GW501516 and comparison of biological activity</span></div><div class="casAuthors">Sharma, Arun K.; Sk, Ugir Hossain; He, Pengfei; Peters, Jeffrey M.; Amin, Shantu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4050-4052</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors and members of the nuclear hormone receptor superfamily.  Herein, we describe an efficient synthesis of a novel isosteric selenium analog of the highly specific PPARβ/δ ligand 2-methyl-4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-thiazol-5-yl)methylsulfanyl)phenoxyacetic acid (GW501516; 1).  The study examd. the efficiency of the novel selenium analog 2-methyl-4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-selenazol-5-yl)methylsulfanyl)phenoxyacetic acid (I) to activate PPARβ/δ and the effect of ligand activation of PPARβ/δ on cell proliferation and target gene expression in human HaCaT keratinocytes.  The results showed that similar to GW501516, the Se-analog I increased expression of the known PPARβ/δ target gene angiopoietin-like protein 4 (ANGPTL4); I was comparable in efficacy as compared to GW501516.  Consistent with a large body of evidence, the Se-analog inhibited cell proliferation in HaCaT keratinocytes similar to that obsd. with GW501516.  In summary, I has been developed as a potent PPARβ/δ ligand that may possess addnl. anti-cancer properties of selenium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOoArm6HI8ErVg90H21EOLACvtfcHk0lirTfZJjh5Edw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVKntLg%253D&md5=3ab66142bfacaebccb3320f1ed20fa75</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.05.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.05.094%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DSk%26aufirst%3DU.%2BH.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DAmin%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520Isosteric%2520Selenium%2520Analog%2520of%2520the%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Agonist%2520GW501516%2520and%2520Comparison%2520of%2520Biological%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4050%26epage%3D4052%26doi%3D10.1016%2Fj.bmcl.2010.05.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span> <span> </span><span class="NLM_article-title">Selective Peroxisome Proliferator-activated Receptor δ Isosteric Selenium Agonists as Potent Anti-atherogenic Agents In Vivo</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">7239</span>– <span class="NLM_lpage">7242</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2010.10.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21074432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7239-7242&author=J.+Chinauthor=J.+Y.+Hongauthor=J.+Leeauthor=H.+Hwangauthor=H.+Koauthor=H.+Choiauthor=D.+Hahnauthor=J.+Koauthor=S.-J.+Namauthor=J.+Takauthor=J.+Hamauthor=H.+Kang&title=Selective+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Isosteric+Selenium+Agonists+as+Potent+Anti-atherogenic+Agents+In+Vivo&doi=10.1016%2Fj.bmcl.2010.10.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Selective peroxisome proliferator-activated receptor δ isosteric selenium agonists as potent anti-atherogenic agents in vivo</span></div><div class="casAuthors">Chin, Jungwook; Hong, Jun Young; Lee, Jaehwan; Hwang, Hoosang; Ko, Hyunsil; Choi, Hyukjae; Hahn, Dongyup; Ko, Jaeyoung; Nam, Sang-Jip; Tak, Jungae; Ham, Jungyeob; Kang, Heonjoong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7239-7242</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and in vivo activity of a novel anti-atherogenic agent, isosteric selenium PPARδ-selective ligand, are reported.  This ligand did not cause significant body or liver wt. changes and did not have obvious adverse effects on intestinal polyp formation.  The overall results demonstrate that PPARδ is a viable drug target for treating atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp4HIL7NiRCbVg90H21EOLACvtfcHk0lgU0R2kCCi2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtLfP&md5=9101c998433c714ff1fda9e0d757822f</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.103%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DKo%26aufirst%3DJ.%26aulast%3DNam%26aufirst%3DS.-J.%26aulast%3DTak%26aufirst%3DJ.%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26atitle%3DSelective%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Isosteric%2520Selenium%2520Agonists%2520as%2520Potent%2520Anti-atherogenic%2520Agents%2520In%2520Vivo%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7239%26epage%3D7242%26doi%3D10.1016%2Fj.bmcl.2010.10.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holla, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seok, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span> <span> </span><span class="NLM_article-title">Discovery, Design and Synthesis of Y-shaped Peroxisome Proliferator-activated Receptor δ Agonists as Potent Anti-obesity Agents In Vivo</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.03.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.ejmech.2012.03.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22534184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVygsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=190-202&author=J.+Hamauthor=H.+Hwangauthor=E.+Kimauthor=J.-a.+Kimauthor=S.+J.+Choauthor=J.+Koauthor=W.+Leeauthor=J.+Leeauthor=H.+Hollaauthor=J.+Banerjeeauthor=S.+Kimauthor=I.+Yangauthor=H.+J.+Leeauthor=K.+Shinauthor=H.+Choiauthor=S.+J.+Namauthor=J.+Takauthor=D.+Hahnauthor=T.+Ohauthor=D.+H.+Wonauthor=T.+G.+Leeauthor=J.+Choiauthor=M.+S.+Parkauthor=C.+Seokauthor=J.+Chinauthor=H.+Kang&title=Discovery%2C+Design+and+Synthesis+of+Y-shaped+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonists+as+Potent+Anti-obesity+Agents+In+Vivo&doi=10.1016%2Fj.ejmech.2012.03.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptor δ agonists as potent anti-obesity agents in vivo</span></div><div class="casAuthors">Ham, Jungyeob; Hwang, Hoosang; Kim, Euno; Kim, Jeong-ah; Cho, Sung Jin; Ko, Jaeyoung; Lee, Woojin; Lee, Jaehwan; Holla, Harish; Banerjee, Joydeep; Kim, Seokho; Yang, Inho; Lee, Hyun Joo; Shin, Kyoungjin; Choi, Hyukjae; Nam, Sang-Jip; Tak, Jungae; Hahn, Dongyup; Oh, Taekyung; Won, Dong Hwan; Lee, Tae Gu; Choi, Jihye; Park, Mi Sun; Seok, Chaok; Chin, Jungwook; Kang, Heonjoong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">190-202</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We have discovered and demonstrated the in vitro and in vivo PPARδ-selective activity of novel Y-shaped agonists.  These compds. activated hPPARδ with EC50 values between 1 and 523 nM.  Surprisingly, compds. 10a, 11d, 11e and 11f were the most potent and most selective hPPARδ agonists with 104-fold selectivity over the other two subtypes, namely, hPPARα and hPPARγ.  The PPARδ ligands 10a, 11e and 11f showed good bioavailability and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov6X-CFACYwbVg90H21EOLACvtfcHk0lgU0R2kCCi2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVygsb4%253D&md5=c2582c96fb5a193e5efbbf1261cd7ab3</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DJ.-a.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DKo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHolla%26aufirst%3DH.%26aulast%3DBanerjee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DShin%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DNam%26aufirst%3DS.%2BJ.%26aulast%3DTak%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DOh%26aufirst%3DT.%26aulast%3DWon%26aufirst%3DD.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BG.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DM.%2BS.%26aulast%3DSeok%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26atitle%3DDiscovery%252C%2520Design%2520and%2520Synthesis%2520of%2520Y-shaped%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonists%2520as%2520Potent%2520Anti-obesity%2520Agents%2520In%2520Vivo%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D53%26spage%3D190%26epage%3D202%26doi%3D10.1016%2Fj.ejmech.2012.03.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluge, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenburg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senaiar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaleel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patane, M. A.</span></span> <span> </span><span class="NLM_article-title">Novel Highly Selective Peroxisome Proliferator-activated Receptor δ (PPARδ) Modulators with Pharmacokinetic Properties Suitable for Once-daily Oral Dosing</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5230</span>– <span class="NLM_lpage">5234</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2017.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=29103972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyht7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5230-5234&author=B.+Laguauthor=A.+F.+Klugeauthor=R.+A.+Fredenburgauthor=E.+Tozzoauthor=R.+S.+Senaiarauthor=M.+Jaleelauthor=S.+K.+Panigrahiauthor=N.+K.+Tiwariauthor=N.+R.+Krishnamurthyauthor=T.+Takahashiauthor=M.+A.+Patane&title=Novel+Highly+Selective+Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29+Modulators+with+Pharmacokinetic+Properties+Suitable+for+Once-daily+Oral+Dosing&doi=10.1016%2Fj.bmcl.2017.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing</span></div><div class="casAuthors">Lagu, Bharat; Kluge, Arthur F.; Fredenburg, Ross A.; Tozzo, Effie; Senaiar, Ramesh S.; Jaleel, Mahaboobi; Panigrahi, Sunil K.; Tiwari, Nirbhay K.; Krishnamurthy, Narasimha R.; Takahashi, Taisuke; Patane, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5230-5234</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Optimization of benzamide PPARδ modulator 1 led to (E)-6-(2-((4-(furan-2-yl)-N-methylbenzamido)methyl)phenoxy)-4-methylhex-4-enoic acid (18), a potent selective PPARδ modulator with significantly improved exposure in multiple species following oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMM6ILDzYAl7Vg90H21EOLACvtfcHk0lgU0R2kCCi2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyht7fI&md5=ceafd53bc69650eea166a90c8b5769af</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DKluge%26aufirst%3DA.%2BF.%26aulast%3DFredenburg%26aufirst%3DR.%2BA.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DSenaiar%26aufirst%3DR.%2BS.%26aulast%3DJaleel%26aufirst%3DM.%26aulast%3DPanigrahi%26aufirst%3DS.%2BK.%26aulast%3DTiwari%26aufirst%3DN.%2BK.%26aulast%3DKrishnamurthy%26aufirst%3DN.%2BR.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520Highly%2520Selective%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%2520Modulators%2520with%2520Pharmacokinetic%2520Properties%2520Suitable%2520for%2520Once-daily%2520Oral%2520Dosing%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5230%26epage%3D5234%26doi%3D10.1016%2Fj.bmcl.2017.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluge, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddeeris, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenburg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chellur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senaiar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaleel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, D. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patane, M. A.</span></span> <span> </span><span class="NLM_article-title">Highly Selective Peroxisome Proliferator-activated Receptor δ (PPARδ) Modulator Demonstrates Improved Safety Profile Compared to GW501516</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2017.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=29275935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVejtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=533-536&author=B.+Laguauthor=A.+F.+Klugeauthor=M.+M.+Goddeerisauthor=E.+Tozzoauthor=R.+A.+Fredenburgauthor=S.+Chellurauthor=R.+S.+Senaiarauthor=M.+Jaleelauthor=D.+R.+K.+Babuauthor=N.+K.+Tiwariauthor=T.+Takahashiauthor=M.+A.+Patane&title=Highly+Selective+Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29+Modulator+Demonstrates+Improved+Safety+Profile+Compared+to+GW501516&doi=10.1016%2Fj.bmcl.2017.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516</span></div><div class="casAuthors">Lagu, Bharat; Kluge, Arthur F.; Goddeeris, Matthew M.; Tozzo, Effie; Fredenburg, Ross A.; Chellur, Shekar; Senaiar, Ramesh S.; Jaleel, Mahaboobi; Babu, D. Ravi Krishna; Tiwari, Nirbhay K.; Takahashi, Taisuke; Patane, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">533-536</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Compd. 1 regulates significantly fewer genes than the PPARδ modulator, GW501516.  Both compds. are efficacious in a thermal injury model of muscle regeneration.  The restricted gene profile of 1 relative to GW501516 suggests that 1 may be pharmacoequivalent to GW501516 with fewer PPAR-related safety concerns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3I-HxzQsbubVg90H21EOLACvtfcHk0lgxFaOT0ysGzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVejtr%252FM&md5=86898b1962a59ce63b0eaf94a67613bc</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DKluge%26aufirst%3DA.%2BF.%26aulast%3DGoddeeris%26aufirst%3DM.%2BM.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DFredenburg%26aufirst%3DR.%2BA.%26aulast%3DChellur%26aufirst%3DS.%26aulast%3DSenaiar%26aufirst%3DR.%2BS.%26aulast%3DJaleel%26aufirst%3DM.%26aulast%3DBabu%26aufirst%3DD.%2BR.%2BK.%26aulast%3DTiwari%26aufirst%3DN.%2BK.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26atitle%3DHighly%2520Selective%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%2520Modulator%2520Demonstrates%2520Improved%2520Safety%2520Profile%2520Compared%2520to%2520GW501516%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D533%26epage%3D536%26doi%3D10.1016%2Fj.bmcl.2017.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senaiar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluge, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallesh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patane, M. A.</span></span> <span> </span><span class="NLM_article-title">Addressing hERG Activity While Maintaining Favorable Potency, Selectivity and Pharmacokinetic Properties of PPARδ modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">126928</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.126928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2019.126928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31889664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFGqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=126928&author=B.+Laguauthor=R.+S.+Senaiarauthor=A.+F.+Klugeauthor=B.+Malleshauthor=M.+Ramakrishnaauthor=R.+Bhatauthor=M.+A.+Patane&title=Addressing+hERG+Activity+While+Maintaining+Favorable+Potency%2C+Selectivity+and+Pharmacokinetic+Properties+of+PPAR%CE%B4+modulators&doi=10.1016%2Fj.bmcl.2019.126928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Addressing hERG activity while maintaining favorable potency, selectivity and pharmacokinetic properties of PPARδ modulators</span></div><div class="casAuthors">Lagu, Bharat; Senaiar, Ramesh S.; Kluge, Arthur F.; Mallesh, B.; Ramakrishna, M.; Bhat, Raveendra; Patane, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">126928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">One of the most commonly used strategies to reduce hERG (human ether-a-go-go) activity in the drug candidates is introduction of a carboxylic acid group.  During the optimization of PPARδ modulators, some of the compds. contg. a carboxylic acid were found to inhibit the hERG channel in a patch clamp assay.  By modifying the basicity of the imidazole core, potent and selective PPARδ modulators that do not inhibit hERG channel were identified.  Some of the modulators have excellent pharmacokinetic profiles in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIMqPzLRB2jrVg90H21EOLACvtfcHk0lgxFaOT0ysGzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFGqsA%253D%253D&md5=d673d98c47aea4c5eb87c2322356f4fd</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.126928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.126928%26sid%3Dliteratum%253Aachs%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DSenaiar%26aufirst%3DR.%2BS.%26aulast%3DKluge%26aufirst%3DA.%2BF.%26aulast%3DMallesh%26aufirst%3DB.%26aulast%3DRamakrishna%26aufirst%3DM.%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26atitle%3DAddressing%2520hERG%2520Activity%2520While%2520Maintaining%2520Favorable%2520Potency%252C%2520Selectivity%2520and%2520Pharmacokinetic%2520Properties%2520of%2520PPAR%25CE%25B4%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D30%26spage%3D126928%26doi%3D10.1016%2Fj.bmcl.2019.126928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadayat, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-H</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S.-J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span> <span> </span><span class="NLM_article-title">Enantioselective Synthesis of a Novel Thiazoline Core as a Potent Peroxisome Proliferator-activated Receptor δ Agonist</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b01689</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b01689" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXislyltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=1970-1976&author=S.-J.+Leeauthor=M.+Samalaauthor=S.+Y.+Wooauthor=D.+Hahnauthor=D.+Kimauthor=T.+M.+Kadayatauthor=K.+Jungauthor=J.+Kimauthor=D.-S.+Kimauthor=S.+Kwonauthor=S.+Kimauthor=K.-H+Kimauthor=S.-J+Namauthor=S.+J.+Choauthor=J.+Chin&title=Enantioselective+Synthesis+of+a+Novel+Thiazoline+Core+as+a+Potent+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist&doi=10.1021%2Facsomega.7b01689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective Synthesis of a Novel Thiazoline Core as a Potent Peroxisome Proliferator-Activated Receptor δ Agonist</span></div><div class="casAuthors">Lee, Su-Jeong; Samala, Mallesham; Woo, Seo Yeon; Hahn, Dongyup; Kim, Dayoung; Kadayat, Tara Man; Jung, Kyungjin; Kim, Jina; Kim, Dong-Su; Kwon, Sugyeong; Kim, Shinae; Kim, Kyung-Hee; Nam, Sang-Jip; Cho, Sung Jin; Chin, Jungwook</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1970-1976</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The convergent and enantioselective synthesis of a highly potent human peroxisome proliferator-activated receptor delta agonist I is presented.  More specifically, the thiazoline structure, which constitutes the biosynthetically distinctive core structure of pulicatin (a secondary metabolite of symbiotic bacteria), was synthesized from a com. available and inexpensive chiral pool of L-threonine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlUvu3_M_wrVg90H21EOLACvtfcHk0lhQ0WF6Wwxmzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXislyltrk%253D&md5=ac8d1130bb1d0cc1be27adcfad076b88</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b01689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b01689%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-J.%26aulast%3DSamala%26aufirst%3DM.%26aulast%3DWoo%26aufirst%3DS.%2BY.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKadayat%26aufirst%3DT.%2BM.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.-S.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DK.-H%26aulast%3DNam%26aufirst%3DS.-J%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DChin%26aufirst%3DJ.%26atitle%3DEnantioselective%2520Synthesis%2520of%2520a%2520Novel%2520Thiazoline%2520Core%2520as%2520a%2520Potent%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%26jtitle%3DACS%2520Omega%26date%3D2018%26volume%3D3%26spage%3D1970%26epage%3D1976%26doi%3D10.1021%2Facsomega.7b01689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadayat, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-H</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a Unique Dimethyl Thiazoline Containing Intermediate of Novel Peroxisome Proliferator-activated Receptors (PPAR) δ Agonists</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4384</span>– <span class="NLM_lpage">4386</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2018.10.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.tetlet.2018.10.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=4384-4386&author=T.+M.+Kadayatauthor=G.+Leeauthor=K.+Jungauthor=H.-J.+Hwangauthor=J.+Jooauthor=D.+Hahnauthor=H.+Hwangauthor=K.-G.+Parkauthor=S.+J.+Choauthor=K.-H+Kimauthor=J.+Chin&title=Synthesis+of+a+Unique+Dimethyl+Thiazoline+Containing+Intermediate+of+Novel+Peroxisome+Proliferator-activated+Receptors+%28PPAR%29+%CE%B4+Agonists&doi=10.1016%2Fj.tetlet.2018.10.051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2018.10.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2018.10.051%26sid%3Dliteratum%253Aachs%26aulast%3DKadayat%26aufirst%3DT.%2BM.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DHwang%26aufirst%3DH.-J.%26aulast%3DJoo%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DK.-G.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DK.-H%26aulast%3DChin%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520a%2520Unique%2520Dimethyl%2520Thiazoline%2520Containing%2520Intermediate%2520of%2520Novel%2520Peroxisome%2520Proliferator-activated%2520Receptors%2520%2528PPAR%2529%2520%25CE%25B4%2520Agonists%26jtitle%3DTetrahedron%2520Lett.%26date%3D2018%26volume%3D59%26spage%3D4384%26epage%3D4386%26doi%3D10.1016%2Fj.tetlet.2018.10.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lione, L.</span></span> <span> </span><span class="NLM_article-title">Harnessing the Benefits of PPARβ/δ Agonists</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">963</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2013.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.lfs.2013.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=24184294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslOltrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2013&pages=963-967&author=L.+S.+Mackenzieauthor=L.+Lione&title=Harnessing+the+Benefits+of+PPAR%CE%B2%2F%CE%B4+Agonists&doi=10.1016%2Fj.lfs.2013.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the benefits of PPARβ/δ agonists</span></div><div class="casAuthors">Mackenzie, Louise S.; Lione, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">25-26</span>),
    <span class="NLM_cas:pages">963-967</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Lipid mediators have complex effects on the cell; one of the key transcriptional factors that moderate proliferation and inflammatory effects is PPARβ/δ.  Following highly successful clin. trials using the PPARβ/δ agonists GW501516 for treatment of diabetes, GSK announced that any further research would be discontinued due to preclin. trials in rodents which linked this drug to wide spread tumor development.  In this review we outline the dual mol. functions of PPARβ/δ and connect these to the diverse results from in vitro studies, and draw parallels with the outcomes of animal and human studies.  The PPARβ/δ agonists have a great potential in terms of therapy, and we hope to provide some insight into the reasons why such contrasting results have been published.  The discussion presented here is important to the future development of PPARβ/δ agonists for the clinic, and for a fuller understanding for their complex regulatory roles in the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruApB5yWZgcLVg90H21EOLACvtfcHk0lhIZv39wYdENw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslOltrbJ&md5=8a650e28aa3938f90f8eea1628b39472</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2013.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2013.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DMackenzie%26aufirst%3DL.%2BS.%26aulast%3DLione%26aufirst%3DL.%26atitle%3DHarnessing%2520the%2520Benefits%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Agonists%26jtitle%3DLife%2520Sci.%26date%3D2013%26volume%3D93%26spage%3D963%26epage%3D967%26doi%3D10.1016%2Fj.lfs.2013.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sznaidman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haffner, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fivush, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goreham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sierra, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeGrumelec, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montana, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, W. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span> <span> </span><span class="NLM_article-title">Novel Selective Small Molecule Agonists for Peroxisome Proliferator-activated Receptor δ (PPARδ)—Synthesis and Biological Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1517</span>– <span class="NLM_lpage">1521</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00207-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS0960-894X%2803%2900207-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=12699745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFemu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1517-1521&author=M.+L.+Sznaidmanauthor=C.+D.+Haffnerauthor=P.+R.+Maloneyauthor=A.+Fivushauthor=E.+Chaoauthor=D.+Gorehamauthor=M.+L.+Sierraauthor=C.+LeGrumelecauthor=H.+E.+Xuauthor=V.+G.+Montanaauthor=M.+H.+Lambertauthor=T.+M.+Willsonauthor=W.+R.+J.+Oliverauthor=D.+D.+Sternbach&title=Novel+Selective+Small+Molecule+Agonists+for+Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29%E2%80%94Synthesis+and+Biological+Activity&doi=10.1016%2FS0960-894X%2803%2900207-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ) - synthesis and biological activity</span></div><div class="casAuthors">Sznaidman, Marcos L.; Haffner, Curt D.; Maloney, Patrick R.; Fivush, Adam; Chao, Esther; Goreham, Donna; Sierra, Michael L.; LeGrumelec, Christelle; Xu, H. Eric; Montana, Valerie G.; Lambert, Millard H.; Willson, Timothy M.; Oliver, William R.; Sternbach, Daniel D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1517-1521</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The authors report the synthesis and biol. activity of a new series of small mol. agonists of the human Peroxisome Proliferator-Activated Receptor δ (PPARδ).  Several hits were identified from original libraries contg. lipophilic carboxylic acids.  Optimization of these hits by structure-guided design led to two compds. (GW501516 and GW0742) which show an EC50 of 1.1 nM against PPARδ with 1000-fold selectivity over the other human subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvtPXSwIFaybVg90H21EOLACvtfcHk0lhIZv39wYdENw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFemu70%253D&md5=9d0d967f6652b200ba3610657b7676b7</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900207-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900207-5%26sid%3Dliteratum%253Aachs%26aulast%3DSznaidman%26aufirst%3DM.%2BL.%26aulast%3DHaffner%26aufirst%3DC.%2BD.%26aulast%3DMaloney%26aufirst%3DP.%2BR.%26aulast%3DFivush%26aufirst%3DA.%26aulast%3DChao%26aufirst%3DE.%26aulast%3DGoreham%26aufirst%3DD.%26aulast%3DSierra%26aufirst%3DM.%2BL.%26aulast%3DLeGrumelec%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DMontana%26aufirst%3DV.%2BG.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DOliver%26aufirst%3DW.%2BR.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26atitle%3DNovel%2520Selective%2520Small%2520Molecule%2520Agonists%2520for%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%25E2%2580%2594Synthesis%2520and%2520Biological%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1517%26epage%3D1521%26doi%3D10.1016%2FS0960-894X%2803%2900207-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bays, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlejohn, T.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerzner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpf, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, B. K.</span></span> <span> </span><span class="NLM_article-title">MBX-8025, a Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin</span>. <i>J. Clin. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">2889</span>– <span class="NLM_lpage">2897</span>, <span class="refDoi"> DOI: 10.1210/jc.2011-1061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1210%2Fjc.2011-1061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21752880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SktLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2011&pages=2889-2897&author=H.+E.+Baysauthor=S.+Schwartzauthor=T.+Littlejohnauthor=B.+Kerznerauthor=R.+M.+Kraussauthor=D.+B.+Karpfauthor=Y.-J.+Choiauthor=X.+Wangauthor=S.+Naimauthor=B.+K.+Roberts&title=MBX-8025%2C+a+Novel+Peroxisome+Proliferator+Receptor-%CE%B4+Agonist%3A+Lipid+and+Other+Metabolic+Effects+in+Dyslipidemic+Overweight+Patients+Treated+with+and+without+Atorvastatin&doi=10.1210%2Fjc.2011-1061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">MBX-8025, a novel peroxisome proliferator receptor-δ agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin</span></div><div class="casAuthors">Bays, Harold E.; Schwartz, Sherwyn; Littlejohn, Thomas, III; Kerzner, Boris; Krauss, Ronald M.; Karpf, David B.; Choi, Yun-Jung; Wang, Xueyan; Naim, Sue; Roberts, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2889-2897</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Preclin. and clin. studies suggest that peroxisome proliferator-activated receptor (PPAR)-δ agonists favorably affect multiple metabolic parameters that are otherwise proatherogenic, many that are not optimally managed with statins alone.  Objective: The aim of this study was to evaluate the effects of MBX-8025 (a novel PPAR-δ agonist) on lipid and other metabolic parameters assocd. with increased atherosclerotic risk, administered alone and in combination with atorvastatin.  Design and Setting: This was a randomized, double-blind, placebo-controlled, parallel group proof-of-concept study conducted at 30 U.S. research sites.  Participants: This study evaluated 181 overweight men and women with mixed dyslipidemia.  Intervention(s): Subjects were administered once daily placebo, atorvastatin 20 mg, or MBX-8025 at 50 or 100 mg alone or combined with atorvastatin for 8 wk.  Main Outcome Measures: The main efficacy measures included change from baseline in apolipoprotein B-100, lipid levels, high-sensitivity C-reactive protein, and addnl. metabolic parameters, as well as the effect on the metabolic syndrome and LDL particle size.  Results: Compared to placebo, MBX-8025 alone and in combination with atorvastatin significantly (P < 0.05) reduced apolipoprotein B-100 20-38%, LDL 18-43%, triglycerides 26-30%, non-high-d. lipoprotein cholesterol 18-41%, free fatty acids 16-28%, and high-sensitivity C-reactive protein 43-72%; it raised high-d. lipoprotein cholesterol 1-12% and also reduced the no. of patients with the metabolic syndrome and a preponderance of small LDL particles.  MBX-8025 was safe and generally well-tolerated.  MBX-8025 also reduced liver enzyme levels.  Conclusion: MBX-8025, a novel PPAR-δ agonist, favorably affected multiple metabolic parameters with and without atorvastatin.  A more complete understanding of MBX-8025 requires a larger future study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9CZr0CONGbLVg90H21EOLACvtfcHk0lgxGaROLNwX1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SktLzE&md5=3e46c42efb64ace0ee4090af910cc07f</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1210%2Fjc.2011-1061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2011-1061%26sid%3Dliteratum%253Aachs%26aulast%3DBays%26aufirst%3DH.%2BE.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DLittlejohn%26aufirst%3DT.%26aulast%3DKerzner%26aufirst%3DB.%26aulast%3DKrauss%26aufirst%3DR.%2BM.%26aulast%3DKarpf%26aufirst%3DD.%2BB.%26aulast%3DChoi%26aufirst%3DY.-J.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DNaim%26aufirst%3DS.%26aulast%3DRoberts%26aufirst%3DB.%2BK.%26atitle%3DMBX-8025%252C%2520a%2520Novel%2520Peroxisome%2520Proliferator%2520Receptor-%25CE%25B4%2520Agonist%253A%2520Lipid%2520and%2520Other%2520Metabolic%2520Effects%2520in%2520Dyslipidemic%2520Overweight%2520Patients%2520Treated%2520with%2520and%2520without%2520Atorvastatin%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2011%26volume%3D96%26spage%3D2889%26epage%3D2897%26doi%3D10.1210%2Fjc.2011-1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span> </span><span class="NLM_article-title">The Strategic
Research Institute’s Sixth Annual Metabolic Diseases Drug Discovery
& Development World Summit, San Diego, CA, USA, 2007</span>.  <i>Cortellis</i>; <span class="NLM_publisher-name">Clarivate Analytics</span>, <span class="NLM_year">2019</span> <a href="https://www.cortellis.com/intelligence/home.do" class="extLink">https://www.cortellis.com/intelligence/home.do</a> (accessed 2020-03-10).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Strategic%0AResearch+Institute%E2%80%99s+Sixth+Annual+Metabolic+Diseases+Drug+Discovery%0A%26+Development+World+Summit%2C+San+Diego%2C+CA%2C+USA%2C+2007.+Cortellis%3B+Clarivate+Analytics%2C+2019+https%3A%2F%2Fwww.cortellis.com%2Fintelligence%2Fhome.do+%28accessed+2020-03-10%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520Strategic%250AResearch%2520Institute%25E2%2580%2599s%2520Sixth%2520Annual%2520Metabolic%2520Diseases%2520Drug%2520Discovery%250A%2526%2520Development%2520World%2520Summit%252C%2520San%2520Diego%252C%2520CA%252C%2520USA%252C%25202007%26jtitle%3DCortellis%26pub%3DClarivate%2520Analytics%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span> <i>Cortellis</i>; <span class="NLM_publisher-name">Clarivate
Analytics</span>, <span class="NLM_year">2019</span>; <a href="https://www.cortellis.com/intelligence/home.do" class="extLink">https://www.cortellis.com/intelligence/home.do</a> (accessed 2020-01-24).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Cortellis%3B+Clarivate%0AAnalytics%2C+2019%3B+https%3A%2F%2Fwww.cortellis.com%2Fintelligence%2Fhome.do+%28accessed+2020-01-24%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DCortellis%26pub%3DClarivate%250AAnalytics%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Risérus, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprecher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirschberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarov-Blat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strum, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheeseman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fielding, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danoff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murgatroyd, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Rahilly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frayn, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpe, F.</span></span> <span> </span><span class="NLM_article-title">Activation of Peroxisome Proliferator–activated Receptor (PPAR) δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.2337/db07-1318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.2337%2Fdb07-1318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18024853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVOktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=332-339&author=U.+Ris%C3%A9rusauthor=D.+Sprecherauthor=T.+Johnsonauthor=E.+Olsonauthor=S.+Hirschbergauthor=A.+Liuauthor=Z.+Fangauthor=P.+Hegdeauthor=D.+Richardsauthor=L.+Sarov-Blatauthor=J.+C.+Strumauthor=S.+Basuauthor=J.+Cheesemanauthor=B.+A.+Fieldingauthor=S.+M.+Humphreysauthor=T.+Danoffauthor=N.+R.+Mooreauthor=P.+Murgatroydauthor=S.+O%E2%80%99Rahillyauthor=P.+Suttonauthor=T.+Willsonauthor=D.+Hassallauthor=K.+N.+Fraynauthor=F.+Karpe&title=Activation+of+Peroxisome+Proliferator%E2%80%93activated+Receptor+%28PPAR%29+%CE%B4+Promotes+Reversal+of+Multiple+Metabolic+Abnormalities%2C+Reduces+Oxidative+Stress%2C+and+Increases+Fatty+Acid+Oxidation+in+Moderately+Obese+Men&doi=10.2337%2Fdb07-1318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of peroxisome proliferator-activated receptor (PPAR)δ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men</span></div><div class="casAuthors">Riserus, Ulf; Sprecher, Dennis; Johnson, Tony; Olson, Eric; Hirschberg, Sandra; Liu, Aixue; Fang, Zeke; Hegde, Priti; Richards, Duncan; Sarov-Blat, Leli; Strum, Jay C.; Basu, Samar; Cheeseman, Jane; Fielding, Barbara A.; Humphreys, Sandy M.; Danoff, Theodore; Moore, Niall R.; Murgatroyd, Peter; O'Rahilly, Stephen; Sutton, Pauline; Willson, Tim; Hassall, David; Frayn, Keith N.; Karpe, Fredrik</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">332-339</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Objective-Pharmacol. use of peroxisome proliferator-activated receptor (PPAR)δ agonists and transgenic overexpression of PPARδ in mice suggest amelioration of features of the metabolic syndrome through enhanced fat oxidn. in skeletal muscle.  We hypothesize a similar mechanism operates in humans.  Research Design and Methods-The PPARδ agonist (10 mg o.d. GW501516), a comparator PPARα agonist (20 μg o.d. GW590735), and placebo were given in a double-blind, randomized, three-parallel group, 2-wk study to six healthy moderately overweight subjects in each group.  Metabolic evaluation was made before and after treatment including liver fat quantification, fasting blood samples, a 6-h meal tolerance test with stable isotope fatty acids, skeletal muscle biopsy for gene expression, and urinary isoprostanes for global oxidative stress.  Results-Treatment with GW501516 showed statistically significant redns. in fasting plasma triglycerides (-30%), apolipoprotein B (-26%), LDL cholesterol (-23%), and insulin (-11%), whereas HDL cholesterol was unchanged.  A 20% redn. in liver fat content (P < 0.05) and 30% redn. in urinary isoprostanes (P = 0.01) were also obsd.  Except for a lowering of triglycerides (-30%, P < 0.05), none of these changes were obsd. in response to GW590735.  The relative proportion of exhaled CO2 directly originating from the fat content of the meal was increased (P < 0.05) in response to GW501516, and skeletal muscle expression of carnitine palmitoyl-transferase 1b (CPT1b) was also significantly increased.  Conclusions-The PPARδ agonist GW501516 reverses multiple abnormalities assocd. with the metabolic syndrome without increasing oxidative stress.  The effect is probably caused by increased fat oxidn. in skeletal muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXPtsdL6apBbVg90H21EOLACvtfcHk0ljkVn9Q8EEe7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVOktrs%253D&md5=3a2d27a6a898aa3c668b08e47ea8a1a9</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.2337%2Fdb07-1318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb07-1318%26sid%3Dliteratum%253Aachs%26aulast%3DRis%25C3%25A9rus%26aufirst%3DU.%26aulast%3DSprecher%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DOlson%26aufirst%3DE.%26aulast%3DHirschberg%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DHegde%26aufirst%3DP.%26aulast%3DRichards%26aufirst%3DD.%26aulast%3DSarov-Blat%26aufirst%3DL.%26aulast%3DStrum%26aufirst%3DJ.%2BC.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DCheeseman%26aufirst%3DJ.%26aulast%3DFielding%26aufirst%3DB.%2BA.%26aulast%3DHumphreys%26aufirst%3DS.%2BM.%26aulast%3DDanoff%26aufirst%3DT.%26aulast%3DMoore%26aufirst%3DN.%2BR.%26aulast%3DMurgatroyd%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Rahilly%26aufirst%3DS.%26aulast%3DSutton%26aufirst%3DP.%26aulast%3DWillson%26aufirst%3DT.%26aulast%3DHassall%26aufirst%3DD.%26aulast%3DFrayn%26aufirst%3DK.%2BN.%26aulast%3DKarpe%26aufirst%3DF.%26atitle%3DActivation%2520of%2520Peroxisome%2520Proliferator%25E2%2580%2593activated%2520Receptor%2520%2528PPAR%2529%2520%25CE%25B4%2520Promotes%2520Reversal%2520of%2520Multiple%2520Metabolic%2520Abnormalities%252C%2520Reduces%2520Oxidative%2520Stress%252C%2520and%2520Increases%2520Fatty%2520Acid%2520Oxidation%2520in%2520Moderately%2520Obese%2520Men%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26spage%3D332%26epage%3D339%26doi%3D10.2337%2Fdb07-1318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2016.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.tem.2016.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27005447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVOnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=319-334&author=M.+V%C3%A1zquez-Carrera&title=Unraveling+the+Effects+of+PPAR%CE%B2%2F%CE%B4+on+Insulin+Resistance+and+Cardiovascular+Disease&doi=10.1016%2Fj.tem.2016.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease</span></div><div class="casAuthors">Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">319-334</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Insulin resistance precedes dyslipidemia and type 2 diabetes mellitus (T2DM) development.  Preclin. evidence suggests that peroxisome proliferator-activated receptor (PPAR) β/δ activators may prevent and treat obesity-induced insulin resistance and T2DM, while clin. trials highlight their potential utility in dyslipidemia.  This review summarizes recent mechanistic insights into the antidiabetic effects of PPARβ/δ activators, including their anti-inflammatory actions, their ability to inhibit endoplasmic reticulum (ER) stress and hepatic lipogenesis, and to improve atherogenesis and insulin sensitivity, as well as their capacity to activate pathways that are also stimulated by exercise.  Findings from clin. trials are also examd.  Dissecting the effects of PPARβ/δ ligands on insulin sensitivity and atherogenesis may provide a basis for the development of therapies for the prevention and treatment of T2DM and cardiovascular disease (CVD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpANomzthPY7Vg90H21EOLACvtfcHk0ljkVn9Q8EEe7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVOnsbk%253D&md5=e57c1de81241f77ae10bafcdef2f1830</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2016.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2016.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DUnraveling%2520the%2520Effects%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520on%2520Insulin%2520Resistance%2520and%2520Cardiovascular%2520Disease%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2016%26volume%3D27%26spage%3D319%26epage%3D334%26doi%3D10.1016%2Fj.tem.2016.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span> <i>CymaBay Therapeutics Announces U.S. Orphan Drug Designation
for MBX-8025
for the Treatment of Primary Biliary Cholangitis</i>; <span class="NLM_publisher-name">Cymabay Therapeutics</span>: <span class="NLM_publisher-loc">Newark, CA</span>, <span class="NLM_year">2016</span>; <a href="https://ir.cymabay.com/press-releases/detail/383/cymabay-therapeutics-announces-u-s-orphan-drug-designation-for-mbx-8025-for-the-treatment-of-primary-biliary-cholangitis" class="extLink">https://ir.cymabay.com/press-releases/detail/383/cymabay-therapeutics-announces-u-s-orphan-drug-designation-for-mbx-8025-for-the-treatment-of-primary-biliary-cholangitis</a> (accessed 2020-01-18).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+CymaBay+Therapeutics+Announces+U.S.+Orphan+Drug+Designation%0Afor+MBX-8025%0Afor+the+Treatment+of+Primary+Biliary+Cholangitis%3B+Cymabay+Therapeutics%3A+Newark%2C+CA%2C+2016%3B+https%3A%2F%2Fir.cymabay.com%2Fpress-releases%2Fdetail%2F383%2Fcymabay-therapeutics-announces-u-s-orphan-drug-designation-for-mbx-8025-for-the-treatment-of-primary-biliary-cholangitis+%28accessed+2020-01-18%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCymaBay%2520Therapeutics%2520Announces%2520U.S.%2520Orphan%2520Drug%2520Designation%250Afor%2520MBX-8025%250Afor%2520the%2520Treatment%2520of%2520Primary%2520Biliary%2520Cholangitis%26pub%3DCymabay%2520Therapeutics%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span> <i>CymaBay Therapeutics Granted
EMA Orphan Drug Designation for Seladelpar
for the Treatment of Primary Biliary Cholangitis</i>; <span class="NLM_publisher-name">Cymabay Therapeutics</span>: <span class="NLM_publisher-loc">Newark, CA</span>, <span class="NLM_year">2017</span>; <a href="https://ir.cymabay.com/press-releases/detail/410/cymabay-therapeutics-granted-ema-orphan-drug-designation-for-seladelpar-for-the-treatment-of-primary-biliary-cholangitis" class="extLink">https://ir.cymabay.com/press-releases/detail/410/cymabay-therapeutics-granted-ema-orphan-drug-designation-for-seladelpar-for-the-treatment-of-primary-biliary-cholangitis</a> (accessed 2020-01-19).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+CymaBay+Therapeutics+Granted%0AEMA+Orphan+Drug+Designation+for+Seladelpar%0Afor+the+Treatment+of+Primary+Biliary+Cholangitis%3B+Cymabay+Therapeutics%3A+Newark%2C+CA%2C+2017%3B+https%3A%2F%2Fir.cymabay.com%2Fpress-releases%2Fdetail%2F410%2Fcymabay-therapeutics-granted-ema-orphan-drug-designation-for-seladelpar-for-the-treatment-of-primary-biliary-cholangitis+%28accessed+2020-01-19%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCymaBay%2520Therapeutics%2520Granted%250AEMA%2520Orphan%2520Drug%2520Designation%2520for%2520Seladelpar%250Afor%2520the%2520Treatment%2520of%2520Primary%2520Biliary%2520Cholangitis%26pub%3DCymabay%2520Therapeutics%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span> <i>CymaBay Therapeutics Halts
Clinical Development of Seladelpar</i>; <span class="NLM_publisher-name">Cymabay
Therapeutics</span>: <span class="NLM_publisher-loc">Newark, CA</span>, <span class="NLM_year">2019</span>; <a href="https://ir.cymabay.com/press-releases/detail/476/cymabay-therapeutics-halts-clinical-development-of-seladelpar" class="extLink">https://ir.cymabay.com/press-releases/detail/476/cymabay-therapeutics-halts-clinical-development-of-seladelpar</a> (accessed 2020-01-28).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+CymaBay+Therapeutics+Halts%0AClinical+Development+of+Seladelpar%3B+Cymabay%0ATherapeutics%3A+Newark%2C+CA%2C+2019%3B+https%3A%2F%2Fir.cymabay.com%2Fpress-releases%2Fdetail%2F476%2Fcymabay-therapeutics-halts-clinical-development-of-seladelpar+%28accessed+2020-01-28%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCymaBay%2520Therapeutics%2520Halts%250AClinical%2520Development%2520of%2520Seladelpar%26pub%3DCymabay%250ATherapeutics%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span> <i>GENFIT: Positive 42-month
DSMB Recommendation for Continuation of
Phase 3 RESOLVE-IT Study of Elafibranor in NASH</i>; <span class="NLM_publisher-name">GENFIT</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>, <span class="NLM_year">2019</span>; <a href="https://ir.genfit.com/news-releases/news-release-details/genfit-positive-42-month-dsmb-recommendation-continuation-phase" class="extLink">https://ir.genfit.com/news-releases/news-release-details/genfit-positive-42-month-dsmb-recommendation-continuation-phase</a> (accessed 2020-02-15).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GENFIT%3A+Positive+42-month%0ADSMB+Recommendation+for+Continuation+of%0APhase+3+RESOLVE-IT+Study+of+Elafibranor+in+NASH%3B+GENFIT%3A+Cambridge%2C+MA%2C+2019%3B+https%3A%2F%2Fir.genfit.com%2Fnews-releases%2Fnews-release-details%2Fgenfit-positive-42-month-dsmb-recommendation-continuation-phase+%28accessed+2020-02-15%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DGENFIT%253A%2520Positive%252042-month%250ADSMB%2520Recommendation%2520for%2520Continuation%2520of%250APhase%25203%2520RESOLVE-IT%2520Study%2520of%2520Elafibranor%2520in%2520NASH%26pub%3DGENFIT%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span> <i>GENFIT: Annual Results
for 2011</i>; <span class="NLM_publisher-name">GENFIT</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>, <span class="NLM_year">2012</span>; <a href="https://www.genfit.com/wp-content/uploads/2014/05/2012.04.25_GENFIT_2011_Annual_Results.pdf" class="extLink">https://www.genfit.com/wp-content/uploads/2014/05/2012.04.25_GENFIT_2011_Annual_Results.pdf</a> (accessed 2020-02-15).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GENFIT%3A+Annual+Results%0Afor+2011%3B+GENFIT%3A+Cambridge%2C+MA%2C+2012%3B+https%3A%2F%2Fwww.genfit.com%2Fwp-content%2Fuploads%2F2014%2F05%2F2012.04.25_GENFIT_2011_Annual_Results.pdf+%28accessed+2020-02-15%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DGENFIT%253A%2520Annual%2520Results%250Afor%25202011%26pub%3DGENFIT%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span> <i>Cymabay Therapeutics Annual
Report, Form 10-K</i>; <span class="NLM_publisher-name">Cymabay Therapeutics</span>; <span class="NLM_publisher-loc">Newark, CA</span>, <span class="NLM_year">2015</span>; p
5 <a href="https://ir.cymabay.com/annual-reports/content/0001193125-16-521392/d41327d10k.htm" class="extLink">https://ir.cymabay.com/annual-reports/content/0001193125-16-521392/d41327d10k.htm</a> (accessed 2020-02-08).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Cymabay+Therapeutics+Annual%0AReport%2C+Form+10-K%3B+Cymabay+Therapeutics%3B+Newark%2C+CA%2C+2015%3B+p%0A5+https%3A%2F%2Fir.cymabay.com%2Fannual-reports%2Fcontent%2F0001193125-16-521392%2Fd41327d10k.htm+%28accessed+2020-02-08%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCymabay%2520Therapeutics%2520Annual%250AReport%252C%2520Form%252010-K%26pub%3DCymabay%2520Therapeutics%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. C. V.</span>; <span class="NLM_string-name">Ohlstein, E.</span></span> <span> </span><span class="NLM_article-title">Use of a PPAR-delta agonist for treating muscle atrophy</span>. International Patent <span class="NLM_patent">US9487493B2</span>, Nov 8, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+C.+V.+Lopez&author=E.+Ohlstein&title=Use+of+a+PPAR-delta+agonist+for+treating+muscle+atrophy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DM.%2BC.%2BV.%26atitle%3DUse%2520of%2520a%2520PPAR-delta%2520agonist%2520for%2520treating%2520muscle%2520atrophy%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span> <i>FDA Grants Orphan Drug
Designation to Reneo Pharmaceuticals for REN001 for Treatment of Fatty
Acid Oxidation Disorders</i>; <span class="NLM_publisher-name">Reneo Pharmaceuticals</span>, <span class="NLM_year">2019</span>; <a href="https://reneopharma.com/fda-grants-orphan-drug-designation-to-reneo-pharmaceuticals-for-ren001-for-treatment-of-fatty-acid-oxidation-disorders/" class="extLink">https://reneopharma.com/fda-grants-orphan-drug-designation-to-reneo-pharmaceuticals-for-ren001-for-treatment-of-fatty-acid-oxidation-disorders/</a> (accessed 2020-01-19).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+FDA+Grants+Orphan+Drug%0ADesignation+to+Reneo+Pharmaceuticals+for+REN001+for+Treatment+of+Fatty%0AAcid+Oxidation+Disorders%3B+Reneo+Pharmaceuticals%2C+2019%3B+https%3A%2F%2Freneopharma.com%2Ffda-grants-orphan-drug-designation-to-reneo-pharmaceuticals-for-ren001-for-treatment-of-fatty-acid-oxidation-disorders%2F+%28accessed+2020-01-19%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DFDA%2520Grants%2520Orphan%2520Drug%250ADesignation%2520to%2520Reneo%2520Pharmaceuticals%2520for%2520REN001%2520for%2520Treatment%2520of%2520Fatty%250AAcid%2520Oxidation%2520Disorders%26pub%3DReneo%2520Pharmaceuticals%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span> <i>U.S. FDA Grants Fast Track
Designation to Astellas for the Development
of ASP1128 for Patients at Risk for Acute Kidney Injury</i>; <span class="NLM_publisher-name">Astellas Pharma</span>, <span class="NLM_year">2019</span>;  <a href="https://www.astellas.com/en/news/15376" class="extLink">https://www.astellas.com/en/news/15376</a> (accessed 2020-02-18).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+U.S.+FDA+Grants+Fast+Track%0ADesignation+to+Astellas+for+the+Development%0Aof+ASP1128+for+Patients+at+Risk+for+Acute+Kidney+Injury%3B+Astellas+Pharma%2C+2019%3B+https%3A%2F%2Fwww.astellas.com%2Fen%2Fnews%2F15376+%28accessed+2020-02-18%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DU.S.%2520FDA%2520Grants%2520Fast%2520Track%250ADesignation%2520to%2520Astellas%2520for%2520the%2520Development%250Aof%2520ASP1128%2520for%2520Patients%2520at%2520Risk%2520for%2520Acute%2520Kidney%2520Injury%26pub%3DAstellas%2520Pharma%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span> <i>Reneo Pharmaceuticals</i>; <span class="NLM_publisher-name">Reneo Pharmaceuticals</span>: <span class="NLM_publisher-loc">San Diego,
CA</span>, <span class="NLM_year">2020</span><a href="https://reneopharma.com/#news" class="extLink">https://reneopharma.com/#news</a> (accessed 2020-02-15).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Reneo+Pharmaceuticals%3B+Reneo+Pharmaceuticals%3A+San+Diego%2C%0ACA%2C+2020https%3A%2F%2Freneopharma.com%2F%23news+%28accessed+2020-02-15%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DReneo%2520Pharmaceuticals%26pub%3DReneo%2520Pharmaceuticals%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sprecher, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlstein, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobe, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. G.</span></span> <span> </span><span class="NLM_article-title">Triglyceride: High-density Lipoprotein Cholesterol Effects in Healthy Subjects Administered a Peroxisome Proliferator-activated Receptor δ Agonist</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1161/01.ATV.0000252790.70572.0c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1161%2F01.ATV.0000252790.70572.0c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17110604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=359-365&author=D.+L.+Sprecherauthor=C.+Massienauthor=G.+Pearceauthor=A.+N.+Billinauthor=I.+Perlsteinauthor=T.+M.+Willsonauthor=D.+G.+Hassallauthor=N.+Ancellinauthor=S.+D.+Pattersonauthor=D.+C.+Lobeauthor=T.+G.+Johnson&title=Triglyceride%3A+High-density+Lipoprotein+Cholesterol+Effects+in+Healthy+Subjects+Administered+a+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist&doi=10.1161%2F01.ATV.0000252790.70572.0c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist</span></div><div class="casAuthors">Sprecher, Dennis L.; Massien, Christine; Pearce, Greg; Billin, Andrew N.; Perlstein, Itay; Willson, Timothy M.; Hassall, David G.; Ancellin, Nicolas; Patterson, Scott D.; Lobe, David C.; Johnson, Tony G.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-365</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Exercise increases fatty acid oxidn. (FAO), improves blood serum high d. lipoprotein cholesterol (HDLc) and triglycerides (TG), and upregulates skeletal muscle peroxisome proliferator activated receptor (PPAR)δ expression.  In parallel, PPARδ agonist-upregulated FAO would induce fatty-acid uptake (via peripheral lipolysis), and influence HDLc and TG-rich lipoprotein particle metab., as suggested in preclin. models.  Healthy volunteers were allocated placebo (n = 6) or PPARδ agonist (GW501516) at 2.5 mg (n = 9) or 10 mg (n = 9), orally, once-daily for 2 wk while hospitalized and sedentary.  Std. lipid/lipoproteins were measured and in vivo fat feeding studies were conducted.  Human skeletal muscle cells were treated with GW501516 in vitro and evaluated for lipid-related gene expression and FAO.  Serum TG trended downwards (10 mg), whereas TG clearance post fat-feeding improved with drug.  HDLc was enhanced in both treatment groups when compared with the decrease in the placebo group (-11.5%).  These findings complimented in vitro cell culture results whereby GW501516 induced FAO and upregulated CPT1 and CD36 expression, in addn. to a 2-fold increase in ABCA1.  However, LpL expression remained unchanged.  This is the 1st report of a PPARδ agonist administered to man.  In this small study, GW501516 significantly influenced HDLc and TGs in healthy volunteers.  Enhanced in vivo serum fat clearance, and the 1st demonstrated in vitro upregulation in human skeletal muscle fat utilization and ABCA1 expression, suggests peripheral fat utilization and lipidation as potential mechanisms toward these HDL:TG effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnNeplvjStLrVg90H21EOLACvtfcHk0lj14S5idbYBSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGruw%253D%253D&md5=7d280853bb767e5a0c9ac2f693c2f9d8</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000252790.70572.0c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000252790.70572.0c%26sid%3Dliteratum%253Aachs%26aulast%3DSprecher%26aufirst%3DD.%2BL.%26aulast%3DMassien%26aufirst%3DC.%26aulast%3DPearce%26aufirst%3DG.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DPerlstein%26aufirst%3DI.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DHassall%26aufirst%3DD.%2BG.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DPatterson%26aufirst%3DS.%2BD.%26aulast%3DLobe%26aufirst%3DD.%2BC.%26aulast%3DJohnson%26aufirst%3DT.%2BG.%26atitle%3DTriglyceride%253A%2520High-density%2520Lipoprotein%2520Cholesterol%2520Effects%2520in%2520Healthy%2520Subjects%2520Administered%2520a%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D359%26epage%3D365%26doi%3D10.1161%2F01.ATV.0000252790.70572.0c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phua, W. W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. S.</span></span> <span> </span><span class="NLM_article-title">An Apparent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-activated Receptors</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1425</span>, <span class="refDoi"> DOI: 10.3390/ijms19051425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms19051425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOrur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1425&author=W.+W.+T.+Phuaauthor=M.+X.+Y.+Wongauthor=Z.+Liaoauthor=N.+S.+Tan&title=An+Apparent+Functional+Consequence+in+Skeletal+Muscle+Physiology+via+Peroxisome+Proliferator-activated+Receptors&doi=10.3390%2Fijms19051425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">An aPPARent functional consequence in skeletal muscle physiology via peroxisome proliferator-activated receptors</span></div><div class="casAuthors">Phua, Wendy Wen Ting; Wong, Melissa Xin Yu; Liao, Zehuan; Tan, Nguan Soon</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1425/1-1425/28</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Skeletal muscle comprises 30-40% of the total body mass and plays a central role in energy homeostasis in the body.  The deregulation of energy homeostasis is a common underlying characteristic of metabolic syndrome.  Over the past decades, peroxisome proliferator-activated receptors (PPARs) have been shown to play crit. regulatory roles in skeletal muscle.  The three family members of PPAR have overlapping roles that contribute to the myriad of processes in skeletal muscle.  This review aims to provide an overview of the functions of different PPAR members in energy homeostasis as well as during skeletal muscle metabolic disorders, with a particular focus on human and relevant mouse model studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIXfJemW9_87Vg90H21EOLACvtfcHk0lj14S5idbYBSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOrur3N&md5=c7d0d3825d386effd22af5437f542a8d</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.3390%2Fijms19051425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19051425%26sid%3Dliteratum%253Aachs%26aulast%3DPhua%26aufirst%3DW.%2BW.%2BT.%26aulast%3DWong%26aufirst%3DM.%2BX.%2BY.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DN.%2BS.%26atitle%3DAn%2520Apparent%2520Functional%2520Consequence%2520in%2520Skeletal%2520Muscle%2520Physiology%2520via%2520Peroxisome%2520Proliferator-activated%2520Receptors%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D1425%26doi%3D10.3390%2Fijms19051425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span> <span> </span><span class="NLM_article-title">The Opportunities and Challenges of Peroxisome Proliferator-activated Receptors Ligands in Clinical Drug Discovery and Development</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2189</span>, <span class="refDoi"> DOI: 10.3390/ijms19082189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms19082189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXns1Squ7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=2189&author=F.+Hongauthor=P.+Xuauthor=Y.+Zhai&title=The+Opportunities+and+Challenges+of+Peroxisome+Proliferator-activated+Receptors+Ligands+in+Clinical+Drug+Discovery+and+Development&doi=10.3390%2Fijms19082189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">The opportunities and challenges of peroxisome proliferator-activated receptors ligands in clinical drug discovery and development</span></div><div class="casAuthors">Hong, Fan; Xu, Pengfei; Zhai, Yonggong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2189/1-2189/29</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are a well-known pharmacol. target for the treatment of multiple diseases, including diabetes mellitus, dyslipidemia, cardiovascular diseases and even primary biliary cholangitis, gout, cancer, Alzheimer's disease and ulcerative colitis.  The three PPAR isoforms (α, β/δ and γ) have emerged as integrators of glucose and lipid metabolic signaling networks.  Typically, PPARα is activated by fibrates, which are commonly used therapeutic agents in the treatment of dyslipidemia.  The pharmacol. activators of PPARγ include thiazolidinediones (TZDs), which are insulin sensitizers used in the treatment of type 2 diabetes mellitus (T2DM), despite some drawbacks.  In this review, we summarize 84 types of PPAR synthetic ligands introduced to date for the treatment of metabolic and other diseases and provide a comprehensive anal. of the current applications and problems of these ligands in clin. drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQYYZAyS4sWLVg90H21EOLACvtfcHk0liB6yvUVQ1rMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXns1Squ7s%253D&md5=70fb7d69d601b20cd2ba0ddcf290b1c5</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.3390%2Fijms19082189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19082189%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DZhai%26aufirst%3DY.%26atitle%3DThe%2520Opportunities%2520and%2520Challenges%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptors%2520Ligands%2520in%2520Clinical%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D2189%26doi%3D10.3390%2Fijms19082189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadayyon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopst, M.</span></span> <span> </span><span class="NLM_article-title">Minireview: Challenges and Opportunities in Development of PPAR Agonists</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1756</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1210/me.2013-1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1210%2Fme.2013-1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25148456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFamtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1756-1768&author=M.+B.+Wrightauthor=M.+Bortoliniauthor=M.+Tadayyonauthor=M.+Bopst&title=Minireview%3A+Challenges+and+Opportunities+in+Development+of+PPAR+Agonists&doi=10.1210%2Fme.2013-1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Minireview: challenges and opportunities in development of PPAR agonists</span></div><div class="casAuthors">Wright, Matthew B.; Bortolini, Michele; Tadayyon, Moh; Bopst, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1756-1768, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">1944-9917</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The clin. impact of the fibrate and thiazolidinedione drugs on dyslipidemia and diabetes is driven mainly through activation of two transcription factors, peroxisome proliferator-activated receptors (PPAR)-α and PPAR-γ.  However, substantial differences exist in the therapeutic and side-effect profiles of specific drugs.  This has been attributed primarily to the complexity of drug-target complexes that involve many coregulatory proteins in the context of specific target gene promoters.  Recent data have revealed that some PPAR ligands interact with other non-PPAR targets.  Here we review concepts used to develop new agents that preferentially modulate transcriptional complex assembly, target more than one PPAR receptor simultaneously, or act as partial agonists.  We highlight newly described on-target mechanisms of PPAR regulation including phosphorylation and nongenomic regulation.  We briefly describe the recently discovered non-PPAR protein targets of thiazolidinediones, mitoNEET, and mTOT.  Finally, we summarize the contributions of on- and off-target actions to select therapeutic and side effects of PPAR ligands including insulin sensitivity, cardiovascular actions, inflammation, and carcinogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgR2Bsq_zCDbVg90H21EOLACvtfcHk0liB6yvUVQ1rMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFamtbY%253D&md5=9f52aab240185e1adf107feb7aa520a7</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1210%2Fme.2013-1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2013-1427%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%2BB.%26aulast%3DBortolini%26aufirst%3DM.%26aulast%3DTadayyon%26aufirst%3DM.%26aulast%3DBopst%26aufirst%3DM.%26atitle%3DMinireview%253A%2520Challenges%2520and%2520Opportunities%2520in%2520Development%2520of%2520PPAR%2520Agonists%26jtitle%3DMol.%2520Endocrinol.%26date%3D2014%26volume%3D28%26spage%3D1756%26epage%3D1768%26doi%3D10.1210%2Fme.2013-1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marvalim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. S.</span></span> <span> </span><span class="NLM_article-title">Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5055</span>, <span class="refDoi"> DOI: 10.3390/ijms20205055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms20205055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovF2hu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=5055&author=H.+S.+Chengauthor=W.+R.+Tanauthor=Z.+S.+Lowauthor=C.+Marvalimauthor=J.+Y.+H.+Leeauthor=N.+S.+Tan&title=Exploration+and+Development+of+PPAR+Modulators+in+Health+and+Disease%3A+An+Update+of+Clinical+Evidence&doi=10.3390%2Fijms20205055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration and development of ppar modulators in health and disease: an update of clinical evidence</span></div><div class="casAuthors">Cheng, Hong Sheng; Tan, Wei Ren; Low, Zun Siong; Marvalim, Charlie; Lee, Justin Yin Hao; Tan, Nguan Soon</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5055</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that govern the expression of genes responsible for energy metab., cellular development, and differentiation.  Their crucial biol. roles dictate the significance of PPAR-targeting synthetic ligands in medical research and drug discovery.  Clin. implications of PPAR agonists span across a wide range of health conditions, including metabolic diseases, chronic inflammatory diseases, infections, autoimmune diseases, neurol. and psychiatric disorders, and malignancies.  In this review we aim to consolidate existing clin. evidence of PPAR modulators, highlighting their clin. prospects and challenges.  Findings from clin. trials revealed that different agonists of the same PPAR subtype could present different safety profiles and clin. outcomes in a disease-dependent manner.  Pemafibrate, due to its high selectivity, is likely to replace other PPARα agonists for dyslipidemia and cardiovascular diseases.  PPARγ agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases.  The clin. niche of PPARβ/δ agonists is less well-explored.  Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alc. fatty liver disease, and primary biliary cholangitis.  Notably, the preclin. and clin. development for PPAR antagonists remains unacceptably deficient.  We anticipate the future design of better PPAR modulators with minimal off-target effects, high selectivity, superior bioavailability, and pharmacokinetics.  This will open new possibilities for PPAR ligands in medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWxCo23vO_P7Vg90H21EOLACvtfcHk0liB6yvUVQ1rMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovF2hu78%253D&md5=bdaac9397063a458ec0427b4a59c3b68</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.3390%2Fijms20205055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20205055%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%2BS.%26aulast%3DTan%26aufirst%3DW.%2BR.%26aulast%3DLow%26aufirst%3DZ.%2BS.%26aulast%3DMarvalim%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DJ.%2BY.%2BH.%26aulast%3DTan%26aufirst%3DN.%2BS.%26atitle%3DExploration%2520and%2520Development%2520of%2520PPAR%2520Modulators%2520in%2520Health%2520and%2520Disease%253A%2520An%2520Update%2520of%2520Clinical%2520Evidence%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D5055%26doi%3D10.3390%2Fijms20205055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Brian J. Kress, Dong Hyun Kim, Jared R. Mayo, Jeffery T. Farris, Benjamin Heck, Jeffrey G. Sarver, Divya Andy, Jill A. Trendel, Bruce E. Heck, <span class="NLM_string-name hlFld-ContribAuthor">Paul W. Erhardt</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of PPARδ Agonists That Promote Osteogenesis in a Human Mesenchymal Stem Cell Culture and in a Mouse Model of Human Osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6996-7032. <a href="https://doi.org/10.1021/acs.jmedchem.1c00560" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00560%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BPPAR%2525CE%2525B4%252BAgonists%252BThat%252BPromote%252BOsteogenesis%252Bin%252Ba%252BHuman%252BMesenchymal%252BStem%252BCell%252BCulture%252Band%252Bin%252Ba%252BMouse%252BModel%252Bof%252BHuman%252BOsteoporosis%26aulast%3DKress%26aufirst%3DBrian%2BJ.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D28032021%26date%3D14052021%26volume%3D64%26issue%3D10%26spage%3D6996%26epage%3D7032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingbo  Shao</span>, <span class="hlFld-ContribAuthor ">Jing  Xia</span>, <span class="hlFld-ContribAuthor ">Pinwen  Wu</span>, <span class="hlFld-ContribAuthor ">Jiazhou  Ying</span>. </span><span class="cited-content_cbyCitation_article-title">Dexmedetomidine protects cardiac microvascular endothelial cells from the damage of ogd/r through regulation of the pparδ‐mediated autophagy. </span><span class="cited-content_cbyCitation_journal-name">Microcirculation</span><span> <strong>2021,</strong> <em>28 </em>
                                    (4)
                                     <a href="https://doi.org/10.1111/micc.12675" title="DOI URL">https://doi.org/10.1111/micc.12675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/micc.12675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fmicc.12675%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrocirculation%26atitle%3DDexmedetomidine%252Bprotects%252Bcardiac%252Bmicrovascular%252Bendothelial%252Bcells%252Bfrom%252Bthe%252Bdamage%252Bof%252Bogd%25252Fr%252Bthrough%252Bregulation%252Bof%252Bthe%252Bppar%2525CE%2525B4%2525E2%252580%252590mediated%252Bautophagy%26aulast%3DShao%26aufirst%3DQingbo%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of (A) Carbaprostacyclin (prostacyclin-derived potent PPARδ agonist), (B) Phosphoiodyn A (marine natural product PPARδ-selective agonist), (C) Picrasidine N (natural plant-derived PPARδ-selective agonist), (D) GSK3787 (synthetic PPARδ-selective antagonist).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. A schematic summary of the effects of PPARδ activation in various diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Schematic one-dimensional representation of the functional domain structures of PPARs. (B) Published Apo PPARδ crystal structure of the three-layered helix sandwich. The three layers of the α-helical sandwich are shown in red, purple, and blue. β-Strands are shown in the yellow shapes and the loops in white.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> (C) General schematic structural features of the binding modes of PPARδ agonists (GW501516, a selective PPARδ agonist). (B) Reprinted with permission from ref <a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a>, Copyright 1999 Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) The structure of GW2433. (B) The reported structure of the ligand-binding site of GW2433-bound hPPARδ (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GWX">1GWX</a>).<a onclick="showRef(event, 'ref114 ref116'); return false;" href="javascript:void(0);" class="ref ref114 ref116">(114,116)</a> The blue dashed lines indicate a Y-shaped ligand-binding cavity, while the extended arms I, II, and III are labeled. Hydrogen bonds between the ligands and residues Y437, H287, and H413 are indicated as black dashed lines. The H2′–H3 loop and activation factor-2 (AF-2) are highlighted in orange and purple, respectively.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> (C) A stereo view of the crystallographic structure of the complex hPPARδ-LBD:GW0742, showing hPPARδ-LBD residues belonging to arm I, arm II, and arm III that stabilize the GW0742. (D) Comparison of the amino acid residues in arms I, II, and III of human PPARα, δ, and γ. Residues of PPARδ ligand-binding sites involved in contact with GW0742 are highlighted in bold blue. Residues Val312 and Ile328 underscored in arm II of PPARδ denote residues responsible for the GW0742’s PPARδ-selective activation.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> (E) Design of a potent and selective PPARδ agonist <b>35</b> and a published complex structure of hPPARδ-LBD with compound <b>35</b>. Close-up view of the ligand-binding site for compound <b>35</b> and hPPARδ-LBD. (B,E) Reprinted with permission from ref <a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a>. Copyright 2017 National Academy of Sciences. (C) Reprinted with permission from ref <a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a>. Copyright 2012 Public Library of Science .</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of rationally designed PPARδ agonists reported by Merck, GlaxoSmithKline, and Bayer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of rationally designed PPARδ agonists reported by Novartis, Novo Nordisk, and Johnson & Johnson.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of rationally designed PPARδ agonists reported by Pfizer, Nippon, AstraZeneca, and Kalypsys.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of selective PPARδ agonists reported by different universities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of rationally designed PPARδ agonists reported by Salk Institute, Mitobridge/Astellas, and DGMIF/SNU.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/medium/jm9b01882_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structure-based design of highly selective PPARδ agonists <b>24</b> and <b>38</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b01882/20200918/images/large/jm9b01882_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01882&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 191 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moller, D. E.</span></span> <span> </span><span class="NLM_article-title">The Mechanisms of Action of PPARs</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">435</span>, <span class="refDoi"> DOI: 10.1146/annurev.med.53.082901.104018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1146%2Fannurev.med.53.082901.104018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11818483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitl2mt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=409-435&author=J.+Bergerauthor=D.+E.+Moller&title=The+Mechanisms+of+Action+of+PPARs&doi=10.1146%2Fannurev.med.53.082901.104018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Mechanisms of Action of PPARs</span></div><div class="casAuthors">Berger, Joel; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">409-435</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The peroxisome proliferator-activated receptors (PPARs) are a group of three nuclear receptor isoforms, PPARγ, PPARα, and PPARδ, encoded by different genes.  PPARs are ligand-regulated transcription factors that control gene expression by binding to specific response elements (PPREs) within promoters.  PPARs bind as heterodimers with a retinoid X receptor and, upon binding agonist, interact with co-factors such that the rate of transcription initiation is increased.  The PPARs play a crit. physiol. role as lipid sensors and regulators of lipid metab.  Fatty acids and eicosanoids have been identified as natural ligands for the PPARs.  More potent synthetic PPAR ligands, including the fibrates and thiazolidinediones, have proven effective in the treatment of dyslipidemia and diabetes.  Use of such ligands has allowed researchers to unveil many potential roles for the PPARs in pathol. states including atherosclerosis, inflammation, cancer, infertility, and demyelination.  Here, we present the current state of knowledge regarding the mol. mechanisms of PPAR action and the involvement of the PPARs in the etiol. and treatment of several chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6rxPu_VgKKLVg90H21EOLACvtfcHk0lhzbp6PTOoU3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitl2mt7s%253D&md5=cc724640866d5fa365b4e637d85f6732</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.53.082901.104018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.53.082901.104018%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DThe%2520Mechanisms%2520of%2520Action%2520of%2520PPARs%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2002%26volume%3D53%26spage%3D409%26epage%3D435%26doi%3D10.1146%2Fannurev.med.53.082901.104018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luquet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Soriano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jehl-Pietri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenrich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimaldi, P. A.</span></span> <span> </span><span class="NLM_article-title">Roles of PPAR delta in Lipid Absorption and Metabolism: A New Target for the Treatment of Type 2 Diabetes</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1740</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2004.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbadis.2004.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15949697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFCrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1740&publication_year=2005&pages=313-317&author=S.+Luquetauthor=C.+Gaudelauthor=D.+Holstauthor=J.+Lopez-Sorianoauthor=C.+Jehl-Pietriauthor=A.+Fredenrichauthor=P.+A.+Grimaldi&title=Roles+of+PPAR+delta+in+Lipid+Absorption+and+Metabolism%3A+A+New+Target+for+the+Treatment+of+Type+2+Diabetes&doi=10.1016%2Fj.bbadis.2004.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes</span></div><div class="casAuthors">Luquet, Serge; Gaudel, Celine; Holst, Dorte; Lopez-Soriano, Joaquin; Jehl-Pietri, Chantal; Fredenrich, Alexandre; Grimaldi, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1740</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-317</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptors (PPARs) are lipid-activated transcription factors exerting several functions in development and metab.  PPARα, activated by polyunsatd. fatty acids and fibrates, is implicated in regulation of lipid metab., lipoprotein synthesis and metab. and inflammatory response in liver and other tissues.  PPARγ plays important roles in regulation of proliferation and differentiation of several cell types, including adipose cells.  Its activation by thiazolidinediones results in insulin sensitization and antidiabetic action.  Until recently, the physiol. functions of PPARδ remain elusive.  The utilization of specific agonists and of appropriate cellular and animal models revealed that PPARδ has an important role in metabolic adaptation of several tissues to environmental changes.  Treatment of obese animals by specific PPARδ agonists results in normalization of metabolic parameters and redn. of adiposity.  The nuclear receptor appeared to be implicated in the regulation of fatty acid burning capacities of skeletal muscle and adipose tissue by controlling the expression of genes involved in fatty acid uptake, β-oxidn. and energy uncoupling.  PPARδ is also implicated in the adaptive metabolic response of skeletal muscle to endurance exercise by controlling the no. of oxidative myofibers.  Given the results obtained with animal models, PPARδ agonists may have therapeutic usefulness in metabolic syndrome by increasing fatty acid consumption in skeletal muscle and adipose tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY-uVNEu9Q3rVg90H21EOLACvtfcHk0liqUQkfJ3VfRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFCrurs%253D&md5=1ec87eda53962cbf2bc5e59739b90905</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2004.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2004.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DLuquet%26aufirst%3DS.%26aulast%3DGaudel%26aufirst%3DC.%26aulast%3DHolst%26aufirst%3DD.%26aulast%3DLopez-Soriano%26aufirst%3DJ.%26aulast%3DJehl-Pietri%26aufirst%3DC.%26aulast%3DFredenrich%26aufirst%3DA.%26aulast%3DGrimaldi%26aufirst%3DP.%2BA.%26atitle%3DRoles%2520of%2520PPAR%2520delta%2520in%2520Lipid%2520Absorption%2520and%2520Metabolism%253A%2520A%2520New%2520Target%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2005%26volume%3D1740%26spage%3D313%26epage%3D317%26doi%3D10.1016%2Fj.bbadis.2004.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, R. K.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptors (PPARs) as Therapeutic Target in Neurodegenerative Disorders</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>483</i></span>,  <span class="NLM_fpage">1166</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.08.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbrc.2016.08.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27514452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyitr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2017&pages=1166-1177&author=S.+Agarwalauthor=A.+Yadavauthor=R.+K.+Chaturvedi&title=Peroxisome+Proliferator-activated+Receptors+%28PPARs%29+as+Therapeutic+Target+in+Neurodegenerative+Disorders&doi=10.1016%2Fj.bbrc.2016.08.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders</span></div><div class="casAuthors">Agarwal, Swati; Yadav, Anuradha; Chaturvedi, Rajnish Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1166-1177</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors and they serve to be a promising therapeutic target for several neurodegenerative disorders, which includes Parkinson disease, Alzheimer's disease, Huntington disease and Amyotrophic Lateral Sclerosis.  PPARs play an important role in the downregulation of mitochondrial dysfunction, proteasomal dysfunction, oxidative stress, and neuroinflammation, which are the major causes of the pathogenesis of neurodegenerative disorders.  In this review, we discuss about the role of PPARs as therapeutic targets in neurodegenerative disorders.  Several exptl. approaches suggest potential application of PPAR agonist as well as antagonist in the treatment of neurodegenerative disorders.  Several epidemiol. studies found that the regular usage of PPAR activating non-steroidal anti-inflammatory drugs is effective in decreasing the progression of neurodegenerative diseases including PD and AD.  We also reviewed the neuroprotective effects of PPAR agonists and assocd. mechanism of action in several neurodegenerative disorders both in vitro as well as in vivo animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmB7cvlUA4M7Vg90H21EOLACvtfcHk0liqUQkfJ3VfRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyitr%252FJ&md5=98a18a443ab2a6e10bcd46a3bf889f3b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.08.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.08.043%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DA.%26aulast%3DChaturvedi%26aufirst%3DR.%2BK.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptors%2520%2528PPARs%2529%2520as%2520Therapeutic%2520Target%2520in%2520Neurodegenerative%2520Disorders%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D483%26spage%3D1166%26epage%3D1177%26doi%3D10.1016%2Fj.bbrc.2016.08.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, R.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ in Human Cancer</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2016.10.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.biochi.2016.10.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27916645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOltrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=90-99&author=R.+M%C3%BCller&title=PPAR%CE%B2%2F%CE%B4+in+Human+Cancer&doi=10.1016%2Fj.biochi.2016.10.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ in human cancer</span></div><div class="casAuthors">Mueller, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90-99</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The nuclear receptor factor peroxisome proliferator-activated receptor (PPARβ/δ) can regulate its target genes by transcriptional activation or repression through both ligand-dependent and independent mechanism as well as by interactions with other transcription factors.  PPARβ/δ exerts essential regulatory functions in intermediary metab. that have been elucidated in detail, but clearly also plays a role in inflammation, differentiation, apoptosis and other cancer-assocd. processes, which is, however, mechanistically only partly understood.  Consistent with these functions clin. assocns. link the expression of PPARβ/δ and its target genes to an unfavorable outcome of several human cancers.  However, the available data do not yield a clear picture of PPARβ/δ's role in cancer-assocd. processes and are in fact partly controversial.  This article provides an overview of this research area and discusses the role of PPARβ/δ in cancer in light of the complex mechanisms of its transcriptional regulation and its potential as a druggable anti-cancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3o_xMr_T8CrVg90H21EOLACvtfcHk0liqUQkfJ3VfRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOltrrL&md5=25f48b7968294de3851ea54736d28286</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2016.10.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2016.10.019%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520in%2520Human%2520Cancer%26jtitle%3DBiochimie%26date%3D2017%26volume%3D136%26spage%3D90%26epage%3D99%26doi%3D10.1016%2Fj.biochi.2016.10.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, T.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span> <span> </span><span class="NLM_article-title">PPARδ is an APC-regulated Target of Nonsteroidal Anti-inflammatory Drugs</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81664-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS0092-8674%2800%2981664-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10555149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Gqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=335-345&author=T.-C.+Heauthor=T.+A.+Chanauthor=B.+Vogelsteinauthor=K.+W.+Kinzler&title=PPAR%CE%B4+is+an+APC-regulated+Target+of+Nonsteroidal+Anti-inflammatory+Drugs&doi=10.1016%2FS0092-8674%2800%2981664-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs</span></div><div class="casAuthors">He, Tong-Chuan; Chan, Timothy A.; Vogelstein, Bert; Kinzler, Kenneth W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">335-345</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PPARδ was identified as a target of APC through the anal. of global gene expression profiles in human colorectal cancer (CRC) cells.  PPARδ expression was elevated in CRCs and repressed by APC in CRC cells.  This repression was mediated by β-catenin/Tcf-4-responsive elements in the PPARδ promoter.  The ability of PPARs to bind eicosanoids suggested that PPARδ might be a target of chemopreventive non-steroidal anti-inflammatory drugs (NSAIDs).  Reporters contg. PPARδ-responsive elements were repressed by the NSAID sulindac.  Furthermore, sulindac was able to disrupt the ability of PPARδ to bind its recognition sequences.  These findings suggest that NSAIDs inhibit tumorigenesis through inhibition of PPARδ, the gene for which is normally regulated by APC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt8U6N3sHH_7Vg90H21EOLACvtfcHk0lh_3OPmKZ9QxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Gqs7k%253D&md5=fa435945158d8e44477fdb3d55219fbe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981664-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981664-5%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DT.-C.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DPPAR%25CE%25B4%2520is%2520an%2520APC-regulated%2520Target%2520of%2520Nonsteroidal%2520Anti-inflammatory%2520Drugs%26jtitle%3DCell%26date%3D1999%26volume%3D99%26spage%3D335%26epage%3D345%26doi%3D10.1016%2FS0092-8674%2800%2981664-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwashita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, N.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective Efficacy of the Peroxisome Proliferator-activated Receptor δ-selective Agonists In Vitro and In Vivo</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>320</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1096</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.115758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1124%2Fjpet.106.115758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17167170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1WgtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1087-1096&author=A.+Iwashitaauthor=Y.+Muramatsuauthor=T.+Yamazakiauthor=M.+Muramotoauthor=Y.+Kitaauthor=S.+Yamazakiauthor=K.+Miharaauthor=A.+Moriguchiauthor=N.+Matsuoka&title=Neuroprotective+Efficacy+of+the+Peroxisome+Proliferator-activated+Receptor+%CE%B4-selective+Agonists+In+Vitro+and+In+Vivo&doi=10.1124%2Fjpet.106.115758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective efficacy of the peroxisome proliferator-activated receptor δ-selective agonists in vitro and in vivo</span></div><div class="casAuthors">Iwashita, Akinori; Muramatsu, Yuko; Yamazaki, Takao; Muramoto, Masakazu; Kita, Yasuhiro; Yamazaki, Shunji; Mihara, Kayoko; Moriguchi, Akira; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1087-1096</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor superfamily and function as ligand-modulated transcription factors that regulate gene expression in many important biol. processes.  The PPARδ subtype has the highest expression in the brain and is postulated to play a major role in neuronal cell function; however, the precise physiol. roles of this receptor remain to be elucidated.  Herein, we show that the high-affinity PPARδ agonists L-165041 [4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propoxyl]phenoxy]-acetic acid and GW501516 [2-methyl4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-triazol-5-yl)-methylsulfanyl)phenoxy acetic acid] protect against cytotoxin-induced SH-SY5Y cell injury in vitro and both ischemic brain injury and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in vivo.  In the SH-SY5Y studies, treatment with L-165041 or GW501516 significantly and concn.-dependently attenuated cell death following thapsigargin, 1-methyl-4-phenylpyridinium, or staurosporine exposure, with the extent of damage correlated with the level of caspase-3 inhibition.  In the transient (90 min) middle cerebral artery occlusion model of ischemic brain injury in rats, i.c.v. infusion of L-165041 or GW501516 significantly attenuated the ischemic brain damage measured 24 h after reperfusion.  Moreover, the PPARδ agonists also significantly attenuated MPTP-induced depletion of striatal dopamine and related metabolite contents in mouse brain.  These results demonstrate that subtype-selective PPARδ agonists possess antiapoptotic properties in vitro, which may underlie their potential neuroprotective potential in in vivo exptl. models of cerebral ischemia and Parkinson's disease (PD).  These findings suggest that PPARδ agonists could be useful tools for understanding the role of PPARδ in other neurodegenerative disorders, as well as attractive therapeutic candidates for stroke and neurodegenerative diseases such as PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyN0bNjzlop7Vg90H21EOLACvtfcHk0lh_3OPmKZ9QxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1WgtLY%253D&md5=ec2b2359134c34cd4efca38c9e33c764</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.115758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.115758%26sid%3Dliteratum%253Aachs%26aulast%3DIwashita%26aufirst%3DA.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DMuramoto%26aufirst%3DM.%26aulast%3DKita%26aufirst%3DY.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DMihara%26aufirst%3DK.%26aulast%3DMoriguchi%26aufirst%3DA.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DNeuroprotective%2520Efficacy%2520of%2520the%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4-selective%2520Agonists%2520In%2520Vitro%2520and%2520In%2520Vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1087%26epage%3D1096%26doi%3D10.1124%2Fjpet.106.115758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peraza, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">The Role of Peroxisome Proliferator-activated Receptor-β/δ in Epithelial Cell Growth and Differentiation</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2005.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.cellsig.2005.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16109478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=9-20&author=A.+D.+Burdickauthor=D.+J.+Kimauthor=M.+A.+Perazaauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=The+Role+of+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+in+Epithelial+Cell+Growth+and+Differentiation&doi=10.1016%2Fj.cellsig.2005.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiation</span></div><div class="casAuthors">Burdick, Andrew D.; Kim, Dae J.; Peraza, Marjorie A.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-20</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The physiol. and pharmacol. roles of peroxisome proliferator-activated receptor-β (PPARβ-also referred to as PPARδ) are just beginning to emerge.  It has recently become clear that PPARβ has a function in epithelial tissues, but controversy exists due to inconsistencies in the literature.  There is strong evidence that ligand activation of PPARβ can induce terminal differentiation of keratinocytes, with a concomitant inhibition of cell proliferation.  However, the role of PPARβ in keratinocyte-specific apoptosis is less clear.  Addnl., the role of PPARβ in colonic epithelium remains unclear due to conflicting evidence suggesting that ligand activation of PPARβ can potentiate, as well as attenuate, intestinal cancer.  Recent studies revealed that ligand activation of PPARβ can induce fatty acid catabolism in skeletal muscle and is assocd. with improved insulin sensitivity, attenuated wt. gain and elevated HDL levels thus demonstrating promising potential for targeting PPARβ for treating obesity, dyslipidemias and type 2 diabetes.  Therefore, it becomes crit. to det. the safety of PPARβ ligands.  This review focuses on recent literature describing the role of PPARβ in epithelial tissues and highlights crit. discrepancies that need to be resolved for a more comprehensive understanding of how this receptor modulates epithelial homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZiOaK1_krLVg90H21EOLACvtfcHk0lh_3OPmKZ9QxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrzM&md5=7b88323aaff8064c499d66efe1c98695</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2005.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2005.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DBurdick%26aufirst%3DA.%2BD.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DPeraza%26aufirst%3DM.%2BA.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520Role%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520in%2520Epithelial%2520Cell%2520Growth%2520and%2520Differentiation%26jtitle%3DCell.%2520Signalling%26date%3D2006%26volume%3D18%26spage%3D9%26epage%3D20%26doi%3D10.1016%2Fj.cellsig.2005.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span> <span> </span><span class="NLM_article-title">PPARbeta/delta Ligands as Modulators of the Inflammatory Response</span>. <i>Curr. Opin. Investig. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18465655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntl2rsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=463-469&author=K.+S.+Kilgoreauthor=A.+N.+Billin&title=PPARbeta%2Fdelta+Ligands+as+Modulators+of+the+Inflammatory+Response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ ligands as modulators of the inflammatory response</span></div><div class="casAuthors">Kilgore, Kenneth S.; Billin, Andrew N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptors (PPARs) are steroid hormone nuclear receptors encoded by three genes: α, γ and β/δ.  Small-mol. agonists of this family of receptors, mostly PPARα and PPARγ agonists, possess pronounced anti-inflammatory effects; however, the use of selective PPARβ/δ agonists in preclin. studies suggests that this subtype also possesses anti-inflammatory properties.  In vivo data suggest that ligands to the β/δ isoform have activity in a no. of disease models that are partly driven by the inflammatory response.  Thus, selective activation of PPARβ/δ may represent a promising therapeutic approach for the treatment of diseases that have inflammation as a central component of their pathophysiol.  An overview of preclin. data that support the ability of PPARβ/δ agonists to modulate the inflammatory response is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolUpPhCY76QbVg90H21EOLACvtfcHk0lhG6AOXsoz5vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntl2rsbs%253D&md5=75966b86679646c97aa02aba93ca00c5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKilgore%26aufirst%3DK.%2BS.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26atitle%3DPPARbeta%252Fdelta%2520Ligands%2520as%2520Modulators%2520of%2520the%2520Inflammatory%2520Response%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2008%26volume%3D9%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Calvo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Marco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astudillo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balsinde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomer, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">The PPARβ/δ Activator GW501516 Prevents the Down-egulation of AMPK Caused by a High-fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">1848</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.1210/en.2010-1468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1210%2Fen.2010-1468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21363937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVKqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=1848-1859&author=E.+Barrosoauthor=R.+Rodr%C3%ADguez-Calvoauthor=L.+Serrano-Marcoauthor=A.+M.+Astudilloauthor=J.+Balsindeauthor=X.+Palomerauthor=M.+V%C3%A1zquez-Carrera&title=The+PPAR%CE%B2%2F%CE%B4+Activator+GW501516+Prevents+the+Down-egulation+of+AMPK+Caused+by+a+High-fat+Diet+in+Liver+and+Amplifies+the+PGC-1%CE%B1-Lipin+1-PPAR%CE%B1+Pathway+Leading+to+Increased+Fatty+Acid+Oxidation&doi=10.1210%2Fen.2010-1468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-lipin 1-PPARα pathway leading to increased fatty acid oxidation</span></div><div class="casAuthors">Barroso, Emma; Rodriguez-Calvo, Ricardo; Serrano-Marco, Lucia; Astudillo, Alma M.; Balsinde, Jesus; Palomer, Xavier; Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1848-1859</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Metabolic syndrome-assocd. dyslipidemia is mainly initiated by hepatic overprodn. of the plasma lipoproteins carrying triglycerides.  Here we examd. the effects of the peroxisome proliferator-activated receptors (PPAR)-β/δ activator GW501516 on high-fat diet (HFD)-induced hypertriglyceridemia and hepatic fatty acid oxidn.  Exposure to the HFD caused hypertriglyceridemia that was accompanied by reduced hepatic mRNA levels of PPAR-γ coactivator 1 (PGC-1)-α and lipin 1, and these effects were prevented by GW501516 treatment.  GW501516 treatment also increased nuclear lipin 1 protein levels, leading to amplification in the PGC-1α-PPARα signaling system, as demonstrated by the increase in PPARα levels and PPARα-DNA binding activity and the increased expression of PPARα-target genes involved in fatty acid oxidn.  These effects of GW501516 were accompanied by an increase in plasma β-hydroxybutyrate levels, demonstrating enhanced hepatic fatty acid oxidn.  Moreover, GW501516 increased the levels of the hepatic endogenous ligand for PPARα, 16:0/18:1-phosphatidilcholine and markedly enhanced the expression of the hepatic Vldl receptor.  Interestingly, GW501516 prevented the redn. in AMP-activated protein kinase (AMPK) phosphorylation and the increase in phosphorylated levels of ERK1/2 caused by HFD.  In addn., our data indicate that the activation of AMPK after GW501516 treatment in mice fed HFD might be the result of an increase in the AMP to ATP ratio in hepatocytes.  These findings indicate that the hypotriglyceridemic effect of GW501516 in HFD-fed mice is accompanied by an increase in phospho-AMPK levels and the amplification of the PGC-1α-lipin 1-PPARα pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoatnfQ6xMbCbVg90H21EOLACvtfcHk0lhG6AOXsoz5vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVKqurc%253D&md5=cd9ea28617eb0777ffe36ecbd28b6104</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1210%2Fen.2010-1468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2010-1468%26sid%3Dliteratum%253Aachs%26aulast%3DBarroso%26aufirst%3DE.%26aulast%3DRodr%25C3%25ADguez-Calvo%26aufirst%3DR.%26aulast%3DSerrano-Marco%26aufirst%3DL.%26aulast%3DAstudillo%26aufirst%3DA.%2BM.%26aulast%3DBalsinde%26aufirst%3DJ.%26aulast%3DPalomer%26aufirst%3DX.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DThe%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Activator%2520GW501516%2520Prevents%2520the%2520Down-egulation%2520of%2520AMPK%2520Caused%2520by%2520a%2520High-fat%2520Diet%2520in%2520Liver%2520and%2520Amplifies%2520the%2520PGC-1%25CE%25B1-Lipin%25201-PPAR%25CE%25B1%2520Pathway%2520Leading%2520to%2520Increased%2520Fatty%2520Acid%2520Oxidation%26jtitle%3DEndocrinology%26date%3D2011%26volume%3D152%26spage%3D1848%26epage%3D1859%26doi%3D10.1210%2Fen.2010-1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barlaka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galatou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellidis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravingerova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazou, A.</span></span> <span> </span><span class="NLM_article-title">Role of Pleiotropic Properties of Peroxisome Proliferator-activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection</span>. <i>Cardiovasc. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1111/1755-5922.12166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1111%2F1755-5922.12166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=26589375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFOktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=37-48&author=E.+Barlakaauthor=E.+Galatouauthor=K.+Mellidisauthor=T.+Ravingerovaauthor=A.+Lazou&title=Role+of+Pleiotropic+Properties+of+Peroxisome+Proliferator-activated+Receptors+in+the+Heart%3A+Focus+on+the+Nonmetabolic+Effects+in+Cardiac+Protection&doi=10.1111%2F1755-5922.12166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection</span></div><div class="casAuthors">Barlaka, Eleftheria; Galatou, Eleftheria; Mellidis, Kyriakos; Ravingerova, Tanya; Lazou, Antigone</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-48</span>CODEN:
                <span class="NLM_cas:coden">CTAHCA</span>;
        ISSN:<span class="NLM_cas:issn">1755-5914</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Peroxisome proliferator-activated receptors, PPARα, PPARβ/δ, and PPARγ, are a group of nuclear receptors that function as transcriptional regulators of lipid metab., energy homeostasis, and inflammation.  Given the role of metab. imbalance under pathol. states of the heart, PPARs have emerged as important therapeutic targets, and accumulating evidence highlights their protective role in the improvement of cardiac function under diverse pathol. settings.  Although the role of PPARs in the regulation of cardiac substrate utilization preference and energy homeostasis is well documented, their effects related to the regulation of cellular inflammatory and redox responses in the heart are less studied.  In this review, we provide an overview on recent progress with respect to understanding the role of the nonmetabolic effects of PPARs in cardiac dysfunction, namely during ischemia/reperfusion injury, hypertrophy, and cardiac failure, and highlight the mechanisms underlying the protective effects against inflammation, oxidative stress, and cell death.  The role of receptor-independent, nongenomic effects of PPAR agonists is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf_rtPnhP9y7Vg90H21EOLACvtfcHk0lhG6AOXsoz5vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFOktQ%253D%253D&md5=379cb4f64c714f661f5ff06b7b219586</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2F1755-5922.12166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1755-5922.12166%26sid%3Dliteratum%253Aachs%26aulast%3DBarlaka%26aufirst%3DE.%26aulast%3DGalatou%26aufirst%3DE.%26aulast%3DMellidis%26aufirst%3DK.%26aulast%3DRavingerova%26aufirst%3DT.%26aulast%3DLazou%26aufirst%3DA.%26atitle%3DRole%2520of%2520Pleiotropic%2520Properties%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptors%2520in%2520the%2520Heart%253A%2520Focus%2520on%2520the%2520Nonmetabolic%2520Effects%2520in%2520Cardiac%2520Protection%26jtitle%3DCardiovasc.%2520Ther.%26date%3D2016%26volume%3D34%26spage%3D37%26epage%3D48%26doi%3D10.1111%2F1755-5922.12166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwaisako, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haimerl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirlin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnabl, B.</span></span> <span> </span><span class="NLM_article-title">Protection from Liver Fibrosis by a Peroxisome Proliferator-activated Receptor δ Agonist</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">E1369</span>– <span class="NLM_lpage">E1376</span>, <span class="refDoi"> DOI: 10.1073/pnas.1202464109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.1202464109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22538808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVOnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=E1369-E1376&author=K.+Iwaisakoauthor=M.+Haimerlauthor=Y.-H.+Paikauthor=K.+Tauraauthor=Y.+Kodamaauthor=C.+Sirlinauthor=E.+Yuauthor=R.+T.+Yuauthor=M.+Downesauthor=R.+M.+Evansauthor=D.+A.+Brennerauthor=B.+Schnabl&title=Protection+from+Liver+Fibrosis+by+a+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist&doi=10.1073%2Fpnas.1202464109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist</span></div><div class="casAuthors">Iwaisako, Keiko; Haimerl, Michael; Paik, Yong-Han; Taura, Kojiro; Kodama, Yuzo; Sirlin, Claude; Yu, Elizabeth; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.; Brenner, David A.; Schnabl, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">E1369-E1376, SE1369/1-SE1369/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor delta (PPARδ), a member of the nuclear receptor family, is emerging as a key metabolic regulator with pleiotropic actions on various tissues including fat, skeletal muscle, and liver.  Here we show that the PPARδ agonist KD3010, but not the well-validated GW501516, dramatically ameliorates liver injury induced by carbon tetrachloride (CCl4) injections.  Deposition of extracellular matrix proteins was lower in the KD3010-treated group than in the vehicle- or GW501516-treated group.  Interestingly, profibrogenic connective tissue growth factor was induced significantly by GW501516, but not by KD3010, following CCl4 treatment.  The hepatoprotective and antifibrotic effect of KD3010 was confirmed in a model of cholestasis-induced liver injury and fibrosis using bile duct ligation for 3 wk.  Primary hepatocytes treated with KD3010 but not GW501516 were protected from starvation or CCl4-induced cell death, in part because of reduced reactive oxygen species prodn.  In conclusion, our data demonstrate that an orally active PPARδ agonist has hepatoprotective and antifibrotic effects in animal models of liver fibrosis, suggesting a possible mechanistic and therapeutic approach in treating patients with chronic liver diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnEkKoHzrbmrVg90H21EOLACvtfcHk0lg5KIZToseFkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVOnt7s%253D&md5=23baed11cc982053df607a0e667e5af2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1202464109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1202464109%26sid%3Dliteratum%253Aachs%26aulast%3DIwaisako%26aufirst%3DK.%26aulast%3DHaimerl%26aufirst%3DM.%26aulast%3DPaik%26aufirst%3DY.-H.%26aulast%3DTaura%26aufirst%3DK.%26aulast%3DKodama%26aufirst%3DY.%26aulast%3DSirlin%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DBrenner%26aufirst%3DD.%2BA.%26aulast%3DSchnabl%26aufirst%3DB.%26atitle%3DProtection%2520from%2520Liver%2520Fibrosis%2520by%2520a%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3DE1369%26epage%3DE1376%26doi%3D10.1073%2Fpnas.1202464109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-g.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paria, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moller, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzaskos, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S. K.</span></span> <span> </span><span class="NLM_article-title">Cyclo-oxygenase-2-derived Prostacyclin Mediates Embryo Implantation in the Mouse via PPARδ</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1561</span>– <span class="NLM_lpage">1574</span>, <span class="refDoi"> DOI: 10.1101/gad.13.12.1561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1101%2Fgad.13.12.1561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10385625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1MXktlOhsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1561-1574&author=H.+Limauthor=R.+A.+Guptaauthor=W.-g.+Maauthor=B.+C.+Pariaauthor=D.+E.+Mollerauthor=J.+D.+Morrowauthor=R.+N.+DuBoisauthor=J.+M.+Trzaskosauthor=S.+K.+Dey&title=Cyclo-oxygenase-2-derived+Prostacyclin+Mediates+Embryo+Implantation+in+the+Mouse+via+PPAR%CE%B4&doi=10.1101%2Fgad.13.12.1561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ</span></div><div class="casAuthors">Lim, Hyunjung; Gupta, Rajnish A.; Ma, Wen-Ge; Paria, Bibhash C.; Moller, David E.; Morrow, Jason D.; DuBois, Raymond N.; Trzaskos, James M.; Dey, Sudhansu K.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1561-1574</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The authors have demonstrated previously that cyclo-oxygenase-2 (COX2), the rate-limiting enzyme in the biosynthesis of prostaglandins (PGs), is essential for blastocyst implantation and decidualization.  However, the candidate PG(s) that participates in these processes and the mechanism of its action remain undefined.  Using COX2-deficient mice and multiple approaches, the authors demonstrate herein that COX2-derived prostacyclin (PGI2) is the primary PG that is essential for implantation and decidualization.  Several lines of evidence suggest that the effects of PGI2 are mediated by its activation of the nuclear hormone receptor PPARδ, demonstrating the first reported biol. function of this receptor signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0jrsofrvVl7Vg90H21EOLACvtfcHk0lg5KIZToseFkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktlOhsbw%253D&md5=9e9bb37755513cff82da6d4d2f9bf26e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.12.1561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.12.1561%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DH.%26aulast%3DGupta%26aufirst%3DR.%2BA.%26aulast%3DMa%26aufirst%3DW.-g.%26aulast%3DParia%26aufirst%3DB.%2BC.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26aulast%3DTrzaskos%26aufirst%3DJ.%2BM.%26aulast%3DDey%26aufirst%3DS.%2BK.%26atitle%3DCyclo-oxygenase-2-derived%2520Prostacyclin%2520Mediates%2520Embryo%2520Implantation%2520in%2520the%2520Mouse%2520via%2520PPAR%25CE%25B4%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D1561%26epage%3D1574%26doi%3D10.1101%2Fgad.13.12.1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geraci, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, R. N.</span></span> <span> </span><span class="NLM_article-title">Prostacyclin-mediated Activation of Peroxisome Proliferator-activated Receptor δ in Colorectal Cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">13275</span>– <span class="NLM_lpage">13280</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.24.13275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.97.24.13275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11087869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVOjsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=13275-13280&author=R.+A.+Guptaauthor=J.+Tanauthor=W.+F.+Krauseauthor=M.+W.+Geraciauthor=T.+M.+Willsonauthor=S.+K.+Deyauthor=R.+N.+DuBois&title=Prostacyclin-mediated+Activation+of+Peroxisome+Proliferator-activated+Receptor+%CE%B4+in+Colorectal+Cancer&doi=10.1073%2Fpnas.97.24.13275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer</span></div><div class="casAuthors">Gupta, Rajnish A.; Tan, Jian; Krause, Wade F.; Geraci, Mark W.; Willson, Timothy M.; Dey, Sudhansu K.; DuBois, Raymond N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13275-13280</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">There is evidence from both genetic and pharmacol. studies to suggest that the cyclooxygenase-2 (COX-2) enzyme plays a causal role in the development of colorectal cancer.  However, little is known about the identity or role of the eicosanoid receptor pathways activated by COX-derived prostaglandins (PG).  The authors previously have reported that COX-2-derived prostacyclin promotes embryo implantation in the mouse uterus via activation of the nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR) δ.  In light of the recent finding that PPARδ is a target of β-catenin transactivation, it is important to det. whether this signaling pathway is operative during the development of colorectal cancer.  Anal. of PPARδ mRNA in matched normal and tumor samples revealed that expression of PPARδ, similar to COX-2, is up-regulated in colorectal carcinomas.  In situ hybridization studies demonstrate that PPARδ is expressed in normal colon and localized to the epithelial cells at the very tips of the mucosal glands.  In contrast, expression of PPARδ mRNA in colorectal tumors was more widespread with increased levels in transformed epithelial cells.  Anal. of PPARδ and COX-2 mRNA in serial sections suggested they were colocalized to the same region within a tumor.  Finally, transient transfection assays established that endogenously synthesized prostacyclin (PGI2) could serve as a ligand for PPARδ.  In addn., the stable PGI2 analog, carbaprostacyclin, and a synthetic PPARδ agonist induced transactivation of endogenous PPARδ in human colon carcinoma cells.  The authors conclude from these observations that PPARδ, similar to COX-2, is aberrantly expressed in colorectal tumors and that endogenous PPARδ is transcriptionally responsive to PGI2.  However, the functional consequence of PPARδ activation in colon carcinogenesis still needs to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosPvlXKDhVXbVg90H21EOLACvtfcHk0lg5KIZToseFkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVOjsr8%253D&md5=8adadad6b2e680dcedd16e256a5341ed</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.24.13275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.24.13275%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DR.%2BA.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DKrause%26aufirst%3DW.%2BF.%26aulast%3DGeraci%26aufirst%3DM.%2BW.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DDey%26aufirst%3DS.%2BK.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26atitle%3DProstacyclin-mediated%2520Activation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520in%2520Colorectal%2520Cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D13275%26epage%3D13280%26doi%3D10.1073%2Fpnas.97.24.13275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schumann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adhikary, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkernagel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnitzer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schober, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nockher, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiewe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinartz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Brüsselbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, R.</span></span> <span> </span><span class="NLM_article-title">Deregulation of PPARβ/δ Target Genes in Tumor-associated Macrophages by Fatty Acid Ligands in the Ovarian Cancer Microenvironment</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">13416</span>– <span class="NLM_lpage">13433</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.18632%2Foncotarget.3826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25968567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC2MfjsFSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=13416-13433&author=T.+Schumannauthor=T.+Adhikaryauthor=A.+Wortmannauthor=F.+Finkernagelauthor=S.+Lieberauthor=E.+Schnitzerauthor=N.+Legrandauthor=Y.+Schoberauthor=W.+A.+Nockherauthor=P.+M.+Tothauthor=W.+E.+Diederichauthor=A.+Nistauthor=T.+Stieweauthor=U.+Wagnerauthor=S.+Reinartzauthor=S.+M%C3%BCller-Br%C3%BCsselbachauthor=R.+M%C3%BCller&title=Deregulation+of+PPAR%CE%B2%2F%CE%B4+Target+Genes+in+Tumor-associated+Macrophages+by+Fatty+Acid+Ligands+in+the+Ovarian+Cancer+Microenvironment&doi=10.18632%2Foncotarget.3826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment</span></div><div class="casAuthors">Schumann Tim; Adhikary Till; Wortmann Annika; Finkernagel Florian; Lieber Sonja; Schnitzer Evelyn; Legrand Nathalie; Muller-Brusselbach Sabine; Muller Rolf; Schober Yvonne; Nockher W Andreas; Toth Philipp M; Diederich Wibke E; Nist Andrea; Stiewe Thorsten; Wagner Uwe; Reinartz Silke</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">13416-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is a lipid ligand-inducible transcription factor associated with macrophage polarization.  However, its function in tumor-associated macrophages (TAMs) has not been investigated to date.  Here, we report the PPARβ/δ-regulated transcriptome and cistrome for TAMs from ovarian carcinoma patients.  Comparison with monocyte-derived macrophages shows that the vast majority of direct PPARβ/δ target genes are upregulated in TAMs and largely refractory to synthetic agonists, but repressible by inverse agonists.  Besides genes with metabolic functions, these include cell type-selective genes associated with immune regulation and tumor progression, e.g., LRP5, CD300A, MAP3K8 and ANGPTL4.  This deregulation is not due to increased expression of PPARβ/δ or its enhanced recruitment to target genes.  Instead, lipidomic analysis of malignancy-associated ascites revealed high concentrations of polyunsaturated fatty acids, in particular linoleic acid, acting as potent PPARβ/δ agonists in macrophages.  These fatty acid ligands accumulate in lipid droplets in TAMs, thereby providing a reservoir of PPARβ/δ ligands.  These observations suggest that the deregulation of PPARβ/δ target genes by ligands of the tumor microenvironment contributes to the pro-tumorigenic polarization of ovarian carcinoma TAMs.  This conclusion is supported by the association of high ANGPTL4 expression with a shorter relapse-free survival in serous ovarian carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQKXDQm87QVYHy-c-E1v-fmfW6udTcc2ear2aLJjNbOq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfjsFSktA%253D%253D&md5=595d16fe0aae865d381c97e7ffec2248</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3826%26sid%3Dliteratum%253Aachs%26aulast%3DSchumann%26aufirst%3DT.%26aulast%3DAdhikary%26aufirst%3DT.%26aulast%3DWortmann%26aufirst%3DA.%26aulast%3DFinkernagel%26aufirst%3DF.%26aulast%3DLieber%26aufirst%3DS.%26aulast%3DSchnitzer%26aufirst%3DE.%26aulast%3DLegrand%26aufirst%3DN.%26aulast%3DSchober%26aufirst%3DY.%26aulast%3DNockher%26aufirst%3DW.%2BA.%26aulast%3DToth%26aufirst%3DP.%2BM.%26aulast%3DDiederich%26aufirst%3DW.%2BE.%26aulast%3DNist%26aufirst%3DA.%26aulast%3DStiewe%26aufirst%3DT.%26aulast%3DWagner%26aufirst%3DU.%26aulast%3DReinartz%26aufirst%3DS.%26aulast%3DM%25C3%25BCller-Br%25C3%25BCsselbach%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26atitle%3DDeregulation%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Target%2520Genes%2520in%2520Tumor-associated%2520Macrophages%2520by%2520Fatty%2520Acid%2520Ligands%2520in%2520the%2520Ovarian%2520Cancer%2520Microenvironment%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D13416%26epage%3D13433%26doi%3D10.18632%2Foncotarget.3826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jawerbaum, A.</span></span> <span> </span><span class="NLM_article-title">Carbaprostacyclin, a PPARdelta Agonist, Ameliorates Excess Lipid Accumulation in Diabetic Rat Placentas</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2010.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.lfs.2010.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=20338185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVenur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=781-790&author=M.+Kurtzauthor=E.+Capobiancoauthor=N.+Mart%C3%ADnezauthor=J.+Fern%C3%A1ndezauthor=R.+Higaauthor=V.+Whiteauthor=A.+Jawerbaum&title=Carbaprostacyclin%2C+a+PPARdelta+Agonist%2C+Ameliorates+Excess+Lipid+Accumulation+in+Diabetic+Rat+Placentas&doi=10.1016%2Fj.lfs.2010.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Carbaprostacyclin, a PPARδ agonist, ameliorates excess lipid accumulation in diabetic rat placentas</span></div><div class="casAuthors">Kurtz, Melisa; Capobianco, Evangelina; Martinez, Nora; Fernandez, Jimena; Higa, Romina; White, Veronica; Jawerbaum, Alicia</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">21-22</span>),
    <span class="NLM_cas:pages">781-790</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aims: Maternal diabetes impairs placental development and metab.  Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors relevant in metabolic homeostasis.  We investigated the concns. of PPARδ and its endogenous agonist prostacyclin (PGI2), as well as the effects of carbaprostacylin (cPGI2, a PPARδ agonist) on lipid metab. in placentas from control and streptozotocin-induced diabetic rats on day 13.5 of gestation.  Main methods: The placentas were explanted to evaluate PPARδ expression and PGI2 concns., and cultured with cPGI2 for further anal. of lipid metab. (concns. and 14C-acetate derived synthesis of triglycerides, cholesteryl esters, phospholipids, cholesterol and free fatty acids; release of glycerol and lipid peroxidn.).  Key findings: Reduced PGI2 concns. were found in the placentas from diabetic rats when compared to controls. cPGI2 addns. reduced the concns. and synthesis of several lipid species, increased lipid catabolism and reduced lipid peroxidn. in the placenta.  These effects were more marked in diabetic tissues, which presented alterations in the lipid metabolic parameters evaluated. cPGI2 addns. increased placental PPARδ and acyl-CoA oxidase expression, which are changes possibly involved in the catabolic effects obsd.  Significance: The present study reveals the capability of cPGI2 to regulate placental lipid metab. and PPARδ expression, and suggests that preserving appropriate PGI2 concns. in the placenta may help to metabolize maternal derived lipid overload in diabetic gestations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkw3Z0cryf8rVg90H21EOLACvtfcHk0li2fuzVnBFBDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVenur8%253D&md5=902cddd4502a10c0bf661831e703eed0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2010.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2010.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DKurtz%26aufirst%3DM.%26aulast%3DCapobianco%26aufirst%3DE.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DN.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DJ.%26aulast%3DHiga%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DJawerbaum%26aufirst%3DA.%26atitle%3DCarbaprostacyclin%252C%2520a%2520PPARdelta%2520Agonist%252C%2520Ameliorates%2520Excess%2520Lipid%2520Accumulation%2520in%2520Diabetic%2520Rat%2520Placentas%26jtitle%3DLife%2520Sci.%26date%3D2010%26volume%3D86%26spage%3D781%26epage%3D790%26doi%3D10.1016%2Fj.lfs.2010.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forman, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Hypolipidemic Drugs, Polyunsaturated Fatty acids, and Eicosanoids are Ligands for Peroxisome Proliferator-activated Receptors α and δ</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">4312</span>– <span class="NLM_lpage">4317</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.9.4312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.94.9.4312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=9113986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK2sXjtVyhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=4312-4317&author=B.+M.+Formanauthor=J.+Chenauthor=R.+M.+Evans&title=Hypolipidemic+Drugs%2C+Polyunsaturated+Fatty+acids%2C+and+Eicosanoids+are+Ligands+for+Peroxisome+Proliferator-activated+Receptors+%CE%B1+and+%CE%B4&doi=10.1073%2Fpnas.94.9.4312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ</span></div><div class="casAuthors">Forman, Barry Marc; Chen, Jasmine; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4312-4317</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fatty acids (FAs) and their derivs. are essential cellular metabolites whose concns. must be closely regulated.  This implies that regulatory circuits exist which can sense changes in FA levels.  Indeed, the peroxisome proliferator-activated receptor α (PPARα) regulates lipid homeostasis and is transcriptionally activated by a variety of lipid-like compds.  It remains nuclear as to how these structurally diverse compds. can activate a single receptor.  A novel conformation-based assay that screens activators for their ability to bind to PPARα/δ and induce DNA binding has been developed.  It is shown here that specific FAs, eicosanoids, and hypolipidemic drugs are ligands for PPARα or PPARδ.  Because altered FA levels are assocd. with obesity, atherosclerosis, hypertension, and diabetes, PPARs may serve as mol. sensors that are central to the development and treatment of these metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ScUan5LKD7Vg90H21EOLACvtfcHk0li2fuzVnBFBDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtVyhsbs%253D&md5=71fa1629903741d90d1e1ca487f69c90</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.9.4312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.9.4312%26sid%3Dliteratum%253Aachs%26aulast%3DForman%26aufirst%3DB.%2BM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DHypolipidemic%2520Drugs%252C%2520Polyunsaturated%2520Fatty%2520acids%252C%2520and%2520Eicosanoids%2520are%2520Ligands%2520for%2520Peroxisome%2520Proliferator-activated%2520Receptors%2520%25CE%25B1%2520and%2520%25CE%25B4%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D4312%26epage%3D4317%26doi%3D10.1073%2Fpnas.94.9.4312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span> <span> </span><span class="NLM_article-title">Phosphoiodyns A and B, Unique Phosphorus-containing Iodinated Polyacetylenes from a Korean Sponge Placospongia sp</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1021/ol3031318</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol3031318" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCjurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=100-103&author=H.+Kimauthor=J.+Chinauthor=H.+Choiauthor=K.+Baekauthor=T.-G.+Leeauthor=S.+E.+Parkauthor=W.+Wangauthor=D.+Hahnauthor=I.+Yangauthor=J.+Leeauthor=B.+Munauthor=M.+Ekinsauthor=S.-J.+Namauthor=H.+Kang&title=Phosphoiodyns+A+and+B%2C+Unique+Phosphorus-containing+Iodinated+Polyacetylenes+from+a+Korean+Sponge+Placospongia+sp&doi=10.1021%2Fol3031318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoiodyns A and B, Unique Phosphorus-Containing Iodinated Polyacetylenes from a Korean Sponge Placospongia sp.</span></div><div class="casAuthors">Kim, Hiyoung; Chin, Jungwook; Choi, Hyukjae; Baek, Kyungryul; Lee, Tae-Gu; Park, Seong Eon; Wang, Weihong; Hahn, Dongyup; Yang, Inho; Lee, Jihye; Mun, Bora; Ekins, Merrick; Nam, Sang-Jip; Kang, Heonjoong</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-103</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two unprecedented phosphorus-contg. iodinated polyacetylenes, phosphoiodyns A and B (1-2), were isolated from a Korean marine sponge Placospongia sp.  Their structures were elucidated by spectroscopic data anal.  Phosphoiodyn A exhibited potent agonistic activity on human peroxisome proliferator-activated receptor delta (hPPARδ) with an EC50 of 23.7 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjCFAfSshMQ7Vg90H21EOLACvtfcHk0lgERi-FjLe-hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCjurzL&md5=bec58cb754ce99ecf8209dbb61810763</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fol3031318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol3031318%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DBaek%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DT.-G.%26aulast%3DPark%26aufirst%3DS.%2BE.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMun%26aufirst%3DB.%26aulast%3DEkins%26aufirst%3DM.%26aulast%3DNam%26aufirst%3DS.-J.%26aulast%3DKang%26aufirst%3DH.%26atitle%3DPhosphoiodyns%2520A%2520and%2520B%252C%2520Unique%2520Phosphorus-containing%2520Iodinated%2520Polyacetylenes%2520from%2520a%2520Korean%2520Sponge%2520Placospongia%2520sp%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D100%26epage%3D103%26doi%3D10.1021%2Fol3031318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakatabi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">Picrasidine N is a Subtype-selective PPARβ/δ Agonist</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00909</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00909" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVynsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=879-885&author=S.+Zhaoauthor=Y.+Kannoauthor=W.+Liauthor=H.+Wakatabiauthor=T.+Sasakiauthor=K.+Koikeauthor=K.+Nemotoauthor=H.+Li&title=Picrasidine+N+is+a+Subtype-selective+PPAR%CE%B2%2F%CE%B4+Agonist&doi=10.1021%2Facs.jnatprod.5b00909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Picrasidine N Is a Subtype-Selective PPARβ/δ Agonist</span></div><div class="casAuthors">Zhao, Shuai; Kanno, Yuichiro; Li, Wei; Wakatabi, Honami; Sasaki, Tatsunori; Koike, Kazuo; Nemoto, Kiyomitsu; Li, Huicheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">879-885</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Recently, growing evidence of the pivotal roles of peroxisome proliferator-activated receptor (PPAR) β/δ in various physiol. functions, including lipid homeostasis, cancer, and inflammation, has raised interest in this receptor.  In this study, the naturally occurring dimeric alkaloid picrasidine N from Picrasma quassioides was identified as a novel PPARβ/δ agonist from a library consisting of plant exts. and natural compds. using a mammalian one-hybrid assay, and this compd. was characterized.  Picrasidine N activated PPARβ/δ but did not activate or slightly activated PPARα and PPARγ.  Furthermore, a peroxisome proliferator response element-driven luciferase reporter gene assay demonstrated that picrasidine N enhanced PPARβ/δ transcriptional activity.  Moreover, picrasidine N selectively induced mRNA expression of ANGPTL4, which is a PPAR target gene.  This observation is quite different from previously identified synthetic PPARβ/δ agonists, which can induce the expression of not only ANGPTL4 but also other PPAR target genes, such as ADRP, PDK4, and CPT-1.  These results demonstrate that picrasidine N is a potent subtype-selective and gene-selective PPARβ/δ agonist, suggesting its potential as a lead compd. for further drug development.  This compd. would also be a useful chem. tool for elucidating the mechanism of PPARβ/δ-regulated specific gene expression and the biol. significance of PPARβ/δ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNePGzGQ45gLVg90H21EOLACvtfcHk0lgERi-FjLe-hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVynsrw%253D&md5=6cecf8ebe753c8e58bcdb81222fe78a4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00909%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWakatabi%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DK.%26aulast%3DNemoto%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DH.%26atitle%3DPicrasidine%2520N%2520is%2520a%2520Subtype-selective%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Agonist%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D879%26epage%3D885%26doi%3D10.1021%2Facs.jnatprod.5b00909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makishima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span> <span> </span><span class="NLM_article-title">Novel Biphenylcarboxylic Acid Peroxisome Proliferator-activated Receptor (PPAR) δ Selective Antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6595</span>– <span class="NLM_lpage">6599</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2009.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19853439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGisLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6595-6599&author=J.-i.+Kasugaauthor=S.+Ishidaauthor=D.+Yamasakiauthor=M.+Makishimaauthor=T.+Doiauthor=Y.+Hashimotoauthor=H.+Miyachi&title=Novel+Biphenylcarboxylic+Acid+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29+%CE%B4+Selective+Antagonists&doi=10.1016%2Fj.bmcl.2009.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Novel biphenylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) δ selective antagonists</span></div><div class="casAuthors">Kasuga, Jun-ichi; Ishida, Seiichi; Yamasaki, Daisuke; Makishima, Makoto; Doi, Takefumi; Hashimoto, Yuichi; Miyachi, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6595-6599</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel PPARδ antagonists were designed and synthesized based on the crystal structure of the PPARδ full agonist TIPP-204 bound to the PPARδ ligand-binding domain, in combination with the nuclear receptor helix 12 folding modification hypothesis.  Representative compd. I exhibits PPARδ-preferential antagonistic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqujjfEhHLLI7Vg90H21EOLACvtfcHk0lgERi-FjLe-hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGisLnJ&md5=a5003619d384470ae60f2f3c5d320c57</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DKasuga%26aufirst%3DJ.-i.%26aulast%3DIshida%26aufirst%3DS.%26aulast%3DYamasaki%26aufirst%3DD.%26aulast%3DMakishima%26aufirst%3DM.%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DNovel%2520Biphenylcarboxylic%2520Acid%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%2520%25CE%25B4%2520Selective%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6595%26epage%3D6599%26doi%3D10.1016%2Fj.bmcl.2009.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiethe, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Way, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leesnitzer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrihew, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeune, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of 4-chloro-<i>N</i>-(2-{[5-trifluoromethyl)-2-pyridyl] sulfonyl} ethyl) Benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-activated Receptor δ (PPARδ) Antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1857</span>– <span class="NLM_lpage">1861</span>, <span class="refDoi"> DOI: 10.1021/jm900464j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900464j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1857-1861&author=B.+G.+Shearerauthor=R.+W.+Wietheauthor=A.+Asheauthor=A.+N.+Billinauthor=J.+M.+Wayauthor=T.+B.+Stanleyauthor=C.+D.+Wagnerauthor=R.+X.+Xuauthor=L.+M.+Leesnitzerauthor=R.+V.+Merrihewauthor=T.+W.+Shearerauthor=M.+R.+Jeuneauthor=J.+C.+Ulrichauthor=T.+M.+Willson&title=Identification+and+Characterization+of+4-chloro-N-%282-%7B%5B5-trifluoromethyl%29-2-pyridyl%5D+sulfonyl%7D+ethyl%29+Benzamide+%28GSK3787%29%2C+a+Selective+and+Irreversible+Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29+Antagonist&doi=10.1021%2Fjm900464j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist</span></div><div class="casAuthors">Shearer, Barry G.; Wiethe, Robert W.; Ashe, Adam; Billin, Andrew N.; Way, James M.; Stanley, Thomas B.; Wagner, Craig D.; Xu, Robert X.; Leesnitzer, Lisa M.; Merrihew, Raymond V.; Shearer, Todd W.; Jeune, Michael R.; Ulrich, John C.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1857-1861</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GSK3787 (I) was identified as a potent and selective ligand for PPARδ with good pharmacokinetic properties.  A detailed binding study using mass spectral anal. confirmed covalent binding to Cys249 within the PPARδ binding pocket.  Gene expression studies showed that pyridylsulfone 3 antagonized the transcriptional activity of PPARδ and inhibited basal CPT1a gene transcription.  Compd. 3 is a PPARδ antagonist with utility as a tool to elucidate PPARδ cell biol. and pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_XYlOh8G0b7Vg90H21EOLACvtfcHk0lhXKHUKz2NSGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGisrc%253D&md5=401381858ca225791e8a90c13bb9d5e4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm900464j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900464j%26sid%3Dliteratum%253Aachs%26aulast%3DShearer%26aufirst%3DB.%2BG.%26aulast%3DWiethe%26aufirst%3DR.%2BW.%26aulast%3DAshe%26aufirst%3DA.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DWay%26aufirst%3DJ.%2BM.%26aulast%3DStanley%26aufirst%3DT.%2BB.%26aulast%3DWagner%26aufirst%3DC.%2BD.%26aulast%3DXu%26aufirst%3DR.%2BX.%26aulast%3DLeesnitzer%26aufirst%3DL.%2BM.%26aulast%3DMerrihew%26aufirst%3DR.%2BV.%26aulast%3DShearer%26aufirst%3DT.%2BW.%26aulast%3DJeune%26aufirst%3DM.%2BR.%26aulast%3DUlrich%26aufirst%3DJ.%2BC.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DIdentification%2520and%2520Characterization%2520of%25204-chloro-N-%25282-%257B%255B5-trifluoromethyl%2529-2-pyridyl%255D%2520sulfonyl%257D%2520ethyl%2529%2520Benzamide%2520%2528GSK3787%2529%252C%2520a%2520Selective%2520and%2520Irreversible%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1857%26epage%3D1861%26doi%3D10.1021%2Fjm900464j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaoude, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrieki, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moussalli, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broaddus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shureiqi, I.</span></span> <span> </span><span class="NLM_article-title">Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">969</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-18-1790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1158%2F0008-5472.CAN-18-1790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30679176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=954-969&author=Y.+Liuauthor=Y.+Deguchiauthor=R.+Tianauthor=D.+Weiauthor=L.+Wuauthor=W.+Chenauthor=W.+Xuauthor=M.+Xuauthor=F.+Liuauthor=S.+Gaoauthor=J.+C.+Jaoudeauthor=S.+P.+Chriekiauthor=M.+J.+Moussalliauthor=M.+Gageaauthor=J.+Morrisauthor=R.+R.+Broaddusauthor=X.+Zuoauthor=I.+Shureiqi&title=Pleiotropic+Effects+of+PPARD+Accelerate+Colorectal+Tumorigenesis%2C+Progression%2C+and+Invasion&doi=10.1158%2F0008-5472.CAN-18-1790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pleiotropic effects of PPARD accelerate colorectal tumorigenesis, progression, and invasion</span></div><div class="casAuthors">Liu, Yi; Deguchi, Yasunori; Tian, Rui; Wei, Daoyan; Wu, Ling; Chen, Weidong; Xul, Weiguo; Xul, Min; Liu, Fuyao; Gaol, Shen; Jaoude, Jonathan C.; Chriekil, Sarah P.; Moussalli, Micheline J.; Gagea, Mihai; Morris, Jeffrey; Broaddus, Russell R.; Zuo, Xiangsheng; Shureiqi, Imad</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">954-969</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">APC mutations activate aberrant β-catenin signaling to drive initiation of colorectal cancer; however, colorectal cancer progression requires addnl. mol. mechanisms.  PPAR-delta (PPARD), a downstream target of β-catenin, is upregulated in colorectal cancer.  However, promotion of intestinal tumorigenesis following deletion of PPARD in Apcmin mice has raised questions about then Federationn Federation effects of PPARD on aberrant 13-catenin activation and colorectal cancer.  In this study, we used mouse models of PPARD overexpression or deletion combined with APC mutation (ApcΔ580) in intestinal epithelial cells (IEC) to elucidate the contributions of PPARD in colorectal cancer.  Overexpression or deletion of PPARD in !LC augmented or suppressed β-catenin activation via up- or downregulation of BMP7/TAK1 signaling and strongly promoted or sup- pressed colorectal cancer, resp.  Depletion of PPARD in human colorectal cancer organoid cells inhibited BMP7/ β-catenin signaling and suppressed organoid self-renewal.  Treatment with PPARD agonist GW501516 enhanced colorectal cancer tumorigenesis in ApcΔ580 mice, whereas treatment with PPARD antagonist GSK3787 suppressed tumorigenesis.  PPARD expression was significantly higher in human colorectal cancer-invasive fronts vs. their paired tumor centers and adenomas.  Reverse-phase protein microarray and validation studies identified PPARD- mediated upregulation of other proinvasive pathways: connexin 43, PDGFRβ, AKT1, EIF4G1, and CDKI.  Our data demonstrate that PPARD strongly potentiates multiple tumorigenic pathways to promote colorectal cancer progression and invasiveness.  Significance: These findings address long-standing. important, and unresolved questions related to the potential role of PPARD in APC mutation-dependent colorectal tumorigenesis by showing PPARD activation enhances APC mutation-dependent tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv23iJAEIvQrVg90H21EOLACvtfcHk0lhXKHUKz2NSGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWjurk%253D&md5=1a48e300b9aee975193d5035f4837b38</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-18-1790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-18-1790%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDeguchi%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DJaoude%26aufirst%3DJ.%2BC.%26aulast%3DChrieki%26aufirst%3DS.%2BP.%26aulast%3DMoussalli%26aufirst%3DM.%2BJ.%26aulast%3DGagea%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DBroaddus%26aufirst%3DR.%2BR.%26aulast%3DZuo%26aufirst%3DX.%26aulast%3DShureiqi%26aufirst%3DI.%26atitle%3DPleiotropic%2520Effects%2520of%2520PPARD%2520Accelerate%2520Colorectal%2520Tumorigenesis%252C%2520Progression%252C%2520and%2520Invasion%26jtitle%3DCancer%2520Res.%26date%3D2019%26volume%3D79%26spage%3D954%26epage%3D969%26doi%3D10.1158%2F0008-5472.CAN-18-1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hack, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foerster, J.</span></span> <span> </span><span class="NLM_article-title">Skin-targeted Inhibition of PPAR β/δ by Selective Antagonists to Treat PPAR β/δ−mediated Psoriasis-like Skin Disease in vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e37097</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0037097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pone.0037097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22606335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFWqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=K.+Hackauthor=L.+Reillyauthor=C.+Palmerauthor=K.+D.+Readauthor=S.+Norvalauthor=R.+Kimeauthor=K.+Boothauthor=J.+Foerster&title=Skin-targeted+Inhibition+of+PPAR+%CE%B2%2F%CE%B4+by+Selective+Antagonists+to+Treat+PPAR+%CE%B2%2F%CE%B4%E2%88%92mediated+Psoriasis-like+Skin+Disease+in+vivo&doi=10.1371%2Fjournal.pone.0037097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ - mediated psoriasis-like skin disease in vivo</span></div><div class="casAuthors">Hack, Katrin; Reilly, Louise; Palmer, Colin; Read, Kevin D.; Norval, Suzanne; Kime, Robert; Booth, Kally; Foerster, John</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e37097</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We have previously shown that peroxisome proliferator activating receptor β/δ (PPAR β/δ is overexpressed in psoriasis.  PPAR β/δ is not present in adult epidermis of mice.  Targeted expression of PPAR β/δ and activation by a selective synthetic agonist is sufficient to induce an inflammatory skin disease resembling psoriasis.  Several signalling pathways dysregulated in psoriasis are replicated in this model, suggesting that PPAR β/δ activation contributes to psoriasis pathogenesis.  Thus, inhibition of PPAR β/δ might harbor therapeutical potential.  Since PPAR β/δ has pleiotropic functions in metab., skin-targeted inhibition offer the potential of reducing systemic adverse effects.  Here, we report that three selective PPAR β/δ antagonists, GSK0660, compd. 3 h, and GSK3787 can be formulated for topical application to the skin and that their skin concn. can be accurately quantified using ultra-high performance liq. chromatog. (UPLC)/mass spectrometry.  These antagonists show efficacy in our transgenic mouse model in reducing psoriasis - like changes triggered by activation of PPAR β/δ.  PPAR β/δ antagonists GSK0660 and compd. 3 do not exhibit systemic drug accumulation after prolonged application to the skin, nor do they induce inflammatory or irritant changes.  Significantly, the irreversible PPAR β/δ antagonist (GSK3787) retains efficacy when applied topically only three times per wk which could be of practical clin. usefulness.  Our data suggest that topical inhibition of PPAR β/δ to treat psoriasis may warrant further exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSSHbNF8VWSbVg90H21EOLACvtfcHk0lhXKHUKz2NSGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFWqtL4%253D&md5=1f3bc7b0dacee685986ea2a674d0aef8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0037097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0037097%26sid%3Dliteratum%253Aachs%26aulast%3DHack%26aufirst%3DK.%26aulast%3DReilly%26aufirst%3DL.%26aulast%3DPalmer%26aufirst%3DC.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DKime%26aufirst%3DR.%26aulast%3DBooth%26aufirst%3DK.%26aulast%3DFoerster%26aufirst%3DJ.%26atitle%3DSkin-targeted%2520Inhibition%2520of%2520PPAR%2520%25CE%25B2%252F%25CE%25B4%2520by%2520Selective%2520Antagonists%2520to%2520Treat%2520PPAR%2520%25CE%25B2%252F%25CE%25B4%25E2%2588%2592mediated%2520Psoriasis-like%2520Skin%2520Disease%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0037097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makishima, M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor Agonists and Antagonists: A Patent Review (2014-present)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1080/13543776.2020.1703952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1080%2F13543776.2020.1703952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31825687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVaqtr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=1-13&author=I.+Takadaauthor=M.+Makishima&title=Peroxisome+Proliferator-activated+Receptor+Agonists+and+Antagonists%3A+A+Patent+Review+%282014-present%29&doi=10.1080%2F13543776.2020.1703952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)</span></div><div class="casAuthors">Takada, Ichiro; Makishima, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptors (PPARs), PPARα, PPARδ, and PPARγ, play an important role in the regulation of various physiol. processes, specifically lipid and energy metab. and immunity.  PPARα agonists (fibrates) and PPARγ agonists (thiazolidinediones) are used for the treatment of hypertriglyceridemia and type 2 diabetes, resp.  PPARδ activation enhances mitochondrial and energy metab. but PPARδ-acting drugs are not yet available.  Many synthetic ligands for PPARs have been developed to expand their therapeutic applications.: The authors searched recent patent activity regarding PPAR ligands.  Novel PPARα agonists, PPARδ agonists, PPARγ agonists, PPARα/γ dual agonists, and PPARγ antagonists have been claimed for the treatment of metabolic disease and inflammatory disease.  Methods for the combination of PPAR ligands with other drugs and expanded application of PPAR agonists for bone and neurol. disease have been also claimed.: Novel PPAR ligands and the combination of PPAR ligands with other drugs have been claimed for the treatment of mitochondrial disease, inflammatory/autoimmune disease, neurol. disease, and cancer in addn. to metabolic diseases including dyslipidemia and type 2 diabetes.  Selective therapeutic actions of PPAR ligands should be exploited to avoid adverse effects.  More basic studies are needed to elucidate the mol. mechanisms of selective actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo51fz3chW3ybVg90H21EOLACvtfcHk0lh780ywPo7U7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVaqtr3L&md5=e31b4fd8d6da157c48ddf77a5412eb08</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1080%2F13543776.2020.1703952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2020.1703952%26sid%3Dliteratum%253Aachs%26aulast%3DTakada%26aufirst%3DI.%26aulast%3DMakishima%26aufirst%3DM.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520Agonists%2520and%2520Antagonists%253A%2520A%2520Patent%2520Review%2520%25282014-present%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2020%26volume%3D30%26spage%3D1%26epage%3D13%26doi%3D10.1080%2F13543776.2020.1703952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sng, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span> <span> </span><span class="NLM_article-title">Transcriptional Control of Physiological and Pathological Processes by the Nuclear Receptor PPAR beta/delta</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2016.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.plipres.2016.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27665713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1WntbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2016&pages=98-122&author=N.+S.+Tanauthor=M.+V%C3%A1zquez-Carreraauthor=A.+Montagnerauthor=M.+K.+Sngauthor=H.+Guillouauthor=W.+Wahli&title=Transcriptional+Control+of+Physiological+and+Pathological+Processes+by+the+Nuclear+Receptor+PPAR+beta%2Fdelta&doi=10.1016%2Fj.plipres.2016.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ</span></div><div class="casAuthors">Tan, Nguan Soon; Vazquez-Carrera, Manuel; Montagner, Alexandra; Sng, Ming Keat; Guillou, Herve; Wahli, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-122</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are a class of transcription factors that belong to the nuclear hormone receptor superfamily, and their activities are dependent on their resp. ligands. Since the discovery of PPARa (NR1C1) as a receptor that mediates peroxisome proliferation in rodent hepatocytes.  We predict that the use of genetic and pharmacol. approaches, such as tissue- and/or cell-type specific conditional knockout animal models along with specific PPARy/d agonists and antagonists, will prove to be useful in clarifying the role of PPARy/d in various diseases. Such approaches may also reveal novel roles of PPARy/d in the initiation and progression of particular diseases, and such studies could aid in the future design of novel and efficient pharmacol. agents that target PPARy/d for the treatment of many diseases. Realizing this goal will require multidisciplinary collaborative efforts of various scientists and clinicians.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaWGFA7GFUh7Vg90H21EOLACvtfcHk0lh780ywPo7U7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1WntbzN&md5=7c200bbc4cb73cfaf915e72af33ed624</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2016.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2016.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DN.%2BS.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26aulast%3DMontagner%26aufirst%3DA.%26aulast%3DSng%26aufirst%3DM.%2BK.%26aulast%3DGuillou%26aufirst%3DH.%26aulast%3DWahli%26aufirst%3DW.%26atitle%3DTranscriptional%2520Control%2520of%2520Physiological%2520and%2520Pathological%2520Processes%2520by%2520the%2520Nuclear%2520Receptor%2520PPAR%2520beta%252Fdelta%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2016%26volume%3D64%26spage%3D98%26epage%3D122%26doi%3D10.1016%2Fj.plipres.2016.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunmair, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dörig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szöcs, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadlbauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gras, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderwald, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nohl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldhäusl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fürnsinn, C.</span></span> <span> </span><span class="NLM_article-title">Activation of PPAR-δ in Isolated Rat Skeletal Muscle Switches Fuel Preference from Glucose to Fatty Acids</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2713</span>– <span class="NLM_lpage">2722</span>, <span class="refDoi"> DOI: 10.1007/s00125-006-0357-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1007%2Fs00125-006-0357-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16960684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOqsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2713-2722&author=B.+Brunmairauthor=K.+Staniekauthor=J.+D%C3%B6rigauthor=Z.+Sz%C3%B6csauthor=K.+Stadlbauerauthor=V.+Marianauthor=F.+Grasauthor=C.+Anderwaldauthor=H.+Nohlauthor=W.+Waldh%C3%A4uslauthor=C.+F%C3%BCrnsinn&title=Activation+of+PPAR-%CE%B4+in+Isolated+Rat+Skeletal+Muscle+Switches+Fuel+Preference+from+Glucose+to+Fatty+Acids&doi=10.1007%2Fs00125-006-0357-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of PPAR-δ in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids</span></div><div class="casAuthors">Brunmair, B.; Staniek, K.; Doerig, J.; Szoecs, Z.; Stadlbauer, K.; Marian, V.; Gras, F.; Anderwald, C.; Nohl, H.; Waldhaeusl, W.; Fuernsinn, C.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2713-2722</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Aims/hypothesis: GW501516, an agonist of peroxisome proliferator-activated receptor-δ (PPAR-δ), increases lipid combustion and exerts antidiabetic action in animals, effects which are attributed mainly to direct effects on skeletal muscle.  We explored such actions further in isolated rat skeletal muscle.  Materials and methods: Specimens of rat skeletal muscle were pretreated with GW501516 (0.01-30 μmol/l) for 0.5, 4 or 24 h and rates of fuel metab. were then measured.  In addn., effects on mitochondrial function were detd. in isolated rat liver mitochondria.  Results: At concns. between 0.01 and 1 μmol/l, GW501516 dose-dependently increased fatty acid oxidn. but reduced glucose utilization in isolated muscle.  Thus after 24 h of preincubation with 1 μmol/l GW501516, palmitate oxidn. increased by +46±10%, and the following decreased as specified: glucose oxidn. -46±8%, glycogen synthesis -42±6%, lactate release -20±2%, glucose transport -15±6% (all p<0.05).  Redn. of glucose utilization persisted independently of insulin stimulation or muscle fiber type, but depended on fatty acid availability (the effect on glucose transport in the absence of fatty acids was an increase of 30±9%, p<0.01), suggesting a role for the glucose-fatty acid cycle.  At higher concns., GW501516 uncoupled oxidative phosphorylation by direct action on isolated mitochondria.  Conclusions/interpretation: GW501516-induced activation of PPAR-δ reduces glucose utilization by skeletal muscle through a switch in mitochondrial substrate preference from carbohydrate to lipid.  High concns. of GW501516 induce mitochondrial uncoupling independently of PPAR-δ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXvcen1q6sYbVg90H21EOLACvtfcHk0lh780ywPo7U7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOqsrrO&md5=117b361468b8db34b89c741dcdbde1e6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00125-006-0357-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-006-0357-6%26sid%3Dliteratum%253Aachs%26aulast%3DBrunmair%26aufirst%3DB.%26aulast%3DStaniek%26aufirst%3DK.%26aulast%3DD%25C3%25B6rig%26aufirst%3DJ.%26aulast%3DSz%25C3%25B6cs%26aufirst%3DZ.%26aulast%3DStadlbauer%26aufirst%3DK.%26aulast%3DMarian%26aufirst%3DV.%26aulast%3DGras%26aufirst%3DF.%26aulast%3DAnderwald%26aufirst%3DC.%26aulast%3DNohl%26aufirst%3DH.%26aulast%3DWaldh%25C3%25A4usl%26aufirst%3DW.%26aulast%3DF%25C3%25BCrnsinn%26aufirst%3DC.%26atitle%3DActivation%2520of%2520PPAR-%25CE%25B4%2520in%2520Isolated%2520Rat%2520Skeletal%2520Muscle%2520Switches%2520Fuel%2520Preference%2520from%2520Glucose%2520to%2520Fatty%2520Acids%26jtitle%3DDiabetologia%26date%3D2006%26volume%3D49%26spage%3D2713%26epage%3D2722%26doi%3D10.1007%2Fs00125-006-0357-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narkar, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banayo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihaylova, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juguilon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">AMPK and PPARδ Agonists are Exercise Mimetics</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2008.06.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.cell.2008.06.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18674809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSis77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2008&pages=405-415&author=V.+A.+Narkarauthor=M.+Downesauthor=R.+T.+Yuauthor=E.+Emblerauthor=Y.-X.+Wangauthor=E.+Banayoauthor=M.+M.+Mihaylovaauthor=M.+C.+Nelsonauthor=Y.+Zouauthor=H.+Juguilonauthor=H.+Kangauthor=R.+Shawauthor=R.+M.+Evans&title=AMPK+and+PPAR%CE%B4+Agonists+are+Exercise+Mimetics&doi=10.1016%2Fj.cell.2008.06.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK and PPARδ agonists are exercise mimetics</span></div><div class="casAuthors">Narkar, Vihang A.; Downes, Michael; Yu, Ruth T.; Embler, Emi; Wang, Yong-Xu; Banayo, Ester; Mihaylova, Maria M.; Nelson, Michael C.; Zou, Yuhua; Juguilon, Henry; Kang, Heonjoong; Shaw, Reuben J.; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-415</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The benefits of endurance exercise on general health make it desirable to identify orally active agents that would mimic or potentiate the effects of exercise to treat metabolic diseases.  Although certain natural compds., such as resveratrol, have endurance-enhancing activities, their exact metabolic targets remain elusive.  The authors therefore tested the effect of pathway-specific drugs on endurance capacities of mice in a treadmill running test.  The authors found that PPARβ/δ agonist and exercise training synergistically increase oxidative myofibers and running endurance in adult mice.  Because training activates AMPK and PGC1α, the authors then tested whether the orally active AMPK agonist AICAR might be sufficient to overcome the exercise requirement.  Unexpectedly, even in sedentary mice, 4 wk of AICAR treatment alone induced metabolic genes and enhanced running endurance by 44%.  These results demonstrate that AMPK-PPARδ pathway can be targeted by orally active drugs to enhance training adaptation or even to increase endurance without exercise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD68stW4M_DrVg90H21EOLACvtfcHk0lgymnKBAwByaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSis77P&md5=a0ee8bab9c8e445554176abc7d65d6e1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.06.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.06.051%26sid%3Dliteratum%253Aachs%26aulast%3DNarkar%26aufirst%3DV.%2BA.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DEmbler%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DBanayo%26aufirst%3DE.%26aulast%3DMihaylova%26aufirst%3DM.%2BM.%26aulast%3DNelson%26aufirst%3DM.%2BC.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DJuguilon%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DR.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DAMPK%2520and%2520PPAR%25CE%25B4%2520Agonists%2520are%2520Exercise%2520Mimetics%26jtitle%3DCell%26date%3D2008%26volume%3D134%26spage%3D405%26epage%3D415%26doi%3D10.1016%2Fj.cell.2008.06.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Australian Government Department
of Health, Therapeutic Goods Administration</span> <a href="https://www.tga.gov.au/book-page/12-cardarine#fn8" class="extLink">https://www.tga.gov.au/book-page/12-cardarine#fn8</a> (accessed Mar 14, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Australian+Government+Department%0Aof+Health%2C+Therapeutic+Goods+Administration+https%3A%2F%2Fwww.tga.gov.au%2Fbook-page%2F12-cardarine%23fn8+%28accessed+Mar+14%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span> <i>The World Anti-Doping
Code: The 2009 Prohibited List International
Standard</i>; <span class="NLM_publisher-name">The World Anti-Doping Agency</span>, <span class="NLM_year">2009</span>;  p 6, <a href="https://www.wada-ama.org/sites/default/files/resources/files/WADA_Prohibited_List_2009_EN.pdf" class="extLink">https://www.wada-ama.org/sites/default/files/resources/files/WADA_Prohibited_List_2009_EN.pdf</a> (accessed 2020-02-16).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+World+Anti-Doping%0ACode%3A+The+2009+Prohibited+List+International%0AStandard%3B+The+World+Anti-Doping+Agency%2C+2009%3B+p+6%2C+https%3A%2F%2Fwww.wada-ama.org%2Fsites%2Fdefault%2Ffiles%2Fresources%2Ffiles%2FWADA_Prohibited_List_2009_EN.pdf+%28accessed+2020-02-16%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520World%2520Anti-Doping%250ACode%253A%2520The%25202009%2520Prohibited%2520List%2520International%250AStandard%26pub%3DThe%2520World%2520Anti-Doping%2520Agency%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-H.</span></span> <span> </span><span class="NLM_article-title">PPARδ as a Therapeutic Target in Metabolic Disease</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>582</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2007.11.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.febslet.2007.11.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18036566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOltb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2008&pages=26-31&author=S.+M.+Reillyauthor=C.-H.+Lee&title=PPAR%CE%B4+as+a+Therapeutic+Target+in+Metabolic+Disease&doi=10.1016%2Fj.febslet.2007.11.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ as a therapeutic target in metabolic disease</span></div><div class="casAuthors">Reilly, Shannon M.; Lee, Chih-Hao</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">582</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-31</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  PPARδ is the only member in the PPAR subfamily of nuclear receptors that is not a target of current drugs.  Animal studies demonstrate PPARδ activation exerts many favorable effects, including reducing wt. gain, increasing skeletal muscle metabolic rate and endurance, improving insulin sensitivity and cardiovascular function and suppressing atherogenic inflammation.  These activities stem largely from the ability of PPARδ to control energy balance, reduce fat burden and protect against lipotoxicity caused by ectopic lipid deposition.  Therefore, PPARδ represents a novel therapeutic target and the development of PPARδ agonists/modulators may be useful for treating the whole spectrum of metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFlGSQ1PqMmbVg90H21EOLACvtfcHk0lgymnKBAwByaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOltb3O&md5=7060f7e5e0c7b59a190b478d5afcd0b5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2007.11.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2007.11.040%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DC.-H.%26atitle%3DPPAR%25CE%25B4%2520as%2520a%2520Therapeutic%2520Target%2520in%2520Metabolic%2520Disease%26jtitle%3DFEBS%2520Lett.%26date%3D2008%26volume%3D582%26spage%3D26%26epage%3D31%26doi%3D10.1016%2Fj.febslet.2007.11.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, J.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor δ (PPARδ), a Novel Target Site for Drug Discovery in Metabolic Syndrome</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2006.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.phrs.2006.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16713711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XltFCntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2006&pages=501-507&author=S.+Takahashiauthor=T.+Tanakaauthor=T.+Kodamaauthor=J.+Sakai&title=Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29%2C+a+Novel+Target+Site+for+Drug+Discovery+in+Metabolic+Syndrome&doi=10.1016%2Fj.phrs.2006.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor δ (PPARδ), a novel target site for drug discovery in metabolic syndrome</span></div><div class="casAuthors">Takahashi, Sadao; Tanaka, Toshiya; Kodama, Tatsuhiko; Sakai, Juro</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">501-507</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The development of new treatments for metabolic syndrome is urgent project for decreasing the prevalence of coronary heart disease and diabetes mellitus in the advanced countries.  Peroxisome proliferator-activated receptor (PPAR)α and γ agonists have shed light on the treatment of hypertriglyceridemia and type 2 diabetes mellitus, resp.  Among PPARs, anal. of the PPARδ functions is lagging behind because specific PPARδ agonists have not been developed.  The appearance of new PPARδ agonists is brightening the prospects for elucidating the physiol. role of PPARδ.  PPARδ is a new target for the treatment of metabolic syndrome.  In particular, the fact that fatty acid oxidn. and energy dissipation in skeletal muscle and adipose tissue by PPARδ agonists lead to improved lipid profile, reduced adiposity and insulin sensitivity is a breakthrough.  It seems that treatment of PPARδ agonists operate similarly to the caloric restriction and prolonged exercise.  We suggest that the physiol. role of PPARδ may be an indicator for switching from glucose metab. to fatty acid metab.  To receive new benefits of PPARδ agonists against metabolic syndrome by increasing fatty acid consumption in skeletal muscle and adipose tissue, we need to unveil more details on the functions of PPARδ itself and its agonists in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplgTkaL1pP8LVg90H21EOLACvtfcHk0lgymnKBAwByaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltFCntLY%253D&md5=9f59c0b468af0a9357508b057f5017ab</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2006.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2006.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DJ.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%252C%2520a%2520Novel%2520Target%2520Site%2520for%2520Drug%2520Discovery%2520in%2520Metabolic%2520Syndrome%26jtitle%3DPharmacol.%2520Res.%26date%3D2006%26volume%3D53%26spage%3D501%26epage%3D507%26doi%3D10.1016%2Fj.phrs.2006.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimaldi, P. A.</span></span> <span> </span><span class="NLM_article-title">Roles of PPARδ in the Control of Muscle Development and Metabolism</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1130</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1042/bst0311130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1042%2Fbst0311130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=14641010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1yqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1130-1132&author=P.+A.+Grimaldi&title=Roles+of+PPAR%CE%B4+in+the+Control+of+Muscle+Development+and+Metabolism&doi=10.1042%2Fbst0311130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of PPARδ in the control of muscle development and metabolism</span></div><div class="casAuthors">Grimaldi, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1130-1132</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">PPARδ (peroxisome proliferator-activated receptor δ)-specific agonists decrease plasma lipids and insulinemia in obese animals.  As skeletal muscle is one of the major organs for fatty acid catabolism, we have investigated the roles of the nuclear receptor in the control of muscle development and lipid metab., by using two approaches.  We have used C2C12 myotubes in which the PPARδ activity was altered by overexpression of either native or dominant-neg. (DN) mutant forms of PPARδ.  Treatment of C2C12 cells by specific PPARδ agonists promotes expression of genes for proteins of fatty acid catabolism and increases fatty acid oxidn.  These responses were increased in C2C12-PPARδ cells and impaired in C2C12-PPARδDN cells.  We also constructed animal models with muscle-specific expression of PPARδ (Cre/Lox approach).  The effects of muscle-specific alteration of PPARδ activity were studied on muscle development and metab. as well as on body fat mass.  These expts. indicated that PPARδ plays a crucial role in myofiber typing detn. and regulation of muscle oxidative capabilities, and that muscle-specific overexpression of the nuclear receptor leads to redn. of adipocyte size and body fat mass.  These data strongly suggest that PPARδ controls fatty acid catabolism in muscle and that its activation by synthetic agonists could prevent or correct obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5cuusDiEyALVg90H21EOLACvtfcHk0lgan6THsBGvqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1yqu7w%253D&md5=1b42a6d28a27e33ef9ef284f7afd6fa2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1042%2Fbst0311130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311130%26sid%3Dliteratum%253Aachs%26aulast%3DGrimaldi%26aufirst%3DP.%2BA.%26atitle%3DRoles%2520of%2520PPAR%25CE%25B4%2520in%2520the%2520Control%2520of%2520Muscle%2520Development%2520and%2520Metabolism%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1130%26epage%3D1132%26doi%3D10.1042%2Fbst0311130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barish, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narkar, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">PPARδ: A Dagger in the Heart of the Metabolic Syndrome</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">590</span>– <span class="NLM_lpage">597</span>, <span class="refDoi"> DOI: 10.1172/JCI27955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1172%2FJCI27955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16511591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlGkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=590-597&author=G.+D.+Barishauthor=V.+A.+Narkarauthor=R.+M.+Evans&title=PPAR%CE%B4%3A+A+Dagger+in+the+Heart+of+the+Metabolic+Syndrome&doi=10.1172%2FJCI27955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ: a dagger in the heart of the metabolic syndrome</span></div><div class="casAuthors">Barish, Grant D.; Narkar, Vihang A.; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">590-597</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Obesity is a growing threat to global health by virtue of its assocn. with insulin resistance, glucose intolerance, hypertension, and dyslipidemia, collectively known as the metabolic syndrome or syndrome X.  The nuclear receptors PPARα and PPARγ are therapeutic targets for hypertriglyceridemia and insulin resistance, resp., and drugs that modulate these receptors are currently in clin. use.  More recent work on the less-described PPAR isotype PPARδ has uncovered a dual benefit for both hypertriglyceridemia and insulin resistance, highlighting the broad potential of PPARδ in the treatment of metabolic disease.  PPARδ enhances fatty acid catabolism and energy uncoupling in adipose tissue and muscle, and it suppresses macrophage-derived inflammation.  Its combined activities in these and other tissues make it a multifaceted therapeutic target for the metabolic syndrome with the potential to control wt. gain, enhance phys. endurance, improve insulin sensitivity, and ameliorate atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTHfUmDmD-sLVg90H21EOLACvtfcHk0lgan6THsBGvqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlGkt7w%253D&md5=0349ad1425ce5277f93a495983eb675d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1172%2FJCI27955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI27955%26sid%3Dliteratum%253Aachs%26aulast%3DBarish%26aufirst%3DG.%2BD.%26aulast%3DNarkar%26aufirst%3DV.%2BA.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DPPAR%25CE%25B4%253A%2520A%2520Dagger%2520in%2520the%2520Heart%2520of%2520the%2520Metabolic%2520Syndrome%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D590%26epage%3D597%26doi%3D10.1172%2FJCI27955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiep, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor δ Activates Fat Metabolism to Prevent Obesity</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(03)00269-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS0092-8674%2803%2900269-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=12705865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlOqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2003&pages=159-170&author=Y.-X.+Wangauthor=C.-H.+Leeauthor=S.+Tiepauthor=R.+T.+Yuauthor=J.+Hamauthor=H.+Kangauthor=R.+M.+Evans&title=Peroxisome+Proliferator-activated+Receptor+%CE%B4+Activates+Fat+Metabolism+to+Prevent+Obesity&doi=10.1016%2FS0092-8674%2803%2900269-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity</span></div><div class="casAuthors">Wang, Yong-Xu; Lee, Chih-Hao; Tiep, Sambath; Yu, Ruth T.; Ham, Jungyeob; Kang, Heonjoong; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-170</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In contrast to the well-established roles of PPARγ and PPARα in lipid metab., little is known for PPARδ in this process.  We show here that targeted activation of PPARδ in adipose tissue specifically induces expression of genes required for fatty acid oxidn. and energy dissipation, which in turn leads to improved lipid profiles and reduced adiposity.  Importantly, these animals are completely resistant to both high-fat diet-induced and genetically predisposed (Leprdb/db) obesity.  As predicted, acute treatment of Leprdb/db mice with a PPARδ agonist depletes lipid accumulation.  In parallel, PPARδ-deficient mice challenged with high-fat diet show reduced energy uncoupling and are prone to obesity.  In vitro, activation of PPARδ in adipocytes and skeletal muscle cells promotes fatty acid oxidn. and utilization.  Our findings suggest that PPARδ serves as a widespread regulator of fat burning and identify PPARδ as a potential target in treatment of obesity and its assocd. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEL6XcVEcZDrVg90H21EOLACvtfcHk0lgan6THsBGvqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlOqs7k%253D&md5=e55d314934eba1f464a74ca145108cff</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2900269-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252900269-1%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DLee%26aufirst%3DC.-H.%26aulast%3DTiep%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Activates%2520Fat%2520Metabolism%2520to%2520Prevent%2520Obesity%26jtitle%3DCell%26date%3D2003%26volume%3D113%26spage%3D159%26epage%3D170%26doi%3D10.1016%2FS0092-8674%2803%2900269-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayuga-Ocampo, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Regulation of Muscle Fiber Type and Running Endurance by PPARδ</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e294</span> <span class="refDoi"> DOI: 10.1371/journal.pbio.0020294</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pbio.0020294" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15328533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BD2crisVCltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&author=Y.-X.+Wangauthor=C.-L.+Zhangauthor=R.+T.+Yuauthor=H.+K.+Choauthor=M.+C.+Nelsonauthor=C.+R.+Bayuga-Ocampoauthor=J.+Hamauthor=H.+Kangauthor=R.+M.+Evans&title=Regulation+of+Muscle+Fiber+Type+and+Running+Endurance+by+PPAR%CE%B4&doi=10.1371%2Fjournal.pbio.0020294"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of muscle fiber type and running endurance by PPARdelta</span></div><div class="casAuthors">Wang Yong-Xu; Zhang Chun-Li; Yu Ruth T; Cho Helen K; Nelson Michael C; Bayuga-Ocampo Corinne R; Ham Jungyeob; Kang Heonjoong; Evans Ronald M</div><div class="citationInfo"><span class="NLM_cas:title">PLoS biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e294</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Endurance exercise training can promote an adaptive muscle fiber transformation and an increase of mitochondrial biogenesis by triggering scripted changes in gene expression.  However, no transcription factor has yet been identified that can direct this process.  We describe the engineering of a mouse capable of continuous running of up to twice the distance of a wild-type littermate.  This was achieved by targeted expression of an activated form of peroxisome proliferator-activated receptor delta (PPARdelta) in skeletal muscle, which induces a switch to form increased numbers of type I muscle fibers.  Treatment of wild-type mice with PPARdelta agonist elicits a similar type I fiber gene expression profile in muscle.  Moreover, these genetically generated fibers confer resistance to obesity with improved metabolic profiles, even in the absence of exercise.  These results demonstrate that complex physiologic properties such as fatigue, endurance, and running capacity can be molecularly analyzed and manipulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJMikAQ3UnnTAEfvC7EH1LfW6udTcc2eYdS2VbYYZm7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crisVCltA%253D%253D&md5=d9d4a4d68234fad3b7ff66c429f96814</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.0020294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.0020294%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DZhang%26aufirst%3DC.-L.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DCho%26aufirst%3DH.%2BK.%26aulast%3DNelson%26aufirst%3DM.%2BC.%26aulast%3DBayuga-Ocampo%26aufirst%3DC.%2BR.%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DRegulation%2520of%2520Muscle%2520Fiber%2520Type%2520and%2520Running%2520Endurance%2520by%2520PPAR%25CE%25B4%26jtitle%3DPLoS%2520Biol.%26date%3D2004%26volume%3D2%26doi%3D10.1371%2Fjournal.pbio.0020294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stechschulte, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favero, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodella, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jude, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, N. G.</span></span> <span> </span><span class="NLM_article-title">PPARδ Binding to Heme Oxygenase 1 Promoter Prevents Angiotensin II-induced Adipocyte Dysfunction in Goldblatt Hypertensive Rats</span>. <i>Int. J. Obes.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1038/ijo.2013.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fijo.2013.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlGjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=456-465&author=K.+Sodhiauthor=N.+Puriauthor=D.+H.+Kimauthor=T.+Hindsauthor=L.+A.+Stechschulteauthor=G.+Faveroauthor=L.+Rodellaauthor=J.+Shapiroauthor=D.+Judeauthor=N.+G.+Abraham&title=PPAR%CE%B4+Binding+to+Heme+Oxygenase+1+Promoter+Prevents+Angiotensin+II-induced+Adipocyte+Dysfunction+in+Goldblatt+Hypertensive+Rats&doi=10.1038%2Fijo.2013.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats</span></div><div class="casAuthors">Sodhi, K.; Puri, N.; Kim, D. H.; Hinds, T. D.; Stechschulte, L. A.; Favero, G.; Rodella, L.; Shapiro, J. I.; Jude, D.; Abraham, N. G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Obesity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">456-465</span>CODEN:
                <span class="NLM_cas:coden">IJOBDP</span>;
        ISSN:<span class="NLM_cas:issn">0307-0565</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Objective: Renin-angiotensin system (RAS) regulates adipogenic response with adipocyte hypertrophy by increasing oxidative stress.  Recent studies have shown the role of peroxisome proliferator-activated receptor-δ (PPARδ) agonist in attenuation of angiotensin II-induced oxidative stress.  The aim of this study was to explore a potential mechanistic link between PPARδ and the cytoprotective enzyme heme oxygenase-1 (HO-1) and to elucidate the contribution of HO-1 to the adipocyte regulatory effects of PPARδ agonism in an animal model of enhanced RAS, the Goldblatt 2 kidney 1 clip (2K1C) model.  Method: We first established a direct stimulatory effect of the PPARδ agonist (GW 501516) on the HO-1 gene by demonstrating increased luciferase activity in COS-7 cells transfected with a luciferase-HO-1 promoter construct.  Sprague-Dawley rats were divided into four groups: sham-operated animals, 2K1C rats and 2K1C rats treated with GW 501516, in the absence or presence of the HO activity inhibitor, stannous mesoporphyrin (SnMP).  Results: 2K1C animals had increased visceral adiposity, adipocyte hypertrophy, increased inflammatory cytokines, increased circulatory and adipose tissue levels of renin and Ang II along with increased adipose tissue gp91 phox expression (P<0.05) when compared with sham-operated animals.  Treatment with GW 501516 increased adipose tissue HO-1 and adiponectin levels (P<0.01) along with enhancement of Wnt10b and β-catenin expression.  HO-1 induction was accompanied by the decreased expression of Wnt5b, mesoderm specific transcript (mest) and C/EBPα levels and an increased no. of small adipocytes (P<0.05).  These effects of GW501516 were reversed in 2K1C animals exposed to SnMP (P<0.05).  Conclusion: Taken together, our study demonstrates, for the first time, that increased levels of Ang II contribute towards adipose tissue dysregulation, which is abated by PPARδ-mediated upregulation of the heme-HO system.  These findings highlight the pivotal role and symbiotic relationship of HO-1, adiponectin and PPARδ in the regulation of metabolic homeostasis in adipose tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmse7rKGJMdbVg90H21EOLACvtfcHk0ljvunURJ6DuOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlGjtbo%253D&md5=0dfca2b1f0b5b299f586fc4d104b3f67</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fijo.2013.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fijo.2013.116%26sid%3Dliteratum%253Aachs%26aulast%3DSodhi%26aufirst%3DK.%26aulast%3DPuri%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DHinds%26aufirst%3DT.%26aulast%3DStechschulte%26aufirst%3DL.%2BA.%26aulast%3DFavero%26aufirst%3DG.%26aulast%3DRodella%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DJ.%26aulast%3DJude%26aufirst%3DD.%26aulast%3DAbraham%26aufirst%3DN.%2BG.%26atitle%3DPPAR%25CE%25B4%2520Binding%2520to%2520Heme%2520Oxygenase%25201%2520Promoter%2520Prevents%2520Angiotensin%2520II-induced%2520Adipocyte%2520Dysfunction%2520in%2520Goldblatt%2520Hypertensive%2520Rats%26jtitle%3DInt.%2520J.%2520Obes.%26date%3D2014%26volume%3D38%26spage%3D456%26epage%3D465%26doi%3D10.1038%2Fijo.2013.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flindt, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristiansen, K.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor δ (PPARδ)-mediated Regulation of Preadipocyte Proliferation and Gene Expression is Dependent on cAMP Signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">3175</span>– <span class="NLM_lpage">3182</span>, <span class="refDoi"> DOI: 10.1074/jbc.M005567200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1074%2Fjbc.M005567200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11069900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtFWjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=3175-3182&author=J.+B.+Hansenauthor=H.+Zhangauthor=T.+H.+Rasmussenauthor=R.+K.+Petersenauthor=E.+N.+Flindtauthor=K.+Kristiansen&title=Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29-mediated+Regulation+of+Preadipocyte+Proliferation+and+Gene+Expression+is+Dependent+on+cAMP+Signaling&doi=10.1074%2Fjbc.M005567200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor δ (PPARδ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling</span></div><div class="casAuthors">Hansen, Jacob B.; Zhang, Hongbin; Rasmussen, Thomas H.; Petersen, Rasmus K.; Flindt, Esben N.; Kristiansen, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3175-3182</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptor γ (PPARγ) is a key regulator of terminal adipocyte differentiation.  PPARδ is expressed in preadipocytes, but the importance of this PPAR subtype in adipogenesis has been a matter of debate.  Here we present a crit. evaluation of the role of PPARδ in adipocyte differentiation.  We demonstrate that treatment of NIH-3T3 fibroblasts overexpressing PPARδ with std. adipogenic inducers led to induction of PPARγ2 expression and terminal adipocyte differentiation in a manner that was strictly dependent on simultaneous administration of a PPARδ ligand and methylisobutylxanthine (MIX) or other cAMP elevating agents.  We further show that ligands and MIX synergistically stimulated PPARδ-mediated transactivation.  In 3T3-L1 preadipocytes, simultaneous administration of a PPARδ-selective ligand and MIX significantly enhanced the early expression of PPARγ and ALBP/aP2, but only modestly promoted terminal differentiation as detd. by lipid accumulation.  Finally, we provide evidence that synergistic activation of PPARδ promotes mitotic clonal expansion in 3T3-L1 cells with or without forced expression of PPARδ.  In conclusion, our results suggest that PPARδ may play a role in the proliferation of adipocyte precursor cells, whereas activation of endogenous PPARδ in 3T3-L1 cells appears to have only minor impact on the processes leading to terminal adipocyte differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUarK1GNdyHrVg90H21EOLACvtfcHk0ljvunURJ6DuOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtFWjtbY%253D&md5=fab72455cfee032150cf8fdfeff39539</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M005567200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M005567200%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DJ.%2BB.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRasmussen%26aufirst%3DT.%2BH.%26aulast%3DPetersen%26aufirst%3DR.%2BK.%26aulast%3DFlindt%26aufirst%3DE.%2BN.%26aulast%3DKristiansen%26aufirst%3DK.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529-mediated%2520Regulation%2520of%2520Preadipocyte%2520Proliferation%2520and%2520Gene%2520Expression%2520is%2520Dependent%2520on%2520cAMP%2520Signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D3175%26epage%3D3182%26doi%3D10.1074%2Fjbc.M005567200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsusue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ Potentiates PPARγ-stimulated Adipocyte Differentiation</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1477</span>– <span class="NLM_lpage">1479</span>, <span class="refDoi"> DOI: 10.1096/fj.04-1944fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1096%2Ffj.04-1944fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15247146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlKku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1477-1479&author=K.+Matsusueauthor=J.+M.+Petersauthor=F.+J.+Gonzalez&title=PPAR%CE%B2%2F%CE%B4+Potentiates+PPAR%CE%B3-stimulated+Adipocyte+Differentiation&doi=10.1096%2Ffj.04-1944fje"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ potentiates PPARγ-stimulated adipocyte differentiation</span></div><div class="casAuthors">Matsusue, Kimihiko; Peters, Jeffrey M.; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1477-1479, 10.1096/fj.04-1944fje</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">It is well established that peroxisome proliferator-activated receptor-γ (PPARγ) has a crit. role in modulating adipocyte differentiation based on gain-of-function and loss-of-function expts.  However, recent gain-of-function expts. suggest that PPARβ may also have a role in mediating adipocyte differentiation.  Because ligands for PPARs can activate more than one receptor isoform, the specific role of PPARβ in adipocyte differentiation was examd. using PPARβ-null adipocytes.  Wild-type adipocytes accumulate lipids in response to differentiation signaling induced from std. differentiation medium, and this effect is significantly reduced in PPARβ-null adipocytes.  The addn. of the PPARβ ligand L165041 to the std. differentiation medium causes enhanced adipocyte differentiation and lipid accumulation, and this effect is diminished in adipocytes lacking expression of PPARPβ.  Treatment of wild-type adipocytes with the PPARγ ligand troglitazone causes accelerated adipocyte differentiation and lipid accumulation, and this effect is marginally reduced in PPARβ-null adipocytes.  Expression patterns of mRNA markers of early and late adipocyte differentiation are consistent with the morphol. and biochem. differences obsd.  Results from these studies demonstrate that in the absence of PPARβ expression, adipocyte differentiation is significantly impaired, providing loss-of-function evidence supporting a role for this receptor in adipocyte differentiation.  These results also demonstrate that L165041-stimulated adipocyte differentiation and lipid accumulation is mediated by PPARβ.  In addn., as the ability of troglitazone to induce adipocyte differentiation is also impaired in PPARβ null adipocytes, this suggests that both PPARβ and PPARγ isoforms are required to facilitate maximal lipid accumulation and differentiation during adipogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ41bYMHz1XrVg90H21EOLACvtfcHk0liHiiA5p_URUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlKku74%253D&md5=8ebec16d28490ec12ab8922c40155bed</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1096%2Ffj.04-1944fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.04-1944fje%26sid%3Dliteratum%253Aachs%26aulast%3DMatsusue%26aufirst%3DK.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520Potentiates%2520PPAR%25CE%25B3-stimulated%2520Adipocyte%2520Differentiation%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D1477%26epage%3D1479%26doi%3D10.1096%2Ffj.04-1944fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenk, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaith, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plunket, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodkin, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winegar, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sznaidman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span> <span> </span><span class="NLM_article-title">A Selective Peroxisome Proliferator-activated Receptor δ Agonist Promotes Reverse Cholesterol Transport</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">5306</span>– <span class="NLM_lpage">5311</span>, <span class="refDoi"> DOI: 10.1073/pnas.091021198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.091021198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11309497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1Ontro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=5306-5311&author=W.+R.+Oliverauthor=J.+L.+Shenkauthor=M.+R.+Snaithauthor=C.+S.+Russellauthor=K.+D.+Plunketauthor=N.+L.+Bodkinauthor=M.+C.+Lewisauthor=D.+A.+Winegarauthor=M.+L.+Sznaidmanauthor=M.+H.+Lambertauthor=H.+E.+Xuauthor=D.+D.+Sternbachauthor=S.+A.+Kliewerauthor=B.+C.+Hansenauthor=T.+M.+Willson&title=A+Selective+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist+Promotes+Reverse+Cholesterol+Transport&doi=10.1073%2Fpnas.091021198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport</span></div><div class="casAuthors">Oliver, William R., Jr.; Shenk, Jennifer L.; Snaith, Mike R.; Russell, Caroline S.; Plunket, Kelli D.; Bodkin, Noni L.; Lewis, Michael C.; Winegar, Deborah A.; Sznaidman, Marcos L.; Lambert, Millard H.; Xu, H. Eric; Sternbach, Daniel D.; Kliewer, Steven A.; Hansen, Barbara C.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5306-5311</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) are dietary lipid sensors that regulate fatty acid and carbohydrate metab.  The hypolipidemic effects of the fibrate drugs and the antidiabetic effects of the glitazone drugs in humans are due to activation of the α (NR1C1) and γ (NR1C3) subtypes, resp.  By contrast, the therapeutic potential of the δ (NR1C2) subtype is unknown, due in part to the lack of selective ligands.  We have used combinatorial chem. and structure-based drug design to develop a potent and subtype-selective PPARδ agonist, GW501516.  In macrophages, fibroblasts, and intestinal cells, GW501516 increases expression of the reverse cholesterol transporter ATP-binding cassette A1 and induces apolipoprotein A1-specific cholesterol efflux.  When dosed to insulin-resistant middle-aged obese rhesus monkeys, GW501516 causes a dramatic dose-dependent rise in serum high d. lipoprotein cholesterol while lowering the levels of small-dense low d. lipoprotein, fasting triglycerides, and fasting insulin.  Our results suggest that PPARδ agonists may be effective drugs to increase reverse cholesterol transport and decrease cardiovascular disease assocd. with the metabolic syndrome X.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL7t8Lud53sbVg90H21EOLACvtfcHk0liHiiA5p_URUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1Ontro%253D&md5=a831ae5815399dad336dd50e852ed3f8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.091021198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.091021198%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DW.%2BR.%26aulast%3DShenk%26aufirst%3DJ.%2BL.%26aulast%3DSnaith%26aufirst%3DM.%2BR.%26aulast%3DRussell%26aufirst%3DC.%2BS.%26aulast%3DPlunket%26aufirst%3DK.%2BD.%26aulast%3DBodkin%26aufirst%3DN.%2BL.%26aulast%3DLewis%26aufirst%3DM.%2BC.%26aulast%3DWinegar%26aufirst%3DD.%2BA.%26aulast%3DSznaidman%26aufirst%3DM.%2BL.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DHansen%26aufirst%3DB.%2BC.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DA%2520Selective%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%2520Promotes%2520Reverse%2520Cholesterol%2520Transport%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D5306%26epage%3D5311%26doi%3D10.1073%2Fpnas.091021198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Der Veen, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruit, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havinga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baller, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lestavel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groot, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groen, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuipers, F.</span></span> <span> </span><span class="NLM_article-title">Reduced Cholesterol Absorption upon PPARdelta Activation Coincides with Decreased Intestinal Expression of NPC1L1</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1194/jlr.M400400-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1194%2Fjlr.M400400-JLR200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15604518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Slsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=526-534&author=J.+N.+Van%0ADer+Veenauthor=J.+K.+Kruitauthor=R.+Havingaauthor=J.+F.+Ballerauthor=G.+Chiminiauthor=S.+Lestavelauthor=B.+Staelsauthor=P.+H.+Grootauthor=A.+K.+Groenauthor=F.+Kuipers&title=Reduced+Cholesterol+Absorption+upon+PPARdelta+Activation+Coincides+with+Decreased+Intestinal+Expression+of+NPC1L1&doi=10.1194%2Fjlr.M400400-JLR200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced cholesterol absorption upon PPARδ activation coincides with decreased intestinal expression of NPC1L1</span></div><div class="casAuthors">Van der Veen, Jelske N.; Kruit, Janine K.; Havinga, Rick; Baller, Julius F. W.; Chimini, Giovanna; Lestavel, Sophie; Staels, Bart; Groot, Pieter H. E.; Groen, Albert K.; Kuipers, Folkert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">526-534</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) control the transcription of genes involved in lipid metab.  Activation of PPARδ may have antiatherogenic effects through the increase of plasma HDL, theor. promoting reverse cholesterol transport from peripheral tissues toward the liver for removal via bile and feces.  Effects of PPARδ activation by GW610742 were evaluated in wild-type and Abca1-deficient (Abca1-/-) mice that lack HDL.  Treatment with GW610742 resulted in an ∼50% increase of plasma HDL-cholesterol in wild-type mice, whereas plasma cholesterol levels remained extremely low in Abca1-/- mice.  Yet, biliary cholesterol secretion rates were similar in untreated wild-type and Abca1-/- mice and unaltered upon treatment.  Unexpectedly, PPARδ activation led to enhanced fecal neutral sterol loss in both groups without any changes in intestinal Abca1, Abcg5, Abcg8, and 3-hydroxy-3-methylglutaryl-CoA reductase expression.  Moreover, GW610742 treatment resulted in a 43% redn. of fractional cholesterol absorption in wild-type mice, coinciding with a significantly reduced expression of the cholesterol absorption protein Niemann-Pick C1-like 1 (Npc1l1) in the intestine.  PPARδ activation is assocd. with increased plasma HDL and reduced intestinal cholesterol absorption efficiency that may be related to decreased intestinal Npc1l1 expression.  Thus, PPARδ is a promising target for drugs aimed to treat or prevent atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp44jjr5VPCw7Vg90H21EOLACvtfcHk0liHiiA5p_URUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Slsbk%253D&md5=d14003c9f632fea50906b6ffa293e8d3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M400400-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M400400-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BVeen%26aufirst%3DJ.%2BN.%26aulast%3DKruit%26aufirst%3DJ.%2BK.%26aulast%3DHavinga%26aufirst%3DR.%26aulast%3DBaller%26aufirst%3DJ.%2BF.%26aulast%3DChimini%26aufirst%3DG.%26aulast%3DLestavel%26aufirst%3DS.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DGroot%26aufirst%3DP.%2BH.%26aulast%3DGroen%26aufirst%3DA.%2BK.%26aulast%3DKuipers%26aufirst%3DF.%26atitle%3DReduced%2520Cholesterol%2520Absorption%2520upon%2520PPARdelta%2520Activation%2520Coincides%2520with%2520Decreased%2520Intestinal%2520Expression%2520of%2520NPC1L1%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2005%26volume%3D46%26spage%3D526%26epage%3D534%26doi%3D10.1194%2Fjlr.M400400-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hevener, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehl, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olefsky, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">PPARδ Regulates Glucose Metabolism and Insulin Sensitivity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">3444</span>– <span class="NLM_lpage">3449</span>, <span class="refDoi"> DOI: 10.1073/pnas.0511253103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.0511253103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16492734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XksF2ku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3444-3449&author=C.-H.+Leeauthor=P.+Olsonauthor=A.+Hevenerauthor=I.+Mehlauthor=L.-W.+Chongauthor=J.+M.+Olefskyauthor=F.+J.+Gonzalezauthor=J.+Hamauthor=H.+Kangauthor=J.+M.+Petersauthor=R.+M.+Evans&title=PPAR%CE%B4+Regulates+Glucose+Metabolism+and+Insulin+Sensitivity&doi=10.1073%2Fpnas.0511253103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ regulates glucose metabolism and insulin sensitivity</span></div><div class="casAuthors">Lee, Chih-Hao; Olson, Peter; Hevener, Andrea; Mehl, Isaac; Chong, Ling-Wa; Olefsky, Jerrold M.; Gonzalez, Frank J.; Ham, Jungyeob; Kang, Heonjoong; Peters, Jeffrey M.; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3444-3449</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The metabolic syndrome is a collection of obesity-related disorders.  The peroxisome proliferator-activated receptors (PPARs) regulate transcription in response to fatty acids and, as such, are potential therapeutic targets for these diseases.  We show that PPARδ (NR1C2) knockout mice are metabolically less active and glucose-intolerant, whereas receptor activation in db/db mice improves insulin sensitivity.  Euglycemic-hyperinsulinemic-clamp expts. further demonstrate that a PPARδ-specific agonist suppresses hepatic glucose output, increases glucose disposal, and inhibits free fatty acid release from adipocytes.  Unexpectedly, gene array and functional analyses suggest that PPARδ ameliorates hyperglycemia by increasing glucose flux through the pentose phosphate pathway and enhancing fatty acid synthesis.  Coupling increased hepatic carbohydrate catabolism with its ability to promote β-oxidn. in muscle allows PPARδ to regulate metabolic homeostasis and enhance insulin action by complementary effects in distinct tissues.  The combined hepatic and peripheral actions of PPARδ suggest new therapeutic approaches to treat type II diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqag9xStyn2Z7Vg90H21EOLACvtfcHk0lh6QwqHqfofDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksF2ku70%253D&md5=fedf92bc22bb42e4c204e3be75abc51f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0511253103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0511253103%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.-H.%26aulast%3DOlson%26aufirst%3DP.%26aulast%3DHevener%26aufirst%3DA.%26aulast%3DMehl%26aufirst%3DI.%26aulast%3DChong%26aufirst%3DL.-W.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DPPAR%25CE%25B4%2520Regulates%2520Glucose%2520Metabolism%2520and%2520Insulin%2520Sensitivity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D3444%26epage%3D3449%26doi%3D10.1073%2Fpnas.0511253103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkart-Hartman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloszy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, D. P.</span></span> <span> </span><span class="NLM_article-title">The Nuclear Receptor PPARβ/δ Programs Muscle Glucose Metabolism in Cooperation with AMPK and MEF2</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2619</span>– <span class="NLM_lpage">2630</span>, <span class="refDoi"> DOI: 10.1101/gad.178434.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1101%2Fgad.178434.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22135324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlsl2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=2619-2630&author=Z.+Ganauthor=E.+M.+Burkart-Hartmanauthor=D.-H.+Hanauthor=B.+Finckauthor=T.+C.+Leoneauthor=E.+Y.+Smithauthor=J.+E.+Ayalaauthor=J.+Holloszyauthor=D.+P.+Kelly&title=The+Nuclear+Receptor+PPAR%CE%B2%2F%CE%B4+Programs+Muscle+Glucose+Metabolism+in+Cooperation+with+AMPK+and+MEF2&doi=10.1101%2Fgad.178434.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The nuclear receptor PPARβ/δ programs muscle glucose metabolism in cooperation with AMPK and MEF2</span></div><div class="casAuthors">Gan, Zhenji; Burkart-Hartman, Eileen M.; Han, Dong-Ho; Finck, Brian; Leone, Teresa C.; Smith, Emily Y.; Ayala, Julio E.; Holloszy, John; Kelly, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2619-2630</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">To identify new gene regulatory pathways controlling skeletal muscle energy metab., comparative studies were conducted on muscle-specific transgenic mouse lines expressing the nuclear receptors peroxisome proliferator-activated receptor α (PPARα; muscle creatine kinase [MCK]-PPARα) or PPARβ/δ (MCK-PPARβ/δ).  MCK-PPARβ/δ mice are known to have enhanced exercise performance, whereas MCK-PPARα mice perform at low levels.  Transcriptional profiling revealed that the lactate dehydrogenase b (Ldhb)/Ldha gene expression ratio is increased in MCK-PPARβ/δ muscle, an isoenzyme shift that diverts pyruvate into the mitochondrion for the final steps of glucose oxidn.  PPARβ/δ gain- and loss-of-function studies in skeletal myotubes demonstrated that PPARβ/δ, but not PPARα, interacts with the exercise-inducible kinase AMP-activated protein kinase (AMPK) to synergistically activate Ldhb gene transcription by cooperating with myocyte enhancer factor 2A (MEF2A) in a PPARβ/δ ligand-independent manner.  MCK-PPARβ/δ muscle was shown to have high glycogen stores, increased levels of GLUT4, and augmented capacity for mitochondrial pyruvate oxidn., suggesting a broad reprogramming of glucose utilization pathways.  Lastly, exercise studies demonstrated that MCK-PPARβ/δ mice persistently oxidized glucose compared with nontransgenic controls, while exhibiting supranormal performance.  These results identify a transcriptional regulatory mechanism that increases capacity for muscle glucose utilization in a pattern that resembles the effects of exercise training.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV2aSoQaRr_bVg90H21EOLACvtfcHk0lh6QwqHqfofDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlsl2msw%253D%253D&md5=957b60674782b37b5f0dd8f0733cc63a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1101%2Fgad.178434.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.178434.111%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DZ.%26aulast%3DBurkart-Hartman%26aufirst%3DE.%2BM.%26aulast%3DHan%26aufirst%3DD.-H.%26aulast%3DFinck%26aufirst%3DB.%26aulast%3DLeone%26aufirst%3DT.%2BC.%26aulast%3DSmith%26aufirst%3DE.%2BY.%26aulast%3DAyala%26aufirst%3DJ.%2BE.%26aulast%3DHolloszy%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DD.%2BP.%26atitle%3DThe%2520Nuclear%2520Receptor%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Programs%2520Muscle%2520Glucose%2520Metabolism%2520in%2520Cooperation%2520with%2520AMPK%2520and%2520MEF2%26jtitle%3DGenes%2520Dev.%26date%3D2011%26volume%3D25%26spage%3D2619%26epage%3D2630%26doi%3D10.1101%2Fgad.178434.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salvadó, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Foix, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomer, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ Prevents Endoplasmic Reticulum Stress-associated Inflammation and Insulin Resistance in Skeletal Muscle Cells Through an AMPK-dependent Mechanism</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2135</span>, <span class="refDoi"> DOI: 10.1007/s00125-014-3331-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1007%2Fs00125-014-3331-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25063273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Gks73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2126-2135&author=L.+Salvad%C3%B3author=E.+Barrosoauthor=A.+M.+G%C3%B3mez-Foixauthor=X.+Palomerauthor=L.+Michalikauthor=W.+Wahliauthor=M.+V%C3%A1zquez-Carrera&title=PPAR%CE%B2%2F%CE%B4+Prevents+Endoplasmic+Reticulum+Stress-associated+Inflammation+and+Insulin+Resistance+in+Skeletal+Muscle+Cells+Through+an+AMPK-dependent+Mechanism&doi=10.1007%2Fs00125-014-3331-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism</span></div><div class="casAuthors">Salvado, Laia; Barroso, Emma; Gomez-Foix, Anna Maria; Palomer, Xavier; Michalik, Liliane; Wahli, Walter; Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2126-2135</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aim/hypothesis: Endoplasmic reticulum (ER) stress, which is involved in the link between inflammation and insulin resistance, contributes to the development of type 2 diabetes mellitus.  In this study, we assessed whether peroxisome proliferator-activated receptor (PPAR)β/δ prevented ER stress-assocd. inflammation and insulin resistance in skeletal muscle cells.  Methods: Studies were conducted in mouse C2C12 myotubes, in the human myogenic cell line LHCN-M2 and in skeletal muscle from wild-type and PPARβ/δ-deficient mice and mice exposed to a high-fat diet.  Results: The PPARβ/δ agonist GW501516 prevented lipid-induced ER stress in mouse and human myotubes and in skeletal muscle of mice fed a high-fat diet.  PPARβ/δ activation also prevented thapsigargin- and tunicamycin-induced ER stress in human and murine skeletal muscle cells.  In agreement with this, PPARβ/δ activation prevented ER stress-assocd. inflammation and insulin resistance, and glucose-intolerant PPARβ/δ-deficient mice showed increased phosphorylated levels of inositol-requiring 1 transmembrane kinase/endonuclease-1α in skeletal muscle.  Our findings demonstrate that PPARβ/δ activation prevents ER stress through the activation of AMP-activated protein kinase (AMPK), and the subsequent inhibition of extracellular-signal-regulated kinase (ERK)1/2 due to the inhibitory crosstalk between AMPK and ERK1/2, since overexpression of a dominant neg. AMPK construct (K45R) reversed the effects attained by PPARβ/δ activation.  Conclusions/interpretation: Overall, these findings indicate that PPARβ/δ prevents ER stress, inflammation and insulin resistance in skeletal muscle cells by activating AMPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHCyGO8lv08LVg90H21EOLACvtfcHk0lhFJRN6ittkug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Gks73E&md5=fca954518b59fd8f82687b4a26262d7e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs00125-014-3331-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-014-3331-8%26sid%3Dliteratum%253Aachs%26aulast%3DSalvad%25C3%25B3%26aufirst%3DL.%26aulast%3DBarroso%26aufirst%3DE.%26aulast%3DG%25C3%25B3mez-Foix%26aufirst%3DA.%2BM.%26aulast%3DPalomer%26aufirst%3DX.%26aulast%3DMichalik%26aufirst%3DL.%26aulast%3DWahli%26aufirst%3DW.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520Prevents%2520Endoplasmic%2520Reticulum%2520Stress-associated%2520Inflammation%2520and%2520Insulin%2520Resistance%2520in%2520Skeletal%2520Muscle%2520Cells%2520Through%2520an%2520AMPK-dependent%2520Mechanism%26jtitle%3DDiabetologia%26date%3D2014%26volume%3D57%26spage%3D2126%26epage%3D2135%26doi%3D10.1007%2Fs00125-014-3331-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cnop, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foufelle, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velloso, L. A.</span></span> <span> </span><span class="NLM_article-title">Endoplasmic Reticulum Stress, Obesity and Diabetes</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2011.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.molmed.2011.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21889406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=59-68&author=M.+Cnopauthor=F.+Foufelleauthor=L.+A.+Velloso&title=Endoplasmic+Reticulum+Stress%2C+Obesity+and+Diabetes&doi=10.1016%2Fj.molmed.2011.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic reticulum stress, obesity and diabetes</span></div><div class="casAuthors">Cnop, Miriam; Foufelle, Fabienne; Velloso, Licio A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-68</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The endoplasmic reticulum (ER) stress response, also commonly known as the unfolded protein response (UPR), is an adaptive response used to align ER functional capacity with demand.  It is activated in various tissues under conditions related to obesity and type 2 diabetes.  Hypothalamic ER stress contributes to inflammation and leptin/insulin resistance.  Hepatic ER stress contributes to the development of steatosis and insulin resistance, and components of the UPR regulate liver lipid metab.  ER stress in enlarged fat tissues induces inflammation and modifies adipokine secretion, and satd. fats cause ER stress in muscle.  Finally, prolonged ER stress impairs insulin synthesis and causes pancreatic β cell apoptosis.  In this review, we discuss ways in which ER stress operates as a common mol. pathway in the pathogenesis of obesity and diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4sRB0R3CMMLVg90H21EOLACvtfcHk0lhFJRN6ittkug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVSgtw%253D%253D&md5=21fb3f4b129b33837cd0ec25e5a740f1</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2011.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2011.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DCnop%26aufirst%3DM.%26aulast%3DFoufelle%26aufirst%3DF.%26aulast%3DVelloso%26aufirst%3DL.%2BA.%26atitle%3DEndoplasmic%2520Reticulum%2520Stress%252C%2520Obesity%2520and%2520Diabetes%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D59%26epage%3D68%26doi%3D10.1016%2Fj.molmed.2011.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Marco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Calvo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Kochairi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomer, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–stimulated Adipocytes</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1990</span>– <span class="NLM_lpage">1999</span>, <span class="refDoi"> DOI: 10.2337/db10-0704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.2337%2Fdb10-0704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21617181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVChu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=1990-1999&author=L.+Serrano-Marcoauthor=R.+Rodr%C3%ADguez-Calvoauthor=I.+El+Kochairiauthor=X.+Palomerauthor=L.+Michalikauthor=W.+Wahliauthor=M.+V%C3%A1zquez-Carrera&title=Activation+of+Peroxisome+Proliferator%E2%80%93Activated+Receptor-%CE%B2%2F-%CE%B4+%28PPAR-%CE%B2%2F-%CE%B4%29+Ameliorates+Insulin+Signaling+and+Reduces+SOCS3+Levels+by+Inhibiting+STAT3+in+Interleukin-6%E2%80%93stimulated+Adipocytes&doi=10.2337%2Fdb10-0704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes</span></div><div class="casAuthors">Serrano-Marco, Lucia; Rodriguez-Calvo, Ricardo; El Kochairi, Ilhem; Palomer, Xavier; Michalik, Liliane; Wahli, Walter; Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1990-1999</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Objective: It has been suggested that interleukin (IL)-6 is one of the mediators linking obesity-derived chronic inflammation with insulin resistance through activation of STAT3, with subsequent upregulation of suppressor of cytokine signaling 3 (SOCS3).  We evaluated whether peroxisome proliferator-activated receptor (PPAR)-β/-δ prevented activation of the IL-6-STAT3-SOCS3 pathway and insulin resistance in adipocytes.  Research Design and Methods: Adipocytes and white adipose tissue from wild-type and PPAR-β/-δ-null mice were used to evaluate the effect of PPAR-β/-δ on the IL-6-STAT3-SOCS3 pathway.  Results: First, we obsd. that the PPAR-β/-δ agonist GW501516 prevented both IL-6-dependent redn. in insulin-stimulated Akt phosphorylation and glucose uptake in adipocytes.  In addn., this drug treatment abolished IL-6-induced SOCS3 expression in differentiated 3T3-L1 adipocytes.  This effect was assocd. with the capacity of the drug to prevent IL-6-induced STAT3 phosphorylation on Tyr705 and Ser727 residues in vitro and in vivo.  Moreover, GW501516 prevented IL-6-dependent induction of extracellular signal-related kinase (ERK)1/2, a serine-threonine-protein kinase involved in serine STAT3 phosphorylation.  Furthermore, in white adipose tissue from PPAR-β/-δ-null mice, STAT3 phosphorylation (Tyr705 and Ser727), STAT3 DNA-binding activity, and SOCS3 protein levels were higher than in wild-type mice.  Several steps in STAT3 activation require its assocn. with heat shock protein 90 (Hsp90), which was prevented by GW501516 as revealed in immunopptn. studies.  Consistent with this finding, the STAT3-Hsp90 assocn. was enhanced in white adipose tissue from PPAR-β/-δ-null mice compared with wild-type mice.  Conclusions: Collectively, our findings indicate that PPAR-β/-δ activation prevents IL-6-induced STAT3 activation by inhibiting ERK1/2 and preventing the STAT3-Hsp90 assocn., an effect that may contribute to the prevention of cytokine-induced insulin resistance in adipocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorMzXks5dNjbVg90H21EOLACvtfcHk0liHmjooSvzMmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVChu7o%253D&md5=8c64a2f948b858413b72aecdff8cef53</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2337%2Fdb10-0704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb10-0704%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano-Marco%26aufirst%3DL.%26aulast%3DRodr%25C3%25ADguez-Calvo%26aufirst%3DR.%26aulast%3DEl%2BKochairi%26aufirst%3DI.%26aulast%3DPalomer%26aufirst%3DX.%26aulast%3DMichalik%26aufirst%3DL.%26aulast%3DWahli%26aufirst%3DW.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DActivation%2520of%2520Peroxisome%2520Proliferator%25E2%2580%2593Activated%2520Receptor-%25CE%25B2%252F-%25CE%25B4%2520%2528PPAR-%25CE%25B2%252F-%25CE%25B4%2529%2520Ameliorates%2520Insulin%2520Signaling%2520and%2520Reduces%2520SOCS3%2520Levels%2520by%2520Inhibiting%2520STAT3%2520in%2520Interleukin-6%25E2%2580%2593stimulated%2520Adipocytes%26jtitle%3DDiabetes%26date%3D2011%26volume%3D60%26spage%3D1990%26epage%3D1999%26doi%3D10.2337%2Fdb10-0704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, h.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-N.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ Agonist GW501516 Inhibits TNFα-induced Repression of Adiponectin and Insulin Receptor in 3T3-L1 Adipocytes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>510</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2019.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbrc.2019.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30739791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXislKrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2019&pages=621-628&author=W.+J.+Kimauthor=W.+Leeauthor=Y.+Jungauthor=h.-J.+Jangauthor=Y.+K.+Kimauthor=S.-N.+Kim&title=PPAR%CE%B2%2F%CE%B4+Agonist+GW501516+Inhibits+TNF%CE%B1-induced+Repression+of+Adiponectin+and+Insulin+Receptor+in+3T3-L1+Adipocytes&doi=10.1016%2Fj.bbrc.2019.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ agonist GW501516 inhibits TNFα-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes</span></div><div class="casAuthors">Kim, Won Jun; Lee, Woojung; Jung, Yujung; Jang, hyuk-Jai; Kim, Yong Kee; Kim, Su-Nam</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">621-628</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous reports have shown that PPARβ/δ agonists ameliorate insulin resistance assocd. with type 2 diabetes mellitus (T2DM).  To det. the role of PPARβ/δ in tumor necrosis factor α (TNFα)-mediated insulin resistance, we investigated expression levels of adiponectin and insulin receptor (IR) in response to treatment with the PPARβ/δ agonist GW501516 with or without TNFα, a proinflammatory cytokine, in differentiated 3T3-L1 adipocytes.  GW501516 induced adipocyte differentiation and the expression of adiponectin in a dose-dependent manner in differentiated adipocytes.  TNFα treatment reduced adiponectin expression at the end of differentiation.  This effect was reversed by GW501516 co-treatment with TNFα.  TNFα treatment decreased adipogenic marker genes such as PPARγ, aP2, resistin, and GLUT4, and GW501516 reversed the effects of TNFα.  GW501516 treatment increased the expression of insulin receptor and inhibited TNFα-mediated repression of insulin receptor.  Our results showed that GW501516 abrogated TNFα-induced insulin resistance.  In summary, our study demonstrated that the PPARβ/δ agonist, GW501516 reversed TNFα-induced decreases in adipocyte differentiation and adiponectin expression, and improved insulin sensitivity by increasing the expression of insulin receptor.  Therefore, PPARδ may be a promising therapeutic target for treatment of insulin resistance in patients with T2DM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj4yd7j2CVVrVg90H21EOLACvtfcHk0liHmjooSvzMmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXislKrtbg%253D&md5=167dabe92b8d52dff6c69dcf5eacbc0e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2019.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2019.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DJang%26aufirst%3Dh.-J.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DKim%26aufirst%3DS.-N.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520Agonist%2520GW501516%2520Inhibits%2520TNF%25CE%25B1-induced%2520Repression%2520of%2520Adiponectin%2520and%2520Insulin%2520Receptor%2520in%25203T3-L1%2520Adipocytes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2019%26volume%3D510%26spage%3D621%26epage%3D628%26doi%3D10.1016%2Fj.bbrc.2019.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmadian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sul, H. S.</span></span> <span> </span><span class="NLM_article-title">Desnutrin/ATGL Activates PPARδ to Promote Mitochondrial Function for insulin Secretion in islet β cells</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">895</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2013.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.cmet.2013.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=24268737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKisLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=883-895&author=T.+Tangauthor=M.+J.+Abbottauthor=M.+Ahmadianauthor=A.+B.+Lopesauthor=Y.+Wangauthor=H.+S.+Sul&title=Desnutrin%2FATGL+Activates+PPAR%CE%B4+to+Promote+Mitochondrial+Function+for+insulin+Secretion+in+islet+%CE%B2+cells&doi=10.1016%2Fj.cmet.2013.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Desnutrin/ATGL Activates PPARδ to Promote Mitochondrial Function for Insulin Secretion in Islet β Cells</span></div><div class="casAuthors">Tang, Tianyi; Abbott, Marcia J.; Ahmadian, Maryam; Lopes, Andressa B.; Wang, Yuhui; Sul, Hei Sook</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">883-895</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Excessive caloric intake leading to obesity is assocd. with insulin resistance and dysfunction of islet β cells.  High-fat feeding decreases desnutrin (also called ATGL/PNPLA2) levels in islets.  Here we show that desnutrin ablation via RIP-Cre (βKO) or RIP-CreER results in hyperglycemia with impaired glucose-stimulated insulin secretion (GSIS).  Due to decreased lipolysis, islets have higher TAG content but lower free FA levels.  βKO islets exhibit impaired mitochondrial respiration and lower prodn. of ATP required for GSIS, along with decreased expression of PPARδ target genes involved in mitochondrial oxidn.  Furthermore, synthetic PPARδ, but not PPARα, agonist restores GSIS and expression of mitochondrial oxidative genes in βKO mice, revealing that desnutrin-catalyzed lipolysis generates PPARδ ligands.  Finally, adenoviral expression of desnutrin in βKO islets restores all defects of βKO islet phenotype and function, including GSIS and mitochondrial defects, demonstrating the crit. role of the desnutrin-PPARδ-mitochondrial oxidn. axis in regulating islet β cell GSIS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAFILYlAE9y7Vg90H21EOLACvtfcHk0lgTOt7A5kpGww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKisLvK&md5=e87675cb448ba5a89e11be77e4fb7087</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2013.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2013.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DT.%26aulast%3DAbbott%26aufirst%3DM.%2BJ.%26aulast%3DAhmadian%26aufirst%3DM.%26aulast%3DLopes%26aufirst%3DA.%2BB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSul%26aufirst%3DH.%2BS.%26atitle%3DDesnutrin%252FATGL%2520Activates%2520PPAR%25CE%25B4%2520to%2520Promote%2520Mitochondrial%2520Function%2520for%2520insulin%2520Secretion%2520in%2520islet%2520%25CE%25B2%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2013%26volume%3D18%26spage%3D883%26epage%3D895%26doi%3D10.1016%2Fj.cmet.2013.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, N.</span></span> <span> </span><span class="NLM_article-title">Activation of PPARβ/δ Protects Pancreatic β cells from Palmitate-induced Apoptosis by Upregulating the Expression of GLP-1 Receptor</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2013.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.cellsig.2013.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=24269940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVSgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=268-278&author=Y.+Yangauthor=Y.+Tongauthor=M.+Gongauthor=Y.+Luauthor=C.+Wangauthor=M.+Zhouauthor=Q.+Yangauthor=T.+Maoauthor=N.+Tong&title=Activation+of+PPAR%CE%B2%2F%CE%B4+Protects+Pancreatic+%CE%B2+cells+from+Palmitate-induced+Apoptosis+by+Upregulating+the+Expression+of+GLP-1+Receptor&doi=10.1016%2Fj.cellsig.2013.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor</span></div><div class="casAuthors">Yang, Yan; Tong, Yuzhen; Gong, Meng; Lu, Yanrong; Wang, Chengshi; Zhou, Mingliang; Yang, Qiu; Mao, Tingrui; Tong, Nanwei</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-278</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We previously showed that activated peroxisome proliferator-activated receptor (PPAR)β/δ can protect pancreatic β cells against lipotoxic apoptosis.  However, the mol. mechanism remained unclear.  Glucagon-like peptide-1 receptor (GLP-1R) has been reported to exhibit a protective effect against lipotoxic apoptosis in pancreatic β cells.  In the present study, we aimed to investigate the underlying mol. mechanisms that PPARβ/δ activation suppressed apoptosis and improved β cell function impaired by fatty acids, focusing on contribution of GLP-1R.  Isolated rat islets and rat insulin-secreting INS-1 cells were treated with the PPARβ/δ agonist GW501516 (GW) in the presence or absence of palmitate (PA) and transfected with siRNA for PPARβ/δ or treated with the PPARβ/δ antagonist GSK0660.  Apoptosis was assessed by DNA fragmentation, Hoechst 33342 staining and flow cytometry.  GLP-1R expression in INS-1 cells and islets was assayed by immunoblotting, quant. PCR (qPCR) and immunofluorescence staining.  SREBP-1c, Caveolin-1, Akt, Bcl-2, Bcl-xl and caspase-3 expression was measured using immunoblotting and qPCR.  Our results showed that PPARβ/δ activation decreased apoptosis in β cells and robustly stimulated GLP-1R expression under lipotoxic conditions.  GW enhanced glucose-stimulated insulin secretion (GSIS) impaired by PA through stimulation of GLP-1R expression in β cells.  Moreover, SREBP-1c/Caveolin-1 signaling was involved in PPARβ/δ-regulated GLP-1R expression.  Finally, GW exerted anti-apoptotic effects via interfering with GLP-1R-dependent Akt/Bcl-2 and Bcl-xl/caspase-3 signaling pathways.  Our study suggested that the anti-apoptotic action of GW may involve its transcriptional regulation of GLP-1R, and PPARβ/δ activation may represent a new therapeutic method for protecting pancreatic β cells from lipotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMcsdJoteZ57Vg90H21EOLACvtfcHk0lgTOt7A5kpGww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVSgsw%253D%253D&md5=4f40fce3a5d4ee5bf816632e8642a89a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2013.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2013.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DGong%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DMao%26aufirst%3DT.%26aulast%3DTong%26aufirst%3DN.%26atitle%3DActivation%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Protects%2520Pancreatic%2520%25CE%25B2%2520cells%2520from%2520Palmitate-induced%2520Apoptosis%2520by%2520Upregulating%2520the%2520Expression%2520of%2520GLP-1%2520Receptor%26jtitle%3DCell.%2520Signalling%26date%3D2014%26volume%3D26%26spage%3D268%26epage%3D278%26doi%3D10.1016%2Fj.cellsig.2013.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doktorova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwarts, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zutphen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van DIjk, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloks, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harkema, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bruin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkade, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, J. W.</span></span> <span> </span><span class="NLM_article-title">Intestinal PPARδ Protects Against Diet-induced Obesity, Insulin Resistance and Dyslipidemia</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">846</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-00889-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fs41598-017-00889-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=28404991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC1cvntlOgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=846&author=M.+Doktorovaauthor=I.+Zwartsauthor=T.+van+Zutphenauthor=T.+H.+Van+DIjkauthor=V.+W.+Bloksauthor=L.+Harkemaauthor=A.+De+Bruinauthor=M.+Downesauthor=R.+M.+Evansauthor=H.+J.+Verkadeauthor=J.+W.+Jonker&title=Intestinal+PPAR%CE%B4+Protects+Against+Diet-induced+Obesity%2C+Insulin+Resistance+and+Dyslipidemia&doi=10.1038%2Fs41598-017-00889-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia</span></div><div class="casAuthors">Doktorova Marcela; Zwarts Irene; Zutphen Tim van; Bloks Vincent W; Bruin Alain de; Verkade Henkjan J; Jonker Johan W; Dijk Theo H van; Harkema Liesbeth; Bruin Alain de; Downes Michael; Evans Ronald M</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">846</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peroxisome proliferator-activated receptor δ (PPARδ) is a ligand-activated transcription factor that has an important role in lipid metabolism.  Activation of PPARδ stimulates fatty acid oxidation in adipose tissue and skeletal muscle and improves dyslipidemia in mice and humans.  PPARδ is highly expressed in the intestinal tract but its physiological function in this organ is not known.  Using mice with an intestinal epithelial cell-specific deletion of PPARδ, we show that intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia.  Furthermore, absence of intestinal PPARδ abolished the ability of PPARδ agonist GW501516 to increase plasma levels of HDL-cholesterol.  Together, our findings show that intestinal PPARδ is important in maintaining metabolic homeostasis and suggest that intestinal-specific activation of PPARδ could be a therapeutic approach for treatment of the metabolic syndrome and dyslipidemia, while avoiding systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxtgej_xcBI6-9TkgmBqTqfW6udTcc2eYMTOVpkqNgH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvntlOgug%253D%253D&md5=94f4cfda86a4c1ed44a993ebbb0357f8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-00889-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-00889-z%26sid%3Dliteratum%253Aachs%26aulast%3DDoktorova%26aufirst%3DM.%26aulast%3DZwarts%26aufirst%3DI.%26aulast%3Dvan%2BZutphen%26aufirst%3DT.%26aulast%3DVan%2BDIjk%26aufirst%3DT.%2BH.%26aulast%3DBloks%26aufirst%3DV.%2BW.%26aulast%3DHarkema%26aufirst%3DL.%26aulast%3DDe%2BBruin%26aufirst%3DA.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DVerkade%26aufirst%3DH.%2BJ.%26aulast%3DJonker%26aufirst%3DJ.%2BW.%26atitle%3DIntestinal%2520PPAR%25CE%25B4%2520Protects%2520Against%2520Diet-induced%2520Obesity%252C%2520Insulin%2520Resistance%2520and%2520Dyslipidemia%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D846%26doi%3D10.1038%2Fs41598-017-00889-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowlus, C. L.</span></span> <span> </span><span class="NLM_article-title">Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis</span>. <i>Gastroenterol. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">154</span>– <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC1MbpvVOrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=154-163&author=R.+Baharauthor=K.+A.+Wongauthor=C.+H.+Liuauthor=C.+L.+Bowlus&title=Update+on+New+Drugs+and+Those+in+Development+for+the+Treatment+of+Primary+Biliary+Cholangitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis</span></div><div class="casAuthors">Bahar Runalia; Wong Kimberly A; Liu Chung H; Bowlus Christopher L</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">154-163</span>
        ISSN:<span class="NLM_cas:issn">1554-7914</span>.
    </div><div class="casAbstract">Primary biliary cholangitis (PBC) is an autoimmune inflammatory liver disease of the interlobular bile ducts that can lead to cirrhosis and liver failure.  Until recently, the only effective treatment was ursodeoxycholic acid (UDCA).  However, up to 40% of PBC patients have an inadequate response to UDCA and may continue to have disease progression.  Several models have been developed, including the UK-PBC and GLOBE scores, to assist in identifying patients who may benefit from second-line therapies, such as the farnesoid X receptor (FXR) agonist obeticholic acid (OCA).  The addition of OCA can significantly improve serum alkaline phosphatase and total bilirubin, which are strong surrogate markers of clinical outcomes in PBC.  Other alternatives, including the peroxisome proliferator-activated receptor (PPAR)-α agonists fenofibrate and bezafibrate, may also improve liver biochemistries in PBC patients with an inadequate response to UDCA, but further study is needed to demonstrate their safety and long-term efficacy.  Other novel agents, including those targeting the FXR pathway and PPAR-δ agonists, have shown promising results and may alter the therapeutic landscape of PBC in the near future.  For now, OCA remains the only approved second-line agent for PBC patients with an inadequate response to UDCA while results of long-term studies of its safety and clinical benefit are awaited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDQCanGEFYzZZoeNcnHOQ9fW6udTcc2eYMTOVpkqNgH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbpvVOrtg%253D%253D&md5=46c31e96ea8a1e92d5c45fb838696bf2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBahar%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DK.%2BA.%26aulast%3DLiu%26aufirst%3DC.%2BH.%26aulast%3DBowlus%26aufirst%3DC.%2BL.%26atitle%3DUpdate%2520on%2520New%2520Drugs%2520and%2520Those%2520in%2520Development%2520for%2520the%2520Treatment%2520of%2520Primary%2520Biliary%2520Cholangitis%26jtitle%3DGastroenterol.%2520Hepatol.%26date%3D2018%26volume%3D14%26spage%3D154%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span> <span> </span><span class="NLM_article-title">Emerging Novel Treatments for Autoimmune Liver Diseases</span>. <i>Hepatol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1111/hepr.13347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1111%2Fhepr.13347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30969002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FjvVKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2019&pages=489-499&author=A.+Tanaka&title=Emerging+Novel+Treatments+for+Autoimmune+Liver+Diseases&doi=10.1111%2Fhepr.13347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging novel treatments for autoimmune liver diseases</span></div><div class="casAuthors">Tanaka Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology research : the official journal of the Japan Society of Hepatology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">489-499</span>
        ISSN:<span class="NLM_cas:issn">1386-6346</span>.
    </div><div class="casAbstract">The etiology of autoimmune liver diseases, such as autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC), still remains largely unknown and no therapeutic agents that are able to "cure" these diseases have been developed.  Although corticosteroids for AIH and ursodeoxycholic acid for PBC have been shown to significantly improve liver transplantation (LT)-free survival and are recommended as first-line drugs, treatment strategies for patients who show incomplete response to these drugs have not yet been fully established.  No drug is significantly associated with long LT-free survival in PSC patients.  Nevertheless, with progress in genetics, immunology, and cellular biology, several new compounds or antibodies are expected to have an effect on autoimmune liver diseases and several drugs are under consideration for clinical use.  Although most clinical trials have been carried out in the USA or Europe, some are, or will be, undertaken in Japan in the future.  In this review, the current standard-of-care of autoimmune liver diseases will be summarized, together with emerging novel treatments relevant to clinical practice in Japan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQN1Ak8wZEfR-_Q9URG6Dx8fW6udTcc2ebbK66BXrKYfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FjvVKgug%253D%253D&md5=e5e2667850ac8f11286a1a36f834291c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fhepr.13347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fhepr.13347%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DA.%26atitle%3DEmerging%2520Novel%2520Treatments%2520for%2520Autoimmune%2520Liver%2520Diseases%26jtitle%3DHepatol.%2520Res.%26date%3D2019%26volume%3D49%26spage%3D489%26epage%3D499%26doi%3D10.1111%2Fhepr.13347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palomer, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro-Delgado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peña, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botteri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montori-Grau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">913</span>, <span class="refDoi"> DOI: 10.3390/ijms19030913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms19030913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOntLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=913&author=X.+Palomerauthor=E.+Barrosoauthor=J.+Pizarro-Delgadoauthor=L.+Pe%C3%B1aauthor=G.+Botteriauthor=M.+Zareiauthor=D.+Aguilarauthor=M.+Montori-Grauauthor=M.+V%C3%A1zquez-Carrera&title=PPAR%CE%B2%2F%CE%B4%3A+A+Key+Therapeutic+Target+in+Metabolic+Disorders&doi=10.3390%2Fijms19030913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ: a key therapeutic target in metabolic disorders</span></div><div class="casAuthors">Palomer, Xavier; Barroso, Emma; Pizarro-Delgado, Javier; Pena, Lucia; Botteri, Gaia; Zarei, Mohammad; Aguilar, David; Montori-Grau, Marta; Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">913/1-913/14</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Research in recent years on peroxisome proliferator-activated receptor (PPAR)β/δ indicates that it plays a key role in the maintenance of energy homeostasis, both at the cellular level and within the organism as a whole.  PPARβ/δ activation might help prevent the development of metabolic disorders, including obesity, dyslipidemia, type 2 diabetes mellitus and non-alc. fatty liver disease.  This review highlights research findings on the PPARβ/δ regulation of energy metab. and the development of diseases related to altered cellular and body metab.  It also describes the potential of the pharmacol. activation of PPARβ/δ as a treatment for human metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0WVMgCBkeK7Vg90H21EOLACvtfcHk0lhCzowlz0ecpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOntLrJ&md5=22b43757cebddc4b1afb814457d92089</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3390%2Fijms19030913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19030913%26sid%3Dliteratum%253Aachs%26aulast%3DPalomer%26aufirst%3DX.%26aulast%3DBarroso%26aufirst%3DE.%26aulast%3DPizarro-Delgado%26aufirst%3DJ.%26aulast%3DPe%25C3%25B1a%26aufirst%3DL.%26aulast%3DBotteri%26aufirst%3DG.%26aulast%3DZarei%26aufirst%3DM.%26aulast%3DAguilar%26aufirst%3DD.%26aulast%3DMontori-Grau%26aufirst%3DM.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%253A%2520A%2520Key%2520Therapeutic%2520Target%2520in%2520Metabolic%2520Disorders%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D913%26doi%3D10.3390%2Fijms19030913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeon, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Je, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, K. S.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor-delta Agonist Ameliorated Inflammasome Activation in Nonalcoholic Fatty Liver Disease</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">12787</span>– <span class="NLM_lpage">12799</span>, <span class="refDoi"> DOI: 10.3748/wjg.v21.i45.12787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3748%2Fwjg.v21.i45.12787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=26668503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSisb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=12787-12799&author=H.+J.+Leeauthor=J.+E.+Yeonauthor=E.+J.+Koauthor=E.+L.+Yoonauthor=S.+J.+Suhauthor=K.+Kangauthor=H.+R.+Kimauthor=S.+H.+Kangauthor=Y.+J.+Yooauthor=J.+Jeauthor=B.+J.+Leeauthor=J.+H.+Kimauthor=Y.+S.+Seoauthor=H.+J.+Yimauthor=K.+S.+Byun&title=Peroxisome+Proliferator-activated+Receptor-delta+Agonist+Ameliorated+Inflammasome+Activation+in+Nonalcoholic+Fatty+Liver+Disease&doi=10.3748%2Fwjg.v21.i45.12787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease</span></div><div class="casAuthors">Lee, Hyun Jung; Yeon, Jong Eun; Ko, Eun Jung; Yoon, Eileen L.; Suh, Sang Jun; Kang, Keunhee; Kim, Hae Rim; Kang, Seoung Hee; Yoo, Yang Jae; Je, Jihye; Lee, Beom Jae; Kim, Ji Hoon; Seo, Yeon Seok; Yim, Hyung Joon; Byun, Kwan Soo</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">12787-12799</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">2219-2840</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Inc.</span>)
        </div><div class="casAbstract">AIM: To evaluate the inflammasome activation and the effect of peroxisome proliferator-activated receptors (PPAR)-δ agonist treatment in nonalcoholic fatty liver disease (NAFLD) models.  METHODS: Male C57BL/6J mice were classified according to control or high fat diet (HFD) with or without PPAR-δ agonist (GW) over period of 12 wk [control, HFD, HFD + lipopolysaccharide (LPS), HFD + LPS + GW group].  HepG2 cells were exposed to palmitic acid (PA) and/or LPS in the absence or presence of GW.  RESULTS: HFD caused glucose intolerance and hepatic steatosis.  In mice fed an HFD with LPS, caspase-1 and interleukin (IL)-1β in the liver were significantly increased.  Treatment with GW ameliorated the steatosis and inhibited overexpression of pro-inflammatory cytokines.  In HepG2 cells, PA and LPS treatment markedly increased mRNA of several nucleotide-binding and oligomerization domain-like receptor family members (NLRP3, NLRP6, and NLRP10), caspase-1 and IL-1β.  PA and LPS also exaggerated reactive oxygen species prodn.  All of the above effects of PA and LPS were reduced by GW.  GW also enhanced the phosphorylation of AMPK-α.  CONCLUSION: PPAR-δ agonist reduces fatty acid induced inflammation and steatosis by suppressing inflammasome activation.  Targeting the inflammasome by the PPAR-δ agonist may have therapeutic implication for NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptDOuwhetQMLVg90H21EOLACvtfcHk0lgY4RXmHswEuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSisb7E&md5=f307e251001832767594ae087be6a67c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v21.i45.12787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v21.i45.12787%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DYeon%26aufirst%3DJ.%2BE.%26aulast%3DKo%26aufirst%3DE.%2BJ.%26aulast%3DYoon%26aufirst%3DE.%2BL.%26aulast%3DSuh%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DKang%26aufirst%3DS.%2BH.%26aulast%3DYoo%26aufirst%3DY.%2BJ.%26aulast%3DJe%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DB.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSeo%26aufirst%3DY.%2BS.%26aulast%3DYim%26aufirst%3DH.%2BJ.%26aulast%3DByun%26aufirst%3DK.%2BS.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor-delta%2520Agonist%2520Ameliorated%2520Inflammasome%2520Activation%2520in%2520Nonalcoholic%2520Fatty%2520Liver%2520Disease%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2015%26volume%3D21%26spage%3D12787%26epage%3D12799%26doi%3D10.3748%2Fwjg.v21.i45.12787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naowaboot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. H.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor δ Agonist Attenuates Hepatic Steatosis by Anti-inflammatory Mechanism</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.3858/emm.2012.44.10.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3858%2Femm.2012.44.10.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22824914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ygtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=578-585&author=M.+Y.+Leeauthor=R.+Choiauthor=H.+M.+Kimauthor=E.+J.+Choauthor=B.+H.+Kimauthor=Y.+S.+Choiauthor=J.+Naowabootauthor=E.+Y.+Leeauthor=Y.+C.+Yangauthor=J.+Y.+Shinauthor=Y.+G.+Shinauthor=C.+H.+Chung&title=Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist+Attenuates+Hepatic+Steatosis+by+Anti-inflammatory+Mechanism&doi=10.3858%2Femm.2012.44.10.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism</span></div><div class="casAuthors">Lee, Mi Young; Choi, Ran; Kim, Hong Min; Cho, Eun Ju; Kim, Bo Hwan; Choi, Yeon Sik; Naowaboot, Jarinyaporn; Lee, Eun Young; Yang, Young Chul; Shin, Jang Yel; Shin, Young Goo; Chung, Choon Hee</div><div class="citationInfo"><span class="NLM_cas:title">Experimental & Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">578-585</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1226-3613</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Although peroxisome proliferator receptor (PPAR)-α and PPAR-γ agonist were developed as chem. tools to uncover biol. roles for the PPARs such as lipid and carbohydrate metab., PPAR-δ was not fully investigated.  In this study, the authors examd. the effects of the PPAR-δ agonist GW0742 on fatty liver changes and inflammatory markers.  The authors investigated the effects of PPAR-δ agonist GW0742 on fatty liver changes in OLETF rats.  Intrahepatic triglyceride contents and expression of inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) and also, PPAR-γ coactivator (PGC)-1α gene were evaluated in liver tissues of OLETF rats and HepG2 cells after GW0742 treatment.  The level of TNF-α and MCP-1 was also examd. in supernatant of Raw264.7 cell culture.  To address the effects of GW0742 on insulin signaling, the authors performed in vitro study with AML12 mouse hepatocytes.  Rats treated with GW0742 (10 mg/kg/day) from 26-36 wk showed improvement in fatty infiltration of the liver.  In liver tissues, mRNA expressions of TNF-α, MCP-1, and PGC-1α were significantly decreased in diabetic rats treated with GW0742 compared to diabetic control rats.  The authors also obsd. that GW0742 had inhibitory effects on palmitic acid-induced fatty accumulation and inflammatory markers in HepG2 and Raw264.7 cells.  The expression level of Akt and IRS-1 was significantly increased by treatment with GW0742.  The PPAR-δ agonist may attenuate hepatic fat accumulation through anti-inflammatory mechanism, reducing hepatic PGC-1α gene expression, and improvement of insulin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF4xueBHzIv7Vg90H21EOLACvtfcHk0lgY4RXmHswEuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ygtrvP&md5=b9f93e8f6546268a9369a12794efa531</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.3858%2Femm.2012.44.10.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3858%252Femm.2012.44.10.066%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BY.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DCho%26aufirst%3DE.%2BJ.%26aulast%3DKim%26aufirst%3DB.%2BH.%26aulast%3DChoi%26aufirst%3DY.%2BS.%26aulast%3DNaowaboot%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DE.%2BY.%26aulast%3DYang%26aufirst%3DY.%2BC.%26aulast%3DShin%26aufirst%3DJ.%2BY.%26aulast%3DShin%26aufirst%3DY.%2BG.%26aulast%3DChung%26aufirst%3DC.%2BH.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%2520Attenuates%2520Hepatic%2520Steatosis%2520by%2520Anti-inflammatory%2520Mechanism%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2012%26volume%3D44%26spage%3D578%26epage%3D585%26doi%3D10.3858%2Femm.2012.44.10.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">PPARδ Attenuates Hepatic Steatosis through Autophagy-mediated Fatty Acid Oxidation</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">197</span>, <span class="refDoi"> DOI: 10.1038/s41419-019-1458-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fs41419-019-1458-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30814493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BB3cfosVyqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=197&author=L.+Tongauthor=L.+Wangauthor=S.+Yaoauthor=L.+Jinauthor=J.+Yangauthor=Y.+Zhangauthor=G.+Ningauthor=Z.+Zhang&title=PPAR%CE%B4+Attenuates+Hepatic+Steatosis+through+Autophagy-mediated+Fatty+Acid+Oxidation&doi=10.1038%2Fs41419-019-1458-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation</span></div><div class="casAuthors">Tong Lei; Wang Long; Yao Shuangshuang; Jin Lina; Yang Jian; Zhang Yifei; Ning Guang; Zhang Zhiguo</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peroxisome proliferator-activated receptor δ (PPARδ) belongs to the nuclear receptor family and is involved in metabolic diseases.  Although PPARδ is known to attenuate hepatic lipid deposition, its mechanism remains unclear.  Here, we show that PPARδ is a potent stimulator of hepatic autophagic flux.  The expression levels of PPARδ and autophagy-related proteins were decreased in liver tissues from obese and ageing mice.  Pharmacological and adenovirus-mediated increases in PPARδ expression and activity were achieved in obese transgenic db/db and high fat diet-fed mice.  Using genetic, pharmacological and metabolic approaches, we demonstrate that PPARδ reduces intrahepatic lipid content and stimulates β-oxidation in liver and hepatic cells by an autophagy-lysosomal pathway involving AMPK/mTOR signalling.  These results provide novel insight into the lipolytic actions of PPARδ through autophagy in the liver and highlight its potential beneficial effects in NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUkuP5l07_zWK_SFaaT9INfW6udTcc2eZydZ3145iEYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfosVyqtw%253D%253D&md5=e08fdeb582efbb2cc5aa12ffb87fe591</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fs41419-019-1458-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-019-1458-8%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DNing%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DPPAR%25CE%25B4%2520Attenuates%2520Hepatic%2520Steatosis%2520through%2520Autophagy-mediated%2520Fatty%2520Acid%2520Oxidation%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26spage%3D197%26doi%3D10.1038%2Fs41419-019-1458-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palkar, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isom, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdew, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Ligand Activation of Peroxisome Proliferator-activated Receptor β/δ (PPARβ/δ) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">418</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfn142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1093%2Ftoxsci%2Fkfn142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18622026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWitL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=418-428&author=W.+Shanauthor=P.+S.+Palkarauthor=I.+A.+Murrayauthor=E.+I.+McDevittauthor=M.+J.+Kennettauthor=B.+H.+Kangauthor=H.+C.+Isomauthor=G.+H.+Perdewauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Ligand+Activation+of+Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+%28PPAR%CE%B2%2F%CE%B4%29+Attenuates+Carbon+Tetrachloride+Hepatotoxicity+by+Downregulating+Proinflammatory+Gene+Expression&doi=10.1093%2Ftoxsci%2Fkfn142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Activation of Peroxisome Proliferator-Activated Receptor β/δ (PPARβ/δ) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression</span></div><div class="casAuthors">Shan, Weiwei; Palkar, Prajakta S.; Murray, Iain A.; McDevitt, Emily I.; Kennett, Mary J.; Kang, Boo Hyon; Isom, Harriet C.; Perdew, Gary H.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">418-428</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor (PPAR) β/δ-null mice exhibit exacerbated hepatotoxicity in response to administration of carbon tetrachloride (CCl4).  To det. whether ligand activation of the receptor protects against chem. toxicity in the liver, wild-type and PPARβ/δ-null mice were administered CCl4 with or without coadministration of the highly specific PPARβ/δ ligand GW0742.  Biomarkers of liver toxicity, including serum alanine aminotransferase (ALT) and hepatic tumor necrosis factor (TNF) α mRNA, were significantly higher in CCl4-treated PPARβ/δ-null mice compared to wild-type mice.  Hepatic expression of TNF-like weak inducer of apoptosis receptor (TWEAKr) and S100 calcium-binding protein A6 (S100A6/calcyclin), genes involved in nuclear factor kappa B signaling, was higher in the CCl4-treated PPARβ/δ-null mice compared to wild-type mice.  GW0742 treatment resulted in reduced serum ALT concn. and lower expression of CCl4-induced TNF-α, S100A6, monocyte chemoattractant protein-1 (MCP1), and TWEAKr in wild-type mice, and these effects were not obsd. in PPARβ/δ-null mice.  Expression of TNF-α was higher in PPARβ/δ-null primary hepatocytes in response to interleukin-1β treatment compared to wild-type hepatocytes, but GW0742 did not significantly modulate TNF-α expression in hepatocytes from either genotype.  While PPARβ/δ-null hepatic stellate exhibited higher rates of proliferation compared to wild-type cells, GW0742 did not affect α-smooth muscle actin expression in these cells.  Combined, these findings demonstrate that ligand activation of PPARβ/δ protects against chem. induced hepatotoxicity by downregulating expression of proinflammatory genes.  Hepatocytes and hepatic stellate cells do not appear to directly mediate the inhibitory effects of ligand activation of PPARβ/δ in liver, suggesting the involvement of paracrine and autocrine events mediated by hepatic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSsc_n7ADSVbVg90H21EOLACvtfcHk0lh3LGRqvrRpfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWitL7F&md5=5b470096f0fac1de1156d7c4bea6f552</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfn142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfn142%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DW.%26aulast%3DPalkar%26aufirst%3DP.%2BS.%26aulast%3DMurray%26aufirst%3DI.%2BA.%26aulast%3DMcDevitt%26aufirst%3DE.%2BI.%26aulast%3DKennett%26aufirst%3DM.%2BJ.%26aulast%3DKang%26aufirst%3DB.%2BH.%26aulast%3DIsom%26aufirst%3DH.%2BC.%26aulast%3DPerdew%26aufirst%3DG.%2BH.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DLigand%2520Activation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520%2528PPAR%25CE%25B2%252F%25CE%25B4%2529%2520Attenuates%2520Carbon%2520Tetrachloride%2520Hepatotoxicity%2520by%2520Downregulating%2520Proinflammatory%2520Gene%2520Expression%26jtitle%3DToxicol.%2520Sci.%26date%3D2008%26volume%3D105%26spage%3D418%26epage%3D428%26doi%3D10.1093%2Ftoxsci%2Fkfn142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor δ Activates Fatty Acid Oxidation in Cultured Neonatal and Adult Cardiomyocytes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2003.11.127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbrc.2003.11.127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=14684157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2004&pages=277-286&author=L.+Chengauthor=G.+Dingauthor=Q.+Qinauthor=Y.+Xiaoauthor=D.+Woodsauthor=Y.+E.+Chenauthor=Q.+Yang&title=Peroxisome+Proliferator-activated+Receptor+%CE%B4+Activates+Fatty+Acid+Oxidation+in+Cultured+Neonatal+and+Adult+Cardiomyocytes&doi=10.1016%2Fj.bbrc.2003.11.127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor δ activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes</span></div><div class="casAuthors">Cheng, Lihong; Ding, Guoliang; Qin, Qianhong; Xiao, Yan; Woods, David; Chen, Yuqing E.; Yang, Qinglin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-286</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARα, -γ and -δ) are nuclear receptors involved in transcriptional regulations of lipid metab.  The effect of PPARα in regulation of cardiac fatty acid oxidn. has been well characterized.  Whether PPARδ also independently regulates fatty acid oxidn. in the heart remains unclear.  In this study, we tested the hypothesis that PPARδ activates fatty acids oxidn. in cardiomyocytes through transcriptional activation that are independent of PPARα.  Our results first indicate that PPARδ abundantly expresses in nucleus of cardiomyocytes.  Palmitate oxidn. rates were significantly increased in both neonatal and adult cardiomyocytes after treatment of a PPARδ-selective ligand (GW0742).  Further increases of fatty acid oxidn. were evident when the treatment was applied to cardiomyocytes overexpressing a wild type PPARδ, but not a mutant PPARδ that lacks the intact carboxyl ligand-binding domain.  Furthermore, genes of fatty acid oxidn. enzymes were significantly upregulated in cultured rat neonatal cardiomyocytes when exposed to GW0742.  GW0742 can restore partly the expression of certain key genes of fatty acid oxidn. in mouse adult cardiomyocytes isolated from PPARα knockout mice.  Therefore, while active crosstalk between PPARδ and -α may exist, PPARδ regulates cardiac fatty acid oxidn. in the heart at least partly independent of PPARα.  We conclude that PPARδ may play a key role in cardiac energy balance and may serve as a "sensor" of fatty acid of other endogenous ligands in controlling fatty acids oxidn. levels in the hearts under normal and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolLqPIht_8XLVg90H21EOLACvtfcHk0liWQkqEkcaVgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWmt7k%253D&md5=a654fa5c5f43f8b44d4404d65f75a4ec</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2003.11.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2003.11.127%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DQ.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DWoods%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%2BE.%26aulast%3DYang%26aufirst%3DQ.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Activates%2520Fatty%2520Acid%2520Oxidation%2520in%2520Cultured%2520Neonatal%2520and%2520Adult%2520Cardiomyocytes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D313%26spage%3D277%26epage%3D286%26doi%3D10.1016%2Fj.bbrc.2003.11.127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, P.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.-T.</span></span> <span> </span><span class="NLM_article-title">Activation of Receptors δ (PPARδ) by Agonist (GW0742) may Enhance Lipid Metabolism in Heart Both In Vivo and In Vitro</span>. <i>Horm. Metab. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1055/s-0033-1348317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1055%2Fs-0033-1348317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23803968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyntrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=880-886&author=S.-C.+Kuoauthor=P.-M.+Kuauthor=L.-J.+Chenauthor=H.-S.+Niuauthor=J.-T.+Cheng&title=Activation+of+Receptors+%CE%B4+%28PPAR%CE%B4%29+by+Agonist+%28GW0742%29+may+Enhance+Lipid+Metabolism+in+Heart+Both+In+Vivo+and+In+Vitro&doi=10.1055%2Fs-0033-1348317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of receptors δ (PPARδ) by agonist (GW0742) may enhance lipid metabolism in heart both in vivo and in vitro</span></div><div class="casAuthors">Kuo, S.-C.; Ku, P.-M.; Chen, L.-J.; Niu, H.-S.; Cheng, J.-T.</div><div class="citationInfo"><span class="NLM_cas:title">Hormone and Metabolic Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">880-886</span>CODEN:
                <span class="NLM_cas:coden">HMMRA2</span>;
        ISSN:<span class="NLM_cas:issn">0018-5043</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">It has been documented that cardiac agents may regulate the lipid metab. through increased expression of PPARδ in cardiac cells.  However, the effect on lipid metab. by direct activation of PPARδ is still unknown.  The present study applied specific PPARδ agonist (GW0742) to investigate this point in the heart of Wistar rats and in the primary cultured cardiomyocytes from neonatal rat.  Expressions of PPARδ in the heart and cardiomyocytes after treatment with GW0742 were detected using Western blots.  The fatty acid (FA) oxidn. and the citric acid (TCA) cycle related genes in cardiomyocytes were also examd.  In addn., PPARδ antagonist (GSK0660) and siRNA-PPARδ were employed to characterize the potential mechanisms.  After a 7-day treatment with GW0742, expressions of PPARδ in the heart were markedly increased.  Increased expressions of FA oxidn. and TCA cycle related genes were also obsd. both in vivo and in vitro.  This action of GW0742 was blocked by GSK0660 or by siRNA-PPARδ.  The obtained results show that activation of PPARδ by GW0742 is responsible for the increase of FA oxidn. and TCA cycle related genes in hearts.  Role of PPARδ in the regulation of lipid metab. in heart is then established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo78rhETtfevLVg90H21EOLACvtfcHk0liWQkqEkcaVgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyntrfN&md5=42084a48f690c7b96f50143eceb3f71f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1055%2Fs-0033-1348317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0033-1348317%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DS.-C.%26aulast%3DKu%26aufirst%3DP.-M.%26aulast%3DChen%26aufirst%3DL.-J.%26aulast%3DNiu%26aufirst%3DH.-S.%26aulast%3DCheng%26aufirst%3DJ.-T.%26atitle%3DActivation%2520of%2520Receptors%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%2520by%2520Agonist%2520%2528GW0742%2529%2520may%2520Enhance%2520Lipid%2520Metabolism%2520in%2520Heart%2520Both%2520In%2520Vivo%2520and%2520In%2520Vitro%26jtitle%3DHorm.%2520Metab.%2520Res.%26date%3D2013%26volume%3D45%26spage%3D880%26epage%3D886%26doi%3D10.1055%2Fs-0033-1348317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Q.</span></span> <span> </span><span class="NLM_article-title">PPARδ, a Potential Therapeutic Target for Heart Disease</span>. <i>Nucl. Receptor Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">101375</span>, <span class="refDoi"> DOI: 10.32527/2018/101375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.32527%2F2018%2F101375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31032335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWnurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=101375&author=Q.+Yangauthor=Q.+Long&title=PPAR%CE%B4%2C+a+Potential+Therapeutic+Target+for+Heart+Disease&doi=10.32527%2F2018%2F101375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ, a potential therapeutic target for heart disease</span></div><div class="casAuthors">Yang, Qinglin; Long, Qinqiang</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Receptor Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101375</span>CODEN:
                <span class="NLM_cas:coden">NRRUAZ</span>;
        ISSN:<span class="NLM_cas:issn">2314-5714</span>.
    
            (<span class="NLM_cas:orgname">AgiAl Publishing House</span>)
        </div><div class="casAbstract">The nuclear receptor peroxisome proliferator-activated receptor δ (PPARδ) can transcriptionally regulate target genes.  PPARδ exerts essential regulatory functions in the heart, which requires const. energy supply.  PPARδ plays a key role in energy metab., controlling not only fatty acid (FA) and glucose oxidn., but also redox homeostasis, mitochondrial biogenesis, inflammation, and cardiomyocyte proliferation.  PPARδ signaling is impaired in the heart under various pathol. conditions, such as pathol. cardiac hypertrophy, myocardial ischemia/reperfusion, doxorubicin cardiotoxicity and diabetic cardiomyopathy.  PPARδ deficiency in the heart leads to cardiac dysfunction, myocardial lipid accumulation, cardiac hypertrophy/remodeling and heart failure.  This article provides an up-today overview of this research area and discusses the role of PPARδ in the heart in light of the complex mechanisms of its transcriptional regulation and its potential as a translatable therapeutic target for the treatment of cardiac disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBl96r48mG7bVg90H21EOLACvtfcHk0ljdvA5Bh1ZN8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWnurfI&md5=ceba6651087fc282dfccf294aff580d1</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.32527%2F2018%2F101375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.32527%252F2018%252F101375%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLong%26aufirst%3DQ.%26atitle%3DPPAR%25CE%25B4%252C%2520a%2520Potential%2520Therapeutic%2520Target%2520for%2520Heart%2520Disease%26jtitle%3DNucl.%2520Receptor%2520Res.%26date%3D2018%26volume%3D5%26spage%3D101375%26doi%3D10.32527%2F2018%2F101375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasmin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flühmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desvergne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span> <span> </span><span class="NLM_article-title">Critical Roles of PPARβ/δ in Keratinocyte Response to Inflammation</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3263</span>– <span class="NLM_lpage">3277</span>, <span class="refDoi"> DOI: 10.1101/gad.207501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1101%2Fgad.207501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11751632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFyktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=3263-3277&author=N.+S.+Tanauthor=L.+Michalikauthor=N.+Noyauthor=R.+Yasminauthor=C.+Pacotauthor=M.+Heimauthor=B.+Fl%C3%BChmannauthor=B.+Desvergneauthor=W.+Wahli&title=Critical+Roles+of+PPAR%CE%B2%2F%CE%B4+in+Keratinocyte+Response+to+Inflammation&doi=10.1101%2Fgad.207501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Critical roles of PPARβ/δ in keratinocyte response to inflammation</span></div><div class="casAuthors">Tan, Nguan Soon; Michalik, Liliane; Noy, Noa; Yasmin, Rubina; Pacot, Corinne; Heim, Manuel; Fluhmann, Beat; Desvergne, Beatrice; Wahli, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3263-3277</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The immediate response to skin injury is the release of inflammatory signals.  It is shown here, by use of cultures of primary keratinocytes from wild-type and PPARβ/δ-/- mice, that such signals including TNF-α and IFN-γ, induce keratinocyte differentiation.  This cytokine-dependent cell differentiation pathway requires up-regulation of the PPARβ/δ gene via the stress-assocd. kinase cascade, which targets an AP-1 site in the PPARβ/δ promoter.  In addn., the pro-inflammatory cytokines also initiate the prodn. of endogenous PPARβ/δ ligands, which are essential for PPARβ/δ activation and action.  Activated PPARβ/δ regulates the expression of genes assocd. with apoptosis resulting in an increased resistance of cultured keratinocytes to cell death.  This effect is also obsd. in vivo during wound healing after an injury, as shown in dorsal skin of PPARβ/δ+/+ and PPARβ/δ+/- mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwvmyqE9fSCrVg90H21EOLACvtfcHk0ljdvA5Bh1ZN8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFyktQ%253D%253D&md5=170d3f3709789dd974f730ac41ec6316</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1101%2Fgad.207501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.207501%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DN.%2BS.%26aulast%3DMichalik%26aufirst%3DL.%26aulast%3DNoy%26aufirst%3DN.%26aulast%3DYasmin%26aufirst%3DR.%26aulast%3DPacot%26aufirst%3DC.%26aulast%3DHeim%26aufirst%3DM.%26aulast%3DFl%25C3%25BChmann%26aufirst%3DB.%26aulast%3DDesvergne%26aufirst%3DB.%26aulast%3DWahli%26aufirst%3DW.%26atitle%3DCritical%2520Roles%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520in%2520Keratinocyte%2520Response%2520to%2520Inflammation%26jtitle%3DGenes%2520Dev.%26date%3D2001%26volume%3D15%26spage%3D3263%26epage%3D3277%26doi%3D10.1101%2Fgad.207501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Guardia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomer, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coll, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Calvo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Kochairi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ Activation Blocks Lipid-induced Inflammatory Pathways in Mouse Heart and Human Cardiac Cells.</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1811</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2010.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbalip.2010.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1811&publication_year=2011&pages=59-67&author=D.+%C3%81lvarez-Guardiaauthor=X.+Palomerauthor=T.+Collauthor=L.+Serranoauthor=R.+Rodr%C3%ADguez-Calvoauthor=M.+M.+Davidsonauthor=M.+Merlosauthor=I.+El+Kochairiauthor=L.+Michalikauthor=W.+Wahliauthor=M.+V%C3%A1zquez-Carrera&title=PPAR%CE%B2%2F%CE%B4+Activation+Blocks+Lipid-induced+Inflammatory+Pathways+in+Mouse+Heart+and+Human+Cardiac+Cells.&doi=10.1016%2Fj.bbalip.2010.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells</span></div><div class="casAuthors">Alvarez-Guardia, David; Palomer, Xavier; Coll, Teresa; Serrano, Lucia; Rodriguez-Calvo, Ricardo; Davidson, Mercy M.; Merlos, Manuel; El Kochairi, Ilhem; Michalik, Liliane; Wahli, Walter; Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1811</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">59-67</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Owing to its high fat content, the classical Western diet has a range of adverse effects on the heart, including enhanced inflammation, hypertrophy, and contractile dysfunction.  Proinflammatory factors secreted by cardiac cells, which are under the transcriptional control of nuclear factor-κB (NF-κB), may contribute to heart failure and dilated cardiomyopathy.  The underlying mechanisms are complex, since they are linked to systemic metabolic abnormalities and changes in cardiomyocyte phenotype.  Peroxisome proliferator-activated receptors (PPARs) are transcription factors that regulate metab. and are capable of limiting myocardial inflammation and hypertrophy via inhibition of NF-κB.  Since PPARβ/δ is the most prevalent PPAR isoform in the heart, we analyzed the effects of the PPARβ/δ agonist GW501516 on inflammatory parameters.  A high-fat diet induced the expression of tumor necrosis factor-α, monocyte chemoattractant protein-1, and interleukin-6, and enhanced the activity of NF-κB in the heart of mice.  GW501516 abrogated this enhanced proinflammatory profile.  Similar results were obtained when human cardiac AC16 cells exposed to palmitate were coincubated with GW501516.  PPARβ/δ activation by GW501516 enhanced the phys. interaction between PPARβ/δ and p65, which suggests that this mechanism may also interfere NF-κB transactivation capacity in the heart.  GW501516-induced PPARβ/δ activation can attenuate the inflammatory response induced in human cardiac AC16 cells exposed to the satd. fatty acid palmitate and in mice fed a high-fat diet.  This is relevant, esp. taking into account that PPARβ/δ has been postulated as a potential target in the treatment of obesity and the insulin resistance state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvPNNTs5H-BLVg90H21EOLACvtfcHk0lgAe6bp5r837w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFOrsw%253D%253D&md5=c40d86185ae9b00c316fde65ad53fd14</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2010.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2010.11.002%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2581lvarez-Guardia%26aufirst%3DD.%26aulast%3DPalomer%26aufirst%3DX.%26aulast%3DColl%26aufirst%3DT.%26aulast%3DSerrano%26aufirst%3DL.%26aulast%3DRodr%25C3%25ADguez-Calvo%26aufirst%3DR.%26aulast%3DDavidson%26aufirst%3DM.%2BM.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DEl%2BKochairi%26aufirst%3DI.%26aulast%3DMichalik%26aufirst%3DL.%26aulast%3DWahli%26aufirst%3DW.%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520Activation%2520Blocks%2520Lipid-induced%2520Inflammatory%2520Pathways%2520in%2520Mouse%2520Heart%2520and%2520Human%2520Cardiac%2520Cells.%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2011%26volume%3D1811%26spage%3D59%26epage%3D67%26doi%3D10.1016%2Fj.bbalip.2010.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chawla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbiztondo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boisvert, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1126/science.1087344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1126%2Fscience.1087344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=12970571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotV2itrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=453-457&author=C.-H.+Leeauthor=A.+Chawlaauthor=N.+Urbiztondoauthor=D.+Liaoauthor=W.+A.+Boisvertauthor=R.+M.+Evans&title=Transcriptional+Repression+of+Atherogenic+Inflammation%3A+Modulation+by+PPAR%CE%B4&doi=10.1126%2Fscience.1087344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ</span></div><div class="casAuthors">Lee, Chih-Hao; Chawla, Ajay; Urbiztondo, Ned; Liao, Debbie; Boisvert, William A.; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5644</span>),
    <span class="NLM_cas:pages">453-457</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The formation of an atherosclerotic lesion is mediated by lipid-laden macrophages (foam cells), which also establish chronic inflammation assocd. with lesion progression.  The peroxisome proliferator-activated receptor (PPAR) γ promotes lipid uptake and efflux in these atherogenic cells.  In contrast, we found that the closely related receptor PPARδ controls the inflammatory status of the macrophage.  Deletion of PPARδ from foam cells increased the availability of inflammatory suppressors, which in turn reduced atherosclerotic lesion area by more than 50%.  We propose an unconventional ligand-dependent transcriptional pathway in which PPARδ controls an inflammatory switch through its assocn. and disassocn. with transcriptional repressors.  PPARδ and its ligands may thus serve as therapeutic targets to attenuate inflammation and slow the progression of atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTSMnhYMagXbVg90H21EOLACvtfcHk0lgAe6bp5r837w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotV2itrw%253D&md5=077a91664a849c9a5d0b8494c703e29f</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1126%2Fscience.1087344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1087344%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.-H.%26aulast%3DChawla%26aufirst%3DA.%26aulast%3DUrbiztondo%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DBoisvert%26aufirst%3DW.%2BA.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DTranscriptional%2520Repression%2520of%2520Atherogenic%2520Inflammation%253A%2520Modulation%2520by%2520PPAR%25CE%25B4%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D453%26epage%3D457%26doi%3D10.1126%2Fscience.1087344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.-G.</span></span> <span> </span><span class="NLM_article-title">Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro</span>. <i>Chin. Med. Sci. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.1016/S1001-9294(16)30008-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS1001-9294%2816%2930008-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=26960306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC28jovFentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=245-251&author=L.+Shengauthor=X.+Yangauthor=P.+Yeauthor=Y.-X.+Liuauthor=C.-G.+Han&title=Effect+of+Atorvastatin+on+Expression+of+Peroxisome+Proliferator-activated+Receptor+beta%2Fdelta+in+Angiotensin+II-induced+Hypertrophic+Myocardial+Cells+In+Vitro&doi=10.1016%2FS1001-9294%2816%2930008-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro</span></div><div class="casAuthors">Sheng Li; Yang Xu; Ye Ping; Liu Yong-xue; Han Chun-guang</div><div class="citationInfo"><span class="NLM_cas:title">Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">245-51</span>
        ISSN:<span class="NLM_cas:issn">1001-9294</span>.
    </div><div class="casAbstract">OBJECTIVE:  To explore the effect of atorvastatin on cardiac hypertrophy and to determine the potential mechanism involved.  METHODS:  An in vitro cardiomyocyte hypertrophy from neonatal rats was induced with angiotensin II (Ang II) stimulation.  Before Ang II stimulation, the cultured rat cardiac myocytes were pretreated with atorvastatin at different concentrations (0.1, 1, and 10 μmol/L).  The following parameters were evaluated: the myocyte surface area, 3H-leucine incorporation into myocytes, mRNA expressions of atrial natriuretic peptide, brain natriuretic peptide, matrix metalloproteinase 9, matrix metalloproteinase 2, and interleukin-1β, mRNA and protein expressions of the δ/β peroxisome proliferator-activated receptor (PPAR) subtypes.  RESULTS:  It was shown that atorvastatin could ameliorate Ang II-induced neonatal cardiomyocyte hypertrophy in the area of cardiomyocytes, 3H-leucine incorporation, and the expression of atrial natriuretic peptide and brain natriuretic peptide markedly.  Meanwhile, atorvastatin also inhibited the augmented mRNA level of several cytokines in hypertrophic myocytes.  Furthermore, the down-regulated expression of PPAR- δ/β at both the mRNA and protein levels in hypertrophic myocytes could be significantly reversed by atorvastatin treatment.  CONCLUSIONS:  Atorvastatin could improve Ang II-induced cardiac hypertrophy and inhibit the expression of cytokines.  Such effect might be partly achieved through activation of the PPAR-δ/β pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTObfLOOe7bTKcY7HFp97qMfW6udTcc2eYJHHYKjstCs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jovFentw%253D%253D&md5=43b17ecd8c64a843b274e8d2609bd7a8</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS1001-9294%2816%2930008-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1001-9294%252816%252930008-6%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.-X.%26aulast%3DHan%26aufirst%3DC.-G.%26atitle%3DEffect%2520of%2520Atorvastatin%2520on%2520Expression%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520beta%252Fdelta%2520in%2520Angiotensin%2520II-induced%2520Hypertrophic%2520Myocardial%2520Cells%2520In%2520Vitro%26jtitle%3DChin.%2520Med.%2520Sci.%2520J.%26date%3D2015%26volume%3D30%26spage%3D245%26epage%3D251%26doi%3D10.1016%2FS1001-9294%2816%2930008-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Baicalin Attenuates Cardiac Dysfunction and Myocardial Remodeling in a Chronic Pressure-overload Mice Model</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1159/000459708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1159%2F000459708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=28214892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2017&pages=849-864&author=Y.+Zhangauthor=P.+Liaoauthor=M.+Zhuauthor=W.+Liauthor=D.+Huauthor=S.+Guanauthor=L.+Chen&title=Baicalin+Attenuates+Cardiac+Dysfunction+and+Myocardial+Remodeling+in+a+Chronic+Pressure-overload+Mice+Model&doi=10.1159%2F000459708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Baicalin Attenuates Cardiac Dysfunction and Myocardial Remodeling in a Chronic Pressure-Overload Mice Model</span></div><div class="casAuthors">Zhang, Yanqing; Liao, Pingping; Zhu, Meng-en; Li, Wei; Hu, Dan; Guan, Siming; Chen, Long</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">849-864</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Baicalin has been shown to be effective for various animal models of cardiovascular diseases, such as pulmonary hypertension, atherosclerosis and myocardial ischemic injury.  However, whether baicalin plays a role in cardiac hypertrophy remains unknown.  Here we investigated the protective effects of baicalin on cardiac hypertrophy induced by pressure overload and explored the potential mechanisms involved.  Methods: C57BL/6J-mice were treated with baicalin or vehicle following transverse aortic constriction or Sham surgery for up to 8 wk, and at different time points, cardiac function and heart size measurement and histol. and biochem. examn. were performed.  Results: Mice under pressure overload exhibited cardiac dysfunction, high mortality, myocardial hypertrophy, increased apoptosis and fibrosis markers, and suppressed cardiac expression of PPARα and PPARβ/δ.  However, oral administration of baicalin improved cardiac dysfunction, decreased mortality, and attenuated histol. and biochem. changes described above.  These protective effects of baicalin were assocd. with reduced heart and cardiomyocyte size, lower fetal genes expression, attenuated cardiac fibrosis, lower expression of profibrotic markers, and decreased apoptosis signals in heart tissue.  Moreover, we found that baicalin induced PPARα and PPARβ/δ expression in vivo and in vitro.  Subsequent expts. demonstrated that long-term baicalin treatment presented no obvious cardiac lipotoxicity.  Conclusions: The present results demonstrated that baicalin attenuates pressure overload induced cardiac dysfunction and ventricular remodeling, which would be due to suppressed cardiac hypertrophy, fibrosis, apoptosis and metabolic abnormality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCobAC6Z8Fq7Vg90H21EOLACvtfcHk0ljlgQZOLH27CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFejtbs%253D&md5=906414a936fc8fec3a7c238278dc9098</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1159%2F000459708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000459708%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DBaicalin%2520Attenuates%2520Cardiac%2520Dysfunction%2520and%2520Myocardial%2520Remodeling%2520in%2520a%2520Chronic%2520Pressure-overload%2520Mice%2520Model%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2017%26volume%3D41%26spage%3D849%26epage%3D864%26doi%3D10.1159%2F000459708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brako, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span> <span> </span><span class="NLM_article-title">Cardiomyocyte-restricted Peroxisome Proliferator-activated Receptor-δ Deletion Perturbs Myocardial Fatty Acid Oxidation and Leads to Cardiomyopathy</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1245</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1038/nm1116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fnm1116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15475963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVOgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1245-1250&author=L.+Chengauthor=G.+Dingauthor=Q.+Qinauthor=Y.+Huangauthor=W.+Lewisauthor=N.+Heauthor=R.+M.+Evansauthor=M.+D.+Schneiderauthor=F.+A.+Brakoauthor=Y.+Xiaoauthor=Y.+E.+Chenauthor=Q.+Yang&title=Cardiomyocyte-restricted+Peroxisome+Proliferator-activated+Receptor-%CE%B4+Deletion+Perturbs+Myocardial+Fatty+Acid+Oxidation+and+Leads+to+Cardiomyopathy&doi=10.1038%2Fnm1116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy</span></div><div class="casAuthors">Cheng, Lihong; Ding, Guoliang; Qin, Qianhong; Huang, Yao; Lewis, William; He, Nu; Evans, Ronald M.; Schneider, Michael D.; Brako, Florence A.; Xiao, Yan; Chen, Yuqing E.; Yang, Qinglin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1245-1250</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fatty acid oxidn. (FAO) is a primary energy source for meeting the heart's energy requirements.  Peroxisome proliferator-activated receptor-δ (PPAR-δ) may have important roles in FAO.  But it remains unclear whether PPAR-δ is required for maintaining basal myocardial FAO.  The authors show that cre-loxP-mediated cardiomyocyte-restricted deletion of PPAR-δ in mice downregulates constitutive expression of key FAO genes and decreases basal myocardial FAO.  These mice have cardiac dysfunction, progressive myocardial lipid accumulation, cardiac hypertrophy and congestive heart failure with reduced survival.  Thus, chronic myocardial PPAR-δ deficiency leads to lipotoxic cardiomyopathy.  Together, the authors' data show that PPAR-δ is a crucial determinant of constitutive myocardial FAO and is necessary to maintain energy balance and normal cardiac function.  The authors suggest that PPAR-δ is a potential therapeutic target in treating lipotoxic cardiomyopathy and other heart diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBGArHkUrGjbVg90H21EOLACvtfcHk0ljlgQZOLH27CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVOgsbo%253D&md5=cb2044c7e9e0fa655769efdec9b0ecea</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnm1116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1116%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLewis%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DN.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DSchneider%26aufirst%3DM.%2BD.%26aulast%3DBrako%26aufirst%3DF.%2BA.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%2BE.%26aulast%3DYang%26aufirst%3DQ.%26atitle%3DCardiomyocyte-restricted%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B4%2520Deletion%2520Perturbs%2520Myocardial%2520Fatty%2520Acid%2520Oxidation%2520and%2520Leads%2520to%2520Cardiomyopathy%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D1245%26epage%3D1250%26doi%3D10.1038%2Fnm1116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbiah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhelyabovska, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor {delta} is an Essential Transcriptional Regulator for Mitochondrial Protection and Biogenesis in Adult Heart</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">911</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.109.206185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1161%2FCIRCRESAHA.109.206185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=20075336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1aku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2010&pages=911-919&author=P.+Wangauthor=J.+Liuauthor=Y.+Liauthor=S.+Wuauthor=J.+Luoauthor=H.+Yangauthor=R.+Subbiahauthor=J.+Chathamauthor=O.+Zhelyabovskaauthor=Q.+Yang&title=Peroxisome+Proliferator-activated+Receptor+%7Bdelta%7D+is+an+Essential+Transcriptional+Regulator+for+Mitochondrial+Protection+and+Biogenesis+in+Adult+Heart&doi=10.1161%2FCIRCRESAHA.109.206185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome Proliferator-Activated Receptor δ Is an Essential Transcriptional Regulator for Mitochondrial Protection and Biogenesis in Adult Heart</span></div><div class="casAuthors">Wang, Peiyong; Liu, Jian; Li, Yuquan; Wu, Sijie; Luo, Jinwen; Yang, Huan; Subbiah, Ramasamy; Chatham, John; Zhelyabovska, Olga; Yang, Qinglin</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">911-919</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Rationale: Peroxisome proliferator-activated receptors (PPARs) (α, γ, and δ/β) are nuclear hormone receptors and ligand-activated transcription factors that serve as key determinants of myocardial fatty acid metab.  Long-term cardiomyocyte-restricted PPARδ deficiency in mice leads to depressed myocardial fatty acid oxidn., bioenergetics, and premature death with lipotoxic cardiomyopathy.  Objective: To explore the essential role of PPARδ in the adult heart.  Methods and results: We investigated the consequences of inducible short-term PPARδ knockout in the adult mouse heart.  In addn. to a substantial transcriptional down regulation of lipid metabolic proteins, short-term PPARδ knockout in the adult mouse heart attenuated cardiac expression of both Cu/Zn superoxide dismutase and manganese superoxide dismutase, leading to increased oxidative damage to the heart.  Moreover, expression of key mitochondrial biogenesis determinants such as PPARγ coactivator-1 were substantially decreased in the short-term PPARδ deficient heart, concomitant with a decreased mitochondrial DNA copy no.  Rates of palmitate and glucose oxidn. were markedly depressed in cardiomyocytes of PPARδ knockout hearts.  Consequently, PPARδ deficiency in the adult heart led to depressed cardiac performance and cardiac hypertrophy.  Conclusions: PPARδ is an essential regulator of cardiac mitochondrial protection and biogenesis and PPARδ activation can be a potential therapeutic target for cardiac disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoddF_qmSjVKLVg90H21EOLACvtfcHk0lgrRZnOE9wx4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1aku7Y%253D&md5=b0df60643f159d8a20c421d5c0f2e621</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.109.206185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.109.206185%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSubbiah%26aufirst%3DR.%26aulast%3DChatham%26aufirst%3DJ.%26aulast%3DZhelyabovska%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DQ.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%257Bdelta%257D%2520is%2520an%2520Essential%2520Transcriptional%2520Regulator%2520for%2520Mitochondrial%2520Protection%2520and%2520Biogenesis%2520in%2520Adult%2520Heart%26jtitle%3DCirc.%2520Res.%26date%3D2010%26volume%3D106%26spage%3D911%26epage%3D919%26doi%3D10.1161%2FCIRCRESAHA.109.206185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castiglia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantozzi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">Activation of Peroxisome Proliferator-activated Receptor-β/δ Attenuates Myocardial Ischemia/Reperfusion Injury in the Rat</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1097/SHK.0b013e3181cd86d6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1097%2FSHK.0b013e3181cd86d6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19997057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFequrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=117-124&author=A.+Kapoorauthor=M.+Collinoauthor=S.+Castigliaauthor=R.+Fantozziauthor=C.+Thiemermann&title=Activation+of+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+Attenuates+Myocardial+Ischemia%2FReperfusion+Injury+in+the+Rat&doi=10.1097%2FSHK.0b013e3181cd86d6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of peroxisome proliferator-activated receptor-β/δ attenuates myocardial ischemia/reperfusion injury in the rat</span></div><div class="casAuthors">Kapoor, Amar; Collino, Massimo; Castiglia, Sara; Fantozzi, Roberto; Thiemermann, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Shock</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">SAGUAI</span>;
        ISSN:<span class="NLM_cas:issn">1073-2322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) is a transcription factor that belongs to the PPAR nuclear hormone receptor family.  There is little information about the effects of the immediate administration of specific ligands of PPAR-β/δ (e.g., GW0742) in animal models of myocardial I/R injury.  Using a rat model of regional myocardial I/R in vivo, we have investigated the effects of immediate administration of GW0742 on myocardial infarct size.  Male Wistar rats were subjected to 25 min of regional ischemia followed by 2 h of reperfusion and treated with GW0742 (3, 30, or 300μg/kg i.v. given at 30 min before ischemia and again at the start of reperfusion).  Higher doses (30 or 300 μg/kg i.v.) of GW0742 caused a redn. in infarct size, whereas the lowest dose used was not effective.  The degree of cardioprotection was similar when GW0742 (30 μg/kg i.v.) was given on reperfusion alone.  The redn. in infarct size afforded by GW0742 was not reduced by the competitive irreversible PPAR-α antagonist GW6471 (1 mg/kg i.v., 15 min before ischemia).  GW0742 (30 μg/kg i.v.) reduced the I/R-induced (a) decrease in the phosphorylation of Akt and glycogen synthase kinase-3β, (b) nuclear translocation of the p65 subunit of nuclear factor-κB (activation of nuclear factor-κB), and (c) increase in the expression of iNOS and cyclooxygenase-2.  Thus, immediate administration of the PPAR-β/δ ligand GW0742 during reperfusion reduces myocardial infarct size in the rat by a mechanism that may involve inhibition of the activity of glycogen synthase kinase-3β secondary to activation of the Akt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6KP7DaNi-bVg90H21EOLACvtfcHk0lgrRZnOE9wx4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFequrY%253D&md5=01198136691767c42bbd926127c345b9</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1097%2FSHK.0b013e3181cd86d6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FSHK.0b013e3181cd86d6%26sid%3Dliteratum%253Aachs%26aulast%3DKapoor%26aufirst%3DA.%26aulast%3DCollino%26aufirst%3DM.%26aulast%3DCastiglia%26aufirst%3DS.%26aulast%3DFantozzi%26aufirst%3DR.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DActivation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520Attenuates%2520Myocardial%2520Ischemia%252FReperfusion%2520Injury%2520in%2520the%2520Rat%26jtitle%3DShock%26date%3D2010%26volume%3D34%26spage%3D117%26epage%3D124%26doi%3D10.1097%2FSHK.0b013e3181cd86d6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magadum, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevarao, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickramasinghe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renikunta, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, F. B.</span></span> <span> </span><span class="NLM_article-title">Live Cell Screening Platform Identifies PPARδ as a Regulator of Cardiomyocyte Proliferation and Cardiac Repair</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1002</span>– <span class="NLM_lpage">1019</span>, <span class="refDoi"> DOI: 10.1038/cr.2017.84</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fcr.2017.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=28621328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCiu77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1002-1019&author=A.+Magadumauthor=Y.+Dingauthor=L.+Heauthor=T.+Kimauthor=M.+D.+Vasudevaraoauthor=Q.+Longauthor=K.+Yangauthor=N.+Wickramasingheauthor=H.+V.+Renikuntaauthor=N.+Duboisauthor=G.+Weidingerauthor=Q.+Yangauthor=F.+B.+Engel&title=Live+Cell+Screening+Platform+Identifies+PPAR%CE%B4+as+a+Regulator+of+Cardiomyocyte+Proliferation+and+Cardiac+Repair&doi=10.1038%2Fcr.2017.84"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repair</span></div><div class="casAuthors">Magadum, Ajit; Ding, Yishu; He, Lan; Kim, Teayoun; Vasudevarao, Mohankrishna Dalvoy; Long, Qinqiang; Yang, Kevin; Wickramasinghe, Nadeera; Renikunta, Harsha V.; Dubois, Nicole; Weidinger, Gilbert; Yang, Qinglin; Engel, Felix B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1002-1019</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Zebrafish can efficiently regenerate their heart through cardiomyocyte proliferation.  In contrast, mammalian cardiomyocytes stop proliferating shortly after birth, limiting the regenerative capacity of the postnatal mammalian heart.  Therefore, if the endogenous potential of postnatal cardiomyocyte proliferation could be enhanced, it could offer a promising future therapy for heart failure patients.  Here, we set out to systematically identify small mols. triggering postnatal cardiomyocyte proliferation.  By screening chem. compd. libraries utilizing a Fucci-based system for assessing cell cycle stages, we identified carbacyclin as an inducer of postnatal cardiomyocyte proliferation.  In vitro, carbacyclin induced proliferation of neonatal and adult mononuclear rat cardiomyocytes via a peroxisome proliferator-activated receptor δ (PPARδ)/PDK1/p308Akt/GSK3β/β-catenin pathway.  Inhibition of PPARδ reduced cardiomyocyte proliferation during zebrafish heart regeneration.  Notably, inducible cardiomyocyte-specific overexpression of constitutively active PPARδ as well as treatment with PPARδ agonist after myocardial infarction in mice induced cell cycle progression in cardiomyocytes, reduced scarring, and improved cardiac function.  Collectively, we established a cardiomyocyte proliferation screening system and present a new drugable target with promise for the treatment of cardiac pathologies caused by cardiomyocyte loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWtdu-HNEs4LVg90H21EOLACvtfcHk0lgzPSWCdgzU_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCiu77M&md5=bd076d337a4d32fc280af2da3ff8edca</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fcr.2017.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2017.84%26sid%3Dliteratum%253Aachs%26aulast%3DMagadum%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DVasudevarao%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DWickramasinghe%26aufirst%3DN.%26aulast%3DRenikunta%26aufirst%3DH.%2BV.%26aulast%3DDubois%26aufirst%3DN.%26aulast%3DWeidinger%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DEngel%26aufirst%3DF.%2BB.%26atitle%3DLive%2520Cell%2520Screening%2520Platform%2520Identifies%2520PPAR%25CE%25B4%2520as%2520a%2520Regulator%2520of%2520Cardiomyocyte%2520Proliferation%2520and%2520Cardiac%2520Repair%26jtitle%3DCell%2520Res.%26date%3D2017%26volume%3D27%26spage%3D1002%26epage%3D1019%26doi%3D10.1038%2Fcr.2017.84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kojonazarov, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luitel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sydykov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahal, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul-Clark, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonvini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schermuly, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. A.</span></span> <span> </span><span class="NLM_article-title">The Peroxisome Proliferator-activated Receptor β/δ Agonist GW0742 has Direct Protective Effects on Right Heart Hypertrophy</span>. <i>Pulm. Circ.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1086/674755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1086%2F674755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25006409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC2cbgslyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=926-935&author=B.+Kojonazarovauthor=H.+Luitelauthor=A.+Sydykovauthor=B.+K.+Dahalauthor=M.+J.+Paul-Clarkauthor=S.+Bonviniauthor=A.+Reedauthor=R.+T.+Schermulyauthor=J.+A.+Mitchell&title=The+Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+Agonist+GW0742+has+Direct+Protective+Effects+on+Right+Heart+Hypertrophy&doi=10.1086%2F674755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">The peroxisome proliferator-activated receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophy</span></div><div class="casAuthors">Kojonazarov Baktybek; Luitel Himal; Sydykov Akylbek; Dahal Bhola K; Schermuly Ralph T; Paul-Clark Mark J; Bonvini Sara; Reed Anna; Mitchell Jane A</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary circulation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">926-35</span>
        ISSN:<span class="NLM_cas:issn">2045-8932</span>.
    </div><div class="casAbstract">Pulmonary hypertension is a debilitating disease with no cure.  We have previously shown that peroxisome proliferator-activated receptor (PPAR) β/δ agonists protect the right heart in hypoxia-driven pulmonary hypertension without affecting vascular remodeling.  PPARβ/δ is an important receptor in lipid metabolism, athletic performance, and the sensing of prostacyclin.  Treatment of right heart hypertrophy and failure in pulmonary hypertension is an emerging target for future therapy.  Here we have investigated the potential of GW0742, a PPARβ agonist, to act directly on the right heart in vivo and what transcriptomic signatures are associated with its actions.  Right heart hypertrophy and failure was induced in mice using a pulmonary artery banding (PAB) model.  GW0742 was administered throughout the study.  Cardiovascular parameters were measured using echocardiography and pressure monitoring.  Fibrosis and cellular changes were measured using immunohistochemistry.  Transcriptomics were measured using the Illumina MouseRef-8v3 BeadChip array and analyzed using GeneSpring GX (ver. 11.0).  PAB resulted in right heart hypertrophy and failure and in increased fibrosis.  GW0742 reduced or prevented the effects of PAB on all parameters measured.  GW0742 altered a number of genes in the transcriptome, with Angptl4 emerging as the top gene altered (increased) in animals with PAB.  In conclusion, the PPARβ/δ agonist GW0742 has direct protective effects on the right heart in vivo.  These observations identify PPARβ/δ as a viable therapeutic target to treat pulmonary hypertension that may complement current and future vasodilator drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkT4oI_ibeCYNpW7w2tapOfW6udTcc2eZ4pl20rvWdyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbgslyjug%253D%253D&md5=f0a36ffc57cc4a73c99f95704489d49d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1086%2F674755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F674755%26sid%3Dliteratum%253Aachs%26aulast%3DKojonazarov%26aufirst%3DB.%26aulast%3DLuitel%26aufirst%3DH.%26aulast%3DSydykov%26aufirst%3DA.%26aulast%3DDahal%26aufirst%3DB.%2BK.%26aulast%3DPaul-Clark%26aufirst%3DM.%2BJ.%26aulast%3DBonvini%26aufirst%3DS.%26aulast%3DReed%26aufirst%3DA.%26aulast%3DSchermuly%26aufirst%3DR.%2BT.%26aulast%3DMitchell%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520Agonist%2520GW0742%2520has%2520Direct%2520Protective%2520Effects%2520on%2520Right%2520Heart%2520Hypertrophy%26jtitle%3DPulm.%2520Circ.%26date%3D2013%26volume%3D3%26spage%3D926%26epage%3D935%26doi%3D10.1086%2F674755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span> <span> </span><span class="NLM_article-title">PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension</span>. <i>Int. J. Hypertens.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">7809216</span>, <span class="refDoi"> DOI: 10.1155/2019/7809216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1155%2F2019%2F7809216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31073415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BB3M7kt1Cltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=7809216&author=Y.+Jiangauthor=Q.+Liauthor=M.+Jiaauthor=Z.+Yan&title=PPAR%CE%B4%3A+A+Potential+Therapeutic+Target+for+the+Treatment+of+Metabolic+Hypertension&doi=10.1155%2F2019%2F7809216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension</span></div><div class="casAuthors">Jiang Yanli; Li Qiang; Jia Mengxiao; Yan Zhencheng</div><div class="citationInfo"><span class="NLM_cas:title">International journal of hypertension</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7809216</span>
        ISSN:<span class="NLM_cas:issn">2090-0384</span>.
    </div><div class="casAbstract">High blood pressure and its associated cardiovascular diseases have been major risks for public health.  Multiple metabolic risk factors can cause the vascular dysfunction and vascular lesion, and the hypertension due to metabolic disturbances was defined as metabolic hypertension.  The members of a subfamily of the nuclear receptors, peroxisome proliferator-activated receptors (PPARs), were found to be key regulators of metabolism and vascular function.  We provide up-to-date knowledge on the role of subtype PPARδ in the regulation of metabolism and vascular function and the effect of its intervention on the metabolic hypertension management.  We hope to give some insights into the development of more effective treatments of metabolic hypertension and its main complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvb05-GXS2e5dYoSR9eyvsfW6udTcc2eZ4pl20rvWdyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7kt1Cltw%253D%253D&md5=419b184b85e88dfdefea34e7c6a85399</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1155%2F2019%2F7809216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2019%252F7809216%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DZ.%26atitle%3DPPAR%25CE%25B4%253A%2520A%2520Potential%2520Therapeutic%2520Target%2520for%2520the%2520Treatment%2520of%2520Metabolic%2520Hypertension%26jtitle%3DInt.%2520J.%2520Hypertens.%26date%3D2019%26volume%3D2019%26spage%3D7809216%26doi%3D10.1155%2F2019%2F7809216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suarez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCollum, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bretz, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capozzi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penn, J. S.</span></span> <span> </span><span class="NLM_article-title">Modulation of VEGF-Induced Retinal Vascular Permeability by Peroxisome Proliferator-activated Receptor-β/δ</span>. <i>Invest. Ophthalmol. Vis. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8232</span>– <span class="NLM_lpage">8240</span>, <span class="refDoi"> DOI: 10.1167/iovs.14-14217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1167%2Fiovs.14-14217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25406289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=8232-8240&author=S.+Suarezauthor=G.+W.+McCollumauthor=C.+A.+Bretzauthor=R.+Yangauthor=M.+E.+Capozziauthor=J.+S.+Penn&title=Modulation+of+VEGF-Induced+Retinal+Vascular+Permeability+by+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4&doi=10.1167%2Fiovs.14-14217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ</span></div><div class="casAuthors">Suarez, Sandra; McCollum, Gary W.; Bretz, Colin A.; Yang, Rong; Capozzi, Megan E.; Penn, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8232-8240</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">PURPOSE.  Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability contributes to diabetic macular edema (DME), a serious vision-threatening condition.  Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) antagonist/reverse agonist, GSK0660, inhibits VEGF-induced human retinal microvascular endothelial cell (HRMEC) proliferation, tubulogenesis, and oxygen-induced retinal vasculopathy in newborn rats.  These VEGF-induced HRMEC behaviors and VEGF-induced disruption of endothelial cell junctional complexes may well share mol. signaling events.  Thus, we sought to examine the role of PPARβ/δ in VEGF-induced retinal hyperpermeability.  METHODS.  Transendothelial elec. resistance (TEER) measurements were performed on HRMEC monolayers to assess permeability.  Claudin-1/Claudin-5 localization in HRMEC monolayers was detd. by immunocytochem.  Extracellular signal-regulated protein kinases 1 and 2 (Erk 1/2) phosphorylation, VEGF receptor 1 (VEGFR1) and R2 were assayed by Western blot anal.  Expression of VEGFR1 and R2 was measured by quant. RT-PCR.  Last, retinal vascular permeability was assayed in vivo by Evans blue extravasation.  RESULTS.  Human retinal microvascular endothelial cell monolayers treated with VEGF for 24 h showed decreased TEER values that were completely reversed by the highest concn. of GSK0660 (10 μM) and PPARβ/δ-directed siRNA (20 μM).  In HRMEC treated with VEGF, GSK0660 stabilized tight-junctions as evidenced by Claudin-1 staining, reduced phosphorylation of Erk1/2, and reduced VEGFR1/2 expression.  Peroxisome proliferator-activated receptor β/δ siRNA had a similar effect on VEGFR expression and Claudin-1, supporting the specificity of GSK0660 in our expts.  Last, GSK0660 significantly inhibited VEGF-induced retinal vascular permeability and reduced retinal VEGFR1and R2 levels in C57BL/6 mice.  CONCLUSIONS.  These data suggest a protective effect for PPARβ/δ antagonism against VEGF induced vascular permeability, possibly through reduced VEGFR expression.  Therefore, antagonism/reverse agonism of PPARβ/δ siRNA may represent a novel therapeutic methodol. against retinal hyperpermeability and is worthy of future investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1o9V79OcYt7Vg90H21EOLACvtfcHk0lhGzsHm-U2-hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSrsro%253D&md5=7b3daae21925d6473298b86e2900ebeb</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1167%2Fiovs.14-14217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.14-14217%26sid%3Dliteratum%253Aachs%26aulast%3DSuarez%26aufirst%3DS.%26aulast%3DMcCollum%26aufirst%3DG.%2BW.%26aulast%3DBretz%26aufirst%3DC.%2BA.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DCapozzi%26aufirst%3DM.%2BE.%26aulast%3DPenn%26aufirst%3DJ.%2BS.%26atitle%3DModulation%2520of%2520VEGF-Induced%2520Retinal%2520Vascular%2520Permeability%2520by%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%26jtitle%3DInvest.%2520Ophthalmol.%2520Vis.%2520Sci.%26date%3D2014%26volume%3D55%26spage%3D8232%26epage%3D8240%26doi%3D10.1167%2Fiovs.14-14217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bishop-Bailey, D.</span></span> <span> </span><span class="NLM_article-title">PPARs and Angiogenesis</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1605</span>, <span class="refDoi"> DOI: 10.1042/BST20110643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1042%2FBST20110643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22103494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaiur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1601-1605&author=D.+Bishop-Bailey&title=PPARs+and+Angiogenesis&doi=10.1042%2FBST20110643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">PPARs and angiogenesis</span></div><div class="casAuthors">Bishop-Bailey, David</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1601-1605</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The PPAR (peroxisome-proliferator-activated receptor) family consists of three ligand-activated nuclear receptors: PPARα, PPARβ/δ and PPARγ.  These PPARs have important roles in the regulation of glucose and fatty acid metab., cell differentiation and immune function, but were also found to be expressed in endothelial cells in the late 1990s.  The early endothelial focus of PPARs was PPARγ, the mol. target for the insulin-sensitizing thiazolidinedione/glitazone class of drugs.  Activation of PPARγ was shown to inhibit angiogenesis in vitro and in models of retinopathy and cancer, whereas more recent data point to a crit. role in the development of the vasculature in the placenta.  Similarly, PPARα, the mol. target for the fibrate class of drugs, also has anti-angiogenic properties in exptl. models.  In contrast, unlike PPARα or PPARγ, activation of PPARβ/δ induces angiogenesis, in vitro and in vivo, and has been suggested to be a crit. component of the angiogenic switch in pancreatic cancer.  Moreover, PPARβ/δ is an exercise mimetic and appears to contribute to the angiogenic remodelling of cardiac and skeletal muscle induced by exercise.  This evidence and the emerging mechanisms by which PPARs act in endothelial cells are discussed in more detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot0HeRp8yoFbVg90H21EOLACvtfcHk0lhGzsHm-U2-hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaiur7E&md5=dd45c2e06051b94dd6648b7aa5680bfd</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1042%2FBST20110643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110643%26sid%3Dliteratum%253Aachs%26aulast%3DBishop-Bailey%26aufirst%3DD.%26atitle%3DPPARs%2520and%2520Angiogenesis%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2011%26volume%3D39%26spage%3D1601%26epage%3D1605%26doi%3D10.1042%2FBST20110643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span> <span> </span><span class="NLM_article-title">Polydatin Restores Endothelium-dependent Relaxation in Rat Aorta Rings Impaired by High Glucose: A Novel Insight Into the PPARβ-NO Signaling Pathway</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0126249</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0126249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pone.0126249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25941823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslSisrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=Y.+Wuauthor=L.+Xueauthor=W.+Duauthor=B.+Huangauthor=C.+Tangauthor=C.+Liuauthor=H.+Qiuauthor=Q.+Jiang&title=Polydatin+Restores+Endothelium-dependent+Relaxation+in+Rat+Aorta+Rings+Impaired+by+High+Glucose%3A+A+Novel+Insight+Into+the+PPAR%CE%B2-NO+Signaling+Pathway&doi=10.1371%2Fjournal.pone.0126249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Polydatin restores endothelium-dependent relaxation in rat aorta rings impaired by high glucose: a novel insight into the PPARβ-NO signaling pathway</span></div><div class="casAuthors">Wu, Yang; Xue, Lai; Du, Weimin; Huang, Bo; Tang, Cuiping; Liu, Changqing; Qiu, Hongmei; Jiang, Qingsong</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0126249/1-e0126249/14</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Polydatin, a natural component from Polygonum Cuspidatum, has important therapeutic effects on metabolic syndrome.  A novel therapeutic strategy using polydatin to improve vascular function has recently been proposed to treat diabetes-related cardiovascular complications.  However, the biol. role and mol. basis of polydatin's action on vascular endothelial cells (VECs)-mediated vasodilatation under diabetes-related hyperglycemia condition remain elusive.  The present study aimed to assess the contribution of polydatin in restoring endothelium-dependent relaxation and to det. the details of its underlying mechanism.  By measuring endothelium-dependent relaxation, we found that acetylcholine-induced vasodilation was impaired by elevated glucose (55 mmol/L); however, polydatin (1, 3, 10 μmol/L) could restore the relaxation in a dose-dependent manner.  Polydatin could also improve the histol. damage to endothelial cells in the thoracic aorta.  Polydatin's effects were mediated via promoting the expression of endothelial NO synthase (eNOS), enhancing eNOS activity and decreasing the inducible NOS (iNOS) level, finally resulting in a beneficial increase in NO release, which probably, at least in part, through activation of the PPARβ signaling pathway.  The results provided a novel insight into polydatin action, via PPARβ-NO signaling pathways, in restoring endothelial function in high glucose conditions.  The results also indicated the potential utility of polydatin to treat diabetes related cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDFPls36iLTrVg90H21EOLACvtfcHk0lhGzsHm-U2-hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslSisrnF&md5=e6eeca6205ae5ee46bb9d7f35d486ee6</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0126249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0126249%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DQ.%26atitle%3DPolydatin%2520Restores%2520Endothelium-dependent%2520Relaxation%2520in%2520Rat%2520Aorta%2520Rings%2520Impaired%2520by%2520High%2520Glucose%253A%2520A%2520Novel%2520Insight%2520Into%2520the%2520PPAR%25CE%25B2-NO%2520Signaling%2520Pathway%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0126249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">PPAR Agonist GW501516 Inhibits PDGF-Stimulated Pulmonary Arterial Smooth Muscle Cell Function Related to Pathological Vascular Remodeling</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">903947</span>, <span class="refDoi"> DOI: 10.1155/2013/903947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1155%2F2013%2F903947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23607100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC3srntlWgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=903947&author=G.+Liuauthor=X.+Liauthor=Y.+Liauthor=X.+Tangauthor=J.+Xuauthor=R.+Liauthor=P.+Haoauthor=Y.+Sun&title=PPAR+Agonist+GW501516+Inhibits+PDGF-Stimulated+Pulmonary+Arterial+Smooth+Muscle+Cell+Function+Related+to+Pathological+Vascular+Remodeling&doi=10.1155%2F2013%2F903947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ agonist GW501516 inhibits PDGF-stimulated pulmonary arterial smooth muscle cell function related to pathological vascular remodeling</span></div><div class="casAuthors">Liu Guangjie; Li Xuan; Li Yan; Tang Xin; Xu Jie; Li Ran; Hao Peng; Sun Yongchang</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">903947</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pulmonary arterial hypertension (PAH) is a severe and progressive disease, a key feature of which is pulmonary vascular remodeling.  Growth factors, cytokines, and lipid mediators are involved in this remodeling process.  Recent reports suggest that the peroxisome proliferator-activated receptors (PPARs) play important roles in the regulation of cell growth and differentiation as well as tissue wounding and repair.  In this study, we examined the role of PPAR δ in the regulation of proliferation, migration, collagen synthesis, and chemokine production in human pulmonary arterial smooth muscle cells (HPASMCs).  The data showed that PPAR δ was the most abundant isoform in HPASMCs.  PPAR δ was upregulated in HPASMCs treated with PDGF, which is the major mediator in pulmonary vascular remodeling.  Activation of PPAR δ by GW501516, a specific PPAR δ ligand, significantly inhibited PDGF-induced proliferation in HPASMCs.  The inhibitory effect of GW501516 on HPASMCs was associated with decreased expression of cyclin D1, cyclin D3, CDK2, and CDK4 as well as increased expression of the cell cycle inhibitory genes G0S2 and P27(kip1).  Pretreatment of HPASMCs with GW501516 significantly inhibited PDGF-induced cell migration and collagen synthesis.  GW501516 also significantly attenuated TNF-mediated expression of MCP-1.  These results suggest that PPAR δ may be a potential therapeutic target against the progression of vascular remodeling in PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKNrPxBH56Bq-9TkgmBqTqfW6udTcc2eZJ_bql_hbhsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srntlWgsg%253D%253D&md5=ee1ee2fd9aa64683ec141b84983b2246</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1155%2F2013%2F903947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F903947%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DHao%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DPPAR%2520Agonist%2520GW501516%2520Inhibits%2520PDGF-Stimulated%2520Pulmonary%2520Arterial%2520Smooth%2520Muscle%2520Cell%2520Function%2520Related%2520to%2520Pathological%2520Vascular%2520Remodeling%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2013%26volume%3D2013%26spage%3D903947%26doi%3D10.1155%2F2013%2F903947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span> <span> </span><span class="NLM_article-title">PPARδ Agonist Prevents Endothelial Dysfunction via Induction of Dihydrofolate Reductase Gene and Activation of Tetrahydrobiopterin Salvage Pathway</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">2945</span>– <span class="NLM_lpage">2961</span>, <span class="refDoi"> DOI: 10.1111/bph.14745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1111%2Fbph.14745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31144304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlalsr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=2945-2961&author=Z.+Zhangauthor=X.+Xieauthor=Q.+Yaoauthor=J.+Liuauthor=Y.+Tianauthor=C.+Yangauthor=L.+Xiaoauthor=N.+Wang&title=PPAR%CE%B4+Agonist+Prevents+Endothelial+Dysfunction+via+Induction+of+Dihydrofolate+Reductase+Gene+and+Activation+of+Tetrahydrobiopterin+Salvage+Pathway&doi=10.1111%2Fbph.14745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ agonist prevents endothelial dysfunction via induction of dihydrofolate reductase gene and activation of tetrahydrobiopterin salvage pathway</span></div><div class="casAuthors">Zhang, Zihui; Xie, Xinya; Yao, Qinyu; Liu, Jia; Tian, Ying; Yang, Chunmiao; Xiao, Lei; Wang, Nanping</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2945-2961</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Impaired endothelium-dependent relaxation (EDR) is a hallmark of endothelial dysfunction.  A deficiency of tetrahydrobiopterin (BH4) causes endothelial NOS to produce ROS rather than NO.  PPARδ is an emerging target for pharmacol. intervention of endothelial dysfunction.  Thus, the present study examd. the role of PPARδ in the regulation of dihydrofolate reductase (DHFR), a key enzyme in the BH4 salvage pathway.  Exptl. Approach : Gene expression was measured by using qRT-PCR and western blotting.  Biopterins and ROS were detd. by using HPLC.  NO was measured with fluorescent dye and ESR spectroscopy.  Vasorelaxation was measured by Multi Myograph System.  Key Results : The PPARδ agonist GW501516 increased DHFR and BH4 levels in endothelial cells (ECs).  The effect was blocked by PPARδ antagonist GSK0660.  Chromatin immunopptn. identified PPAR-responsive elements within the 5'-flanking region of the human DHFR gene.  The promoter activity was examd. with luciferase assays using deletion reporters.  Importantly, DHFR expression was suppressed by palmitic acid (PA, a satd. fatty acid) but increased by docosahexaenoic acid (DHA, a polyunsatd. fatty acid).  GSK0660 prevented DHA-induced increased DHFR expression.  Conversely, the suppressive effect of PA was mitigated by GW501516.  In mouse aortae, GW501516 ameliorated the PA-impaired EDR.  However, this vasoprotective effect was attenuated by DHFR siRNA or methotrexate.  In EC-specific Ppard knockout mice, GW501516 failed to improve vasorelaxation.  Conclusion and Implications : PPARδ prevented endothelial dysfunction by increasing DHFR and activating the BH4 salvage pathway.  These results provide a novel mechanism for the protective roles of PPARδ against vascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCA0-O8x5bPrVg90H21EOLACvtfcHk0liMKigsCxW-qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlalsr7M&md5=3c6f127dd43c6c38820ce00e6335c159</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1111%2Fbph.14745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14745%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DN.%26atitle%3DPPAR%25CE%25B4%2520Agonist%2520Prevents%2520Endothelial%2520Dysfunction%2520via%2520Induction%2520of%2520Dihydrofolate%2520Reductase%2520Gene%2520and%2520Activation%2520of%2520Tetrahydrobiopterin%2520Salvage%2520Pathway%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D176%26spage%3D2945%26epage%3D2961%26doi%3D10.1111%2Fbph.14745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magadum, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, F.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ: Linking Metabolism to Regeneration</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2013</span>, <span class="refDoi"> DOI: 10.3390/ijms19072013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms19072013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKlsbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=2013&author=A.+Magadumauthor=F.+Engel&title=PPAR%CE%B2%2F%CE%B4%3A+Linking+Metabolism+to+Regeneration&doi=10.3390%2Fijms19072013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ: linking metabolism to regeneration</span></div><div class="casAuthors">Magadum, Ajit; Engel, Felix B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2013/1-2013/23</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In contrast to the general belief that regeneration is a rare event, mainly occurring in simple organisms, the ability of regeneration is widely distributed in the animal kingdom.  Yet, the efficiency and extent of regeneration varies greatly.  Humans can recover from blood loss as well as damage to tissues like bone and liver.  Yet damage to the heart and brain cannot be reversed, resulting in scaring.  Thus, there is a great interest in understanding the mol. mechanisms of naturally occurring regeneration and to apply this knowledge to repair human organs.  During regeneration, injury-activated immune cells induce wound healing, extracellular matrix remodeling, migration, dedifferentiation and/or proliferation with subsequent differentiation of somatic or stem cells.  An anti-inflammatory response stops the regenerative process, which ends with tissue remodeling to achieve the original functional state.  Notably, many of these processes are assocd. with enhanced glycolysis.  Therefore, peroxisome proliferator-activated receptor (PPAR) β/δ-which is known to be involved for example in lipid catabolism, glucose homeostasis, inflammation, survival, proliferation, differentiation, as well as mammalian regeneration of the skin, bone and liver-appears to be a promising target to promote mammalian regeneration.  This review summarizes our current knowledge of PPARβ/δ in processes assocd. with wound healing and regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSpDhpZVmuS7Vg90H21EOLACvtfcHk0lhFMHpLtekvwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKlsbjJ&md5=3eed4eb37e49a1ae7ad64e7fa4f766e9</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.3390%2Fijms19072013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19072013%26sid%3Dliteratum%253Aachs%26aulast%3DMagadum%26aufirst%3DA.%26aulast%3DEngel%26aufirst%3DF.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%253A%2520Linking%2520Metabolism%2520to%2520Regeneration%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D2013%26doi%3D10.3390%2Fijms19072013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyner, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katusic, Z. S.</span></span> <span> </span><span class="NLM_article-title">Activation of Peroxisome Proliferator-activated Receptor−δ Enhances Regenerative Capacity of Human Endothelial Progenitor Cells by Stimulating Biosynthesis of Tetrahydrobiopterin</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.111.172189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1161%2FHYPERTENSIONAHA.111.172189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21709207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFCktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2011&pages=287-294&author=T.+Heauthor=L.+A.+Smithauthor=T.+Luauthor=M.+J.+Joynerauthor=Z.+S.+Katusic&title=Activation+of+Peroxisome+Proliferator-activated+Receptor%E2%88%92%CE%B4+Enhances+Regenerative+Capacity+of+Human+Endothelial+Progenitor+Cells+by+Stimulating+Biosynthesis+of+Tetrahydrobiopterin&doi=10.1161%2FHYPERTENSIONAHA.111.172189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Peroxisome Proliferator-Activated Receptor-δ Enhances Regenerative Capacity of Human Endothelial Progenitor Cells by Stimulating Biosynthesis of Tetrahydrobiopterin</span></div><div class="casAuthors">He, Tongrong; Smith, Leslie A.; Lu, Tong; Joyner, Michael J.; Katusic, Zvonimir S.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-294</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The mechanisms underlying the regenerative capacity of endothelial progenitor cells (EPCs) are not fully understood.  We hypothesized that biosynthesis of tetrahydrobiopterin is an important mechanism responsible for the stimulatory effects of peroxisome proliferator-activated receptor-δ (PPARδ) activation on regenerative function of human EPCs.  Treatment of human EPCs with a selective PPARδ agonist GW 501516 for 24 h increased the levels of mRNA, protein, and enzymic activity of GTP cyclohydrolase I (GTPCH I), as well as the prodn. of tetrahydrobiopterin.  The effects of GW 501516 were mediated by suppression of PTEN expression, thereby increasing phosphorylation of AKT.  The AKT signaling also mediated GW 501516-induced phosphorylation of endothelial NO synthase.  In addn., activation of PPARδ significantly enhanced proliferation of EPCs.  This effect was abolished by the GTPCH I inhibitor, 2,4-diamino-6-hydroxypyrimidine, or genetic inactivation of GTPCH I with small interfering RNA but not by inhibition of endothelial NO synthase with N-nitro-L-arginine Me ester.  Supplementation of NO did not reverse 2,4-diamino-6-hydroxypyrimidine-inhibited 5-bromodeoxyuridine incorporation.  Furthermore, transplantation of human EPCs stimulated re-endothelialization in a mouse model of carotid artery injury.  Pretreatment of EPCs with GW 501516 significantly enhanced the ability of transplanted EPCs to repair denuded endothelium.  GTPCH I-small interfering RNA transfection significantly inhibited in vivo regenerative capacity of EPCs stimulated with GW 501516.  Thus, in human EPCs, activation of PPARδ stimulates expression and activity of GTPCH I and biosynthesis of tetrahydrobiopterin via PTEN-AKT signaling pathway.  This effect enhances the regenerative function of EPCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF8vGp5RLSWbVg90H21EOLACvtfcHk0lhFMHpLtekvwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFCktrs%253D&md5=c5798c3145711166144bc9077584453d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.111.172189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.111.172189%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DJoyner%26aufirst%3DM.%2BJ.%26aulast%3DKatusic%26aufirst%3DZ.%2BS.%26atitle%3DActivation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%25E2%2588%2592%25CE%25B4%2520Enhances%2520Regenerative%2520Capacity%2520of%2520Human%2520Endothelial%2520Progenitor%2520Cells%2520by%2520Stimulating%2520Biosynthesis%2520of%2520Tetrahydrobiopterin%26jtitle%3DHypertension%26date%3D2011%26volume%3D58%26spage%3D287%26epage%3D294%26doi%3D10.1161%2FHYPERTENSIONAHA.111.172189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, S.</span></span> <span> </span><span class="NLM_article-title">Functional Role of PPARδ in Corneal Epithelial Wound Healing</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">598</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2011.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.ajpath.2011.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22119718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVentbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2012&pages=583-598&author=Y.+Nakamuraauthor=T.+Nakamuraauthor=T.+Taruiauthor=J.+Inoueauthor=S.+Kinoshita&title=Functional+Role+of+PPAR%CE%B4+in+Corneal+Epithelial+Wound+Healing&doi=10.1016%2Fj.ajpath.2011.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Functional role of PPARδ in corneal epithelial wound healing</span></div><div class="casAuthors">Nakamura, Yoshikuni; Nakamura, Takahiro; Tarui, Takeshi; Inoue, Jun; Kinoshita, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">583-598</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptor (PPAR) δ is involved in tissue repair.  In this study, we investigated the functional role of PPARδ in corneal epithelial wound healing.  In an in vivo corneal wound-healing model, the changes of PPARδ expression in corneal epithelia were examd. by immunofluorescence microscopy, and the effect of topical administrations of a PPARδ agonist on corneal wound healing was also evaluated.  The inhibitory effect of a PPARδ agonist on the cytokine-induced death of human corneal epithelial cells was evaluated using a DNA fragmentation assay kit.  The changes of PPARδ expression and epithelial cell death were also investigated using human corneoscleral tissues ex vivo.  Our findings showed that PPARδ expression was temporally up-regulated in corneal epithelial cells during exptl. wound healing and that topical administration of a PPARδ agonist significantly promoted the healing of exptl. corneal epithelial wounds.  In human corneal epithelial cells, up-regulation of PPARδ and DNA fragmentation was demonstrated by stimulation with cytokines, and the DNA fragmentation was significantly inhibited by pretreatment with a PPARδ agonist.  By using human corneoscleral tissues ex vivo, PPARδ was up-regulated in both healthy corneal epithelia (during re-epithelialization) and diseased corneal epithelia.  Inflammatory stimulation-induced corneal epithelial cell death was inhibited by pretreatment with a PPARδ agonist.  These results strongly suggest that PPARδ is involved in the corneal epithelial wound healing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsZx_xbNt1SrVg90H21EOLACvtfcHk0lgk8uP0oQvIgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVentbw%253D&md5=5f292abef860492ccf53871707ffcd21</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DTarui%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DJ.%26aulast%3DKinoshita%26aufirst%3DS.%26atitle%3DFunctional%2520Role%2520of%2520PPAR%25CE%25B4%2520in%2520Corneal%2520Epithelial%2520Wound%2520Healing%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D180%26spage%3D583%26epage%3D598%26doi%3D10.1016%2Fj.ajpath.2011.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scholtysek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenbeisser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uderhardt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ipseiz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donhauser, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djouad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuckermann, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desvergne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronke, G.</span></span> <span> </span><span class="NLM_article-title">PPARβ/δ Governs Wnt Signaling and Bone Turnover</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1038/nm.3146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fnm.3146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23542786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFOqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=608-613&author=C.+Scholtysekauthor=J.+Katzenbeisserauthor=H.+Fuauthor=S.+Uderhardtauthor=N.+Ipseizauthor=C.+Stollauthor=M.+M.+Zaissauthor=M.+Stockauthor=L.+Donhauserauthor=C.+B%C3%B6hmauthor=A.+Kleyerauthor=A.+Hessauthor=K.+Engelkeauthor=J.+P.+Davidauthor=F.+Djouadauthor=J.+P.+Tuckermannauthor=B.+Desvergneauthor=G.+Schettauthor=G.+Kronke&title=PPAR%CE%B2%2F%CE%B4+Governs+Wnt+Signaling+and+Bone+Turnover&doi=10.1038%2Fnm.3146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ/δ governs Wnt signaling and bone turnover</span></div><div class="casAuthors">Scholtysek, Carina; Katzenbeisser, Julia; Fu, He; Uderhardt, Stefan; Ipseiz, Natacha; Stoll, Cornelia; Zaiss, Mario M.; Stock, Michael; Donhauser, Laura; Boehm, Christina; Kleyer, Arnd; Hess, Andreas; Engelke, Klaus; David, Jean-Pierre; Djouad, Farida; Tuckermann, Jan Peter; Desvergne, Beatrice; Schett, Georg; Kroenke, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">608-613</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) act as metabolic sensors and central regulators of fat and glucose homeostasis.  Furthermore, PPARγ has been implicated as major catabolic regulator of bone mass in mice and humans.  However, a potential involvement of other PPAR subtypes in the regulation of bone homeostasis has remained elusive.  Here we report a previously unrecognized role of PPARβ/δ as a key regulator of bone turnover and the crosstalk between osteoblasts and osteoclasts.  In contrast to activation of PPARγ, activation of PPARβ/δ amplified Wnt-dependent and β-catenin-dependent signaling and gene expression in osteoblasts, resulting in increased expression of osteoprotegerin (OPG) and attenuation of osteoblast-mediated osteoclastogenesis.  Accordingly, PPARβ/δ-deficient mice had lower Wnt signaling activity, lower serum concns. of OPG, higher nos. of osteoclasts and osteopenia.  Pharmacol. activation of PPARβ/δ in a mouse model of postmenopausal osteoporosis led to normalization of the altered ratio of tumor necrosis factor superfamily, member 11 (RANKL, also called TNFSF11) to OPG, a rebalancing of bone turnover and the restoration of normal bone d.  Our findings identify PPARβ/δ as a promising target for an alternative approach in the treatment of osteoporosis and related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxWzkK_7oC47Vg90H21EOLACvtfcHk0lgk8uP0oQvIgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFOqt7k%253D&md5=b9dfec00b6d5fc0fc1a26ae1d6fd3bcb</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fnm.3146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3146%26sid%3Dliteratum%253Aachs%26aulast%3DScholtysek%26aufirst%3DC.%26aulast%3DKatzenbeisser%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DUderhardt%26aufirst%3DS.%26aulast%3DIpseiz%26aufirst%3DN.%26aulast%3DStoll%26aufirst%3DC.%26aulast%3DZaiss%26aufirst%3DM.%2BM.%26aulast%3DStock%26aufirst%3DM.%26aulast%3DDonhauser%26aufirst%3DL.%26aulast%3DB%25C3%25B6hm%26aufirst%3DC.%26aulast%3DKleyer%26aufirst%3DA.%26aulast%3DHess%26aufirst%3DA.%26aulast%3DEngelke%26aufirst%3DK.%26aulast%3DDavid%26aufirst%3DJ.%2BP.%26aulast%3DDjouad%26aufirst%3DF.%26aulast%3DTuckermann%26aufirst%3DJ.%2BP.%26aulast%3DDesvergne%26aufirst%3DB.%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DKronke%26aufirst%3DG.%26atitle%3DPPAR%25CE%25B2%252F%25CE%25B4%2520Governs%2520Wnt%2520Signaling%2520and%2520Bone%2520Turnover%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D608%26epage%3D613%26doi%3D10.1038%2Fnm.3146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manickam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span> <span> </span><span class="NLM_article-title">Roles of Peroxisome Proliferator-activated Receptor β/δ in Skeletal Muscle Physiology</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2016.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.biochi.2016.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27916646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOlu77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=42-48&author=R.+Manickamauthor=W.+Wahli&title=Roles+of+Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+in+Skeletal+Muscle+Physiology&doi=10.1016%2Fj.biochi.2016.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology</span></div><div class="casAuthors">Manickam, Ravikumar; Wahli, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-48</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">More than two decades of studying Peroxisome Proliferator-Activated Receptors (PPARs) has led to an understanding of their implications in various physiol. processes that are key for health and disease.  All three PPAR isotypes, PPARα, PPARβ/δ, and PPARγ, are activated by a variety of mols., including fatty acids, eicosanoids and phospholipids, and regulate a spectrum of genes involved in development, lipid and carbohydrate metab., inflammation, and proliferation and differentiation of many cell types in different tissues.  The hypolipidemic and antidiabetic functions of PPARα and PPARγ in response to fibrate and thiazolidinedione treatment, resp., are well documented.  However, until more recently the functions of PPARβ/δ were less well defined, but are now becoming more recognized in fatty acid metab., energy expenditure, and tissue repair.  Skeletal muscle is an active metabolic organ with high plasticity for adaptive responses to varying conditions such as fasting or phys. exercise.  It is the major site of energy expenditure resulting from lipid and glucose catabolism.  Here, we review the multifaceted roles of PPARβ/δ in skeletal muscle physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjKJDWc2-Nc7Vg90H21EOLACvtfcHk0ljyWGqrKbJPVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOlu77O&md5=a0567f3f548a4eb2dc6c98a606ecbea6</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2016.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2016.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DManickam%26aufirst%3DR.%26aulast%3DWahli%26aufirst%3DW.%26atitle%3DRoles%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520in%2520Skeletal%2520Muscle%2520Physiology%26jtitle%3DBiochimie%26date%3D2017%26volume%3D136%26spage%3D42%26epage%3D48%26doi%3D10.1016%2Fj.biochi.2016.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.-J.</span></span> <span> </span><span class="NLM_article-title">PPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e65644</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0065644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pone.0065644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23823620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVOhs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=H.-X.+Liuauthor=Y.+Fangauthor=Y.+Huauthor=F.+J.+Gonzalezauthor=J.+Fangauthor=Y.-J.+Wan&title=PPAR%CE%B2+Regulates+Liver+Regeneration+by+Modulating+Akt+and+E2f+Signaling&doi=10.1371%2Fjournal.pone.0065644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">PPARβ regulates liver regeneration by modulating Akt and E2f signaling</span></div><div class="casAuthors">Liu, Hui-Xin; Fang, Yaping; Hu, Ying; Gonzalez, Frank J.; Fang, Jianwen; Wan, Yu-Jui Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e65644</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The current study tests the hypothesis that peroxisome proliferator-activated receptor β (PPARβ) has a role in liver regeneration due to its effect in regulating energy homeostasis and cell proliferation.  The role of PPARβ in liver regeneration was studied using two-third partial hepatectomy (PH) in Wild-type (WT) and PPARβ-null (KO) mice.  In KO mice, liver regeneration was delayed and the no. of Ki-67 pos. cells reached the peak at 60 h rather than at 36-48 h after PH shown in WT mice.  RNA-sequencing uncovered 1344 transcriptomes that were differentially expressed in regenerating WT and KO livers.  About 70% of those differentially expressed genes involved in glycolysis and fatty acid synthesis pathways failed to induce during liver regeneration due to PPARβ deficiency.  The delayed liver regeneration in KO mice was accompanied by lack of activation of phosphoinositide-dependent kinase 1 (PDK1)/Akt.  In addn., cell proliferation-assocd. increase of genes encoding E2f transcription factor (E2f) 1-2 and E2f7-8 as well as their downstream target genes were not noted in KO livers 36-48 h after PH.  E2fs have dual roles in regulating metab. and proliferation.  Moreover, transient steatosis was only found in WT, but not in KO mice 36 h after PH.  These data suggested that PPARβ-regulated PDK1/Akt and E2f signaling that controls metab. and proliferation is involved in the normal progression of liver regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog6SyDx5tgwrVg90H21EOLACvtfcHk0ljyWGqrKbJPVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVOhs77L&md5=ada732e7441f6943bc41fbf1a6dad3b2</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0065644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0065644%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.-J.%26atitle%3DPPAR%25CE%25B2%2520Regulates%2520Liver%2520Regeneration%2520by%2520Modulating%2520Akt%2520and%2520E2f%2520Signaling%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0065644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burkart, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandam, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtois, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gierasch, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoghi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, D. P.</span></span> <span> </span><span class="NLM_article-title">Nuclear Receptors PPARβ/δ and PPARα Direct Distinct Metabolic Regulatory Programs in the Mouse Heart</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">3930</span>– <span class="NLM_lpage">3939</span>, <span class="refDoi"> DOI: 10.1172/JCI32578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1172%2FJCI32578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18037994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsValsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=3930-3939&author=E.+M.+Burkartauthor=N.+Sambandamauthor=X.+Hanauthor=R.+W.+Grossauthor=M.+Courtoisauthor=C.+M.+Gieraschauthor=K.+Shoghiauthor=M.+J.+Welchauthor=D.+P.+Kelly&title=Nuclear+Receptors+PPAR%CE%B2%2F%CE%B4+and+PPAR%CE%B1+Direct+Distinct+Metabolic+Regulatory+Programs+in+the+Mouse+Heart&doi=10.1172%2FJCI32578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart</span></div><div class="casAuthors">Burkart, Eileen M.; Sambandam, Nandakumar; Han, Xianlin; Gross, Richard W.; Courtois, Michael; Gierasch, Carolyn M.; Shoghi, Kooresh; Welch, Michael J.; Kelly, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3930-3939</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">In the diabetic heart, chronic activation of the PPARα pathway drives excessive fatty acid (FA) oxidn., lipid accumulation, reduced glucose utilization, and cardiomyopathy.  The related nuclear receptor, PPARβ/δ, is also highly expressed in the heart, yet its function has not been fully delineated.  To address its role in myocardial metab., we generated transgenic mice with cardiac-specific expression of PPARβ/δ, driven by the myosin heavy chain (MHC-PPARβ/δ mice).  In striking contrast to MHC-PPARα mice, MHC-PPARβ/δ mice had increased myocardial glucose utilization, did not accumulate myocardial lipid, and had normal cardiac function.  Consistent with these obsd. metabolic phenotypes, we found that expression of genes involved in cellular FA transport were activated by PPARα but not by PPARβ/δ.  Conversely, cardiac glucose transport and glycolytic genes were activated in MHC-PPARβ/δ mice, but repressed in MHC-PPARα mice.  In reporter assays, we showed that PPARβ/δ and PPARα exerted differential transcriptional control of the GLUT4 promoter, which may explain the obsd. isotype-specific effects on glucose uptake.  Furthermore, myocardial injury due to ischemia/reperfusion injury was significantly reduced in the MHC-PPARβ/δ mice compared with control or MHC-PPARα mice, consistent with an increased capacity for myocardial glucose utilization.  These results demonstrate that PPARα and PPARβ/δ drive distinct cardiac metabolic regulatory programs and identify PPARβ/δ as a potential target for metabolic modulation therapy aimed at cardiac dysfunction caused by diabetes and ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr06Tz8YFObBLVg90H21EOLACvtfcHk0liqPNQLQfF8PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsValsLzM&md5=e47e82eb0c9b93c4974c3a0581dc5495</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1172%2FJCI32578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI32578%26sid%3Dliteratum%253Aachs%26aulast%3DBurkart%26aufirst%3DE.%2BM.%26aulast%3DSambandam%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DGross%26aufirst%3DR.%2BW.%26aulast%3DCourtois%26aufirst%3DM.%26aulast%3DGierasch%26aufirst%3DC.%2BM.%26aulast%3DShoghi%26aufirst%3DK.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DKelly%26aufirst%3DD.%2BP.%26atitle%3DNuclear%2520Receptors%2520PPAR%25CE%25B2%252F%25CE%25B4%2520and%2520PPAR%25CE%25B1%2520Direct%2520Distinct%2520Metabolic%2520Regulatory%2520Programs%2520in%2520the%2520Mouse%2520Heart%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D3930%26epage%3D3939%26doi%3D10.1172%2FJCI32578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quignodon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desvergne, B.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor <i>β/δ</i> in the Brain: Facts and Hypothesis</span>. <i>PPAR Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>2008</i></span>,  <span class="NLM_fpage">780452</span>, <span class="refDoi"> DOI: 10.1155/2008/780452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1155%2F2008%2F780452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19009042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BD1cjjvFOquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=780452&author=M.+J.+Hallauthor=L.+Quignodonauthor=B.+Desvergne&title=Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+in+the+Brain%3A+Facts+and+Hypothesis&doi=10.1155%2F2008%2F780452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome Proliferator-Activated Receptor beta/delta in the Brain: Facts and Hypothesis</span></div><div class="casAuthors">Hall M G; Quignodon Laure; Desvergne Beatrice</div><div class="citationInfo"><span class="NLM_cas:title">PPAR research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">2008</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">780452</span>
        ISSN:<span class="NLM_cas:issn">1687-4757</span>.
    </div><div class="casAbstract">peroxisome proliferator-activated receptors (PPARs) are nuclear receptors acting as lipid sensors.  Besides its metabolic activity in peripheral organs, the PPAR beta/delta isotype is highly expressed in the brain and its deletion in mice induces a brain developmental defect.  Nevertheless, exploration of PPARbeta action in the central nervous system remains sketchy.  The lipid content alteration observed in PPARbeta null brains and the positive action of PPARbeta agonists on oligodendrocyte differentiation, a process characterized by lipid accumulation, suggest that PPARbeta acts on the fatty acids and/or cholesterol metabolisms in the brain.  PPARbeta could also regulate central inflammation and antioxidant mechanisms in the damaged brain.  Even if not fully understood, the neuroprotective effect of PPARbeta agonists highlights their potential benefit to treat various acute or chronic neurological disorders.  In this perspective, we need to better understand the basic function of PPARbeta in the brain.  This review proposes different leads for future researches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ73SzE7ijUMgyMywPm6HgQfW6udTcc2eYTC18eYHw2hLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjjvFOquw%253D%253D&md5=1233ad6ab1fa2596a1502c52bc4e319c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1155%2F2008%2F780452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2008%252F780452%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DM.%2BJ.%26aulast%3DQuignodon%26aufirst%3DL.%26aulast%3DDesvergne%26aufirst%3DB.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520in%2520the%2520Brain%253A%2520Facts%2520and%2520Hypothesis%26jtitle%3DPPAR%2520Res.%26date%3D2008%26volume%3D2008%26spage%3D780452%26doi%3D10.1155%2F2008%2F780452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suppiramaniam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span> <span> </span><span class="NLM_article-title">Hippocampal Genetic Knockdown of PPARδ Causes Depression-Like Behaviors and Neurogenesis Suppression</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1093/ijnp/pyz008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1093%2Fijnp%2Fpyz008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31038173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFCmtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2019&pages=372-382&author=F.+Chenauthor=X.+Yuauthor=G.+Mengauthor=Z.+Meiauthor=Y.+Duauthor=H.+Sunauthor=M.+N.+Reedauthor=L.+Kongauthor=V.+Suppiramaniamauthor=H.+Hongauthor=S.+Tang&title=Hippocampal+Genetic+Knockdown+of+PPAR%CE%B4+Causes+Depression-Like+Behaviors+and+Neurogenesis+Suppression&doi=10.1093%2Fijnp%2Fpyz008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Hippocampal genetic knockdown of PPARδ causes depression-like behaviors and neurogenesis suppression</span></div><div class="casAuthors">Chen, Fang; Yu, Xuben; Meng, Guoliang; Mei, Zhenlin; Du, Yifeng; Sun, Hongbin; Reed, Miranda N.; Kong, Lingyi; Suppiramaniam, Vishnu; Hong, Hao; Tang, Susu</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">372-382</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Although depression is the leading cause of disability worldwide, its pathophysiol. is poorly understood.  Our previous study showed that hippocampal peroxisome proliferator-activated receptor δ (PPARδ) overexpression displays antidepressive effect and enhances hippocampal neurogenesis during chronic stress.  Herein, we further extended our curiosity to investigate whether downregulating PPARδ could cause depressive-like behaviors through downregulation of neurogenesis.  Methods: Stereotaxic injection of lentiviral vector, expressing short hairpin RNA complementary to the coding exon of PPARδ, was done into the bilateral dentate gyri of the hippocampus, and the depression-like behaviors were obsd. in mice.  Addnl., hippocampal neurogenesis, brain-derived neurotrophic factor and cAMP response element-binding protein were measured both in vivo and in vitro.  Results: Hippocampal PPARδ knockdown caused depressive-like behaviors and significantly decreased neurogenesis, neuronal differentiation, levels of mature brain-derived neurotrophic factor and phosphorylated cAMP response element-binding protein in the hippocampus.  In vitro study further confirmed that PPARδ knockdown could inhibit proliferation and differentiation of neural stem cells.  Furthermore, these effects were mimicked by repeated systemic administration of a PPARδ antagonist, GSK0660 (1 or 3 mg/kg i.p. for 21 d).  Conclusions: These findings suggest that downregulation of hippocampal PPARδ is assocd. with depressive behaviors in mice through an inhibitory effect on cAMP response element-binding protein/brain-derived neurotrophic factor-mediated adult neurogenesis in the hippocampus, providing new insights into the pathogenesis of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2gkFSx93J7Vg90H21EOLACvtfcHk0liK1D1TILQcfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFCmtbfN&md5=71d7ed18e4ffed64298fca31cf9adf22</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Fijnp%2Fpyz008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fijnp%252Fpyz008%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DMeng%26aufirst%3DG.%26aulast%3DMei%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DReed%26aufirst%3DM.%2BN.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DSuppiramaniam%26aufirst%3DV.%26aulast%3DHong%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DS.%26atitle%3DHippocampal%2520Genetic%2520Knockdown%2520of%2520PPAR%25CE%25B4%2520Causes%2520Depression-Like%2520Behaviors%2520and%2520Neurogenesis%2520Suppression%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2019%26volume%3D22%26spage%3D372%26epage%3D382%26doi%3D10.1093%2Fijnp%2Fpyz008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blass, B.</span></span> <span> </span><span class="NLM_article-title">PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00301</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00301" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVSnsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=824-825&author=B.+Blass&title=PPAR+Agonists%2C+Compounds%2C+Pharmaceutical+Compositions%2C+and+Methods+of+Use+Thereof&doi=10.1021%2Facsmedchemlett.6b00301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof</span></div><div class="casAuthors">Blass, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">824-825</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEu_Gipk89W7Vg90H21EOLACvtfcHk0liK1D1TILQcfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVSnsLnL&md5=3f2a34ac0e31059f810fdbfbe0569db8</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00301%26sid%3Dliteratum%253Aachs%26aulast%3DBlass%26aufirst%3DB.%26atitle%3DPPAR%2520Agonists%252C%2520Compounds%252C%2520Pharmaceutical%2520Compositions%252C%2520and%2520Methods%2520of%2520Use%2520Thereof%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D824%26epage%3D825%26doi%3D10.1021%2Facsmedchemlett.6b00301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polak, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dello Russo, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilyuk, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinstein, D. L.</span></span> <span> </span><span class="NLM_article-title">Protective Effects of a Peroxisome Proliferator-activated Receptor-β/δ Agonist in Experimental Autoimmune Encephalomyelitis</span>. <i>J. Neuroimmunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.jneuroim.2005.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.jneuroim.2005.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16098614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVynt7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2005&pages=65-75&author=P.+E.+Polakauthor=S.+Kalininauthor=C.+D.+Dello+Russoauthor=V.+Gavrilyukauthor=A.+Sharpauthor=J.+M.+Petersauthor=J.+Richardsonauthor=T.+M.+Willsonauthor=G.+Weinbergauthor=D.+L.+Feinstein&title=Protective+Effects+of+a+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+Agonist+in+Experimental+Autoimmune+Encephalomyelitis&doi=10.1016%2Fj.jneuroim.2005.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effects of a peroxisome proliferator-activated receptor-β/δ agonist in experimental autoimmune encephalomyelitis</span></div><div class="casAuthors">Polak, Paul E.; Kalinin, Sergey; Dello Russo, Cinzia; Gavrilyuk, Vitaliy; Sharp, Anthony; Peters, Jeffrey M.; Richardson, Jill; Willson, Tim M.; Weinberg, Guy; Feinstein, Douglas L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">65-75</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Agonists of the peroxisome proliferator-activated receptor gamma (PPARγ) exert anti-inflammatory and anti-proliferative effects which led to testing of these drugs in exptl. autoimmune encephalomyelitis (EAE), a model for multiple sclerosis.  In contrast, the effect of PPAR delta (PPARδ) agonists in EAE is not yet known.  We show that oral administration of the selective PPARδ agonist GW0742 reduced clin. symptoms in C57BL/6 mice that had been immunized with encephalitogenic myelin oligodendrocyte glycoprotein (MOG) peptide.  In contrast to previous results with PPARγ agonists, GW0742 only modestly attenuated clin. symptoms when the drug was provided simultaneously with immunization, but a greater redn. was obsd. if administered during disease progression.  Reduced clin. symptoms were accompanied by a redn. in the appearance of new cortical lesions, however cerebellar lesion load was not reduced.  Treatment of T-cells with GW0742 either in vivo or in vitro did not reduce IFNγ prodn.; however GW0742 reduced astroglial and microglial inflammatory activation and IL-1β levels in EAE brain.  RTPCR anal. showed that GW0742 increased expression of some myelin genes.  These data demonstrate that PPARδ agonists, like other PPAR ligands, can exert protective actions in an autoimmune model of demyelinating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozoFhbYjLPLLVg90H21EOLACvtfcHk0ljQSba3KAM5TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVynt7bJ&md5=6cfd07b1f8b870cf47361a68e1758c12</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2005.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2005.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DPolak%26aufirst%3DP.%2BE.%26aulast%3DKalinin%26aufirst%3DS.%26aulast%3DDello%2BRusso%26aufirst%3DC.%2BD.%26aulast%3DGavrilyuk%26aufirst%3DV.%26aulast%3DSharp%26aufirst%3DA.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DJ.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWeinberg%26aufirst%3DG.%26aulast%3DFeinstein%26aufirst%3DD.%2BL.%26atitle%3DProtective%2520Effects%2520of%2520a%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520Agonist%2520in%2520Experimental%2520Autoimmune%2520Encephalomyelitis%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2005%26volume%3D168%26spage%3D65%26epage%3D75%26doi%3D10.1016%2Fj.jneuroim.2005.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalinin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinstein, D. L.</span></span> <span> </span><span class="NLM_article-title">A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.2174/156720509789207949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.2174%2F156720509789207949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19874267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFChtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=431-437&author=S.+Kalininauthor=J.+C.+Richardsonauthor=D.+L.+Feinstein&title=A+PPARdelta+Agonist+Reduces+Amyloid+Burden+and+Brain+Inflammation+in+a+Transgenic+Mouse+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.2174%2F156720509789207949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease</span></div><div class="casAuthors">Kalinin, Sergey; Richardson, Jill C.; Feinstein, Douglas L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">431-437</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Agonists of the peroxisome proliferator activated receptor gamma (PPARγ) have been shown to reduce inflammatory responses in several animal models of neurol. diseases and conditions and to reduce amyloid burden in transgenic mice expressing mutant forms of human amyloid precursor protein.  However, the effects of activating the related receptor PPARdelta (PPARδ), which is expressed at higher levels in the brain than PPARγ, on inflammation and amyloid burden have not been explored.  In this study we tested the effects of the selective PPARδ agonist GW742 in 5xFAD mice which harbor 3 mutations in amyloid precursor protein and 2 mutations in presenilin 1, develop plaques by 5-6 wk of age, and show robust inflammation and neuronal damage.  Oral delivery of GW742 significantly reduced amyloid plaque burden in the subiculum region of 3-mo old male and female 5xFAD mice.  GW742 also significantly reduced astrocyte activation, suggesting anti-inflammatory effects on glia cells.  The changes in plaque burden were accompanied by increased expression of the amyloid degrading enzymes neprilysin and insulin degrading enzyme, while in transfected HEK293 cells, GW742 activated a neprilysin promoter driving luciferase expression.  These results suggest that, as found for some PPARγ agonists, PPARδ agonists can also reduce amyloid burden likely to be mediated by effects on amyloid clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-PRmA2bp067Vg90H21EOLACvtfcHk0ljQSba3KAM5TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFChtrvJ&md5=8702ee6f785b6389ec4e85141e7c89a3</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2174%2F156720509789207949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720509789207949%26sid%3Dliteratum%253Aachs%26aulast%3DKalinin%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DJ.%2BC.%26aulast%3DFeinstein%26aufirst%3DD.%2BL.%26atitle%3DA%2520PPARdelta%2520Agonist%2520Reduces%2520Amyloid%2520Burden%2520and%2520Brain%2520Inflammation%2520in%2520a%2520Transgenic%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2009%26volume%3D6%26spage%3D431%26epage%3D437%26doi%3D10.2174%2F156720509789207949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mounsey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustafa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teismann, P.</span></span> <span> </span><span class="NLM_article-title">A Peroxisome Proliferator-activated Receptor-δ Agonist Provides Neuroprotection in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine Model of Parkinson’s Disease</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>240</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2013.02.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.neuroscience.2013.02.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23500098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=240&publication_year=2013&pages=191-203&author=H.+Martinauthor=R.+Mounseyauthor=K.+Satheauthor=S.+Mustafaauthor=M.+Nelsonauthor=R.+Evansauthor=P.+Teismann&title=A+Peroxisome+Proliferator-activated+Receptor-%CE%B4+Agonist+Provides+Neuroprotection+in+the+1-Methyl-4-phenyl-1%2C+2%2C+3%2C+6-tetrahydropyridine+Model+of+Parkinson%E2%80%99s+Disease&doi=10.1016%2Fj.neuroscience.2013.02.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">A peroxisome proliferator-activated receptor-δ agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease</span></div><div class="casAuthors">Martin, H. L.; Mounsey, R. B.; Sathe, K.; Mustafa, S.; Nelson, M. C.; Evans, R. M.; Teismann, P.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">240</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-203</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor (PPAR)-γ and PPARα have shown neuroprotective effects in models of Parkinson's disease (PD).  The role of the third, more ubiquitous isoform PPARδ has not been fully explored.  This study investigated the role of PPARδ in PD using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to model the dopaminergic neurodegeneration of PD.  In vitro administration of the PPARδ antagonist GSK0660 (1 μM) increased the detrimental effect of 1-methyl-4-phenylpyridinium iodide (MPP+) on cell viability, which was reversed by co-treatment with agonist GW0742 (1 μM).  GW0742 alone did not affect MPP+ toxicity.  PPARδ was expressed in the nucleus of dopaminergic neurons and in astrocytes.  Striatal PPARδ levels were increased (over two-fold) immediately after MPTP treatment (30 mg/kg for 5 consecutive days) compared to saline-treated mice.  PPARδ heterozygous mice were not protected against MPTP toxicity.  Intra-striatal infusion of GW0742 (84 μg/day) reduced the MPTP-induced loss of dopaminergic neurons (5036 ± 195) when compared to vehicle-infused mice (3953 ± 460).  These results indicate that agonism of PPARδ provides protection against MPTP toxicity, in agreement with the effects of other PPAR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkRqduiWHIobVg90H21EOLACvtfcHk0ljpSGjBZukTHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVGhs7s%253D&md5=f386ef071f15887b3027029ed80f9064</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.02.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.02.058%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DH.%26aulast%3DMounsey%26aufirst%3DR.%26aulast%3DSathe%26aufirst%3DK.%26aulast%3DMustafa%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DR.%26aulast%3DTeismann%26aufirst%3DP.%26atitle%3DA%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B4%2520Agonist%2520Provides%2520Neuroprotection%2520in%2520the%25201-Methyl-4-phenyl-1%252C%25202%252C%25203%252C%25206-tetrahydropyridine%2520Model%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D240%26spage%3D191%26epage%3D203%26doi%3D10.1016%2Fj.neuroscience.2013.02.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore-Hall, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampat, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttgereit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, M.-J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arreola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimov, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaasterland, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarowski, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopher, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masliah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Spada, A. R.</span></span> <span> </span><span class="NLM_article-title">PPAR-δ is Repressed in Huntington’s disease, is Required for Normal Neuronal Function and can be Targeted Therapeutically</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1038/nm.4003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fnm.4003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=26642438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFOmtbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=37-45&author=A.+S.+Dickeyauthor=V.+V.+Pinedaauthor=T.+Tsunemiauthor=P.+P.+Liuauthor=H.+C.+Mirandaauthor=S.+K.+Gilmore-Hallauthor=N.+Lomasauthor=K.+R.+Sampatauthor=A.+Buttgereitauthor=M.-J.+M.+Torresauthor=A.+L.+Floresauthor=M.+Arreolaauthor=N.+Arbezauthor=S.+S.+Akimovauthor=T.+C.+Gaasterlandauthor=E.+R.+Lazarowskiauthor=C.+A.+Rossauthor=G.+W.+Yeoauthor=B.+L.+Sopherauthor=G.+K.+Magnusonauthor=A.+B.+Pinkertonauthor=E.+Masliahauthor=A.+R.+La+Spada&title=PPAR-%CE%B4+is+Repressed+in+Huntington%E2%80%99s+disease%2C+is+Required+for+Normal+Neuronal+Function+and+can+be+Targeted+Therapeutically&doi=10.1038%2Fnm.4003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically</span></div><div class="casAuthors">Dickey, Audrey S.; Pineda, Victor V.; Tsunemi, Taiji; Liu, Patrick P.; Miranda, Helen C.; Gilmore-Hall, Stephen K.; Lomas, Nicole; Sampat, Kunal R.; Buttgereit, Anne; Torres, Mark-Joseph Manalang; Flores, April L.; Arreola, Martin; Arbez, Nicolas; Akimov, Sergey S.; Gaasterland, Terry; Lazarowski, Eduardo R.; Ross, Christopher A.; Yeo, Gene W.; Sopher, Bryce L.; Magnuson, Gavin K.; Pinkerton, Anthony B.; Masliah, Eliezer; La Spada, Albert R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-45</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the huntingtin (HTT) gene, which encodes a polyglutamine tract in the HTT protein.  We found that peroxisome proliferator-activated receptor delta (PPAR-δ) interacts with HTT and that mutant HTT represses PPAR-δ-mediated transactivation.  Increased PPAR-δ transactivation ameliorated mitochondrial dysfunction and improved cell survival of neurons from mouse models of HD.  Expression of dominant-neg. PPAR-δ in the central nervous system of mice was sufficient to induce motor dysfunction, neurodegeneration, mitochondrial abnormalities and transcriptional alterations that recapitulated HD-like phenotypes.  Expression of dominant-neg. PPAR-δ specifically in the striatum of medium spiny neurons in mice yielded HD-like motor phenotypes, accompanied by striatal neuron loss.  In mouse models of HD, pharmacol. activation of PPAR-δ using the agonist KD3010 improved motor function, reduced neurodegeneration and increased survival.  PPAR-δ activation also reduced HTT-induced neurotoxicity in vitro and in medium spiny-like neurons generated from stem cells derived from individuals with HD, indicating that PPAR-δ activation may be beneficial in HD and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-Qe2EEES9-LVg90H21EOLACvtfcHk0ljpSGjBZukTHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFOmtbzO&md5=750ff43fc3796bd941cc58c87b9dd534</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fnm.4003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4003%26sid%3Dliteratum%253Aachs%26aulast%3DDickey%26aufirst%3DA.%2BS.%26aulast%3DPineda%26aufirst%3DV.%2BV.%26aulast%3DTsunemi%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DP.%2BP.%26aulast%3DMiranda%26aufirst%3DH.%2BC.%26aulast%3DGilmore-Hall%26aufirst%3DS.%2BK.%26aulast%3DLomas%26aufirst%3DN.%26aulast%3DSampat%26aufirst%3DK.%2BR.%26aulast%3DButtgereit%26aufirst%3DA.%26aulast%3DTorres%26aufirst%3DM.-J.%2BM.%26aulast%3DFlores%26aufirst%3DA.%2BL.%26aulast%3DArreola%26aufirst%3DM.%26aulast%3DArbez%26aufirst%3DN.%26aulast%3DAkimov%26aufirst%3DS.%2BS.%26aulast%3DGaasterland%26aufirst%3DT.%2BC.%26aulast%3DLazarowski%26aufirst%3DE.%2BR.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DYeo%26aufirst%3DG.%2BW.%26aulast%3DSopher%26aufirst%3DB.%2BL.%26aulast%3DMagnuson%26aufirst%3DG.%2BK.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DLa%2BSpada%26aufirst%3DA.%2BR.%26atitle%3DPPAR-%25CE%25B4%2520is%2520Repressed%2520in%2520Huntington%25E2%2580%2599s%2520disease%252C%2520is%2520Required%2520for%2520Normal%2520Neuronal%2520Function%2520and%2520can%2520be%2520Targeted%2520Therapeutically%26jtitle%3DNat.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D37%26epage%3D45%26doi%3D10.1038%2Fnm.4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arreola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampat, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kanegan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore-Hall, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masliah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Spada, A. R.</span></span> <span> </span><span class="NLM_article-title">PPARδ Activation by Bexarotene Promotes Neuroprotection by Restoring Bioenergetic and Quality Control Homeostasis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">eaal2332</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aal2332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1126%2Fscitranslmed.aal2332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=29212711" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=eaal2332&author=A.+S.+Dickeyauthor=D.+N.+Sanchezauthor=M.+Arreolaauthor=K.+R.+Sampatauthor=W.+Fanauthor=N.+Arbezauthor=S.+Akimovauthor=M.+J.+Van+Kaneganauthor=K.+Ohnishiauthor=S.+K.+Gilmore-Hallauthor=A.+L.+Floresauthor=J.+M.+Nguyenauthor=N.+Lomasauthor=C.+L.+Hsuauthor=D.+C.+Loauthor=C.+A.+Rossauthor=E.+Masliahauthor=R.+M.+Evansauthor=A.+R.+La+Spada&title=PPAR%CE%B4+Activation+by+Bexarotene+Promotes+Neuroprotection+by+Restoring+Bioenergetic+and+Quality+Control+Homeostasis&doi=10.1126%2Fscitranslmed.aal2332"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aal2332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aal2332%26sid%3Dliteratum%253Aachs%26aulast%3DDickey%26aufirst%3DA.%2BS.%26aulast%3DSanchez%26aufirst%3DD.%2BN.%26aulast%3DArreola%26aufirst%3DM.%26aulast%3DSampat%26aufirst%3DK.%2BR.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DArbez%26aufirst%3DN.%26aulast%3DAkimov%26aufirst%3DS.%26aulast%3DVan%2BKanegan%26aufirst%3DM.%2BJ.%26aulast%3DOhnishi%26aufirst%3DK.%26aulast%3DGilmore-Hall%26aufirst%3DS.%2BK.%26aulast%3DFlores%26aufirst%3DA.%2BL.%26aulast%3DNguyen%26aufirst%3DJ.%2BM.%26aulast%3DLomas%26aufirst%3DN.%26aulast%3DHsu%26aufirst%3DC.%2BL.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DLa%2BSpada%26aufirst%3DA.%2BR.%26atitle%3DPPAR%25CE%25B4%2520Activation%2520by%2520Bexarotene%2520Promotes%2520Neuroprotection%2520by%2520Restoring%2520Bioenergetic%2520and%2520Quality%2520Control%2520Homeostasis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26spage%3Deaal2332%26doi%3D10.1126%2Fscitranslmed.aal2332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Q.</span></span> <span> </span><span class="NLM_article-title">PPARß/δ Agonist Alleviates NLRP3 Inflammasome-mediated Neuroinflammation in the MPTP Mouse Model of Parkinson’s Disease</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2018.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbr.2018.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=29885849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1agsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2019&pages=483-489&author=L.+Chenauthor=L.+Xueauthor=J.+Zhengauthor=X.+Tianauthor=Y.+Zhangauthor=Q.+Tong&title=PPAR%C3%9F%2F%CE%B4+Agonist+Alleviates+NLRP3+Inflammasome-mediated+Neuroinflammation+in+the+MPTP+Mouse+Model+of+Parkinson%E2%80%99s+Disease&doi=10.1016%2Fj.bbr.2018.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">PPARss/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease</span></div><div class="casAuthors">Chen, Linfang; Xue, Liujun; Zheng, Jinlong; Tian, Xiangyang; Zhang, Yingdong; Tong, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">483-489</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recent studies have indicated that peroxisome proliferator-activated receptor β/δ (PPARss/δ) agonists exert neuroprotective effects in the model of Parkinson's disease (PD).  Furthermore, PPARss/δ agonists have been shown to have potential anti-inflammatory activity, but the underlying mechanisms remain obscure.  Emerging evidence indicates that the nucleotide-binding domain and leucine-rich-repeat-protein 3 (NLRP3) inflammasome-mediated neuroinflammation plays a crucial role in the pathogenesis of PD.  In the present study we investigate whether PPARss/δ agonists alleviate NLRP3-mediated neuroinflammation in the 1- methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of PD.  We administered GW501516, a selective and high-affinity PPARss/δ agonist, via intracerebroventricular infusion.  Locomotor activities were tested by open field tests and the pole test.  The levels of dopamine and its metabolites were detd. using highperformance liq. chromatog.  Dopaminergic neurodegeneration was assessed via Western blot anal.  The levels of oxidative stress were detected via spectrophotometric assays.  The expressions of pro-inflammatory cytokines were measured by performing quant. real-time RT-PCR and ELISA.  Western blot anal. was used to assess NLRP3 inflammasome activation.  Our results show that GW501516 reduced movement impairment in PD mice; furthermore, it attenuated dopaminergic neurodegeneration in the midbrain and the depletion of dopamine in the striatum and it inhibited inflammatory reactions and NLRP3 inflammasome activation in the midbrain of PD mice.  More importantly, it attenuated astrocytic reaction but had no significant effect on microglial reaction in the midbrain of PD mice.  Collectively, our findings demonstrate for the first time that the specific PPARss/δ agonist GW501516 alleviates NLRP3 inflammasome-mediated neuroinflammation in astrocytes in the MPTP mouse model of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqotnME7QYESLVg90H21EOLACvtfcHk0lgPg7BDe6d_UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1agsb7I&md5=3c8e84371c2968069bfda5ade2238d17</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2018.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2018.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DQ.%26atitle%3DPPAR%25C3%259F%252F%25CE%25B4%2520Agonist%2520Alleviates%2520NLRP3%2520Inflammasome-mediated%2520Neuroinflammation%2520in%2520the%2520MPTP%2520Mouse%2520Model%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2019%26volume%3D356%26spage%3D483%26epage%3D489%26doi%3D10.1016%2Fj.bbr.2018.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, R.</span></span> <span> </span><span class="NLM_article-title">Establishing the Role of PPARβ/δ in Carcinogenesis</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2015.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.tem.2015.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=26490384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=595-607&author=J.+M.+Petersauthor=F.+J.+Gonzalezauthor=R.+M%C3%BCller&title=Establishing+the+Role+of+PPAR%CE%B2%2F%CE%B4+in+Carcinogenesis&doi=10.1016%2Fj.tem.2015.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Establishing the Role of PPARβ/δ in Carcinogenesis</span></div><div class="casAuthors">Peters, Jeffrey M.; Gonzalez, Frank J.; Muller, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">595-607</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The role of the nuclear hormone receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in carcinogenesis is controversial because conflicting studies indicate that it both inhibits and promotes tumorigenesis.  In this review, we focus on recent studies on PPARβ/δ including the significance of increased or decreased PPARβ/δ expression in cancers; a range of opposing mechanisms describing how PPARβ/δ agonists, antagonists, and inverse agonists regulate tumorigenesis and/or whether there may be cell context-specific mechanisms; and whether activating or inhibiting PPARβ/δ is feasible for cancer chemoprevention and/or therapy.  Research questions that need to be addressed are highlighted to establish whether PPARβ/δ can be effectively targeted for cancer chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknhl6H-zW0rVg90H21EOLACvtfcHk0lhA_MuVzfr2Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqurnK&md5=5ff1d51b2103f66d78d245ce5ba90f91</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2015.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2015.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26atitle%3DEstablishing%2520the%2520Role%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520in%2520Carcinogenesis%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2015%26volume%3D26%26spage%3D595%26epage%3D607%26doi%3D10.1016%2Fj.tem.2015.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colby, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaoude, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shureiqi, I.</span></span> <span> </span><span class="NLM_article-title">The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3339</span>, <span class="refDoi"> DOI: 10.3390/ijms19113339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms19113339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlGjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=3339&author=Y.+Liuauthor=J.+K.+Colbyauthor=X.+Zuoauthor=J.+Jaoudeauthor=D.+Weiauthor=I.+Shureiqi&title=The+Role+of+PPAR-%CE%B4+in+Metabolism%2C+Inflammation%2C+and+Cancer%3A+Many+Characters+of+a+Critical+Transcription+Factor&doi=10.3390%2Fijms19113339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">The role of PPAR-δ in metabolism, inflammation, and cancer: many characters of a critical transcription factor</span></div><div class="casAuthors">Liu, Yi; Colby, Jennifer K.; Zuo, Xiangsheng; Jaoude, Jonathan; Wei, Daoyan; Shureiqi, Imad</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3339/1-3339/14</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptor-delta (PPAR-δ), one of three members of the PPAR group in the nuclear receptor superfamily, is a ligand-activated transcription factor.  PPAR-δ regulates important cellular metabolic functions that contribute to maintaining energy balance.  PPAR-δ is esp. important in regulating fatty acid uptake, transport, and β-oxidn. as well as insulin secretion and sensitivity.  These salutary PPAR-δ functions in normal cells are thought to protect against metabolic-syndrome-related diseases, such as obesity, dyslipidemia, insulin resistance/type 2 diabetes, hepatosteatosis, and atherosclerosis.  Given the high clin. burden these diseases pose, highly selective synthetic activating ligands of PPAR-δ were developed as potential preventive/therapeutic agents.  Some of these compds. showed some efficacy in clin. trials focused on metabolic-syndrome-related conditions.  However, the clin. development of PPAR-δ agonists was halted because various lines of evidence demonstrated that cancer cells upregulated PPAR-δ expression/activity as a defense mechanism against nutritional deprivation and energy stresses, improving their survival and promoting cancer progression.  This review discusses the complex relationship between PPAR-δ in health and disease and highlights our current knowledge regarding the different roles that PPAR-δ plays in metab., inflammation, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgFda63KBmOLVg90H21EOLACvtfcHk0lhA_MuVzfr2Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlGjtrs%253D&md5=14c2f5c1423bd28a64b302bbef07ec8d</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3390%2Fijms19113339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19113339%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DColby%26aufirst%3DJ.%2BK.%26aulast%3DZuo%26aufirst%3DX.%26aulast%3DJaoude%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DShureiqi%26aufirst%3DI.%26atitle%3DThe%2520Role%2520of%2520PPAR-%25CE%25B4%2520in%2520Metabolism%252C%2520Inflammation%252C%2520and%2520Cancer%253A%2520Many%2520Characters%2520of%2520a%2520Critical%2520Transcription%2520Factor%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D3339%26doi%3D10.3390%2Fijms19113339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borland, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Ligand Activation of Peroxisome Proliferator-activated Receptor-β/δ (PPARβ/δ) and Inhibition of Cyclooxygenase 2 (COX2) Attenuate Colon Carcinogenesis through Independent Signaling Mechanisms</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgm209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1093%2Fcarcin%2Fbgm209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17893232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1aitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=169-176&author=H.+E.+Hollingsheadauthor=M.+G.+Borlandauthor=A.+N.+Billinauthor=T.+M.+Willsonauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Ligand+Activation+of+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+%28PPAR%CE%B2%2F%CE%B4%29+and+Inhibition+of+Cyclooxygenase+2+%28COX2%29+Attenuate+Colon+Carcinogenesis+through+Independent+Signaling+Mechanisms&doi=10.1093%2Fcarcin%2Fbgm209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms</span></div><div class="casAuthors">Hollingshead, Holly E.; Borland, Michael G.; Billin, Andrew N.; Willson, Timothy M.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-176</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Cyclooxygenase (COX) 2-derived prostaglandin E2 (PGE2) promotes colorectal carcinoma growth and invasion, and inhibition of COX2 by non-steroidal anti-inflammatory drugs is known to inhibit these processes.  There is controversy regarding the effect of ligand activation of peroxisome proliferator-activated receptor (PPAR)-β/δ on colon carcinogenesis, although collective evidence from independent labs. suggest that ligand activation of PPARβ/δ leads to the induction of terminal differentiation coupled with inhibition of cell growth in a variety of models.  The present study examd. the hypothesis that ligand activation of PPARβ/δ and inhibition of COX2 attenuate colon cancer through independent mechanisms and that combining these two mechanisms will enhance this inhibition.  Colon cancer was induced by administering azoxymethane to wild-type and PPARβ/δ-null mice.  Cohorts of mice were treated with GW0742 (a PPARβ/δ ligand), nimesulide (a COX2 inhibitor) or a combination of GW0742 and nimesulide.  Inhibition of COX2 by nimesulide attenuated colon cancer and ligand activation of PPARβ/δ by GW0742 had inhibitory effects.  However, the combined treatment of GW0742 and nimesulide did not cause an enhancement in the attenuation of colon cancer.  Mechanistically, the effects of these compds. occurred through independent mechanisms as increased levels of differentiation markers as a result of ligand activation of PPARβ/δ were not found with COX2 inhibition, and a redn. in PGE2 levels resulting from COX2 inhibition was not obsd. in response to ligand activation of PPARβ/δ.  Results from these studies effectively dissoc. COX2 inhibition and PPARβ/δ activity during colon carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoruGMOyB6ISbVg90H21EOLACvtfcHk0ljaMuoBuNdzDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1aitr4%253D&md5=8943f24f7fadb2da1549142c1350a35e</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgm209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgm209%26sid%3Dliteratum%253Aachs%26aulast%3DHollingshead%26aufirst%3DH.%2BE.%26aulast%3DBorland%26aufirst%3DM.%2BG.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DLigand%2520Activation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520%2528PPAR%25CE%25B2%252F%25CE%25B4%2529%2520and%2520Inhibition%2520of%2520Cyclooxygenase%25202%2520%2528COX2%2529%2520Attenuate%2520Colon%2520Carcinogenesis%2520through%2520Independent%2520Signaling%2520Mechanisms%26jtitle%3DCarcinogenesis%26date%3D2008%26volume%3D29%26spage%3D169%26epage%3D176%26doi%3D10.1093%2Fcarcin%2Fbgm209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorczynski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaner, D.</span></span> <span> </span><span class="NLM_article-title">PPAR-delta Promotes Survival of Breast Cancer Cells in Harsh Metabolic Conditions</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e232</span> <span class="refDoi"> DOI: 10.1038/oncsis.2016.41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Foncsis.2016.41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27270614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2rtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&author=X.+Wangauthor=G.+Wangauthor=Y.+Shiauthor=L.+Sunauthor=R.+Gorczynskiauthor=Y.+Liauthor=Z.+Xuauthor=D.+Spaner&title=PPAR-delta+Promotes+Survival+of+Breast+Cancer+Cells+in+Harsh+Metabolic+Conditions&doi=10.1038%2Foncsis.2016.41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions</span></div><div class="casAuthors">Wang, X.; Wang, G.; Shi, Y.; Sun, L.; Gorczynski, R.; Li, Y.-J.; Xu, Z.; Spaner, D. E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogenesis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e232</span>CODEN:
                <span class="NLM_cas:coden">ONCOCT</span>;
        ISSN:<span class="NLM_cas:issn">2157-9024</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Expression of the nuclear receptor peroxisome proliferator activated receptor delta (PPARδ) in breast cancer cells is neg. assocd. with patient survival, but the underlying mechanisms are not clear.  High PPARδ protein levels in rat breast adenocarcinomas were found to be assocd. with increased growth in soft agar and mice.  Transgenic expression of PPARδ increased the ability of human breast cancer cell lines to migrate in vitro and form lung metastases in mice.  PPARδ also conferred the ability to grow in exhausted tissue culture media and survive in low-glucose and other endoplasmic reticulum stress conditions such as hypoxia.  Upregulation of PPARδ by glucocorticoids or synthetic agonists also protected human breast cancer cells from low glucose.  Survival in low glucose was related to increased antioxidant defenses mediated in part by catalase and also to late AKT phosphorylation, which is assocd. with the prolonged glucose-deprivation response.  Synthetic antagonists reversed the survival benefits conferred by PPARδ in vitro.  These findings suggest that PPARδ conditions breast cancer cells to survive in harsh microenvironmental conditions by reducing oxidative stress and enhancing survival signaling responses.  Drugs that target PPARδ may have a role in the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquHZ575ike5rVg90H21EOLACvtfcHk0ljaMuoBuNdzDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2rtL8%253D&md5=17c864f609ffb2b862d40bafdd0aadbf</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Foncsis.2016.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foncsis.2016.41%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DGorczynski%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DSpaner%26aufirst%3DD.%26atitle%3DPPAR-delta%2520Promotes%2520Survival%2520of%2520Breast%2520Cancer%2520Cells%2520in%2520Harsh%2520Metabolic%2520Conditions%26jtitle%3DOncogenesis%26date%3D2016%26volume%3D5%26doi%3D10.1038%2Foncsis.2016.41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pedchenko, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massion, P. P.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor β/δ Expression and Activation in Lung Cancer</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2007-0426OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1165%2Frcmb.2007-0426OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18566335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKitrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2008&pages=689-696&author=T.+V.+Pedchenkoauthor=A.+L.+Gonzalezauthor=D.+Wangauthor=R.+N.+DuBoisauthor=P.+P.+Massion&title=Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+Expression+and+Activation+in+Lung+Cancer&doi=10.1165%2Frcmb.2007-0426OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor β/δ expression and activation in lung cancer</span></div><div class="casAuthors">Pedchenko, Tetyana V.; Gonzalez, Adriana L.; Wang, DingZhi; DuBois, Raymond N.; Massion, Pierre P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">689-696</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is a ligand-binding inducible transcriptional factor linked to carcinogenesis.  Important functions of PPARβ/δ were demonstrated in series of human epithelial cancers; however, its role in lung cancer remains controversial.  We investigated the differential expression level and localization of PPARβ/δ in tumors and adjacent normal lung tissue, and the effect of PPARβ/δ activation on lung cancer cell proliferation and apoptosis.  PPARβ/δ was expressed in all studied human non-small cell lung cancers, and strong PPARβ/δ immunoreactivity was obsd. in epithelial cells of more than 75% of studied lung tumors.  PPARβ/δ expression was consistently limited to the cancer cells in tumor tissue, while in adjacent normal lung tissue it was limited predominantly to the mononuclear cells.  We found that ligand-binding activation of PPARβ/δ stimulates cell proliferation (an effect that was blocked by a dominant-neg. construct of PPARβ/δ), stimulates anchorage-independent cell growth, and inhibits apoptosis in lung cancer cell lines.  Importantly, the activation of PPARβ/δ induces Akt phosphorylation correlated with up-regulation of PDK1, down-regulation of PTEN, and increased expression of Bcl-xL and COX-2.  These findings indicate that PPARβ/δ exerts proliferative and anti-apoptotic effects via PI3K/Akt1 and COX-2 pathways.  In conclusion, PPARβ/δ is strongly expressed in the majority of lung cancers, and its activation induces proliferative and survival response in non-small cell lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5ad7OPzQyTrVg90H21EOLACvtfcHk0ljaMuoBuNdzDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKitrfI&md5=52d6a291e2678edc6cb87846d02ed29b</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2007-0426OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2007-0426OC%26sid%3Dliteratum%253Aachs%26aulast%3DPedchenko%26aufirst%3DT.%2BV.%26aulast%3DGonzalez%26aufirst%3DA.%2BL.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26aulast%3DMassion%26aufirst%3DP.%2BP.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520Expression%2520and%2520Activation%2520in%2520Lung%2520Cancer%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2008%26volume%3D39%26spage%3D689%26epage%3D696%26doi%3D10.1165%2Frcmb.2007-0426OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Escudero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbone, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catapano, C. V.</span></span> <span> </span><span class="NLM_article-title">Transcriptional and Non-transcriptional Functions of PPARβ/δ in Non-small Cell Lung Cancer</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e46009</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0046009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pone.0046009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=23049921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGhtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=D.+Geniniauthor=R.+Garcia-Escuderoauthor=G.+M.+Carboneauthor=C.+V.+Catapano&title=Transcriptional+and+Non-transcriptional+Functions+of+PPAR%CE%B2%2F%CE%B4+in+Non-small+Cell+Lung+Cancer&doi=10.1371%2Fjournal.pone.0046009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional and non-transcriptional functions of PPARβ/δ in non-small cell lung cancer</span></div><div class="casAuthors">Genini, Davide; Garcia-Escudero, Ramon; Carbone, Giuseppina M.; Catapano, Carlo V.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e46009</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is a nuclear receptor involved in regulation of lipid and glucose metab., wound healing and inflammation.  PPARβ/δ has been assocd. also with cancer.  Here we investigated the expression of PPARβ/δ and components of the prostaglandin biosynthetic pathway in non-small cell lung cancer (NSCLC).  We found increased expression of PPARβ/δ, Cox-2, cPLA2, PGES and VEGF in human NSCLC compared to normal lung.  In NSCLC cell lines PPARβ/δ activation increased proliferation and survival, while PPARβ/δ knock-down reduced viability and increased apoptosis.  PPARβ/δ agonists induced Cox-2 and VEGF transcription, suggesting the existence of feed-forward loops promoting cell survival, inflammation and angiogenesis.  These effects were seen only in high PPARβ/δ expressing cells, while low expressing cells were less or not affected.  The effects were also abolished by PPARβ/δ knock-down or incubation with a PPARβ/δ antagonist.  Induction of VEGF was due to both binding of PPARβ/δ to the VEGF promoter and PI3K activation through a non-genomic mechanism.  We found that PPARβ/δ interacted with the PI3K regulatory subunit p85α leading to PI3K activation and Akt phosphorylation.  Collectively, these data indicate that PPARβ/δ might be a central element in lung carcinogenesis controlling multiple pathways and representing a potential target for NSCLC treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYO_bRePhvx7Vg90H21EOLACvtfcHk0ljTMnm3jke-wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGhtLfI&md5=5e02eac5c95bb48dfdb6b7f11c1e7bf1</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0046009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0046009%26sid%3Dliteratum%253Aachs%26aulast%3DGenini%26aufirst%3DD.%26aulast%3DGarcia-Escudero%26aufirst%3DR.%26aulast%3DCarbone%26aufirst%3DG.%2BM.%26aulast%3DCatapano%26aufirst%3DC.%2BV.%26atitle%3DTranscriptional%2520and%2520Non-transcriptional%2520Functions%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520in%2520Non-small%2520Cell%2520Lung%2520Cancer%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0046009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montagner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallichet
Blanc, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sng, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottaz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degueurce, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baruchet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antsiferova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Saati, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span> <span> </span><span class="NLM_article-title">Src is Activated by the Nuclear Receptor Peroxisome Proliferator-activated Receptor β/δ in Ultraviolet Radiation Induced Skin Cancer</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1002/emmm.201302666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1002%2Femmm.201302666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=24203162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvFKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=80-98&author=A.+Montagnerauthor=M.+B.+Delgadoauthor=C.+Tallichet%0ABlancauthor=J.+S.+Chanauthor=M.+K.+Sngauthor=H.+Mottazauthor=G.+Degueurceauthor=Y.+Lippiauthor=C.+Moretauthor=M.+Baruchetauthor=M.+Antsiferovaauthor=S.+Wernerauthor=D.+Hohlauthor=T.+Al+Saatiauthor=P.+J.+Farmerauthor=N.+S.+Tanauthor=L.+Michalikauthor=W.+Wahli&title=Src+is+Activated+by+the+Nuclear+Receptor+Peroxisome+Proliferator-activated+Receptor+%CE%B2%2F%CE%B4+in+Ultraviolet+Radiation+Induced+Skin+Cancer&doi=10.1002%2Femmm.201302666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer</span></div><div class="casAuthors">Montagner, Alexandra; Delgado, Maria B.; Tallichet-Blanc, Corinne; Chan, Jeremy S. K.; Sng, Ming K.; Mottaz, Helene; Degueurce, Gwendoline; Lippi, Yannick; Moret, Catherine; Baruchet, Michael; Antsiferova, Maria; Werner, Sabine; Hohl, Daniel; Al Saati, Talal; Farmer, Pierre J.; Tan, Nguan S.; Michalik, Liliane; Wahli, Walter</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-98</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Although non-melanoma skin cancer (NMSC) is the most common human cancer and its incidence continues to rise worldwide, the mechanisms underlying its development remain incompletely understood.  Here, we unveil a cascade of events involving peroxisome proliferator-activated receptor (PPAR) β/δ and the oncogene Src, which promotes the development of UV-induced skin cancer in mice.  UV-induced PPARβ/δ activity, which directly stimulated Src expression, increased Src kinase activity and enhanced the EGFR/Erk1/2 signalling pathway, resulting in increased epithelial-to-mesenchymal transition (EMT) marker expression.  Consistent with these observations, PPARβ/δ-null mice developed fewer and smaller skin tumors, and a PPARβ/δ antagonist prevented UV-dependent Src stimulation.  Furthermore, the expression of PPARβ/δ pos. correlated with the expression of SRC and EMT markers in human skin squamous cell carcinoma (SCC), and critically, linear models applied to several human epithelial cancers revealed an interaction between PPARβ/δ and SRC and TGFβ1 transcriptional levels.  Taken together, these observations motivate the future evaluation of PPARβ/δ modulators to attenuate the development of several epithelial cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKDhlgcaReIrVg90H21EOLACvtfcHk0ljTMnm3jke-wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvFKhuw%253D%253D&md5=daebc7b735f53c0dad38e00b09139d9f</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Femmm.201302666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201302666%26sid%3Dliteratum%253Aachs%26aulast%3DMontagner%26aufirst%3DA.%26aulast%3DDelgado%26aufirst%3DM.%2BB.%26aulast%3DTallichet%2BBlanc%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DJ.%2BS.%26aulast%3DSng%26aufirst%3DM.%2BK.%26aulast%3DMottaz%26aufirst%3DH.%26aulast%3DDegueurce%26aufirst%3DG.%26aulast%3DLippi%26aufirst%3DY.%26aulast%3DMoret%26aufirst%3DC.%26aulast%3DBaruchet%26aufirst%3DM.%26aulast%3DAntsiferova%26aufirst%3DM.%26aulast%3DWerner%26aufirst%3DS.%26aulast%3DHohl%26aufirst%3DD.%26aulast%3DAl%2BSaati%26aufirst%3DT.%26aulast%3DFarmer%26aufirst%3DP.%2BJ.%26aulast%3DTan%26aufirst%3DN.%2BS.%26aulast%3DMichalik%26aufirst%3DL.%26aulast%3DWahli%26aufirst%3DW.%26atitle%3DSrc%2520is%2520Activated%2520by%2520the%2520Nuclear%2520Receptor%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%252F%25CE%25B4%2520in%2520Ultraviolet%2520Radiation%2520Induced%2520Skin%2520Cancer%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D80%26epage%3D98%26doi%3D10.1002%2Femmm.201302666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katkuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, R. N.</span></span> <span> </span><span class="NLM_article-title">Activation of Nuclear Hormone Receptor Peroxisome Proliferator-activated Receptor-δ Accelerates Intestinal Adenoma Growth</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1038/nm993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fnm993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=14758356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Wnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=245-247&author=R.+A.+Guptaauthor=D.+Wangauthor=S.+Katkuriauthor=H.+Wangauthor=S.+K.+Deyauthor=R.+N.+DuBois&title=Activation+of+Nuclear+Hormone+Receptor+Peroxisome+Proliferator-activated+Receptor-%CE%B4+Accelerates+Intestinal+Adenoma+Growth&doi=10.1038%2Fnm993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-δ accelerates intestinal adenoma growth</span></div><div class="casAuthors">Gupta, Rajnish A.; Wang, Dingzhi; Katkuri, Sharada; Wang, Haibin; Dey, Sudhansu K.; DuBois, Raymond N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-247</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors treated Apcmin mice, which are predisposed to intestinal polyposis, with a selective synthetic agonist of peroxisome proliferator-activated receptor-δ (PPAR-δ).  Exposure of Apcmin mice to the PPAR-δ ligand GW501516 resulted in a significant increase in the no. and size of intestinal polyps.  The most prominent effect was on polyp size; mice treated with the PPAR-δ activator had a fivefold increase in the no. of polyps larger than 2 mm.  The authors' results implicate PPAR-δ in the regulation of intestinal adenoma growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9HsQ1uQcNULVg90H21EOLACvtfcHk0ljTMnm3jke-wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Wnur0%253D&md5=6864a34542e02b3680fdf86492a2d678</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fnm993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm993%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DKatkuri%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDey%26aufirst%3DS.%2BK.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26atitle%3DActivation%2520of%2520Nuclear%2520Hormone%2520Receptor%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B4%2520Accelerates%2520Intestinal%2520Adenoma%2520Growth%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D245%26epage%3D247%26doi%3D10.1038%2Fnm993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marin, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peraza, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Ligand Activation of Peroxisome Proliferator-activated Receptor β Inhibits Colon Carcinogenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">4394</span>– <span class="NLM_lpage">4401</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-4277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1158%2F0008-5472.CAN-05-4277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16618765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFSlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4394-4401&author=H.+E.+Marinauthor=M.+A.+Perazaauthor=A.+N.+Billinauthor=T.+M.+Willsonauthor=J.+M.+Wardauthor=M.+J.+Kennettauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Ligand+Activation+of+Peroxisome+Proliferator-activated+Receptor+%CE%B2+Inhibits+Colon+Carcinogenesis&doi=10.1158%2F0008-5472.CAN-05-4277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Activation of Peroxisome Proliferator-Activated Receptor β Inhibits Colon Carcinogenesis</span></div><div class="casAuthors">Marin, Holly E.; Peraza, Marjorie A.; Billin, Andrew N.; Willson, Timothy M.; Ward, Jerrold M.; Kennett, Mary J.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4394-4401</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">There is considerable debate whether peroxisome proliferator-activated receptor β/δ (PPARβ/δ) ligands potentiate or suppress colon carcinogenesis.  Whereas administration of a PPARβ ligand causes increased small intestinal tumorigenesis in Apcmin/+ mice, PPARβ-null (Pparb-/-) mice exhibit increased colon polyp multiplicity in colon cancer bioassays, suggesting that ligand activation of this receptor will inhibit colon carcinogenesis.  This hypothesis was examd. by treating wild-type (Pparb+/+) and Pparb-/- with azoxymethane, coupled with a highly specific PPARβ ligand, GW0742.  Ligand activation of PPARβ in Pparb+/+ mice caused an increase in the expression of mRNA encoding adipocyte differentiation-related protein, fatty acid-binding protein, and cathepsin E.  These findings are indicative of colonocyte differentiation, which was confirmed by immunohistochem. anal.  No PPARβ-dependent differences in replicative DNA synthesis or expression of phosphatase and tensin homolog, phosphoinositide-dependent kinase, integrin-linked kinase, or phospho-Akt were detected in ligand-treated mouse colonic epithelial cells although increased apoptosis was found in GW0742-treated Pparb+/+ mice.  Consistent with increased colonocyte differentiation and apoptosis, inhibition of colon polyp multiplicity was also found in ligand-treated Pparb+/+ mice, and all of these effects were not found in Pparb-/- mice.  In contrast to previous reports suggesting that activation of PPARβ potentiates intestinal tumorigenesis, here we show that ligand activation of PPARβ attenuates chem. induced colon carcinogenesis and that PPARβ-dependent induction of cathepsin E could explain the reported disparity in the literature about the effect of ligand activation of PPARβ in the intestine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3kmul5SHAMbVg90H21EOLACvtfcHk0lig2xNEVKc2Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFSlur8%253D&md5=6d5f90159a456ad15d2f35b043a7beb8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-4277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-4277%26sid%3Dliteratum%253Aachs%26aulast%3DMarin%26aufirst%3DH.%2BE.%26aulast%3DPeraza%26aufirst%3DM.%2BA.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWard%26aufirst%3DJ.%2BM.%26aulast%3DKennett%26aufirst%3DM.%2BJ.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DLigand%2520Activation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%2520Inhibits%2520Colon%2520Carcinogenesis%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4394%26epage%3D4401%26doi%3D10.1158%2F0008-5472.CAN-05-4277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Girroir, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor-β/δ (PPARβ/δ) Ligands Inhibit Growth of UACC903 and MCF7 Human Cancer Cell Lines</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>243</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1016/j.tox.2007.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.tox.2007.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18054822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCgtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=2008&pages=236-243&author=E.+E.+Girroirauthor=H.+E.+Hollingsheadauthor=A.+N.+Billinauthor=T.+M.+Willsonauthor=G.+P.+Robertsonauthor=A.+K.+Sharmaauthor=S.+Aminauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+%28PPAR%CE%B2%2F%CE%B4%29+Ligands+Inhibit+Growth+of+UACC903+and+MCF7+Human+Cancer+Cell+Lines&doi=10.1016%2Fj.tox.2007.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines</span></div><div class="casAuthors">Girroir, Elizabeth E.; Hollingshead, Holly E.; Billin, Andrew N.; Willson, Timothy M.; Robertson, Gavin P.; Sharma, Arun K.; Amin, Shantu; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">236-243</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands for the treatment of diseases including metabolic syndrome, diabetes and obesity has been hampered due to contradictory findings on their potential safety.  For example, while some reports show that ligand activation of PPARβ/δ promotes the induction of terminal differentiation and inhibition of cell growth, other reports suggest that PPARβ/δ ligands potentiate tumorigenesis by increasing cell proliferation.  Some of the contradictory findings could be due in part to differences in the ligand examd., the presence or absence of serum in cell cultures, differences in cell lines or differences in the method used to quantify cell growth.  For these reasons, this study examd. the effect of ligand activation of PPARβ/δ on cell growth of two human cancer cell lines, MCF7 (breast cancer) and UACC903 (melanoma) in the presence or absence of serum using two highly specific PPARβ/δ ligands, GW0742 or GW501516.  Culturing cells in the presence of either GW0742 or GW501516 caused upregulation of the known PPARβ/δ target gene angiopoietin-like protein 4 (ANGPTL4).  Inhibition of cell growth was obsd. in both cell lines cultured in the presence of either GW0742 or GW501516, and the presence or absence of serum had little influence on this inhibition.  Results from the present studies demonstrate that ligand activation of PPARβ/δ inhibits the growth of both MCF7 and UACC903 cell lines and provide further evidence that PPARβ/δ ligands are not mitogenic in human cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhAIn0DDsKNrVg90H21EOLACvtfcHk0lig2xNEVKc2Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCgtrnL&md5=98bc5bef67aa676258b8232a3b6fcb43</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.tox.2007.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tox.2007.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DGirroir%26aufirst%3DE.%2BE.%26aulast%3DHollingshead%26aufirst%3DH.%2BE.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DRobertson%26aufirst%3DG.%2BP.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520%2528PPAR%25CE%25B2%252F%25CE%25B4%2529%2520Ligands%2520Inhibit%2520Growth%2520of%2520UACC903%2520and%2520MCF7%2520Human%2520Cancer%2520Cell%2520Lines%26jtitle%3DToxicology%26date%3D2008%26volume%3D243%26spage%3D236%26epage%3D243%26doi%3D10.1016%2Fj.tox.2007.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span> <span> </span><span class="NLM_article-title">PPARδ Agonist Enhances Colitis-associated Colorectal Cancer</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>842</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2018.10.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.ejphar.2018.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30391747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyqsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=842&publication_year=2019&pages=248-254&author=D.+Zhouauthor=J.+Jinauthor=Q.+Liuauthor=J.+Shiauthor=Y.+Hou&title=PPAR%CE%B4+Agonist+Enhances+Colitis-associated+Colorectal+Cancer&doi=10.1016%2Fj.ejphar.2018.10.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ agonist enhances colitis-associated colorectal cancer</span></div><div class="casAuthors">Zhou, Danya; Jin, Jianhua; Liu, Qian; Shi, Juanjuan; Hou, Yongzhong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">842</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">248-254</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As a nuclear receptor, peroxisome proliferator-activated receptor-δ (PPARδ) plays a crit. role in regulating inflammation and cancer, while it is still unclear the mechanism of PPARδ agonist GW501516 on colitis-assocd. colorectal cancer.  Here we found that GW501516 significantly enhanced colitis-assocd. colorectal cancer in AOM/DSS-induced mice.  In addn., PPARδ agonist GW501516 enhanced pro-inflammatory gene expressions (COX-2, IL-6, IL-8 and MCP-1) in inflamed colon.  Further anal. showed that GW501516 increased the expressions of Glut1 and SLC1A5 in colon cancer cells as well as AOM/DSS-induced colorectal tumors.  These findings revealed a new mechanism of PPARδ agonist GW501516-mediated colitis-assocd. colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAAd6HgYlvO7Vg90H21EOLACvtfcHk0lig2xNEVKc2Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyqsbvJ&md5=126a502e69d849530f46787b49fcf1cc</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2018.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2018.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DY.%26atitle%3DPPAR%25CE%25B4%2520Agonist%2520Enhances%2520Colitis-associated%2520Colorectal%2520Cancer%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D842%26spage%3D248%26epage%3D254%26doi%3D10.1016%2Fj.ejphar.2018.10.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span> <span> </span><span class="NLM_article-title">Metformin Inhibits PPARδ Agonist-mediated Tumor Growth by Reducing Glut1 and SLC1A5 Expressions of Cancer Cells</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>857</i></span>,  <span class="NLM_fpage">172425</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2019.172425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.ejphar.2019.172425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31150647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2iu7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=857&publication_year=2019&pages=172425&author=J.+Dingauthor=Q.+Gouauthor=J.+Jinauthor=J.+Shiauthor=Q.+Liuauthor=Y.+Hou&title=Metformin+Inhibits+PPAR%CE%B4+Agonist-mediated+Tumor+Growth+by+Reducing+Glut1+and+SLC1A5+Expressions+of+Cancer+Cells&doi=10.1016%2Fj.ejphar.2019.172425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells</span></div><div class="casAuthors">Ding, Jiajun; Gou, Qian; Jin, Jianhua; Shi, Juanjuan; Liu, Qian; Hou, Yongzhong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">857</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">172425</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As a nuclear receptor, ligand binding and activated PPARδ (peroxisome-proliferator-activated receptor δ) plays an important role in regulation of inflammation, metab. and cancer, while it is unclear the effect of metformin on PPARδ-mediated cancer cell metab.  Here we found that PPARδ agonist GW501516 significantly increased Glut1 (Glucose transporter 1) and SLC1A5 (solutecarrier family 1 member 5) gene and protein expressions in HCT-116, SW480, HeLa, and MCF-7 cancer cell lines, while metformin inhibited this event, which was assocd. with metformin-mediated inhibition of PPARδ activity in response to GW501516.  Importantly, GW501516 inhibited the binding of PPARδ to AMPK, while metformin reversed this process.  Metformin inhibited Glut1 and SLC1A5 expressions leading to reduced influx of glucose and glutamine in cancer cells, which is assocd. with reduced tumor growth.  These findings suggest that metformin inhibited PPARδ agonist GW501516-induced cancer cell metab. and tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0jao2pRmabVg90H21EOLACvtfcHk0lgKVl6knc77jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2iu7vN&md5=d05b096d427480e3058794ed8aa3c161</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2019.172425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2019.172425%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGou%26aufirst%3DQ.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DY.%26atitle%3DMetformin%2520Inhibits%2520PPAR%25CE%25B4%2520Agonist-mediated%2520Tumor%2520Growth%2520by%2520Reducing%2520Glut1%2520and%2520SLC1A5%2520Expressions%2520of%2520Cancer%2520Cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D857%26spage%3D172425%26doi%3D10.1016%2Fj.ejphar.2019.172425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmi, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, R. C.</span></span> <span> </span><span class="NLM_article-title">PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma</span>. <i>Nucl. Receptor Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">101306</span>, <span class="refDoi"> DOI: 10.11131/2018/101306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.11131%2F2018%2F101306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=29450204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWnurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=101306&author=A.+Bannoauthor=A.+T.+Reddyauthor=S.+P.+Lakshmiauthor=R.+C.+Reddy&title=PPARs%3A+Key+Regulators+of+Airway+Inflammation+and+Potential+Therapeutic+Targets+in+Asthma&doi=10.11131%2F2018%2F101306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">PPARs: key regulators of airway inflammation and potential therapeutic targets in asthma</span></div><div class="casAuthors">Banno, Asoka; Reddy, Aravind T.; Lakshmi, Sowmya P.; Reddy, Raju C.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Receptor Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101306</span>CODEN:
                <span class="NLM_cas:coden">NRRUAZ</span>;
        ISSN:<span class="NLM_cas:issn">2314-5714</span>.
    
            (<span class="NLM_cas:orgname">AgiAl Publishing House</span>)
        </div><div class="casAbstract">Asthma affects approx. 300 million people worldwide, significantly impacting quality of life and healthcare costs.  While current therapies are effective in controlling many patients' symptoms, a large no. continue to experience exacerbations or treatment-related adverse effects.  Alternative therapies are thus urgently needed.  Accumulating evidence has shown that the peroxisome proliferator-activated receptor (PPAR) family of nuclear hormone receptors, comprising PPARα, PPARβ/δ, and PPARγ, is involved in asthma pathogenesis and that ligand-induced activation of these receptors suppresses asthma pathol.  PPAR agonists exert their anti-inflammatory effects primarily by suppressing pro-inflammatory mediators and antagonizing the pro-inflammatory functions of various cell types relevant to asthma pathophysiol.  Exptl. findings strongly support the potential clin. benefits of PPAR agonists in the treatment of asthma.  We review current literature, highlighting PPARs' key role in asthma pathogenesis and their agonists' therapeutic potential.  With addnl. research and rigorous clin. studies, PPARs may become attractive therapeutic targets in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJAqMw2GP0LVg90H21EOLACvtfcHk0lgKVl6knc77jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWnurrF&md5=0b6ea7f25f43a7710251de8febf61ad7</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.11131%2F2018%2F101306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.11131%252F2018%252F101306%26sid%3Dliteratum%253Aachs%26aulast%3DBanno%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DA.%2BT.%26aulast%3DLakshmi%26aufirst%3DS.%2BP.%26aulast%3DReddy%26aufirst%3DR.%2BC.%26atitle%3DPPARs%253A%2520Key%2520Regulators%2520of%2520Airway%2520Inflammation%2520and%2520Potential%2520Therapeutic%2520Targets%2520in%2520Asthma%26jtitle%3DNucl.%2520Receptor%2520Res.%26date%3D2018%26volume%3D5%26spage%3D101306%26doi%3D10.11131%2F2018%2F101306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galuppo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterniti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span> <span> </span><span class="NLM_article-title">GW0742, A High Affinity PPAR-β/δ Agonist Reduces Lung Inflammation Induced by Bleomycin Instillation in Mice</span>. <i>Int. J. Immunopathol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1046</span>, <span class="refDoi"> DOI: 10.1177/039463201002300408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1177%2F039463201002300408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21244753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivFWmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=1033-1046&author=M.+Galuppoauthor=R.+Di+Paolaauthor=E.+Mazzonauthor=E.+Espositoauthor=I.+Paternitiauthor=A.+Kapoorauthor=C.+Thiemermannauthor=S.+Cuzzocrea&title=GW0742%2C+A+High+Affinity+PPAR-%CE%B2%2F%CE%B4+Agonist+Reduces+Lung+Inflammation+Induced+by+Bleomycin+Instillation+in+Mice&doi=10.1177%2F039463201002300408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">GW 0742, a high affinity PPAR-β/δ agonist reduces lung inflammation induced by bleomycin instillation in mice</span></div><div class="casAuthors">Galuppo, M.; Di Paola, R.; Mazzon, E.; Esposito, E.; Paterniti, I.; Kapoor, A.; Thiemermann, C.; Cuzzocrea, S.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopathology and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1033-1046</span>CODEN:
                <span class="NLM_cas:coden">IJIPE4</span>;
        ISSN:<span class="NLM_cas:issn">0394-6320</span>.
    
            (<span class="NLM_cas:orgname">Biolife s.a.s.</span>)
        </div><div class="casAbstract">Peroxisome Proliferator-Activated Receptor β/δ belongs to a family of ligand-activated transcription factors.  Recent data have clarified its metabolic roles and enhanced the potential role of this receptor as a pharmacol. target.  Moreover, although its role in acute inflammation remains unclear, being the nuclear receptor PPAR β/δ widely expressed in many tissues, including the vascular endothelium, we assume that the infiltration of PMNs into tissues, a prominent feature in inflammation, may also be related to PPAR β/δ.  Mice subjected to intratracheal instillation of bleomycin (BLEO, 1 mg/kg), a glycopeptide produced by the bacterium Streptomyces verticillus, develop lung inflammation and injury characterized by a significant neutrophil infiltration and tissue edema.  Therefore, the aim of this study was to investigate the effects of GW0742, a synthetic high affinity PPAR β/δ agonist, and its possible role in preventing the advance of inflammatory and apoptotic processes induced by bleomycin, that long-term leads to the appearance of pulmonary fibrosis.  Our data showed that GW0742-treatment (0.3 mg/Kg, 10% DMSO, i.p.) has therapeutic effects on pulmonary damage, decreasing many inflammatory and apoptotic parameters detected by measurement of: (1) cytokine prodn.; (2) leukocyte accumulation, indirectly measured as decrease of myeloperoxidase (MPO) activity; (3) IκBα degrdn. and NF-κB nuclear translocation; (4) ERK phosphorylation; (5) stress oxidative by NO formation due to iNOS expression; (6) nitrotyrosine and PAR localization; (7) the degree of apoptosis, evaluated by Bax and Bcl-2 balance, FAS ligand expression and TUNEL staining.  Taken together, our results clearly show that GW0742 reduces the lung injury and inflammation due to the intratracheal BLEO-instillation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu-3Auf7LufrVg90H21EOLACvtfcHk0ljZBJKbF-lOQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivFWmtr0%253D&md5=ff1928c215061f6823f1c56d785db212</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1177%2F039463201002300408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F039463201002300408%26sid%3Dliteratum%253Aachs%26aulast%3DGaluppo%26aufirst%3DM.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DPaterniti%26aufirst%3DI.%26aulast%3DKapoor%26aufirst%3DA.%26aulast%3DThiemermann%26aufirst%3DC.%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3DGW0742%252C%2520A%2520High%2520Affinity%2520PPAR-%25CE%25B2%252F%25CE%25B4%2520Agonist%2520Reduces%2520Lung%2520Inflammation%2520Induced%2520by%2520Bleomycin%2520Instillation%2520in%2520Mice%26jtitle%3DInt.%2520J.%2520Immunopathol.%2520Pharmacol.%26date%3D2010%26volume%3D23%26spage%3D1033%26epage%3D1046%26doi%3D10.1177%2F039463201002300408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haskova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, K.</span></span> <span> </span><span class="NLM_article-title">Modulation of LPS-induced Pulmonary Neutrophil Infiltration and Cytokine Production by the Selective PPARβ/δ Ligand GW0742</span>. <i>Inflammation Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1007/s00011-007-7157-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1007%2Fs00011-007-7157-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18622687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSrsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=314-321&author=Z.+Haskovaauthor=B.+Hoangauthor=G.+Luoauthor=L.+Morganauthor=A.+Billinauthor=F.+Baroneauthor=B.+Shearerauthor=M.+Bartonauthor=K.+Kilgore&title=Modulation+of+LPS-induced+Pulmonary+Neutrophil+Infiltration+and+Cytokine+Production+by+the+Selective+PPAR%CE%B2%2F%CE%B4+Ligand+GW0742&doi=10.1007%2Fs00011-007-7157-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARβ/δ ligand GW0742</span></div><div class="casAuthors">Haskova, Z.; Hoang, B.; Luo, G.; Morgan, L. A.; Billin, A. N.; Barone, F. C.; Shearer, B. G.; Barton, M. E.; Kilgore, K. S.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">314-321</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">The objective was to define the antiinflammatory effects of PPARβ/δ activation by use of the selective PPARβ/δ ligand (GW0742) in a model of lipopolysaccharide (LPS)-induced pulmonary inflammation.  Male BALB/c mice were pretreated for three days with the PPARβ/δ agonist, GW0742, prior to induction of LPS-mediated pulmonary inflammation.  Bronchial alveolar lavage fluid (BALF) was analyzed for inflammatory cell influx and for levels of pro-inflammatory mediators.  BALF-derived inflammatory cells were also collected for mRNA anal.  Pretreatment with GW0742 resulted in a significant decrease in leukocyte recruitment into the pulmonary space.  Protein and mRNA levels of the pro-inflammatory cytokines IL-6, IL-1β and TNFα in BALF were found to be significantly decreased in GW0742-treated animals (30 mg/kg).  A significant decrease in granulocyte macrophage-colony stimulating factor (GM-CSF), a major regulator of neutrophil chemotaxis (via its downstream actions on TNFα and other cytokines/chemokines), activation and survival, was also noted in the BALF levels of GW0742-treated animals.  The present study demonstrates that activation of PPARβ/δ attenuates the degree of inflammation in a model of LPS-induced pulmonary inflammation and may therefore represent a novel therapeutic approach for the treatment of inflammation-mediated pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0s9m0a5fBDLVg90H21EOLACvtfcHk0ljZBJKbF-lOQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSrsL%252FO&md5=bd8d4381a20ab0712a214831a4089fc6</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1007%2Fs00011-007-7157-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-007-7157-4%26sid%3Dliteratum%253Aachs%26aulast%3DHaskova%26aufirst%3DZ.%26aulast%3DHoang%26aufirst%3DB.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DMorgan%26aufirst%3DL.%26aulast%3DBillin%26aufirst%3DA.%26aulast%3DBarone%26aufirst%3DF.%26aulast%3DShearer%26aufirst%3DB.%26aulast%3DBarton%26aufirst%3DM.%26aulast%3DKilgore%26aufirst%3DK.%26atitle%3DModulation%2520of%2520LPS-induced%2520Pulmonary%2520Neutrophil%2520Infiltration%2520and%2520Cytokine%2520Production%2520by%2520the%2520Selective%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Ligand%2520GW0742%26jtitle%3DInflammation%2520Res.%26date%3D2008%26volume%3D57%26spage%3D314%26epage%3D321%26doi%3D10.1007%2Fs00011-007-7157-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ali, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FitzGerald, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desvergne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahli, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop-Bailey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. A.</span></span> <span> </span><span class="NLM_article-title">Role of Prostacyclin versus Peroxisome Proliferator-activated Receptor β Receptors in Prostacyclin Sensing by Lung Fibroblasts</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2005-0289OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1165%2Frcmb.2005-0289OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16239641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVGrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=242-246&author=F.+Y.+Aliauthor=K.+Eganauthor=G.+A.+FitzGeraldauthor=B.+Desvergneauthor=W.+Wahliauthor=D.+Bishop-Baileyauthor=T.+D.+Warnerauthor=J.+A.+Mitchell&title=Role+of+Prostacyclin+versus+Peroxisome+Proliferator-activated+Receptor+%CE%B2+Receptors+in+Prostacyclin+Sensing+by+Lung+Fibroblasts&doi=10.1165%2Frcmb.2005-0289OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Role of prostacyclin versus peroxisome proliferator-activated receptor β receptors in prostacyclin sensing by lung fibroblasts</span></div><div class="casAuthors">Ali, Ferhana Y.; Egan, Karine; FitzGerald, Garret A.; Desvergne, Beatrice; Wahli, Walter; Bishop-Bailey, David; Warner, Timothy D.; Mitchell, Jane A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-246</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Prostacyclin and its mimetics are used therapeutically for the treatment of pulmonary hypertension.  These drugs act via cell surface prostacyclin receptors (IP receptors); however, some of them can also activate the nuclear receptor peroxisome proliferator-activated receptor β (PPARβ).  We examd. the possibility that PPARβ is a therapeutic target for the treatment of pulmonary hypertension.  Using the newly approved (for pulmonary hypertension) prostacyclin mimetic treprostinil sodium, reporter gene assays for PPARβ activation and measurement of lung fibroblast proliferation were analyzed.  Treprostinil sodium was found to activate PPARβ in reporter gene assays and to inhibit proliferation of human lung fibroblasts at concns. consistent with an effect on PPARs but not on IP receptors.  The effects of treprostinil sodium on human lung cell proliferation are mimicked by those of the highly selective PPARβ ligand GW 0742.  There are no receptor antagonists for PPARβ or for IP receptors, but by using lung fibroblasts cultured from mice lacking PPARβ (PPARβ-/-) or IP (IP-/-), we demonstrate that the antiproliferative effects of treprostinil sodium are mediated by PPARβ and not IP in lung fibroblasts.  These observations suggest that some of the local, longer-term benefits of treprostinil sodium on reducing the remodeling assocd. with pulmonary hypertension may be mediated by PPARβ.  This study is the first to identify PPARβ as a potential therapeutic target for the treatment of pulmonary hypertension, which is important because orally active PPARβ ligands have been developed for the treatment of dyslipidemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpILe62RqewJLVg90H21EOLACvtfcHk0ljZBJKbF-lOQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVGrtrc%253D&md5=8283d611a1e4c185939969a544a6d04a</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2005-0289OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2005-0289OC%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DF.%2BY.%26aulast%3DEgan%26aufirst%3DK.%26aulast%3DFitzGerald%26aufirst%3DG.%2BA.%26aulast%3DDesvergne%26aufirst%3DB.%26aulast%3DWahli%26aufirst%3DW.%26aulast%3DBishop-Bailey%26aufirst%3DD.%26aulast%3DWarner%26aufirst%3DT.%2BD.%26aulast%3DMitchell%26aufirst%3DJ.%2BA.%26atitle%3DRole%2520of%2520Prostacyclin%2520versus%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%2520Receptors%2520in%2520Prostacyclin%2520Sensing%2520by%2520Lung%2520Fibroblasts%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2006%26volume%3D34%26spage%3D242%26epage%3D246%26doi%3D10.1165%2Frcmb.2005-0289OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heck, B. E.</span>; <span class="NLM_string-name">Kim, D. H.</span>; <span class="NLM_string-name">Erhardt, P.</span>; <span class="NLM_string-name">Kress, B.</span></span>, <span> </span><span class="NLM_article-title">Analogs of Peroxisome Proliferator-activated Receptor (PPAR) Agonists, and Methods of Using the Same</span>. US <span class="NLM_patent">9695137B2</span>, Jul 4, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=B.+E.+Heck&author=D.+H.+Kim&author=P.+Erhardt&author=B.+Kress&title=Analogs+of+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29+Agonists%2C+and+Methods+of+Using+the+Same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHeck%26aufirst%3DB.%2BE.%26atitle%3DAnalogs%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%2520Agonists%252C%2520and%2520Methods%2520of%2520Using%2520the%2520Same%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span>; <span class="NLM_string-name">Evans, R. M.</span>; <span class="NLM_string-name">Kluge, A.</span>; <span class="NLM_string-name">Lagu, B.</span>; <span class="NLM_string-name">Miura, M.</span>; <span class="NLM_string-name">Panigrahi, S. K.</span>; <span class="NLM_string-name">Patane, M.</span>; <span class="NLM_string-name">Samajdar, S.</span>; <span class="NLM_string-name">Senaiar, R.</span>; <span class="NLM_string-name">Takahashi, T.</span></span> <span> </span><span class="NLM_article-title">PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof</span>. US <span class="NLM_patent">10479775B1</span>, Nov 19, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=M.+Downes&author=R.+M.+Evans&author=A.+Kluge&author=B.+Lagu&author=M.+Miura&author=S.+K.+Panigrahi&author=M.+Patane&author=S.+Samajdar&author=R.+Senaiar&author=T.+Takahashi&title=PPAR+Agonists%2C+Compounds%2C+Pharmaceutical+Compositions%2C+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDownes%26aufirst%3DM.%26atitle%3DPPAR%2520Agonists%252C%2520Compounds%252C%2520Pharmaceutical%2520Compositions%252C%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluge, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenburg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddeeris, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basinski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senaiar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaleel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patane, M. A.</span></span> <span> </span><span class="NLM_article-title">Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00287</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00287" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWrsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=935-940&author=B.+Laguauthor=A.+F.+Klugeauthor=E.+Tozzoauthor=R.+Fredenburgauthor=E.+L.+Bellauthor=M.+M.+Goddeerisauthor=P.+Dwyerauthor=A.+Basinskiauthor=R.+S.+Senaiarauthor=M.+Jaleelauthor=N.+K.+Tiwariauthor=S.+K.+Panigrahiauthor=N.+R.+Krishnamurthyauthor=T.+Takahashiauthor=M.+A.+Patane&title=Selective+PPAR%CE%B4+Modulators+Improve+Mitochondrial+Function%3A+Potential+Treatment+for+Duchenne+Muscular+Dystrophy+%28DMD%29&doi=10.1021%2Facsmedchemlett.8b00287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)</span></div><div class="casAuthors">Lagu, Bharat; Kluge, Arthur F.; Tozzo, Effie; Fredenburg, Ross; Bell, Eric L.; Goddeeris, Matthew M.; Dwyer, Peter; Basinski, Andrew; Senaiar, Ramesh S.; Jaleel, Mahaboobi; Tiwari, Nirbhay Kumar; Panigrahi, Sunil K.; Krishnamurthy, Narasimha Rao; Takahashi, Taisuke; Patane, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">935-940</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arylheterocyclylmethylphenoxyalkanoic and -alkenoic acids such as I were prepd. as selective activators of PPARδ for potential use in improving mitochondrial function and for treatment of Duchenne muscular dystrophy (DMD); the heterocyclyl moiety was designed to mimic the cis-amide conformation found in the crystal structure of a previously prepd. PPARδ activator to the ligand binding domain of PPARδ.  The activation of PPARδ, selectivities for PPARδ over PPARα and PPARγ, and pharmacokinetics (half-lives, clearance, and AUC) in mice were detd. for the compds.  I (MA-0204) was a potent, selective PPARδ modulator with good pharmacokinetic properties.  I was tested in vivo in mice and in myoblasts isolated from a DMD patient; I altered the expression of PPARδ target genes and improved fatty acid oxidn., indicating that I may be useful for treating DMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO9q2q5vM90LVg90H21EOLACvtfcHk0lhV-6VxMqfnwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWrsLbN&md5=2c9dccc70c48966cbd30df8f27c06304</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00287%26sid%3Dliteratum%253Aachs%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DKluge%26aufirst%3DA.%2BF.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DFredenburg%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DE.%2BL.%26aulast%3DGoddeeris%26aufirst%3DM.%2BM.%26aulast%3DDwyer%26aufirst%3DP.%26aulast%3DBasinski%26aufirst%3DA.%26aulast%3DSenaiar%26aufirst%3DR.%2BS.%26aulast%3DJaleel%26aufirst%3DM.%26aulast%3DTiwari%26aufirst%3DN.%2BK.%26aulast%3DPanigrahi%26aufirst%3DS.%2BK.%26aulast%3DKrishnamurthy%26aufirst%3DN.%2BR.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26atitle%3DSelective%2520PPAR%25CE%25B4%2520Modulators%2520Improve%2520Mitochondrial%2520Function%253A%2520Potential%2520Treatment%2520for%2520Duchenne%2520Muscular%2520Dystrophy%2520%2528DMD%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D935%26epage%3D940%26doi%3D10.1021%2Facsmedchemlett.8b00287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span> <i>MA-0204 Modulation
of PPARd Protects and Promotes Recovery after
AKI in Normal Rats and Aged Diabetic CKD Zsf1 Rats by Enhancing Fatty
Acid Oxidation in Proximal Tubular Epithelial Cells</i>; <span class="NLM_publisher-name">Mitobridge</span>, <span class="NLM_year">2020</span>; <a href="https://www.mitobridge.com/images/resources/ASNposter1.pdf" class="extLink">https://www.mitobridge.com/images/resources/ASNposter1.pdf</a> (accessed
2020-02-06).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MA-0204+Modulation%0Aof+PPARd+Protects+and+Promotes+Recovery+after%0AAKI+in+Normal+Rats+and+Aged+Diabetic+CKD+Zsf1+Rats+by+Enhancing+Fatty%0AAcid+Oxidation+in+Proximal+Tubular+Epithelial+Cells%3B+Mitobridge%2C+2020%3B+https%3A%2F%2Fwww.mitobridge.com%2Fimages%2Fresources%2FASNposter1.pdf+%28accessed%0A2020-02-06%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DMA-0204%2520Modulation%250Aof%2520PPARd%2520Protects%2520and%2520Promotes%2520Recovery%2520after%250AAKI%2520in%2520Normal%2520Rats%2520and%2520Aged%2520Diabetic%2520CKD%2520Zsf1%2520Rats%2520by%2520Enhancing%2520Fatty%250AAcid%2520Oxidation%2520in%2520Proximal%2520Tubular%2520Epithelial%2520Cells%26pub%3DMitobridge%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boitier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautier, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R.</span></span> <span> </span><span class="NLM_article-title">Advances in Understanding the Regulation of Apoptosis and Mitosis by Peroxisome Proliferator-activated Receptors in Pre-clinical Models: Relevance for Human Health and Disease</span>. <i>Comp. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1186/1476-5926-2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1186%2F1476-5926-2-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=12622871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BC2sbntFamug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=3&author=E.+Boitierauthor=J.-C.+Gautierauthor=R.+Roberts&title=Advances+in+Understanding+the+Regulation+of+Apoptosis+and+Mitosis+by+Peroxisome+Proliferator-activated+Receptors+in+Pre-clinical+Models%3A+Relevance+for+Human+Health+and+Disease&doi=10.1186%2F1476-5926-2-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease</span></div><div class="casAuthors">Boitier Eric; Gautier Jean-Charles; Roberts Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Comparative hepatology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn">1476-5926</span>.
    </div><div class="casAbstract">Peroxisome proliferator activated receptors (PPARs) are a family of related receptors implicated in a diverse array of biological processes.  There are 3 main isotypes of PPARs known as PPARalpha, PPARbeta and PPARgamma and each is organized into domains associated with a function such as ligand binding, activation and DNA binding.  PPARs are activated by ligands, which can be both endogenous such as fatty acids or their derivatives, or synthetic, such as peroxisome proliferators, hypolipidaemic drugs, anti-inflammatory or insulin-sensitizing drugs.  Once activated, PPARs bind to DNA and regulate gene transcription.  The different isotypes differ in their expression patterns, lending clues on their function.  PPARalpha is expressed mainly in liver whereas PPARgamma is expressed in fat and in some macrophages.  Activation of PPARalpha in rodent liver is associated with peroxisome proliferation and with suppression of apoptosis and induction of cell proliferation.  The mechanism by which activation of PPARalpha regulates apoptosis and proliferation is unclear but is likely to involve target gene transcription.  Similarly, PPARgamma is involved in the induction of cell growth arrest occurring during the differentiation process of fibroblasts to adipocytes.  However, it has been implicated in the regulation of cell cycle and cell proliferation in colon cancer models.  Less in known concerning PPARbeta but it was identified as a downstream target gene for APC/beta-catenin/T cell factor-4 tumor suppressor pathway, which is involved in the regulation of growth promoting genes such as c-myc and cyclin D1.  Marked species and tissue differences in the expression of PPARs complicate the extrapolation of pre-clinical data to humans.  For example, PPARalpha ligands such as the hypolipidaemic fibrates have been used extensively in the clinic over the past 20 years to treat cardiovascular disease and side effects of clinical fibrate use are rare, despite the observation that these compounds are rodent carcinogens.  Similarly, adverse clinical responses have been seen with PPARgamma ligands that were not predicted by pre-clinical models.  Here, we consider the response to PPAR ligands seen in pre-clinical models of efficacy and safety in the context of human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4NRYnlY2Xr62q3xNe7a7QfW6udTcc2ea45QDMvz25_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbntFamug%253D%253D&md5=4dd9e4a1df8593635a7e60cd443e67c0</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1186%2F1476-5926-2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-5926-2-3%26sid%3Dliteratum%253Aachs%26aulast%3DBoitier%26aufirst%3DE.%26aulast%3DGautier%26aufirst%3DJ.-C.%26aulast%3DRoberts%26aufirst%3DR.%26atitle%3DAdvances%2520in%2520Understanding%2520the%2520Regulation%2520of%2520Apoptosis%2520and%2520Mitosis%2520by%2520Peroxisome%2520Proliferator-activated%2520Receptors%2520in%2520Pre-clinical%2520Models%253A%2520Relevance%2520for%2520Human%2520Health%2520and%2520Disease%26jtitle%3DComp.%2520Hepatol.%26date%3D2003%26volume%3D2%26spage%3D3%26doi%3D10.1186%2F1476-5926-2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brélivet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moras, D.</span></span> <span> </span><span class="NLM_article-title">Structural Analysis of Nuclear Receptors: From Isolated Domains to Integral Proteins</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2011.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.mce.2011.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21888944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFegsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2012&pages=466-473&author=Y.+Br%C3%A9livetauthor=N.+Rochelauthor=D.+Moras&title=Structural+Analysis+of+Nuclear+Receptors%3A+From+Isolated+Domains+to+Integral+Proteins&doi=10.1016%2Fj.mce.2011.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of nuclear receptors: From isolated domains to integral proteins</span></div><div class="casAuthors">Brelivet, Yann; Rochel, Natacha; Moras, Dino</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">466-473</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NRs) are ligand dependent transcription factors that regulate gene expression.  A no. of in depth structure-function relationship studies have been performed, in particular with drug design perspectives.  Recent structural results concerning integral receptors in diverse functional states, obtained using a combination of different methods, now allow a better understanding of the mechanisms involved in mol. regulation.  The structural data highlight the importance of DNA sequences for binding selectivity and the role of promoter response elements in the spatial organization of the protein domains into functional complexes.  The soln. structures of several heterodimer complexes reveal how the DNA directs the positioning of coactivators.  In the case of PPARγ-RXRα the comparison with the crystal structure reveals two different conformational states that illustrate the flexibility of the receptors.  The results shed light on the dynamics of the mol. recognition process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPsKh1SmCr-rVg90H21EOLACvtfcHk0liyCor34Cgmtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFegsbzI&md5=c9f9061705e48b5ee67411b28a5f449d</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2011.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2011.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25A9livet%26aufirst%3DY.%26aulast%3DRochel%26aufirst%3DN.%26aulast%3DMoras%26aufirst%3DD.%26atitle%3DStructural%2520Analysis%2520of%2520Nuclear%2520Receptors%253A%2520From%2520Isolated%2520Domains%2520to%2520Integral%2520Proteins%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2012%26volume%3D348%26spage%3D466%26epage%3D473%26doi%3D10.1016%2Fj.mce.2011.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montana, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plunket, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oplinger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gampe, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span> <span> </span><span class="NLM_article-title">Structural Determinants of Ligand Binding Selectivity between the Peroxisome Proliferator-activated Receptors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">13919</span>– <span class="NLM_lpage">13924</span>, <span class="refDoi"> DOI: 10.1073/pnas.241410198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.241410198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=11698662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVyntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=13919-13924&author=H.+E.+Xuauthor=M.+H.+Lambertauthor=V.+G.+Montanaauthor=K.+D.+Plunketauthor=L.+B.+Mooreauthor=J.+L.+Collinsauthor=J.+A.+Oplingerauthor=S.+A.+Kliewerauthor=R.+T.+Gampeauthor=D.+D.+McKeeauthor=J.+T.+Mooreauthor=T.+M.+Willson&title=Structural+Determinants+of+Ligand+Binding+Selectivity+between+the+Peroxisome+Proliferator-activated+Receptors&doi=10.1073%2Fpnas.241410198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors</span></div><div class="casAuthors">Xu, H. Eric; Lambert, Millard H.; Montana, Valerie G.; Plunket, Kelli D.; Moore, Linda B.; Collins, Jon L.; Oplinger, Jeffery A.; Kliewer, Steven A.; Gampe, Robert T., Jr.; McKee, David D.; Moore, John T.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13919-13924</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) are transcriptional regulators of glucose, lipid, and cholesterol metab.  We report the x-ray crystal structure of the ligand binding domain of PPARα (NR1C1) as a complex with the agonist ligand GW409544 and a coactivator motif from the steroid receptor coactivator 1.  Through comparison of the crystal structures of the ligand binding domains of the three human PPARs, we have identified mol. determinants of subtype selectivity.  A single amino acid, which is tyrosine in PPARα and histidine in PPARγ, imparts subtype selectivity for both thiazolidinedione and nonthiazolidinedione ligands.  The availability of high-resoln. cocrystal structures of the three PPAR subtypes will aid the design of drugs for the treatments of metabolic and cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOdfCKg7wgXrVg90H21EOLACvtfcHk0liyCor34Cgmtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVyntbk%253D&md5=563a630106a1396dc047ea6f89d7e0e1</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1073%2Fpnas.241410198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.241410198%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DMontana%26aufirst%3DV.%2BG.%26aulast%3DPlunket%26aufirst%3DK.%2BD.%26aulast%3DMoore%26aufirst%3DL.%2BB.%26aulast%3DCollins%26aufirst%3DJ.%2BL.%26aulast%3DOplinger%26aufirst%3DJ.%2BA.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DGampe%26aufirst%3DR.%2BT.%26aulast%3DMcKee%26aufirst%3DD.%2BD.%26aulast%3DMoore%26aufirst%3DJ.%2BT.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DStructural%2520Determinants%2520of%2520Ligand%2520Binding%2520Selectivity%2520between%2520the%2520Peroxisome%2520Proliferator-activated%2520Receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D13919%26epage%3D13924%26doi%3D10.1073%2Fpnas.241410198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montana, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisely, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milburn, M. V.</span></span> <span> </span><span class="NLM_article-title">Molecular Recognition of Fatty Acids by Peroxisome Proliferator-activated Receptors</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(00)80467-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS1097-2765%2800%2980467-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10198642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1MXit1OmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1999&pages=397-403&author=H.+E.+Xuauthor=M.+H.+Lambertauthor=V.+G.+Montanaauthor=D.+J.+Parksauthor=S.+G.+Blanchardauthor=P.+J.+Brownauthor=D.+D.+Sternbachauthor=J.+M.+Lehmannauthor=G.+B.+Wiselyauthor=T.+M.+Willsonauthor=S.+A.+Kliewerauthor=M.+V.+Milburn&title=Molecular+Recognition+of+Fatty+Acids+by+Peroxisome+Proliferator-activated+Receptors&doi=10.1016%2FS1097-2765%2800%2980467-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of fatty acids by peroxisome proliferator-activated receptors</span></div><div class="casAuthors">Xu, H. Eric; Lambert, Millard H.; Montana, Valerie G.; Parks, Derek J.; Blanchard, Steven G.; Brown, Peter J.; Sternbach, Daniel D.; Lehmann, Jurgen M.; Wisely, G. Bruce; Willson, Timothy M.; Kliewer, Steven A.; Milburn, Michael V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-403</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) are nuclear receptors for fatty acids (FAs) that regulate glucose and lipid homeostasis.  We report the crystal structure of the PPARδ ligand-binding domain (LBD) bound to either the FA eicosapentaenoic acid (EPA) or the synthetic fibrate GW2433.  The carboxylic acids of EPA and GW2433 interact directly with the activation function 2 (AF-2) helix.  The hydrophobic tail of EPA adopts two distinct conformations within the large hydrophobic cavity.  GW2433 occupies essentially the same space as EPA bound in both conformations.  These structures provide mol. insight into the propensity for PPARs to interact with a variety of synthetic and natural compds., including FAs that vary in both chain length and degree of satn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMNTuvvB2z5LVg90H21EOLACvtfcHk0lhe-ut4JaL2_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1OmsLY%253D&md5=890b5f9178bbe6ceb4959a069889fc5c</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2800%2980467-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252800%252980467-0%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DMontana%26aufirst%3DV.%2BG.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DBlanchard%26aufirst%3DS.%2BG.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26aulast%3DWisely%26aufirst%3DG.%2BB.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26atitle%3DMolecular%2520Recognition%2520of%2520Fatty%2520Acids%2520by%2520Peroxisome%2520Proliferator-activated%2520Receptors%26jtitle%3DMol.%2520Cell%26date%3D1999%26volume%3D3%26spage%3D397%26epage%3D403%26doi%3D10.1016%2FS1097-2765%2800%2980467-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoete, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosdidier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michielin, O.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor structures: Ligand Specificity, Molecular Switch and Interactions with Regulators</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1771</i></span>,  <span class="NLM_fpage">915</span>– <span class="NLM_lpage">925</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2007.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bbalip.2007.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17317294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFensrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1771&publication_year=2007&pages=915-925&author=V.+Zoeteauthor=A.+Grosdidierauthor=O.+Michielin&title=Peroxisome+Proliferator-activated+Receptor+structures%3A+Ligand+Specificity%2C+Molecular+Switch+and+Interactions+with+Regulators&doi=10.1016%2Fj.bbalip.2007.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators</span></div><div class="casAuthors">Zoete, Vincent; Grosdidier, Aurelien; Michielin, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1771</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">915-925</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptors (PPARs) compose a family of nuclear receptors that mediate the effects of lipidic ligands at the transcriptional level.  In this review, we highlight advances in the understanding of the PPAR ligand binding domain (LBD) structure at the at. level.  The overall structure of PPARs LBD is described, and important protein ligand interactions are presented.  Structure-activity relationships between isotypes structures and ligand specificity are addressed.  It is shown that the numerous exptl. three-dimensional structures available, together with in silico simulations, help understanding the role played by the activating function-2 (AF-2) in PPARs activation and its underlying mol. mechanism.  The relation between the PPARs constitutive activity and the intrinsic stability of the active conformation is discussed.  Finally, the interactions of PPARs LBD with co-activators or co-repressors, as well as with the retinoid X receptor (RXR) are described and considered in relation to PPARs activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolFocNTpJfvbVg90H21EOLACvtfcHk0lhe-ut4JaL2_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFensrs%253D&md5=09981bf8f4413e95010ac28a46a749cf</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2007.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2007.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DZoete%26aufirst%3DV.%26aulast%3DGrosdidier%26aufirst%3DA.%26aulast%3DMichielin%26aufirst%3DO.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520structures%253A%2520Ligand%2520Specificity%252C%2520Molecular%2520Switch%2520and%2520Interactions%2520with%2520Regulators%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2007%26volume%3D1771%26spage%3D915%26epage%3D925%26doi%3D10.1016%2Fj.bbalip.2007.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baiga, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Clair, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockley-Noel, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Specific Ligation of the Peroxisome Proliferator-activated Receptor δ</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E2563</span>– <span class="NLM_lpage">E2570</span>, <span class="refDoi"> DOI: 10.1073/pnas.1621513114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1073%2Fpnas.1621513114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=28320959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksV2rtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E2563-E2570&author=C.-C.+Wuauthor=T.+J.+Baigaauthor=M.+Downesauthor=J.+J.+La+Clairauthor=A.+R.+Atkinsauthor=S.+B.+Richardauthor=W.+Fanauthor=T.+A.+Stockley-Noelauthor=M.+E.+Bowmanauthor=J.+P.+Noelauthor=R.+M.+Evans&title=Structural+Basis+for+Specific+Ligation+of+the+Peroxisome+Proliferator-activated+Receptor+%CE%B4&doi=10.1073%2Fpnas.1621513114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ</span></div><div class="casAuthors">Wu, Chyuan-Chuan; Baiga, Thomas J.; Downes, Michael; La Clair, James J.; Atkins, Annette R.; Richard, Stephane B.; Fan, Weiwei; Stockley-Noel, Theresa A.; Bowman, Marianne E.; Noel, Joseph P.; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">E2563-E2570</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptor (PPAR) family comprises 3 subtypes: PPARα, PPARγ, and PPARδ.  PPARδ transcriptionally modulates lipid metab. and the control of energy homeostasis; therefore, PPARδ agonists are promising agents for treating a variety of metabolic disorders.  In the present study, we developed a panel of rationally designed PPARδ agonists.  The modular motif afforded efficient syntheses using building blocks optimized for interactions with subtype-specific residues in the PPARδ ligand-binding domain (LBD).  A combination of at.-resoln. protein x-ray crystallog. structures, ligand-dependent LBD stabilization assays, and cell-based transactivation measurements delineated structure-activity relations (SARs) for PPARδ-selective targeting and structural modulation.  We identified key ligand-induced conformational transitions of a conserved Trp side-chain in the LBD that triggered reorganization of the H2'-H3 surface segment of PPARδ.  The subtype-specific conservation of H2'-H3 sequences suggested that this architectural remodeling constitutes a previously unrecognized conformational switch accompanying ligand-dependent PPARδ transcriptional regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_4Y68bHgj87Vg90H21EOLACvtfcHk0lhe-ut4JaL2_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksV2rtr0%253D&md5=36b00797c0931f7c08dc2a223b815dee</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1621513114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1621513114%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.-C.%26aulast%3DBaiga%26aufirst%3DT.%2BJ.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DLa%2BClair%26aufirst%3DJ.%2BJ.%26aulast%3DAtkins%26aufirst%3DA.%2BR.%26aulast%3DRichard%26aufirst%3DS.%2BB.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DStockley-Noel%26aufirst%3DT.%2BA.%26aulast%3DBowman%26aufirst%3DM.%2BE.%26aulast%3DNoel%26aufirst%3DJ.%2BP.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DStructural%2520Basis%2520for%2520Specific%2520Ligation%2520of%2520the%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE2563%26epage%3DE2570%26doi%3D10.1073%2Fpnas.1621513114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batista, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivella, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratieri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueira, A. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polikarpov, I.</span></span> <span> </span><span class="NLM_article-title">Structural Insights into Human Peroxisome Proliferator-activated Receptor delta (PPAR-delta) Selective Ligand Binding</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e33643</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0033643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1371%2Fjournal.pone.0033643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22606221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslOqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=F.+A.+Batistaauthor=D.+B.+Trivellaauthor=A.+Bernardesauthor=J.+Gratieriauthor=P.+S.+Oliveiraauthor=A.+C.+M.+Figueiraauthor=P.+Webbauthor=I.+Polikarpov&title=Structural+Insights+into+Human+Peroxisome+Proliferator-activated+Receptor+delta+%28PPAR-delta%29+Selective+Ligand+Binding&doi=10.1371%2Fjournal.pone.0033643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into human peroxisome proliferator activated receptor delta (PPAR-Delta) selective ligand binding</span></div><div class="casAuthors">Batista, Fernanda A. H.; Trivella, Daniela B. B.; Bernardes, Amanda; Gratieri, Joyce; Oliveira, Paulo S. L.; Figueira, Ana Carolina M.; Webb, Paul; Polikarpov, Igor</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e33643</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Peroxisome proliferator activated receptors (PPARs δ, α and γ) are closely related transcription factors that exert distinct effects on fatty acid and glucose metab., cardiac disease, inflammatory response and other processes.  Several groups developed PPAR subtype specific modulators to trigger desirable effects of particular PPARs without harmful side effects assocd. with activation of other subtypes.  Presently, however, many compds. that bind to one of the PPARs cross-react with others and rational strategies to obtain highly selective PPAR modulators are far from clear.  GW0742 is a synthetic ligand that binds PPARδ more than 300-fold more tightly than PPARα or PPARγ but the structural basis of PPARδ:GW0742 interactions and reasons for strong selectivity are not clear.  Here we report the crystal structure of the PPARδ:GW0742 complex.  Comparisons of the PPARδ:GW0742 complex with published structures of PPARs in complex with α and γ selective agonists and pan agonists suggests that two residues (Val312 and Ile328) in the buried hormone binding pocket play special roles in PPARδ selective binding and exptl. and computational anal. of effects of mutations in these residues confirms this and suggests that bulky substituents that line the PPARα and γ ligand binding pockets as structural barriers for GW0742 binding.  This anal. suggests general strategies for selective PPARδ ligand design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr48uxmn7tYRLVg90H21EOLACvtfcHk0lgITjA2CgHQUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslOqtrw%253D&md5=6689a8eecf63013e382bc85e10720e68</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0033643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0033643%26sid%3Dliteratum%253Aachs%26aulast%3DBatista%26aufirst%3DF.%2BA.%26aulast%3DTrivella%26aufirst%3DD.%2BB.%26aulast%3DBernardes%26aufirst%3DA.%26aulast%3DGratieri%26aufirst%3DJ.%26aulast%3DOliveira%26aufirst%3DP.%2BS.%26aulast%3DFigueira%26aufirst%3DA.%2BC.%2BM.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DPolikarpov%26aufirst%3DI.%26atitle%3DStructural%2520Insights%2520into%2520Human%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520delta%2520%2528PPAR-delta%2529%2520Selective%2520Ligand%2520Binding%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0033643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maltarollo, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronenberger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windshugel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrenger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trossini, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honorio, K. M.</span></span> <span> </span><span class="NLM_article-title">Advances and Challenges in Drug Design of PPARδ Ligands</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.2174/1389450118666170414113159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.2174%2F1389450118666170414113159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=28413978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ansLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=144-154&author=V.+G.+Maltarolloauthor=T.+Kronenbergerauthor=B.+Windshugelauthor=C.+Wrengerauthor=G.+H.+Trossiniauthor=K.+M.+Honorio&title=Advances+and+Challenges+in+Drug+Design+of+PPAR%CE%B4+Ligands&doi=10.2174%2F1389450118666170414113159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Advances and Challenges in Drug Design of PPARδ Ligands</span></div><div class="casAuthors">Maltarollo, Vinicius Goncalves; Kronenberger, Thales; Windshugel, Bjorn; Wrenger, Carsten; Goulart Trossini, Gustavo Henrique; Honorio, Kathia Maria</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-154</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Peroxisome proliferator-activated receptors (PPAR) are nuclear receptors activated by endogenous fatty acids and prostaglandins that are classified into three types: &#945;, &#947; and &#948;, which have different functions and tissue distribution.  PPAR modulators have been exploited to the treatment of important metabolic diseases, such as type 2 diabetes mellitus and metabolic syndrome, which are considered relevant epidemic diseases currently.  Along the last decades, several studies have reported structural differences between the three PPAR subtypes assocd. with the discovery of selective ligands, dual and pan-agonists.  Nowadays, there are several approved drugs that activate PPAR&#945; (fibrates) and PPAR&#947; (glitazones), but up to now there is none clin. used drug targeting PPAR&#948;.  Addnl., several side-effects assocd. with the use of PPAR&#945; and &#947; agonists are reported by regulatory agencies, which do not indicate anymore their use as first-line drugs.  Objective: A significant new market has grown in the last years, focusing on the development of new PPAR&#948; agonists as drug candidates to treat metabolic diseases and, in this sense, this study proposes to review the structural requirements to achieve selective PPAR&#948; activation, as well to discuss the most relevant agonists in clin. trials, providing information on the current phase in the drug discovery and design targeting PPAR&#948;.  Conclusion: Several PPAR&#948; ligands with high potency were reported in the literature and were designed or discovered by a combination of exptl. and computational approaches.  Furthermore, the reported importance of pockets and individual residues at PPAR&#948; binding site as well as the importance of substituent and some physicochem. properties that could help to design of new classes of agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreETjwJhVMmLVg90H21EOLACvtfcHk0lgITjA2CgHQUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ansLo%253D&md5=0d98d8a7d47b65866e46288607d60f6a</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.2174%2F1389450118666170414113159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450118666170414113159%26sid%3Dliteratum%253Aachs%26aulast%3DMaltarollo%26aufirst%3DV.%2BG.%26aulast%3DKronenberger%26aufirst%3DT.%26aulast%3DWindshugel%26aufirst%3DB.%26aulast%3DWrenger%26aufirst%3DC.%26aulast%3DTrossini%26aufirst%3DG.%2BH.%26aulast%3DHonorio%26aufirst%3DK.%2BM.%26atitle%3DAdvances%2520and%2520Challenges%2520in%2520Drug%2520Design%2520of%2520PPAR%25CE%25B4%2520Ligands%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2018%26volume%3D19%26spage%3D144%26epage%3D154%26doi%3D10.2174%2F1389450118666170414113159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutledge, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A.</span></span> <span> </span><span class="NLM_article-title">Structural Requirements and Cell-type Specificity for Ligand Activation of Peroxisome Proliferator-activated Receptors</span>. <i>J. Steroid Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/S0960-0760(97)00064-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS0960-0760%2897%2900064-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=9449199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1cXksF2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1997&pages=1-8&author=T.+E.+Johnsonauthor=M.+K.+Hollowayauthor=R.+Vogelauthor=S.+J.+Rutledgeauthor=J.+J.+Perkinsauthor=G.+A.+Rodanauthor=A.+Schmidt&title=Structural+Requirements+and+Cell-type+Specificity+for+Ligand+Activation+of+Peroxisome+Proliferator-activated+Receptors&doi=10.1016%2FS0960-0760%2897%2900064-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors</span></div><div class="casAuthors">Johnson, Timothy E.; Holloway, M. Katharine; Vogel, Robert; Rutledge, Sue Jane; Perkins, James J.; Rodan, Gideon A.; Schmidt, Azriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The mammalian peroxisome proliferator-activated receptor (PPAR) family consists of three different subtypes, PPARα, hNUC1/PPARσ and PPARγ.  Selective agonists have been identified for PPARα and PPARγ but not for hNUC1, and consequently little is known about the genes that are controlled by this receptor.  Using ligand-dependent transcription assays in COS-7 cells, we screened a variety of PPAR activating agents to identify a selective activator of hNUC1.  We found that the potent peroxisome proliferator, Wy-14643, and the PPARγ-selective thiazolidinedione, BRL 49653, were poor activators of hNUC1 (EC50s of >100 μM).  Short chain fatty acids (FAs) appeared more selective for PPARα than for hNUC1, whereas the very long chain FA, erucic acid (C22:1) was more selective for hNUC1.  Using erucic acid as a probe, we conducted a topol. similarity search of the Merck Chem. Collection and identified a fatty acid-like compd., L-631,033 4-(2-acetyl-6-hydroxyundecyl) cinnamic acid, that was a selective activator of hNUC1 (EC50 of 2 μM), but was much less selective for PPARα or PPARγ (EC50s of >100 μM).  Structure-function anal. of PPAR activation by L-631,033 structural analogs showed that receptor selectivity depends on the position of the carboxyl group relative to the Ph ring on the mol.  Transfection expts. in several cell types: an osteoblastic cell line (MB 1.8), a mouse liver cell line (ML-457), rat aortic smooth muscle cells (RSMCs) and COS-7 cells revealed differences in the activation profile of specific ligands.  The most notable differences were obsd. in RSMCs, where transactivation by L-631,033 and Wy-14643, but not by BRL 49653, was markedly reduced, and in MB 1.8 cells, where oleic acid failed to activate PPARs.  These findings identify certain structural features in PPAR-activating agents that modulate PPAR activation, and suggest that as with other nuclear receptors, activation is cell-type specific.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryGLf9zoMyWbVg90H21EOLACvtfcHk0lgITjA2CgHQUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksF2huw%253D%253D&md5=e7057442ad5d4d4496c7ee25d7b67e1e</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2897%2900064-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252897%252900064-2%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BE.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DVogel%26aufirst%3DR.%26aulast%3DRutledge%26aufirst%3DS.%2BJ.%26aulast%3DPerkins%26aufirst%3DJ.%2BJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DSchmidt%26aufirst%3DA.%26atitle%3DStructural%2520Requirements%2520and%2520Cell-type%2520Specificity%2520for%2520Ligand%2520Activation%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptors%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D63%26spage%3D1%26epage%3D8%26doi%3D10.1016%2FS0960-0760%2897%2900064-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luckhurst, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botterell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chohan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walding, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of N-alkylated 8-oxybenz [c] azepine Derivatives as Selective PPARδ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2010.10.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21075629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SqsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=531-536&author=C.+A.+Luckhurstauthor=M.+Ratcliffeauthor=L.+Steinauthor=M.+Furberauthor=S.+Botterellauthor=D.+Laughtonauthor=W.+Tomlinsonauthor=R.+Weaverauthor=K.+Chohanauthor=A.+Walding&title=Synthesis+and+Biological+Evaluation+of+N-alkylated+8-oxybenz+%5Bc%5D+azepine+Derivatives+as+Selective+PPAR%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2010.10.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonists</span></div><div class="casAuthors">Luckhurst, Christopher A.; Ratcliffe, Marianne; Stein, Linda; Furber, Mark; Botterell, Sara; Laughton, David; Tomlinson, Wendy; Weaver, Richard; Chohan, Kamaldeep; Walding, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">531-536</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of small mol. benzazepine derivs., e.g. I (R1 = H, Et, n-Bu; R2 = 4-ClC6H4, 2,4-Cl2C6H3, 2,5-MeC6H3, 3,5-dichloro-2-pyridyl, etc.), as agonists of human peroxisome proliferator-activated receptor δ (PPARδ) that displayed excellent selectivity over the PPARα and PPARγ subtypes is described.  Compd. I [R1 = (R)-Et; R2 = 2,4-Cl2C6H3] displayed good PK in the rat and efficacy in upregulation of pyruvate dehydrogenase kinase, isoenzyme 4 (PDK4) mRNA in human primary myotubes, a biomarker for increased fatty acid oxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLXsb3CuLUr7Vg90H21EOLACvtfcHk0li2bnxpZENkrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SqsbnL&md5=6ef76030deb80d6f1765816d57e409ac</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.083%26sid%3Dliteratum%253Aachs%26aulast%3DLuckhurst%26aufirst%3DC.%2BA.%26aulast%3DRatcliffe%26aufirst%3DM.%26aulast%3DStein%26aufirst%3DL.%26aulast%3DFurber%26aufirst%3DM.%26aulast%3DBotterell%26aufirst%3DS.%26aulast%3DLaughton%26aufirst%3DD.%26aulast%3DTomlinson%26aufirst%3DW.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DChohan%26aufirst%3DK.%26aulast%3DWalding%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520N-alkylated%25208-oxybenz%2520%255Bc%255D%2520azepine%2520Derivatives%2520as%2520Selective%2520PPAR%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D531%26epage%3D536%26doi%3D10.1016%2Fj.bmcl.2010.10.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londhe, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadayat, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of an Orally Available “Y”-shaped Biaryl Peroxisome Proliferator-activated Receptor δ Agonist</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4382</span>– <span class="NLM_lpage">4389</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.06.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmc.2018.06.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30054191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVShsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=4382-4389&author=D.-S.+Kimauthor=J.+Leeauthor=A.+M.+Londheauthor=T.+M.+Kadayatauthor=J.+Jooauthor=H.+Hwangauthor=K.-H.+Kimauthor=A.+N.+Paeauthor=J.+Chinauthor=S.+J.+Choauthor=H.+Kang&title=Synthesis+and+Evaluation+of+an+Orally+Available+%E2%80%9CY%E2%80%9D-shaped+Biaryl+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist&doi=10.1016%2Fj.bmc.2018.06.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of an orally available "Y"-shaped biaryl peroxisome proliferator-activated receptor δ agonist</span></div><div class="casAuthors">Kim, Dong-Su; Lee, Jaehwan; Londhe, Ashwini M.; Kadayat, Tara Man; Joo, Jeongmin; Hwang, Hayoung; Kim, Kyung-Hee; Pae, Ae Nim; Chin, Jungwook; Cho, Sung Jin; Kang, Heonjoong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4382-4389</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, we designed and synthesized several novel "Y"-shaped biaryl PPARδ agonists.  Structure-activity relationship (SAR) studies demonstrated that compd. 3a was the most active agonist with an EC50 of 2.6nM.  We also synthesized and evaluated enantiospecific R and S isomers of compd. 3a to confirm that R isomer (EC50=0.7nM) shows much more potent activity than S isomer (EC50=6.1nM).  Mol. docking studies between the PPAR ligand binding domain and enantiospecific R and S isomers of compd. 3a were performed.  In vitro absorption, distribution, metab., excretion, and toxicity (ADMET) and in vivo PK profiles show that compd. 3a possesses superior drug-like properties including good bioavailability.  Our overall results clearly demonstrate that this orally administrable PPARδ agonist 3a is a viable drug candidate for the treatment of various PPARδ-related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5dkyhwpT29bVg90H21EOLACvtfcHk0li2bnxpZENkrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVShsbvF&md5=55a0cadbcad38a53bd58547afe441951</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.06.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.06.044%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.-S.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLondhe%26aufirst%3DA.%2BM.%26aulast%3DKadayat%26aufirst%3DT.%2BM.%26aulast%3DJoo%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.-H.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520an%2520Orally%2520Available%2520%25E2%2580%259CY%25E2%2580%259D-shaped%2520Biaryl%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D4382%26epage%3D4389%26doi%3D10.1016%2Fj.bmc.2018.06.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Da’adoosh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldblum, A.</span></span> <span> </span><span class="NLM_article-title">Discovering Highly Selective and Diverse PPAR-delta Agonists by Ligand Based Machine Learning and Structural Modeling</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1106</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-38508-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fs41598-019-38508-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=30705343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BB3cjns1Cmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1106&author=B.+Da%E2%80%99adooshauthor=D.+Marcusauthor=A.+Rayanauthor=F.+Kingauthor=J.+Cheauthor=A.+Goldblum&title=Discovering+Highly+Selective+and+Diverse+PPAR-delta+Agonists+by+Ligand+Based+Machine+Learning+and+Structural+Modeling&doi=10.1038%2Fs41598-019-38508-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling</span></div><div class="casAuthors">Da'adoosh Benny; Marcus David; Rayan Anwar; Goldblum Amiram; Rayan Anwar; Rayan Anwar; King Fred; Che Jianwei; Che Jianwei</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1106</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PPAR-δ agonists are known to enhance fatty acid metabolism, preserving glucose and physical endurance and are suggested as candidates for treating metabolic diseases.  None have reached the clinic yet.  Our Machine Learning algorithm called "Iterative Stochastic Elimination" (ISE) was applied to construct a ligand-based multi-filter ranking model to distinguish between confirmed PPAR-δ agonists and random molecules.  Virtual screening of 1.56 million molecules by this model picked ~2500 top ranking molecules.  Subsequent docking to PPAR-δ structures was mainly evaluated by geometric analysis of the docking poses rather than by energy criteria, leading to a set of 306 molecules that were sent for testing in vitro.  Out of those, 13 molecules were found as potential PPAR-δ agonist leads with EC50 between 4-19 nM and 14 others with EC50 below 10 μM.  Most of the nanomolar agonists were found to be highly selective for PPAR-δ and are structurally different than agonists used for model building.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLZIEKyN30hpWtyewyzkyLfW6udTcc2eZYd1Tg7VLuDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjns1Cmtg%253D%253D&md5=aa6c1094a1b74e8626b851b734edfae7</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-38508-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-38508-8%26sid%3Dliteratum%253Aachs%26aulast%3DDa%25E2%2580%2599adoosh%26aufirst%3DB.%26aulast%3DMarcus%26aufirst%3DD.%26aulast%3DRayan%26aufirst%3DA.%26aulast%3DKing%26aufirst%3DF.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DGoldblum%26aufirst%3DA.%26atitle%3DDiscovering%2520Highly%2520Selective%2520and%2520Diverse%2520PPAR-delta%2520Agonists%2520by%2520Ligand%2520Based%2520Machine%2520Learning%2520and%2520Structural%2520Modeling%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D1106%26doi%3D10.1038%2Fs41598-019-38508-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibowitz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doebber, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbrecht, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullinan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moller, D. E.</span></span> <span> </span><span class="NLM_article-title">Novel Peroxisome Proliferator-activated Receptor (PPAR)γ and PPARδ Ligands Produce Distinct Biological Effects</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">6718</span>– <span class="NLM_lpage">6725</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.10.6718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1074%2Fjbc.274.10.6718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10037770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1ektb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=6718-6725&author=J.+Bergerauthor=M.+D.+Leibowitzauthor=T.+W.+Doebberauthor=A.+Elbrechtauthor=B.+Zhangauthor=G.+Zhouauthor=C.+Biswasauthor=C.+A.+Cullinanauthor=N.+S.+Hayesauthor=Y.+Liauthor=M.+Tanenauthor=J.+Ventreauthor=M.+S.+Wuauthor=G.+D.+Bergerauthor=R.+Mosleyauthor=R.+Marquisauthor=C.+Santiniauthor=S.+P.+Sahooauthor=R.+L.+Tolmanauthor=R.+G.+Smithauthor=D.+E.+Moller&title=Novel+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29%CE%B3+and+PPAR%CE%B4+Ligands+Produce+Distinct+Biological+Effects&doi=10.1074%2Fjbc.274.10.6718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects</span></div><div class="casAuthors">Berger, Joel; Leibowitz, Mark D.; Doebber, Thomas W.; Elbrecht, Alex; Zhang, Bei; Zhou, Gaochou; Biswas, Chhabi; Cullinan, Catherine A.; Hayes, Nancy S.; Li, Ying; Tanen, Michael; Ventre, John; Wu, Margaret S.; Berger, Gregory D.; Mosley, Ralph; Marquis, Robert; Santini, Conrad; Sahoo, Soumya P.; Tolman, Richard L.; Smith, Roy G.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6718-6725</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) include three receptor subtypes encoded by sep. genes: PPARα, PPARδ, and PPARγ.  PPARγ has been implicated as a mediator of adipocyte differentiation and the mechanism by which thiazolidinedione drugs exert in vivo insulin sensitization.  Here we characterized novel, non-thiazolidinedione agonists for PPARγy and PPARδ that were identified by radioligand binding assays.  In transient transactivation assays these ligands were agonists of the receptors to which they bind.  Protease protection studies showed that ligand binding produced specific alterations in receptor conformation.  Both PPARγ and PPARδ directly interacted with a nuclear receptor co-activator (CREB-binding protein) in an agonist-dependent manner.  Only the PPARγ agonists were able to promote differentiation of 3T3-L1 preadipocytes.  In diabetic db/db mice all PPARγ agonists were orally active insulin-sensitizing agents producing redns. of elevated plasma glucose and triglyceride concns.  In contrast, selective in vivo activation of PPARδ did not significantly affect these parameters.  In vivo PPARα activation with WY-14653 resulted in redns. in elevated triglyceride levels with minimal effect on hyperglycemia.  We conclude that: 1. synthetic non-thiazolidinediones can serve as ligands of PPARγ and PPARδ; 2. ligand-dependent activation of PPARδ involves an apparent conformational change and assocn. of the receptor ligand binding domain with CREB-binding protein; 3. PPARγ activation (but not PPARδ or PPARα activation) is sufficient to potentiate preadipocyte differentiation; 4. non-thiazolidinedione PPARγ agonists improve hyperglycemia and hypertriglyceridemia in vivo; 5. although PPARα activation is sufficient to affect triglyceride metab., PPARδ activation does not appear to modulate glucose or triglyceride levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprKgGs_6YukLVg90H21EOLACvtfcHk0lhUGHWrjyeukg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1ektb0%253D&md5=c62b5d778386a81d91221d6330f8e8d3</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.10.6718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.10.6718%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DLeibowitz%26aufirst%3DM.%2BD.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DCullinan%26aufirst%3DC.%2BA.%26aulast%3DHayes%26aufirst%3DN.%2BS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%2BS.%26aulast%3DBerger%26aufirst%3DG.%2BD.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DMarquis%26aufirst%3DR.%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DSahoo%26aufirst%3DS.%2BP.%26aulast%3DTolman%26aufirst%3DR.%2BL.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DNovel%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%25CE%25B3%2520and%2520PPAR%25CE%25B4%2520Ligands%2520Produce%2520Distinct%2520Biological%2520Effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D6718%26epage%3D6725%26doi%3D10.1074%2Fjbc.274.10.6718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henke, B. R.</span></span> <span> </span><span class="NLM_article-title">The PPARs: From Orphan Receptors to Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1021/jm990554g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990554g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht1Churk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=527-550&author=T.+M.+Willsonauthor=P.+J.+Brownauthor=D.+D.+Sternbachauthor=B.+R.+Henke&title=The+PPARs%3A+From+Orphan+Receptors+to+Drug+Discovery&doi=10.1021%2Fjm990554g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">The PPARs: From orphan receptors to drug discovery</span></div><div class="casAuthors">Willson, Timothy M.; Brown, Peter J.; Sternbach, Daniel D.; Henke, Brad R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-550</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 326 refs. is given on peroxisome proliferator-activated receptors (PPARs).  The structural and functional anal. of the different PPAR subtypes is summarized and their function as hormone receptors for dietary fatty acids and certain eicosanoids in different species and in many metabolically active tissues is described.  Progress is reported in the development of drugs, which use PPARs as mol. targets, for the treatment of human metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocp31Cq_kgebVg90H21EOLACvtfcHk0lhUGHWrjyeukg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht1Churk%253D&md5=003b19fe3fdf813411d6a2ac5aefdc01</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm990554g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990554g%26sid%3Dliteratum%253Aachs%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DHenke%26aufirst%3DB.%2BR.%26atitle%3DThe%2520PPARs%253A%2520From%2520Orphan%2520Receptors%2520to%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D527%26epage%3D550%26doi%3D10.1021%2Fjm990554g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.-Y.</span></span> <span> </span><span class="NLM_article-title">PPARδ ligand L-165041 Ameliorates Western Diet-induced Hepatic Lipid Accumulation and Inflammation in LDLR–/– Mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>622</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2009.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.ejphar.2009.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19766624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OnsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=622&publication_year=2009&pages=45-51&author=H.-J.+Limauthor=J.-H.+Parkauthor=S.+Leeauthor=H.-E.+Choiauthor=K.-S.+Leeauthor=H.-Y.+Park&title=PPAR%CE%B4+ligand+L-165041+Ameliorates+Western+Diet-induced+Hepatic+Lipid+Accumulation+and+Inflammation+in+LDLR%E2%80%93%2F%E2%80%93+Mice&doi=10.1016%2Fj.ejphar.2009.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR-/- mice</span></div><div class="casAuthors">Lim, Hyun-Joung; Park, Jin-Hee; Lee, Seahyoung; Choi, Hye-Eun; Lee, Kuy-Sook; Park, Hyun-Young</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">622</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Although peroxisome proliferator-activated receptor delta (PPARδ) has been implicated in energy metab. and lipid oxidn. process, detailed roles of PPARδ in lipid homeostasis under pathol. conditions still remain controversial.  Thus, we investigated the effect of PPARδ ligand L-165041 on Western diet-induced fatty liver using low-d. lipoprotein receptor-deficient (LDLR-/-) mice.  LDLR-/- mice received either L-165041 (5 mg/kg/day) or vehicle (0.1 N NaOH) with Western diet for 16 wk.  According to our data, L-165041 drastically reduced lipid accumulation in the liver, decreasing total hepatic cholesterol and triglyceride content compared to the vehicle group.  Gene expression anal. demonstrated that L-165041 lowered hepatic expression of PPARγ, apolipoprotein B, interleukin 1 beta (IL-1β), and interleukin-6.  In contrast, L-165041 increased hepatic expressions of PPARδ, lipoprotein lipase (LPL), and ATP-binding cassette transporter G1 (ABCG1).  Our data suggest that L-165041 might be effective in preventing Western diet-induced hepatic steatosis by regulating genes involved in lipid metab. and the inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlaPZ68NJirVg90H21EOLACvtfcHk0lglNXGbl5r7JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OnsrrP&md5=91243b3e20bfe4dc0f3c8b6555413bc9</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DH.-J.%26aulast%3DPark%26aufirst%3DJ.-H.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DH.-E.%26aulast%3DLee%26aufirst%3DK.-S.%26aulast%3DPark%26aufirst%3DH.-Y.%26atitle%3DPPAR%25CE%25B4%2520ligand%2520L-165041%2520Ameliorates%2520Western%2520Diet-induced%2520Hepatic%2520Lipid%2520Accumulation%2520and%2520Inflammation%2520in%2520LDLR%25E2%2580%2593%252F%25E2%2580%2593%2520Mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D622%26spage%3D45%26epage%3D51%26doi%3D10.1016%2Fj.ejphar.2009.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.-Y.</span></span> <span> </span><span class="NLM_article-title">PPARδ agonist L-165041 Inhibits Rat Vascular Smooth Muscle Cell Proliferation and Migration via Inhibition of Cell Cycle</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2008.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.atherosclerosis.2008.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18585719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2009&pages=446-454&author=H.-J.+Limauthor=S.+Leeauthor=J.-H.+Parkauthor=K.-S.+Leeauthor=H.-E.+Choiauthor=K.-S.+Chungauthor=H.-H.+Leeauthor=H.-Y.+Park&title=PPAR%CE%B4+agonist+L-165041+Inhibits+Rat+Vascular+Smooth+Muscle+Cell+Proliferation+and+Migration+via+Inhibition+of+Cell+Cycle&doi=10.1016%2Fj.atherosclerosis.2008.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle</span></div><div class="casAuthors">Lim, Hyun-Joung; Lee, Seahyoung; Park, Jin-Hee; Lee, Kuy-Sook; Choi, Hye-Eun; Chung, Kyung-Sook; Lee, Hyoung-Hee; Park, Hyun-Young</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">446-454</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptor (PPAR) family of nuclear hormone receptors consists of three subtypes (α, β/δ, and γ).  PPARδ is ubiquitously expressed and involved in lipid and glucose metab.  However, the effect of PPARδ on vascular smooth muscle cell (VSMC) proliferation and migration has not been fully elucidated yet.  Here, we investigated the effect of L-165041, a selective ligand for PPARδ, on PDGF-induced rat VSMC proliferation.  Our data show that L-165041 inhibited rat VSMC proliferation in a dose dependent manner by blocking G1 to S phase progression and repressing the phosphorylation of retinoblastoma protein (Rb).  Furthermore, L-165041 inhibited PDGF-induced expression of cyclin D1 and CDK4.  These effects less likely involve PPARγ pathway because PPARγ antagonist GW9662 pretreatment failed to reverse the inhibitory effect of L-165041 on rVSMC proliferation and migration.  For in vivo studies, L-165041 was administered to Sprague-Dawley rats using osmotic pumps before and after the carotid balloon injury, and L-165041 decreased neointima formation after the carotid injury.  In conclusion, our results suggest that PPARδ ligand L-165041 can be a therapeutic agent to control pathol. cardiovascular conditions such as restenosis and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopY78gEGyaeLVg90H21EOLACvtfcHk0lglNXGbl5r7JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFegsrw%253D&md5=5f62f073a45cef807d14107652d22e0f</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2008.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2008.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DH.-J.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DJ.-H.%26aulast%3DLee%26aufirst%3DK.-S.%26aulast%3DChoi%26aufirst%3DH.-E.%26aulast%3DChung%26aufirst%3DK.-S.%26aulast%3DLee%26aufirst%3DH.-H.%26aulast%3DPark%26aufirst%3DH.-Y.%26atitle%3DPPAR%25CE%25B4%2520agonist%2520L-165041%2520Inhibits%2520Rat%2520Vascular%2520Smooth%2520Muscle%2520Cell%2520Proliferation%2520and%2520Migration%2520via%2520Inhibition%2520of%2520Cell%2520Cycle%26jtitle%3DAtherosclerosis%26date%3D2009%26volume%3D202%26spage%3D446%26epage%3D454%26doi%3D10.1016%2Fj.atherosclerosis.2008.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacNaul, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doebber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moller, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, S. P.</span></span> <span> </span><span class="NLM_article-title">Phenylacetic Acid Derivatives as hPPAR Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1280</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00115-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS0960-894X%2803%2900115-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=12657263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1277-1280&author=C.+Santiniauthor=G.+D.+Bergerauthor=W.+Hanauthor=R.+Mosleyauthor=K.+MacNaulauthor=J.+Bergerauthor=T.+Doebberauthor=M.+Wuauthor=D.+E.+Mollerauthor=R.+L.+Tolmanauthor=S.+P.+Sahoo&title=Phenylacetic+Acid+Derivatives+as+hPPAR+Agonists&doi=10.1016%2FS0960-894X%2803%2900115-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylacetic acid derivatives as hPPAR agonists</span></div><div class="casAuthors">Santini, Conrad; Berger, Gregory D.; Han, Wei; Mosley, Ralph; MacNaul, Karen; Berger, Joel; Doebber, Thomas; Wu, Margaret; Moller, David E.; Tolman, Richard L.; Sahoo, Soumya P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1277-1280</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Beginning with the weakly active lead structure (I), a new series of hPPAR agonists was developed.  In vivo glucose and triglyceride lowering activity was obtained by homologation and oxamination , then conversion to substituted benzisoxazoles.  Further manipulation afforded two benzofurans.  One compd. was of comparable potency as a glucose and triglyceride lowering agent in insulin resistant rodents to BRL 49653.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-EZ1ky1nXpbVg90H21EOLACvtfcHk0lglNXGbl5r7JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKjtrY%253D&md5=93d7025b97fde7e0ed16878eb08ec941</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900115-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900115-X%26sid%3Dliteratum%253Aachs%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DG.%2BD.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DMacNaul%26aufirst%3DK.%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DDoebber%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DTolman%26aufirst%3DR.%2BL.%26aulast%3DSahoo%26aufirst%3DS.%2BP.%26atitle%3DPhenylacetic%2520Acid%2520Derivatives%2520as%2520hPPAR%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1277%26epage%3D1280%26doi%3D10.1016%2FS0960-894X%2803%2900115-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Oliver, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomkinson, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fivush, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T.M.</span></span> <span> </span><span class="NLM_article-title">Identification of Peroxisome Proliferator-activated Receptor Ligands from a Biased Chemical Library</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(97)90299-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS1074-5521%2897%2990299-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=9427656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADyaK1MXkslCnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=909-918&author=P.+J.+Brownauthor=T.+A.+Smith-Oliverauthor=P.+S.+Charifsonauthor=N.+C.+Tomkinsonauthor=A.+M.+Fivushauthor=D.+D.+Sternbachauthor=L.+E.+Wadeauthor=L.+Orband-Millerauthor=D.+J.+Parksauthor=S.+G.+Blanchardauthor=S.+A.+Kliewerauthor=J.+M.+Lehmannauthor=T.M.+Willson&title=Identification+of+Peroxisome+Proliferator-activated+Receptor+Ligands+from+a+Biased+Chemical+Library&doi=10.1016%2FS1074-5521%2897%2990299-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library</span></div><div class="casAuthors">Brown, Peter J.; Smith-Oliver, Tracey A.; Charifson, Paul S.; Tomkinson, Nicholas C. O.; Fivush, Adam M.; Sternbach, Daniel D.; Wade, Laura E.; Orband-Miller, Lisa; Parks, Derek J.; Blanchard, Steven G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-918</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">Background: The peroxisome proliferator-activated receptors (PPARs) were cloned as orphan members of the nuclear receptor superfamily of transcription factors.  The identification of subtype-selective ligands for PPARα and PPARγ has led to the discovery of their roles in the regulation of lipid metab. and glucose homeostasis.  No subtype-selective PPARδ ligands are available and the function of this subtype is currently unknown.  Results: A three-component library was designed in which one of the monomers was biased towards the PPARs and the other two monomers were chosen to add chem. diversity.  Synthesis and screening of the library resulted in the identification of pools with activity on each of the PPAR subtypes.  Deconvolution of the pools with the highest activity on PPARδ led to the identification of GW 2433 as the first high-affinity PPARδ ligand.  [3H]GW 2433 is an effective radioligand for use in PPARδ competition-binding assays.  Conclusions: The synthesis of biased chem. libraries is an efficient approach to the identification of lead mols. for members of sequence-related receptor families.  This approach is well suited to the discovery of small-mol. ligands for orphan receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjqD5wlZOv2LVg90H21EOLACvtfcHk0lipyHLfd6fkew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslCnsbo%253D&md5=40dca84a8aa5de38f8d444f782c98c16</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2897%2990299-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252897%252990299-4%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSmith-Oliver%26aufirst%3DT.%2BA.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DTomkinson%26aufirst%3DN.%2BC.%26aulast%3DFivush%26aufirst%3DA.%2BM.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DWade%26aufirst%3DL.%2BE.%26aulast%3DOrband-Miller%26aufirst%3DL.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DBlanchard%26aufirst%3DS.%2BG.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26aulast%3DWillson%26aufirst%3DT.M.%26atitle%3DIdentification%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520Ligands%2520from%2520a%2520Biased%2520Chemical%2520Library%26jtitle%3DChem.%2520Biol.%26date%3D1997%26volume%3D4%26spage%3D909%26epage%3D918%26doi%3D10.1016%2FS1074-5521%2897%2990299-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span> <span> </span><span class="NLM_article-title">PPAR-β/δ Agonists for Type 2 Diabetes and Dyslipidemia: an Adopted Orphan Still Looking for a Home</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1465</span>– <span class="NLM_lpage">1471</span>, <span class="refDoi"> DOI: 10.1517/13543784.17.10.1465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1517%2F13543784.17.10.1465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18808307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCjurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1465-1471&author=A.+N.+Billin&title=PPAR-%CE%B2%2F%CE%B4+Agonists+for+Type+2+Diabetes+and+Dyslipidemia%3A+an+Adopted+Orphan+Still+Looking+for+a+Home&doi=10.1517%2F13543784.17.10.1465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR-β/δ agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home</span></div><div class="casAuthors">Billin, Andrew N.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1465-1471</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The identification of small mol. agonists for the nuclear receptor peroxisome proliferator-activated receptor beta/delta (PPAR-β/δ, NR1C2) has enabled the characterization of this receptor's functions in preclin. models.  Subsequently, a no. of small mol. agonists of PPAR-β/δ have been progressed into clin. trials.  This review will examine the major preclin. findings that underpin the hypothesis that PPAR-β/δ agonists may be beneficial in treating dyslipidemia and Type 2 diabetes, as well as emerging clin. data with a variety of PPAR-β/δ agonists.  The literature concerning preclin. expts. that combine in vivo and in vitro mechanistic studies are reviewed and compared with the results of the early clin. trials.  Thus far, the activities of the agonists seen in the clinic are broadly similar to those seen in preclin. models.  However, it is still not known if PPAR-β/δ agonists will truly be differentiated enough from current treatments to justify their use in treating dyslipidemia or Type 2 diabetes.  Major challenges for the development of PPAR-β/δ agonists exist and the path forward is as yet undefined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiP0MwvREFjrVg90H21EOLACvtfcHk0lipyHLfd6fkew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCjurrN&md5=2809a5fe9644b50f92c797f890866cbe</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1517%2F13543784.17.10.1465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.17.10.1465%26sid%3Dliteratum%253Aachs%26aulast%3DBillin%26aufirst%3DA.%2BN.%26atitle%3DPPAR-%25CE%25B2%252F%25CE%25B4%2520Agonists%2520for%2520Type%25202%2520Diabetes%2520and%2520Dyslipidemia%253A%2520an%2520Adopted%2520Orphan%2520Still%2520Looking%2520for%2520a%2520Home%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1465%26epage%3D1471%26doi%3D10.1517%2F13543784.17.10.1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahebkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, G. F.</span></span> <span> </span><span class="NLM_article-title">New Peroxisome Proliferator-activated Receptor Agonists: Potential Treatments for Atherogenic Dyslipidemia and Non-alcoholic Fatty Liver Disease</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1517/14656566.2014.876992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1517%2F14656566.2014.876992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=24428677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFamsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=493-503&author=A.+Sahebkarauthor=G.+T.+Chewauthor=G.+F.+Watts&title=New+Peroxisome+Proliferator-activated+Receptor+Agonists%3A+Potential+Treatments+for+Atherogenic+Dyslipidemia+and+Non-alcoholic+Fatty+Liver+Disease&doi=10.1517%2F14656566.2014.876992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease</span></div><div class="casAuthors">Sahebkar, Amirhossein; Chew, Gerard T.; Watts, Gerald F.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">493-503</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Novel peroxisome proliferator-activated receptor (PPAR) modulators (selective PPAR modulators [SPPARMs]) and dual PPAR agonists may have an important role in the treatment of cardiometabolic disorders owing to lipid-modifying, insulin-sensitizing and anti-inflammatory effects.  Areas covered: This review summarizes the efficacy of new PPAR agonists and SPPARMs that are under development for the treatment of atherogenic dyslipidemia and non-alc. fatty liver disease (NAFLD).  Expert opinion: ABT-335 is a new formulation of fenofibrate that has been approved for concomitant use with statins.  K-877, a SPPARM-α with encouraging preliminary results in modulating atherogenic dyslipidemia, and INT131, a SPPARM-γ with predominantly insulin-sensitizing actions, may also have favorable lipid-modifying effects.  Although the development of dual PPAR-α/γ agonists (glitazars) and the SPPARM-δ GW501516 has been abandoned because of safety issues, another SPPARM-δ (MBX-8025) and a dual PPAR-α/δ agonist (GFT-505) have shown promising efficacy in decreasing plasma triglyceride and increasing high-d. lipoprotein cholesterol concns., as well as improving insulin sensitivity and liver function.  The beneficial effects of GFT-505 are complemented by preclin. findings that indicate redn. of hepatic fat accumulation, inflammation and fibrosis, making it a promising candidate for the treatment of NAFLD/nonalcoholic steatohepatitis (NASH).  Long-term trials are required to test the efficacy and safety of these new PPAR agonists in reducing cardiovascular outcomes and treating NAFLD/NASH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG9sfsoyVFALVg90H21EOLACvtfcHk0lipyHLfd6fkew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFamsbg%253D&md5=7a70b9ae9ea4dd1db45d1ff04a2026e9</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1517%2F14656566.2014.876992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2014.876992%26sid%3Dliteratum%253Aachs%26aulast%3DSahebkar%26aufirst%3DA.%26aulast%3DChew%26aufirst%3DG.%2BT.%26aulast%3DWatts%26aufirst%3DG.%2BF.%26atitle%3DNew%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520Agonists%253A%2520Potential%2520Treatments%2520for%2520Atherogenic%2520Dyslipidemia%2520and%2520Non-alcoholic%2520Fatty%2520Liver%2520Disease%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2014%26volume%3D15%26spage%3D493%26epage%3D503%26doi%3D10.1517%2F14656566.2014.876992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geiger, L.</span>; <span class="NLM_string-name">Dunsford, W.</span>; <span class="NLM_string-name">Lewis, D.</span>; <span class="NLM_string-name">Brennan, C.</span>; <span class="NLM_string-name">Liu, K.</span>; <span class="NLM_string-name">Newsholme, S.</span></span> <span> </span><span class="NLM_article-title">PS 895-Rat Carcinogenicity Study with GW501516, a PPAR delta Agonist</span>.  <i>48th Annual Meeting of the Society of Toxicology, March 15–19, 2009, Baltimore</i>; <span class="NLM_publisher-name">Society of Toxicology</span>, <span class="NLM_year">2009</span>; p  <span class="NLM_fpage">185</span>. <a href="https://web.archive.org/web/20150504013406/http:/www.toxicology.org/AI/PUB/Tox/2009Tox.pdf" class="extLink">https://web.archive.org/web/20150504013406/http:/www.toxicology.org/AI/PUB/Tox/2009Tox.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=185&author=L.+Geiger&author=W.+Dunsford&author=D.+Lewis&author=C.+Brennan&author=K.+Liu&author=S.+Newsholme&title=PS+895-Rat+Carcinogenicity+Study+with+GW501516%2C+a+PPAR+delta+Agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGeiger%26aufirst%3DL.%26atitle%3DPS%2520895-Rat%2520Carcinogenicity%2520Study%2520with%2520GW501516%252C%2520a%2520PPAR%2520delta%2520Agonist%26jtitle%3D48th%2520Annual%2520Meeting%2520of%2520the%2520Society%2520of%2520Toxicology%252C%2520March%252015%25E2%2580%259319%252C%25202009%252C%2520Baltimore%26pub%3DSociety%2520of%2520Toxicology%26date%3D2009%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newsholme, S.</span>; <span class="NLM_string-name">Dunsford, W.</span>; <span class="NLM_string-name">Brodie, T.</span>; <span class="NLM_string-name">Brennan, C.</span>; <span class="NLM_string-name">Brown, M.</span>; <span class="NLM_string-name">Geiger, L.</span></span> <span> </span><span class="NLM_article-title">PS 896-Mouse Carcinogenicity Study with GW501516, a PPAR delta Agonist</span>.  <i>48th Annual Meeting of the Society of Toxicology, March 16–19, 2009, Baltimore</i>. <span class="NLM_publisher-name">Society of Toxicology</span>, <span class="NLM_year">2009</span>; p  <span class="NLM_fpage">185</span>. <a href="https://web.archive.org/web/20150504013406/http:/www.toxicology.org/AI/PUB/Tox/2009Tox.pdf" class="extLink">https://web.archive.org/web/20150504013406/http:/www.toxicology.org/AI/PUB/Tox/2009Tox.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=185&author=S.+Newsholme&author=W.+Dunsford&author=T.+Brodie&author=C.+Brennan&author=M.+Brown&author=L.+Geiger&title=PS+896-Mouse+Carcinogenicity+Study+with+GW501516%2C+a+PPAR+delta+Agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DNewsholme%26aufirst%3DS.%26atitle%3DPS%2520896-Mouse%2520Carcinogenicity%2520Study%2520with%2520GW501516%252C%2520a%2520PPAR%2520delta%2520Agonist%26jtitle%3D48th%2520Annual%2520Meeting%2520of%2520the%2520Society%2520of%2520Toxicology%252C%2520March%252016%25E2%2580%259319%252C%25202009%252C%2520Baltimore%26pub%3DSociety%2520of%2520Toxicology%26date%3D2009%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tesse, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andriantsitohaina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragot, T.</span></span> <span> </span><span class="NLM_article-title">PPAR Activity in Cardiovascular Diseases: a Potential Pharmacological Target</span>. <i>PPAR Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span>,  <span class="NLM_fpage">745821</span>, <span class="refDoi"> DOI: 10.1155/2009/745821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1155%2F2009%2F745821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19325917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BD1M3jslejtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=745821&author=A.+Tesseauthor=R.+Andriantsitohainaauthor=T.+Ragot&title=PPAR+Activity+in+Cardiovascular+Diseases%3A+a+Potential+Pharmacological+Target&doi=10.1155%2F2009%2F745821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">PPARδ activity in cardiovascular diseases: A potential pharmacological target</span></div><div class="casAuthors">Tesse Angela; Andriantsitohaina Ramaroson; Ragot Thierry</div><div class="citationInfo"><span class="NLM_cas:title">PPAR research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2009</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">745821</span>
        ISSN:<span class="NLM_cas:issn">1687-4757</span>.
    </div><div class="casAbstract">Activation of peroxisome proliferator-activated receptors (PPARs), and particularly of PPARα and PPARγ, using selective agonists, is currently used in the treatment of metabolic diseases such as hypertriglyceridemia and type 2 diabetes mellitus.  PPARα and PPARγ anti-inflammatory, antiproliferative and antiangiogenic properties in cardiovascular cells were extensively clarified in a variety of in vitro and in vivo models.  In contrast, the role of PPARδ in cardiovascular system is poorly understood.  Prostacyclin, the predominant prostanoid released by vascular cells, is a putative endogenous agonist for PPARδ, but only recently PPARδ selective synthetic agonists were found, improving studies about the physiological and pathophysiological roles of PPARδ activation.  Recent reports suggest that the PPARδ activation may play a pivotal role to regulate inflammation, apoptosis, and cell proliferation, suggesting that this transcriptional factor could become an interesting pharmacological target to regulate cardiovascular cell apoptosis, proliferation, inflammation, and metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPs-wl7dOX5a2q3xNe7a7QfW6udTcc2eaZdXW7rOk3Vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3jslejtA%253D%253D&md5=d74d12f08066eb941c3258ce552e151c</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1155%2F2009%2F745821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2009%252F745821%26sid%3Dliteratum%253Aachs%26aulast%3DTesse%26aufirst%3DA.%26aulast%3DAndriantsitohaina%26aufirst%3DR.%26aulast%3DRagot%26aufirst%3DT.%26atitle%3DPPAR%2520Activity%2520in%2520Cardiovascular%2520Diseases%253A%2520a%2520Potential%2520Pharmacological%2520Target%26jtitle%3DPPAR%2520Res.%26date%3D2009%26volume%3D2009%26spage%3D745821%26doi%3D10.1155%2F2009%2F745821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasrallah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hébert, R. L.</span></span> <span> </span><span class="NLM_article-title">The PPAR Ligand GW501516 Reduces Growth but Not Apoptosis in Mouse Inner Medullary Collecting Duct Cells</span>. <i>PPAR Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span>,  <span class="NLM_fpage">706283</span>, <span class="refDoi"> DOI: 10.1155/2009/706283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1155%2F2009%2F706283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19266055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ovFKrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=706283&author=J.+Clarkauthor=R.+Nasrallahauthor=R.+L.+H%C3%A9bert&title=The+PPAR+Ligand+GW501516+Reduces+Growth+but+Not+Apoptosis+in+Mouse+Inner+Medullary+Collecting+Duct+Cells&doi=10.1155%2F2009%2F706283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">The PPARδ ligand GW501516 reduces growth but not apoptosis in mouse inner medullary collecting duct cells</span></div><div class="casAuthors">Clark Jordan; Nasrallah Rania; Hebert Richard L</div><div class="citationInfo"><span class="NLM_cas:title">PPAR research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2009</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">706283</span>
        ISSN:<span class="NLM_cas:issn">1687-4757</span>.
    </div><div class="casAbstract">The collecting duct (CD) expresses considerable amounts of PPARδ.  While its role is unknown in the CD, in other renal cells it has been shown to regulate both growth and apoptosis.  We thus hypothesized that PPARδ reduces apoptotic responses and stimulates cell growth in the mouse CD, and examined the effect of GW501516, a synthetic PPARδ ligand, on these responses in mouse IMCD-K2 cells.  High doses of GW501516 decreased both DNA and protein synthesis in these cells by 80%, but had no overall effect on cell viability.  Although anisomycin treatment resulted in an increase of caspase-3 levels of about 2.59-fold of control, GW501516 did not affect anisomycin-induced changes in active caspase-3 levels.  These results show that a PPARδ ligand inhibits growth but does not affect anisomycin-apoptosis in a mouse IMCD cell line.  This could have therapeutic implications for renal diseases associated with increased CD growth responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOHATOeyYDN0Q0lWbKiCflfW6udTcc2eaZdXW7rOk3Vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ovFKrtw%253D%253D&md5=a294ebb4236546cc8b43b1b41ec51765</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1155%2F2009%2F706283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2009%252F706283%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DNasrallah%26aufirst%3DR.%26aulast%3DH%25C3%25A9bert%26aufirst%3DR.%2BL.%26atitle%3DThe%2520PPAR%2520Ligand%2520GW501516%2520Reduces%2520Growth%2520but%2520Not%2520Apoptosis%2520in%2520Mouse%2520Inner%2520Medullary%2520Collecting%2520Duct%2520Cells%26jtitle%3DPPAR%2520Res.%26date%3D2009%26volume%3D2009%26spage%3D706283%26doi%3D10.1155%2F2009%2F706283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weigand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittrich-Wengenroth, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckroth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaupel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, M.</span></span> <span> </span><span class="NLM_article-title">Minor Structural Modifications Convert a Selective PPARα Agonist into a Potent, Highly Selective PPARδ Agonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4619</span>– <span class="NLM_lpage">4623</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2005.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16115765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVSru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4619-4623&author=S.+Weigandauthor=H.+Bischoffauthor=E.+Dittrich-Wengenrothauthor=H.+Heckrothauthor=D.+Langauthor=A.+Vaupelauthor=M.+Woltering&title=Minor+Structural+Modifications+Convert+a+Selective+PPAR%CE%B1+Agonist+into+a+Potent%2C+Highly+Selective+PPAR%CE%B4+Agonist&doi=10.1016%2Fj.bmcl.2005.06.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Minor structural modifications convert a selective PPARα agonist into a potent, highly selective PPARδ agonist</span></div><div class="casAuthors">Weigand, Stefan; Bischoff, Hilmar; Dittrich-Wengenroth, Elke; Heckroth, Heike; Lang, Dieter; Vaupel, Andrea; Woltering, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4619-4623</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the solid-phase synthesis and pharmacol. evaluation of a new series of small-mol. agonists of the human peroxisome proliferator-activated receptor δ (PPARδ) based on a lead structure from our PPARα program.  Compd. I showed good pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGF1DtnxMwqbVg90H21EOLACvtfcHk0lglLb_h9YKqyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVSru78%253D&md5=3a159829fddcfa41ac96c2951fa22ad2</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DWeigand%26aufirst%3DS.%26aulast%3DBischoff%26aufirst%3DH.%26aulast%3DDittrich-Wengenroth%26aufirst%3DE.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DLang%26aufirst%3DD.%26aulast%3DVaupel%26aufirst%3DA.%26aulast%3DWoltering%26aufirst%3DM.%26atitle%3DMinor%2520Structural%2520Modifications%2520Convert%2520a%2520Selective%2520PPAR%25CE%25B1%2520Agonist%2520into%2520a%2520Potent%252C%2520Highly%2520Selective%2520PPAR%25CE%25B4%2520Agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4619%26epage%3D4623%26doi%3D10.1016%2Fj.bmcl.2005.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Epple, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerken, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iskandar, M.</span></span> <span> </span><span class="NLM_article-title">1, 3, 5-Trisubstituted Aryls as Highly Selective PPARδ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2969</span>– <span class="NLM_lpage">2973</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.02.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2006.02.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16546385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFygt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2969-2973&author=R.+Eppleauthor=M.+Azimioaraauthor=R.+Russoauthor=B.+Bursulayaauthor=S.-S.+Tianauthor=A.+Gerkenauthor=M.+Iskandar&title=1%2C+3%2C+5-Trisubstituted+Aryls+as+Highly+Selective+PPAR%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2006.02.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">1,3,5-Trisubstituted aryls as highly selective PPARδ agonists</span></div><div class="casAuthors">Epple, Robert; Azimioara, Mihai; Russo, Ross; Bursulaya, Badry; Tian, Shin-Shay; Gerken, Andrea; Iskandar, Maya</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2969-2973</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of highly potent and selective PPARδ agonists is described using the known non-selective ligand GW2433 as a structural template.  Compd. 1 is bioavailable, potent (10 nM), and shows no cross-activity with other PPAR subtypes up to 10 μM, making it a useful tool in studying the biol. effects of selective PPARδ activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW7T2nUocvn7Vg90H21EOLACvtfcHk0lglLb_h9YKqyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFygt7c%253D&md5=88ee3a803c1d49a04a07dd5f08b063d4</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.02.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.02.079%26sid%3Dliteratum%253Aachs%26aulast%3DEpple%26aufirst%3DR.%26aulast%3DAzimioara%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DS.-S.%26aulast%3DGerken%26aufirst%3DA.%26aulast%3DIskandar%26aufirst%3DM.%26atitle%3D1%252C%25203%252C%25205-Trisubstituted%2520Aryls%2520as%2520Highly%2520Selective%2520PPAR%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2969%26epage%3D2973%26doi%3D10.1016%2Fj.bmcl.2006.02.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Epple, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wityak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanewsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerken, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iskandar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.-S.</span></span> <span> </span><span class="NLM_article-title">3, 4, 5-Trisubstituted Isoxazoles as Novel PPARδ Agonists: Part 1</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4376</span>– <span class="NLM_lpage">4380</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2006.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16750626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFertLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4376-4380&author=R.+Eppleauthor=R.+Russoauthor=M.+Azimioaraauthor=C.+Cowauthor=Y.+Xieauthor=X.+Wangauthor=J.+Wityakauthor=D.+Karanewskyauthor=A.+Gerkenauthor=M.+Iskandarauthor=E.+Saezauthor=M.+H.+Seidelauthor=S.-S.+Tian&title=3%2C+4%2C+5-Trisubstituted+Isoxazoles+as+Novel+PPAR%CE%B4+Agonists%3A+Part+1&doi=10.1016%2Fj.bmcl.2006.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists</span></div><div class="casAuthors">Epple, Robert; Russo, Ross; Azimioara, Mihai; Cow, Christopher; Xie, Yongping; Wang, Xing; Wityak, John; Karanewsky, Don; Gerken, Andrea; Iskandar, Maya; Saez, Enrique; Seidel, H. Martin; Tian, Shin-Shay</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4376-4380</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors report the identification of a novel series of trisubstituted isoxazoles as PPAR activators from a high-throughput screen.  A series of structural optimizations led to improved efficacy and excellent functional receptor selectivity for PPARδ.  The isoxazoles represent a series of agonists which display a scaffold that lies outside the typical PPAR agonist motif.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAvw4diG8II7Vg90H21EOLACvtfcHk0lhhWQOmK7dMKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFertLY%253D&md5=879c14f32d1515ce9099d1f8685530dd</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DEpple%26aufirst%3DR.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DAzimioara%26aufirst%3DM.%26aulast%3DCow%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DKaranewsky%26aufirst%3DD.%26aulast%3DGerken%26aufirst%3DA.%26aulast%3DIskandar%26aufirst%3DM.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DSeidel%26aufirst%3DM.%2BH.%26aulast%3DTian%26aufirst%3DS.-S.%26atitle%3D3%252C%25204%252C%25205-Trisubstituted%2520Isoxazoles%2520as%2520Novel%2520PPAR%25CE%25B4%2520Agonists%253A%2520Part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4376%26epage%3D4380%26doi%3D10.1016%2Fj.bmcl.2006.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Epple, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wityak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanewsky, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyên-Trân, V. T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spalding, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerken, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iskandar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.-S.</span></span> <span> </span><span class="NLM_article-title">Novel Bisaryl Substituted Thiazoles and Oxazoles as Highly Potent and Selective Peroxisome Proliferator-activated Receptor δ Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1021/jm9007399</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9007399" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVClurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=77-105&author=R.+Eppleauthor=C.+Cowauthor=Y.+Xieauthor=M.+Azimioaraauthor=R.+Russoauthor=X.+Wangauthor=J.+Wityakauthor=D.+S.+Karanewskyauthor=T.+Tuntlandauthor=V.+T.+B.+Nguy%C3%AAn-Tr%C3%A2nauthor=C.+C.+Ngoauthor=D.+Huangauthor=E.+Saezauthor=T.+Spaldingauthor=A.+Gerkenauthor=M.+Iskandarauthor=H.+M.+Seidelauthor=S.-S.+Tian&title=Novel+Bisaryl+Substituted+Thiazoles+and+Oxazoles+as+Highly+Potent+and+Selective+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonists&doi=10.1021%2Fjm9007399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Bisaryl Substituted Thiazoles and Oxazoles as Highly Potent and Selective Peroxisome Proliferator-Activated Receptor δ Agonists</span></div><div class="casAuthors">Epple, Robert; Cow, Christopher; Xie, Yongping; Azimioara, Mihai; Russo, Ross; Wang, Xing; Wityak, John; Karanewsky, Donald S.; Tuntland, Tove; Nguyen-Tran, Van T. B.; Cuc Ngo, Cara; Huang, David; Saez, Enrique; Spalding, Tracy; Gerken, Andrea; Iskandar, Maya; Seidel, H. Martin; Tian, Shin-Shay</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-105</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery, synthesis, and optimization of compd. I from a high-throughput screening hit to highly potent and selective peroxisome proliferator-activated receptor δ (PPARδ) agonists are reported.  The synthesis and structure-activity relationship in this series are described in detail.  On the basis of a general schematic PPAR pharmacophore model, scaffold I was divided into headgroup, linker, and tailgroup and successively optimized for PPAR activation using in vitro PPAR transactivation assays.  A (2-methylphenoxy)acetic acid headgroup, a flexible linker, and a five-membered heteroarom. center ring with two hydrophobic aryl substituents were required for efficient and selective PPARδ activation.  The fine-tuning of these aryl substituents led to an array of highly potent and selective compds. such as compd. II, displaying an excellent pharmacokinetic profile in mouse.  In an in vivo acute dosing model, selected members of this array were shown to induce the expression of pyruvate dehydrogenase kinase-4 (PDK4) and uncoupling protein-3 (UCP3), genes that are known to be involved in energy homeostasis and regulated by PPARδ in skeletal muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMfZfyIV-SvrVg90H21EOLACvtfcHk0lhhWQOmK7dMKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVClurnJ&md5=943649f2307befb02170b34ceca4326e</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm9007399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9007399%26sid%3Dliteratum%253Aachs%26aulast%3DEpple%26aufirst%3DR.%26aulast%3DCow%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DAzimioara%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DKaranewsky%26aufirst%3DD.%2BS.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DNguy%25C3%25AAn-Tr%25C3%25A2n%26aufirst%3DV.%2BT.%2BB.%26aulast%3DNgo%26aufirst%3DC.%2BC.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DSpalding%26aufirst%3DT.%26aulast%3DGerken%26aufirst%3DA.%26aulast%3DIskandar%26aufirst%3DM.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DTian%26aufirst%3DS.-S.%26atitle%3DNovel%2520Bisaryl%2520Substituted%2520Thiazoles%2520and%2520Oxazoles%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D77%26epage%3D105%26doi%3D10.1021%2Fjm9007399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Havranek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogensen, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratina, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppesen, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihera, P.</span></span> <span> </span><span class="NLM_article-title">Novel Selective PPARδ Agonists: Optimization of Activity by Modification of Alkynylallylic Moiety</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4144</span>– <span class="NLM_lpage">4149</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2007.05.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17553681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVKns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4144-4149&author=M.+Havranekauthor=P.+Sauerbergauthor=J.+P.+Mogensenauthor=P.+Kratinaauthor=C.+B.+Jeppesenauthor=I.+Petterssonauthor=P.+Pihera&title=Novel+Selective+PPAR%CE%B4+Agonists%3A+Optimization+of+Activity+by+Modification+of+Alkynylallylic+Moiety&doi=10.1016%2Fj.bmcl.2007.05.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective PPARδ agonists: Optimization of activity by modification of alkynylallylic moiety</span></div><div class="casAuthors">Havranek, Miroslav; Sauerberg, Per; Mogensen, John P.; Kratina, Pavel; Jeppesen, Claus B.; Pettersson, Ingrid; Pihera, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4144-4149</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Y-shaped mols. bearing alkynylallylic moieties were found to be potent and selective PPARδ activators.  The alkynylallylic moiety was synthesized from alkyn-1-ols by hydroalumination followed by a cross-coupling reaction.  Series of active compds. were obtained by stepwise changing the structure of a known PPARpan agonist into Y-shaped compds.  The most active and selective compd., I, had a PPARδ potency of 0.13 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmhoVrD4tMVbVg90H21EOLACvtfcHk0lhkgE1OpmT0Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVKns7c%253D&md5=e8d583937cdb724730deb423d536f278</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.051%26sid%3Dliteratum%253Aachs%26aulast%3DHavranek%26aufirst%3DM.%26aulast%3DSauerberg%26aufirst%3DP.%26aulast%3DMogensen%26aufirst%3DJ.%2BP.%26aulast%3DKratina%26aufirst%3DP.%26aulast%3DJeppesen%26aufirst%3DC.%2BB.%26aulast%3DPettersson%26aufirst%3DI.%26aulast%3DPihera%26aufirst%3DP.%26atitle%3DNovel%2520Selective%2520PPAR%25CE%25B4%2520Agonists%253A%2520Optimization%2520of%2520Activity%2520by%2520Modification%2520of%2520Alkynylallylic%2520Moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4144%26epage%3D4149%26doi%3D10.1016%2Fj.bmcl.2007.05.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sauerberg, S.</span>; <span class="NLM_string-name">Pihera, P.</span>; <span class="NLM_string-name">Polivka, Z.</span>; <span class="NLM_string-name">Havranek, M.</span>; <span class="NLM_string-name">Pettersson, I.</span>; <span class="NLM_string-name">Mogensen, J. P.</span></span> <span> </span><span class="NLM_article-title">Phenoxy Acetic Acids as PPAR delta Activators</span>. International Patent <span class="NLM_patent">WO2007071766A2</span>, Jun 28, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=S.+Sauerberg&author=P.+Pihera&author=Z.+Polivka&author=M.+Havranek&author=I.+Pettersson&author=J.+P.+Mogensen&title=Phenoxy+Acetic+Acids+as+PPAR+delta+Activators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSauerberg%26aufirst%3DS.%26atitle%3DPhenoxy%2520Acetic%2520Acids%2520as%2520PPAR%2520delta%2520Activators%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colca, J. R.</span></span> <span> </span><span class="NLM_article-title">Discontinued Drug in 2007: Renal, Endocrine and Metabolic Drugs</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1641</span>– <span class="NLM_lpage">1650</span>, <span class="refDoi"> DOI: 10.1517/13543784.17.11.1641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1517%2F13543784.17.11.1641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18922101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CmsbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1641-1650&author=J.+R.+Colca&title=Discontinued+Drug+in+2007%3A+Renal%2C+Endocrine+and+Metabolic+Drugs&doi=10.1517%2F13543784.17.11.1641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Discontinued drug in 2007: renal, endocrine and metabolic drugs</span></div><div class="casAuthors">Colca, Jerry R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1641-1650</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  This perspective is the first part of an annual series of papers discussing drugs dropped from clin. development in the previous year.  Specifically, this paper focuses on the 14 renal, endocrine and metabolic drugs discontinued in 2007.  The candidates covered in this summary were being developed for treatment of diabetes, obesity, reproductive and urogenital health issues, and growth hormone deficiency.  Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase I - III clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNtGm68GBILLVg90H21EOLACvtfcHk0lhkgE1OpmT0Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CmsbbO&md5=2e063ec890e78d7f8992630e0b7590d5</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1517%2F13543784.17.11.1641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.17.11.1641%26sid%3Dliteratum%253Aachs%26aulast%3DColca%26aufirst%3DJ.%2BR.%26atitle%3DDiscontinued%2520Drug%2520in%25202007%253A%2520Renal%252C%2520Endocrine%2520and%2520Metabolic%2520Drugs%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1641%26epage%3D1650%26doi%3D10.1517%2F13543784.17.11.1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span> <i>HPP593</i>; <span class="NLM_publisher-name">vTv Therapeutics</span>, <span class="NLM_year">2017</span>; <a href="https://vtvtherapeutics.com/pipeline/hpp593/" class="extLink">https://vtvtherapeutics.com/pipeline/hpp593/</a> (accessed 2020-02-12).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+HPP593%3B+vTv+Therapeutics%2C+2017%3B+https%3A%2F%2Fvtvtherapeutics.com%2Fpipeline%2Fhpp593%2F+%28accessed+2020-02-12%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DHPP593%26pub%3DvTv%2520Therapeutics%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarest, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, G.-H.</span></span> <span> </span><span class="NLM_article-title">Discovery of Para-alkylthiophenoxyacetic Acids as a Novel Series of Potent and Selective PPARδ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3855</span>– <span class="NLM_lpage">3859</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2007.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17524639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVCltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3855-3859&author=R.+Zhangauthor=A.+Wangauthor=A.+DeAngelisauthor=P.+Peltonauthor=J.+Xuauthor=P.+Zhuauthor=L.+Zhouauthor=K.+Demarestauthor=W.+V.+Murrayauthor=G.-H.+Kuo&title=Discovery+of+Para-alkylthiophenoxyacetic+Acids+as+a+Novel+Series+of+Potent+and+Selective+PPAR%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2007.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of para-alkylthiophenoxyacetic acids as a novel series of potent and selective PPARδ agonists</span></div><div class="casAuthors">Zhang, Rui; Wang, Aihua; DeAngelis, Alan; Pelton, Patricia; Xu, Jun; Zhu, Peifang; Zhou, Lubing; Demarest, Keith; Murray, William V.; Kuo, Gee-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3855-3859</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A novel series of potent and selective PPARδ agonists, p-alkylthiophenoxyacetic acids [I, X = S, O, S(O); Y = O, CH2; R = OH, MeO, OMOM, Me, etc.] was identified.  The synthesis and structure-activity relationships are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrewkJuqJPxjbVg90H21EOLACvtfcHk0ljTut9JAI43ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVCltbw%253D&md5=b7974387d421bb4f1fa6882ab89733df</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DDeAngelis%26aufirst%3DA.%26aulast%3DPelton%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26aulast%3DKuo%26aufirst%3DG.-H.%26atitle%3DDiscovery%2520of%2520Para-alkylthiophenoxyacetic%2520Acids%2520as%2520a%2520Novel%2520Series%2520of%2520Potent%2520and%2520Selective%2520PPAR%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3855%26epage%3D3859%26doi%3D10.1016%2Fj.bmcl.2007.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber-McMaster, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarest, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, G. H.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR of Para-alkylthiophenoxyacetic Acids as Potent and Selective PPARδ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1101</span>– <span class="NLM_lpage">1104</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.12.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2008.12.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19168353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1101-1104&author=R.+Zhangauthor=A.+DeAngelisauthor=A.+Wangauthor=E.+Sieber-McMasterauthor=X.+Liauthor=R.+Russellauthor=P.+Peltonauthor=J.+Xuauthor=P.+Zhuauthor=L.+Zhouauthor=K.+Demarestauthor=W.+V.+Murrayauthor=G.+H.+Kuo&title=Discovery+and+SAR+of+Para-alkylthiophenoxyacetic+Acids+as+Potent+and+Selective+PPAR%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2008.12.113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARδ agonists</span></div><div class="casAuthors">Zhang, Rui; De Angelis, Alan; Wang, Aihua; Sieber-McMaster, Ellen; Li, Xun; Russell, Ronald; Pelton, Patricia; Xu, Jun; Zhu, Peifang; Zhou, Lubing; Demarest, Keith; Murray, William V.; Kuo, Gee-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1101-1104</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthesis and SAR of para-alkylthiophenoxyacetic acids was described.  Achiral compds. I [R1R2 = CMe2, (CH2)2; R1 = R2 = n-Pr] were identified as potent and selective PPARδ agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXrta22nBA_bVg90H21EOLACvtfcHk0ljTut9JAI43ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wrt7g%253D&md5=6028da6eee6963cd3bb6abd2a66a3d36</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.113%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDeAngelis%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSieber-McMaster%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DPelton%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26aulast%3DKuo%26aufirst%3DG.%2BH.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520Para-alkylthiophenoxyacetic%2520Acids%2520as%2520Potent%2520and%2520Selective%2520PPAR%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1101%26epage%3D1104%26doi%3D10.1016%2Fj.bmcl.2008.12.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber-McMaster, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarest, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, G. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Structure–activity Relationships of Thiadiazole-derivatives as Potent and Orally Active Peroxisome Proliferator-activated Receptor α/δ Dual Agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3321</span>– <span class="NLM_lpage">3341</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmc.2007.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18155554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFeqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=3321-3341&author=L.+Shenauthor=Y.+Zhangauthor=A.+Wangauthor=E.+Sieber-McMasterauthor=X.+Chenauthor=P.+Peltonauthor=J.+Z.+Xuauthor=M.+Yangauthor=P.+Zhuauthor=L.+Zhouauthor=M.+Reumanauthor=Z.+Huauthor=R.+Russellauthor=A.+C.+Gibbsauthor=H.+Rossauthor=K.+Demarestauthor=W.+V.+Murrayauthor=G.+H.+Kuo&title=Synthesis+and+Structure%E2%80%93activity+Relationships+of+Thiadiazole-derivatives+as+Potent+and+Orally+Active+Peroxisome+Proliferator-activated+Receptor+%CE%B1%2F%CE%B4+Dual+Agonists&doi=10.1016%2Fj.bmc.2007.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors α/δ dual agonists</span></div><div class="casAuthors">Shen, Lan; Zhang, Yan; Wang, Aihua; Sieber-McMaster, Ellen; Chen, Xiaoli; Pelton, Patricia; Xu, June Z.; Yang, Maria; Zhu, Peifang; Zhou, Lubing; Reuman, Michael; Hu, Zhiyong; Russell, Ronald; Gibbs, Alan C.; Ross, Hamish; Demarest, Keith; Murray, William V.; Kuo, Gee-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3321-3341</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Replacement of the methyl-thiazole moiety of GW501516 (a PPARδ selective agonist) with [1,2,4]thiadiazole gave compd. 21 (I) which unexpectedly displayed submicromolar potency as a partial agonist at PPARα in addn. to the high potency at PPARδ.  A structure-activity relationships study of 21 resulted in the identification of 40 as a potent and selective PPARα/δ dual agonist.  Compd. 40 and its close analogs represent a new series of PPARα/δ dual agonists.  The high potency, high selectivity, significant gene induction, excellent PK profiles, low P 450 inhibition or induction, and good in vivo efficacy in four animal models support 40 being selected as a pre-clin. study candidate, and may render 40 as a valuable pharmacol. tool in elucidating the complex roles of PPARα/δ dual agonists, and the potential usage for the treatment of metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0jJSgGujySLVg90H21EOLACvtfcHk0lidi0Q2dff4gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFeqsbs%253D&md5=f97267398567b5034c7edae1dd0f1632</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSieber-McMaster%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPelton%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%2BZ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DReuman%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DRoss%26aufirst%3DH.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26aulast%3DKuo%26aufirst%3DG.%2BH.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593activity%2520Relationships%2520of%2520Thiadiazole-derivatives%2520as%2520Potent%2520and%2520Orally%2520Active%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B1%252F%25CE%25B4%2520Dual%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D3321%26epage%3D3341%26doi%3D10.1016%2Fj.bmc.2007.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bratton, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulaski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unangst, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Potent and Selective Benzyloxybenzyl-based Peroxisome Proliferator-activated Receptor (PPAR) δ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3624</span>– <span class="NLM_lpage">3629</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.04.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2007.04.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17498950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFaitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3624-3629&author=L.+D.+Brattonauthor=G.+F.+Filzenauthor=A.+Geyerauthor=J.+K.+Hoffmanauthor=G.+Luauthor=J.+Pulaskiauthor=B.+K.+Trivediauthor=P.+C.+Unangstauthor=X.+Xu&title=Discovery+of+Highly+Potent+and+Selective+Benzyloxybenzyl-based+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29+%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2007.04.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent and selective benzyloxybenzyl-based peroxisome proliferator-activator receptor (PPAR) δ agonists</span></div><div class="casAuthors">Bratton, Larry D.; Filzen, Gary F.; Geyer, Andrew; Hoffman, Jennifer K.; Lu, Gina; Pulaski, Jim; Trivedi, Bharat K.; Unangst, Paul C.; Xu, Xiangyang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3624-3629</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 1,4-benzyloxybenzylsulfanylaryl carboxylic acids, e.g. I (R1 = Ph, 4-MeOC6H4, 4-ClC6H4, etc.) and II (R2 = H, F), were prepd. and their activities for PPAR receptor subtypes (α, δ, and γ) with potential indications for the treatment of dyslipidemia were investigated.  I (R1 = 4-F3CC6H4) displayed the greatest binding affinity (IC50 = 10 nM) and selectivity (120-fold) for PPARδ over PPARα.  Many of the analogs investigated were found to be highly selective for PPARδ and were dependent on the point of attachment of the substituent.  In the 1,2-series, analog II (R2 = 5-F) was found to be the most potent (IC50 = 1.7 nM) and selective (>1000-fold) compd. for PPARδ.  None of the compds. tested showed appreciable binding affinity for PPARγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhZz78FnwEkrVg90H21EOLACvtfcHk0ljNB46IlUFm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFaitL0%253D&md5=b8078689543a9d9330039e23cc663575</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.04.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.04.046%26sid%3Dliteratum%253Aachs%26aulast%3DBratton%26aufirst%3DL.%2BD.%26aulast%3DFilzen%26aufirst%3DG.%2BF.%26aulast%3DGeyer%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%2BK.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DPulaski%26aufirst%3DJ.%26aulast%3DTrivedi%26aufirst%3DB.%2BK.%26aulast%3DUnangst%26aufirst%3DP.%2BC.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520Highly%2520Potent%2520and%2520Selective%2520Benzyloxybenzyl-based%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%2520%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3624%26epage%3D3629%26doi%3D10.1016%2Fj.bmcl.2007.04.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erasga, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulaski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorenson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unangst, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of Selective Benzothiophene, Benzofuran, and Indole-based Peroxisome Proliferator-activated Receptor δ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3630</span>– <span class="NLM_lpage">3635</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.04.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2007.04.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17512197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFaitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3630-3635&author=G.+F.+Filzenauthor=L.+Brattonauthor=X.-M.+Chengauthor=N.+Erasgaauthor=A.+Geyerauthor=C.+Leeauthor=G.+Luauthor=J.+Pulaskiauthor=R.+J.+Sorensonauthor=P.+C.+Unangstauthor=B.+K.+Trivediauthor=X.+Xu&title=Synthesis+and+SAR+of+Selective+Benzothiophene%2C+Benzofuran%2C+and+Indole-based+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2007.04.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor δ agonists</span></div><div class="casAuthors">Filzen, Gary F.; Bratton, Larry; Cheng, Xue-Min; Erasga, Noe; Geyer, Andrew; Lee, Chitase; Lu, Gina; Pulaski, Jim; Sorenson, Roderick J.; Unangst, Paul C.; Trivedi, B. K.; Xu, Xiangyang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3630-3635</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Recent literature has suggested the benefit of selective PPARδ agonists for the treatment of atherosclerosis and other disease states assocd. with the metabolic syndrome.  Therefore the synthesis and structure-activity relationships of selective PPARδ agonists are reported.  The research began with identification of a benzothiophene template which was modified by the addn. of various thiazolyl, isoxazolyl, and benzyloxy-benzyl moieties.  Further elucidation of the SAR led to the identification of benzofuran and indole based templates.  Three chem. templates, e.g., I (X = O, S) and II, with varying degrees of affinity and potency for PPARδ vs. the PPARα and PPARγ subtypes were discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp879sbRiaFVbVg90H21EOLACvtfcHk0ljNB46IlUFm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFaitLo%253D&md5=c0faf4559e4130413b84abfef09bfbc4</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.04.047%26sid%3Dliteratum%253Aachs%26aulast%3DFilzen%26aufirst%3DG.%2BF.%26aulast%3DBratton%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DX.-M.%26aulast%3DErasga%26aufirst%3DN.%26aulast%3DGeyer%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DPulaski%26aufirst%3DJ.%26aulast%3DSorenson%26aufirst%3DR.%2BJ.%26aulast%3DUnangst%26aufirst%3DP.%2BC.%26aulast%3DTrivedi%26aufirst%3DB.%2BK.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520Selective%2520Benzothiophene%252C%2520Benzofuran%252C%2520and%2520Indole-based%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3630%26epage%3D3635%26doi%3D10.1016%2Fj.bmcl.2007.04.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakawa, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a Novel Human PPARδ Selective Agonist and its Stimulatory Effect on Oligodendrocyte Differentiation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2010.11.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21112784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sqsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=240-244&author=S.+Sakumaauthor=T.+Endoauthor=T.+Kandaauthor=H.+Nakamuraauthor=S.+Yamasakiauthor=T.+Yamakawa&title=Synthesis+of+a+Novel+Human+PPAR%CE%B4+Selective+Agonist+and+its+Stimulatory+Effect+on+Oligodendrocyte+Differentiation&doi=10.1016%2Fj.bmcl.2010.11.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a novel human PPARδ selective agonist and its stimulatory effect on oligodendrocyte differentiation</span></div><div class="casAuthors">Sakuma, Shogo; Endo, Tsuyoshi; Kanda, Takashi; Nakamura, Hideki; Yamasaki, Satomi; Yamakawa, Tomio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-244</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel peroxisome proliferator-activated receptor (PPAR)δ selective agonist with a characteristic benzisoxazole ring, I, was successfully synthesized.  Compd. I exhibited potent human PPARδ transactivation activity and high δ selectivity.  Further, it stimulated differentiation of primary oligodendrocyte precursor cells in vitro, indicating that it may be an effective drug in the treatment of demyelinating disorders such as multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4B5Mta2tQlLVg90H21EOLACvtfcHk0lhM35NVqLA0QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sqsb7J&md5=3a7d74f2f007c601a273b75699478f26</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DSakuma%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DT.%26aulast%3DKanda%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DYamasaki%26aufirst%3DS.%26aulast%3DYamakawa%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520a%2520Novel%2520Human%2520PPAR%25CE%25B4%2520Selective%2520Agonist%2520and%2520its%2520Stimulatory%2520Effect%2520on%2520Oligodendrocyte%2520Differentiation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D240%26epage%3D244%26doi%3D10.1016%2Fj.bmcl.2010.11.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakawa, T.</span></span> <span> </span><span class="NLM_article-title">Effects of a Novel PPARδ Agonist NCP-1046 on the Wound Healing in Animal Models</span>. <i>J. Dermatol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>86</i></span>, <span class="NLM_elocation-id">e92</span> <span class="refDoi"> DOI: 10.1016/j.jdermsci.2017.02.269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.jdermsci.2017.02.269" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2017&author=T.+Hiraiauthor=T.+Hamanoauthor=T.+Yamakawa&title=Effects+of+a+Novel+PPAR%CE%B4+Agonist+NCP-1046+on+the+Wound+Healing+in+Animal+Models&doi=10.1016%2Fj.jdermsci.2017.02.269"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.jdermsci.2017.02.269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdermsci.2017.02.269%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DT.%26aulast%3DHamano%26aufirst%3DT.%26aulast%3DYamakawa%26aufirst%3DT.%26atitle%3DEffects%2520of%2520a%2520Novel%2520PPAR%25CE%25B4%2520Agonist%2520NCP-1046%2520on%2520the%2520Wound%2520Healing%2520in%2520Animal%2520Models%26jtitle%3DJ.%2520Dermatol.%2520Sci.%26date%3D2017%26volume%3D86%26doi%3D10.1016%2Fj.jdermsci.2017.02.269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luckhurst, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allenby, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botterell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walding, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Isoindoline and Tetrahydroisoquinoline Derivatives as Potent, Selective PPARδ Agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2010.10.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21094606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SqsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=492-496&author=C.+A.+Luckhurstauthor=L.+A.+Steinauthor=M.+Furberauthor=N.+Webbauthor=M.+J.+Ratcliffeauthor=G.+Allenbyauthor=S.+Botterellauthor=W.+Tomlinsonauthor=B.+Martinauthor=A.+Walding&title=Discovery+of+Isoindoline+and+Tetrahydroisoquinoline+Derivatives+as+Potent%2C+Selective+PPAR%CE%B4+Agonists&doi=10.1016%2Fj.bmcl.2010.10.117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARδ agonists</span></div><div class="casAuthors">Luckhurst, Christopher A.; Stein, Linda A.; Furber, Mark; Webb, Nicola; Ratcliffe, Marianne J.; Allenby, Gary; Botterell, Sara; Tomlinson, Wendy; Martin, Barrie; Walding, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">492-496</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small mol. isoindoline and tetrahydroisoquinoline derivs. have been identified as selective agonists of human peroxisome proliferator-activated receptor δ (PPARδ).  Compd. 18 (I) demonstrated efficacy in a biomarker for increased fatty acid oxidn., with upregulation of pyruvate dehydrogenase kinase, isoenzyme 4 (PDK4) in human primary myotubes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOjy--dYG4fbVg90H21EOLACvtfcHk0lhM35NVqLA0QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SqsbjK&md5=781fec41ffa71df5e2422561e66dc037</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.117%26sid%3Dliteratum%253Aachs%26aulast%3DLuckhurst%26aufirst%3DC.%2BA.%26aulast%3DStein%26aufirst%3DL.%2BA.%26aulast%3DFurber%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DN.%26aulast%3DRatcliffe%26aufirst%3DM.%2BJ.%26aulast%3DAllenby%26aufirst%3DG.%26aulast%3DBotterell%26aufirst%3DS.%26aulast%3DTomlinson%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DB.%26aulast%3DWalding%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520Isoindoline%2520and%2520Tetrahydroisoquinoline%2520Derivatives%2520as%2520Potent%252C%2520Selective%2520PPAR%25CE%25B4%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D492%26epage%3D496%26doi%3D10.1016%2Fj.bmcl.2010.10.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span>; <span class="NLM_string-name">Malecha, J. M.</span>; <span class="NLM_string-name">Noble, S. G.</span>; <span class="NLM_string-name">Duron, S. G.</span>; <span class="NLM_string-name">Lindstrom, A. K.</span>; <span class="NLM_string-name">Shiau, A. K.</span></span> <span> </span><span class="NLM_article-title">Aryl Sulfonamide and Sulfonyl Compounds as Modulators of PPAR and Methods of Treating Metabolic Disorders</span>. International Patent <span class="NLM_patent">WO2005115983A1</span>, Dec 8, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=C.+Zhao&author=J.+M.+Malecha&author=S.+G.+Noble&author=S.+G.+Duron&author=A.+K.+Lindstrom&author=A.+K.+Shiau&title=Aryl+Sulfonamide+and+Sulfonyl+Compounds+as+Modulators+of+PPAR+and+Methods+of+Treating+Metabolic+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DC.%26atitle%3DAryl%2520Sulfonamide%2520and%2520Sulfonyl%2520Compounds%2520as%2520Modulators%2520of%2520PPAR%2520and%2520Methods%2520of%2520Treating%2520Metabolic%2520Disorders%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malecha, J. M.</span>; <span class="NLM_string-name">Zhao, C.</span>; <span class="NLM_string-name">Robinson, C. K. M.</span>; <span class="NLM_string-name">Duron, S. G.</span>; <span class="NLM_string-name">Sertc, M.</span></span>’ <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, S. A.</span></span> <span> </span><span class="NLM_article-title">(5-(2-Phenyl)-thiazol-5-ylmethoxy)-indol-1-yl)-acetic Acid Derivatives and Related Compounds as Modulators of the Human PPAR-delta Receptor for the Treatment of Metabolic Disorders such as Type 2 Diabetes</span>. International Patent <span class="NLM_patent">WO2005060958A1</span>, Jul 7, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.+M.+Malecha&author=C.+Zhao&author=C.+K.+M.+Robinson&author=S.+G.+Duron&author=M.+Sertcauthor=S.+A.+Noble&title=%285-%282-Phenyl%29-thiazol-5-ylmethoxy%29-indol-1-yl%29-acetic+Acid+Derivatives+and+Related+Compounds+as+Modulators+of+the+Human+PPAR-delta+Receptor+for+the+Treatment+of+Metabolic+Disorders+such+as+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMalecha%26aufirst%3DJ.%2BM.%26aulast%3DNoble%26aufirst%3DS.%2BA.%26atitle%3D%25285-%25282-Phenyl%2529-thiazol-5-ylmethoxy%2529-indol-1-yl%2529-acetic%2520Acid%2520Derivatives%2520and%2520Related%2520Compounds%2520as%2520Modulators%2520of%2520the%2520Human%2520PPAR-delta%2520Receptor%2520for%2520the%2520Treatment%2520of%2520Metabolic%2520Disorders%2520such%2520as%2520Type%25202%2520Diabetes%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guha, M.</span>; <span class="NLM_string-name">Deng, M.</span>; <span class="NLM_string-name">Malecha, J.</span>; <span class="NLM_string-name">Kabakibi, A.</span>; <span class="NLM_string-name">Oshiro, G.</span>; <span class="NLM_string-name">Rao, T.</span></span> <span> </span><span class="NLM_article-title">KD3010, a PPARβ/δ Selective Small Molecule Agonist, Improves Hyperglycemia and Insulin Resistance While Alleviating Rosiglitazone-induced Side Effects in Murine Models</span>.  <i>Circulation</i> <span class="NLM_year">2006</span>,  <span class="NLM_volume">114</span>, <span class="NLM_issue">18</span>,  <span class="NLM_fpage">843</span> <a href="https://www.ahajournals.org/doi/abs/10.1161/circ.114.suppl_18.II_843-a" class="extLink">https://www.ahajournals.org/doi/abs/10.1161/circ.114.suppl_18.II_843-a</a>(accessed 2019-10-14)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Guha&author=M.+Deng&author=J.+Malecha&author=A.+Kabakibi&author=G.+Oshiro&author=T.+Rao&title=KD3010%2C+a+PPAR%CE%B2%2F%CE%B4+Selective+Small+Molecule+Agonist%2C+Improves+Hyperglycemia+and+Insulin+Resistance+While+Alleviating+Rosiglitazone-induced+Side+Effects+in+Murine+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGuha%26aufirst%3DM.%26atitle%3DKD3010%252C%2520a%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Selective%2520Small%2520Molecule%2520Agonist%252C%2520Improves%2520Hyperglycemia%2520and%2520Insulin%2520Resistance%2520While%2520Alleviating%2520Rosiglitazone-induced%2520Side%2520Effects%2520in%2520Murine%2520Models%26jtitle%3DCirculation%26date%3D2006%26volume%3D114%26issue%3D18%26spage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guha, M.</span>; <span class="NLM_string-name">Grint, P.</span></span> <span> </span><span class="NLM_article-title">Sulfonyl-substituted Bicyclic Compounds as PPAR Modulators for the Treatment of Non-alcoholic Steatohepatitis</span>. International Patent <span class="NLM_patent">WO2008091863A1</span>, Jul 31, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+Guha&author=P.+Grint&title=Sulfonyl-substituted+Bicyclic+Compounds+as+PPAR+Modulators+for+the+Treatment+of+Non-alcoholic+Steatohepatitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuha%26aufirst%3DM.%26atitle%3DSulfonyl-substituted%2520Bicyclic%2520Compounds%2520as%2520PPAR%2520Modulators%2520for%2520the%2520Treatment%2520of%2520Non-alcoholic%2520Steatohepatitis%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ekambomé Basséne, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzenet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennuyer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caignard, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacquet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillaumet, G.</span></span> <span> </span><span class="NLM_article-title">Studies Towards the Conception of New Selective PPARβ/δ Ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4528</span>– <span class="NLM_lpage">4532</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2006.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=16797985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFOlt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4528-4532&author=C.+E.+Ekambom%C3%A9+Bass%C3%A9neauthor=F.+Suzenetauthor=N.+Hennuyerauthor=B.+Staelsauthor=D.-H.+Caignardauthor=C.+Dacquetauthor=P.+Renardauthor=G.+Guillaumet&title=Studies+Towards+the+Conception+of+New+Selective+PPAR%CE%B2%2F%CE%B4+Ligands&doi=10.1016%2Fj.bmcl.2006.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Studies towards the conception of new selective PPARβ/δ ligands</span></div><div class="casAuthors">Ekambome Bassene, Carine; Suzenet, Franck; Hennuyer, Nathalie; Staels, Bart; Caignard, Daniel-Henri; Dacquet, Catherine; Renard, Pierre; Guillaumet, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4528-4532</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to define new PPARβ/δ ligands, SAR study on the selective PPARβ/δ activator L-165,041 led to the identification of one key functional group for selective PPARβ/δ activation.  Furthermore, taking advantage of SAR studies done elsewhere on the most selective PPARβ/δ ligand GW501516, the conception of new ligands showing good affinity for PPARβ/δ is reported.  Finally, synthesis and biol. evaluation of pyridine analogs have shown the beneficial effect of the pyridine ring on the PPARβ/δ subtype selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6qJYTerZ9r7Vg90H21EOLACvtfcHk0lgs2r3KjHAbhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFOlt7c%253D&md5=bf968057270f35ded9f2574eb301dbbe</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DEkambom%25C3%25A9%2BBass%25C3%25A9ne%26aufirst%3DC.%2BE.%26aulast%3DSuzenet%26aufirst%3DF.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DCaignard%26aufirst%3DD.-H.%26aulast%3DDacquet%26aufirst%3DC.%26aulast%3DRenard%26aufirst%3DP.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DStudies%2520Towards%2520the%2520Conception%2520of%2520New%2520Selective%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4528%26epage%3D4532%26doi%3D10.1016%2Fj.bmcl.2006.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagome, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sako, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makishima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of Potent, Structurally Novel Peroxisome Proliferator-activated Receptor (PPAR) δ-selective Agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5177</span>– <span class="NLM_lpage">5190</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmc.2007.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17532641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlahtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5177-5190&author=J.-i.+Kasugaauthor=I.+Nakagomeauthor=A.+Aoyamaauthor=K.+Sakoauthor=M.+Ishizawaauthor=M.+Oguraauthor=M.+Makishimaauthor=S.+Hironoauthor=Y.+Hashimotoauthor=H.+Miyachi&title=Design%2C+Synthesis%2C+and+Evaluation+of+Potent%2C+Structurally+Novel+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29+%CE%B4-selective+Agonists&doi=10.1016%2Fj.bmc.2007.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) δ-selective agonists</span></div><div class="casAuthors">Kasuga, Jun-ichi; Nakagome, Izumi; Aoyama, Atsushi; Sako, Kumiko; Ishizawa, Michiyasu; Ogura, Michitaka; Makishima, Makoto; Hirono, Shuichi; Hashimoto, Yuichi; Miyachi, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5177-5190</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 3-(4-alkoxyphenyl)propanoic acid derivs. was prepd. as candidate peroxisome proliferator-activated receptor (PPAR) δ-selective agonists, based on our previously discovered potent human PPARα/δ dual agonist TIPP-401 as a lead compd.  Structure-activity relationship studies clearly indicated the importance of the chain length of the alkoxy group at the 4-position, and the n-butoxy compd. exhibited the most potent PPARδ transactivation activity and highest PPARδ selectivity.  The (S)-enantiomer of a representative compd. exhibited extremely potent PPARδ transactivation activity, comparable with or somewhat superior to that of the known PPARδ-selective agonist, GW-501516.  The representative compd. regulated the expression of genes involved in lipid and glucose homeostasis, and should be useful not only as a chem. tool to study PPARδ function, but also as a candidate drug for the treatment of metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoFPJ77LHuI7Vg90H21EOLACvtfcHk0lgs2r3KjHAbhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlahtrc%253D&md5=d59bbd64acfb30e221ee6a09bb30186b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DKasuga%26aufirst%3DJ.-i.%26aulast%3DNakagome%26aufirst%3DI.%26aulast%3DAoyama%26aufirst%3DA.%26aulast%3DSako%26aufirst%3DK.%26aulast%3DIshizawa%26aufirst%3DM.%26aulast%3DOgura%26aufirst%3DM.%26aulast%3DMakishima%26aufirst%3DM.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Potent%252C%2520Structurally%2520Novel%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%2520%25CE%25B4-selective%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5177%26epage%3D5190%26doi%3D10.1016%2Fj.bmc.2007.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirakawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, K.</span></span> <span> </span><span class="NLM_article-title">Adaptability and Selectivity of Human Peroxisome Proliferator-activated Receptor (PPAR) Pan Agonists Revealed from Crystal Structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1107/S0907444909015935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1107%2FS0907444909015935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=19622862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=786-795&author=T.+Oyamaauthor=K.+Toyotaauthor=T.+Wakuauthor=Y.+Hirakawaauthor=N.+Nagasawaauthor=J.-i.+Kasugaauthor=Y.+Hashimotoauthor=H.+Miyachiauthor=K.+Morikawa&title=Adaptability+and+Selectivity+of+Human+Peroxisome+Proliferator-activated+Receptor+%28PPAR%29+Pan+Agonists+Revealed+from+Crystal+Structures&doi=10.1107%2FS0907444909015935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures</span></div><div class="casAuthors">Oyama, Takuji; Toyota, Kenji; Waku, Tsuyoshi; Hirakawa, Yuko; Nagasawa, Naoko; Kasuga, Jun ichi; Hashimoto, Yuichi; Miyachi, Hiroyuki; Morikawa, Kosuke</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">786-795</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear hormone receptor family, which is defined as transcriptional factors that are activated by the binding of ligands to their ligand-binding domains (LBDs).  Although the three PPAR subtypes display different tissue distribution patterns and distinct pharmacol. profiles, they all are essentially related to fatty-acid and glucose metab.  Since the PPARs share similar 3-dimensional structures within the LBDs, synthetic ligands which simultaneously activate 2 or all of the PPARs could be potent candidates in terms of drugs for the treatment of abnormal metabolic homeostasis.  The structures of several PPAR LBDs were detd. in complex with synthetic ligands, derivs. of 3-(4-alkoxyphenyl)propanoic acid, which exhibit unique agonistic activities.  The PPARα and PPARγ LBDs were complexed with the same pan agonist, TIPP-703, which activates all three PPARs and their crystal structures were detd.  The two LBD-ligand complex structures revealed how the pan agonist is adapted to the similar, but significantly different, ligand-binding pockets of the PPARs.  The structures of the PPARδ LBD in complex with an α/δ-selective ligand, TIPP-401, and with a related δ-specific ligand, TIPP-204, were also detd.  The comparison between the two PPARδ complexes revealed how each ligand exhibits either a 'dual selective' or 'single specific' binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsqRY6vaJ6TLVg90H21EOLACvtfcHk0lgYvrsIgrbX8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCgurs%253D&md5=417380ca8b0392b5ee4909ec3f9eb017</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1107%2FS0907444909015935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909015935%26sid%3Dliteratum%253Aachs%26aulast%3DOyama%26aufirst%3DT.%26aulast%3DToyota%26aufirst%3DK.%26aulast%3DWaku%26aufirst%3DT.%26aulast%3DHirakawa%26aufirst%3DY.%26aulast%3DNagasawa%26aufirst%3DN.%26aulast%3DKasuga%26aufirst%3DJ.-i.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DMiyachi%26aufirst%3DH.%26aulast%3DMorikawa%26aufirst%3DK.%26atitle%3DAdaptability%2520and%2520Selectivity%2520of%2520Human%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%2528PPAR%2529%2520Pan%2520Agonists%2520Revealed%2520from%2520Crystal%2520Structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D786%26epage%3D795%26doi%3D10.1107%2FS0907444909015935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor β (δ)-dependent Regulation of Ubiquitin C Expression Contributes to Attenuation of Skin Carcinogenesis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">23719</span>– <span class="NLM_lpage">23727</span>, <span class="refDoi"> DOI: 10.1074/jbc.M312063200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1074%2Fjbc.M312063200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15033975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Giu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=23719-23727&author=D.+J.+Kimauthor=T.+E.+Akiyamaauthor=F.+S.+Harmanauthor=A.+M.+Burnsauthor=W.+Shanauthor=J.+M.+Wardauthor=M.+J.+Kennettauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Peroxisome+Proliferator-activated+Receptor+%CE%B2+%28%CE%B4%29-dependent+Regulation+of+Ubiquitin+C+Expression+Contributes+to+Attenuation+of+Skin+Carcinogenesis&doi=10.1074%2Fjbc.M312063200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome Proliferator-activated Receptor β (δ)-dependent Regulation of Ubiquitin C Expression Contributes to Attenuation of Skin Carcinogenesis</span></div><div class="casAuthors">Kim, Dae J.; Akiyama, Taro E.; Harman, Fred S.; Burns, Amanda M.; Shan, Weiwei; Ward, Jerrold M.; Kennett, Mary J.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">23719-23727</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The role of peroxisome proliferator-activated receptor-β (PPARβ) in the mol. regulation of skin carcinogenesis was examd.  Increased caspase-3 activity assocd. with apoptosis was found in the skin of wild-type mice after tumor promotion with 12-O-tetradecanoylphorbol-13-acetate, and this effect was diminished in PPARβ-null mice.  The onset of tumor formation, tumor size, and tumor multiplicity induced from a two-stage carcinogen bioassay (7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate) were significantly enhanced in PPARβ-null mice compared with wild-type mice.  To begin to characterize the mol. changes underlying this PPARβ-dependent phenotype, microarray anal. was performed and a no. of differentially regulated gene products were identified including ubiquitin C.  Subsequent promoter anal., reporter gene assays, site-directed mutagenesis, and electrophoretic mobility shift assays provide evidence that PPARβ regulates ubiquitin C expression, and that ubiquitination of proteins is influenced by PPARβ.  These results strongly suggest that activation of PPARβ-dependent target genes provides a novel strategy to inhibit tumor promotion and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDNr7zKPcEmrVg90H21EOLACvtfcHk0lgYvrsIgrbX8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Giu7w%253D&md5=37d2da030b72ecade40160ec168828eb</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M312063200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M312063200%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DHarman%26aufirst%3DF.%2BS.%26aulast%3DBurns%26aufirst%3DA.%2BM.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DWard%26aufirst%3DJ.%2BM.%26aulast%3DKennett%26aufirst%3DM.%2BJ.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B2%2520%2528%25CE%25B4%2529-dependent%2520Regulation%2520of%2520Ubiquitin%2520C%2520Expression%2520Contributes%2520to%2520Attenuation%2520of%2520Skin%2520Carcinogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D23719%26epage%3D23727%26doi%3D10.1074%2Fjbc.M312063200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicol, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator–activated Receptor-δ Attenuates Colon Carcinogenesis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1038/nm1026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1038%2Fnm1026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15048110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsF2jt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=481-483&author=F.+S.+Harmanauthor=C.+J.+Nicolauthor=H.+E.+Marinauthor=J.+M.+Wardauthor=F.+J.+Gonzalezauthor=J.+M.+Peters&title=Peroxisome+Proliferator%E2%80%93activated+Receptor-%CE%B4+Attenuates+Colon+Carcinogenesis&doi=10.1038%2Fnm1026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor-δ attenuates colon carcinogenesis</span></div><div class="casAuthors">Harman, Fred S.; Nicol, Christopher J.; Marin, Holly E.; Ward, Jerrold M.; Gonzalez, Frank J.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">481-483</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor-δ (PPAR-δ; also known as PPAR-β) is expressed at high levels in colon tumors, but its contribution to colon cancer is unclear.  The authors examd. the role of PPAR-δ in colon carcinogenesis using PPAR-δ-deficient (Ppard-/-) mice.  In both the Min mutant and chem. induced mouse models, colon polyp formation was significantly greater in mice nullizygous for PPAR-δ.  In contrast to previous reports suggesting that activation of PPAR-δ potentiates colon polyp formation, here the authors show that PPAR-δ attenuates colon carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpztWIaEnnr-LVg90H21EOLACvtfcHk0ljaOqqduFTNew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsF2jt7c%253D&md5=45a168cdec14e5641e068b76e206c0e2</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1038%2Fnm1026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1026%26sid%3Dliteratum%253Aachs%26aulast%3DHarman%26aufirst%3DF.%2BS.%26aulast%3DNicol%26aufirst%3DC.%2BJ.%26aulast%3DMarin%26aufirst%3DH.%2BE.%26aulast%3DWard%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DPeroxisome%2520Proliferator%25E2%2580%2593activated%2520Receptor-%25CE%25B4%2520Attenuates%2520Colon%2520Carcinogenesis%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D481%26epage%3D483%26doi%3D10.1038%2Fnm1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdew, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome Proliferator-activated Receptor-β/δ Inhibits Epidermal Cell Proliferation by Down-regulation of Kinase Activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">9519</span>– <span class="NLM_lpage">9527</span>, <span class="refDoi"> DOI: 10.1074/jbc.M413808200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1074%2Fjbc.M413808200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=15632134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVChs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=9519-9527&author=D.+J.+Kimauthor=I.+A.+Murrayauthor=A.+M.+Burnsauthor=F.+J.+Gonzalezauthor=G.+H.+Perdewauthor=J.+M.+Peters&title=Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+Inhibits+Epidermal+Cell+Proliferation+by+Down-regulation+of+Kinase+Activity&doi=10.1074%2Fjbc.M413808200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor-β/δ inhibits epidermal cell proliferation by down-regulation of kinase activity</span></div><div class="casAuthors">Kim, Dae J.; Murray, Iain A.; Burns, Amanda M.; Gonzalez, Frank J.; Perdew, Gary H.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">9519-9527</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Recent work has shown that peroxisome proliferator-activated receptor β (PPARβ) attenuates cell proliferation and skin carcinogenesis, and this is due in part to regulation of ubiquitin C expression.  In these studies, the role of PPARβ in modulating ubiquitin-dependent protein kinase Cα (PKCα) levels and phosphorylation signaling pathways was evaluated.  Intracellular phosphorylation anal. showed that phosphorylated PKCα and other kinases were lower in wild-type mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate (TPA) as compared with PPARβ-null mouse skin.  No differences in expression levels of other PKC isoforms present in skin were obsd.  Lower ubiquitination of PKCα was found in TPA-treated PPARβ-null skin as compared with wild-type, and inhibition of ubiquitin-dependent proteasome degrdn. prevented TPA-induced down-regulation of PKCα.  The activity of PKCα and downstream signaling kinases is enhanced, and expression of cyclooxygenase-2 (COX-2) is significantly greater, in PPARβ-null mouse skin in response to TPA compared with wild-type mouse skin.  Inhibition of PKCα or COX-2 reduced cell proliferation in TPA-treated PPARβ-null keratinocytes in a dose-dependent manner, whereas it only slightly influenced cell proliferation in wild-type keratinocytes.  Combined, these studies provide strong evidence that PPARβ attenuates cell proliferation by modulating PKCα/Raf1/MEK/ERK activity that may be due in part to reduced ubiquitin-dependent turnover of PKCα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonQT5SU3gzfrVg90H21EOLACvtfcHk0ljaOqqduFTNew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVChs74%253D&md5=fe96e026833cd5a6f93fa9095b4754b0</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413808200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413808200%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DMurray%26aufirst%3DI.%2BA.%26aulast%3DBurns%26aufirst%3DA.%2BM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DPerdew%26aufirst%3DG.%2BH.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DPeroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520Inhibits%2520Epidermal%2520Cell%2520Proliferation%2520by%2520Down-regulation%2520of%2520Kinase%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D9519%26epage%3D9527%26doi%3D10.1074%2Fjbc.M413808200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foreman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borland, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epifano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span> <span> </span><span class="NLM_article-title">A Natural Propenoic Acid Derivative Activates Peroxisome Proliferator-activated Receptor-β/δ (PPARβ/δ)</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2010.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.lfs.2010.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=20153754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=493-498&author=S.+Genoveseauthor=J.+E.+Foremanauthor=M.+G.+Borlandauthor=F.+Epifanoauthor=F.+J.+Gonzalezauthor=M.+Curiniauthor=J.+M.+Peters&title=A+Natural+Propenoic+Acid+Derivative+Activates+Peroxisome+Proliferator-activated+Receptor-%CE%B2%2F%CE%B4+%28PPAR%CE%B2%2F%CE%B4%29&doi=10.1016%2Fj.lfs.2010.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)</span></div><div class="casAuthors">Genovese, Salvatore; Foreman, Jennifer E.; Borland, Michael G.; Epifano, Francesco; Gonzalez, Frank J.; Curini, Massimo; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">493-498</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aims: Previous studies showed that natural prenyloxyphenylpropanoid derivs. have potent biol. properties in vivo.  Given the structural similarities between these compds. and known peroxisome proliferator-activated receptor (PPAR) agonists, the present study examd. the hypothesis that propenoic acid derivs. activate PPARs.  Main methods: Chimeric reporter assays were performed to identify propenoic acid derivates that could activate PPARs.  Quant. polymerase chain reaction (qPCR) anal. of wild-type and Pparβ/δ-null mouse primary keratinocytes was performed to det. if a test compd. could specifically activate PPARβ/δ.  A human epithelial carcinoma cell line and primary mouse keratinocytes were used to det. the effect of the compd. on cell proliferation.  Key findings: Three of the propenoic acid derivs. activated PPARs, with the greatest efficacy being obsd. with prenyloxycinnamic acid derivs. 4'-geranyloxyferulic acid (compd. 1) for PPARβ/δ.  Compd. 1 increased expression of a known PPARβ/δ target gene through a mechanism that requires PPARβ/δ.  Inhibition of cell proliferation by compd. 1 was found in a human epithelial carcinoma cell line.  Significance: Results from these studies demonstrate that compd. 1 can activate PPARβ/δ and inhibit cell proliferation of a human skin cancer cell line, suggesting that the biol. effects of 4'-geranyloxyferulic acid may be mediated in part by activating this PPAR isoform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0Cdkj3zx6bVg90H21EOLACvtfcHk0lgcuq4WgkaAfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslShsLo%253D&md5=0decd8ffe5bd0855cbb304029de8ed32</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2010.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2010.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DS.%26aulast%3DForeman%26aufirst%3DJ.%2BE.%26aulast%3DBorland%26aufirst%3DM.%2BG.%26aulast%3DEpifano%26aufirst%3DF.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DCurini%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Natural%2520Propenoic%2520Acid%2520Derivative%2520Activates%2520Peroxisome%2520Proliferator-activated%2520Receptor-%25CE%25B2%252F%25CE%25B4%2520%2528PPAR%25CE%25B2%252F%25CE%25B4%2529%26jtitle%3DLife%2520Sci.%26date%3D2010%26volume%3D86%26spage%3D493%26epage%3D498%26doi%3D10.1016%2Fj.lfs.2010.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sk, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Isosteric Selenium Analog of the PPARβ/δ Agonist GW501516 and Comparison of Biological Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4050</span>– <span class="NLM_lpage">4052</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.05.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2010.05.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=20542425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4050-4052&author=A.+K.+Sharmaauthor=U.+H.+Skauthor=P.+Heauthor=J.+M.+Petersauthor=S.+Amin&title=Synthesis+of+Isosteric+Selenium+Analog+of+the+PPAR%CE%B2%2F%CE%B4+Agonist+GW501516+and+Comparison+of+Biological+Activity&doi=10.1016%2Fj.bmcl.2010.05.094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of isosteric selenium analog of the PPARβ/δ agonist GW501516 and comparison of biological activity</span></div><div class="casAuthors">Sharma, Arun K.; Sk, Ugir Hossain; He, Pengfei; Peters, Jeffrey M.; Amin, Shantu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4050-4052</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors and members of the nuclear hormone receptor superfamily.  Herein, we describe an efficient synthesis of a novel isosteric selenium analog of the highly specific PPARβ/δ ligand 2-methyl-4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-thiazol-5-yl)methylsulfanyl)phenoxyacetic acid (GW501516; 1).  The study examd. the efficiency of the novel selenium analog 2-methyl-4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-selenazol-5-yl)methylsulfanyl)phenoxyacetic acid (I) to activate PPARβ/δ and the effect of ligand activation of PPARβ/δ on cell proliferation and target gene expression in human HaCaT keratinocytes.  The results showed that similar to GW501516, the Se-analog I increased expression of the known PPARβ/δ target gene angiopoietin-like protein 4 (ANGPTL4); I was comparable in efficacy as compared to GW501516.  Consistent with a large body of evidence, the Se-analog inhibited cell proliferation in HaCaT keratinocytes similar to that obsd. with GW501516.  In summary, I has been developed as a potent PPARβ/δ ligand that may possess addnl. anti-cancer properties of selenium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOoArm6HI8ErVg90H21EOLACvtfcHk0lgcuq4WgkaAfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVKntLg%253D&md5=3ab66142bfacaebccb3320f1ed20fa75</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.05.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.05.094%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DSk%26aufirst%3DU.%2BH.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DAmin%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520Isosteric%2520Selenium%2520Analog%2520of%2520the%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Agonist%2520GW501516%2520and%2520Comparison%2520of%2520Biological%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4050%26epage%3D4052%26doi%3D10.1016%2Fj.bmcl.2010.05.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span> <span> </span><span class="NLM_article-title">Selective Peroxisome Proliferator-activated Receptor δ Isosteric Selenium Agonists as Potent Anti-atherogenic Agents In Vivo</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">7239</span>– <span class="NLM_lpage">7242</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2010.10.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21074432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7239-7242&author=J.+Chinauthor=J.+Y.+Hongauthor=J.+Leeauthor=H.+Hwangauthor=H.+Koauthor=H.+Choiauthor=D.+Hahnauthor=J.+Koauthor=S.-J.+Namauthor=J.+Takauthor=J.+Hamauthor=H.+Kang&title=Selective+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Isosteric+Selenium+Agonists+as+Potent+Anti-atherogenic+Agents+In+Vivo&doi=10.1016%2Fj.bmcl.2010.10.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Selective peroxisome proliferator-activated receptor δ isosteric selenium agonists as potent anti-atherogenic agents in vivo</span></div><div class="casAuthors">Chin, Jungwook; Hong, Jun Young; Lee, Jaehwan; Hwang, Hoosang; Ko, Hyunsil; Choi, Hyukjae; Hahn, Dongyup; Ko, Jaeyoung; Nam, Sang-Jip; Tak, Jungae; Ham, Jungyeob; Kang, Heonjoong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7239-7242</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and in vivo activity of a novel anti-atherogenic agent, isosteric selenium PPARδ-selective ligand, are reported.  This ligand did not cause significant body or liver wt. changes and did not have obvious adverse effects on intestinal polyp formation.  The overall results demonstrate that PPARδ is a viable drug target for treating atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp4HIL7NiRCbVg90H21EOLACvtfcHk0ljEO_YJAIhOKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtLfP&md5=9101c998433c714ff1fda9e0d757822f</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.103%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DKo%26aufirst%3DJ.%26aulast%3DNam%26aufirst%3DS.-J.%26aulast%3DTak%26aufirst%3DJ.%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26atitle%3DSelective%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Isosteric%2520Selenium%2520Agonists%2520as%2520Potent%2520Anti-atherogenic%2520Agents%2520In%2520Vivo%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7239%26epage%3D7242%26doi%3D10.1016%2Fj.bmcl.2010.10.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holla, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seok, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span> <span> </span><span class="NLM_article-title">Discovery, Design and Synthesis of Y-shaped Peroxisome Proliferator-activated Receptor δ Agonists as Potent Anti-obesity Agents In Vivo</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.03.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.ejmech.2012.03.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=22534184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVygsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=190-202&author=J.+Hamauthor=H.+Hwangauthor=E.+Kimauthor=J.-a.+Kimauthor=S.+J.+Choauthor=J.+Koauthor=W.+Leeauthor=J.+Leeauthor=H.+Hollaauthor=J.+Banerjeeauthor=S.+Kimauthor=I.+Yangauthor=H.+J.+Leeauthor=K.+Shinauthor=H.+Choiauthor=S.+J.+Namauthor=J.+Takauthor=D.+Hahnauthor=T.+Ohauthor=D.+H.+Wonauthor=T.+G.+Leeauthor=J.+Choiauthor=M.+S.+Parkauthor=C.+Seokauthor=J.+Chinauthor=H.+Kang&title=Discovery%2C+Design+and+Synthesis+of+Y-shaped+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonists+as+Potent+Anti-obesity+Agents+In+Vivo&doi=10.1016%2Fj.ejmech.2012.03.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptor δ agonists as potent anti-obesity agents in vivo</span></div><div class="casAuthors">Ham, Jungyeob; Hwang, Hoosang; Kim, Euno; Kim, Jeong-ah; Cho, Sung Jin; Ko, Jaeyoung; Lee, Woojin; Lee, Jaehwan; Holla, Harish; Banerjee, Joydeep; Kim, Seokho; Yang, Inho; Lee, Hyun Joo; Shin, Kyoungjin; Choi, Hyukjae; Nam, Sang-Jip; Tak, Jungae; Hahn, Dongyup; Oh, Taekyung; Won, Dong Hwan; Lee, Tae Gu; Choi, Jihye; Park, Mi Sun; Seok, Chaok; Chin, Jungwook; Kang, Heonjoong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">190-202</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We have discovered and demonstrated the in vitro and in vivo PPARδ-selective activity of novel Y-shaped agonists.  These compds. activated hPPARδ with EC50 values between 1 and 523 nM.  Surprisingly, compds. 10a, 11d, 11e and 11f were the most potent and most selective hPPARδ agonists with 104-fold selectivity over the other two subtypes, namely, hPPARα and hPPARγ.  The PPARδ ligands 10a, 11e and 11f showed good bioavailability and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov6X-CFACYwbVg90H21EOLACvtfcHk0ljEO_YJAIhOKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVygsb4%253D&md5=c2582c96fb5a193e5efbbf1261cd7ab3</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DJ.-a.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DKo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHolla%26aufirst%3DH.%26aulast%3DBanerjee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DShin%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DNam%26aufirst%3DS.%2BJ.%26aulast%3DTak%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DOh%26aufirst%3DT.%26aulast%3DWon%26aufirst%3DD.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BG.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DM.%2BS.%26aulast%3DSeok%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26atitle%3DDiscovery%252C%2520Design%2520and%2520Synthesis%2520of%2520Y-shaped%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonists%2520as%2520Potent%2520Anti-obesity%2520Agents%2520In%2520Vivo%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D53%26spage%3D190%26epage%3D202%26doi%3D10.1016%2Fj.ejmech.2012.03.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluge, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenburg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senaiar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaleel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patane, M. A.</span></span> <span> </span><span class="NLM_article-title">Novel Highly Selective Peroxisome Proliferator-activated Receptor δ (PPARδ) Modulators with Pharmacokinetic Properties Suitable for Once-daily Oral Dosing</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5230</span>– <span class="NLM_lpage">5234</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2017.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=29103972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyht7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5230-5234&author=B.+Laguauthor=A.+F.+Klugeauthor=R.+A.+Fredenburgauthor=E.+Tozzoauthor=R.+S.+Senaiarauthor=M.+Jaleelauthor=S.+K.+Panigrahiauthor=N.+K.+Tiwariauthor=N.+R.+Krishnamurthyauthor=T.+Takahashiauthor=M.+A.+Patane&title=Novel+Highly+Selective+Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29+Modulators+with+Pharmacokinetic+Properties+Suitable+for+Once-daily+Oral+Dosing&doi=10.1016%2Fj.bmcl.2017.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing</span></div><div class="casAuthors">Lagu, Bharat; Kluge, Arthur F.; Fredenburg, Ross A.; Tozzo, Effie; Senaiar, Ramesh S.; Jaleel, Mahaboobi; Panigrahi, Sunil K.; Tiwari, Nirbhay K.; Krishnamurthy, Narasimha R.; Takahashi, Taisuke; Patane, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5230-5234</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Optimization of benzamide PPARδ modulator 1 led to (E)-6-(2-((4-(furan-2-yl)-N-methylbenzamido)methyl)phenoxy)-4-methylhex-4-enoic acid (18), a potent selective PPARδ modulator with significantly improved exposure in multiple species following oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMM6ILDzYAl7Vg90H21EOLACvtfcHk0liZrNQfg6ke1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyht7fI&md5=ceafd53bc69650eea166a90c8b5769af</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DKluge%26aufirst%3DA.%2BF.%26aulast%3DFredenburg%26aufirst%3DR.%2BA.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DSenaiar%26aufirst%3DR.%2BS.%26aulast%3DJaleel%26aufirst%3DM.%26aulast%3DPanigrahi%26aufirst%3DS.%2BK.%26aulast%3DTiwari%26aufirst%3DN.%2BK.%26aulast%3DKrishnamurthy%26aufirst%3DN.%2BR.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520Highly%2520Selective%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%2520Modulators%2520with%2520Pharmacokinetic%2520Properties%2520Suitable%2520for%2520Once-daily%2520Oral%2520Dosing%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5230%26epage%3D5234%26doi%3D10.1016%2Fj.bmcl.2017.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluge, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddeeris, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenburg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chellur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senaiar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaleel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, D. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patane, M. A.</span></span> <span> </span><span class="NLM_article-title">Highly Selective Peroxisome Proliferator-activated Receptor δ (PPARδ) Modulator Demonstrates Improved Safety Profile Compared to GW501516</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2017.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=29275935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVejtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=533-536&author=B.+Laguauthor=A.+F.+Klugeauthor=M.+M.+Goddeerisauthor=E.+Tozzoauthor=R.+A.+Fredenburgauthor=S.+Chellurauthor=R.+S.+Senaiarauthor=M.+Jaleelauthor=D.+R.+K.+Babuauthor=N.+K.+Tiwariauthor=T.+Takahashiauthor=M.+A.+Patane&title=Highly+Selective+Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29+Modulator+Demonstrates+Improved+Safety+Profile+Compared+to+GW501516&doi=10.1016%2Fj.bmcl.2017.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516</span></div><div class="casAuthors">Lagu, Bharat; Kluge, Arthur F.; Goddeeris, Matthew M.; Tozzo, Effie; Fredenburg, Ross A.; Chellur, Shekar; Senaiar, Ramesh S.; Jaleel, Mahaboobi; Babu, D. Ravi Krishna; Tiwari, Nirbhay K.; Takahashi, Taisuke; Patane, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">533-536</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Compd. 1 regulates significantly fewer genes than the PPARδ modulator, GW501516.  Both compds. are efficacious in a thermal injury model of muscle regeneration.  The restricted gene profile of 1 relative to GW501516 suggests that 1 may be pharmacoequivalent to GW501516 with fewer PPAR-related safety concerns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3I-HxzQsbubVg90H21EOLACvtfcHk0liZrNQfg6ke1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVejtr%252FM&md5=86898b1962a59ce63b0eaf94a67613bc</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DKluge%26aufirst%3DA.%2BF.%26aulast%3DGoddeeris%26aufirst%3DM.%2BM.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DFredenburg%26aufirst%3DR.%2BA.%26aulast%3DChellur%26aufirst%3DS.%26aulast%3DSenaiar%26aufirst%3DR.%2BS.%26aulast%3DJaleel%26aufirst%3DM.%26aulast%3DBabu%26aufirst%3DD.%2BR.%2BK.%26aulast%3DTiwari%26aufirst%3DN.%2BK.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26atitle%3DHighly%2520Selective%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%2520Modulator%2520Demonstrates%2520Improved%2520Safety%2520Profile%2520Compared%2520to%2520GW501516%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D533%26epage%3D536%26doi%3D10.1016%2Fj.bmcl.2017.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senaiar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluge, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallesh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patane, M. A.</span></span> <span> </span><span class="NLM_article-title">Addressing hERG Activity While Maintaining Favorable Potency, Selectivity and Pharmacokinetic Properties of PPARδ modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">126928</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.126928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.bmcl.2019.126928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=31889664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFGqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=126928&author=B.+Laguauthor=R.+S.+Senaiarauthor=A.+F.+Klugeauthor=B.+Malleshauthor=M.+Ramakrishnaauthor=R.+Bhatauthor=M.+A.+Patane&title=Addressing+hERG+Activity+While+Maintaining+Favorable+Potency%2C+Selectivity+and+Pharmacokinetic+Properties+of+PPAR%CE%B4+modulators&doi=10.1016%2Fj.bmcl.2019.126928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Addressing hERG activity while maintaining favorable potency, selectivity and pharmacokinetic properties of PPARδ modulators</span></div><div class="casAuthors">Lagu, Bharat; Senaiar, Ramesh S.; Kluge, Arthur F.; Mallesh, B.; Ramakrishna, M.; Bhat, Raveendra; Patane, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">126928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">One of the most commonly used strategies to reduce hERG (human ether-a-go-go) activity in the drug candidates is introduction of a carboxylic acid group.  During the optimization of PPARδ modulators, some of the compds. contg. a carboxylic acid were found to inhibit the hERG channel in a patch clamp assay.  By modifying the basicity of the imidazole core, potent and selective PPARδ modulators that do not inhibit hERG channel were identified.  Some of the modulators have excellent pharmacokinetic profiles in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIMqPzLRB2jrVg90H21EOLACvtfcHk0lgOxBHcirFKaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFGqsA%253D%253D&md5=d673d98c47aea4c5eb87c2322356f4fd</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.126928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.126928%26sid%3Dliteratum%253Aachs%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DSenaiar%26aufirst%3DR.%2BS.%26aulast%3DKluge%26aufirst%3DA.%2BF.%26aulast%3DMallesh%26aufirst%3DB.%26aulast%3DRamakrishna%26aufirst%3DM.%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26atitle%3DAddressing%2520hERG%2520Activity%2520While%2520Maintaining%2520Favorable%2520Potency%252C%2520Selectivity%2520and%2520Pharmacokinetic%2520Properties%2520of%2520PPAR%25CE%25B4%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D30%26spage%3D126928%26doi%3D10.1016%2Fj.bmcl.2019.126928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadayat, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-H</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S.-J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span> <span> </span><span class="NLM_article-title">Enantioselective Synthesis of a Novel Thiazoline Core as a Potent Peroxisome Proliferator-activated Receptor δ Agonist</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b01689</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b01689" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXislyltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=1970-1976&author=S.-J.+Leeauthor=M.+Samalaauthor=S.+Y.+Wooauthor=D.+Hahnauthor=D.+Kimauthor=T.+M.+Kadayatauthor=K.+Jungauthor=J.+Kimauthor=D.-S.+Kimauthor=S.+Kwonauthor=S.+Kimauthor=K.-H+Kimauthor=S.-J+Namauthor=S.+J.+Choauthor=J.+Chin&title=Enantioselective+Synthesis+of+a+Novel+Thiazoline+Core+as+a+Potent+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist&doi=10.1021%2Facsomega.7b01689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective Synthesis of a Novel Thiazoline Core as a Potent Peroxisome Proliferator-Activated Receptor δ Agonist</span></div><div class="casAuthors">Lee, Su-Jeong; Samala, Mallesham; Woo, Seo Yeon; Hahn, Dongyup; Kim, Dayoung; Kadayat, Tara Man; Jung, Kyungjin; Kim, Jina; Kim, Dong-Su; Kwon, Sugyeong; Kim, Shinae; Kim, Kyung-Hee; Nam, Sang-Jip; Cho, Sung Jin; Chin, Jungwook</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1970-1976</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The convergent and enantioselective synthesis of a highly potent human peroxisome proliferator-activated receptor delta agonist I is presented.  More specifically, the thiazoline structure, which constitutes the biosynthetically distinctive core structure of pulicatin (a secondary metabolite of symbiotic bacteria), was synthesized from a com. available and inexpensive chiral pool of L-threonine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlUvu3_M_wrVg90H21EOLACvtfcHk0lgOxBHcirFKaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXislyltrk%253D&md5=ac8d1130bb1d0cc1be27adcfad076b88</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b01689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b01689%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-J.%26aulast%3DSamala%26aufirst%3DM.%26aulast%3DWoo%26aufirst%3DS.%2BY.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKadayat%26aufirst%3DT.%2BM.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.-S.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DK.-H%26aulast%3DNam%26aufirst%3DS.-J%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DChin%26aufirst%3DJ.%26atitle%3DEnantioselective%2520Synthesis%2520of%2520a%2520Novel%2520Thiazoline%2520Core%2520as%2520a%2520Potent%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%26jtitle%3DACS%2520Omega%26date%3D2018%26volume%3D3%26spage%3D1970%26epage%3D1976%26doi%3D10.1021%2Facsomega.7b01689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadayat, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-H</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a Unique Dimethyl Thiazoline Containing Intermediate of Novel Peroxisome Proliferator-activated Receptors (PPAR) δ Agonists</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4384</span>– <span class="NLM_lpage">4386</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2018.10.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.tetlet.2018.10.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=4384-4386&author=T.+M.+Kadayatauthor=G.+Leeauthor=K.+Jungauthor=H.-J.+Hwangauthor=J.+Jooauthor=D.+Hahnauthor=H.+Hwangauthor=K.-G.+Parkauthor=S.+J.+Choauthor=K.-H+Kimauthor=J.+Chin&title=Synthesis+of+a+Unique+Dimethyl+Thiazoline+Containing+Intermediate+of+Novel+Peroxisome+Proliferator-activated+Receptors+%28PPAR%29+%CE%B4+Agonists&doi=10.1016%2Fj.tetlet.2018.10.051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2018.10.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2018.10.051%26sid%3Dliteratum%253Aachs%26aulast%3DKadayat%26aufirst%3DT.%2BM.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DHwang%26aufirst%3DH.-J.%26aulast%3DJoo%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DK.-G.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DK.-H%26aulast%3DChin%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520a%2520Unique%2520Dimethyl%2520Thiazoline%2520Containing%2520Intermediate%2520of%2520Novel%2520Peroxisome%2520Proliferator-activated%2520Receptors%2520%2528PPAR%2529%2520%25CE%25B4%2520Agonists%26jtitle%3DTetrahedron%2520Lett.%26date%3D2018%26volume%3D59%26spage%3D4384%26epage%3D4386%26doi%3D10.1016%2Fj.tetlet.2018.10.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lione, L.</span></span> <span> </span><span class="NLM_article-title">Harnessing the Benefits of PPARβ/δ Agonists</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">963</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2013.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.lfs.2013.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=24184294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslOltrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2013&pages=963-967&author=L.+S.+Mackenzieauthor=L.+Lione&title=Harnessing+the+Benefits+of+PPAR%CE%B2%2F%CE%B4+Agonists&doi=10.1016%2Fj.lfs.2013.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the benefits of PPARβ/δ agonists</span></div><div class="casAuthors">Mackenzie, Louise S.; Lione, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">25-26</span>),
    <span class="NLM_cas:pages">963-967</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Lipid mediators have complex effects on the cell; one of the key transcriptional factors that moderate proliferation and inflammatory effects is PPARβ/δ.  Following highly successful clin. trials using the PPARβ/δ agonists GW501516 for treatment of diabetes, GSK announced that any further research would be discontinued due to preclin. trials in rodents which linked this drug to wide spread tumor development.  In this review we outline the dual mol. functions of PPARβ/δ and connect these to the diverse results from in vitro studies, and draw parallels with the outcomes of animal and human studies.  The PPARβ/δ agonists have a great potential in terms of therapy, and we hope to provide some insight into the reasons why such contrasting results have been published.  The discussion presented here is important to the future development of PPARβ/δ agonists for the clinic, and for a fuller understanding for their complex regulatory roles in the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruApB5yWZgcLVg90H21EOLACvtfcHk0ljhY161CgPwQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslOltrbJ&md5=8a650e28aa3938f90f8eea1628b39472</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2013.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2013.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DMackenzie%26aufirst%3DL.%2BS.%26aulast%3DLione%26aufirst%3DL.%26atitle%3DHarnessing%2520the%2520Benefits%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520Agonists%26jtitle%3DLife%2520Sci.%26date%3D2013%26volume%3D93%26spage%3D963%26epage%3D967%26doi%3D10.1016%2Fj.lfs.2013.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sznaidman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haffner, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fivush, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goreham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sierra, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeGrumelec, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montana, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, W. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span> <span> </span><span class="NLM_article-title">Novel Selective Small Molecule Agonists for Peroxisome Proliferator-activated Receptor δ (PPARδ)—Synthesis and Biological Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1517</span>– <span class="NLM_lpage">1521</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00207-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2FS0960-894X%2803%2900207-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=12699745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFemu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1517-1521&author=M.+L.+Sznaidmanauthor=C.+D.+Haffnerauthor=P.+R.+Maloneyauthor=A.+Fivushauthor=E.+Chaoauthor=D.+Gorehamauthor=M.+L.+Sierraauthor=C.+LeGrumelecauthor=H.+E.+Xuauthor=V.+G.+Montanaauthor=M.+H.+Lambertauthor=T.+M.+Willsonauthor=W.+R.+J.+Oliverauthor=D.+D.+Sternbach&title=Novel+Selective+Small+Molecule+Agonists+for+Peroxisome+Proliferator-activated+Receptor+%CE%B4+%28PPAR%CE%B4%29%E2%80%94Synthesis+and+Biological+Activity&doi=10.1016%2FS0960-894X%2803%2900207-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ) - synthesis and biological activity</span></div><div class="casAuthors">Sznaidman, Marcos L.; Haffner, Curt D.; Maloney, Patrick R.; Fivush, Adam; Chao, Esther; Goreham, Donna; Sierra, Michael L.; LeGrumelec, Christelle; Xu, H. Eric; Montana, Valerie G.; Lambert, Millard H.; Willson, Timothy M.; Oliver, William R.; Sternbach, Daniel D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1517-1521</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The authors report the synthesis and biol. activity of a new series of small mol. agonists of the human Peroxisome Proliferator-Activated Receptor δ (PPARδ).  Several hits were identified from original libraries contg. lipophilic carboxylic acids.  Optimization of these hits by structure-guided design led to two compds. (GW501516 and GW0742) which show an EC50 of 1.1 nM against PPARδ with 1000-fold selectivity over the other human subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvtPXSwIFaybVg90H21EOLACvtfcHk0liNhTTzODfCeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFemu70%253D&md5=9d0d967f6652b200ba3610657b7676b7</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900207-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900207-5%26sid%3Dliteratum%253Aachs%26aulast%3DSznaidman%26aufirst%3DM.%2BL.%26aulast%3DHaffner%26aufirst%3DC.%2BD.%26aulast%3DMaloney%26aufirst%3DP.%2BR.%26aulast%3DFivush%26aufirst%3DA.%26aulast%3DChao%26aufirst%3DE.%26aulast%3DGoreham%26aufirst%3DD.%26aulast%3DSierra%26aufirst%3DM.%2BL.%26aulast%3DLeGrumelec%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DMontana%26aufirst%3DV.%2BG.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DOliver%26aufirst%3DW.%2BR.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26atitle%3DNovel%2520Selective%2520Small%2520Molecule%2520Agonists%2520for%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520%2528PPAR%25CE%25B4%2529%25E2%2580%2594Synthesis%2520and%2520Biological%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1517%26epage%3D1521%26doi%3D10.1016%2FS0960-894X%2803%2900207-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bays, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlejohn, T.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerzner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpf, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, B. K.</span></span> <span> </span><span class="NLM_article-title">MBX-8025, a Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin</span>. <i>J. Clin. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">2889</span>– <span class="NLM_lpage">2897</span>, <span class="refDoi"> DOI: 10.1210/jc.2011-1061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1210%2Fjc.2011-1061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=21752880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SktLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2011&pages=2889-2897&author=H.+E.+Baysauthor=S.+Schwartzauthor=T.+Littlejohnauthor=B.+Kerznerauthor=R.+M.+Kraussauthor=D.+B.+Karpfauthor=Y.-J.+Choiauthor=X.+Wangauthor=S.+Naimauthor=B.+K.+Roberts&title=MBX-8025%2C+a+Novel+Peroxisome+Proliferator+Receptor-%CE%B4+Agonist%3A+Lipid+and+Other+Metabolic+Effects+in+Dyslipidemic+Overweight+Patients+Treated+with+and+without+Atorvastatin&doi=10.1210%2Fjc.2011-1061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">MBX-8025, a novel peroxisome proliferator receptor-δ agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin</span></div><div class="casAuthors">Bays, Harold E.; Schwartz, Sherwyn; Littlejohn, Thomas, III; Kerzner, Boris; Krauss, Ronald M.; Karpf, David B.; Choi, Yun-Jung; Wang, Xueyan; Naim, Sue; Roberts, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2889-2897</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Preclin. and clin. studies suggest that peroxisome proliferator-activated receptor (PPAR)-δ agonists favorably affect multiple metabolic parameters that are otherwise proatherogenic, many that are not optimally managed with statins alone.  Objective: The aim of this study was to evaluate the effects of MBX-8025 (a novel PPAR-δ agonist) on lipid and other metabolic parameters assocd. with increased atherosclerotic risk, administered alone and in combination with atorvastatin.  Design and Setting: This was a randomized, double-blind, placebo-controlled, parallel group proof-of-concept study conducted at 30 U.S. research sites.  Participants: This study evaluated 181 overweight men and women with mixed dyslipidemia.  Intervention(s): Subjects were administered once daily placebo, atorvastatin 20 mg, or MBX-8025 at 50 or 100 mg alone or combined with atorvastatin for 8 wk.  Main Outcome Measures: The main efficacy measures included change from baseline in apolipoprotein B-100, lipid levels, high-sensitivity C-reactive protein, and addnl. metabolic parameters, as well as the effect on the metabolic syndrome and LDL particle size.  Results: Compared to placebo, MBX-8025 alone and in combination with atorvastatin significantly (P < 0.05) reduced apolipoprotein B-100 20-38%, LDL 18-43%, triglycerides 26-30%, non-high-d. lipoprotein cholesterol 18-41%, free fatty acids 16-28%, and high-sensitivity C-reactive protein 43-72%; it raised high-d. lipoprotein cholesterol 1-12% and also reduced the no. of patients with the metabolic syndrome and a preponderance of small LDL particles.  MBX-8025 was safe and generally well-tolerated.  MBX-8025 also reduced liver enzyme levels.  Conclusion: MBX-8025, a novel PPAR-δ agonist, favorably affected multiple metabolic parameters with and without atorvastatin.  A more complete understanding of MBX-8025 requires a larger future study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9CZr0CONGbLVg90H21EOLACvtfcHk0liNhTTzODfCeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SktLzE&md5=3e46c42efb64ace0ee4090af910cc07f</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1210%2Fjc.2011-1061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2011-1061%26sid%3Dliteratum%253Aachs%26aulast%3DBays%26aufirst%3DH.%2BE.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DLittlejohn%26aufirst%3DT.%26aulast%3DKerzner%26aufirst%3DB.%26aulast%3DKrauss%26aufirst%3DR.%2BM.%26aulast%3DKarpf%26aufirst%3DD.%2BB.%26aulast%3DChoi%26aufirst%3DY.-J.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DNaim%26aufirst%3DS.%26aulast%3DRoberts%26aufirst%3DB.%2BK.%26atitle%3DMBX-8025%252C%2520a%2520Novel%2520Peroxisome%2520Proliferator%2520Receptor-%25CE%25B4%2520Agonist%253A%2520Lipid%2520and%2520Other%2520Metabolic%2520Effects%2520in%2520Dyslipidemic%2520Overweight%2520Patients%2520Treated%2520with%2520and%2520without%2520Atorvastatin%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2011%26volume%3D96%26spage%3D2889%26epage%3D2897%26doi%3D10.1210%2Fjc.2011-1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span> </span><span class="NLM_article-title">The Strategic
Research Institute’s Sixth Annual Metabolic Diseases Drug Discovery
& Development World Summit, San Diego, CA, USA, 2007</span>.  <i>Cortellis</i>; <span class="NLM_publisher-name">Clarivate Analytics</span>, <span class="NLM_year">2019</span> <a href="https://www.cortellis.com/intelligence/home.do" class="extLink">https://www.cortellis.com/intelligence/home.do</a> (accessed 2020-03-10).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Strategic%0AResearch+Institute%E2%80%99s+Sixth+Annual+Metabolic+Diseases+Drug+Discovery%0A%26+Development+World+Summit%2C+San+Diego%2C+CA%2C+USA%2C+2007.+Cortellis%3B+Clarivate+Analytics%2C+2019+https%3A%2F%2Fwww.cortellis.com%2Fintelligence%2Fhome.do+%28accessed+2020-03-10%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520Strategic%250AResearch%2520Institute%25E2%2580%2599s%2520Sixth%2520Annual%2520Metabolic%2520Diseases%2520Drug%2520Discovery%250A%2526%2520Development%2520World%2520Summit%252C%2520San%2520Diego%252C%2520CA%252C%2520USA%252C%25202007%26jtitle%3DCortellis%26pub%3DClarivate%2520Analytics%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span> <i>Cortellis</i>; <span class="NLM_publisher-name">Clarivate
Analytics</span>, <span class="NLM_year">2019</span>; <a href="https://www.cortellis.com/intelligence/home.do" class="extLink">https://www.cortellis.com/intelligence/home.do</a> (accessed 2020-01-24).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Cortellis%3B+Clarivate%0AAnalytics%2C+2019%3B+https%3A%2F%2Fwww.cortellis.com%2Fintelligence%2Fhome.do+%28accessed+2020-01-24%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DCortellis%26pub%3DClarivate%250AAnalytics%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Risérus, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprecher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirschberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarov-Blat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strum, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheeseman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fielding, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danoff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murgatroyd, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Rahilly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frayn, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpe, F.</span></span> <span> </span><span class="NLM_article-title">Activation of Peroxisome Proliferator–activated Receptor (PPAR) δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.2337/db07-1318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.2337%2Fdb07-1318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=18024853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVOktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=332-339&author=U.+Ris%C3%A9rusauthor=D.+Sprecherauthor=T.+Johnsonauthor=E.+Olsonauthor=S.+Hirschbergauthor=A.+Liuauthor=Z.+Fangauthor=P.+Hegdeauthor=D.+Richardsauthor=L.+Sarov-Blatauthor=J.+C.+Strumauthor=S.+Basuauthor=J.+Cheesemanauthor=B.+A.+Fieldingauthor=S.+M.+Humphreysauthor=T.+Danoffauthor=N.+R.+Mooreauthor=P.+Murgatroydauthor=S.+O%E2%80%99Rahillyauthor=P.+Suttonauthor=T.+Willsonauthor=D.+Hassallauthor=K.+N.+Fraynauthor=F.+Karpe&title=Activation+of+Peroxisome+Proliferator%E2%80%93activated+Receptor+%28PPAR%29+%CE%B4+Promotes+Reversal+of+Multiple+Metabolic+Abnormalities%2C+Reduces+Oxidative+Stress%2C+and+Increases+Fatty+Acid+Oxidation+in+Moderately+Obese+Men&doi=10.2337%2Fdb07-1318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of peroxisome proliferator-activated receptor (PPAR)δ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men</span></div><div class="casAuthors">Riserus, Ulf; Sprecher, Dennis; Johnson, Tony; Olson, Eric; Hirschberg, Sandra; Liu, Aixue; Fang, Zeke; Hegde, Priti; Richards, Duncan; Sarov-Blat, Leli; Strum, Jay C.; Basu, Samar; Cheeseman, Jane; Fielding, Barbara A.; Humphreys, Sandy M.; Danoff, Theodore; Moore, Niall R.; Murgatroyd, Peter; O'Rahilly, Stephen; Sutton, Pauline; Willson, Tim; Hassall, David; Frayn, Keith N.; Karpe, Fredrik</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">332-339</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Objective-Pharmacol. use of peroxisome proliferator-activated receptor (PPAR)δ agonists and transgenic overexpression of PPARδ in mice suggest amelioration of features of the metabolic syndrome through enhanced fat oxidn. in skeletal muscle.  We hypothesize a similar mechanism operates in humans.  Research Design and Methods-The PPARδ agonist (10 mg o.d. GW501516), a comparator PPARα agonist (20 μg o.d. GW590735), and placebo were given in a double-blind, randomized, three-parallel group, 2-wk study to six healthy moderately overweight subjects in each group.  Metabolic evaluation was made before and after treatment including liver fat quantification, fasting blood samples, a 6-h meal tolerance test with stable isotope fatty acids, skeletal muscle biopsy for gene expression, and urinary isoprostanes for global oxidative stress.  Results-Treatment with GW501516 showed statistically significant redns. in fasting plasma triglycerides (-30%), apolipoprotein B (-26%), LDL cholesterol (-23%), and insulin (-11%), whereas HDL cholesterol was unchanged.  A 20% redn. in liver fat content (P < 0.05) and 30% redn. in urinary isoprostanes (P = 0.01) were also obsd.  Except for a lowering of triglycerides (-30%, P < 0.05), none of these changes were obsd. in response to GW590735.  The relative proportion of exhaled CO2 directly originating from the fat content of the meal was increased (P < 0.05) in response to GW501516, and skeletal muscle expression of carnitine palmitoyl-transferase 1b (CPT1b) was also significantly increased.  Conclusions-The PPARδ agonist GW501516 reverses multiple abnormalities assocd. with the metabolic syndrome without increasing oxidative stress.  The effect is probably caused by increased fat oxidn. in skeletal muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXPtsdL6apBbVg90H21EOLACvtfcHk0ljgH6hzT2PpVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVOktrs%253D&md5=3a2d27a6a898aa3c668b08e47ea8a1a9</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.2337%2Fdb07-1318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb07-1318%26sid%3Dliteratum%253Aachs%26aulast%3DRis%25C3%25A9rus%26aufirst%3DU.%26aulast%3DSprecher%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DOlson%26aufirst%3DE.%26aulast%3DHirschberg%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DHegde%26aufirst%3DP.%26aulast%3DRichards%26aufirst%3DD.%26aulast%3DSarov-Blat%26aufirst%3DL.%26aulast%3DStrum%26aufirst%3DJ.%2BC.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DCheeseman%26aufirst%3DJ.%26aulast%3DFielding%26aufirst%3DB.%2BA.%26aulast%3DHumphreys%26aufirst%3DS.%2BM.%26aulast%3DDanoff%26aufirst%3DT.%26aulast%3DMoore%26aufirst%3DN.%2BR.%26aulast%3DMurgatroyd%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Rahilly%26aufirst%3DS.%26aulast%3DSutton%26aufirst%3DP.%26aulast%3DWillson%26aufirst%3DT.%26aulast%3DHassall%26aufirst%3DD.%26aulast%3DFrayn%26aufirst%3DK.%2BN.%26aulast%3DKarpe%26aufirst%3DF.%26atitle%3DActivation%2520of%2520Peroxisome%2520Proliferator%25E2%2580%2593activated%2520Receptor%2520%2528PPAR%2529%2520%25CE%25B4%2520Promotes%2520Reversal%2520of%2520Multiple%2520Metabolic%2520Abnormalities%252C%2520Reduces%2520Oxidative%2520Stress%252C%2520and%2520Increases%2520Fatty%2520Acid%2520Oxidation%2520in%2520Moderately%2520Obese%2520Men%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26spage%3D332%26epage%3D339%26doi%3D10.2337%2Fdb07-1318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Carrera, M.</span></span> <span> </span><span class="NLM_article-title">Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2016.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1016%2Fj.tem.2016.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=27005447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVOnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=319-334&author=M.+V%C3%A1zquez-Carrera&title=Unraveling+the+Effects+of+PPAR%CE%B2%2F%CE%B4+on+Insulin+Resistance+and+Cardiovascular+Disease&doi=10.1016%2Fj.tem.2016.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease</span></div><div class="casAuthors">Vazquez-Carrera, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">319-334</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Insulin resistance precedes dyslipidemia and type 2 diabetes mellitus (T2DM) development.  Preclin. evidence suggests that peroxisome proliferator-activated receptor (PPAR) β/δ activators may prevent and treat obesity-induced insulin resistance and T2DM, while clin. trials highlight their potential utility in dyslipidemia.  This review summarizes recent mechanistic insights into the antidiabetic effects of PPARβ/δ activators, including their anti-inflammatory actions, their ability to inhibit endoplasmic reticulum (ER) stress and hepatic lipogenesis, and to improve atherogenesis and insulin sensitivity, as well as their capacity to activate pathways that are also stimulated by exercise.  Findings from clin. trials are also examd.  Dissecting the effects of PPARβ/δ ligands on insulin sensitivity and atherogenesis may provide a basis for the development of therapies for the prevention and treatment of T2DM and cardiovascular disease (CVD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpANomzthPY7Vg90H21EOLACvtfcHk0ljgH6hzT2PpVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVOnsbk%253D&md5=e57c1de81241f77ae10bafcdef2f1830</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2016.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2016.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A1zquez-Carrera%26aufirst%3DM.%26atitle%3DUnraveling%2520the%2520Effects%2520of%2520PPAR%25CE%25B2%252F%25CE%25B4%2520on%2520Insulin%2520Resistance%2520and%2520Cardiovascular%2520Disease%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2016%26volume%3D27%26spage%3D319%26epage%3D334%26doi%3D10.1016%2Fj.tem.2016.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span> <i>CymaBay Therapeutics Announces U.S. Orphan Drug Designation
for MBX-8025
for the Treatment of Primary Biliary Cholangitis</i>; <span class="NLM_publisher-name">Cymabay Therapeutics</span>: <span class="NLM_publisher-loc">Newark, CA</span>, <span class="NLM_year">2016</span>; <a href="https://ir.cymabay.com/press-releases/detail/383/cymabay-therapeutics-announces-u-s-orphan-drug-designation-for-mbx-8025-for-the-treatment-of-primary-biliary-cholangitis" class="extLink">https://ir.cymabay.com/press-releases/detail/383/cymabay-therapeutics-announces-u-s-orphan-drug-designation-for-mbx-8025-for-the-treatment-of-primary-biliary-cholangitis</a> (accessed 2020-01-18).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+CymaBay+Therapeutics+Announces+U.S.+Orphan+Drug+Designation%0Afor+MBX-8025%0Afor+the+Treatment+of+Primary+Biliary+Cholangitis%3B+Cymabay+Therapeutics%3A+Newark%2C+CA%2C+2016%3B+https%3A%2F%2Fir.cymabay.com%2Fpress-releases%2Fdetail%2F383%2Fcymabay-therapeutics-announces-u-s-orphan-drug-designation-for-mbx-8025-for-the-treatment-of-primary-biliary-cholangitis+%28accessed+2020-01-18%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCymaBay%2520Therapeutics%2520Announces%2520U.S.%2520Orphan%2520Drug%2520Designation%250Afor%2520MBX-8025%250Afor%2520the%2520Treatment%2520of%2520Primary%2520Biliary%2520Cholangitis%26pub%3DCymabay%2520Therapeutics%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span> <i>CymaBay Therapeutics Granted
EMA Orphan Drug Designation for Seladelpar
for the Treatment of Primary Biliary Cholangitis</i>; <span class="NLM_publisher-name">Cymabay Therapeutics</span>: <span class="NLM_publisher-loc">Newark, CA</span>, <span class="NLM_year">2017</span>; <a href="https://ir.cymabay.com/press-releases/detail/410/cymabay-therapeutics-granted-ema-orphan-drug-designation-for-seladelpar-for-the-treatment-of-primary-biliary-cholangitis" class="extLink">https://ir.cymabay.com/press-releases/detail/410/cymabay-therapeutics-granted-ema-orphan-drug-designation-for-seladelpar-for-the-treatment-of-primary-biliary-cholangitis</a> (accessed 2020-01-19).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+CymaBay+Therapeutics+Granted%0AEMA+Orphan+Drug+Designation+for+Seladelpar%0Afor+the+Treatment+of+Primary+Biliary+Cholangitis%3B+Cymabay+Therapeutics%3A+Newark%2C+CA%2C+2017%3B+https%3A%2F%2Fir.cymabay.com%2Fpress-releases%2Fdetail%2F410%2Fcymabay-therapeutics-granted-ema-orphan-drug-designation-for-seladelpar-for-the-treatment-of-primary-biliary-cholangitis+%28accessed+2020-01-19%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCymaBay%2520Therapeutics%2520Granted%250AEMA%2520Orphan%2520Drug%2520Designation%2520for%2520Seladelpar%250Afor%2520the%2520Treatment%2520of%2520Primary%2520Biliary%2520Cholangitis%26pub%3DCymabay%2520Therapeutics%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span> <i>CymaBay Therapeutics Halts
Clinical Development of Seladelpar</i>; <span class="NLM_publisher-name">Cymabay
Therapeutics</span>: <span class="NLM_publisher-loc">Newark, CA</span>, <span class="NLM_year">2019</span>; <a href="https://ir.cymabay.com/press-releases/detail/476/cymabay-therapeutics-halts-clinical-development-of-seladelpar" class="extLink">https://ir.cymabay.com/press-releases/detail/476/cymabay-therapeutics-halts-clinical-development-of-seladelpar</a> (accessed 2020-01-28).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+CymaBay+Therapeutics+Halts%0AClinical+Development+of+Seladelpar%3B+Cymabay%0ATherapeutics%3A+Newark%2C+CA%2C+2019%3B+https%3A%2F%2Fir.cymabay.com%2Fpress-releases%2Fdetail%2F476%2Fcymabay-therapeutics-halts-clinical-development-of-seladelpar+%28accessed+2020-01-28%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCymaBay%2520Therapeutics%2520Halts%250AClinical%2520Development%2520of%2520Seladelpar%26pub%3DCymabay%250ATherapeutics%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span> <i>GENFIT: Positive 42-month
DSMB Recommendation for Continuation of
Phase 3 RESOLVE-IT Study of Elafibranor in NASH</i>; <span class="NLM_publisher-name">GENFIT</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>, <span class="NLM_year">2019</span>; <a href="https://ir.genfit.com/news-releases/news-release-details/genfit-positive-42-month-dsmb-recommendation-continuation-phase" class="extLink">https://ir.genfit.com/news-releases/news-release-details/genfit-positive-42-month-dsmb-recommendation-continuation-phase</a> (accessed 2020-02-15).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GENFIT%3A+Positive+42-month%0ADSMB+Recommendation+for+Continuation+of%0APhase+3+RESOLVE-IT+Study+of+Elafibranor+in+NASH%3B+GENFIT%3A+Cambridge%2C+MA%2C+2019%3B+https%3A%2F%2Fir.genfit.com%2Fnews-releases%2Fnews-release-details%2Fgenfit-positive-42-month-dsmb-recommendation-continuation-phase+%28accessed+2020-02-15%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DGENFIT%253A%2520Positive%252042-month%250ADSMB%2520Recommendation%2520for%2520Continuation%2520of%250APhase%25203%2520RESOLVE-IT%2520Study%2520of%2520Elafibranor%2520in%2520NASH%26pub%3DGENFIT%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span> <i>GENFIT: Annual Results
for 2011</i>; <span class="NLM_publisher-name">GENFIT</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>, <span class="NLM_year">2012</span>; <a href="https://www.genfit.com/wp-content/uploads/2014/05/2012.04.25_GENFIT_2011_Annual_Results.pdf" class="extLink">https://www.genfit.com/wp-content/uploads/2014/05/2012.04.25_GENFIT_2011_Annual_Results.pdf</a> (accessed 2020-02-15).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GENFIT%3A+Annual+Results%0Afor+2011%3B+GENFIT%3A+Cambridge%2C+MA%2C+2012%3B+https%3A%2F%2Fwww.genfit.com%2Fwp-content%2Fuploads%2F2014%2F05%2F2012.04.25_GENFIT_2011_Annual_Results.pdf+%28accessed+2020-02-15%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DGENFIT%253A%2520Annual%2520Results%250Afor%25202011%26pub%3DGENFIT%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span> <i>Cymabay Therapeutics Annual
Report, Form 10-K</i>; <span class="NLM_publisher-name">Cymabay Therapeutics</span>; <span class="NLM_publisher-loc">Newark, CA</span>, <span class="NLM_year">2015</span>; p
5 <a href="https://ir.cymabay.com/annual-reports/content/0001193125-16-521392/d41327d10k.htm" class="extLink">https://ir.cymabay.com/annual-reports/content/0001193125-16-521392/d41327d10k.htm</a> (accessed 2020-02-08).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Cymabay+Therapeutics+Annual%0AReport%2C+Form+10-K%3B+Cymabay+Therapeutics%3B+Newark%2C+CA%2C+2015%3B+p%0A5+https%3A%2F%2Fir.cymabay.com%2Fannual-reports%2Fcontent%2F0001193125-16-521392%2Fd41327d10k.htm+%28accessed+2020-02-08%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCymabay%2520Therapeutics%2520Annual%250AReport%252C%2520Form%252010-K%26pub%3DCymabay%2520Therapeutics%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. C. V.</span>; <span class="NLM_string-name">Ohlstein, E.</span></span> <span> </span><span class="NLM_article-title">Use of a PPAR-delta agonist for treating muscle atrophy</span>. International Patent <span class="NLM_patent">US9487493B2</span>, Nov 8, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+C.+V.+Lopez&author=E.+Ohlstein&title=Use+of+a+PPAR-delta+agonist+for+treating+muscle+atrophy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DM.%2BC.%2BV.%26atitle%3DUse%2520of%2520a%2520PPAR-delta%2520agonist%2520for%2520treating%2520muscle%2520atrophy%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span> <i>FDA Grants Orphan Drug
Designation to Reneo Pharmaceuticals for REN001 for Treatment of Fatty
Acid Oxidation Disorders</i>; <span class="NLM_publisher-name">Reneo Pharmaceuticals</span>, <span class="NLM_year">2019</span>; <a href="https://reneopharma.com/fda-grants-orphan-drug-designation-to-reneo-pharmaceuticals-for-ren001-for-treatment-of-fatty-acid-oxidation-disorders/" class="extLink">https://reneopharma.com/fda-grants-orphan-drug-designation-to-reneo-pharmaceuticals-for-ren001-for-treatment-of-fatty-acid-oxidation-disorders/</a> (accessed 2020-01-19).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+FDA+Grants+Orphan+Drug%0ADesignation+to+Reneo+Pharmaceuticals+for+REN001+for+Treatment+of+Fatty%0AAcid+Oxidation+Disorders%3B+Reneo+Pharmaceuticals%2C+2019%3B+https%3A%2F%2Freneopharma.com%2Ffda-grants-orphan-drug-designation-to-reneo-pharmaceuticals-for-ren001-for-treatment-of-fatty-acid-oxidation-disorders%2F+%28accessed+2020-01-19%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DFDA%2520Grants%2520Orphan%2520Drug%250ADesignation%2520to%2520Reneo%2520Pharmaceuticals%2520for%2520REN001%2520for%2520Treatment%2520of%2520Fatty%250AAcid%2520Oxidation%2520Disorders%26pub%3DReneo%2520Pharmaceuticals%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span> <i>U.S. FDA Grants Fast Track
Designation to Astellas for the Development
of ASP1128 for Patients at Risk for Acute Kidney Injury</i>; <span class="NLM_publisher-name">Astellas Pharma</span>, <span class="NLM_year">2019</span>;  <a href="https://www.astellas.com/en/news/15376" class="extLink">https://www.astellas.com/en/news/15376</a> (accessed 2020-02-18).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+U.S.+FDA+Grants+Fast+Track%0ADesignation+to+Astellas+for+the+Development%0Aof+ASP1128+for+Patients+at+Risk+for+Acute+Kidney+Injury%3B+Astellas+Pharma%2C+2019%3B+https%3A%2F%2Fwww.astellas.com%2Fen%2Fnews%2F15376+%28accessed+2020-02-18%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DU.S.%2520FDA%2520Grants%2520Fast%2520Track%250ADesignation%2520to%2520Astellas%2520for%2520the%2520Development%250Aof%2520ASP1128%2520for%2520Patients%2520at%2520Risk%2520for%2520Acute%2520Kidney%2520Injury%26pub%3DAstellas%2520Pharma%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span> <i>Reneo Pharmaceuticals</i>; <span class="NLM_publisher-name">Reneo Pharmaceuticals</span>: <span class="NLM_publisher-loc">San Diego,
CA</span>, <span class="NLM_year">2020</span><a href="https://reneopharma.com/#news" class="extLink">https://reneopharma.com/#news</a> (accessed 2020-02-15).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Reneo+Pharmaceuticals%3B+Reneo+Pharmaceuticals%3A+San+Diego%2C%0ACA%2C+2020https%3A%2F%2Freneopharma.com%2F%23news+%28accessed+2020-02-15%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DReneo%2520Pharmaceuticals%26pub%3DReneo%2520Pharmaceuticals%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sprecher, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlstein, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobe, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. G.</span></span> <span> </span><span class="NLM_article-title">Triglyceride: High-density Lipoprotein Cholesterol Effects in Healthy Subjects Administered a Peroxisome Proliferator-activated Receptor δ Agonist</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1161/01.ATV.0000252790.70572.0c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1161%2F01.ATV.0000252790.70572.0c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=17110604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=359-365&author=D.+L.+Sprecherauthor=C.+Massienauthor=G.+Pearceauthor=A.+N.+Billinauthor=I.+Perlsteinauthor=T.+M.+Willsonauthor=D.+G.+Hassallauthor=N.+Ancellinauthor=S.+D.+Pattersonauthor=D.+C.+Lobeauthor=T.+G.+Johnson&title=Triglyceride%3A+High-density+Lipoprotein+Cholesterol+Effects+in+Healthy+Subjects+Administered+a+Peroxisome+Proliferator-activated+Receptor+%CE%B4+Agonist&doi=10.1161%2F01.ATV.0000252790.70572.0c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist</span></div><div class="casAuthors">Sprecher, Dennis L.; Massien, Christine; Pearce, Greg; Billin, Andrew N.; Perlstein, Itay; Willson, Timothy M.; Hassall, David G.; Ancellin, Nicolas; Patterson, Scott D.; Lobe, David C.; Johnson, Tony G.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-365</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Exercise increases fatty acid oxidn. (FAO), improves blood serum high d. lipoprotein cholesterol (HDLc) and triglycerides (TG), and upregulates skeletal muscle peroxisome proliferator activated receptor (PPAR)δ expression.  In parallel, PPARδ agonist-upregulated FAO would induce fatty-acid uptake (via peripheral lipolysis), and influence HDLc and TG-rich lipoprotein particle metab., as suggested in preclin. models.  Healthy volunteers were allocated placebo (n = 6) or PPARδ agonist (GW501516) at 2.5 mg (n = 9) or 10 mg (n = 9), orally, once-daily for 2 wk while hospitalized and sedentary.  Std. lipid/lipoproteins were measured and in vivo fat feeding studies were conducted.  Human skeletal muscle cells were treated with GW501516 in vitro and evaluated for lipid-related gene expression and FAO.  Serum TG trended downwards (10 mg), whereas TG clearance post fat-feeding improved with drug.  HDLc was enhanced in both treatment groups when compared with the decrease in the placebo group (-11.5%).  These findings complimented in vitro cell culture results whereby GW501516 induced FAO and upregulated CPT1 and CD36 expression, in addn. to a 2-fold increase in ABCA1.  However, LpL expression remained unchanged.  This is the 1st report of a PPARδ agonist administered to man.  In this small study, GW501516 significantly influenced HDLc and TGs in healthy volunteers.  Enhanced in vivo serum fat clearance, and the 1st demonstrated in vitro upregulation in human skeletal muscle fat utilization and ABCA1 expression, suggests peripheral fat utilization and lipidation as potential mechanisms toward these HDL:TG effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnNeplvjStLrVg90H21EOLACvtfcHk0lig0nRCZagK9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGruw%253D%253D&md5=7d280853bb767e5a0c9ac2f693c2f9d8</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000252790.70572.0c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000252790.70572.0c%26sid%3Dliteratum%253Aachs%26aulast%3DSprecher%26aufirst%3DD.%2BL.%26aulast%3DMassien%26aufirst%3DC.%26aulast%3DPearce%26aufirst%3DG.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DPerlstein%26aufirst%3DI.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DHassall%26aufirst%3DD.%2BG.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DPatterson%26aufirst%3DS.%2BD.%26aulast%3DLobe%26aufirst%3DD.%2BC.%26aulast%3DJohnson%26aufirst%3DT.%2BG.%26atitle%3DTriglyceride%253A%2520High-density%2520Lipoprotein%2520Cholesterol%2520Effects%2520in%2520Healthy%2520Subjects%2520Administered%2520a%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520%25CE%25B4%2520Agonist%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D359%26epage%3D365%26doi%3D10.1161%2F01.ATV.0000252790.70572.0c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phua, W. W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. S.</span></span> <span> </span><span class="NLM_article-title">An Apparent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-activated Receptors</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1425</span>, <span class="refDoi"> DOI: 10.3390/ijms19051425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms19051425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOrur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1425&author=W.+W.+T.+Phuaauthor=M.+X.+Y.+Wongauthor=Z.+Liaoauthor=N.+S.+Tan&title=An+Apparent+Functional+Consequence+in+Skeletal+Muscle+Physiology+via+Peroxisome+Proliferator-activated+Receptors&doi=10.3390%2Fijms19051425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">An aPPARent functional consequence in skeletal muscle physiology via peroxisome proliferator-activated receptors</span></div><div class="casAuthors">Phua, Wendy Wen Ting; Wong, Melissa Xin Yu; Liao, Zehuan; Tan, Nguan Soon</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1425/1-1425/28</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Skeletal muscle comprises 30-40% of the total body mass and plays a central role in energy homeostasis in the body.  The deregulation of energy homeostasis is a common underlying characteristic of metabolic syndrome.  Over the past decades, peroxisome proliferator-activated receptors (PPARs) have been shown to play crit. regulatory roles in skeletal muscle.  The three family members of PPAR have overlapping roles that contribute to the myriad of processes in skeletal muscle.  This review aims to provide an overview of the functions of different PPAR members in energy homeostasis as well as during skeletal muscle metabolic disorders, with a particular focus on human and relevant mouse model studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIXfJemW9_87Vg90H21EOLACvtfcHk0liGupsbfKr8Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOrur3N&md5=c7d0d3825d386effd22af5437f542a8d</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.3390%2Fijms19051425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19051425%26sid%3Dliteratum%253Aachs%26aulast%3DPhua%26aufirst%3DW.%2BW.%2BT.%26aulast%3DWong%26aufirst%3DM.%2BX.%2BY.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DN.%2BS.%26atitle%3DAn%2520Apparent%2520Functional%2520Consequence%2520in%2520Skeletal%2520Muscle%2520Physiology%2520via%2520Peroxisome%2520Proliferator-activated%2520Receptors%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D1425%26doi%3D10.3390%2Fijms19051425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span> <span> </span><span class="NLM_article-title">The Opportunities and Challenges of Peroxisome Proliferator-activated Receptors Ligands in Clinical Drug Discovery and Development</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2189</span>, <span class="refDoi"> DOI: 10.3390/ijms19082189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms19082189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC1MXns1Squ7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=2189&author=F.+Hongauthor=P.+Xuauthor=Y.+Zhai&title=The+Opportunities+and+Challenges+of+Peroxisome+Proliferator-activated+Receptors+Ligands+in+Clinical+Drug+Discovery+and+Development&doi=10.3390%2Fijms19082189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">The opportunities and challenges of peroxisome proliferator-activated receptors ligands in clinical drug discovery and development</span></div><div class="casAuthors">Hong, Fan; Xu, Pengfei; Zhai, Yonggong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2189/1-2189/29</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are a well-known pharmacol. target for the treatment of multiple diseases, including diabetes mellitus, dyslipidemia, cardiovascular diseases and even primary biliary cholangitis, gout, cancer, Alzheimer's disease and ulcerative colitis.  The three PPAR isoforms (α, β/δ and γ) have emerged as integrators of glucose and lipid metabolic signaling networks.  Typically, PPARα is activated by fibrates, which are commonly used therapeutic agents in the treatment of dyslipidemia.  The pharmacol. activators of PPARγ include thiazolidinediones (TZDs), which are insulin sensitizers used in the treatment of type 2 diabetes mellitus (T2DM), despite some drawbacks.  In this review, we summarize 84 types of PPAR synthetic ligands introduced to date for the treatment of metabolic and other diseases and provide a comprehensive anal. of the current applications and problems of these ligands in clin. drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQYYZAyS4sWLVg90H21EOLACvtfcHk0liGupsbfKr8Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXns1Squ7s%253D&md5=70fb7d69d601b20cd2ba0ddcf290b1c5</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.3390%2Fijms19082189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19082189%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DZhai%26aufirst%3DY.%26atitle%3DThe%2520Opportunities%2520and%2520Challenges%2520of%2520Peroxisome%2520Proliferator-activated%2520Receptors%2520Ligands%2520in%2520Clinical%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D2189%26doi%3D10.3390%2Fijms19082189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadayyon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopst, M.</span></span> <span> </span><span class="NLM_article-title">Minireview: Challenges and Opportunities in Development of PPAR Agonists</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1756</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1210/me.2013-1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.1210%2Fme.2013-1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=25148456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFamtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1756-1768&author=M.+B.+Wrightauthor=M.+Bortoliniauthor=M.+Tadayyonauthor=M.+Bopst&title=Minireview%3A+Challenges+and+Opportunities+in+Development+of+PPAR+Agonists&doi=10.1210%2Fme.2013-1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Minireview: challenges and opportunities in development of PPAR agonists</span></div><div class="casAuthors">Wright, Matthew B.; Bortolini, Michele; Tadayyon, Moh; Bopst, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1756-1768, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">1944-9917</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The clin. impact of the fibrate and thiazolidinedione drugs on dyslipidemia and diabetes is driven mainly through activation of two transcription factors, peroxisome proliferator-activated receptors (PPAR)-α and PPAR-γ.  However, substantial differences exist in the therapeutic and side-effect profiles of specific drugs.  This has been attributed primarily to the complexity of drug-target complexes that involve many coregulatory proteins in the context of specific target gene promoters.  Recent data have revealed that some PPAR ligands interact with other non-PPAR targets.  Here we review concepts used to develop new agents that preferentially modulate transcriptional complex assembly, target more than one PPAR receptor simultaneously, or act as partial agonists.  We highlight newly described on-target mechanisms of PPAR regulation including phosphorylation and nongenomic regulation.  We briefly describe the recently discovered non-PPAR protein targets of thiazolidinediones, mitoNEET, and mTOT.  Finally, we summarize the contributions of on- and off-target actions to select therapeutic and side effects of PPAR ligands including insulin sensitivity, cardiovascular actions, inflammation, and carcinogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgR2Bsq_zCDbVg90H21EOLACvtfcHk0liGupsbfKr8Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFamtbY%253D&md5=9f52aab240185e1adf107feb7aa520a7</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1210%2Fme.2013-1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2013-1427%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%2BB.%26aulast%3DBortolini%26aufirst%3DM.%26aulast%3DTadayyon%26aufirst%3DM.%26aulast%3DBopst%26aufirst%3DM.%26atitle%3DMinireview%253A%2520Challenges%2520and%2520Opportunities%2520in%2520Development%2520of%2520PPAR%2520Agonists%26jtitle%3DMol.%2520Endocrinol.%26date%3D2014%26volume%3D28%26spage%3D1756%26epage%3D1768%26doi%3D10.1210%2Fme.2013-1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marvalim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N. S.</span></span> <span> </span><span class="NLM_article-title">Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5055</span>, <span class="refDoi"> DOI: 10.3390/ijms20205055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=10.3390%2Fijms20205055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovF2hu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=5055&author=H.+S.+Chengauthor=W.+R.+Tanauthor=Z.+S.+Lowauthor=C.+Marvalimauthor=J.+Y.+H.+Leeauthor=N.+S.+Tan&title=Exploration+and+Development+of+PPAR+Modulators+in+Health+and+Disease%3A+An+Update+of+Clinical+Evidence&doi=10.3390%2Fijms20205055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration and development of ppar modulators in health and disease: an update of clinical evidence</span></div><div class="casAuthors">Cheng, Hong Sheng; Tan, Wei Ren; Low, Zun Siong; Marvalim, Charlie; Lee, Justin Yin Hao; Tan, Nguan Soon</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5055</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that govern the expression of genes responsible for energy metab., cellular development, and differentiation.  Their crucial biol. roles dictate the significance of PPAR-targeting synthetic ligands in medical research and drug discovery.  Clin. implications of PPAR agonists span across a wide range of health conditions, including metabolic diseases, chronic inflammatory diseases, infections, autoimmune diseases, neurol. and psychiatric disorders, and malignancies.  In this review we aim to consolidate existing clin. evidence of PPAR modulators, highlighting their clin. prospects and challenges.  Findings from clin. trials revealed that different agonists of the same PPAR subtype could present different safety profiles and clin. outcomes in a disease-dependent manner.  Pemafibrate, due to its high selectivity, is likely to replace other PPARα agonists for dyslipidemia and cardiovascular diseases.  PPARγ agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases.  The clin. niche of PPARβ/δ agonists is less well-explored.  Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alc. fatty liver disease, and primary biliary cholangitis.  Notably, the preclin. and clin. development for PPAR antagonists remains unacceptably deficient.  We anticipate the future design of better PPAR modulators with minimal off-target effects, high selectivity, superior bioavailability, and pharmacokinetics.  This will open new possibilities for PPAR ligands in medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWxCo23vO_P7Vg90H21EOLACvtfcHk0lgrsbNr30zxUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovF2hu78%253D&md5=bdaac9397063a458ec0427b4a59c3b68</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.3390%2Fijms20205055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20205055%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%2BS.%26aulast%3DTan%26aufirst%3DW.%2BR.%26aulast%3DLow%26aufirst%3DZ.%2BS.%26aulast%3DMarvalim%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DJ.%2BY.%2BH.%26aulast%3DTan%26aufirst%3DN.%2BS.%26atitle%3DExploration%2520and%2520Development%2520of%2520PPAR%2520Modulators%2520in%2520Health%2520and%2520Disease%253A%2520An%2520Update%2520of%2520Clinical%2520Evidence%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D5055%26doi%3D10.3390%2Fijms20205055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GWX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GWX','PDB','1GWX'); return false;">PDB: 1GWX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TKM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TKM','PDB','3TKM'); return false;">PDB: 3TKM</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01882&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01882%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01882" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0ff1e0e4bd952","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
